<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Infant formulas containing hydrolysed protein for prevention of allergic disease - Osborn, DA - 2018 | Cochrane Library</title> <meta content="Infant formulas containing hydrolysed protein for prevention of allergic disease - Osborn, DA - 2018 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003664.pub6/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Infant formulas containing hydrolysed protein for prevention of allergic disease - Osborn, DA - 2018 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003664.pub6/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD003664.pub6" name="dc.identifier" scheme="DOI"/> <meta content="Infant formulas containing hydrolysed protein for prevention of allergic disease" name="citation_title"/> <meta content="David A Osborn" name="citation_author"/> <meta content="Central Clinical School, School of Medicine, The University of Sydney" name="citation_author_institution"/> <meta content="John KH Sinn" name="citation_author"/> <meta content="Royal North Shore Hospital, The University of Sydney" name="citation_author_institution"/> <meta content="john.sinn@sydney.edu.au" name="citation_author_email"/> <meta content="Lisa J Jones" name="citation_author"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="10" name="citation_issue"/> <meta content="10.1002/14651858.CD003664.pub6" name="citation_doi"/> <meta content="2018" name="citation_date"/> <meta content="2018/10/19" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003664.pub6/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003664.pub6/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003664.pub6/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Dietary Proteins; Asthma [epidemiology]; Breast Feeding; Dermatitis, Atopic [epidemiology]; Food Hypersensitivity [*prevention &amp; control]; Infant Formula [*chemistry]; Milk; Milk Hypersensitivity [prevention &amp; control]; Milk, Human; Protein Hydrolysates [*administration &amp; dosage]; Randomized Controlled Trials as Topic" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003664.pub6&amp;doi=10.1002/14651858.CD003664.pub6&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003664.pub6&amp;doi=10.1002/14651858.CD003664.pub6&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003664.pub6&amp;doi=10.1002/14651858.CD003664.pub6&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003664.pub6&amp;doi=10.1002/14651858.CD003664.pub6&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003664.pub6&amp;doi=10.1002/14651858.CD003664.pub6&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003664.pub6&amp;doi=10.1002/14651858.CD003664.pub6&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003664.pub6&amp;doi=10.1002/14651858.CD003664.pub6&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003664.pub6&amp;doi=10.1002/14651858.CD003664.pub6&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003664.pub6&amp;doi=10.1002/14651858.CD003664.pub6&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003664.pub6&amp;doi=10.1002/14651858.CD003664.pub6&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003664.pub6&amp;doi=10.1002/14651858.CD003664.pub6&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003664.pub6&amp;doi=10.1002/14651858.CD003664.pub6&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003664.pub6&amp;doi=10.1002/14651858.CD003664.pub6&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003664.pub6&amp;doi=10.1002/14651858.CD003664.pub6&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003664.pub6&amp;doi=10.1002/14651858.CD003664.pub6&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003664.pub6&amp;doi=10.1002/14651858.CD003664.pub6&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003664.pub6&amp;doi=10.1002/14651858.CD003664.pub6&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003664.pub6&amp;doi=10.1002/14651858.CD003664.pub6&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003664.pub6&amp;doi=10.1002/14651858.CD003664.pub6&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003664.pub6&amp;doi=10.1002/14651858.CD003664.pub6&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003664.pub6&amp;doi=10.1002/14651858.CD003664.pub6&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003664.pub6&amp;doi=10.1002/14651858.CD003664.pub6&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003664.pub6&amp;doi=10.1002/14651858.CD003664.pub6&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774054000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774081000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000"}};Liferay.authToken="PMzGcYGP";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD003664\x2epub6\x26doi\x3d10\x2e1002\x2f14651858\x2eCD003664\x2epub6\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003664\x2epub6\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD003664\x2epub6\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1559916434000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","zh_HANS","zh_HANT","ru","ms","pl","fr","th","ja","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD003664.pub6",title:"Infant formulas containing hydrolysed protein for prevention of allergic disease",firstPublishedDate:"Oct 19, 2018 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Neonatal Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738735355000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=PMzGcYGP&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD003664.pub6&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD003664.pub6';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD003664.pub6/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD003664.pub6/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD003664.pub6%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD003664.PUB6" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;บทคัดย่อ&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Abstract&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Laienverständliche Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;ข้้อสรุปภาษาธรรมดา&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;Plain language summary&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD003664.pub6/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD003664.PUB6" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD003664.pub6/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD003664.pub6/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>12002 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD003664.pub6" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003664.pub6/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003664.pub6/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003664.pub6/full#CD003664-abs-0005"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003664.pub6/full#CD003664-sec-0138"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003664.pub6/full#CD003664-sec-0029"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003664.pub6/full#CD003664-sec-0030"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003664.pub6/full#CD003664-sec-0035"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003664.pub6/full#CD003664-sec-0036"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003664.pub6/full#CD003664-sec-0067"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003664.pub6/full#CD003664-sec-0127"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003664.pub6/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003664.pub6/appendices#CD003664-sec-0143"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003664.pub6/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003664.pub6/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/table_n/CD003664StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/table_n/CD003664StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003664.pub6/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003664.pub6/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003664.pub6/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD003664.pub6/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD003664.pub6/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD003664.pub6/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2018 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> <li aria-label="There has been an important change to the conclusions of the review." class="status-item up-to-date custom-tooltip" data-status="conclusionchanged" title="There has been an important change to the conclusions of the review."> <a class="btn secondary" href="information#history">Conclusions changed</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Infant formulas containing hydrolysed protein for prevention of allergic disease</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD003664.pub6/information#CD003664-cr-0002">David A Osborn</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD003664.pub6/information#CD003664-cr-0003"><i class="icon corresponding-author fa fa-envelope"></i>John KH Sinn</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD003664.pub6/information#CD003664-cr-0004">Lisa J Jones</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/information/en#CD003664-sec-0152">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 19 October 2018 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD003664.pub6">https://doi.org/10.1002/14651858.CD003664.pub6</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD003664-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD003664-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD003664-abs-0004">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD003664-abs-0017">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD003664-abs-0003">Français</a> </li> <li class="section-language"> <a class="" href="full/th#CD003664-abs-0014">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD003664-abs-0002">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD003664-abs-0001" lang="en"> <section id="CD003664-sec-0001"> <h3 class="title" id="CD003664-sec-0001">Background</h3> <p>Infant formulas containing hydrolysed proteins have been widely advocated for preventing allergic disease in infants, in place of standard cow’s milk formula (CMF). However, it is unclear whether the clinical trial evidence supports this. </p> </section> <section id="CD003664-sec-0002"> <h3 class="title" id="CD003664-sec-0002">Objectives</h3> <p>To compare effects on allergic disease when infants are fed a hydrolysed formula versus CMF or human breast milk. If hydrolysed formulas are effective, to determine what type of hydrolysed formula is most effective, including extensively or partially hydrolysed formula (EHF/PHF). To determine whether infants at low or high risk of allergic disease, and whether infants receiving early short‐term (first few days after birth) or prolonged formula feeding benefit from hydrolysed formulas. </p> </section> <section id="CD003664-sec-0003"> <h3 class="title" id="CD003664-sec-0003">Search methods</h3> <p>We searched the Cochrane Central Register of Controlled Trials (CENTRAL 2017, Issue 11), MEDLINE (1948 to 3 November 2017), and Embase (1974 to 3 November 2017). We also searched clinical trials databases, conference proceedings, and the reference lists of retrieved articles and previous reviews for randomised controlled trials and quasi‐randomised trials. </p> </section> <section id="CD003664-sec-0004"> <h3 class="title" id="CD003664-sec-0004">Selection criteria</h3> <p>We searched for randomised and quasi‐randomised trials that compared use of a hydrolysed formula versus human milk or CMF. Outcomes with ≥ 80% follow‐up of participants from eligible trials were eligible for inclusion. </p> </section> <section id="CD003664-sec-0005"> <h3 class="title" id="CD003664-sec-0005">Data collection and analysis</h3> <p>Two review authors independently selected trials, assessed trial quality and extracted data from the included studies. Fixed‐effect analyses were performed. The treatment effects were expressed as risk ratio (RR) and risk difference (RD) with 95% confidence intervals and quality of evidence using the GRADE quality of evidence approach. The primary outcome was all allergic disease (including asthma, atopic dermatitis, allergic rhinitis and food allergy). </p> </section> <section id="CD003664-sec-0006"> <h3 class="title" id="CD003664-sec-0006">Main results</h3> <p>A total of 16 studies were included.</p> <p>Two studies assessed the effect of three to four days infant supplementation with an EHF while in hospital after birth versus pasteurised human milk feed. A single study enrolling 90 infants reported no difference in all allergic disease (RR 1.43, 95% CI 0.38 to 5.37) or any specific allergic disease up to childhood including cow's milk allergy (CMA) (RR 7.11, 95% CI 0.35 to 143.84). A single study reported no difference in infant CMA (RR 0.87, 95% CI 0.52 to 1.46; participants = 3559). Quality of evidence was assessed as very low for all outcomes. </p> <p>No eligible trials compared prolonged hydrolysed formula versus human milk feeding.</p> <p>Two studies assessed the effect of three to four days infant supplementation with an EHF versus a CMF. A single study enrolling 90 infants reported no difference in all allergic disease (RR 1.37, 95% CI 0.33 to 5.71; participants = 77) or any specific allergic disease including CMA up to childhood. A single study reported a reduction in infant CMA of borderline significance (RR 0.62, 95% CI 0.38 to 1.00; participants = 3473). Quality of evidence was assessed as very low for all outcomes. </p> <p>Twelve studies assessed the effect of prolonged infant feeding with a hydrolysed formula compared with a CMF. The data showed no difference in all allergic disease in infants (typical RR 0.88, 95% CI 0.76 to 1.01; participants = 2852; studies = 8) and children (typical RR 0.85, 95% CI 0.69 to 1.05; participants = 950; studies = 2), and no difference in any specific allergic disease including infant asthma (typical RR 0.57, 95% CI 0.31 to 1.04; participants = 318; studies = 4), eczema (typical RR 0.93, 95% CI 0.79 to 1.09; participants = 2896; studies = 9), rhinitis (typical RR 0.52, 95% CI 0.14 to 1.85; participants = 256; studies = 3), food allergy (typical RR 1.42, 95% CI 0.87 to 2.33; participants = 479; studies = 2), and CMA (RR 2.31, 95% CI 0.24 to 21.97; participants = 338; studies = 1). Quality of evidence was assessed as very low for all outcomes. </p> </section> <section id="CD003664-sec-0007"> <h3 class="title" id="CD003664-sec-0007">Authors' conclusions</h3> <p>We found no evidence to support short‐term or prolonged feeding with a hydrolysed formula compared with exclusive breast feeding for prevention of allergic disease. Very low‐quality evidence indicates that short‐term use of an EHF compared with a CMF may prevent infant CMA. Further trials are recommended before implementation of this practice. </p> <p>We found no evidence to support prolonged feeding with a hydrolysed formula compared with a CMF for prevention of allergic disease in infants unable to be exclusively breast fed. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD003664-abs-0005" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD003664-abs-0005">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD003664-abs-0006">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD003664-abs-0013">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD003664-abs-0018">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD003664-abs-0012">Français</a> </li> <li class="section-language"> <a class="" href="full/ja#CD003664-abs-0016">日本語</a> </li> <li class="section-language"> <a class="" href="full/ms#CD003664-abs-0010">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pl#CD003664-abs-0011">Polski</a> </li> <li class="section-language"> <a class="" href="full/ru#CD003664-abs-0009">Русский</a> </li> <li class="section-language"> <a class="" href="full/th#CD003664-abs-0015">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD003664-abs-0007">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD003664-abs-0008">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD003664-abs-0005" lang="en"> <h3>Formulas containing hydrolysed protein for prevention of allergic disease in infants</h3> <p><b>Review question</b> </p> <p>Does feeding infants with a formula containing hydrolysed protein result in decreased risk of developing allergic disease such as asthma, dermatitis/eczema, hay fever and food allergy during infancy and childhood? </p> <p><b>Background</b> </p> <p>Allergic disease is responsible for a substantial health burden among infants, children and adults. Early dietary intake may influence the development of allergic disease. When babies are not exclusively breast fed, use of hydrolysed formula instead of ordinary cow's milk formula may reduce allergic disease among babies and children, although additional studies are needed to confirm this. Infant formulas have been designed to lower the chance of infants developing allergic disease. These include hydrolysed cow's milk and soy milk formulas. Hydrolysed formulas break down milk proteins into smaller, potentially less allergy‐producing proteins. </p> <p><b>Results</b> </p> <p>This review of trials found no evidence to support feeding with a hydrolysed formula to prevent allergic disease in preference to exclusive breast feeding. This review also found that for infants who are unable to be exclusively breast fed, there is no evidence that prolonged infant feeding with a hydrolysed formula compared with a cow's milk is associated with any difference in allergic disease, asthma, eczema, rhinitis, food allergy or cow's milk formula at any time point. However, limited data in infants who are exclusively formula fed suggest that feeding with a hydrolysed formula instead of a cow's milk formula may reduce infant allergic disease. Concerns regarding quality of the evidence and consistency of the results indicate that continued study is needed. The evidence in this review comes from literature searches updated until November 2017. </p> <p><b>Conclusions</b> </p> <p>We found no substantial evidence to support short‐term or prolonged feeding with a hydrolysed formula compared with a cow's milk formula for prevention of allergic disease in infants unable to be exclusively breast fed. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD003664-sec-0138" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD003664-sec-0138"></div> <h3 class="title" id="CD003664-sec-0139">Implications for practice</h3> <section id="CD003664-sec-0139"> <p>We found no evidence to support feeding with a hydrolysed formula compared with exclusive breast feeding for prevention of allergic disease. Until high‐quality trials compare prolonged hydrolysed formula feeding versus breast or expressed human milk feeding, hydrolysed formula should not be routinely offered to infants for prevention of allergic disease in preference to breast milk. </p> <p>We found no evidence of benefit from use of a hydrolysed formula in preference to human milk for early, short‐term feeding of low‐risk infants. When an infant requires a formula for short‐term feeding (e.g. three to four days in hospital), very low‐quality evidence indicates that use of an extensively hydrolysed formula (EHF) may prevent cow’s milk allergy (CMA). No included studies assessed the effect of short‐term feeding with a partially hydrolysed formula (PHF). On current evidence, a hydrolysed formula cannot be recommended for early short‐term feeding of infants unable to be exclusively breast fed. </p> <p>For infants (irrespective of risk of allergic disease) who cannot be exclusively breast fed, very low‐quality evidence suggests that prolonged feeding with a hydrolysed formula compared with a cow’s milk formula (CMF) was not associated with any differences in infant or childhood allergic disease, asthma, eczema or rhinitis, or infant food allergy or CMA. </p> </section> <h3 class="title" id="CD003664-sec-0140">Implications for research</h3> <section id="CD003664-sec-0140"> <p>Additional studies are needed to determine if infants benefit from short‐term feeding with a hydrolysed formula in hospital when human milk is unavailable for prevention of allergic disease and CMA. </p> <p>For infants unable to be exclusively breast fed, the quality of evidence for the effect of prolonged use of a hydrolysed formula versus a CMF for prevention of allergic disease or CMA was graded as very low. Although overall there were no significant effects found, subgroup analysis of infants exclusively formula fed found a reduction in infant allergic disease from use of a hydrolysed formula compared to a CMF. The analysis was limited to five trials reporting outcomes for 425 infants. An additional subgroup analysis of prolonged feeding with an extensively hydrolysed casein formula versus a CMF also found a reduction in childhood allergic disease incidence, and eczema incidence and prevalence, although the findings are limited to a single study (<a href="./references#CD003664-bbs2-0015" title="BergA , KramerU , LinkE , BollrathC , HeinrichJ , BrockowI , et al. GINIplus study group. Impact of early feeding on childhood eczema: development after nutritional intervention compared with the natural course ‐ the GINIplus study up to the age of 6 years. Clinical and Experimental Allergy2010;40(4):627‐36. [DOI: 10.1111/j.1365‐2222.2009.03444.x; PUBMED: 20082618] BrockowI , ZutavernA , HoffmannU , GrublA , vonBergA , KoletzkoS , et al. GINIplus Study Group. Early allergic sensitizations and their relevance to atopic diseases in children aged 6 years: results of the GINI study. Journal of Investigational Allergology &amp; Clinical Immunology2009;19(3):180‐7. [DOI: 19610260] LaubereauB , BrockowI , ZirngiblA , KoletzkoS , GrueblA , vonBergA , et al. GINI Study Group. Effect of breast‐feeding on the development of atopic dermatitis during the first 3 years of life ‐ results from the GINI‐birth cohort study. Journal of Pediatrics2004;144(5):602‐7. [DOI: 10.1016/j.jpeds.2003.12.029; PUBMED: 15126993] LaubereauB , Filipiak‐PittroffB , vonBergA , GrublA , ReinhardtD , WichmannHE , et al. Caesarean section and gastrointestinal symptoms, atopic dermatitis, and sensitisation during the first year of life. Archives of Disease in Childhood2004;89(11):993‐7. [DOI: 10.1136/adc.2003.043265; PUBMED: 15499049] RzehakP , SausenthalerS , KoletzkoS , BauerCP , SchaafB , vonBergA , et al. Period‐specific growth, overweight and modification by breastfeeding in the GINI and LISA birth cohorts up to age 6 years. European Journal of Epidemiology2009;24(8):449‐67. [DOI: 10.1007/s10654‐009‐9356‐5; PUBMED: 19521784] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. GINI‐plus Study Group. Long‐term effects of hydrolyzed protein infant formulas on growth ‐ extended follow‐up to 10 y of age: results from the German Infant Nutritional Intervention (GINI) study. American Journal of Clinical Nutrition2011;94(6 Suppl):1803S‐7S. [DOI: 10.3945/ajcn.110.000679; PUBMED: 21849601] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. German Infant Nutritional Intervention Study Group. Short‐ and long‐term effects of feeding hydrolyzed protein infant formulas on growth at &lt; or = 6 y of age: results from the German Infant Nutritional Intervention Study. American Journal of Clinical Nutrition2009;89(6):1846‐56. [DOI: 10.3945/ajcn.2008.27373; PUBMED: 19369380] SausenthalerS , KoletzkoS , KoletzkoB , ReinhardtD , KramerU , vonBergA , et al. GINIplus study group. Effect of hydrolysed formula feeding on taste preferences at 10 years. Data from the German Infant Nutritional Intervention Program Plus Study. Clinical Nutrition2010;29(3):304‐6. [DOI: 10.1016/j.clnu.2010.01.007; PUBMED: 20110140] SchoetzauA , Filipiak‐PittroffB , FrankeK , KoletzkoS , VonBergA , GrueblA , et al. German Infant Nutritional Intervention Study Group. Effect of exclusive breast‐feeding and early solid food avoidance on the incidence of atopic dermatitis in high‐risk infants at 1 year of age. Pediatric Allergy and Immunology2002;13(4):234‐42. [PUBMED: 12390439] SchoetzauA , GehringU , FrankeK , GrublA , KoletzkoS , vonBergA , et al. Gini Study Group. Maternal compliance with nutritional recommendations in an allergy preventive programme. Archives of Disease in Childhood2002;86(3):180‐4. [PUBMED: 11861235] VonBergA , Filipiak‐PittroffB , KrämerU , LinkE , HeinrichJ , KoletzkoS , et al. The German Infant Nutritional Intervention Study (GINI) for the preventive effect of hydrolysed infant formulas in infants at high risk for allergic diseases. Design and selected results. Allergologie2012;35(1):32‐43. VonBergA , Filipiak‐PittroffB , SchulzH , HoffmannU , LinkE , SussmannM , et al. GINIplus study group. Allergic manifestation 15 years after early intervention with hydrolyzed formulas ‐ the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2016;71(2):210‐9. [DOI: 10.1111/all.12790; PUBMED: 26465137] vonBergA , FilipiakB , KoletzkoS , KrämerU , HoffmannB , LinkE , et al. Long‐term effect of cow milk protein hydrolysates in high‐risk children. Results from the 10‐years follow‐up of the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2013;68:295‐6. vonBergA , Filipiak‐PittroffB , KramerU , HoffmannB , LinkE , BeckmannC , et al. GINIplus study group. Allergies in high‐risk schoolchildren after early intervention with cow's milk protein hydrolysates: 10‐year results from the German Infant Nutritional Intervention (GINI) study. Journal of Allergy and Clinical Immunology2013;131(6):1565‐73. [DOI: 10.1016/j.jaci.2013.01.006; PUBMED: 23506844] vonBergA , Filipiak‐PittroffB , KramerU , LinkE , BollrathC , BrockowI , et al. GINIplus study group. Preventive effect of hydrolyzed infant formulas persists until age 6 years: long‐term results from the German Infant Nutritional Intervention Study (GINI). Journal of Allergy and Clinical Immunology2008;121(6):1442‐7. [DOI: 10.1016/j.jaci.2008.04.021; PUBMED: 18539195] vonBergA , KoletzkoS , Filipiak‐PittroffB , LaubereauB , GrublA , WichmannHE , et al. German Infant Nutritional Intervention Study Group. Certain hydrolyzed formulas reduce the incidence of atopic dermatitis but not that of asthma: three‐year results of the German Infant Nutritional Intervention Study. Journal of Allergy and Clinical Immunology2007;119(3):718‐25. [DOI: 10.1016/j.jaci.2006.11.017; PUBMED: 17240440] vonBergA , KoletzkoS , GrublA , Filipiak‐PittroffB , WichmannHE , BauerCP , et al. German Infant Nutritional Intervention Study Group. The effect of hydrolyzed cow's milk formula for allergy prevention in the first year of life: the German Infant Nutritional Intervention Study, a randomized double‐blind trial. Journal of Allergy and Clinical Immunology2003;111(3):533‐40. [PUBMED: 12642834] ">von Berg 2003</a>). Further studies are needed to determine if infants derive benefit from using a hydrolysed formula for prolonged feeding when unable to be exclusively breast fed for prevention of allergic disease. Considerations in trial design include enrolling infants at high risk of allergic disease; stratifying patient allocation according to whether the infant receives exclusive or partial formula feeding; and the specific type of hydrolysed formula. Trials should perform intention‐to‐treat analyses by reporting all infants randomised in allocated group. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD003664-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD003664-sec-0029"></div> <div class="table" id="CD003664-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Early short‐term feeding: hydrolysed formula versus human milk feeding ‐ low‐risk infants for prevention of allergic disease</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Early short‐term feeding of hydrolysed formula versus human milk for prevention of allergic disease</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> infants not selected for allergic disease risk.<br/> <b>Settings:</b> hospitals.<br/> <b>Intervention:</b> early short‐term feeding: hydrolysed formula versus human milk feeding for prevention of allergic disease </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Number of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Early short‐term feeding: hydrolysed formula vs human milk ‐ low‐risk infants</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>All allergic disease ‐ childhood (incidence)</b><br/> Follow‐up: mean 3 years </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.43</b> <br/> (0.38 to 5.37) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>90<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>a,b,c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Quality of evidence downgraded due to risk of bias, imprecision and potential for reporting or publication bias. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>75 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>108 per 1000</b><br/> (29 to 405) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Asthma ‐ childhood (incidence)</b><br/> Follow‐up: mean 3 years </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.48</b> <br/> (0.05 to 4.41) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>90<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>a,b,c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Quality of evidence downgraded due to risk of bias, imprecision and potential for reporting or publication bias. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>57 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>27 per 1000</b><br/> (3 to 250) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Eczema ‐ childhood (incidence)</b><br/> Follow‐up: mean 3 years </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.48</b> <br/> (0.05 to 4.41) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>90<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>a,b,c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Quality of evidence downgraded due to risk of bias, imprecision and potential for reporting or publication bias. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>57 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>27 per 1000</b><br/> (3 to 250) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Food allergy ‐ childhood (incidence)</b><br/> Follow‐up: mean 3 years </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.43</b> <br/> (0.38 to 5.37) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>90<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>a,b,c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Quality of evidence downgraded due to risk of bias, imprecision and potential for reporting or publication bias. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>75 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>108 per 1000</b><br/> (29 to 405) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Cow's milk allergy ‐ infancy (incidence)</b><br/> Follow‐up: mean 27 months </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.87</b> <br/> (0.52 to 1.46) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>3559<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>c,d,e</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Quality of evidence downgraded due to risk of bias, imprecision and potential for reporting or publication bias. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>17 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>15 per 1000</b><br/> (9 to 25) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Cow's milk allergy ‐ childhood (incidence)</b><br/> Follow‐up: mean 3 years </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 7.11</b> <br/> (0.35 to 143.84) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>90<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>a,b,c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Quality of evidence downgraded due to risk of bias, imprecision and potential for reporting or publication bias. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>0 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>0 per 1000</b><br/> (0 to 0) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI)<br/> <b>CI:</b> confidence interval; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate<br/> <b>Very low quality:</b> We are very uncertain about the estimate </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Methodological concerns including quasi‐random sequence allocation, incomplete outcome data and imbalances at baseline<br/> <sup>b</sup>Imprecision of estimate ‐ single small study<br/> <sup>c</sup>Reported by only a single study<br/> <sup>d</sup>Methodological concerns including quasi‐random sequence allocation and incomplete outcome data<br/> <sup>e</sup>Impression of estimate ‐ low incidence of outcome </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD003664-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Early short‐term feeding: hydrolysed formula versus cow's milk formula ‐ low‐risk infants for prevention of allergic disease and food allergy</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Early short‐term feeding of hydrolysed formula versus cow's milk formula for prevention of allergic disease</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> infants not selected for allergic disease risk.<br/> <b>Settings:</b> hospitals.<br/> <b>Intervention:</b> early short‐term feeding of hydrolysed formula versus cow's milk formula for prevention of allergic disease </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Number of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Early short‐term feeding: hydrolysed formula vs cow's milk formula ‐ low‐risk infants</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>All allergic disease ‐ childhood (incidence)</b><br/> Follow‐up: mean 3 years </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.37</b> <br/> (0.33 to 5.71) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>77<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>a,b,c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Quality of evidence downgraded due to risk of bias, imprecision and potential for reporting or publication bias. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>77 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>105 per 1000</b><br/> (25 to 439) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Asthma ‐ childhood (incidence)</b><br/> Follow‐up: mean 3 years </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 3.08</b> <br/> (0.13 to 73.26) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>77<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>a,b,c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Quality of evidence downgraded due to risk of bias, imprecision and potential for reporting or publication bias. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>0 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>0 per 1000</b><br/> (0 to 0) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Eczema ‐ childhood (incidence)</b><br/> Follow‐up: mean 3 years </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.34</b> <br/> (0.04 to 3.15) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>77<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>a,b,c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Quality of evidence downgraded due to risk of bias, imprecision and potential for reporting or publication bias. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>77 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>26 per 1000</b><br/> (3 to 242) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Food allergy ‐ childhood (incidence)</b><br/> Follow‐up: mean 3 years </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.37</b> <br/> (0.33 to 5.71) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>77<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>a,b,c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Quality of evidence downgraded due to risk of bias, imprecision and potential for reporting or publication bias. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>77 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>105 per 1000</b><br/> (25 to 439) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Cow's milk allergy ‐ infancy (incidence)</b><br/> Follow‐up: mean 3 years </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.62</b> <br/> (0.38 to 1) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>3473<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>a,c,d</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Quality of evidence downgraded due to risk of bias, imprecision and potential for reporting or publication bias. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>24 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>15 per 1000</b><br/> (9 to 24) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Cow's milk allergy ‐ childhood (incidence)</b><br/> Follow‐up: mean 3 years </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 5.13</b> <br/> (0.25 to 103.43) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>77<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>a,b,c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Quality of evidence downgraded due to risk of bias, imprecision and potential for reporting or publication bias. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>0 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>0 per 1000</b><br/> (0 to 0) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI)<br/> <b>CI:</b> confidence interval; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate<br/> <b>Very low quality:</b> We are very uncertain about the estimate </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Methodological concerns including quasi‐random sequence allocation, incomplete outcome data and imbalances at baseline<br/> <sup>b</sup>Imprecision of estimate ‐ single small study<br/> <sup>c</sup>Reported only by a single study<br/> <sup>d</sup>Imprecision of estimate ‐ low incidence of outcome </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD003664-tbl-0003"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Prolonged feeding: hydrolysed formula versus cow's milk formula for prevention of allergic disease</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Prolonged feeding: hydrolysed formula versus cow's milk formula for prevention of allergic disease</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> infants.<br/> <b>Settings:</b> home.<br/> <b>Intervention:</b> prolonged feeding of hydrolysed formula versus cow's milk formula for prevention of allergic disease </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Prolonged feeding: hydrolysed formula versus cow's milk formula</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>All allergic disease ‐ Infancy (incidence)</b><br/> Follow‐up: 2 years </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.88</b> <br/> (0.76 to 1.01) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2852<br/> (8 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,2,3,4,5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Quality of evidence downgraded due to risk of bias, imprecision and risk of reporting or publication bias. </p> <p>Subgroup analyses found no differences in: low‐risk or high‐risk infants; infants fed a partially hydrolysed formula versus cow's milk formula; infants fed extensively hydrolysed formula versus cow's milk formula; or infants fed partially versus extensively hydrolysed formula. </p> <p>A reduction in infant allergy was found in subgroup analysis of studies that enrolled infants receiving prolonged exclusive formula feeding (typical RR 0.61, 95% CI 0.46 to 0.80; participants = 425; studies = 5; I<sup>2</sup> = 0%). </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>274 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>241 per 1000</b><br/> (208 to 277) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>All allergic disease ‐ Childhood (incidence)</b><br/> Follow‐up: 3 years </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.85</b> <br/> (0.69 to 1.05) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>950<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,2,3,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Quality of evidence downgraded due to risk of bias, imprecision and risk of reporting or publication bias. </p> <p>Subgroup analyses found no differences in: high‐risk infants; infants fed a partially hydrolysed formula versus cow's milk formula; infants fed extensively hydrolysed formula versus cow's milk formula; or infants fed partially versus extensively hydrolysed formula. </p> <p>A single small study that enrolled infants receiving prolonged exclusive formula feeding reported a reduction in childhood allergy incidence (RR 0.42, 95% CI 0.19 to 0.90; participants = 78). </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>353 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>300 per 1000</b><br/> (244 to 371) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Asthma ‐ Infancy (incidence)</b><br/> Follow‐up: 2 years </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.57</b> <br/> (0.31 to 1.04) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>318<br/> (4 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,3,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Quality of evidence downgraded due to risk of bias, imprecision and risk of reporting or publication bias. </p> <p>Subgroup analyses found no differences in: high‐risk infants; infants fed a partially hydrolysed formula versus cow's milk formula; infants fed extensively hydrolysed formula versus cow's milk formula; infants fed partially versus extensively hydrolysed formula; or infants receiving prolonged exclusive formula feeding. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>175 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>100 per 1000</b><br/> (54 to 182) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Eczema ‐ Infancy (incidence)</b><br/> Follow‐up: 2 years </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.93</b> <br/> (0.79 to 1.09) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2896<br/> (9 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,3,4,5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Quality of evidence downgraded due to risk of bias, imprecision and risk of reporting or publication bias. </p> <p>Subgroup analyses found no differences in: high‐risk infants; infants fed a partially hydrolysed formula versus cow's milk formula; infants fed extensively hydrolysed formula versus cow's milk formula; infants fed partially versus extensively hydrolysed formula; or infants receiving prolonged exclusive formula feeding. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>202 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>187 per 1000</b><br/> (159 to 220) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Rhinitis ‐ Infancy (incidence)</b><br/> Follow‐up: 2 years </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.52</b> <br/> (0.14 to 1.85) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>256<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,3,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Quality of evidence downgraded due to risk of bias, imprecision and risk of reporting or publication bias. </p> <p>Subgroup analyses found no differences in: high‐risk infants; infants fed extensively hydrolysed formula versus cow's milk formula; infants fed partially versus extensively hydrolysed formula; or infants receiving prolonged exclusive formula feeding. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>58 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>30 per 1000</b><br/> (8 to 107) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Food allergy ‐ Infancy (incidence)</b><br/> Follow‐up: 2 years </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.42</b> <br/> (0.87 to 2.33) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>479<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,3,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Quality of evidence downgraded due to risk of bias, imprecision and risk of reporting or publication bias. </p> <p>Subgroup analyses found no differences in: high‐risk infants; infants fed a partially hydrolysed formula versus cow's milk formula; infants fed extensively hydrolysed formula versus cow's milk formula; or infants fed partially versus extensively hydrolysed formula. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>109 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>155 per 1000</b><br/> (95 to 254) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Cow's milk allergy ‐ Infancy (incidence)</b><br/> Follow‐up: 2 years </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 2.31</b> <br/> (0.24 to 21.97) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>338<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>3,6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Quality of evidence downgraded due to risk of bias, imprecision and risk of reporting or publication bias. </p> <p>Subgroup analyses found no differences in: high‐risk infants; or infants fed a partially hydrolysed formula versus cow's milk formula. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>7 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>16 per 1000</b><br/> (2 to 149) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Majority of studies had substantial methodological concerns.<br/> <sup>2</sup> Moderate heterogeneity between studies found.<br/> <sup>3</sup> Wide confidence intervals.<br/> <sup>4</sup> Substantial number of studies did not report outcome. <br/> <sup>5</sup> Funnel plot appears asymmetric.<br/> <sup>6</sup> Reported by a single study. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD003664-sec-0030" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD003664-sec-0030"></div> <section id="CD003664-sec-0031"> <h3 class="title" id="CD003664-sec-0031">Description of the condition</h3> <p>Food allergy and other allergic disease are prevalent and represent a substantial health problem that may be increasing in developed countries (<a href="./references#CD003664-bbs2-0118" title="BurrML , ButlandBK , KingS , Vaughan‐WilliamsE . Changes in asthma prevalence: two surveys 15 years apart. Archives of Disease in Childhood1989;64(10):1452‐6. [PUBMED: 2817930] ">Burr 1989</a>; <a href="./references#CD003664-bbs2-0127" title="HalkenS . Prevention of allergic disease in childhood: clinical and epidemiological aspects of primary and secondary allergy prevention. Pediatric Allergy and Immunology2004;15(Suppl 16):4‐5. [DOI: 10.1111/j.1399‐3038.2004.0148b.x; PUBMED: 15125698] ">Halken 2004</a>; <a href="./references#CD003664-bbs2-0149" title="PrescottSL , TangML , Australasian Society of Clinical Immunology and Allergy. The Australasian Society of Clinical Immunology and Allergy position statement: Summary of allergy prevention in children. Medical Journal of Australia2005;182(9):464‐7. [PUBMED: 15865590] ">Prescott 2005</a>; <a href="./references#CD003664-bbs2-0156" title="Schultz LarsenF . Atopic dermatitis: an increasing problem. Pediatric Allergy and Immunology1996;7(9 Suppl):51‐3. [PUBMED: 9156729] ">Schultz Larsen 1996</a>). Although less than half of those who develop childhood allergic disease have a first‐degree relative with a history of allergic disease, the risk of allergic disease increases substantially with a positive family history (<a href="./references#CD003664-bbs2-0113" title="BergmannRL , BergmannKE , Lau‐SchadensdorfS , LuckW , DannemannA , BauerCP , et al. Atopic diseases in infancy. The German multicenter atopy study (MAS‐90). Pediatric Allergy and Immunology1994;5(6 Suppl):19‐25. [PUBMED: 7728224] ">Bergmann 1994</a>; <a href="./references#CD003664-bbs2-0158" title="SearsMR , HoldawayMD , FlanneryEM , HerbisonGP , SilvaPA . Parental and neonatal risk factors for atopy, airway hyper‐responsiveness, and asthma. Archives of Disease in Childhood1996;75(5):392‐8. [PUBMED: 8957951] ">Sears 1996</a>; <a href="./references#CD003664-bbs2-0093" title="TariqSM , MatthewsSM , HakimEA , StevensM , ArshadSH , HideDW . The prevalence of and risk factors for atopy in early childhood: a whole population birth cohort study. Journal of Allergy and Clinical Immunology1998;101(5):587‐93. [DOI: 10.1016/S0091‐6749(98)70164‐2; PUBMED: 9600493] ">Tariq 1998</a>). Approximately 10% of children without an allergic first‐degree relative develop allergic disease compared with 20% to 30% with an allergic first‐degree relative (parent or sibling) and 40% to 50% with two affected relatives (<a href="./references#CD003664-bbs2-0112" title="ArshadSH , KurukulaaratchyRJ , FennM , MatthewsS . Early life risk factors for current wheeze, asthma, and bronchial hyperresponsiveness at 10 years of age. Chest2005;127(2):502‐8. [DOI: 10.1378/chest.127.2.502; PUBMED: 15705988] ">Arshad 2005</a>; <a href="./references#CD003664-bbs2-0114" title="BergmannRL , EdenharterG , BergmannKE , Guggenmoos‐HolzmannI , ForsterJ , BauerCP , et al. Predictability of early atopy by cord blood‐IgE and parental history. Clinical and Experimental Allergy1997;27(7):752‐60. [PUBMED: 9249267] ">Bergmann 1997</a>; <a href="./references#CD003664-bbs2-0128" title="HansenLG , HalkenS , HostA , MollerK , OsterballeO . Prediction of allergy from family history and cord blood IgE levels. A follow‐up at the age of 5 years. Cord blood IgE. IV. Pediatric Allergy and Immunology1993;4(1):34‐40. [PUBMED: 8348254] ">Hansen 1993</a>; <a href="./references#CD003664-bbs2-0139" title="KjellmanNI . Atopic disease in seven‐year‐old children. Incidence in relation to family history. Acta Paediatrica Scandinavica1997;66(4):465‐71. [PUBMED: 899762] ">Kjellman 1977</a>). The predictive value of family history is increased with the addition of cord blood immunoglobulin (Ig) E antibody testing, although its accuracy may not be adequate for population screening (<a href="./references#CD003664-bbs2-0114" title="BergmannRL , EdenharterG , BergmannKE , Guggenmoos‐HolzmannI , ForsterJ , BauerCP , et al. Predictability of early atopy by cord blood‐IgE and parental history. Clinical and Experimental Allergy1997;27(7):752‐60. [PUBMED: 9249267] ">Bergmann 1997</a>; <a href="./references#CD003664-bbs2-0115" title="BergmannR , WoodcockA . Whole population or high‐risk group? Childhood asthma. European Respiratory Journal. Supplement1998;27:9S‐12S. [PUBMED: 9699777] ">Bergmann 1998</a>; <a href="./references#CD003664-bbs2-0093" title="TariqSM , MatthewsSM , HakimEA , StevensM , ArshadSH , HideDW . The prevalence of and risk factors for atopy in early childhood: a whole population birth cohort study. Journal of Allergy and Clinical Immunology1998;101(5):587‐93. [DOI: 10.1016/S0091‐6749(98)70164‐2; PUBMED: 9600493] ">Tariq 1998</a>). </p> <p>Manifestations of allergic disease are age dependent. Infants commonly present with symptoms and signs of atopic eczema, gastrointestinal symptoms and recurrent wheezing. Asthma and rhino conjunctivitis become prevalent in later childhood. Sensitisation to allergens tends to follow a characteristic pattern (<a href="./references#CD003664-bbs2-0127" title="HalkenS . Prevention of allergic disease in childhood: clinical and epidemiological aspects of primary and secondary allergy prevention. Pediatric Allergy and Immunology2004;15(Suppl 16):4‐5. [DOI: 10.1111/j.1399‐3038.2004.0148b.x; PUBMED: 15125698] ">Halken 2004</a>), with sensitisation to food allergens in the first two to three years of life, followed by indoor allergens (e.g. house dust mite, pets) and subsequently outdoor allergens (e.g. rye, timothy grass). The cumulative prevalence of allergic disease during childhood is high, with up to 7% to 8% developing a food allergy, 15% to 20% atopic eczema and 31% to 34% asthma or recurrent wheezing (<a href="./references#CD003664-bbs2-0127" title="HalkenS . Prevention of allergic disease in childhood: clinical and epidemiological aspects of primary and secondary allergy prevention. Pediatric Allergy and Immunology2004;15(Suppl 16):4‐5. [DOI: 10.1111/j.1399‐3038.2004.0148b.x; PUBMED: 15125698] ">Halken 2004</a>). Of these, 7% to 10% will continue to have asthma symptoms beyond five years of age (<a href="./references#CD003664-bbs2-0127" title="HalkenS . Prevention of allergic disease in childhood: clinical and epidemiological aspects of primary and secondary allergy prevention. Pediatric Allergy and Immunology2004;15(Suppl 16):4‐5. [DOI: 10.1111/j.1399‐3038.2004.0148b.x; PUBMED: 15125698] ">Halken 2004</a>). Food hypersensitivities affect approximately 6% of infants younger than three years, and prevalence decreases over the first decade (<a href="./references#CD003664-bbs2-0146" title="OsterballeM , HansenTK , MortzCG , HostA , Bindslev‐JensenC . The prevalence of food hypersensitivity in an unselected population of children and adults. Pediatric Allergy and Immunology2005;16(7):567‐73. [DOI: 10.1111/j.1399‐3038.2005.00251.x; PUBMED: 16238581] ">Osterballe 2005</a>; <a href="./references#CD003664-bbs2-0155" title="SampsonHA . Update on food allergy. Journal of Allergy and Clinical Immunology2004;113(5):805‐19. [DOI: 10.1016/j.jaci.2004.03.014; PUBMED: 15131561] ">Sampson 2004</a>). </p> <p>Allergic disease may be diagnosed by questionnaire or clinician assessment, and the diagnosis may be confirmed by specific skin or serological testing, or by allergen challenge. Diagnostic criteria for different allergic diseases are not uniform, and the mode of ascertainment of allergic disease is variable. Although tests of bronchial hyper‐responsiveness, challenge tests and classical tests of IgE‐mediated allergy have an imperfect correlation with allergy symptoms and clinical signs (<a href="./references#CD003664-bbs2-0123" title="DarsowU , RingJ . Airborne and dietary allergens in atopic eczema: a comprehensive review of diagnostic tests. Clinical and Experimental Dermatology2000;25(7):544‐51. [PUBMED: 11122226] ">Darsow 2000</a>; <a href="./references#CD003664-bbs2-0147" title="PeatJK , ToelleBG , MellisCM . Problems and possibilities in understanding the natural history of asthma. Journal of Allergy and Clinical Immunology2000;106(3 Suppl):S144‐52. [PUBMED: 10984395] ">Peat 2000</a>), they are associated with an increased likelihood of allergic disease (<a href="./references#CD003664-bbs2-0152" title="RonmarkE , JonssonE , Platts‐MillsT , LundbackB . Incidence and remission of asthma in schoolchildren: report from the obstructive lung disease in northern Sweden studies. Pediatrics2001;107(3):E37. [PUBMED: 11230618] ">Ronmark 2001</a>; <a href="./references#CD003664-bbs2-0159" title="SearsMR . Evolution of asthma through childhood. Clinical &amp; Experimental Allergy1998;28(Suppl 5):82‐91. [PUBMED: 9988452] ">Sears 1998</a>; <a href="./references#CD003664-bbs2-0160" title="SlyRM . Changing prevalence of allergic rhinitis and asthma. Annals of Allergy, Asthma and Immunology1999;82(3):233‐48. [DOI: 10.1016/S1081‐1206(10)62603‐8; PUBMED: 10094214] ">Sly 1999</a>; <a href="./references#CD003664-bbs2-0161" title="StrachanDP , ButlandBK , AndersonHR . Incidence and prognosis of asthma and wheezing illness from early childhood to age 33 in a national British cohort. BMJ1996;312(7040):1195‐9. [PUBMED: 8634562] ">Strachan 1996</a>). In addition, some evidence suggests that questionnaires, although compromised by selection and recall bias (<a href="./references#CD003664-bbs2-0148" title="PeatJK , ToelleBG , MarksGB , MellisCM . Continuing the debate about measuring asthma in population studies. Thorax2001;56(5):406‐11. [PUBMED: 11312411] ">Peat 2001</a>), are suitable for allergic disease screening (<a href="./references#CD003664-bbs2-0138" title="KilpeläinenM , TerhoEO , HeleniusH , KoskenvuoM . Validation of a new questionnaire on asthma, allergic rhinitis, and conjunctivitis in young adults. Allergy2001;56(5):377‐84. [PUBMED: 11350300] ">Kilpeläinen 2001</a>; <a href="./references#CD003664-bbs2-0150" title="RavaultC , KauffmannF . Validity of the IUATLD (1986) questionnaire in the EGEA study. International Union Against Tuberculosis and Lung Disease. Epidemiological study on the genetics and environment of asthma, bronchial hyperresponsiveness and atopy. Journal of Tuberculosis and Lung Disease2001;5(2):191‐6. [PUBMED: 11258514] ">Ravault 2001</a>). This review includes trials that diagnosed allergic disease by questionnaire or by clinician assessment, with or without confirmation by laboratory testing. Criteria for diagnosis of allergic disease should include typical symptoms and/or signs, with evidence of precipitants, persistence or recurrence typical of allergic disease, or with test evidence confirming atopy or bronchial hyperreactivity. </p> <p>The World Allergy Organization 2003 consensus (<a href="./references#CD003664-bbs2-0135" title="JohanssonSG , BieberT , DahlR , FriedmannPS , LanierBQ , LockeyRF , et al. Revised nomenclature for allergy for global use. Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. Journal of Allergy and Clinical Immunology2004;113(5):832‐6. [DOI: 10.1016/j.jaci.2003.12.591; PUBMED: 15131563] ">Johansson 2004</a>) recommended that the term 'hypersensitivity' should be used to describe objectively reproducible symptoms or signs initiated by exposure to a defined stimulus at a dose tolerated by normal persons. 'Allergy' is a hypersensitivity reaction initiated by specific immunological mechanisms. The term 'food allergy' is used when immunological mechanisms have been demonstrated. Food‐specific IgG antibodies in serum are not of clinical importance but merely indicate previous exposure to a specific food. If IgE is involved in the reaction, the term 'IgE‐mediated food allergy' is appropriate. Food hypersensitivity is diagnosed by resolution of typical symptoms with elimination from the diet, with confirmation by blinded challenge. Around 2% to 3% of babies develop hypersensitivity to a particular food. Principal symptoms among infants with proven cow's milk protein hypersensitivity (CMPH) are gastrointestinal (˜ 50%), dermatological (˜ 31%) and respiratory (˜ 19%) in nature (<a href="./references#CD003664-bbs2-0131" title="HøstA . Cow's milk protein allergy and intolerance in infancy. Some clinical, epidemiological and immunological aspects. Pediatric Allergy and Immunology1994;5(5 Suppl):1‐36. ">Høst 1994</a>; <a href="./references#CD003664-bbs2-0132" title="HøstA , JacobsenHP , HalkenS , HolmenlundD . The natural history of cow's milk protein allergy/intolerance. European Journal of Clinical Nutrition1995;49(Suppl 1):S13‐8. [PUBMED: 8647059] ">Høst 1995</a>; <a href="./references#CD003664-bbs2-0086" title="SchranderJJ , van denBogartJP , ForgetPP , Schrander‐StumpelCT , KuijtenRH , KesterAD . Cow's milk protein intolerance in infants under 1 year of age: a prospective epidemiological study. European Journal of Pediatrics1993;152(8):640‐4. [PUBMED: 8404966] ">Schrander 1993</a>). Two of every three infants with CMPH have a family history of atopy (<a href="./references#CD003664-bbs2-0086" title="SchranderJJ , van denBogartJP , ForgetPP , Schrander‐StumpelCT , KuijtenRH , KesterAD . Cow's milk protein intolerance in infants under 1 year of age: a prospective epidemiological study. European Journal of Pediatrics1993;152(8):640‐4. [PUBMED: 8404966] ">Schrander 1993</a>). CMPH is strongly associated with feeding of cow's milk formula (CMF) to infants during the first month of life (<a href="./references#CD003664-bbs2-0051" title="HøstA . Importance of the first meal on the development of cow's milk allergy and intolerance. Allergy Proceedings1991;12(4):227‐32. [PUBMED: 1936970] ">Høst 1991</a>). Many infants with CMPH become tolerant over time, with approximately 30% at one year, 50% at two years and 70% at three years tolerant to cow's milk challenge. The risk of persisting hypersensitivity is increased with evidence of atopy (<a href="./references#CD003664-bbs2-0132" title="HøstA , JacobsenHP , HalkenS , HolmenlundD . The natural history of cow's milk protein allergy/intolerance. European Journal of Clinical Nutrition1995;49(Suppl 1):S13‐8. [PUBMED: 8647059] ">Høst 1995</a>). </p> </section> <section id="CD003664-sec-0032"> <h3 class="title" id="CD003664-sec-0032">Description of the intervention</h3> <p>Measures to prevent allergic disease including food allergy have included maternal allergen avoidance during pregnancy (<a href="./references#CD003664-bbs2-0121" title="CustovicA , SimpsonBM , SimpsonA , HallamC , CravenM , BrutscheM , et al. Manchester Asthma and Allergy Study: low‐allergen environment can be achieved and maintained during pregnancy and in early life. Journal of Allergy and Clinical Immunology2000;105(2 Pt 1):252‐8. [PUBMED: 10669844] ">Custovic 2000</a>; <a href="./references#CD003664-bbs2-0122" title="CustovicA , SimpsonBM , SimpsonA , KissenP , WoodcockA . NAC Manchester Asthma and Allergy Study Group. Effect of environmental manipulation in pregnancy and early life on respiratory symptoms and atopy during first year of life: a randomised trial. Lancet2001;358(9277):188‐93. [DOI: 10.1016/S0140‐6736(01)05406‐X; PUBMED: 11476835] ">Custovic 2001</a>; <a href="./references#CD003664-bbs2-0141" title="KramerMS , KakumaR . Maternal dietary antigen avoidance during pregnancy or lactation, or both, for preventing or treating atopic disease in the child. Cochrane Database of Systematic Reviews2012, Issue 9. [DOI: 10.1002/14651858.CD000133.pub3] ">Kramer 2012</a>; <a href="./references#CD003664-bbs2-0102" title="ZeigerRS , HellerS . Development of nasal basophilic cells and nasal eosinophils from age 4 months through 4 years in children of atopic parents. Journal of Allergy and Clinical Immunology1993;91(3):723‐34. [PUBMED: 8454794] ZeigerRS , HellerS . The development and prediction of atopy in high‐risk children: follow‐up at age seven years in a prospective randomized study of combined maternal and infant food allergen avoidance. Journal of Allergy and Clinical Immunology1995;95(6):1179‐90. [PUBMED: 7797786] ZeigerRS , HellerS , MellonMH , ForsytheAB , O'ConnorRD , HamburgerRN , et al. Effect of combined maternal and infant food‐allergen avoidance on development of atopy in early infancy: a randomized study. Journal of Allergy and Clinical Immunology1989;84:72‐89. ZeigerRS , HellerS , MellonMH , HalseyJF , HamburgerRN , SampsonHA . Genetic and environmental factors affecting the development of atopy through age 4 in children of atopic parents: a prospective randomized study of food allergen avoidance. Pediatric Allergy and Immunology1992;3(3):110‐27. ">Zeiger 1989</a>) and/or lactation (<a href="./references#CD003664-bbs2-0121" title="CustovicA , SimpsonBM , SimpsonA , HallamC , CravenM , BrutscheM , et al. Manchester Asthma and Allergy Study: low‐allergen environment can be achieved and maintained during pregnancy and in early life. Journal of Allergy and Clinical Immunology2000;105(2 Pt 1):252‐8. [PUBMED: 10669844] ">Custovic 2000</a>; <a href="./references#CD003664-bbs2-0122" title="CustovicA , SimpsonBM , SimpsonA , KissenP , WoodcockA . NAC Manchester Asthma and Allergy Study Group. Effect of environmental manipulation in pregnancy and early life on respiratory symptoms and atopy during first year of life: a randomised trial. Lancet2001;358(9277):188‐93. [DOI: 10.1016/S0140‐6736(01)05406‐X; PUBMED: 11476835] ">Custovic 2001</a>; <a href="./references#CD003664-bbs2-0102" title="ZeigerRS , HellerS . Development of nasal basophilic cells and nasal eosinophils from age 4 months through 4 years in children of atopic parents. Journal of Allergy and Clinical Immunology1993;91(3):723‐34. [PUBMED: 8454794] ZeigerRS , HellerS . The development and prediction of atopy in high‐risk children: follow‐up at age seven years in a prospective randomized study of combined maternal and infant food allergen avoidance. Journal of Allergy and Clinical Immunology1995;95(6):1179‐90. [PUBMED: 7797786] ZeigerRS , HellerS , MellonMH , ForsytheAB , O'ConnorRD , HamburgerRN , et al. Effect of combined maternal and infant food‐allergen avoidance on development of atopy in early infancy: a randomized study. Journal of Allergy and Clinical Immunology1989;84:72‐89. ZeigerRS , HellerS , MellonMH , HalseyJF , HamburgerRN , SampsonHA . Genetic and environmental factors affecting the development of atopy through age 4 in children of atopic parents: a prospective randomized study of food allergen avoidance. Pediatric Allergy and Immunology1992;3(3):110‐27. ">Zeiger 1989</a>), periods of exclusive breast feeding (<a href="./references#CD003664-bbs2-0121" title="CustovicA , SimpsonBM , SimpsonA , HallamC , CravenM , BrutscheM , et al. Manchester Asthma and Allergy Study: low‐allergen environment can be achieved and maintained during pregnancy and in early life. Journal of Allergy and Clinical Immunology2000;105(2 Pt 1):252‐8. [PUBMED: 10669844] ">Custovic 2000</a>; <a href="./references#CD003664-bbs2-0122" title="CustovicA , SimpsonBM , SimpsonA , KissenP , WoodcockA . NAC Manchester Asthma and Allergy Study Group. Effect of environmental manipulation in pregnancy and early life on respiratory symptoms and atopy during first year of life: a randomised trial. Lancet2001;358(9277):188‐93. [DOI: 10.1016/S0140‐6736(01)05406‐X; PUBMED: 11476835] ">Custovic 2001</a>; <a href="./references#CD003664-bbs2-0126" title="GruskayFL . Comparison of breast, cow, and soy feedings in the prevention of onset of allergic disease: a 15‐year prospective study. Clinical Pediatrics1982;21(8):486‐91. [DOI: 10.1177/000992288202100807; PUBMED: 7200847] ">Gruskay 1982</a>; <a href="./references#CD003664-bbs2-0145" title="OddyWH , HoltPG , SlyPD , ReadAW , LandauLI , StanleyFJ , et al. Association between breast feeding and asthma in 6 year old children: findings of a prospective birth cohort study. BMJ1999;319(7213):815‐9. [PUBMED: 10496824] ">Oddy 1999</a>; <a href="./references#CD003664-bbs2-0153" title="SaarinenUM , KajosaariM . Breastfeeding as prophylaxis against atopic disease: prospective follow‐up study until 17 years old. Lancet1995;346(8982):1065‐9. [PUBMED: 7564787] ">Saarinen 1995</a>; <a href="./references#CD003664-bbs2-0154" title="SaarinenKM , SavilahtiE . Infant feeding patterns affect the subsequent immunological features in cow's milk allergy. Clinical &amp; Experimental Allergy2000;30(3):400‐6. [PUBMED: 10691899] ">Saarinen 2000</a>), and avoidance of potential allergens including food and environmental antigens during the first year of life and beyond (<a href="./references#CD003664-bbs2-0121" title="CustovicA , SimpsonBM , SimpsonA , HallamC , CravenM , BrutscheM , et al. Manchester Asthma and Allergy Study: low‐allergen environment can be achieved and maintained during pregnancy and in early life. Journal of Allergy and Clinical Immunology2000;105(2 Pt 1):252‐8. [PUBMED: 10669844] ">Custovic 2000</a>). Formulas prescribed for infants with the intention of preventing allergic disease including food allergy include hydrolysed cow's milk and elemental formula, as well as soy or hydrolysed soy formula. These formulas may be produced from cow's milk or soy milk, may be derived predominantly from whey or casein proteins and may be partially or extensively hydrolysed. Protein modification is performed through a variety of physiochemical processes including ultra heating and enzymatic cleavage, most often with trypsin and chymotrypsin. </p> <p>The American Academy of Pediatrics (AAP) recommends that hypoallergenic formulas should be tested in trials in which investigators examine human infants for toxicity and suitability to maintain a positive nitrogen balance, while attempting to predict whether infants allergic to cow’s milk will react adversely to these formulas (<a href="./references#CD003664-bbs2-0109" title="Americal Academy of Pediatrics: Committee on Nutrition. Hypoallergenic infant formulas. Pediatrics2000;106(2 Pt 1):346‐9. [PUBMED: 10920165] ">AAP 2000</a>). These formulas are studied in infants with cow’s milk or cow’s milk‐based formula allergic reactions verified by double‐blind placebo‐controlled challenge (DBPCC) (<a href="./references#CD003664-bbs2-0116" title="BockSA , SampsonHA , AtkinsFM , ZeigerRS , LehrerS , SachsM , et al. Double‐blind, placebo‐controlled food challenge (DBPCFC) as an office procedure: a manual. Journal of Allergy and Clinical Immunology1988;82(6):986‐97. [PUBMED: 3060514] ">Bock 1988</a>). At a minimum, these tests should ensure with 95% confidence that 90% of infants with documented cow’s milk allergy respond to treatment and do not react during challenge (<a href="./references#CD003664-bbs2-0140" title="KleinmanRE , BahnaS , PowellGF , SampsonHA . Use of infant formulas in infants with cow milk allergy. A review and recommendations. Pediatric Allergy and Immunology1991;2(4):146‐55. ">Kleinman 1991</a>). Protein particle size does not appear to be a prerequisite for defining a formula as hypoallergenic, although amino acid‐based formulas and those with more extensive hydrolysis are less likely to produce reactions among infants with cow's milk allergy (CMA) (<a href="./references#CD003664-bbs2-0130" title="HillDJ , MurchSH , RaffertyK , WallisP , GreenCJ . The efficacy of amino acid‐based formulas in relieving the symptoms of cow's milk allergy: a systematic review. Clinical and Experimental Allergy2007;37(6):808‐22. [DOI: 10.1111/j.1365‐2222.2007.02724.x; PUBMED: 17517094] ">Hill 2007</a>). Although universal agreement has not been reached on the definition (<a href="./references#CD003664-bbs2-0119" title="ChafenJJ , NewberrySJ , RiedlMA , BravataDM , MaglioneM , SuttorpMJ , et al. Diagnosing and managing common food allergies: a systematic review. JAMA2010;303(18):1848‐56. [DOI: 10.1001/jama.2010.582; PUBMED: 20460624] ">Chaffen 2010</a>; <a href="./references#CD003664-bbs2-0133" title="HøstA , KoletzkoB , DreborgS , MuraroA , WahnU , AggettP , et al. Dietary products used in infants for treatment and prevention of food allergy. Joint Statement of the European Society for Paediatric Allergology and Clinical Immunology (ESPACI) Committee on Hypoallergenic Formulas and the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) Committee on Nutrition. Archives of Disease in Childhood1999;81(1):80‐4. [PUBMED: 10373144] ">Høst 1999</a>), for the purposes of this review an extensively hydrolysed formula (EHF) will be regarded as one meeting the AAP definition for hypoallergenic formula (<a href="./references#CD003664-bbs2-0109" title="Americal Academy of Pediatrics: Committee on Nutrition. Hypoallergenic infant formulas. Pediatrics2000;106(2 Pt 1):346‐9. [PUBMED: 10920165] ">AAP 2000</a>), and those with less extensive hydrolysis will be regarded as partially hydrolysed. </p> </section> <section id="CD003664-sec-0033"> <h3 class="title" id="CD003664-sec-0033">How the intervention might work</h3> <p>Infants' immune systems become sensitised or tolerant to allergens in the order in which they are exposed. Early life exposure to allergens occurs frequently through ingested protein, particularly cow's milk protein in formula (<a href="./references#CD003664-bbs2-0143" title="MuraroA , DreborgS , HalkenS , HostA , NiggemannB , AalberseR , et al. Dietary prevention of allergic diseases in infants and small children. Part II. Evaluation of methods in allergy prevention studies and sensitization markers. Definitions and diagnostic criteria of allergic diseases. Pediatric Allergy and Immunology2004;15(3):196‐205. [DOI: 10.1111/j.1399‐3038.2004.00128.x; PUBMED: 15209950] ">Muraro 2004</a>). Amino acid‐based and extensively hydrolysed protein formulas are produced so as to substantially reduce the antigenicity of the protein and prevent sensitisation of infants to commonly ingested antigens, including cow's milk protein. However, low concentrations of food allergens, especially cow's milk proteins, are present in human milk. It has been suggested that the low incidence of cow's milk protein allergy among exclusively breast fed infants ‐ at 0.5% in unselected infants and 1.3% in high‐risk infants ‐ in prospective birth cohort studies was due to low‐level exposure‐induced tolerance rather than to disease (<a href="./references#CD003664-bbs2-0127" title="HalkenS . Prevention of allergic disease in childhood: clinical and epidemiological aspects of primary and secondary allergy prevention. Pediatric Allergy and Immunology2004;15(Suppl 16):4‐5. [DOI: 10.1111/j.1399‐3038.2004.0148b.x; PUBMED: 15125698] ">Halken 2004</a>). It has been proposed that prolonged exposure to allergenic proteins or to proteins with reduced but not absent allergenicity may induce tolerance over time (<a href="./references#CD003664-bbs2-0111" title="AllenCW , CampbellDE , KempAS . Food allergy: is strict avoidance the only answer?. Pediatric Allergy and Immunology2009;20(5):415‐22. [DOI: 10.1111/j.1399‐3038.2008.00811.x; PUBMED: 18798797] ">Allen 2009</a>). Although most infants with cow’s milk hypersensitivity exhibit this in the first year of life, more than 80% subsequently develop clinical tolerance (<a href="./references#CD003664-bbs2-0137" title="KatzY , GoldbergMR , RajuanN , CohenA , LeshnoM . The prevalence and natural course of food protein‐induced enterocolitis syndrome to cow's milk: a large‐scale, prospective population‐based study. Journal of Allergy and Clinical Immunology2011;127(3):647‐53 e1‐3. [DOI: 10.1016/j.jaci.2010.12.1105; PUBMED: 21377033] ">Katz 2011</a>; <a href="./references#CD003664-bbs2-0155" title="SampsonHA . Update on food allergy. Journal of Allergy and Clinical Immunology2004;113(5):805‐19. [DOI: 10.1016/j.jaci.2004.03.014; PUBMED: 15131561] ">Sampson 2004</a>). The concern is that early avoidance of cow's milk protein may reduce the likelihood that infants will subsequently develop tolerance to the allergen (<a href="./references#CD003664-bbs2-0136" title="KatzY , RajuanN , GoldbergMR , EisenbergE , HeymanE , CohenA , et al. Early exposure to cow's milk protein is protective against IgE‐mediated cow's milk protein allergy. Journal of Allergy and Clinical Immunology2010;126(1):77‐82 e1. [DOI: 10.1016/j.jaci.2010.04.020; PUBMED: 20541249] ">Katz 2010</a>). </p> </section> <section id="CD003664-sec-0034"> <h3 class="title" id="CD003664-sec-0034">Why it is important to do this review</h3> <p>The aim of this review is to gather evidence on the use of hydrolysed formulas for prevention of allergic disease including food allergy. This review does not include treatment of infants with clinically recognised allergic disease. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD003664-sec-0035" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD003664-sec-0035"></div> <p>To compare effects on allergic disease including food allergy when infants are fed a hydrolysed formula versus cow's milk formula (CMF) or human breast milk. If hydrolysed formulas are effective, to determine what type of hydrolysed formula is most effective, including extensively or partially hydrolysed formula (EHF/PHF). To determine which infants at low or high risk of allergic disease and which infants receiving early, short‐term or prolonged formula feeding may benefit from hydrolysed formulas. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD003664-sec-0036" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD003664-sec-0036"></div> <section id="CD003664-sec-0037"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD003664-sec-0038"> <h4 class="title">Types of studies</h4> <p>We searched for randomised and quasi‐randomised trials that compared the use of a hydrolysed formula versus human milk or cow's milk formula (CMF). Randomised and quasi‐randomised (e.g. using alternation) trials with ≥ 80% follow‐up of participants were eligible for inclusion. </p> </section> <section id="CD003664-sec-0039"> <h4 class="title">Types of participants</h4> <p>Infants in the first six months of life without clinical evidence of allergic disease.</p> </section> <section id="CD003664-sec-0040"> <h4 class="title">Types of interventions</h4> <p>Hydrolysed formulas included:</p> <p> <ul id="CD003664-list-0001"> <li> <p>hydrolysed cow's milk and soy formulas; and</p> </li> <li> <p>extensively and partially hydrolysed formulas (EHF/PHF).</p> </li> </ul> </p> <p>Hydrolysed formulas may be used for:</p> <p> <ul id="CD003664-list-0002"> <li> <p>early, short‐term supplementary or sole formula feeding of infants unable to be exclusively breast fed in the first days of life; </p> </li> <li> <p>prolonged supplementation of breast fed infants or infants fed solely with formula in the first months of life; and </p> </li> <li> <p>weaning from the breast with infant formula.</p> </li> </ul> </p> <p>The control group may include infants who receive:</p> <p> <ul id="CD003664-list-0003"> <li> <p>exclusive human milk (breast fed or expressed); and</p> </li> <li> <p>cow's milk formula (CMF).</p> </li> </ul> </p> <p>Study authors had to pre specify the following comparisons.</p> <p> <ul id="CD003664-list-0004"> <li> <p>Early short‐term hydrolysed formula versus human milk.</p> </li> <li> <p>Prolonged use of a hydrolysed formula versus human milk.</p> </li> <li> <p>Early short‐term hydrolysed formula versus CMF.</p> </li> <li> <p>Prolonged use of a hydrolysed formula versus CMF.</p> </li> </ul> </p> <p>Prespecified subgroup analyses included the following (see <a href="#CD003664-sec-0065">Subgroup analysis and investigation of heterogeneity</a> for definitions). </p> <p> <ul id="CD003664-list-0005"> <li> <p>Infant risk of allergic disease.</p> </li> </ul> <ul class="plain" id="CD003664-list-0006"> <li> <ul id="CD003664-list-0007"> <li> <p>Low‐risk infants (no family history of allergic disease among first‐degree relatives).</p> </li> <li> <p>High‐risk infants (family history of allergic disease among first‐degree relatives or high cord IgE level). </p> </li> </ul> </li> </ul> <ul id="CD003664-list-0008"> <li> <p>Extent of protein hydrolysis.</p> </li> </ul> <ul class="plain" id="CD003664-list-0009"> <li> <ul id="CD003664-list-0010"> <li> <p>EHF versus CMF.</p> </li> <li> <p>PHF versus CMF.</p> </li> <li> <p>EHF versus PHF.</p> </li> </ul> </li> </ul> <ul id="CD003664-list-0011"> <li> <p>Indication for use.</p> </li> </ul> <ul class="plain" id="CD003664-list-0012"> <li> <ul id="CD003664-list-0013"> <li> <p>Prolonged sole formula feeding.</p> </li> <li> <p>Supplemental feeding or weaning from the breast using infant formula.</p> </li> </ul> </li> </ul> <ul id="CD003664-list-0014"> <li> <p>Method of ascertainment of allergic disease.</p> </li> </ul> <ul class="plain" id="CD003664-list-0015"> <li> <ul id="CD003664-list-0016"> <li> <p>Allergic disease confirmed by test.</p> </li> <li> <p>Blinded measurement for allergic disease.</p> </li> </ul> </li> </ul> <ul id="CD003664-list-0017"> <li> <p>Type of protein hydrolysate used.</p> </li> </ul> <ul class="plain" id="CD003664-list-0018"> <li> <ul id="CD003664-list-0019"> <li> <p>Partially hydrolysed whey formula versus cow's milk formula.</p> </li> <li> <p>Partially hydrolysed casein formula versus cow's milk formula.</p> </li> <li> <p>Extensively hydrolysed whey formula versus cow's milk formula.</p> </li> <li> <p>Extensively hydrolysed casein formula versus cow's milk formula.</p> </li> <li> <p>Hydrolysed soy formula versus cow's milk formula.</p> </li> </ul> </li> </ul> </p> <p>We excluded studies that included other allergy prevention interventions (e.g. maternal dietary avoidance measures, environmental allergy reduction measures) in the treatment group and not in the control group. Studies that provided other allergy prevention interventions for both treatment and control groups were eligible. </p> </section> <section id="CD003664-sec-0041"> <h4 class="title">Types of outcome measures</h4> <section id="CD003664-sec-0042"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD003664-list-0020"> <li> <p>All allergic diseases, including asthma, atopic dermatitis, allergic rhinitis and food allergy </p> </li> </ul> </p> </section> <section id="CD003664-sec-0043"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD003664-list-0021"> <li> <p>Asthma</p> </li> <li> <p>Atopic dermatitis/eczema</p> </li> <li> <p>Allergic rhinitis</p> </li> <li> <p>Cow's milk or soy protein allergy</p> </li> <li> <p>Food allergy</p> </li> <li> <p>Urticaria</p> </li> <li> <p>Anaphylaxis</p> </li> </ul> </p> <p>In the 2017 review update, we no longer reported previously reported food hypersensitivity and potential harms, including growth parameters, cost and infant feed refusal. Definitions of allergic disease must be compatible with the World Allergy Organization 2003 consensus (<a href="./references#CD003664-bbs2-0135" title="JohanssonSG , BieberT , DahlR , FriedmannPS , LanierBQ , LockeyRF , et al. Revised nomenclature for allergy for global use. Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. Journal of Allergy and Clinical Immunology2004;113(5):832‐6. [DOI: 10.1016/j.jaci.2003.12.591; PUBMED: 15131563] ">Johansson 2004</a>). </p> <p>Researchers may have diagnosed a specific allergic disease on the basis of:</p> <p> <ul id="CD003664-list-0022"> <li> <p>history of recurrent and persistent symptoms typical of the allergic disease;</p> </li> <li> <p>clinician diagnosis of allergic disease; or</p> </li> <li> <p>clinical allergy confirmed by testing including detection of allergen sensitisation by skin testing or by serological testing for specific IgE (e.g. radioallergosorbent (RAST), enzyme‐allergosorbent (EAST)), or asthma confirmed by respiratory function testing for the presence of bronchial hyper‐responsiveness confirmed by elimination/challenge. </p> </li> </ul> </p> <p>Investigators used the following definitions of age of allergic disease.</p> <p> <ul id="CD003664-list-0023"> <li> <p>Infant allergic disease incidence: allergic disease occurring up to two years of age.</p> </li> <li> <p>Childhood allergic disease incidence: allergic disease occurring up to 10 years of age (or up to age of latest report between two and 10 years). </p> </li> <li> <p>Childhood allergic disease prevalence: reported allergic disease that was present between two and 10 years of age. </p> </li> <li> <p>Adolescent allergic disease: allergic disease present from 10 to 18 years of age.</p> </li> <li> <p>Adult allergic disease: allergic disease present after 18 years of age.</p> </li> </ul> </p> </section> </section> </section> <section id="CD003664-sec-0044"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD003664-sec-0045"> <h4 class="title">Electronic searches</h4> <p>We conducted a comprehensive search including: Cochrane Central Register of Controlled Trials (CENTRAL 2017, Issue 11) in the Cochrane Library; MEDLINE (1948 to 3 November 2017) and Embase (1974 to 3 November 2017). We also searched citations of authors of included studies and citation lists of articles and reviews. We did not apply language restrictions.<br/> <br/> We searched clinical trials registries for ongoing or recently completed trials (clinicaltrials.gov; the World Health Organization’s International Trials Registry and Platform www.whoint/ictrp/search/en/, and the ISRCTN Registry). </p> <p>We documented the search strategies in <a href="./appendices#CD003664-sec-0144">Appendix 1,</a><a href="./appendices#CD003664-sec-0145">Appendix 2</a>, and <a href="./appendices#CD003664-sec-0146">Appendix 3</a>. </p> </section> <section id="CD003664-sec-0046"> <h4 class="title">Searching other resources</h4> <p>We performed a search of previous reviews including cross references (all articles referenced), abstracts, conferences (Paediatric Academic Societies 2003 to 2016; Perinatal Society of Australia and New Zealand 2003 to 2017), recent review citations and expert informants. </p> <p>We also updated in November 2017 our search of clinical trials registries for ongoing or recently completed trials (<a href="http://clinicaltrials.gov/" target="_blank">clinicaltrials.gov</a>; <a href="http://controlled-trials.com/" target="_blank">controlled‐trials.com</a>; <a href="http://www.who.int/ictrp/en/" target="_blank">who.int/ictrp</a>). Search strategies are detailed in <a href="./appendices#CD003664-sec-0147">Appendix 4</a> and <a href="./appendices#CD003664-sec-0148">Appendix 5</a>. </p> </section> </section> <section id="CD003664-sec-0047"> <h3 class="title" id="CD003664-sec-0047">Data collection and analysis</h3> <p>This review updates previous versions (<a href="./references#CD003664-bbs2-0163" title="OsbornDA , SinnJK . Formulas containing hydrolysed protein for prevention of allergy and food intolerance in infants. Cochrane Database of Systematic Reviews2003, Issue 3. [DOI: 10.1002/14651858.CD003664] ">Osborn 2003</a>; <a href="./references#CD003664-bbs2-0164" title="OsbornDA , SinnJK . Formulas containing hydrolysed protein for prevention of allergy and food intolerance in infants. Cochrane Database of Systematic Reviews2006, Issue 2. [DOI: 10.1002/14651858.CD003664.pub2] ">Osborn 2006a</a>; <a href="./references#CD003664-bbs2-0165" title="OsbornDA , SinnJ . Formulas containing hydrolysed protein for prevention of allergy and food intolerance in infants. Cochrane Database of Systematic Reviews2006, Issue 4. [DOI: 10.1002/14651858.CD003664.pub3] ">Osborn 2006b</a>; <a href="./references#CD003664-bbs2-0166" title="OsbornDA , SinnJK , JonesLJ . Infant formulas containing hydrolysed protein for prevention of allergic disease and food allergy. Cochrane Database of Systematic Reviews2017, Issue 3. [DOI: 10.1002/14651858.CD003664.pub4] ">Osborn 2017a</a>; <a href="./references#CD003664-bbs2-0167" title="OsbornDA , SinnJK , JonesLJ . Infant formulas containing hydrolysed protein for prevention of allergic disease and food allergy. Cochrane Database of Systematic Reviews2017, Issue 5. [DOI: 10.1002/14651858.CD003664.pub5] ">Osborn 2017b</a>). </p> <p>Each review author independently assessed eligibility of studies for inclusion. We included only studies with ≥ 80% reporting of randomised infants. We used the criteria and standard methods of the Cochrane Neonatal Review Group to assess the methodological quality of included trials regarding adequacy of randomisation and allocation concealment, blinding of parents or caregivers and assessors to intervention and completeness of assessment of all randomised individuals. We used a data collection form to aid extraction of relevant information and data from each included study. Each review author extracted the data separately, and review authors compared data and resolved differences by consensus. We used the standard methods of the Cochrane Neonatal Review Group to synthesise the data and expressed effects as risk ratio (RR), risk difference (RD) with 95% confidence intervals (CIs) for categorical data, and planned to use mean difference (MD) and 95% CIs for continuous data. We used the Chi² test to examine data for heterogeneity, and we quantified heterogeneity using the I² statistic. We used the fixed‐effect model for meta‐analysis when enrolled infants and interventions were similar and no significant heterogeneity was found. We explored sources of heterogeneity by performing subgroup analysis. </p> <p>The term 'hydrolysed formula' used without a reference to type refers to both extensively and partially hydrolysed formulas (EHF/PHF). We did not pool studies that used hydrolysed formula for early (first few days of life) supplemental or sole infant feeding with studies that used hydrolysed formula for prolonged feeding. We performed all comparisons by including only studies with no different co‐interventions prescribed for prevention of allergic disease in either study arm (e.g. in treatment group but not in control group). Allergic disease‐preventing co‐interventions included modifications to mother's diet when pregnant or breast feeding and environmental modifications such as avoidance of pet hair and host dust mite reduction measures. The protocol did not originally pre specify that we should restrict analyses to studies with no differential co‐interventions. </p> <section id="CD003664-sec-0048"> <h4 class="title">Selection of studies</h4> <p>We included all randomised and quasi‐randomised controlled trials fulfilling the selection criteria described in the previous section. Each review author reviewed the search results and separately selected studies for inclusion. Review authors resolved disagreements by discussion. </p> </section> <section id="CD003664-sec-0049"> <h4 class="title">Data extraction and management</h4> <p>Each review author extracted the data separately. Review authors compared data and resolved differences by consensus. </p> <p>We obtained additional method details and data from the authors of two studies (<a href="./references#CD003664-bbs2-0004" title="HillD . A report on the analysis of the Melbourne Atopy Cohort Study. A study designed to test the effectiveness of different formula types on the development of atopic symptoms and signs on a cohort of atopy‐at‐risk infants. Report at year 2. Nestec Internal Report. HillDJ , SporikR , ThorburnJ , HoskingCS . The association of atopic dermatitis in infancy with immunoglobulin E food sensitization. Journal of Pediatrics2000;137(4):475‐9. [DOI: 10.1067/mpd.2000.108207; PUBMED: 11035824] KoplinJ , DharmageSC , GurrinL , OsborneN , TangML , LoweAJ , et al. Soy consumption is not a risk factor for peanut sensitization. Journal of Allergy and Clinical Immunology2008;121(6):1455‐9. [DOI: 10.1016/j.jaci.2008.03.017; PUBMED: 18436294] LoweA , HoskingC , BennettC , AllenK , CarlinJ , DharmageS , et al. The Melbourne Atopy Cohort Study: a RCT of a partially hydrolysed whey formula for the prevention of allergic disease. Internal Medicine Journal2008;38:A158. LoweAJ , AbramsonMJ , HoskingCS , CarlinJB , BennettCM , DharmageSC , et al. The temporal sequence of allergic sensitization and onset of infantile eczema. Clinical &amp; Experimental Allergy2007;37(4):536‐42; Erratum in: Clinical &amp; Experimental Allergy 2007; 37(12);1895. [DOI: 10.1111/j.1365‐2222.2007.02691.x; PUBMED: 17430350] LoweAJ , CarlinJB , BennettCM , HoskingCS , AllenKJ , RobertsonCF , et al. Paracetamol use in early life and asthma: prospective birth cohort study. BMJ2010;341:c4616. [PUBMED: 20843914] LoweAJ , HoskingCS , BennettCM , AllenKJ , AxelradC , CarlinJB , et al. Effect of a partially hydrolyzed whey infant formula at weaning on risk of allergic disease in high‐risk children: a randomized controlled trial. Journal of Allergy and Clinical Immunology2011;128(2):360‐5.e4. [DOI: 10.1016/j.jaci.2010.05.006; PUBMED: 21696814] StoneyRM , WoodsRK , HoskingCS , HillDJ , AbramsonMJ , ThienFC . Maternal breast milk long‐chain n‐3 fatty acids are associated with increased risk of atopy in breastfed infants. Clinical and Experimental Allergy2004;34(2):194‐200; Erratum in: Clinical &amp; Experimental Allergy 2007; 37(12);1895. [PUBMED: 14987297] ThomsonJA , WidjajaC , DarmaputraAA , LoweA , MathesonMC , BennettCM , et al. Early childhood infections and immunisation and the development of allergic disease in particular asthma in a high‐risk cohort: a prospective study of allergy‐prone children from birth to six years. Pediatric Allergy and Immunology2010;21(7):1076‐85. [DOI: 10.1111/j.1399‐3038.2010.01018.x; PUBMED: 20337970] ">Hill 2000</a>; <a href="./references#CD003664-bbs2-0015" title="BergA , KramerU , LinkE , BollrathC , HeinrichJ , BrockowI , et al. GINIplus study group. Impact of early feeding on childhood eczema: development after nutritional intervention compared with the natural course ‐ the GINIplus study up to the age of 6 years. Clinical and Experimental Allergy2010;40(4):627‐36. [DOI: 10.1111/j.1365‐2222.2009.03444.x; PUBMED: 20082618] BrockowI , ZutavernA , HoffmannU , GrublA , vonBergA , KoletzkoS , et al. GINIplus Study Group. Early allergic sensitizations and their relevance to atopic diseases in children aged 6 years: results of the GINI study. Journal of Investigational Allergology &amp; Clinical Immunology2009;19(3):180‐7. [DOI: 19610260] LaubereauB , BrockowI , ZirngiblA , KoletzkoS , GrueblA , vonBergA , et al. GINI Study Group. Effect of breast‐feeding on the development of atopic dermatitis during the first 3 years of life ‐ results from the GINI‐birth cohort study. Journal of Pediatrics2004;144(5):602‐7. [DOI: 10.1016/j.jpeds.2003.12.029; PUBMED: 15126993] LaubereauB , Filipiak‐PittroffB , vonBergA , GrublA , ReinhardtD , WichmannHE , et al. Caesarean section and gastrointestinal symptoms, atopic dermatitis, and sensitisation during the first year of life. Archives of Disease in Childhood2004;89(11):993‐7. [DOI: 10.1136/adc.2003.043265; PUBMED: 15499049] RzehakP , SausenthalerS , KoletzkoS , BauerCP , SchaafB , vonBergA , et al. Period‐specific growth, overweight and modification by breastfeeding in the GINI and LISA birth cohorts up to age 6 years. European Journal of Epidemiology2009;24(8):449‐67. [DOI: 10.1007/s10654‐009‐9356‐5; PUBMED: 19521784] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. GINI‐plus Study Group. Long‐term effects of hydrolyzed protein infant formulas on growth ‐ extended follow‐up to 10 y of age: results from the German Infant Nutritional Intervention (GINI) study. American Journal of Clinical Nutrition2011;94(6 Suppl):1803S‐7S. [DOI: 10.3945/ajcn.110.000679; PUBMED: 21849601] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. German Infant Nutritional Intervention Study Group. Short‐ and long‐term effects of feeding hydrolyzed protein infant formulas on growth at &lt; or = 6 y of age: results from the German Infant Nutritional Intervention Study. American Journal of Clinical Nutrition2009;89(6):1846‐56. [DOI: 10.3945/ajcn.2008.27373; PUBMED: 19369380] SausenthalerS , KoletzkoS , KoletzkoB , ReinhardtD , KramerU , vonBergA , et al. GINIplus study group. Effect of hydrolysed formula feeding on taste preferences at 10 years. Data from the German Infant Nutritional Intervention Program Plus Study. Clinical Nutrition2010;29(3):304‐6. [DOI: 10.1016/j.clnu.2010.01.007; PUBMED: 20110140] SchoetzauA , Filipiak‐PittroffB , FrankeK , KoletzkoS , VonBergA , GrueblA , et al. German Infant Nutritional Intervention Study Group. Effect of exclusive breast‐feeding and early solid food avoidance on the incidence of atopic dermatitis in high‐risk infants at 1 year of age. Pediatric Allergy and Immunology2002;13(4):234‐42. [PUBMED: 12390439] SchoetzauA , GehringU , FrankeK , GrublA , KoletzkoS , vonBergA , et al. Gini Study Group. Maternal compliance with nutritional recommendations in an allergy preventive programme. Archives of Disease in Childhood2002;86(3):180‐4. [PUBMED: 11861235] VonBergA , Filipiak‐PittroffB , KrämerU , LinkE , HeinrichJ , KoletzkoS , et al. The German Infant Nutritional Intervention Study (GINI) for the preventive effect of hydrolysed infant formulas in infants at high risk for allergic diseases. Design and selected results. Allergologie2012;35(1):32‐43. VonBergA , Filipiak‐PittroffB , SchulzH , HoffmannU , LinkE , SussmannM , et al. GINIplus study group. Allergic manifestation 15 years after early intervention with hydrolyzed formulas ‐ the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2016;71(2):210‐9. [DOI: 10.1111/all.12790; PUBMED: 26465137] vonBergA , FilipiakB , KoletzkoS , KrämerU , HoffmannB , LinkE , et al. Long‐term effect of cow milk protein hydrolysates in high‐risk children. Results from the 10‐years follow‐up of the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2013;68:295‐6. vonBergA , Filipiak‐PittroffB , KramerU , HoffmannB , LinkE , BeckmannC , et al. GINIplus study group. Allergies in high‐risk schoolchildren after early intervention with cow's milk protein hydrolysates: 10‐year results from the German Infant Nutritional Intervention (GINI) study. Journal of Allergy and Clinical Immunology2013;131(6):1565‐73. [DOI: 10.1016/j.jaci.2013.01.006; PUBMED: 23506844] vonBergA , Filipiak‐PittroffB , KramerU , LinkE , BollrathC , BrockowI , et al. GINIplus study group. Preventive effect of hydrolyzed infant formulas persists until age 6 years: long‐term results from the German Infant Nutritional Intervention Study (GINI). Journal of Allergy and Clinical Immunology2008;121(6):1442‐7. [DOI: 10.1016/j.jaci.2008.04.021; PUBMED: 18539195] vonBergA , KoletzkoS , Filipiak‐PittroffB , LaubereauB , GrublA , WichmannHE , et al. German Infant Nutritional Intervention Study Group. Certain hydrolyzed formulas reduce the incidence of atopic dermatitis but not that of asthma: three‐year results of the German Infant Nutritional Intervention Study. Journal of Allergy and Clinical Immunology2007;119(3):718‐25. [DOI: 10.1016/j.jaci.2006.11.017; PUBMED: 17240440] vonBergA , KoletzkoS , GrublA , Filipiak‐PittroffB , WichmannHE , BauerCP , et al. German Infant Nutritional Intervention Study Group. The effect of hydrolyzed cow's milk formula for allergy prevention in the first year of life: the German Infant Nutritional Intervention Study, a randomized double‐blind trial. Journal of Allergy and Clinical Immunology2003;111(3):533‐40. [PUBMED: 12642834] ">von Berg 2003</a>). For one study (<a href="./references#CD003664-bbs2-0007" title="LamBC , YeungCY . The effect of breast milk, infant formula and hypoallergenic formula on incidence of atopic manifestation in high risk infants. Nestle Internal Report1992. ">Lam 1992</a>), we extracted methods and data from a thesis. </p> <p>For the 2016 update, we performed all analyses using Review Manager software (<a href="./references#CD003664-bbs2-0151" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">Review Manager 2014</a>). </p> </section> <section id="CD003664-sec-0050"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>We used the criteria and standard methods of the Cochrane Neonatal Review Group to assess the methodological quality of included trials. We evaluated the quality of included trials in terms of adequacy of randomisation and allocation concealment, blinding of parents or caregivers and assessors to intervention and completeness of assessment in all randomised individuals. </p> <p>For the 2016 and 2017 updates, we incorporated previous assessments into RevMan 5 'Risk of bias' tables. We assessed risk of bias for each study using the criteria outlined in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD003664-bbs2-0129" title="HigginsJP , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.2.0 (updated June 2017). The Cochrane Collaboration, 2017. Available from training.cochrane.org/handbook. ">Higgins 2017</a>) by examining the following. </p> <section id="CD003664-sec-0051"> <h5 class="title">Sequence generation (checking for possible selection bias)</h5> <p> <ul id="CD003664-list-0024"> <li> <p>Adequate (any truly random process, e.g. random number table; computer random number generator) </p> </li> <li> <p>Inadequate (any non‐random process, e.g. odd or even date of birth; hospital or clinic record number) </p> </li> <li> <p>Unclear   </p> </li> </ul> </p> </section> <section id="CD003664-sec-0052"> <h5 class="title">Allocation concealment (checking for possible selection bias)</h5> <p> <ul id="CD003664-list-0025"> <li> <p>Adequate (e.g. telephone or central randomisation; consecutively numbered sealed opaque envelopes) </p> </li> <li> <p>Inadequate (open random allocation; unsealed or non‐opaque envelopes, alternation; date of birth) </p> </li> <li> <p>Unclear   </p> </li> </ul> </p> </section> <section id="CD003664-sec-0053"> <h5 class="title">Blinding (checking for possible performance bias)</h5> <p> <ul id="CD003664-list-0026"> <li> <p>Adequate, inadequate or unclear for participants</p> </li> <li> <p>Adequate, inadequate or unclear for personnel</p> </li> <li> <p>Adequate, inadequate or unclear for outcome assessors</p> </li> </ul> </p> </section> <section id="CD003664-sec-0054"> <h5 class="title">Incomplete outcome data (checking for possible attrition bias through withdrawals, dropouts, protocol deviations) </h5> <p> <ul id="CD003664-list-0027"> <li> <p>Adequate (&lt; 20% missing data)</p> </li> <li> <p>Inadequate</p> </li> <li> <p>Unclear</p> </li> </ul> </p> </section> <section id="CD003664-sec-0055"> <h5 class="title">Selective reporting bias</h5> <p> <ul id="CD003664-list-0028"> <li> <p>Adequate (when it is clear that all of the study’s prespecified outcomes and all expected outcomes of interest to the review have been reported) </p> </li> <li> <p>Inadequate (when not all of the study’s prespecified outcomes have been reported; one or more reported primary outcomes were not prespecified; outcomes of interest were reported incompletely and so cannot be used; study failed to include results of a key outcome that would have been expected to have been reported) </p> </li> <li> <p>Unclear</p> </li> </ul> </p> </section> <section id="CD003664-sec-0056"> <h5 class="title">Other sources of bias</h5> <p>We assessed the possibility of other sources of bias (e.g. early termination of trial due to data‐dependent process, extreme baseline imbalance) as follows. </p> <p> <ul id="CD003664-list-0029"> <li> <p>Yes.</p> </li> <li> <p>No.</p> </li> <li> <p>Unclear.</p> </li> </ul> </p> </section> <section id="CD003664-sec-0057"> <h5 class="title">Overall risk of bias</h5> <p>We made explicit judgements about whether studies were at high risk of bias, according to the criteria given in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD003664-bbs2-0129" title="HigginsJP , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.2.0 (updated June 2017). The Cochrane Collaboration, 2017. Available from training.cochrane.org/handbook. ">Higgins 2017</a>). With reference to the criteria above, we assessed the likely magnitude and direction of bias, and whether it was likely to have an impact on study findings. We explored the impact of the level of bias by undertaking sensitivity analyses (see <a href="#CD003664-sec-0066">Sensitivity analysis</a> section).  </p> </section> </section> <section id="CD003664-sec-0058"> <h4 class="title">Measures of treatment effect</h4> <p>We used the standard methods of the Cochrane Neonatal Review Group to synthesise data and expressed effects as risk ratio (RR) and risk difference (RD) with 95% confidence intervals (CIs) for categorical data, and planned to use mean difference (MD) with 95% CIs for continuous data. </p> </section> <section id="CD003664-sec-0059"> <h4 class="title">Unit of analysis issues</h4> <p>The unit of analysis was the individual participant (infant).</p> </section> <section id="CD003664-sec-0060"> <h4 class="title">Dealing with missing data</h4> <p>We recorded missing data in 'Risk of bias' tables and assessed the effect of missing data by performing sensitivity analysis. </p> <p>We performed all analyses by 'intention to treat' when data were available. When intention‐to‐treat data were not available, we reported data as infants assessed by group of assignment as well as losses after randomisation. </p> </section> <section id="CD003664-sec-0061"> <h4 class="title">Assessment of heterogeneity</h4> <p>We used the two formal statistics described here.</p> <p> <ul id="CD003664-list-0030"> <li> <p>Chi<sup>2</sup> test: to assess whether observed variability in effect sizes between studies is greater than would be expected by chance. This test has low power when the number of studies included in the meta‐analysis is small, so we planned to set the probability at the 10% level of significance. </p> </li> <li> <p>I<sup>2</sup> statistic, to ensure that pooling of data is valid. We graded the degree of heterogeneity as follows: none (&lt; 25%); low (25% to 49%); moderate (50% to 74%); or high (≥ 75%). </p> </li> </ul> </p> <p>When we found evidence of apparent or statistical heterogeneity, we planned to assess the source of the heterogeneity by conducting sensitivity and subgroup analyses to look for evidence of bias or methodological differences between trials. </p> </section> <section id="CD003664-sec-0062"> <h4 class="title">Assessment of reporting biases</h4> <p>We documented in the <a href="./references#CD003664-sec-0159" title="">Characteristics of excluded studies</a> table all studies that reported use of a prebiotic in a potentially eligible infant population but did not report allergic disease‐related outcomes. We assessed reporting and publication bias by examining the degree of asymmetry of a funnel plot. </p> </section> <section id="CD003664-sec-0063"> <h4 class="title">Data synthesis</h4> <p>We used the fixed‐effect model and Mantel‐Haenszel methods for meta‐analysis.</p> <section id="CD003664-sec-0064"> <h5 class="title">Quality of evidence</h5> <p>We used the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach, as outlined in the <i>GRADE Handbook</i> (<a href="./references#CD003664-bbs2-0157" title="SchünemannH , BrożekJ , GuyattG , OxmanA , editor(s) . Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach (updated October 2013). GRADE Working Group, 2013. Available from gdt.guidelinedevelopment.org/app/handbook/handbook.html. ">Schünemann 2013</a>), to assess the quality of evidence for the following (clinically relevant) outcomes: all allergic disease; specific allergies including asthma, atopic dermatitis/eczema, allergic rhinitis, cow's milk or soy protein allergy, food allergy, urticaria and anaphylaxis. </p> <p>Two review authors independently assessed the quality of the evidence for each of the outcomes above. We considered evidence from randomised controlled trials as high quality but downgraded the evidence one level for serious (and two levels for very serious) limitations on the basis of the following: design (risk of bias), consistency across studies, directness of evidence, precision of estimates and presence of publication bias. We used the <a href="./references#CD003664-bbs2-0125" title="McMaster University (developed by Evidence Prime). GRADEpro GDT. Version accessed 22 May 2018. Hamilton (ON): McMaster University (developed by Evidence Prime), 2015. ">GRADEpro GDT</a> Guideline Development Tool to create ‘Summary of findings’ tables to report the quality of the evidence. </p> <p>The GRADE approach yields an assessment of the quality of a body of evidence by one of four grades. </p> <p> <ul id="CD003664-list-0031"> <li> <p>High: we are very confident that the true effect lies close to the estimate of effect.</p> </li> <li> <p>Moderate: we are moderately confident in the effect estimate. The true effect is likely to be close to the estimate of effect but may be substantially different. </p> </li> <li> <p>Low: our confidence in the effect estimate is limited. The true effect may be substantially different from the estimate of effect. </p> </li> <li> <p>Very low: we have very little confidence in the effect estimate. The true effect is likely to be substantially different from the estimate of effect. </p> </li> </ul> </p> </section> </section> <section id="CD003664-sec-0065"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We performed subgroup analyses according to the following.</p> <p> <ul id="CD003664-list-0032"> <li> <p>Infant risk of allergic disease: low‐risk infants (no family history of allergic disease in first‐degree relatives); high‐risk infants (family history of allergic disease in first‐degree relatives or high cord blood IgE level). </p> </li> <li> <p>Extent of protein hydrolysis: EHF versus CMF; PHF versus CMF; EHF versus PHF. An EHF should meet the definition provided by the AAP Committee on Nutrition (<a href="./references#CD003664-bbs2-0109" title="Americal Academy of Pediatrics: Committee on Nutrition. Hypoallergenic infant formulas. Pediatrics2000;106(2 Pt 1):346‐9. [PUBMED: 10920165] ">AAP 2000</a>) ‐ extensively hydrolysed proteins derived from cow's milk in which most of the nitrogen is present in the form of free amino acids and peptides ≤ 1500 kDaltons ‐ and should, at a minimum, ensure with 95% confidence that 90% of infants with documented cow's milk allergy (CMA) will not react with defined symptoms to the formula under double‐blind, placebo‐controlled conditions. </p> </li> <li> <p>Indication for use: prolonged sole formula feeding; supplemental formula feeding; weaning from the breast with infant formula. </p> </li> <li> <p>Method of ascertainment of allergic disease: clinical allergic disease confirmed by challenge testing or by testing for atopy (e.g. skin testing or serological testing for specific IgE, asthma confirmed by testing for presence of bronchial hyper‐responsiveness, food allergy confirmed by elimination/challenge). Included in this definition is clinical allergic disease in a patient for whom atopy has been confirmed by testing (e.g. asthma when atopy has been confirmed by skin prick testing or RAST for specific IgE); blinded measurement for allergic disease ‐ when measurement of outcome was blinded to treatment allocation (this analysis was not prespecified). </p> </li> <li> <p>Type of protein hydrolysate used: partially hydrolysed whey formula versus CMF; partially hydrolysed casein formula versus CMF; extensively hydrolysed whey formula versus CMF; extensively hydrolysed casein formula versus CMF; hydrolysed soy formula versus CMF. </p> </li> </ul> </p> </section> <section id="CD003664-sec-0066"> <h4 class="title">Sensitivity analysis</h4> <p>We prespecified a sensitivity analysis to determine whether review findings were affected by including only studies at low risk of bias, defined as those with adequate randomisation and allocation concealment and &lt; 10% loss to follow‐up. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD003664-sec-0067" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD003664-sec-0067"></div> <section id="CD003664-sec-0068"> <h3 class="title">Description of studies</h3> <p>This report updates a previous publication that was withdrawn (<a href="./references#CD003664-bbs2-0166" title="OsbornDA , SinnJK , JonesLJ . Infant formulas containing hydrolysed protein for prevention of allergic disease and food allergy. Cochrane Database of Systematic Reviews2017, Issue 3. [DOI: 10.1002/14651858.CD003664.pub4] ">Osborn 2017a</a>; <a href="./references#CD003664-bbs2-0167" title="OsbornDA , SinnJK , JonesLJ . Infant formulas containing hydrolysed protein for prevention of allergic disease and food allergy. Cochrane Database of Systematic Reviews2017, Issue 5. [DOI: 10.1002/14651858.CD003664.pub5] ">Osborn 2017b</a>). A data entry error in the review was identified that had potential to impact the review conclusions. This review corrects the data error and updates the search. </p> <section id="CD003664-sec-0069"> <h4 class="title">Results of the search</h4> <p>We performed searches on 22 January 2016 (see <a href="#CD003664-fig-0001">Figure 1</a> for study flow diagram). We searched MEDLINE using OVID and retrieved 198 reports (<a href="./appendices#CD003664-sec-0144">Appendix 1</a>); CENTRAL and retrieved 242 reports (<a href="./appendices#CD003664-sec-0146">Appendix 3</a>); and Embase and retrieved 199 reports (<a href="./appendices#CD003664-sec-0145">Appendix 2</a>). We identified eight ongoing or unpublished studies (<a href="./references#CD003664-bbs2-0068" title="NCT01987154 . Tolerance of an extensively hydrolyzed protein infant formula versus a premature infant formula. clinicaltrials.gov/show/NCT01987154 (first received 19 November 2013). ">NCT01987154</a>; <a href="./references#CD003664-bbs2-0067" title="NCT00936637 . Effects on growth of an extensively hydrolyzed formula fed to term [A 16‐week growth study of an extensively hydrolyzed infant formula, 3 Months treatment and 1 month follow‐up for a duration of 4 months]. clinicaltrials.gov/show/NCT00936637 (first received 10 July 2009). ">NCT00936637</a>; <a href="./references#CD003664-bbs2-0104" title="NCT01156493 . Hydrolized protein formula for premature infants [Randomized trial of hydrolyzed protein premature formula]. clinicaltrials.gov/show/ NCT01156493 (first received 02 July 2010). ">NCT01156493</a>; <a href="./references#CD003664-bbs2-0107" title="NCT01735123 . Early dietary intervention and later signs of beta‐cell autoimmunity (EDIA). clinicaltrials.gov/show/NCT01735123 (first received 28 November 2012). ">NCT01735123</a>; <a href="./references#CD003664-bbs2-0106" title='NCT01700205 . "Watch your baby grow" study (GRO) [Impact of diet composition on energy balance and satiety during infancy]. clinicaltrials.gov/show/NCT01700205 (first received 4 October 2012). '>NCT01700205</a>; <a href="./references#CD003664-bbs2-0105" title="NCT01210391 . Growth of infants fed an extensively hydrolyzed infant formula [Assessment of growth of infants fed a 100% whey extensively hydrolyzed formula]. clinicaltrials.gov/show/NCT01210391 (first received 28 September 2010). ">NCT01210391</a>; <a href="./references#CD003664-bbs2-0103" title="NCT01036243 . Digestive tolerance of slightly hydrolyzed starter infant formula with probiotics [Tolerance of a slightly hydrolyzed starter formula containing probiotics]. clinicaltrials.gov/show/NCT01036243 (first received 21 December 2009). ">NCT01036243</a>; <a href="./references#CD003664-bbs2-0108" title="YinLP , QianLJ , ZhuH , ChenY , LiH , HanJN , et al. Application effect of extensively hydrolyzed milk protein formula and follow‐up in preterm children with a gestational age of less than 34 weeks: study protocol for a randomized controlled trial. Trials2015;16:498. [DOI: 10.1186/s13063‐015‐1030‐5; PUBMED: 26537897] ">Yin 2015</a>) (see <a href="./appendices#CD003664-sec-0147">Appendix 4</a> and <a href="./appendices#CD003664-sec-0148">Appendix 5</a>). We updated the search on 3 November 2017 and found one additional excluded study (<a href="./references#CD003664-bbs2-0030" title="BoyleRJ , TangMLK , ChiangWC , ChuaMC , IsmailI , NautaA , et al. PATCH study investigators. Prebiotic‐supplemented partially hydrolysed cow's milk formula for the prevention of eczema in high‐risk infants: a randomized controlled trial. Allergy2016;71(5):701‐10. [DOI: 10.1111/all.12848; PUBMED: 27111273] TangM , RijnierseA , NautaA , BoyleR , HourihaneJ , ChiangW , et al. Influence of early feeding patterns on eczema development in high‐risk infants. Allergy2017;72:15. ">Boyle 2016</a>) and an additional 15‐year follow‐up report from a previously included study (<a href="./references#CD003664-bbs2-0015" title="BergA , KramerU , LinkE , BollrathC , HeinrichJ , BrockowI , et al. GINIplus study group. Impact of early feeding on childhood eczema: development after nutritional intervention compared with the natural course ‐ the GINIplus study up to the age of 6 years. Clinical and Experimental Allergy2010;40(4):627‐36. [DOI: 10.1111/j.1365‐2222.2009.03444.x; PUBMED: 20082618] BrockowI , ZutavernA , HoffmannU , GrublA , vonBergA , KoletzkoS , et al. GINIplus Study Group. Early allergic sensitizations and their relevance to atopic diseases in children aged 6 years: results of the GINI study. Journal of Investigational Allergology &amp; Clinical Immunology2009;19(3):180‐7. [DOI: 19610260] LaubereauB , BrockowI , ZirngiblA , KoletzkoS , GrueblA , vonBergA , et al. GINI Study Group. Effect of breast‐feeding on the development of atopic dermatitis during the first 3 years of life ‐ results from the GINI‐birth cohort study. Journal of Pediatrics2004;144(5):602‐7. [DOI: 10.1016/j.jpeds.2003.12.029; PUBMED: 15126993] LaubereauB , Filipiak‐PittroffB , vonBergA , GrublA , ReinhardtD , WichmannHE , et al. Caesarean section and gastrointestinal symptoms, atopic dermatitis, and sensitisation during the first year of life. Archives of Disease in Childhood2004;89(11):993‐7. [DOI: 10.1136/adc.2003.043265; PUBMED: 15499049] RzehakP , SausenthalerS , KoletzkoS , BauerCP , SchaafB , vonBergA , et al. Period‐specific growth, overweight and modification by breastfeeding in the GINI and LISA birth cohorts up to age 6 years. European Journal of Epidemiology2009;24(8):449‐67. [DOI: 10.1007/s10654‐009‐9356‐5; PUBMED: 19521784] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. GINI‐plus Study Group. Long‐term effects of hydrolyzed protein infant formulas on growth ‐ extended follow‐up to 10 y of age: results from the German Infant Nutritional Intervention (GINI) study. American Journal of Clinical Nutrition2011;94(6 Suppl):1803S‐7S. [DOI: 10.3945/ajcn.110.000679; PUBMED: 21849601] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. German Infant Nutritional Intervention Study Group. Short‐ and long‐term effects of feeding hydrolyzed protein infant formulas on growth at &lt; or = 6 y of age: results from the German Infant Nutritional Intervention Study. American Journal of Clinical Nutrition2009;89(6):1846‐56. [DOI: 10.3945/ajcn.2008.27373; PUBMED: 19369380] SausenthalerS , KoletzkoS , KoletzkoB , ReinhardtD , KramerU , vonBergA , et al. GINIplus study group. Effect of hydrolysed formula feeding on taste preferences at 10 years. Data from the German Infant Nutritional Intervention Program Plus Study. Clinical Nutrition2010;29(3):304‐6. [DOI: 10.1016/j.clnu.2010.01.007; PUBMED: 20110140] SchoetzauA , Filipiak‐PittroffB , FrankeK , KoletzkoS , VonBergA , GrueblA , et al. German Infant Nutritional Intervention Study Group. Effect of exclusive breast‐feeding and early solid food avoidance on the incidence of atopic dermatitis in high‐risk infants at 1 year of age. Pediatric Allergy and Immunology2002;13(4):234‐42. [PUBMED: 12390439] SchoetzauA , GehringU , FrankeK , GrublA , KoletzkoS , vonBergA , et al. Gini Study Group. Maternal compliance with nutritional recommendations in an allergy preventive programme. Archives of Disease in Childhood2002;86(3):180‐4. [PUBMED: 11861235] VonBergA , Filipiak‐PittroffB , KrämerU , LinkE , HeinrichJ , KoletzkoS , et al. The German Infant Nutritional Intervention Study (GINI) for the preventive effect of hydrolysed infant formulas in infants at high risk for allergic diseases. Design and selected results. Allergologie2012;35(1):32‐43. VonBergA , Filipiak‐PittroffB , SchulzH , HoffmannU , LinkE , SussmannM , et al. GINIplus study group. Allergic manifestation 15 years after early intervention with hydrolyzed formulas ‐ the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2016;71(2):210‐9. [DOI: 10.1111/all.12790; PUBMED: 26465137] vonBergA , FilipiakB , KoletzkoS , KrämerU , HoffmannB , LinkE , et al. Long‐term effect of cow milk protein hydrolysates in high‐risk children. Results from the 10‐years follow‐up of the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2013;68:295‐6. vonBergA , Filipiak‐PittroffB , KramerU , HoffmannB , LinkE , BeckmannC , et al. GINIplus study group. Allergies in high‐risk schoolchildren after early intervention with cow's milk protein hydrolysates: 10‐year results from the German Infant Nutritional Intervention (GINI) study. Journal of Allergy and Clinical Immunology2013;131(6):1565‐73. [DOI: 10.1016/j.jaci.2013.01.006; PUBMED: 23506844] vonBergA , Filipiak‐PittroffB , KramerU , LinkE , BollrathC , BrockowI , et al. GINIplus study group. Preventive effect of hydrolyzed infant formulas persists until age 6 years: long‐term results from the German Infant Nutritional Intervention Study (GINI). Journal of Allergy and Clinical Immunology2008;121(6):1442‐7. [DOI: 10.1016/j.jaci.2008.04.021; PUBMED: 18539195] vonBergA , KoletzkoS , Filipiak‐PittroffB , LaubereauB , GrublA , WichmannHE , et al. German Infant Nutritional Intervention Study Group. Certain hydrolyzed formulas reduce the incidence of atopic dermatitis but not that of asthma: three‐year results of the German Infant Nutritional Intervention Study. Journal of Allergy and Clinical Immunology2007;119(3):718‐25. [DOI: 10.1016/j.jaci.2006.11.017; PUBMED: 17240440] vonBergA , KoletzkoS , GrublA , Filipiak‐PittroffB , WichmannHE , BauerCP , et al. German Infant Nutritional Intervention Study Group. The effect of hydrolyzed cow's milk formula for allergy prevention in the first year of life: the German Infant Nutritional Intervention Study, a randomized double‐blind trial. Journal of Allergy and Clinical Immunology2003;111(3):533‐40. [PUBMED: 12642834] ">von Berg 2003</a>). </p> <div class="figure" id="CD003664-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram: review update." data-id="CD003664-fig-0001" src="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram: review update.</p> </div> </div> </div> <p>The search of MEDLINE, CENTRAL and Embase was updated from January 2016 to November 2017. After de‐duplication, 32 additional reports were reviewed. No additional reports of included studies were found. Five additional reports were found that were added to excluded studies (<a href="./references#CD003664-bbs2-0030" title="BoyleRJ , TangMLK , ChiangWC , ChuaMC , IsmailI , NautaA , et al. PATCH study investigators. Prebiotic‐supplemented partially hydrolysed cow's milk formula for the prevention of eczema in high‐risk infants: a randomized controlled trial. Allergy2016;71(5):701‐10. [DOI: 10.1111/all.12848; PUBMED: 27111273] TangM , RijnierseA , NautaA , BoyleR , HourihaneJ , ChiangW , et al. Influence of early feeding patterns on eczema development in high‐risk infants. Allergy2017;72:15. ">Boyle 2016</a>; <a href="./references#CD003664-bbs2-0054" title="HyytinenM , SavilahtiE , VirtanenSM , HarkonenT , IlonenJ , LuopajarviK , et al. Finnish TRIGR Pilot Study Group. Avoidance of cow's milk‐based formula for at‐risk infants does not reduce development of celiac disease: a randomized controlled trial. Gastroenterology2017;153(4):961‐70.e3. KnipM , VirtanenSM , SeppaK , IlonenJ , SavilahtiE , VaaralaO , et al. Finnish TRIGR Study Group. Dietary intervention in infancy and later signs of beta‐cell autoimmunity. New England Journal of Medicine2010;363(20):1900‐8. [DOI: 10.1056/NEJMoa1004809; PUBMED: 21067382] ">Knip 2010</a>; <a href="./references#CD003664-bbs2-0055" title="KnipM , AkerblomHK , BeckerD , DoschHM , DupreJ , FraserW , et al. TRIGR Study Group. Hydrolyzed infant formula and early beta‐cell autoimmunity: a randomized clinical trial. JAMA2014;311(22):2279‐87. [DOI: 10.1001/jama.2014.5610; PUBMED: 24915259] KnipM , VirtanenSM , BeckerD , DupreJ , KrischerJP , AkerblomHK , TRIGR Study Group. Early feeding and risk of type 1 diabetes: experiences from the Trial to Reduce Insulin‐dependent diabetes mellitus in the Genetically at Risk (TRIGR). American Journal of Clinical Nutrition2011;94(6 Suppl):1814S‐20S. [DOI: 10.3945/ajcn.110.000711; PUBMED: 21653795] KrischerJP . Hydrolyzed infant formula and early beta‐cell autoimmunity. Diabetes2014;63:A7. NCT00179777 . TRIGR ‐ Primary prevention study for Type 1 Diabetes in children at risk [TRIGR ‐ Trial to Reduce IDDM in the Genetically at Risk]. clinicaltrials.gov/show/NCT00179777 (first received 16 September 2005). TRIGR Study Group, AkerblomHK , KrischerJ , VirtanenSM , BersethC , BeckerD , DupreJ , et al. The trial to reduce IDDM in the genetically at risk (TRIGR) study: recruitment, intervention and follow‐up. Diabetologia2011;54(3):627‐33; Erratum in: Diabetologia. 2011;54(8):2210. [DOI: 10.1007/s00125‐010‐1964‐9; NCT00179777; PUBMED: 21153533] Writing Group for the TRIGR Study Group, KnipM , ÅkerblomHK , Al TajiE , BeckerD , BruiningJ , CastanoL , et al. Effect of hydrolyzed infant formula vs conventional formula on risk of Type 1 diabetes: The TRIGR randomized clinical trial. JAMA2018;319(1):38‐48. [DOI: 10.1001/jama.2017.19826; NCT00179777; PUBMED: 29297078] ">Knip 2011</a>; <a href="./references#CD003664-bbs2-0082" title="ScalabrinD , BersethC , MarunyczJ , MitmesserS . Long term safety, growth, and health effects of lactobacillus GG (LGG) added to partially and extensively hydrolyzed infant formulas. Allergy: European Journal of Allergy and Clinical Immunology2009;64(1171):447. ScalabrinD , HarrisC , JohnstonWH , BersethCL . Long‐term safety assessment in children who received hydrolyzed protein formulas with Lactobacillus rhamnosus GG: a 5‐year follow‐up. European Journal of Pediatrics2017;176(2):217‐24. [DOI: 10.1007/s00431‐016‐2825‐4; PUBMED: 27975116] ScalabrinDM , JohnstonWH , HoffmanDR , P'PoolVL , HarrisCL , MitmesserSH . Growth and tolerance of healthy term infants receiving hydrolyzed infant formulas supplemented with Lactobacillus rhamnosus GG: randomized, double‐blind, controlled trial. Clinical Pediatrics2009;48(7):734‐44. [DOI: 10.1177/0009922809332682; NCT00655720; PUBMED: 19264721] ScalabrinDMF , HarrisC , StrongPV , LiuB , BersethCL . Infant supplementation with Lactobacillus rhamnosus GG (LGG) and long‐term growth and health: a 5‐year follow‐up. Allergy: European Journal of Allergy and Clinical Immunology2014;69(451):196‐7. ">Scalabrin 2009</a>; <a href="./references#CD003664-bbs2-0100" title="XiniasI , AnalitisA , VandenplasY . A synbiotic partial whey hydrolysate with reduced lactose decreases infantile colic and improves quality of life; A randomized open pilot study. Journal of Pediatric Gastroenterology and Nutrition2017;64:143. ">Xinias 2017</a>). An expert informant identified an additional unpublished study, the author was unable to get sponsor approval for data release for (<a href="./references#CD003664-bbs2-0021" title="ArshadSH . Randomised controlled trial of cow’s milk formula versus hydrolysed formula for the prevention of allergy. Author email communication November 2017. ">Arshad 1990</a>) (see Characteristics of studies awaiting classification). </p> </section> <section id="CD003664-sec-0070"> <h4 class="title">Included studies</h4> <p>We assessed 16 studies as eligible for inclusion ‐ see <a href="./references#CD003664-sec-0158" title="">Characteristics of included studies</a> table. A previously included study (<a href="./references#CD003664-bbs2-0089" title="SorensenRU , InostrozaJ , HebalE , VinetAM , FierroJ . Weaning to a partially hydrolyzed whey formula at three months of age protects against the later development of anti‐cow milk lgE antibodies in comparison to whole cows milk or extensively hydrolyzed whey formulas. Journal of Allergy and Clinical Immunology2007;119(1):S120. ">Sorensen 2007</a>) has been moved to excluded studies as it did not reported an allergic disease outcome. The search revealed an additional study that we assessed as an included study (<a href="./references#CD003664-bbs2-0006" title="KwintaP , SawiecP , KlimekM , LisG , Cichocka‐JaroszE , PietrzykJJ . Correlation between early neonatal diet and atopic symptoms up to 5‐7 years of age in very low birth weight infants: follow‐up of randomized, double‐blind study. Pediatric Allergy and Immunology2009;20(5):458‐66. [DOI: 10.1111/j.1399‐3038.2008.00814.x; PUBMED: 19490477] ">Kwinta 2009</a>). We found an additional publication (<a href="./references#CD003664-bbs2-0004" title="HillD . A report on the analysis of the Melbourne Atopy Cohort Study. A study designed to test the effectiveness of different formula types on the development of atopic symptoms and signs on a cohort of atopy‐at‐risk infants. Report at year 2. Nestec Internal Report. HillDJ , SporikR , ThorburnJ , HoskingCS . The association of atopic dermatitis in infancy with immunoglobulin E food sensitization. Journal of Pediatrics2000;137(4):475‐9. [DOI: 10.1067/mpd.2000.108207; PUBMED: 11035824] KoplinJ , DharmageSC , GurrinL , OsborneN , TangML , LoweAJ , et al. Soy consumption is not a risk factor for peanut sensitization. Journal of Allergy and Clinical Immunology2008;121(6):1455‐9. [DOI: 10.1016/j.jaci.2008.03.017; PUBMED: 18436294] LoweA , HoskingC , BennettC , AllenK , CarlinJ , DharmageS , et al. The Melbourne Atopy Cohort Study: a RCT of a partially hydrolysed whey formula for the prevention of allergic disease. Internal Medicine Journal2008;38:A158. LoweAJ , AbramsonMJ , HoskingCS , CarlinJB , BennettCM , DharmageSC , et al. The temporal sequence of allergic sensitization and onset of infantile eczema. Clinical &amp; Experimental Allergy2007;37(4):536‐42; Erratum in: Clinical &amp; Experimental Allergy 2007; 37(12);1895. [DOI: 10.1111/j.1365‐2222.2007.02691.x; PUBMED: 17430350] LoweAJ , CarlinJB , BennettCM , HoskingCS , AllenKJ , RobertsonCF , et al. Paracetamol use in early life and asthma: prospective birth cohort study. BMJ2010;341:c4616. [PUBMED: 20843914] LoweAJ , HoskingCS , BennettCM , AllenKJ , AxelradC , CarlinJB , et al. Effect of a partially hydrolyzed whey infant formula at weaning on risk of allergic disease in high‐risk children: a randomized controlled trial. Journal of Allergy and Clinical Immunology2011;128(2):360‐5.e4. [DOI: 10.1016/j.jaci.2010.05.006; PUBMED: 21696814] StoneyRM , WoodsRK , HoskingCS , HillDJ , AbramsonMJ , ThienFC . Maternal breast milk long‐chain n‐3 fatty acids are associated with increased risk of atopy in breastfed infants. Clinical and Experimental Allergy2004;34(2):194‐200; Erratum in: Clinical &amp; Experimental Allergy 2007; 37(12);1895. [PUBMED: 14987297] ThomsonJA , WidjajaC , DarmaputraAA , LoweA , MathesonMC , BennettCM , et al. Early childhood infections and immunisation and the development of allergic disease in particular asthma in a high‐risk cohort: a prospective study of allergy‐prone children from birth to six years. Pediatric Allergy and Immunology2010;21(7):1076‐85. [DOI: 10.1111/j.1399‐3038.2010.01018.x; PUBMED: 20337970] ">Hill 2000</a>) of a study that we had previously assessed as an excluded study as it had reported a per‐protocol analysis with excess losses. We combined a new report of an 'intention‐to‐treat' analysis with trial data obtained from study authors and have assessed this trial as an included study. Data from sequential publications of the GINI study (<a href="./references#CD003664-bbs2-0015" title="BergA , KramerU , LinkE , BollrathC , HeinrichJ , BrockowI , et al. GINIplus study group. Impact of early feeding on childhood eczema: development after nutritional intervention compared with the natural course ‐ the GINIplus study up to the age of 6 years. Clinical and Experimental Allergy2010;40(4):627‐36. [DOI: 10.1111/j.1365‐2222.2009.03444.x; PUBMED: 20082618] BrockowI , ZutavernA , HoffmannU , GrublA , vonBergA , KoletzkoS , et al. GINIplus Study Group. Early allergic sensitizations and their relevance to atopic diseases in children aged 6 years: results of the GINI study. Journal of Investigational Allergology &amp; Clinical Immunology2009;19(3):180‐7. [DOI: 19610260] LaubereauB , BrockowI , ZirngiblA , KoletzkoS , GrueblA , vonBergA , et al. GINI Study Group. Effect of breast‐feeding on the development of atopic dermatitis during the first 3 years of life ‐ results from the GINI‐birth cohort study. Journal of Pediatrics2004;144(5):602‐7. [DOI: 10.1016/j.jpeds.2003.12.029; PUBMED: 15126993] LaubereauB , Filipiak‐PittroffB , vonBergA , GrublA , ReinhardtD , WichmannHE , et al. Caesarean section and gastrointestinal symptoms, atopic dermatitis, and sensitisation during the first year of life. Archives of Disease in Childhood2004;89(11):993‐7. [DOI: 10.1136/adc.2003.043265; PUBMED: 15499049] RzehakP , SausenthalerS , KoletzkoS , BauerCP , SchaafB , vonBergA , et al. Period‐specific growth, overweight and modification by breastfeeding in the GINI and LISA birth cohorts up to age 6 years. European Journal of Epidemiology2009;24(8):449‐67. [DOI: 10.1007/s10654‐009‐9356‐5; PUBMED: 19521784] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. GINI‐plus Study Group. Long‐term effects of hydrolyzed protein infant formulas on growth ‐ extended follow‐up to 10 y of age: results from the German Infant Nutritional Intervention (GINI) study. American Journal of Clinical Nutrition2011;94(6 Suppl):1803S‐7S. [DOI: 10.3945/ajcn.110.000679; PUBMED: 21849601] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. German Infant Nutritional Intervention Study Group. Short‐ and long‐term effects of feeding hydrolyzed protein infant formulas on growth at &lt; or = 6 y of age: results from the German Infant Nutritional Intervention Study. American Journal of Clinical Nutrition2009;89(6):1846‐56. [DOI: 10.3945/ajcn.2008.27373; PUBMED: 19369380] SausenthalerS , KoletzkoS , KoletzkoB , ReinhardtD , KramerU , vonBergA , et al. GINIplus study group. Effect of hydrolysed formula feeding on taste preferences at 10 years. Data from the German Infant Nutritional Intervention Program Plus Study. Clinical Nutrition2010;29(3):304‐6. [DOI: 10.1016/j.clnu.2010.01.007; PUBMED: 20110140] SchoetzauA , Filipiak‐PittroffB , FrankeK , KoletzkoS , VonBergA , GrueblA , et al. German Infant Nutritional Intervention Study Group. Effect of exclusive breast‐feeding and early solid food avoidance on the incidence of atopic dermatitis in high‐risk infants at 1 year of age. Pediatric Allergy and Immunology2002;13(4):234‐42. [PUBMED: 12390439] SchoetzauA , GehringU , FrankeK , GrublA , KoletzkoS , vonBergA , et al. Gini Study Group. Maternal compliance with nutritional recommendations in an allergy preventive programme. Archives of Disease in Childhood2002;86(3):180‐4. [PUBMED: 11861235] VonBergA , Filipiak‐PittroffB , KrämerU , LinkE , HeinrichJ , KoletzkoS , et al. The German Infant Nutritional Intervention Study (GINI) for the preventive effect of hydrolysed infant formulas in infants at high risk for allergic diseases. Design and selected results. Allergologie2012;35(1):32‐43. VonBergA , Filipiak‐PittroffB , SchulzH , HoffmannU , LinkE , SussmannM , et al. GINIplus study group. Allergic manifestation 15 years after early intervention with hydrolyzed formulas ‐ the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2016;71(2):210‐9. [DOI: 10.1111/all.12790; PUBMED: 26465137] vonBergA , FilipiakB , KoletzkoS , KrämerU , HoffmannB , LinkE , et al. Long‐term effect of cow milk protein hydrolysates in high‐risk children. Results from the 10‐years follow‐up of the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2013;68:295‐6. vonBergA , Filipiak‐PittroffB , KramerU , HoffmannB , LinkE , BeckmannC , et al. GINIplus study group. Allergies in high‐risk schoolchildren after early intervention with cow's milk protein hydrolysates: 10‐year results from the German Infant Nutritional Intervention (GINI) study. Journal of Allergy and Clinical Immunology2013;131(6):1565‐73. [DOI: 10.1016/j.jaci.2013.01.006; PUBMED: 23506844] vonBergA , Filipiak‐PittroffB , KramerU , LinkE , BollrathC , BrockowI , et al. GINIplus study group. Preventive effect of hydrolyzed infant formulas persists until age 6 years: long‐term results from the German Infant Nutritional Intervention Study (GINI). Journal of Allergy and Clinical Immunology2008;121(6):1442‐7. [DOI: 10.1016/j.jaci.2008.04.021; PUBMED: 18539195] vonBergA , KoletzkoS , Filipiak‐PittroffB , LaubereauB , GrublA , WichmannHE , et al. German Infant Nutritional Intervention Study Group. Certain hydrolyzed formulas reduce the incidence of atopic dermatitis but not that of asthma: three‐year results of the German Infant Nutritional Intervention Study. Journal of Allergy and Clinical Immunology2007;119(3):718‐25. [DOI: 10.1016/j.jaci.2006.11.017; PUBMED: 17240440] vonBergA , KoletzkoS , GrublA , Filipiak‐PittroffB , WichmannHE , BauerCP , et al. German Infant Nutritional Intervention Study Group. The effect of hydrolyzed cow's milk formula for allergy prevention in the first year of life: the German Infant Nutritional Intervention Study, a randomized double‐blind trial. Journal of Allergy and Clinical Immunology2003;111(3):533‐40. [PUBMED: 12642834] ">von Berg 2003</a>) beyond three years remain ineligible for inclusion in this review owing to excess losses to follow‐up. For the GINI study, data from a single centre (Wessel) has been used in this review as other centres had excess losses (&gt; 20%) at all time points. We have moved to the excluded studies list five previously included studies (<a href="./references#CD003664-bbs2-0059" title="MaggioL , ZuppaAA , SawatzkiG , ValsasinaR , SchubertW , TortoroloG . Higher urinary excretion of essential amino acids in preterm infants fed protein hydrolysates. Acta Paediatrica2005;94(1):75‐84. [PUBMED: 15858965] ZuppaAA , GirlandoP , ScapillatiME , MaggioL , RomagnoliC , TortoroloG . [Effects on growth, tolerability and biochemical parameters of two different human milk fortifiers in very low birth‐weight newborns]. Pediatria Medica e Chirurgica2004;26(1):45‐9. [PUBMED: 15529811] ">Maggio 2005</a>; <a href="./references#CD003664-bbs2-0074" title="PicaudJC , LapillonneA , RigoJ , NormandS , ReygrobelletB , ClarisO , et al. Nitrogen utilization and bone mineralization in very low birth weight infants fed partially hydrolyzed preterm formula. Seminars in Perinatology2002;26(6):439‐46; Retraction in: Seminars in Perinatology 2013; 37(2):138. [PUBMED: 12537316] PicaudJC , RigoJ , NormandS , LapillonneA , ReygrobelletB , ClarisO , et al. Nutritional efficacy of preterm formula with a partially hydrolyzed protein source: a randomized pilot study. Journal of Pediatric Gastroenterology and Nutrition2001;32(5):555‐61. [PUBMED: 11429516] ">Picaud 2001</a>; <a href="./references#CD003664-bbs2-0089" title="SorensenRU , InostrozaJ , HebalE , VinetAM , FierroJ . Weaning to a partially hydrolyzed whey formula at three months of age protects against the later development of anti‐cow milk lgE antibodies in comparison to whole cows milk or extensively hydrolyzed whey formulas. Journal of Allergy and Clinical Immunology2007;119(1):S120. ">Sorensen 2007</a>; <a href="./references#CD003664-bbs2-0091" title="SzajewskaH , AlbrechtP , StoinskaB , ProchowskaA , GaweckaA , Laskowska‐KlitaT . Extensive and partial protein hydrolysate preterm formulas: the effect on growth rate, protein metabolism indices, and plasma amino acid concentrations. Journal of Pediatric Gastroenterology and Nutrition2001;32(3):303‐9. [PUBMED: 11345180] ">Szajewska 2001</a>; <a href="./references#CD003664-bbs2-0098" title="HauserB , BleckerU , KeymolenK , SuysB , GerloE , VandenplasY . Plasma amino acid concentrations in term‐born infants fed a whey predominant or a whey hydrolysate formula. JPEN. Journal of Parenteral and Enteral Nutrition1997;21(1):27‐30. [DOI: 10.1177/014860719702100127; PUBMED: 9002081] HauserB , KeymolenK , BleckerU , SuysB , BougatefA , LoebH , et al. A comparative evaluation of whey hydrolysate and whey‐predominant formulas. How well do infants accept and tolerate them?. Clinical Pediatrics1993;62:433‐7. VandenplasY , HauserB , BleckerU , SuysB , PeetersS , KeymolenK , et al. The nutritional value of a whey hydrolysate formula compared with a whey‐predominant formula in healthy infants. Journal of Pediatric Gastroenterology and Nutrition1993;17(1):92‐6. [PUBMED: 8350218] ">Vandenplas 1993</a>) that have reported no outcome data able to be used in this review. </p> <section id="CD003664-sec-0071"> <h5 class="title">Types of infants enrolled</h5> <p> <ul id="CD003664-list-0033"> <li> <p>High risk of allergic disease: a total of 13 studies (<a href="./references#CD003664-bbs2-0001" title="ChiricoG , GasparoniA , CiardelliL , DeAmiciM , ColomboA , RondiniG . Immunogenicity and antigenicity of a partially hydrolyzed cow's milk infant formula. Allergy1997;52(1):82‐8. [PUBMED: 9062633] ">Chirico 1997</a>; <a href="./references#CD003664-bbs2-0002" title="deSetaL , SianiP , CirilloG , DiGruttolaM , CimaduomoL , ColettaS . The prevention of allergic diseases with a hypoallergenic formula: a follow‐up at 24 months. The preliminary results. [Italian]. La Pediatria Medica e Chirurgica: Medical and Surgical Pediatrics1994;16(3):251‐4. [PUBMED: 7971447] ">de Seta 1994</a>; <a href="./references#CD003664-bbs2-0003" title="HalkenS , HansenKS , JacobsenHP , EstmannA , FaellingAE , HansenLG , et al. Comparison of a partially hydrolyzed infant formula with two extensively hydrolyzed formulas for allergy prevention: a prospective, randomized study. Pediatric Allergy and Immunology2000;11(3):149‐61. [PUBMED: 10981524] ">Halken 2000</a>; <a href="./references#CD003664-bbs2-0004" title="HillD . A report on the analysis of the Melbourne Atopy Cohort Study. A study designed to test the effectiveness of different formula types on the development of atopic symptoms and signs on a cohort of atopy‐at‐risk infants. Report at year 2. Nestec Internal Report. HillDJ , SporikR , ThorburnJ , HoskingCS . The association of atopic dermatitis in infancy with immunoglobulin E food sensitization. Journal of Pediatrics2000;137(4):475‐9. [DOI: 10.1067/mpd.2000.108207; PUBMED: 11035824] KoplinJ , DharmageSC , GurrinL , OsborneN , TangML , LoweAJ , et al. Soy consumption is not a risk factor for peanut sensitization. Journal of Allergy and Clinical Immunology2008;121(6):1455‐9. [DOI: 10.1016/j.jaci.2008.03.017; PUBMED: 18436294] LoweA , HoskingC , BennettC , AllenK , CarlinJ , DharmageS , et al. The Melbourne Atopy Cohort Study: a RCT of a partially hydrolysed whey formula for the prevention of allergic disease. Internal Medicine Journal2008;38:A158. LoweAJ , AbramsonMJ , HoskingCS , CarlinJB , BennettCM , DharmageSC , et al. The temporal sequence of allergic sensitization and onset of infantile eczema. Clinical &amp; Experimental Allergy2007;37(4):536‐42; Erratum in: Clinical &amp; Experimental Allergy 2007; 37(12);1895. [DOI: 10.1111/j.1365‐2222.2007.02691.x; PUBMED: 17430350] LoweAJ , CarlinJB , BennettCM , HoskingCS , AllenKJ , RobertsonCF , et al. Paracetamol use in early life and asthma: prospective birth cohort study. BMJ2010;341:c4616. [PUBMED: 20843914] LoweAJ , HoskingCS , BennettCM , AllenKJ , AxelradC , CarlinJB , et al. Effect of a partially hydrolyzed whey infant formula at weaning on risk of allergic disease in high‐risk children: a randomized controlled trial. Journal of Allergy and Clinical Immunology2011;128(2):360‐5.e4. [DOI: 10.1016/j.jaci.2010.05.006; PUBMED: 21696814] StoneyRM , WoodsRK , HoskingCS , HillDJ , AbramsonMJ , ThienFC . Maternal breast milk long‐chain n‐3 fatty acids are associated with increased risk of atopy in breastfed infants. Clinical and Experimental Allergy2004;34(2):194‐200; Erratum in: Clinical &amp; Experimental Allergy 2007; 37(12);1895. [PUBMED: 14987297] ThomsonJA , WidjajaC , DarmaputraAA , LoweA , MathesonMC , BennettCM , et al. Early childhood infections and immunisation and the development of allergic disease in particular asthma in a high‐risk cohort: a prospective study of allergy‐prone children from birth to six years. Pediatric Allergy and Immunology2010;21(7):1076‐85. [DOI: 10.1111/j.1399‐3038.2010.01018.x; PUBMED: 20337970] ">Hill 2000</a>; <a href="./references#CD003664-bbs2-0007" title="LamBC , YeungCY . The effect of breast milk, infant formula and hypoallergenic formula on incidence of atopic manifestation in high risk infants. Nestle Internal Report1992. ">Lam 1992</a>; <a href="./references#CD003664-bbs2-0008" title="MalletE , HenocqA . Long‐term prevention of allergic diseases by using protein hydrolysate formula in at‐risk infants. Journal of Pediatrics1992;121(5 Pt 2):S95‐100. [PUBMED: 1447641] ">Mallet 1992</a>; <a href="./references#CD003664-bbs2-0009" title="MariniA , AgostiM , MottaG , MoscaF . Effects of a dietary and environmental prevention programme on the incidence of allergic symptoms in high atopic risk infants: three years' follow‐up. Acta Paediatrica Supplement1996;414:1‐21. [PUBMED: 8831855] ">Marini 1996</a>; <a href="./references#CD003664-bbs2-0010" title="NentwichI , MichkovaE , NevoralJ , UrbanekR , SzepfalusiZ . Cow's milk‐specific cellular and humoral immune responses and atopy skin symptoms in infants from atopic families fed a partially (pHF) or extensively (eHF) hydrolyzed infant formula. Allergy2001;56(12):1144‐56. [PUBMED: 11736743] ">Nentwich 2001</a>; <a href="./references#CD003664-bbs2-0011" title="OldaeusG , AnjouK , BjorkstenB , MoranJR , KjellmanNI . Extensively and partially hydrolysed infant formulas for allergy prophylaxis. Archives of Disease in Childhood1997;77(1):4‐10. [PUBMED: 9279143] OldaeusG , BjorkstenB , JenmalmMC , KjellmanNI . Cow's milk IgE and IgG antibody responses to cow's milk formulas. Allergy1999;54(4):352‐7. [PUBMED: 10371094] ">Oldaeus 1997</a>; <a href="./references#CD003664-bbs2-0013" title="TsaiYT , ChouCC , HsiehKH . The effect of hypoallergenic formula on the occurrence of allergic diseases in high risk infants. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi1991;32(3):137‐44. [PUBMED: 1776437] ">Tsai 1991</a>; <a href="./references#CD003664-bbs2-0014" title="VandenplasY . Atopy at 3 years in high‐risk infants fed whey hydrolysate or conventional formula. Lancet1992;339(8801):1118. [PUBMED: 1349137] VandenplasY , HauserB , Van denBorreC , ClybouwC , MahlerT , Hachimi‐IdrissiS , et al. The long‐term effect of a partial whey hydrolysate formula on the prophylaxis of atopic disease. European Journal of Pediatrics1995;154(6):488‐94. [PUBMED: 7671948] VandenplasY , HauserB , Van denBorreC , SacreL , DabI . Effect of a whey hydrolysate prophylaxis of atopic disease. Annals of Allergy1992;68(5):419‐24. [PUBMED: 1586005] ">Vandenplas 1992</a>; <a href="./references#CD003664-bbs2-0015" title="BergA , KramerU , LinkE , BollrathC , HeinrichJ , BrockowI , et al. GINIplus study group. Impact of early feeding on childhood eczema: development after nutritional intervention compared with the natural course ‐ the GINIplus study up to the age of 6 years. Clinical and Experimental Allergy2010;40(4):627‐36. [DOI: 10.1111/j.1365‐2222.2009.03444.x; PUBMED: 20082618] BrockowI , ZutavernA , HoffmannU , GrublA , vonBergA , KoletzkoS , et al. GINIplus Study Group. Early allergic sensitizations and their relevance to atopic diseases in children aged 6 years: results of the GINI study. Journal of Investigational Allergology &amp; Clinical Immunology2009;19(3):180‐7. [DOI: 19610260] LaubereauB , BrockowI , ZirngiblA , KoletzkoS , GrueblA , vonBergA , et al. GINI Study Group. Effect of breast‐feeding on the development of atopic dermatitis during the first 3 years of life ‐ results from the GINI‐birth cohort study. Journal of Pediatrics2004;144(5):602‐7. [DOI: 10.1016/j.jpeds.2003.12.029; PUBMED: 15126993] LaubereauB , Filipiak‐PittroffB , vonBergA , GrublA , ReinhardtD , WichmannHE , et al. Caesarean section and gastrointestinal symptoms, atopic dermatitis, and sensitisation during the first year of life. Archives of Disease in Childhood2004;89(11):993‐7. [DOI: 10.1136/adc.2003.043265; PUBMED: 15499049] RzehakP , SausenthalerS , KoletzkoS , BauerCP , SchaafB , vonBergA , et al. Period‐specific growth, overweight and modification by breastfeeding in the GINI and LISA birth cohorts up to age 6 years. European Journal of Epidemiology2009;24(8):449‐67. [DOI: 10.1007/s10654‐009‐9356‐5; PUBMED: 19521784] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. GINI‐plus Study Group. Long‐term effects of hydrolyzed protein infant formulas on growth ‐ extended follow‐up to 10 y of age: results from the German Infant Nutritional Intervention (GINI) study. American Journal of Clinical Nutrition2011;94(6 Suppl):1803S‐7S. [DOI: 10.3945/ajcn.110.000679; PUBMED: 21849601] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. German Infant Nutritional Intervention Study Group. Short‐ and long‐term effects of feeding hydrolyzed protein infant formulas on growth at &lt; or = 6 y of age: results from the German Infant Nutritional Intervention Study. American Journal of Clinical Nutrition2009;89(6):1846‐56. [DOI: 10.3945/ajcn.2008.27373; PUBMED: 19369380] SausenthalerS , KoletzkoS , KoletzkoB , ReinhardtD , KramerU , vonBergA , et al. GINIplus study group. Effect of hydrolysed formula feeding on taste preferences at 10 years. Data from the German Infant Nutritional Intervention Program Plus Study. Clinical Nutrition2010;29(3):304‐6. [DOI: 10.1016/j.clnu.2010.01.007; PUBMED: 20110140] SchoetzauA , Filipiak‐PittroffB , FrankeK , KoletzkoS , VonBergA , GrueblA , et al. German Infant Nutritional Intervention Study Group. Effect of exclusive breast‐feeding and early solid food avoidance on the incidence of atopic dermatitis in high‐risk infants at 1 year of age. Pediatric Allergy and Immunology2002;13(4):234‐42. [PUBMED: 12390439] SchoetzauA , GehringU , FrankeK , GrublA , KoletzkoS , vonBergA , et al. Gini Study Group. Maternal compliance with nutritional recommendations in an allergy preventive programme. Archives of Disease in Childhood2002;86(3):180‐4. [PUBMED: 11861235] VonBergA , Filipiak‐PittroffB , KrämerU , LinkE , HeinrichJ , KoletzkoS , et al. The German Infant Nutritional Intervention Study (GINI) for the preventive effect of hydrolysed infant formulas in infants at high risk for allergic diseases. Design and selected results. Allergologie2012;35(1):32‐43. VonBergA , Filipiak‐PittroffB , SchulzH , HoffmannU , LinkE , SussmannM , et al. GINIplus study group. Allergic manifestation 15 years after early intervention with hydrolyzed formulas ‐ the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2016;71(2):210‐9. [DOI: 10.1111/all.12790; PUBMED: 26465137] vonBergA , FilipiakB , KoletzkoS , KrämerU , HoffmannB , LinkE , et al. Long‐term effect of cow milk protein hydrolysates in high‐risk children. Results from the 10‐years follow‐up of the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2013;68:295‐6. vonBergA , Filipiak‐PittroffB , KramerU , HoffmannB , LinkE , BeckmannC , et al. GINIplus study group. Allergies in high‐risk schoolchildren after early intervention with cow's milk protein hydrolysates: 10‐year results from the German Infant Nutritional Intervention (GINI) study. Journal of Allergy and Clinical Immunology2013;131(6):1565‐73. [DOI: 10.1016/j.jaci.2013.01.006; PUBMED: 23506844] vonBergA , Filipiak‐PittroffB , KramerU , LinkE , BollrathC , BrockowI , et al. GINIplus study group. Preventive effect of hydrolyzed infant formulas persists until age 6 years: long‐term results from the German Infant Nutritional Intervention Study (GINI). Journal of Allergy and Clinical Immunology2008;121(6):1442‐7. [DOI: 10.1016/j.jaci.2008.04.021; PUBMED: 18539195] vonBergA , KoletzkoS , Filipiak‐PittroffB , LaubereauB , GrublA , WichmannHE , et al. German Infant Nutritional Intervention Study Group. Certain hydrolyzed formulas reduce the incidence of atopic dermatitis but not that of asthma: three‐year results of the German Infant Nutritional Intervention Study. Journal of Allergy and Clinical Immunology2007;119(3):718‐25. [DOI: 10.1016/j.jaci.2006.11.017; PUBMED: 17240440] vonBergA , KoletzkoS , GrublA , Filipiak‐PittroffB , WichmannHE , BauerCP , et al. German Infant Nutritional Intervention Study Group. The effect of hydrolyzed cow's milk formula for allergy prevention in the first year of life: the German Infant Nutritional Intervention Study, a randomized double‐blind trial. Journal of Allergy and Clinical Immunology2003;111(3):533‐40. [PUBMED: 12642834] ">von Berg 2003</a>; <a href="./references#CD003664-bbs2-0016" title="WillemsR , DuchateauJ , MagrezP , DenisR , CasimirG . Influence of hypoallergenic milk formula on the incidence of early allergic manifestations in infants predisposed to atopic diseases. Annals of Allergy1993;71(2):147‐50. [PUBMED: 8346868] ">Willems 1993</a>) enrolled infants at high risk of allergic disease on the basis of a history of allergic disease in a first‐degree relative and/or a high cord IgE level, although <a href="./references#CD003664-bbs2-0007" title="LamBC , YeungCY . The effect of breast milk, infant formula and hypoallergenic formula on incidence of atopic manifestation in high risk infants. Nestle Internal Report1992. ">Lam 1992</a> did not report 'high‐risk' criteria. </p> </li> <li> <p>Risk of allergic disease not specified: three studies did not enrol infants on the basis of risk of allergic disease; <a href="./references#CD003664-bbs2-0005" title="JuvonenP , ManssonM , AnderssonC , JakobssonI . Allergy development and macromolecular absorption in infants with different feeding regimens during the first three days of life. A three‐year prospective follow‐up. Acta Paediatrica1996;85(9):1047‐52. [PUBMED: 8888916] JuvonenP , ManssonM , JakobssonI . Does early diet have an effect on subsequent macromolecular absorption and serum IgE?. Journal of Pediatric Gastroenterology and Nutrition1994;18(3):344‐9. [PUBMED: 8057219] JuvonenP , ManssonM , KjellmanNI , BjorkstenB , JakobssonI . Development of immunoglobulin G and immunoglobulin E antibodies to cow's milk proteins and ovalbumin after a temporary neonatal exposure to hydrolyzed and whole cow's milk proteins. Pediatric Allergy and Immunology1999;10(3):191‐8. [PUBMED: 10565560] ">Juvonen 1996</a> enrolled healthy term infants, although 62% had a family history of allergic disease; <a href="./references#CD003664-bbs2-0006" title="KwintaP , SawiecP , KlimekM , LisG , Cichocka‐JaroszE , PietrzykJJ . Correlation between early neonatal diet and atopic symptoms up to 5‐7 years of age in very low birth weight infants: follow‐up of randomized, double‐blind study. Pediatric Allergy and Immunology2009;20(5):458‐66. [DOI: 10.1111/j.1399‐3038.2008.00814.x; PUBMED: 19490477] ">Kwinta 2009</a> enrolled very low birth weight infants (≤ 1500 g); and <a href="./references#CD003664-bbs2-0012" title="SaarinenKM , Juntunen‐BackmanK , JarvenpaaAL , KlemettiP , KuitunenP , LopeL , et al. Breast‐feeding and the development of cows' milk protein allergy. Advances in Experimental Medicine and Biology2000;478:121‐30. [DOI: 10.1007/0‐306‐46830‐1_10; PUBMED: 11065065] SaarinenKM , Juntunen‐BackmanK , JarvenpaaAL , KuitunenP , LopeL , RenlundM , et al. Supplementary feeding in maternity hospitals and the risk of cow's milk allergy: a prospective study of 6209 infants. Journal of Allergy and Clinical Immunology1999;104(2 Pt 1):457‐61. [PUBMED: 10452771] SaarinenKM , SavilahtiE . Infant feeding patterns affect the subsequent immunological features in cow's milk allergy. Clinical and Experimental Allergy2000;30(3):400‐6. [DOI: 10691899] SaarinenKM , SuomalainenH , SavilahtiE . Diagnostic value of skin‐prick and patch tests and serum eosinophil cationic protein and cow's milk‐specific IgE in infants with cow's milk allergy. Clinical and Experimental Allergy2001;31(3):423‐9. [PUBMED: 11260154] SaarinenKM , VaaralaO , KlemettiP , SavilahtiE . Transforming growth factor‐beta1 in mothers' colostrum and immune responses to cows' milk proteins in infants with cows' milk allergy. Journal of Allergy and Clinical Immunology1999;104(5):1093‐8. [PUBMED: 10550758] SavilahtiE , SaarinenKM . Early infant feeding and type 1 diabetes. European Journal of Nutrition2009;48(4):243‐9. [DOI: 10.1007/s00394‐009‐0008‐z; PUBMED: 19263185] SavilahtiEM , SaarinenKM , SavilahtiE . Specific antibodies to cow's milk proteins in infants: effect of early feeding and diagnosis of cow's milk allergy. European Journal of Nutrition2010;49(8):501‐4. [DOI: 10.1007/s00394‐010‐0109‐8; PUBMED: 20405136] SiltanenM , KajosaariM , PoussaT , SaarinenKM , SavilahtiE . A dual long‐term effect of breastfeeding on atopy in relation to heredity in children at 4 years of age. Allergy2003;58(6):524‐30. [PUBMED: 12757455] ">Saarinen 1999</a> enrolled healthy term infants requiring supplemental feeding in hospital. </p> </li> <li> <p>Low risk of allergic disease: no study reporting allergic disease outcomes enrolled infants at low risk of allergic disease. </p> </li> </ul> </p> </section> <section id="CD003664-sec-0072"> <h5 class="title">Types of interventions</h5> <p>See <a href="./references#CD003664-sec-0158" title="">Characteristics of included studies</a> for types of formula used in each study. </p> <section id="CD003664-sec-0073"> <h6 class="title">Early short‐term feeding: hydrolysed formula versus human milk feeding ‐ low‐risk infants </h6> <p>Two studies (<a href="./references#CD003664-bbs2-0005" title="JuvonenP , ManssonM , AnderssonC , JakobssonI . Allergy development and macromolecular absorption in infants with different feeding regimens during the first three days of life. A three‐year prospective follow‐up. Acta Paediatrica1996;85(9):1047‐52. [PUBMED: 8888916] JuvonenP , ManssonM , JakobssonI . Does early diet have an effect on subsequent macromolecular absorption and serum IgE?. Journal of Pediatric Gastroenterology and Nutrition1994;18(3):344‐9. [PUBMED: 8057219] JuvonenP , ManssonM , KjellmanNI , BjorkstenB , JakobssonI . Development of immunoglobulin G and immunoglobulin E antibodies to cow's milk proteins and ovalbumin after a temporary neonatal exposure to hydrolyzed and whole cow's milk proteins. Pediatric Allergy and Immunology1999;10(3):191‐8. [PUBMED: 10565560] ">Juvonen 1996</a>; <a href="./references#CD003664-bbs2-0012" title="SaarinenKM , Juntunen‐BackmanK , JarvenpaaAL , KlemettiP , KuitunenP , LopeL , et al. Breast‐feeding and the development of cows' milk protein allergy. Advances in Experimental Medicine and Biology2000;478:121‐30. [DOI: 10.1007/0‐306‐46830‐1_10; PUBMED: 11065065] SaarinenKM , Juntunen‐BackmanK , JarvenpaaAL , KuitunenP , LopeL , RenlundM , et al. Supplementary feeding in maternity hospitals and the risk of cow's milk allergy: a prospective study of 6209 infants. Journal of Allergy and Clinical Immunology1999;104(2 Pt 1):457‐61. [PUBMED: 10452771] SaarinenKM , SavilahtiE . Infant feeding patterns affect the subsequent immunological features in cow's milk allergy. Clinical and Experimental Allergy2000;30(3):400‐6. [DOI: 10691899] SaarinenKM , SuomalainenH , SavilahtiE . Diagnostic value of skin‐prick and patch tests and serum eosinophil cationic protein and cow's milk‐specific IgE in infants with cow's milk allergy. Clinical and Experimental Allergy2001;31(3):423‐9. [PUBMED: 11260154] SaarinenKM , VaaralaO , KlemettiP , SavilahtiE . Transforming growth factor‐beta1 in mothers' colostrum and immune responses to cows' milk proteins in infants with cows' milk allergy. Journal of Allergy and Clinical Immunology1999;104(5):1093‐8. [PUBMED: 10550758] SavilahtiE , SaarinenKM . Early infant feeding and type 1 diabetes. European Journal of Nutrition2009;48(4):243‐9. [DOI: 10.1007/s00394‐009‐0008‐z; PUBMED: 19263185] SavilahtiEM , SaarinenKM , SavilahtiE . Specific antibodies to cow's milk proteins in infants: effect of early feeding and diagnosis of cow's milk allergy. European Journal of Nutrition2010;49(8):501‐4. [DOI: 10.1007/s00394‐010‐0109‐8; PUBMED: 20405136] SiltanenM , KajosaariM , PoussaT , SaarinenKM , SavilahtiE . A dual long‐term effect of breastfeeding on atopy in relation to heredity in children at 4 years of age. Allergy2003;58(6):524‐30. [PUBMED: 12757455] ">Saarinen 1999</a>) compared a hydrolysed formula versus pasteurised donor human milk used for early short‐term infant feeding. <a href="./references#CD003664-bbs2-0005" title="JuvonenP , ManssonM , AnderssonC , JakobssonI . Allergy development and macromolecular absorption in infants with different feeding regimens during the first three days of life. A three‐year prospective follow‐up. Acta Paediatrica1996;85(9):1047‐52. [PUBMED: 8888916] JuvonenP , ManssonM , JakobssonI . Does early diet have an effect on subsequent macromolecular absorption and serum IgE?. Journal of Pediatric Gastroenterology and Nutrition1994;18(3):344‐9. [PUBMED: 8057219] JuvonenP , ManssonM , KjellmanNI , BjorkstenB , JakobssonI . Development of immunoglobulin G and immunoglobulin E antibodies to cow's milk proteins and ovalbumin after a temporary neonatal exposure to hydrolyzed and whole cow's milk proteins. Pediatric Allergy and Immunology1999;10(3):191‐8. [PUBMED: 10565560] ">Juvonen 1996</a> gave sole bottle feeds for three days, then all infants were exclusively breast fed. <a href="./references#CD003664-bbs2-0012" title="SaarinenKM , Juntunen‐BackmanK , JarvenpaaAL , KlemettiP , KuitunenP , LopeL , et al. Breast‐feeding and the development of cows' milk protein allergy. Advances in Experimental Medicine and Biology2000;478:121‐30. [DOI: 10.1007/0‐306‐46830‐1_10; PUBMED: 11065065] SaarinenKM , Juntunen‐BackmanK , JarvenpaaAL , KuitunenP , LopeL , RenlundM , et al. Supplementary feeding in maternity hospitals and the risk of cow's milk allergy: a prospective study of 6209 infants. Journal of Allergy and Clinical Immunology1999;104(2 Pt 1):457‐61. [PUBMED: 10452771] SaarinenKM , SavilahtiE . Infant feeding patterns affect the subsequent immunological features in cow's milk allergy. Clinical and Experimental Allergy2000;30(3):400‐6. [DOI: 10691899] SaarinenKM , SuomalainenH , SavilahtiE . Diagnostic value of skin‐prick and patch tests and serum eosinophil cationic protein and cow's milk‐specific IgE in infants with cow's milk allergy. Clinical and Experimental Allergy2001;31(3):423‐9. [PUBMED: 11260154] SaarinenKM , VaaralaO , KlemettiP , SavilahtiE . Transforming growth factor‐beta1 in mothers' colostrum and immune responses to cows' milk proteins in infants with cows' milk allergy. Journal of Allergy and Clinical Immunology1999;104(5):1093‐8. [PUBMED: 10550758] SavilahtiE , SaarinenKM . Early infant feeding and type 1 diabetes. European Journal of Nutrition2009;48(4):243‐9. [DOI: 10.1007/s00394‐009‐0008‐z; PUBMED: 19263185] SavilahtiEM , SaarinenKM , SavilahtiE . Specific antibodies to cow's milk proteins in infants: effect of early feeding and diagnosis of cow's milk allergy. European Journal of Nutrition2010;49(8):501‐4. [DOI: 10.1007/s00394‐010‐0109‐8; PUBMED: 20405136] SiltanenM , KajosaariM , PoussaT , SaarinenKM , SavilahtiE . A dual long‐term effect of breastfeeding on atopy in relation to heredity in children at 4 years of age. Allergy2003;58(6):524‐30. [PUBMED: 12757455] ">Saarinen 1999</a> gave supplemental feeds when required while infants were in hospital (average four days). Mothers were then encouraged to breast feed. </p> </section> <section id="CD003664-sec-0074"> <h6 class="title">Early short‐term feeding: hydrolysed formula versus cow's milk formula (CMF) ‐ low‐risk infants </h6> <p>Two studies (<a href="./references#CD003664-bbs2-0005" title="JuvonenP , ManssonM , AnderssonC , JakobssonI . Allergy development and macromolecular absorption in infants with different feeding regimens during the first three days of life. A three‐year prospective follow‐up. Acta Paediatrica1996;85(9):1047‐52. [PUBMED: 8888916] JuvonenP , ManssonM , JakobssonI . Does early diet have an effect on subsequent macromolecular absorption and serum IgE?. Journal of Pediatric Gastroenterology and Nutrition1994;18(3):344‐9. [PUBMED: 8057219] JuvonenP , ManssonM , KjellmanNI , BjorkstenB , JakobssonI . Development of immunoglobulin G and immunoglobulin E antibodies to cow's milk proteins and ovalbumin after a temporary neonatal exposure to hydrolyzed and whole cow's milk proteins. Pediatric Allergy and Immunology1999;10(3):191‐8. [PUBMED: 10565560] ">Juvonen 1996</a>; <a href="./references#CD003664-bbs2-0012" title="SaarinenKM , Juntunen‐BackmanK , JarvenpaaAL , KlemettiP , KuitunenP , LopeL , et al. Breast‐feeding and the development of cows' milk protein allergy. Advances in Experimental Medicine and Biology2000;478:121‐30. [DOI: 10.1007/0‐306‐46830‐1_10; PUBMED: 11065065] SaarinenKM , Juntunen‐BackmanK , JarvenpaaAL , KuitunenP , LopeL , RenlundM , et al. Supplementary feeding in maternity hospitals and the risk of cow's milk allergy: a prospective study of 6209 infants. Journal of Allergy and Clinical Immunology1999;104(2 Pt 1):457‐61. [PUBMED: 10452771] SaarinenKM , SavilahtiE . Infant feeding patterns affect the subsequent immunological features in cow's milk allergy. Clinical and Experimental Allergy2000;30(3):400‐6. [DOI: 10691899] SaarinenKM , SuomalainenH , SavilahtiE . Diagnostic value of skin‐prick and patch tests and serum eosinophil cationic protein and cow's milk‐specific IgE in infants with cow's milk allergy. Clinical and Experimental Allergy2001;31(3):423‐9. [PUBMED: 11260154] SaarinenKM , VaaralaO , KlemettiP , SavilahtiE . Transforming growth factor‐beta1 in mothers' colostrum and immune responses to cows' milk proteins in infants with cows' milk allergy. Journal of Allergy and Clinical Immunology1999;104(5):1093‐8. [PUBMED: 10550758] SavilahtiE , SaarinenKM . Early infant feeding and type 1 diabetes. European Journal of Nutrition2009;48(4):243‐9. [DOI: 10.1007/s00394‐009‐0008‐z; PUBMED: 19263185] SavilahtiEM , SaarinenKM , SavilahtiE . Specific antibodies to cow's milk proteins in infants: effect of early feeding and diagnosis of cow's milk allergy. European Journal of Nutrition2010;49(8):501‐4. [DOI: 10.1007/s00394‐010‐0109‐8; PUBMED: 20405136] SiltanenM , KajosaariM , PoussaT , SaarinenKM , SavilahtiE . A dual long‐term effect of breastfeeding on atopy in relation to heredity in children at 4 years of age. Allergy2003;58(6):524‐30. [PUBMED: 12757455] ">Saarinen 1999</a>) compared a hydrolysed formula versus CMF for early short‐term infant feeding. <a href="./references#CD003664-bbs2-0005" title="JuvonenP , ManssonM , AnderssonC , JakobssonI . Allergy development and macromolecular absorption in infants with different feeding regimens during the first three days of life. A three‐year prospective follow‐up. Acta Paediatrica1996;85(9):1047‐52. [PUBMED: 8888916] JuvonenP , ManssonM , JakobssonI . Does early diet have an effect on subsequent macromolecular absorption and serum IgE?. Journal of Pediatric Gastroenterology and Nutrition1994;18(3):344‐9. [PUBMED: 8057219] JuvonenP , ManssonM , KjellmanNI , BjorkstenB , JakobssonI . Development of immunoglobulin G and immunoglobulin E antibodies to cow's milk proteins and ovalbumin after a temporary neonatal exposure to hydrolyzed and whole cow's milk proteins. Pediatric Allergy and Immunology1999;10(3):191‐8. [PUBMED: 10565560] ">Juvonen 1996</a> gave sole bottle feeds for three days, then all infants were exclusively breast fed. <a href="./references#CD003664-bbs2-0012" title="SaarinenKM , Juntunen‐BackmanK , JarvenpaaAL , KlemettiP , KuitunenP , LopeL , et al. Breast‐feeding and the development of cows' milk protein allergy. Advances in Experimental Medicine and Biology2000;478:121‐30. [DOI: 10.1007/0‐306‐46830‐1_10; PUBMED: 11065065] SaarinenKM , Juntunen‐BackmanK , JarvenpaaAL , KuitunenP , LopeL , RenlundM , et al. Supplementary feeding in maternity hospitals and the risk of cow's milk allergy: a prospective study of 6209 infants. Journal of Allergy and Clinical Immunology1999;104(2 Pt 1):457‐61. [PUBMED: 10452771] SaarinenKM , SavilahtiE . Infant feeding patterns affect the subsequent immunological features in cow's milk allergy. Clinical and Experimental Allergy2000;30(3):400‐6. [DOI: 10691899] SaarinenKM , SuomalainenH , SavilahtiE . Diagnostic value of skin‐prick and patch tests and serum eosinophil cationic protein and cow's milk‐specific IgE in infants with cow's milk allergy. Clinical and Experimental Allergy2001;31(3):423‐9. [PUBMED: 11260154] SaarinenKM , VaaralaO , KlemettiP , SavilahtiE . Transforming growth factor‐beta1 in mothers' colostrum and immune responses to cows' milk proteins in infants with cows' milk allergy. Journal of Allergy and Clinical Immunology1999;104(5):1093‐8. [PUBMED: 10550758] SavilahtiE , SaarinenKM . Early infant feeding and type 1 diabetes. European Journal of Nutrition2009;48(4):243‐9. [DOI: 10.1007/s00394‐009‐0008‐z; PUBMED: 19263185] SavilahtiEM , SaarinenKM , SavilahtiE . Specific antibodies to cow's milk proteins in infants: effect of early feeding and diagnosis of cow's milk allergy. European Journal of Nutrition2010;49(8):501‐4. [DOI: 10.1007/s00394‐010‐0109‐8; PUBMED: 20405136] SiltanenM , KajosaariM , PoussaT , SaarinenKM , SavilahtiE . A dual long‐term effect of breastfeeding on atopy in relation to heredity in children at 4 years of age. Allergy2003;58(6):524‐30. [PUBMED: 12757455] ">Saarinen 1999</a> gave supplemental feeds when required while infants were in hospital (average four days). Mothers were then encouraged to breast feed. </p> </section> <section id="CD003664-sec-0075"> <h6 class="title">Prolonged feeding: hydrolysed formula versus human milk feeding</h6> <p>We found no studies for this comparison.</p> </section> <section id="CD003664-sec-0076"> <h6 class="title">Prolonged feeding: hydrolysed formula versus cow's milk formula (CMF)</h6> <p>Twelve studies compared prolonged supplemental or sole feeding with a hydrolysed formula versus CMF without differential co‐interventions (<a href="./references#CD003664-bbs2-0001" title="ChiricoG , GasparoniA , CiardelliL , DeAmiciM , ColomboA , RondiniG . Immunogenicity and antigenicity of a partially hydrolyzed cow's milk infant formula. Allergy1997;52(1):82‐8. [PUBMED: 9062633] ">Chirico 1997</a>; <a href="./references#CD003664-bbs2-0002" title="deSetaL , SianiP , CirilloG , DiGruttolaM , CimaduomoL , ColettaS . The prevention of allergic diseases with a hypoallergenic formula: a follow‐up at 24 months. The preliminary results. [Italian]. La Pediatria Medica e Chirurgica: Medical and Surgical Pediatrics1994;16(3):251‐4. [PUBMED: 7971447] ">de Seta 1994</a>; <a href="./references#CD003664-bbs2-0004" title="HillD . A report on the analysis of the Melbourne Atopy Cohort Study. A study designed to test the effectiveness of different formula types on the development of atopic symptoms and signs on a cohort of atopy‐at‐risk infants. Report at year 2. Nestec Internal Report. HillDJ , SporikR , ThorburnJ , HoskingCS . The association of atopic dermatitis in infancy with immunoglobulin E food sensitization. Journal of Pediatrics2000;137(4):475‐9. [DOI: 10.1067/mpd.2000.108207; PUBMED: 11035824] KoplinJ , DharmageSC , GurrinL , OsborneN , TangML , LoweAJ , et al. Soy consumption is not a risk factor for peanut sensitization. Journal of Allergy and Clinical Immunology2008;121(6):1455‐9. [DOI: 10.1016/j.jaci.2008.03.017; PUBMED: 18436294] LoweA , HoskingC , BennettC , AllenK , CarlinJ , DharmageS , et al. The Melbourne Atopy Cohort Study: a RCT of a partially hydrolysed whey formula for the prevention of allergic disease. Internal Medicine Journal2008;38:A158. LoweAJ , AbramsonMJ , HoskingCS , CarlinJB , BennettCM , DharmageSC , et al. The temporal sequence of allergic sensitization and onset of infantile eczema. Clinical &amp; Experimental Allergy2007;37(4):536‐42; Erratum in: Clinical &amp; Experimental Allergy 2007; 37(12);1895. [DOI: 10.1111/j.1365‐2222.2007.02691.x; PUBMED: 17430350] LoweAJ , CarlinJB , BennettCM , HoskingCS , AllenKJ , RobertsonCF , et al. Paracetamol use in early life and asthma: prospective birth cohort study. BMJ2010;341:c4616. [PUBMED: 20843914] LoweAJ , HoskingCS , BennettCM , AllenKJ , AxelradC , CarlinJB , et al. Effect of a partially hydrolyzed whey infant formula at weaning on risk of allergic disease in high‐risk children: a randomized controlled trial. Journal of Allergy and Clinical Immunology2011;128(2):360‐5.e4. [DOI: 10.1016/j.jaci.2010.05.006; PUBMED: 21696814] StoneyRM , WoodsRK , HoskingCS , HillDJ , AbramsonMJ , ThienFC . Maternal breast milk long‐chain n‐3 fatty acids are associated with increased risk of atopy in breastfed infants. Clinical and Experimental Allergy2004;34(2):194‐200; Erratum in: Clinical &amp; Experimental Allergy 2007; 37(12);1895. [PUBMED: 14987297] ThomsonJA , WidjajaC , DarmaputraAA , LoweA , MathesonMC , BennettCM , et al. Early childhood infections and immunisation and the development of allergic disease in particular asthma in a high‐risk cohort: a prospective study of allergy‐prone children from birth to six years. Pediatric Allergy and Immunology2010;21(7):1076‐85. [DOI: 10.1111/j.1399‐3038.2010.01018.x; PUBMED: 20337970] ">Hill 2000</a>; <a href="./references#CD003664-bbs2-0006" title="KwintaP , SawiecP , KlimekM , LisG , Cichocka‐JaroszE , PietrzykJJ . Correlation between early neonatal diet and atopic symptoms up to 5‐7 years of age in very low birth weight infants: follow‐up of randomized, double‐blind study. Pediatric Allergy and Immunology2009;20(5):458‐66. [DOI: 10.1111/j.1399‐3038.2008.00814.x; PUBMED: 19490477] ">Kwinta 2009</a>; <a href="./references#CD003664-bbs2-0007" title="LamBC , YeungCY . The effect of breast milk, infant formula and hypoallergenic formula on incidence of atopic manifestation in high risk infants. Nestle Internal Report1992. ">Lam 1992</a>; <a href="./references#CD003664-bbs2-0008" title="MalletE , HenocqA . Long‐term prevention of allergic diseases by using protein hydrolysate formula in at‐risk infants. Journal of Pediatrics1992;121(5 Pt 2):S95‐100. [PUBMED: 1447641] ">Mallet 1992</a>; <a href="./references#CD003664-bbs2-0009" title="MariniA , AgostiM , MottaG , MoscaF . Effects of a dietary and environmental prevention programme on the incidence of allergic symptoms in high atopic risk infants: three years' follow‐up. Acta Paediatrica Supplement1996;414:1‐21. [PUBMED: 8831855] ">Marini 1996</a>; <a href="./references#CD003664-bbs2-0011" title="OldaeusG , AnjouK , BjorkstenB , MoranJR , KjellmanNI . Extensively and partially hydrolysed infant formulas for allergy prophylaxis. Archives of Disease in Childhood1997;77(1):4‐10. [PUBMED: 9279143] OldaeusG , BjorkstenB , JenmalmMC , KjellmanNI . Cow's milk IgE and IgG antibody responses to cow's milk formulas. Allergy1999;54(4):352‐7. [PUBMED: 10371094] ">Oldaeus 1997</a>; <a href="./references#CD003664-bbs2-0013" title="TsaiYT , ChouCC , HsiehKH . The effect of hypoallergenic formula on the occurrence of allergic diseases in high risk infants. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi1991;32(3):137‐44. [PUBMED: 1776437] ">Tsai 1991</a>; <a href="./references#CD003664-bbs2-0014" title="VandenplasY . Atopy at 3 years in high‐risk infants fed whey hydrolysate or conventional formula. Lancet1992;339(8801):1118. [PUBMED: 1349137] VandenplasY , HauserB , Van denBorreC , ClybouwC , MahlerT , Hachimi‐IdrissiS , et al. The long‐term effect of a partial whey hydrolysate formula on the prophylaxis of atopic disease. European Journal of Pediatrics1995;154(6):488‐94. [PUBMED: 7671948] VandenplasY , HauserB , Van denBorreC , SacreL , DabI . Effect of a whey hydrolysate prophylaxis of atopic disease. Annals of Allergy1992;68(5):419‐24. [PUBMED: 1586005] ">Vandenplas 1992</a>; <a href="./references#CD003664-bbs2-0015" title="BergA , KramerU , LinkE , BollrathC , HeinrichJ , BrockowI , et al. GINIplus study group. Impact of early feeding on childhood eczema: development after nutritional intervention compared with the natural course ‐ the GINIplus study up to the age of 6 years. Clinical and Experimental Allergy2010;40(4):627‐36. [DOI: 10.1111/j.1365‐2222.2009.03444.x; PUBMED: 20082618] BrockowI , ZutavernA , HoffmannU , GrublA , vonBergA , KoletzkoS , et al. GINIplus Study Group. Early allergic sensitizations and their relevance to atopic diseases in children aged 6 years: results of the GINI study. Journal of Investigational Allergology &amp; Clinical Immunology2009;19(3):180‐7. [DOI: 19610260] LaubereauB , BrockowI , ZirngiblA , KoletzkoS , GrueblA , vonBergA , et al. GINI Study Group. Effect of breast‐feeding on the development of atopic dermatitis during the first 3 years of life ‐ results from the GINI‐birth cohort study. Journal of Pediatrics2004;144(5):602‐7. [DOI: 10.1016/j.jpeds.2003.12.029; PUBMED: 15126993] LaubereauB , Filipiak‐PittroffB , vonBergA , GrublA , ReinhardtD , WichmannHE , et al. Caesarean section and gastrointestinal symptoms, atopic dermatitis, and sensitisation during the first year of life. Archives of Disease in Childhood2004;89(11):993‐7. [DOI: 10.1136/adc.2003.043265; PUBMED: 15499049] RzehakP , SausenthalerS , KoletzkoS , BauerCP , SchaafB , vonBergA , et al. Period‐specific growth, overweight and modification by breastfeeding in the GINI and LISA birth cohorts up to age 6 years. European Journal of Epidemiology2009;24(8):449‐67. [DOI: 10.1007/s10654‐009‐9356‐5; PUBMED: 19521784] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. GINI‐plus Study Group. Long‐term effects of hydrolyzed protein infant formulas on growth ‐ extended follow‐up to 10 y of age: results from the German Infant Nutritional Intervention (GINI) study. American Journal of Clinical Nutrition2011;94(6 Suppl):1803S‐7S. [DOI: 10.3945/ajcn.110.000679; PUBMED: 21849601] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. German Infant Nutritional Intervention Study Group. Short‐ and long‐term effects of feeding hydrolyzed protein infant formulas on growth at &lt; or = 6 y of age: results from the German Infant Nutritional Intervention Study. American Journal of Clinical Nutrition2009;89(6):1846‐56. [DOI: 10.3945/ajcn.2008.27373; PUBMED: 19369380] SausenthalerS , KoletzkoS , KoletzkoB , ReinhardtD , KramerU , vonBergA , et al. GINIplus study group. Effect of hydrolysed formula feeding on taste preferences at 10 years. Data from the German Infant Nutritional Intervention Program Plus Study. Clinical Nutrition2010;29(3):304‐6. [DOI: 10.1016/j.clnu.2010.01.007; PUBMED: 20110140] SchoetzauA , Filipiak‐PittroffB , FrankeK , KoletzkoS , VonBergA , GrueblA , et al. German Infant Nutritional Intervention Study Group. Effect of exclusive breast‐feeding and early solid food avoidance on the incidence of atopic dermatitis in high‐risk infants at 1 year of age. Pediatric Allergy and Immunology2002;13(4):234‐42. [PUBMED: 12390439] SchoetzauA , GehringU , FrankeK , GrublA , KoletzkoS , vonBergA , et al. Gini Study Group. Maternal compliance with nutritional recommendations in an allergy preventive programme. Archives of Disease in Childhood2002;86(3):180‐4. [PUBMED: 11861235] VonBergA , Filipiak‐PittroffB , KrämerU , LinkE , HeinrichJ , KoletzkoS , et al. The German Infant Nutritional Intervention Study (GINI) for the preventive effect of hydrolysed infant formulas in infants at high risk for allergic diseases. Design and selected results. Allergologie2012;35(1):32‐43. VonBergA , Filipiak‐PittroffB , SchulzH , HoffmannU , LinkE , SussmannM , et al. GINIplus study group. Allergic manifestation 15 years after early intervention with hydrolyzed formulas ‐ the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2016;71(2):210‐9. [DOI: 10.1111/all.12790; PUBMED: 26465137] vonBergA , FilipiakB , KoletzkoS , KrämerU , HoffmannB , LinkE , et al. Long‐term effect of cow milk protein hydrolysates in high‐risk children. Results from the 10‐years follow‐up of the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2013;68:295‐6. vonBergA , Filipiak‐PittroffB , KramerU , HoffmannB , LinkE , BeckmannC , et al. GINIplus study group. Allergies in high‐risk schoolchildren after early intervention with cow's milk protein hydrolysates: 10‐year results from the German Infant Nutritional Intervention (GINI) study. Journal of Allergy and Clinical Immunology2013;131(6):1565‐73. [DOI: 10.1016/j.jaci.2013.01.006; PUBMED: 23506844] vonBergA , Filipiak‐PittroffB , KramerU , LinkE , BollrathC , BrockowI , et al. GINIplus study group. Preventive effect of hydrolyzed infant formulas persists until age 6 years: long‐term results from the German Infant Nutritional Intervention Study (GINI). Journal of Allergy and Clinical Immunology2008;121(6):1442‐7. [DOI: 10.1016/j.jaci.2008.04.021; PUBMED: 18539195] vonBergA , KoletzkoS , Filipiak‐PittroffB , LaubereauB , GrublA , WichmannHE , et al. German Infant Nutritional Intervention Study Group. Certain hydrolyzed formulas reduce the incidence of atopic dermatitis but not that of asthma: three‐year results of the German Infant Nutritional Intervention Study. Journal of Allergy and Clinical Immunology2007;119(3):718‐25. [DOI: 10.1016/j.jaci.2006.11.017; PUBMED: 17240440] vonBergA , KoletzkoS , GrublA , Filipiak‐PittroffB , WichmannHE , BauerCP , et al. German Infant Nutritional Intervention Study Group. The effect of hydrolyzed cow's milk formula for allergy prevention in the first year of life: the German Infant Nutritional Intervention Study, a randomized double‐blind trial. Journal of Allergy and Clinical Immunology2003;111(3):533‐40. [PUBMED: 12642834] ">von Berg 2003</a>; <a href="./references#CD003664-bbs2-0016" title="WillemsR , DuchateauJ , MagrezP , DenisR , CasimirG . Influence of hypoallergenic milk formula on the incidence of early allergic manifestations in infants predisposed to atopic diseases. Annals of Allergy1993;71(2):147‐50. [PUBMED: 8346868] ">Willems 1993</a>). Three studies (<a href="./references#CD003664-bbs2-0001" title="ChiricoG , GasparoniA , CiardelliL , DeAmiciM , ColomboA , RondiniG . Immunogenicity and antigenicity of a partially hydrolyzed cow's milk infant formula. Allergy1997;52(1):82‐8. [PUBMED: 9062633] ">Chirico 1997</a>; <a href="./references#CD003664-bbs2-0009" title="MariniA , AgostiM , MottaG , MoscaF . Effects of a dietary and environmental prevention programme on the incidence of allergic symptoms in high atopic risk infants: three years' follow‐up. Acta Paediatrica Supplement1996;414:1‐21. [PUBMED: 8831855] ">Marini 1996</a>; <a href="./references#CD003664-bbs2-0011" title="OldaeusG , AnjouK , BjorkstenB , MoranJR , KjellmanNI . Extensively and partially hydrolysed infant formulas for allergy prophylaxis. Archives of Disease in Childhood1997;77(1):4‐10. [PUBMED: 9279143] OldaeusG , BjorkstenB , JenmalmMC , KjellmanNI . Cow's milk IgE and IgG antibody responses to cow's milk formulas. Allergy1999;54(4):352‐7. [PUBMED: 10371094] ">Oldaeus 1997</a>) reported additional allergy avoidance measures in both hydrolysed formula and CMF groups. </p> </section> <section id="CD003664-sec-0077"> <h6 class="title">Prolonged feeding: hydrolysed formula versus cow's milk formula (CMF) ‐ low‐risk infants</h6> <p><a href="./references#CD003664-bbs2-0006" title="KwintaP , SawiecP , KlimekM , LisG , Cichocka‐JaroszE , PietrzykJJ . Correlation between early neonatal diet and atopic symptoms up to 5‐7 years of age in very low birth weight infants: follow‐up of randomized, double‐blind study. Pediatric Allergy and Immunology2009;20(5):458‐66. [DOI: 10.1111/j.1399‐3038.2008.00814.x; PUBMED: 19490477] ">Kwinta 2009</a> compared prolonged feeding with a hydrolysed formula versus CMF in low‐risk infants. </p> </section> <section id="CD003664-sec-0078"> <h6 class="title">Prolonged feeding: hydrolysed formula versus cow's milk formula (CMF) ‐ high‐risk infants </h6> <p>Eleven studies (<a href="./references#CD003664-bbs2-0001" title="ChiricoG , GasparoniA , CiardelliL , DeAmiciM , ColomboA , RondiniG . Immunogenicity and antigenicity of a partially hydrolyzed cow's milk infant formula. Allergy1997;52(1):82‐8. [PUBMED: 9062633] ">Chirico 1997</a>; <a href="./references#CD003664-bbs2-0002" title="deSetaL , SianiP , CirilloG , DiGruttolaM , CimaduomoL , ColettaS . The prevention of allergic diseases with a hypoallergenic formula: a follow‐up at 24 months. The preliminary results. [Italian]. La Pediatria Medica e Chirurgica: Medical and Surgical Pediatrics1994;16(3):251‐4. [PUBMED: 7971447] ">de Seta 1994</a>; <a href="./references#CD003664-bbs2-0004" title="HillD . A report on the analysis of the Melbourne Atopy Cohort Study. A study designed to test the effectiveness of different formula types on the development of atopic symptoms and signs on a cohort of atopy‐at‐risk infants. Report at year 2. Nestec Internal Report. HillDJ , SporikR , ThorburnJ , HoskingCS . The association of atopic dermatitis in infancy with immunoglobulin E food sensitization. Journal of Pediatrics2000;137(4):475‐9. [DOI: 10.1067/mpd.2000.108207; PUBMED: 11035824] KoplinJ , DharmageSC , GurrinL , OsborneN , TangML , LoweAJ , et al. Soy consumption is not a risk factor for peanut sensitization. Journal of Allergy and Clinical Immunology2008;121(6):1455‐9. [DOI: 10.1016/j.jaci.2008.03.017; PUBMED: 18436294] LoweA , HoskingC , BennettC , AllenK , CarlinJ , DharmageS , et al. The Melbourne Atopy Cohort Study: a RCT of a partially hydrolysed whey formula for the prevention of allergic disease. Internal Medicine Journal2008;38:A158. LoweAJ , AbramsonMJ , HoskingCS , CarlinJB , BennettCM , DharmageSC , et al. The temporal sequence of allergic sensitization and onset of infantile eczema. Clinical &amp; Experimental Allergy2007;37(4):536‐42; Erratum in: Clinical &amp; Experimental Allergy 2007; 37(12);1895. [DOI: 10.1111/j.1365‐2222.2007.02691.x; PUBMED: 17430350] LoweAJ , CarlinJB , BennettCM , HoskingCS , AllenKJ , RobertsonCF , et al. Paracetamol use in early life and asthma: prospective birth cohort study. BMJ2010;341:c4616. [PUBMED: 20843914] LoweAJ , HoskingCS , BennettCM , AllenKJ , AxelradC , CarlinJB , et al. Effect of a partially hydrolyzed whey infant formula at weaning on risk of allergic disease in high‐risk children: a randomized controlled trial. Journal of Allergy and Clinical Immunology2011;128(2):360‐5.e4. [DOI: 10.1016/j.jaci.2010.05.006; PUBMED: 21696814] StoneyRM , WoodsRK , HoskingCS , HillDJ , AbramsonMJ , ThienFC . Maternal breast milk long‐chain n‐3 fatty acids are associated with increased risk of atopy in breastfed infants. Clinical and Experimental Allergy2004;34(2):194‐200; Erratum in: Clinical &amp; Experimental Allergy 2007; 37(12);1895. [PUBMED: 14987297] ThomsonJA , WidjajaC , DarmaputraAA , LoweA , MathesonMC , BennettCM , et al. Early childhood infections and immunisation and the development of allergic disease in particular asthma in a high‐risk cohort: a prospective study of allergy‐prone children from birth to six years. Pediatric Allergy and Immunology2010;21(7):1076‐85. [DOI: 10.1111/j.1399‐3038.2010.01018.x; PUBMED: 20337970] ">Hill 2000</a>; <a href="./references#CD003664-bbs2-0007" title="LamBC , YeungCY . The effect of breast milk, infant formula and hypoallergenic formula on incidence of atopic manifestation in high risk infants. Nestle Internal Report1992. ">Lam 1992</a>; <a href="./references#CD003664-bbs2-0008" title="MalletE , HenocqA . Long‐term prevention of allergic diseases by using protein hydrolysate formula in at‐risk infants. Journal of Pediatrics1992;121(5 Pt 2):S95‐100. [PUBMED: 1447641] ">Mallet 1992</a>; <a href="./references#CD003664-bbs2-0009" title="MariniA , AgostiM , MottaG , MoscaF . Effects of a dietary and environmental prevention programme on the incidence of allergic symptoms in high atopic risk infants: three years' follow‐up. Acta Paediatrica Supplement1996;414:1‐21. [PUBMED: 8831855] ">Marini 1996</a>; <a href="./references#CD003664-bbs2-0011" title="OldaeusG , AnjouK , BjorkstenB , MoranJR , KjellmanNI . Extensively and partially hydrolysed infant formulas for allergy prophylaxis. Archives of Disease in Childhood1997;77(1):4‐10. [PUBMED: 9279143] OldaeusG , BjorkstenB , JenmalmMC , KjellmanNI . Cow's milk IgE and IgG antibody responses to cow's milk formulas. Allergy1999;54(4):352‐7. [PUBMED: 10371094] ">Oldaeus 1997</a>; <a href="./references#CD003664-bbs2-0013" title="TsaiYT , ChouCC , HsiehKH . The effect of hypoallergenic formula on the occurrence of allergic diseases in high risk infants. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi1991;32(3):137‐44. [PUBMED: 1776437] ">Tsai 1991</a>; <a href="./references#CD003664-bbs2-0014" title="VandenplasY . Atopy at 3 years in high‐risk infants fed whey hydrolysate or conventional formula. Lancet1992;339(8801):1118. [PUBMED: 1349137] VandenplasY , HauserB , Van denBorreC , ClybouwC , MahlerT , Hachimi‐IdrissiS , et al. The long‐term effect of a partial whey hydrolysate formula on the prophylaxis of atopic disease. European Journal of Pediatrics1995;154(6):488‐94. [PUBMED: 7671948] VandenplasY , HauserB , Van denBorreC , SacreL , DabI . Effect of a whey hydrolysate prophylaxis of atopic disease. Annals of Allergy1992;68(5):419‐24. [PUBMED: 1586005] ">Vandenplas 1992</a>; <a href="./references#CD003664-bbs2-0015" title="BergA , KramerU , LinkE , BollrathC , HeinrichJ , BrockowI , et al. GINIplus study group. Impact of early feeding on childhood eczema: development after nutritional intervention compared with the natural course ‐ the GINIplus study up to the age of 6 years. Clinical and Experimental Allergy2010;40(4):627‐36. [DOI: 10.1111/j.1365‐2222.2009.03444.x; PUBMED: 20082618] BrockowI , ZutavernA , HoffmannU , GrublA , vonBergA , KoletzkoS , et al. GINIplus Study Group. Early allergic sensitizations and their relevance to atopic diseases in children aged 6 years: results of the GINI study. Journal of Investigational Allergology &amp; Clinical Immunology2009;19(3):180‐7. [DOI: 19610260] LaubereauB , BrockowI , ZirngiblA , KoletzkoS , GrueblA , vonBergA , et al. GINI Study Group. Effect of breast‐feeding on the development of atopic dermatitis during the first 3 years of life ‐ results from the GINI‐birth cohort study. Journal of Pediatrics2004;144(5):602‐7. [DOI: 10.1016/j.jpeds.2003.12.029; PUBMED: 15126993] LaubereauB , Filipiak‐PittroffB , vonBergA , GrublA , ReinhardtD , WichmannHE , et al. Caesarean section and gastrointestinal symptoms, atopic dermatitis, and sensitisation during the first year of life. Archives of Disease in Childhood2004;89(11):993‐7. [DOI: 10.1136/adc.2003.043265; PUBMED: 15499049] RzehakP , SausenthalerS , KoletzkoS , BauerCP , SchaafB , vonBergA , et al. Period‐specific growth, overweight and modification by breastfeeding in the GINI and LISA birth cohorts up to age 6 years. European Journal of Epidemiology2009;24(8):449‐67. [DOI: 10.1007/s10654‐009‐9356‐5; PUBMED: 19521784] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. GINI‐plus Study Group. Long‐term effects of hydrolyzed protein infant formulas on growth ‐ extended follow‐up to 10 y of age: results from the German Infant Nutritional Intervention (GINI) study. American Journal of Clinical Nutrition2011;94(6 Suppl):1803S‐7S. [DOI: 10.3945/ajcn.110.000679; PUBMED: 21849601] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. German Infant Nutritional Intervention Study Group. Short‐ and long‐term effects of feeding hydrolyzed protein infant formulas on growth at &lt; or = 6 y of age: results from the German Infant Nutritional Intervention Study. American Journal of Clinical Nutrition2009;89(6):1846‐56. [DOI: 10.3945/ajcn.2008.27373; PUBMED: 19369380] SausenthalerS , KoletzkoS , KoletzkoB , ReinhardtD , KramerU , vonBergA , et al. GINIplus study group. Effect of hydrolysed formula feeding on taste preferences at 10 years. Data from the German Infant Nutritional Intervention Program Plus Study. Clinical Nutrition2010;29(3):304‐6. [DOI: 10.1016/j.clnu.2010.01.007; PUBMED: 20110140] SchoetzauA , Filipiak‐PittroffB , FrankeK , KoletzkoS , VonBergA , GrueblA , et al. German Infant Nutritional Intervention Study Group. Effect of exclusive breast‐feeding and early solid food avoidance on the incidence of atopic dermatitis in high‐risk infants at 1 year of age. Pediatric Allergy and Immunology2002;13(4):234‐42. [PUBMED: 12390439] SchoetzauA , GehringU , FrankeK , GrublA , KoletzkoS , vonBergA , et al. Gini Study Group. Maternal compliance with nutritional recommendations in an allergy preventive programme. Archives of Disease in Childhood2002;86(3):180‐4. [PUBMED: 11861235] VonBergA , Filipiak‐PittroffB , KrämerU , LinkE , HeinrichJ , KoletzkoS , et al. The German Infant Nutritional Intervention Study (GINI) for the preventive effect of hydrolysed infant formulas in infants at high risk for allergic diseases. Design and selected results. Allergologie2012;35(1):32‐43. VonBergA , Filipiak‐PittroffB , SchulzH , HoffmannU , LinkE , SussmannM , et al. GINIplus study group. Allergic manifestation 15 years after early intervention with hydrolyzed formulas ‐ the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2016;71(2):210‐9. [DOI: 10.1111/all.12790; PUBMED: 26465137] vonBergA , FilipiakB , KoletzkoS , KrämerU , HoffmannB , LinkE , et al. Long‐term effect of cow milk protein hydrolysates in high‐risk children. Results from the 10‐years follow‐up of the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2013;68:295‐6. vonBergA , Filipiak‐PittroffB , KramerU , HoffmannB , LinkE , BeckmannC , et al. GINIplus study group. Allergies in high‐risk schoolchildren after early intervention with cow's milk protein hydrolysates: 10‐year results from the German Infant Nutritional Intervention (GINI) study. Journal of Allergy and Clinical Immunology2013;131(6):1565‐73. [DOI: 10.1016/j.jaci.2013.01.006; PUBMED: 23506844] vonBergA , Filipiak‐PittroffB , KramerU , LinkE , BollrathC , BrockowI , et al. GINIplus study group. Preventive effect of hydrolyzed infant formulas persists until age 6 years: long‐term results from the German Infant Nutritional Intervention Study (GINI). Journal of Allergy and Clinical Immunology2008;121(6):1442‐7. [DOI: 10.1016/j.jaci.2008.04.021; PUBMED: 18539195] vonBergA , KoletzkoS , Filipiak‐PittroffB , LaubereauB , GrublA , WichmannHE , et al. German Infant Nutritional Intervention Study Group. Certain hydrolyzed formulas reduce the incidence of atopic dermatitis but not that of asthma: three‐year results of the German Infant Nutritional Intervention Study. Journal of Allergy and Clinical Immunology2007;119(3):718‐25. [DOI: 10.1016/j.jaci.2006.11.017; PUBMED: 17240440] vonBergA , KoletzkoS , GrublA , Filipiak‐PittroffB , WichmannHE , BauerCP , et al. German Infant Nutritional Intervention Study Group. The effect of hydrolyzed cow's milk formula for allergy prevention in the first year of life: the German Infant Nutritional Intervention Study, a randomized double‐blind trial. Journal of Allergy and Clinical Immunology2003;111(3):533‐40. [PUBMED: 12642834] ">von Berg 2003</a>; <a href="./references#CD003664-bbs2-0016" title="WillemsR , DuchateauJ , MagrezP , DenisR , CasimirG . Influence of hypoallergenic milk formula on the incidence of early allergic manifestations in infants predisposed to atopic diseases. Annals of Allergy1993;71(2):147‐50. [PUBMED: 8346868] ">Willems 1993</a>) compared prolonged feeding with a hydrolysed formula versus CMF in high‐risk infants. </p> </section> <section id="CD003664-sec-0079"> <h6 class="title">Prolonged feeding: partially hydrolysed formula (PHF) versus cow's milk formula (CMF)</h6> <p>Eleven studies (<a href="./references#CD003664-bbs2-0001" title="ChiricoG , GasparoniA , CiardelliL , DeAmiciM , ColomboA , RondiniG . Immunogenicity and antigenicity of a partially hydrolyzed cow's milk infant formula. Allergy1997;52(1):82‐8. [PUBMED: 9062633] ">Chirico 1997</a>; <a href="./references#CD003664-bbs2-0002" title="deSetaL , SianiP , CirilloG , DiGruttolaM , CimaduomoL , ColettaS . The prevention of allergic diseases with a hypoallergenic formula: a follow‐up at 24 months. The preliminary results. [Italian]. La Pediatria Medica e Chirurgica: Medical and Surgical Pediatrics1994;16(3):251‐4. [PUBMED: 7971447] ">de Seta 1994</a>; <a href="./references#CD003664-bbs2-0006" title="KwintaP , SawiecP , KlimekM , LisG , Cichocka‐JaroszE , PietrzykJJ . Correlation between early neonatal diet and atopic symptoms up to 5‐7 years of age in very low birth weight infants: follow‐up of randomized, double‐blind study. Pediatric Allergy and Immunology2009;20(5):458‐66. [DOI: 10.1111/j.1399‐3038.2008.00814.x; PUBMED: 19490477] ">Kwinta 2009</a>; <a href="./references#CD003664-bbs2-0004" title="HillD . A report on the analysis of the Melbourne Atopy Cohort Study. A study designed to test the effectiveness of different formula types on the development of atopic symptoms and signs on a cohort of atopy‐at‐risk infants. Report at year 2. Nestec Internal Report. HillDJ , SporikR , ThorburnJ , HoskingCS . The association of atopic dermatitis in infancy with immunoglobulin E food sensitization. Journal of Pediatrics2000;137(4):475‐9. [DOI: 10.1067/mpd.2000.108207; PUBMED: 11035824] KoplinJ , DharmageSC , GurrinL , OsborneN , TangML , LoweAJ , et al. Soy consumption is not a risk factor for peanut sensitization. Journal of Allergy and Clinical Immunology2008;121(6):1455‐9. [DOI: 10.1016/j.jaci.2008.03.017; PUBMED: 18436294] LoweA , HoskingC , BennettC , AllenK , CarlinJ , DharmageS , et al. The Melbourne Atopy Cohort Study: a RCT of a partially hydrolysed whey formula for the prevention of allergic disease. Internal Medicine Journal2008;38:A158. LoweAJ , AbramsonMJ , HoskingCS , CarlinJB , BennettCM , DharmageSC , et al. The temporal sequence of allergic sensitization and onset of infantile eczema. Clinical &amp; Experimental Allergy2007;37(4):536‐42; Erratum in: Clinical &amp; Experimental Allergy 2007; 37(12);1895. [DOI: 10.1111/j.1365‐2222.2007.02691.x; PUBMED: 17430350] LoweAJ , CarlinJB , BennettCM , HoskingCS , AllenKJ , RobertsonCF , et al. Paracetamol use in early life and asthma: prospective birth cohort study. BMJ2010;341:c4616. [PUBMED: 20843914] LoweAJ , HoskingCS , BennettCM , AllenKJ , AxelradC , CarlinJB , et al. Effect of a partially hydrolyzed whey infant formula at weaning on risk of allergic disease in high‐risk children: a randomized controlled trial. Journal of Allergy and Clinical Immunology2011;128(2):360‐5.e4. [DOI: 10.1016/j.jaci.2010.05.006; PUBMED: 21696814] StoneyRM , WoodsRK , HoskingCS , HillDJ , AbramsonMJ , ThienFC . Maternal breast milk long‐chain n‐3 fatty acids are associated with increased risk of atopy in breastfed infants. Clinical and Experimental Allergy2004;34(2):194‐200; Erratum in: Clinical &amp; Experimental Allergy 2007; 37(12);1895. [PUBMED: 14987297] ThomsonJA , WidjajaC , DarmaputraAA , LoweA , MathesonMC , BennettCM , et al. Early childhood infections and immunisation and the development of allergic disease in particular asthma in a high‐risk cohort: a prospective study of allergy‐prone children from birth to six years. Pediatric Allergy and Immunology2010;21(7):1076‐85. [DOI: 10.1111/j.1399‐3038.2010.01018.x; PUBMED: 20337970] ">Hill 2000</a>; <a href="./references#CD003664-bbs2-0007" title="LamBC , YeungCY . The effect of breast milk, infant formula and hypoallergenic formula on incidence of atopic manifestation in high risk infants. Nestle Internal Report1992. ">Lam 1992</a>; <a href="./references#CD003664-bbs2-0009" title="MariniA , AgostiM , MottaG , MoscaF . Effects of a dietary and environmental prevention programme on the incidence of allergic symptoms in high atopic risk infants: three years' follow‐up. Acta Paediatrica Supplement1996;414:1‐21. [PUBMED: 8831855] ">Marini 1996</a>; <a href="./references#CD003664-bbs2-0011" title="OldaeusG , AnjouK , BjorkstenB , MoranJR , KjellmanNI . Extensively and partially hydrolysed infant formulas for allergy prophylaxis. Archives of Disease in Childhood1997;77(1):4‐10. [PUBMED: 9279143] OldaeusG , BjorkstenB , JenmalmMC , KjellmanNI . Cow's milk IgE and IgG antibody responses to cow's milk formulas. Allergy1999;54(4):352‐7. [PUBMED: 10371094] ">Oldaeus 1997</a>; <a href="./references#CD003664-bbs2-0013" title="TsaiYT , ChouCC , HsiehKH . The effect of hypoallergenic formula on the occurrence of allergic diseases in high risk infants. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi1991;32(3):137‐44. [PUBMED: 1776437] ">Tsai 1991</a>; <a href="./references#CD003664-bbs2-0014" title="VandenplasY . Atopy at 3 years in high‐risk infants fed whey hydrolysate or conventional formula. Lancet1992;339(8801):1118. [PUBMED: 1349137] VandenplasY , HauserB , Van denBorreC , ClybouwC , MahlerT , Hachimi‐IdrissiS , et al. The long‐term effect of a partial whey hydrolysate formula on the prophylaxis of atopic disease. European Journal of Pediatrics1995;154(6):488‐94. [PUBMED: 7671948] VandenplasY , HauserB , Van denBorreC , SacreL , DabI . Effect of a whey hydrolysate prophylaxis of atopic disease. Annals of Allergy1992;68(5):419‐24. [PUBMED: 1586005] ">Vandenplas 1992</a>; <a href="./references#CD003664-bbs2-0015" title="BergA , KramerU , LinkE , BollrathC , HeinrichJ , BrockowI , et al. GINIplus study group. Impact of early feeding on childhood eczema: development after nutritional intervention compared with the natural course ‐ the GINIplus study up to the age of 6 years. Clinical and Experimental Allergy2010;40(4):627‐36. [DOI: 10.1111/j.1365‐2222.2009.03444.x; PUBMED: 20082618] BrockowI , ZutavernA , HoffmannU , GrublA , vonBergA , KoletzkoS , et al. GINIplus Study Group. Early allergic sensitizations and their relevance to atopic diseases in children aged 6 years: results of the GINI study. Journal of Investigational Allergology &amp; Clinical Immunology2009;19(3):180‐7. [DOI: 19610260] LaubereauB , BrockowI , ZirngiblA , KoletzkoS , GrueblA , vonBergA , et al. GINI Study Group. Effect of breast‐feeding on the development of atopic dermatitis during the first 3 years of life ‐ results from the GINI‐birth cohort study. Journal of Pediatrics2004;144(5):602‐7. [DOI: 10.1016/j.jpeds.2003.12.029; PUBMED: 15126993] LaubereauB , Filipiak‐PittroffB , vonBergA , GrublA , ReinhardtD , WichmannHE , et al. Caesarean section and gastrointestinal symptoms, atopic dermatitis, and sensitisation during the first year of life. Archives of Disease in Childhood2004;89(11):993‐7. [DOI: 10.1136/adc.2003.043265; PUBMED: 15499049] RzehakP , SausenthalerS , KoletzkoS , BauerCP , SchaafB , vonBergA , et al. Period‐specific growth, overweight and modification by breastfeeding in the GINI and LISA birth cohorts up to age 6 years. European Journal of Epidemiology2009;24(8):449‐67. [DOI: 10.1007/s10654‐009‐9356‐5; PUBMED: 19521784] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. GINI‐plus Study Group. Long‐term effects of hydrolyzed protein infant formulas on growth ‐ extended follow‐up to 10 y of age: results from the German Infant Nutritional Intervention (GINI) study. American Journal of Clinical Nutrition2011;94(6 Suppl):1803S‐7S. [DOI: 10.3945/ajcn.110.000679; PUBMED: 21849601] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. German Infant Nutritional Intervention Study Group. Short‐ and long‐term effects of feeding hydrolyzed protein infant formulas on growth at &lt; or = 6 y of age: results from the German Infant Nutritional Intervention Study. American Journal of Clinical Nutrition2009;89(6):1846‐56. [DOI: 10.3945/ajcn.2008.27373; PUBMED: 19369380] SausenthalerS , KoletzkoS , KoletzkoB , ReinhardtD , KramerU , vonBergA , et al. GINIplus study group. Effect of hydrolysed formula feeding on taste preferences at 10 years. Data from the German Infant Nutritional Intervention Program Plus Study. Clinical Nutrition2010;29(3):304‐6. [DOI: 10.1016/j.clnu.2010.01.007; PUBMED: 20110140] SchoetzauA , Filipiak‐PittroffB , FrankeK , KoletzkoS , VonBergA , GrueblA , et al. German Infant Nutritional Intervention Study Group. Effect of exclusive breast‐feeding and early solid food avoidance on the incidence of atopic dermatitis in high‐risk infants at 1 year of age. Pediatric Allergy and Immunology2002;13(4):234‐42. [PUBMED: 12390439] SchoetzauA , GehringU , FrankeK , GrublA , KoletzkoS , vonBergA , et al. Gini Study Group. Maternal compliance with nutritional recommendations in an allergy preventive programme. Archives of Disease in Childhood2002;86(3):180‐4. [PUBMED: 11861235] VonBergA , Filipiak‐PittroffB , KrämerU , LinkE , HeinrichJ , KoletzkoS , et al. The German Infant Nutritional Intervention Study (GINI) for the preventive effect of hydrolysed infant formulas in infants at high risk for allergic diseases. Design and selected results. Allergologie2012;35(1):32‐43. VonBergA , Filipiak‐PittroffB , SchulzH , HoffmannU , LinkE , SussmannM , et al. GINIplus study group. Allergic manifestation 15 years after early intervention with hydrolyzed formulas ‐ the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2016;71(2):210‐9. [DOI: 10.1111/all.12790; PUBMED: 26465137] vonBergA , FilipiakB , KoletzkoS , KrämerU , HoffmannB , LinkE , et al. Long‐term effect of cow milk protein hydrolysates in high‐risk children. Results from the 10‐years follow‐up of the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2013;68:295‐6. vonBergA , Filipiak‐PittroffB , KramerU , HoffmannB , LinkE , BeckmannC , et al. GINIplus study group. Allergies in high‐risk schoolchildren after early intervention with cow's milk protein hydrolysates: 10‐year results from the German Infant Nutritional Intervention (GINI) study. Journal of Allergy and Clinical Immunology2013;131(6):1565‐73. [DOI: 10.1016/j.jaci.2013.01.006; PUBMED: 23506844] vonBergA , Filipiak‐PittroffB , KramerU , LinkE , BollrathC , BrockowI , et al. GINIplus study group. Preventive effect of hydrolyzed infant formulas persists until age 6 years: long‐term results from the German Infant Nutritional Intervention Study (GINI). Journal of Allergy and Clinical Immunology2008;121(6):1442‐7. [DOI: 10.1016/j.jaci.2008.04.021; PUBMED: 18539195] vonBergA , KoletzkoS , Filipiak‐PittroffB , LaubereauB , GrublA , WichmannHE , et al. German Infant Nutritional Intervention Study Group. Certain hydrolyzed formulas reduce the incidence of atopic dermatitis but not that of asthma: three‐year results of the German Infant Nutritional Intervention Study. Journal of Allergy and Clinical Immunology2007;119(3):718‐25. [DOI: 10.1016/j.jaci.2006.11.017; PUBMED: 17240440] vonBergA , KoletzkoS , GrublA , Filipiak‐PittroffB , WichmannHE , BauerCP , et al. German Infant Nutritional Intervention Study Group. The effect of hydrolyzed cow's milk formula for allergy prevention in the first year of life: the German Infant Nutritional Intervention Study, a randomized double‐blind trial. Journal of Allergy and Clinical Immunology2003;111(3):533‐40. [PUBMED: 12642834] ">von Berg 2003</a>; <a href="./references#CD003664-bbs2-0016" title="WillemsR , DuchateauJ , MagrezP , DenisR , CasimirG . Influence of hypoallergenic milk formula on the incidence of early allergic manifestations in infants predisposed to atopic diseases. Annals of Allergy1993;71(2):147‐50. [PUBMED: 8346868] ">Willems 1993</a>) compared prolonged feeding with a PHF versus CMF. </p> </section> <section id="CD003664-sec-0080"> <h6 class="title">Prolonged feeding: extensively hydrolysed formula (EHF) versus cow's milk formula (CMF) </h6> <p>Four studies (<a href="./references#CD003664-bbs2-0006" title="KwintaP , SawiecP , KlimekM , LisG , Cichocka‐JaroszE , PietrzykJJ . Correlation between early neonatal diet and atopic symptoms up to 5‐7 years of age in very low birth weight infants: follow‐up of randomized, double‐blind study. Pediatric Allergy and Immunology2009;20(5):458‐66. [DOI: 10.1111/j.1399‐3038.2008.00814.x; PUBMED: 19490477] ">Kwinta 2009</a>; <a href="./references#CD003664-bbs2-0008" title="MalletE , HenocqA . Long‐term prevention of allergic diseases by using protein hydrolysate formula in at‐risk infants. Journal of Pediatrics1992;121(5 Pt 2):S95‐100. [PUBMED: 1447641] ">Mallet 1992</a>; <a href="./references#CD003664-bbs2-0011" title="OldaeusG , AnjouK , BjorkstenB , MoranJR , KjellmanNI . Extensively and partially hydrolysed infant formulas for allergy prophylaxis. Archives of Disease in Childhood1997;77(1):4‐10. [PUBMED: 9279143] OldaeusG , BjorkstenB , JenmalmMC , KjellmanNI . Cow's milk IgE and IgG antibody responses to cow's milk formulas. Allergy1999;54(4):352‐7. [PUBMED: 10371094] ">Oldaeus 1997</a>; <a href="./references#CD003664-bbs2-0015" title="BergA , KramerU , LinkE , BollrathC , HeinrichJ , BrockowI , et al. GINIplus study group. Impact of early feeding on childhood eczema: development after nutritional intervention compared with the natural course ‐ the GINIplus study up to the age of 6 years. Clinical and Experimental Allergy2010;40(4):627‐36. [DOI: 10.1111/j.1365‐2222.2009.03444.x; PUBMED: 20082618] BrockowI , ZutavernA , HoffmannU , GrublA , vonBergA , KoletzkoS , et al. GINIplus Study Group. Early allergic sensitizations and their relevance to atopic diseases in children aged 6 years: results of the GINI study. Journal of Investigational Allergology &amp; Clinical Immunology2009;19(3):180‐7. [DOI: 19610260] LaubereauB , BrockowI , ZirngiblA , KoletzkoS , GrueblA , vonBergA , et al. GINI Study Group. Effect of breast‐feeding on the development of atopic dermatitis during the first 3 years of life ‐ results from the GINI‐birth cohort study. Journal of Pediatrics2004;144(5):602‐7. [DOI: 10.1016/j.jpeds.2003.12.029; PUBMED: 15126993] LaubereauB , Filipiak‐PittroffB , vonBergA , GrublA , ReinhardtD , WichmannHE , et al. Caesarean section and gastrointestinal symptoms, atopic dermatitis, and sensitisation during the first year of life. Archives of Disease in Childhood2004;89(11):993‐7. [DOI: 10.1136/adc.2003.043265; PUBMED: 15499049] RzehakP , SausenthalerS , KoletzkoS , BauerCP , SchaafB , vonBergA , et al. Period‐specific growth, overweight and modification by breastfeeding in the GINI and LISA birth cohorts up to age 6 years. European Journal of Epidemiology2009;24(8):449‐67. [DOI: 10.1007/s10654‐009‐9356‐5; PUBMED: 19521784] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. GINI‐plus Study Group. Long‐term effects of hydrolyzed protein infant formulas on growth ‐ extended follow‐up to 10 y of age: results from the German Infant Nutritional Intervention (GINI) study. American Journal of Clinical Nutrition2011;94(6 Suppl):1803S‐7S. [DOI: 10.3945/ajcn.110.000679; PUBMED: 21849601] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. German Infant Nutritional Intervention Study Group. Short‐ and long‐term effects of feeding hydrolyzed protein infant formulas on growth at &lt; or = 6 y of age: results from the German Infant Nutritional Intervention Study. American Journal of Clinical Nutrition2009;89(6):1846‐56. [DOI: 10.3945/ajcn.2008.27373; PUBMED: 19369380] SausenthalerS , KoletzkoS , KoletzkoB , ReinhardtD , KramerU , vonBergA , et al. GINIplus study group. Effect of hydrolysed formula feeding on taste preferences at 10 years. Data from the German Infant Nutritional Intervention Program Plus Study. Clinical Nutrition2010;29(3):304‐6. [DOI: 10.1016/j.clnu.2010.01.007; PUBMED: 20110140] SchoetzauA , Filipiak‐PittroffB , FrankeK , KoletzkoS , VonBergA , GrueblA , et al. German Infant Nutritional Intervention Study Group. Effect of exclusive breast‐feeding and early solid food avoidance on the incidence of atopic dermatitis in high‐risk infants at 1 year of age. Pediatric Allergy and Immunology2002;13(4):234‐42. [PUBMED: 12390439] SchoetzauA , GehringU , FrankeK , GrublA , KoletzkoS , vonBergA , et al. Gini Study Group. Maternal compliance with nutritional recommendations in an allergy preventive programme. Archives of Disease in Childhood2002;86(3):180‐4. [PUBMED: 11861235] VonBergA , Filipiak‐PittroffB , KrämerU , LinkE , HeinrichJ , KoletzkoS , et al. The German Infant Nutritional Intervention Study (GINI) for the preventive effect of hydrolysed infant formulas in infants at high risk for allergic diseases. Design and selected results. Allergologie2012;35(1):32‐43. VonBergA , Filipiak‐PittroffB , SchulzH , HoffmannU , LinkE , SussmannM , et al. GINIplus study group. Allergic manifestation 15 years after early intervention with hydrolyzed formulas ‐ the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2016;71(2):210‐9. [DOI: 10.1111/all.12790; PUBMED: 26465137] vonBergA , FilipiakB , KoletzkoS , KrämerU , HoffmannB , LinkE , et al. Long‐term effect of cow milk protein hydrolysates in high‐risk children. Results from the 10‐years follow‐up of the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2013;68:295‐6. vonBergA , Filipiak‐PittroffB , KramerU , HoffmannB , LinkE , BeckmannC , et al. GINIplus study group. Allergies in high‐risk schoolchildren after early intervention with cow's milk protein hydrolysates: 10‐year results from the German Infant Nutritional Intervention (GINI) study. Journal of Allergy and Clinical Immunology2013;131(6):1565‐73. [DOI: 10.1016/j.jaci.2013.01.006; PUBMED: 23506844] vonBergA , Filipiak‐PittroffB , KramerU , LinkE , BollrathC , BrockowI , et al. GINIplus study group. Preventive effect of hydrolyzed infant formulas persists until age 6 years: long‐term results from the German Infant Nutritional Intervention Study (GINI). Journal of Allergy and Clinical Immunology2008;121(6):1442‐7. [DOI: 10.1016/j.jaci.2008.04.021; PUBMED: 18539195] vonBergA , KoletzkoS , Filipiak‐PittroffB , LaubereauB , GrublA , WichmannHE , et al. German Infant Nutritional Intervention Study Group. Certain hydrolyzed formulas reduce the incidence of atopic dermatitis but not that of asthma: three‐year results of the German Infant Nutritional Intervention Study. Journal of Allergy and Clinical Immunology2007;119(3):718‐25. [DOI: 10.1016/j.jaci.2006.11.017; PUBMED: 17240440] vonBergA , KoletzkoS , GrublA , Filipiak‐PittroffB , WichmannHE , BauerCP , et al. German Infant Nutritional Intervention Study Group. The effect of hydrolyzed cow's milk formula for allergy prevention in the first year of life: the German Infant Nutritional Intervention Study, a randomized double‐blind trial. Journal of Allergy and Clinical Immunology2003;111(3):533‐40. [PUBMED: 12642834] ">von Berg 2003</a>) compared prolonged feeding with an EHF versus CMF. </p> </section> <section id="CD003664-sec-0081"> <h6 class="title">Prolonged feeding: extensively hydrolysed formula (EHF) versus partially hydrolysed formula (PHF) </h6> <p>Four studies (<a href="./references#CD003664-bbs2-0003" title="HalkenS , HansenKS , JacobsenHP , EstmannA , FaellingAE , HansenLG , et al. Comparison of a partially hydrolyzed infant formula with two extensively hydrolyzed formulas for allergy prevention: a prospective, randomized study. Pediatric Allergy and Immunology2000;11(3):149‐61. [PUBMED: 10981524] ">Halken 2000</a>; <a href="./references#CD003664-bbs2-0010" title="NentwichI , MichkovaE , NevoralJ , UrbanekR , SzepfalusiZ . Cow's milk‐specific cellular and humoral immune responses and atopy skin symptoms in infants from atopic families fed a partially (pHF) or extensively (eHF) hydrolyzed infant formula. Allergy2001;56(12):1144‐56. [PUBMED: 11736743] ">Nentwich 2001</a>; <a href="./references#CD003664-bbs2-0011" title="OldaeusG , AnjouK , BjorkstenB , MoranJR , KjellmanNI . Extensively and partially hydrolysed infant formulas for allergy prophylaxis. Archives of Disease in Childhood1997;77(1):4‐10. [PUBMED: 9279143] OldaeusG , BjorkstenB , JenmalmMC , KjellmanNI . Cow's milk IgE and IgG antibody responses to cow's milk formulas. Allergy1999;54(4):352‐7. [PUBMED: 10371094] ">Oldaeus 1997</a>; <a href="./references#CD003664-bbs2-0015" title="BergA , KramerU , LinkE , BollrathC , HeinrichJ , BrockowI , et al. GINIplus study group. Impact of early feeding on childhood eczema: development after nutritional intervention compared with the natural course ‐ the GINIplus study up to the age of 6 years. Clinical and Experimental Allergy2010;40(4):627‐36. [DOI: 10.1111/j.1365‐2222.2009.03444.x; PUBMED: 20082618] BrockowI , ZutavernA , HoffmannU , GrublA , vonBergA , KoletzkoS , et al. GINIplus Study Group. Early allergic sensitizations and their relevance to atopic diseases in children aged 6 years: results of the GINI study. Journal of Investigational Allergology &amp; Clinical Immunology2009;19(3):180‐7. [DOI: 19610260] LaubereauB , BrockowI , ZirngiblA , KoletzkoS , GrueblA , vonBergA , et al. GINI Study Group. Effect of breast‐feeding on the development of atopic dermatitis during the first 3 years of life ‐ results from the GINI‐birth cohort study. Journal of Pediatrics2004;144(5):602‐7. [DOI: 10.1016/j.jpeds.2003.12.029; PUBMED: 15126993] LaubereauB , Filipiak‐PittroffB , vonBergA , GrublA , ReinhardtD , WichmannHE , et al. Caesarean section and gastrointestinal symptoms, atopic dermatitis, and sensitisation during the first year of life. Archives of Disease in Childhood2004;89(11):993‐7. [DOI: 10.1136/adc.2003.043265; PUBMED: 15499049] RzehakP , SausenthalerS , KoletzkoS , BauerCP , SchaafB , vonBergA , et al. Period‐specific growth, overweight and modification by breastfeeding in the GINI and LISA birth cohorts up to age 6 years. European Journal of Epidemiology2009;24(8):449‐67. [DOI: 10.1007/s10654‐009‐9356‐5; PUBMED: 19521784] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. GINI‐plus Study Group. Long‐term effects of hydrolyzed protein infant formulas on growth ‐ extended follow‐up to 10 y of age: results from the German Infant Nutritional Intervention (GINI) study. American Journal of Clinical Nutrition2011;94(6 Suppl):1803S‐7S. [DOI: 10.3945/ajcn.110.000679; PUBMED: 21849601] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. German Infant Nutritional Intervention Study Group. Short‐ and long‐term effects of feeding hydrolyzed protein infant formulas on growth at &lt; or = 6 y of age: results from the German Infant Nutritional Intervention Study. American Journal of Clinical Nutrition2009;89(6):1846‐56. [DOI: 10.3945/ajcn.2008.27373; PUBMED: 19369380] SausenthalerS , KoletzkoS , KoletzkoB , ReinhardtD , KramerU , vonBergA , et al. GINIplus study group. Effect of hydrolysed formula feeding on taste preferences at 10 years. Data from the German Infant Nutritional Intervention Program Plus Study. Clinical Nutrition2010;29(3):304‐6. [DOI: 10.1016/j.clnu.2010.01.007; PUBMED: 20110140] SchoetzauA , Filipiak‐PittroffB , FrankeK , KoletzkoS , VonBergA , GrueblA , et al. German Infant Nutritional Intervention Study Group. Effect of exclusive breast‐feeding and early solid food avoidance on the incidence of atopic dermatitis in high‐risk infants at 1 year of age. Pediatric Allergy and Immunology2002;13(4):234‐42. [PUBMED: 12390439] SchoetzauA , GehringU , FrankeK , GrublA , KoletzkoS , vonBergA , et al. Gini Study Group. Maternal compliance with nutritional recommendations in an allergy preventive programme. Archives of Disease in Childhood2002;86(3):180‐4. [PUBMED: 11861235] VonBergA , Filipiak‐PittroffB , KrämerU , LinkE , HeinrichJ , KoletzkoS , et al. The German Infant Nutritional Intervention Study (GINI) for the preventive effect of hydrolysed infant formulas in infants at high risk for allergic diseases. Design and selected results. Allergologie2012;35(1):32‐43. VonBergA , Filipiak‐PittroffB , SchulzH , HoffmannU , LinkE , SussmannM , et al. GINIplus study group. Allergic manifestation 15 years after early intervention with hydrolyzed formulas ‐ the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2016;71(2):210‐9. [DOI: 10.1111/all.12790; PUBMED: 26465137] vonBergA , FilipiakB , KoletzkoS , KrämerU , HoffmannB , LinkE , et al. Long‐term effect of cow milk protein hydrolysates in high‐risk children. Results from the 10‐years follow‐up of the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2013;68:295‐6. vonBergA , Filipiak‐PittroffB , KramerU , HoffmannB , LinkE , BeckmannC , et al. GINIplus study group. Allergies in high‐risk schoolchildren after early intervention with cow's milk protein hydrolysates: 10‐year results from the German Infant Nutritional Intervention (GINI) study. Journal of Allergy and Clinical Immunology2013;131(6):1565‐73. [DOI: 10.1016/j.jaci.2013.01.006; PUBMED: 23506844] vonBergA , Filipiak‐PittroffB , KramerU , LinkE , BollrathC , BrockowI , et al. GINIplus study group. Preventive effect of hydrolyzed infant formulas persists until age 6 years: long‐term results from the German Infant Nutritional Intervention Study (GINI). Journal of Allergy and Clinical Immunology2008;121(6):1442‐7. [DOI: 10.1016/j.jaci.2008.04.021; PUBMED: 18539195] vonBergA , KoletzkoS , Filipiak‐PittroffB , LaubereauB , GrublA , WichmannHE , et al. German Infant Nutritional Intervention Study Group. Certain hydrolyzed formulas reduce the incidence of atopic dermatitis but not that of asthma: three‐year results of the German Infant Nutritional Intervention Study. Journal of Allergy and Clinical Immunology2007;119(3):718‐25. [DOI: 10.1016/j.jaci.2006.11.017; PUBMED: 17240440] vonBergA , KoletzkoS , GrublA , Filipiak‐PittroffB , WichmannHE , BauerCP , et al. German Infant Nutritional Intervention Study Group. The effect of hydrolyzed cow's milk formula for allergy prevention in the first year of life: the German Infant Nutritional Intervention Study, a randomized double‐blind trial. Journal of Allergy and Clinical Immunology2003;111(3):533‐40. [PUBMED: 12642834] ">von Berg 2003</a>) compared prolonged feeding with an EHF versus a PHF. </p> </section> <section id="CD003664-sec-0082"> <h6 class="title">Prolonged exclusive feeding: hydrolysed formula versus cow's milk formula (CMF)</h6> <p>Seven studies reported prolonged exclusive hydrolysed formula versus CMF (<a href="./references#CD003664-bbs2-0001" title="ChiricoG , GasparoniA , CiardelliL , DeAmiciM , ColomboA , RondiniG . Immunogenicity and antigenicity of a partially hydrolyzed cow's milk infant formula. Allergy1997;52(1):82‐8. [PUBMED: 9062633] ">Chirico 1997</a>; <a href="./references#CD003664-bbs2-0002" title="deSetaL , SianiP , CirilloG , DiGruttolaM , CimaduomoL , ColettaS . The prevention of allergic diseases with a hypoallergenic formula: a follow‐up at 24 months. The preliminary results. [Italian]. La Pediatria Medica e Chirurgica: Medical and Surgical Pediatrics1994;16(3):251‐4. [PUBMED: 7971447] ">de Seta 1994</a>; <a href="./references#CD003664-bbs2-0006" title="KwintaP , SawiecP , KlimekM , LisG , Cichocka‐JaroszE , PietrzykJJ . Correlation between early neonatal diet and atopic symptoms up to 5‐7 years of age in very low birth weight infants: follow‐up of randomized, double‐blind study. Pediatric Allergy and Immunology2009;20(5):458‐66. [DOI: 10.1111/j.1399‐3038.2008.00814.x; PUBMED: 19490477] ">Kwinta 2009</a>; <a href="./references#CD003664-bbs2-0007" title="LamBC , YeungCY . The effect of breast milk, infant formula and hypoallergenic formula on incidence of atopic manifestation in high risk infants. Nestle Internal Report1992. ">Lam 1992</a>; <a href="./references#CD003664-bbs2-0009" title="MariniA , AgostiM , MottaG , MoscaF . Effects of a dietary and environmental prevention programme on the incidence of allergic symptoms in high atopic risk infants: three years' follow‐up. Acta Paediatrica Supplement1996;414:1‐21. [PUBMED: 8831855] ">Marini 1996</a>; <a href="./references#CD003664-bbs2-0014" title="VandenplasY . Atopy at 3 years in high‐risk infants fed whey hydrolysate or conventional formula. Lancet1992;339(8801):1118. [PUBMED: 1349137] VandenplasY , HauserB , Van denBorreC , ClybouwC , MahlerT , Hachimi‐IdrissiS , et al. The long‐term effect of a partial whey hydrolysate formula on the prophylaxis of atopic disease. European Journal of Pediatrics1995;154(6):488‐94. [PUBMED: 7671948] VandenplasY , HauserB , Van denBorreC , SacreL , DabI . Effect of a whey hydrolysate prophylaxis of atopic disease. Annals of Allergy1992;68(5):419‐24. [PUBMED: 1586005] ">Vandenplas 1992</a>; <a href="./references#CD003664-bbs2-0016" title="WillemsR , DuchateauJ , MagrezP , DenisR , CasimirG . Influence of hypoallergenic milk formula on the incidence of early allergic manifestations in infants predisposed to atopic diseases. Annals of Allergy1993;71(2):147‐50. [PUBMED: 8346868] ">Willems 1993</a>). </p> </section> <section id="CD003664-sec-0083"> <h6 class="title">Prolonged feeding: hydrolysed formula versus cow's milk formula (CMF) ‐ studies with blinded measurement </h6> <p>Four studies assessed allergic disease without knowledge of participant allocation (<a href="./references#CD003664-bbs2-0006" title="KwintaP , SawiecP , KlimekM , LisG , Cichocka‐JaroszE , PietrzykJJ . Correlation between early neonatal diet and atopic symptoms up to 5‐7 years of age in very low birth weight infants: follow‐up of randomized, double‐blind study. Pediatric Allergy and Immunology2009;20(5):458‐66. [DOI: 10.1111/j.1399‐3038.2008.00814.x; PUBMED: 19490477] ">Kwinta 2009</a>; <a href="./references#CD003664-bbs2-0011" title="OldaeusG , AnjouK , BjorkstenB , MoranJR , KjellmanNI . Extensively and partially hydrolysed infant formulas for allergy prophylaxis. Archives of Disease in Childhood1997;77(1):4‐10. [PUBMED: 9279143] OldaeusG , BjorkstenB , JenmalmMC , KjellmanNI . Cow's milk IgE and IgG antibody responses to cow's milk formulas. Allergy1999;54(4):352‐7. [PUBMED: 10371094] ">Oldaeus 1997</a>; <a href="./references#CD003664-bbs2-0014" title="VandenplasY . Atopy at 3 years in high‐risk infants fed whey hydrolysate or conventional formula. Lancet1992;339(8801):1118. [PUBMED: 1349137] VandenplasY , HauserB , Van denBorreC , ClybouwC , MahlerT , Hachimi‐IdrissiS , et al. The long‐term effect of a partial whey hydrolysate formula on the prophylaxis of atopic disease. European Journal of Pediatrics1995;154(6):488‐94. [PUBMED: 7671948] VandenplasY , HauserB , Van denBorreC , SacreL , DabI . Effect of a whey hydrolysate prophylaxis of atopic disease. Annals of Allergy1992;68(5):419‐24. [PUBMED: 1586005] ">Vandenplas 1992</a>; <a href="./references#CD003664-bbs2-0015" title="BergA , KramerU , LinkE , BollrathC , HeinrichJ , BrockowI , et al. GINIplus study group. Impact of early feeding on childhood eczema: development after nutritional intervention compared with the natural course ‐ the GINIplus study up to the age of 6 years. Clinical and Experimental Allergy2010;40(4):627‐36. [DOI: 10.1111/j.1365‐2222.2009.03444.x; PUBMED: 20082618] BrockowI , ZutavernA , HoffmannU , GrublA , vonBergA , KoletzkoS , et al. GINIplus Study Group. Early allergic sensitizations and their relevance to atopic diseases in children aged 6 years: results of the GINI study. Journal of Investigational Allergology &amp; Clinical Immunology2009;19(3):180‐7. [DOI: 19610260] LaubereauB , BrockowI , ZirngiblA , KoletzkoS , GrueblA , vonBergA , et al. GINI Study Group. Effect of breast‐feeding on the development of atopic dermatitis during the first 3 years of life ‐ results from the GINI‐birth cohort study. Journal of Pediatrics2004;144(5):602‐7. [DOI: 10.1016/j.jpeds.2003.12.029; PUBMED: 15126993] LaubereauB , Filipiak‐PittroffB , vonBergA , GrublA , ReinhardtD , WichmannHE , et al. Caesarean section and gastrointestinal symptoms, atopic dermatitis, and sensitisation during the first year of life. Archives of Disease in Childhood2004;89(11):993‐7. [DOI: 10.1136/adc.2003.043265; PUBMED: 15499049] RzehakP , SausenthalerS , KoletzkoS , BauerCP , SchaafB , vonBergA , et al. Period‐specific growth, overweight and modification by breastfeeding in the GINI and LISA birth cohorts up to age 6 years. European Journal of Epidemiology2009;24(8):449‐67. [DOI: 10.1007/s10654‐009‐9356‐5; PUBMED: 19521784] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. GINI‐plus Study Group. Long‐term effects of hydrolyzed protein infant formulas on growth ‐ extended follow‐up to 10 y of age: results from the German Infant Nutritional Intervention (GINI) study. American Journal of Clinical Nutrition2011;94(6 Suppl):1803S‐7S. [DOI: 10.3945/ajcn.110.000679; PUBMED: 21849601] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. German Infant Nutritional Intervention Study Group. Short‐ and long‐term effects of feeding hydrolyzed protein infant formulas on growth at &lt; or = 6 y of age: results from the German Infant Nutritional Intervention Study. American Journal of Clinical Nutrition2009;89(6):1846‐56. [DOI: 10.3945/ajcn.2008.27373; PUBMED: 19369380] SausenthalerS , KoletzkoS , KoletzkoB , ReinhardtD , KramerU , vonBergA , et al. GINIplus study group. Effect of hydrolysed formula feeding on taste preferences at 10 years. Data from the German Infant Nutritional Intervention Program Plus Study. Clinical Nutrition2010;29(3):304‐6. [DOI: 10.1016/j.clnu.2010.01.007; PUBMED: 20110140] SchoetzauA , Filipiak‐PittroffB , FrankeK , KoletzkoS , VonBergA , GrueblA , et al. German Infant Nutritional Intervention Study Group. Effect of exclusive breast‐feeding and early solid food avoidance on the incidence of atopic dermatitis in high‐risk infants at 1 year of age. Pediatric Allergy and Immunology2002;13(4):234‐42. [PUBMED: 12390439] SchoetzauA , GehringU , FrankeK , GrublA , KoletzkoS , vonBergA , et al. Gini Study Group. Maternal compliance with nutritional recommendations in an allergy preventive programme. Archives of Disease in Childhood2002;86(3):180‐4. [PUBMED: 11861235] VonBergA , Filipiak‐PittroffB , KrämerU , LinkE , HeinrichJ , KoletzkoS , et al. The German Infant Nutritional Intervention Study (GINI) for the preventive effect of hydrolysed infant formulas in infants at high risk for allergic diseases. Design and selected results. Allergologie2012;35(1):32‐43. VonBergA , Filipiak‐PittroffB , SchulzH , HoffmannU , LinkE , SussmannM , et al. GINIplus study group. Allergic manifestation 15 years after early intervention with hydrolyzed formulas ‐ the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2016;71(2):210‐9. [DOI: 10.1111/all.12790; PUBMED: 26465137] vonBergA , FilipiakB , KoletzkoS , KrämerU , HoffmannB , LinkE , et al. Long‐term effect of cow milk protein hydrolysates in high‐risk children. Results from the 10‐years follow‐up of the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2013;68:295‐6. vonBergA , Filipiak‐PittroffB , KramerU , HoffmannB , LinkE , BeckmannC , et al. GINIplus study group. Allergies in high‐risk schoolchildren after early intervention with cow's milk protein hydrolysates: 10‐year results from the German Infant Nutritional Intervention (GINI) study. Journal of Allergy and Clinical Immunology2013;131(6):1565‐73. [DOI: 10.1016/j.jaci.2013.01.006; PUBMED: 23506844] vonBergA , Filipiak‐PittroffB , KramerU , LinkE , BollrathC , BrockowI , et al. GINIplus study group. Preventive effect of hydrolyzed infant formulas persists until age 6 years: long‐term results from the German Infant Nutritional Intervention Study (GINI). Journal of Allergy and Clinical Immunology2008;121(6):1442‐7. [DOI: 10.1016/j.jaci.2008.04.021; PUBMED: 18539195] vonBergA , KoletzkoS , Filipiak‐PittroffB , LaubereauB , GrublA , WichmannHE , et al. German Infant Nutritional Intervention Study Group. Certain hydrolyzed formulas reduce the incidence of atopic dermatitis but not that of asthma: three‐year results of the German Infant Nutritional Intervention Study. Journal of Allergy and Clinical Immunology2007;119(3):718‐25. [DOI: 10.1016/j.jaci.2006.11.017; PUBMED: 17240440] vonBergA , KoletzkoS , GrublA , Filipiak‐PittroffB , WichmannHE , BauerCP , et al. German Infant Nutritional Intervention Study Group. The effect of hydrolyzed cow's milk formula for allergy prevention in the first year of life: the German Infant Nutritional Intervention Study, a randomized double‐blind trial. Journal of Allergy and Clinical Immunology2003;111(3):533‐40. [PUBMED: 12642834] ">von Berg 2003</a>). </p> </section> <section id="CD003664-sec-0084"> <h6 class="title">Prolonged feeding: hydrolysed formula versus cow's milk formula (CMF) ‐ studies at low risk of bias </h6> <p>We assessed no studies as eligible for inclusion in the sensitivity analysis of adequate study methods (adequate randomisation, allocation concealment and &lt; 10% losses to follow‐up). </p> </section> <section id="CD003664-sec-0085"> <h6 class="title">Prolonged feeding: partially hydrolysed whey formula versus cow's milk formula (CMF)</h6> <p>Nine studies (<a href="./references#CD003664-bbs2-0001" title="ChiricoG , GasparoniA , CiardelliL , DeAmiciM , ColomboA , RondiniG . Immunogenicity and antigenicity of a partially hydrolyzed cow's milk infant formula. Allergy1997;52(1):82‐8. [PUBMED: 9062633] ">Chirico 1997</a>; <a href="./references#CD003664-bbs2-0002" title="deSetaL , SianiP , CirilloG , DiGruttolaM , CimaduomoL , ColettaS . The prevention of allergic diseases with a hypoallergenic formula: a follow‐up at 24 months. The preliminary results. [Italian]. La Pediatria Medica e Chirurgica: Medical and Surgical Pediatrics1994;16(3):251‐4. [PUBMED: 7971447] ">de Seta 1994</a>; <a href="./references#CD003664-bbs2-0004" title="HillD . A report on the analysis of the Melbourne Atopy Cohort Study. A study designed to test the effectiveness of different formula types on the development of atopic symptoms and signs on a cohort of atopy‐at‐risk infants. Report at year 2. Nestec Internal Report. HillDJ , SporikR , ThorburnJ , HoskingCS . The association of atopic dermatitis in infancy with immunoglobulin E food sensitization. Journal of Pediatrics2000;137(4):475‐9. [DOI: 10.1067/mpd.2000.108207; PUBMED: 11035824] KoplinJ , DharmageSC , GurrinL , OsborneN , TangML , LoweAJ , et al. Soy consumption is not a risk factor for peanut sensitization. Journal of Allergy and Clinical Immunology2008;121(6):1455‐9. [DOI: 10.1016/j.jaci.2008.03.017; PUBMED: 18436294] LoweA , HoskingC , BennettC , AllenK , CarlinJ , DharmageS , et al. The Melbourne Atopy Cohort Study: a RCT of a partially hydrolysed whey formula for the prevention of allergic disease. Internal Medicine Journal2008;38:A158. LoweAJ , AbramsonMJ , HoskingCS , CarlinJB , BennettCM , DharmageSC , et al. The temporal sequence of allergic sensitization and onset of infantile eczema. Clinical &amp; Experimental Allergy2007;37(4):536‐42; Erratum in: Clinical &amp; Experimental Allergy 2007; 37(12);1895. [DOI: 10.1111/j.1365‐2222.2007.02691.x; PUBMED: 17430350] LoweAJ , CarlinJB , BennettCM , HoskingCS , AllenKJ , RobertsonCF , et al. Paracetamol use in early life and asthma: prospective birth cohort study. BMJ2010;341:c4616. [PUBMED: 20843914] LoweAJ , HoskingCS , BennettCM , AllenKJ , AxelradC , CarlinJB , et al. Effect of a partially hydrolyzed whey infant formula at weaning on risk of allergic disease in high‐risk children: a randomized controlled trial. Journal of Allergy and Clinical Immunology2011;128(2):360‐5.e4. [DOI: 10.1016/j.jaci.2010.05.006; PUBMED: 21696814] StoneyRM , WoodsRK , HoskingCS , HillDJ , AbramsonMJ , ThienFC . Maternal breast milk long‐chain n‐3 fatty acids are associated with increased risk of atopy in breastfed infants. Clinical and Experimental Allergy2004;34(2):194‐200; Erratum in: Clinical &amp; Experimental Allergy 2007; 37(12);1895. [PUBMED: 14987297] ThomsonJA , WidjajaC , DarmaputraAA , LoweA , MathesonMC , BennettCM , et al. Early childhood infections and immunisation and the development of allergic disease in particular asthma in a high‐risk cohort: a prospective study of allergy‐prone children from birth to six years. Pediatric Allergy and Immunology2010;21(7):1076‐85. [DOI: 10.1111/j.1399‐3038.2010.01018.x; PUBMED: 20337970] ">Hill 2000</a>; <a href="./references#CD003664-bbs2-0007" title="LamBC , YeungCY . The effect of breast milk, infant formula and hypoallergenic formula on incidence of atopic manifestation in high risk infants. Nestle Internal Report1992. ">Lam 1992</a>; <a href="./references#CD003664-bbs2-0009" title="MariniA , AgostiM , MottaG , MoscaF . Effects of a dietary and environmental prevention programme on the incidence of allergic symptoms in high atopic risk infants: three years' follow‐up. Acta Paediatrica Supplement1996;414:1‐21. [PUBMED: 8831855] ">Marini 1996</a>; <a href="./references#CD003664-bbs2-0013" title="TsaiYT , ChouCC , HsiehKH . The effect of hypoallergenic formula on the occurrence of allergic diseases in high risk infants. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi1991;32(3):137‐44. [PUBMED: 1776437] ">Tsai 1991</a>; <a href="./references#CD003664-bbs2-0014" title="VandenplasY . Atopy at 3 years in high‐risk infants fed whey hydrolysate or conventional formula. Lancet1992;339(8801):1118. [PUBMED: 1349137] VandenplasY , HauserB , Van denBorreC , ClybouwC , MahlerT , Hachimi‐IdrissiS , et al. The long‐term effect of a partial whey hydrolysate formula on the prophylaxis of atopic disease. European Journal of Pediatrics1995;154(6):488‐94. [PUBMED: 7671948] VandenplasY , HauserB , Van denBorreC , SacreL , DabI . Effect of a whey hydrolysate prophylaxis of atopic disease. Annals of Allergy1992;68(5):419‐24. [PUBMED: 1586005] ">Vandenplas 1992</a>; <a href="./references#CD003664-bbs2-0015" title="BergA , KramerU , LinkE , BollrathC , HeinrichJ , BrockowI , et al. GINIplus study group. Impact of early feeding on childhood eczema: development after nutritional intervention compared with the natural course ‐ the GINIplus study up to the age of 6 years. Clinical and Experimental Allergy2010;40(4):627‐36. [DOI: 10.1111/j.1365‐2222.2009.03444.x; PUBMED: 20082618] BrockowI , ZutavernA , HoffmannU , GrublA , vonBergA , KoletzkoS , et al. GINIplus Study Group. Early allergic sensitizations and their relevance to atopic diseases in children aged 6 years: results of the GINI study. Journal of Investigational Allergology &amp; Clinical Immunology2009;19(3):180‐7. [DOI: 19610260] LaubereauB , BrockowI , ZirngiblA , KoletzkoS , GrueblA , vonBergA , et al. GINI Study Group. Effect of breast‐feeding on the development of atopic dermatitis during the first 3 years of life ‐ results from the GINI‐birth cohort study. Journal of Pediatrics2004;144(5):602‐7. [DOI: 10.1016/j.jpeds.2003.12.029; PUBMED: 15126993] LaubereauB , Filipiak‐PittroffB , vonBergA , GrublA , ReinhardtD , WichmannHE , et al. Caesarean section and gastrointestinal symptoms, atopic dermatitis, and sensitisation during the first year of life. Archives of Disease in Childhood2004;89(11):993‐7. [DOI: 10.1136/adc.2003.043265; PUBMED: 15499049] RzehakP , SausenthalerS , KoletzkoS , BauerCP , SchaafB , vonBergA , et al. Period‐specific growth, overweight and modification by breastfeeding in the GINI and LISA birth cohorts up to age 6 years. European Journal of Epidemiology2009;24(8):449‐67. [DOI: 10.1007/s10654‐009‐9356‐5; PUBMED: 19521784] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. GINI‐plus Study Group. Long‐term effects of hydrolyzed protein infant formulas on growth ‐ extended follow‐up to 10 y of age: results from the German Infant Nutritional Intervention (GINI) study. American Journal of Clinical Nutrition2011;94(6 Suppl):1803S‐7S. [DOI: 10.3945/ajcn.110.000679; PUBMED: 21849601] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. German Infant Nutritional Intervention Study Group. Short‐ and long‐term effects of feeding hydrolyzed protein infant formulas on growth at &lt; or = 6 y of age: results from the German Infant Nutritional Intervention Study. American Journal of Clinical Nutrition2009;89(6):1846‐56. [DOI: 10.3945/ajcn.2008.27373; PUBMED: 19369380] SausenthalerS , KoletzkoS , KoletzkoB , ReinhardtD , KramerU , vonBergA , et al. GINIplus study group. Effect of hydrolysed formula feeding on taste preferences at 10 years. Data from the German Infant Nutritional Intervention Program Plus Study. Clinical Nutrition2010;29(3):304‐6. [DOI: 10.1016/j.clnu.2010.01.007; PUBMED: 20110140] SchoetzauA , Filipiak‐PittroffB , FrankeK , KoletzkoS , VonBergA , GrueblA , et al. German Infant Nutritional Intervention Study Group. Effect of exclusive breast‐feeding and early solid food avoidance on the incidence of atopic dermatitis in high‐risk infants at 1 year of age. Pediatric Allergy and Immunology2002;13(4):234‐42. [PUBMED: 12390439] SchoetzauA , GehringU , FrankeK , GrublA , KoletzkoS , vonBergA , et al. Gini Study Group. Maternal compliance with nutritional recommendations in an allergy preventive programme. Archives of Disease in Childhood2002;86(3):180‐4. [PUBMED: 11861235] VonBergA , Filipiak‐PittroffB , KrämerU , LinkE , HeinrichJ , KoletzkoS , et al. The German Infant Nutritional Intervention Study (GINI) for the preventive effect of hydrolysed infant formulas in infants at high risk for allergic diseases. Design and selected results. Allergologie2012;35(1):32‐43. VonBergA , Filipiak‐PittroffB , SchulzH , HoffmannU , LinkE , SussmannM , et al. GINIplus study group. Allergic manifestation 15 years after early intervention with hydrolyzed formulas ‐ the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2016;71(2):210‐9. [DOI: 10.1111/all.12790; PUBMED: 26465137] vonBergA , FilipiakB , KoletzkoS , KrämerU , HoffmannB , LinkE , et al. Long‐term effect of cow milk protein hydrolysates in high‐risk children. Results from the 10‐years follow‐up of the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2013;68:295‐6. vonBergA , Filipiak‐PittroffB , KramerU , HoffmannB , LinkE , BeckmannC , et al. GINIplus study group. Allergies in high‐risk schoolchildren after early intervention with cow's milk protein hydrolysates: 10‐year results from the German Infant Nutritional Intervention (GINI) study. Journal of Allergy and Clinical Immunology2013;131(6):1565‐73. [DOI: 10.1016/j.jaci.2013.01.006; PUBMED: 23506844] vonBergA , Filipiak‐PittroffB , KramerU , LinkE , BollrathC , BrockowI , et al. GINIplus study group. Preventive effect of hydrolyzed infant formulas persists until age 6 years: long‐term results from the German Infant Nutritional Intervention Study (GINI). Journal of Allergy and Clinical Immunology2008;121(6):1442‐7. [DOI: 10.1016/j.jaci.2008.04.021; PUBMED: 18539195] vonBergA , KoletzkoS , Filipiak‐PittroffB , LaubereauB , GrublA , WichmannHE , et al. German Infant Nutritional Intervention Study Group. Certain hydrolyzed formulas reduce the incidence of atopic dermatitis but not that of asthma: three‐year results of the German Infant Nutritional Intervention Study. Journal of Allergy and Clinical Immunology2007;119(3):718‐25. [DOI: 10.1016/j.jaci.2006.11.017; PUBMED: 17240440] vonBergA , KoletzkoS , GrublA , Filipiak‐PittroffB , WichmannHE , BauerCP , et al. German Infant Nutritional Intervention Study Group. The effect of hydrolyzed cow's milk formula for allergy prevention in the first year of life: the German Infant Nutritional Intervention Study, a randomized double‐blind trial. Journal of Allergy and Clinical Immunology2003;111(3):533‐40. [PUBMED: 12642834] ">von Berg 2003</a>; <a href="./references#CD003664-bbs2-0016" title="WillemsR , DuchateauJ , MagrezP , DenisR , CasimirG . Influence of hypoallergenic milk formula on the incidence of early allergic manifestations in infants predisposed to atopic diseases. Annals of Allergy1993;71(2):147‐50. [PUBMED: 8346868] ">Willems 1993</a>) compared a partially hydrolysed whey formula versus CMF. </p> </section> <section id="CD003664-sec-0086"> <h6 class="title">Prolonged feeding: partially hydrolysed casein‐containing formula versus cow's milk formula (CMF) </h6> <p>Two studies (<a href="./references#CD003664-bbs2-0006" title="KwintaP , SawiecP , KlimekM , LisG , Cichocka‐JaroszE , PietrzykJJ . Correlation between early neonatal diet and atopic symptoms up to 5‐7 years of age in very low birth weight infants: follow‐up of randomized, double‐blind study. Pediatric Allergy and Immunology2009;20(5):458‐66. [DOI: 10.1111/j.1399‐3038.2008.00814.x; PUBMED: 19490477] ">Kwinta 2009</a>; <a href="./references#CD003664-bbs2-0011" title="OldaeusG , AnjouK , BjorkstenB , MoranJR , KjellmanNI . Extensively and partially hydrolysed infant formulas for allergy prophylaxis. Archives of Disease in Childhood1997;77(1):4‐10. [PUBMED: 9279143] OldaeusG , BjorkstenB , JenmalmMC , KjellmanNI . Cow's milk IgE and IgG antibody responses to cow's milk formulas. Allergy1999;54(4):352‐7. [PUBMED: 10371094] ">Oldaeus 1997</a>) compared a PHF containing casein versus CMF. </p> </section> <section id="CD003664-sec-0087"> <h6 class="title">Prolonged feeding: extensively hydrolysed whey formula versus cow's milk formula (CMF)</h6> <p>One study (<a href="./references#CD003664-bbs2-0015" title="BergA , KramerU , LinkE , BollrathC , HeinrichJ , BrockowI , et al. GINIplus study group. Impact of early feeding on childhood eczema: development after nutritional intervention compared with the natural course ‐ the GINIplus study up to the age of 6 years. Clinical and Experimental Allergy2010;40(4):627‐36. [DOI: 10.1111/j.1365‐2222.2009.03444.x; PUBMED: 20082618] BrockowI , ZutavernA , HoffmannU , GrublA , vonBergA , KoletzkoS , et al. GINIplus Study Group. Early allergic sensitizations and their relevance to atopic diseases in children aged 6 years: results of the GINI study. Journal of Investigational Allergology &amp; Clinical Immunology2009;19(3):180‐7. [DOI: 19610260] LaubereauB , BrockowI , ZirngiblA , KoletzkoS , GrueblA , vonBergA , et al. GINI Study Group. Effect of breast‐feeding on the development of atopic dermatitis during the first 3 years of life ‐ results from the GINI‐birth cohort study. Journal of Pediatrics2004;144(5):602‐7. [DOI: 10.1016/j.jpeds.2003.12.029; PUBMED: 15126993] LaubereauB , Filipiak‐PittroffB , vonBergA , GrublA , ReinhardtD , WichmannHE , et al. Caesarean section and gastrointestinal symptoms, atopic dermatitis, and sensitisation during the first year of life. Archives of Disease in Childhood2004;89(11):993‐7. [DOI: 10.1136/adc.2003.043265; PUBMED: 15499049] RzehakP , SausenthalerS , KoletzkoS , BauerCP , SchaafB , vonBergA , et al. Period‐specific growth, overweight and modification by breastfeeding in the GINI and LISA birth cohorts up to age 6 years. European Journal of Epidemiology2009;24(8):449‐67. [DOI: 10.1007/s10654‐009‐9356‐5; PUBMED: 19521784] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. GINI‐plus Study Group. Long‐term effects of hydrolyzed protein infant formulas on growth ‐ extended follow‐up to 10 y of age: results from the German Infant Nutritional Intervention (GINI) study. American Journal of Clinical Nutrition2011;94(6 Suppl):1803S‐7S. [DOI: 10.3945/ajcn.110.000679; PUBMED: 21849601] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. German Infant Nutritional Intervention Study Group. Short‐ and long‐term effects of feeding hydrolyzed protein infant formulas on growth at &lt; or = 6 y of age: results from the German Infant Nutritional Intervention Study. American Journal of Clinical Nutrition2009;89(6):1846‐56. [DOI: 10.3945/ajcn.2008.27373; PUBMED: 19369380] SausenthalerS , KoletzkoS , KoletzkoB , ReinhardtD , KramerU , vonBergA , et al. GINIplus study group. Effect of hydrolysed formula feeding on taste preferences at 10 years. Data from the German Infant Nutritional Intervention Program Plus Study. Clinical Nutrition2010;29(3):304‐6. [DOI: 10.1016/j.clnu.2010.01.007; PUBMED: 20110140] SchoetzauA , Filipiak‐PittroffB , FrankeK , KoletzkoS , VonBergA , GrueblA , et al. German Infant Nutritional Intervention Study Group. Effect of exclusive breast‐feeding and early solid food avoidance on the incidence of atopic dermatitis in high‐risk infants at 1 year of age. Pediatric Allergy and Immunology2002;13(4):234‐42. [PUBMED: 12390439] SchoetzauA , GehringU , FrankeK , GrublA , KoletzkoS , vonBergA , et al. Gini Study Group. Maternal compliance with nutritional recommendations in an allergy preventive programme. Archives of Disease in Childhood2002;86(3):180‐4. [PUBMED: 11861235] VonBergA , Filipiak‐PittroffB , KrämerU , LinkE , HeinrichJ , KoletzkoS , et al. The German Infant Nutritional Intervention Study (GINI) for the preventive effect of hydrolysed infant formulas in infants at high risk for allergic diseases. Design and selected results. Allergologie2012;35(1):32‐43. VonBergA , Filipiak‐PittroffB , SchulzH , HoffmannU , LinkE , SussmannM , et al. GINIplus study group. Allergic manifestation 15 years after early intervention with hydrolyzed formulas ‐ the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2016;71(2):210‐9. [DOI: 10.1111/all.12790; PUBMED: 26465137] vonBergA , FilipiakB , KoletzkoS , KrämerU , HoffmannB , LinkE , et al. Long‐term effect of cow milk protein hydrolysates in high‐risk children. Results from the 10‐years follow‐up of the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2013;68:295‐6. vonBergA , Filipiak‐PittroffB , KramerU , HoffmannB , LinkE , BeckmannC , et al. GINIplus study group. Allergies in high‐risk schoolchildren after early intervention with cow's milk protein hydrolysates: 10‐year results from the German Infant Nutritional Intervention (GINI) study. Journal of Allergy and Clinical Immunology2013;131(6):1565‐73. [DOI: 10.1016/j.jaci.2013.01.006; PUBMED: 23506844] vonBergA , Filipiak‐PittroffB , KramerU , LinkE , BollrathC , BrockowI , et al. GINIplus study group. Preventive effect of hydrolyzed infant formulas persists until age 6 years: long‐term results from the German Infant Nutritional Intervention Study (GINI). Journal of Allergy and Clinical Immunology2008;121(6):1442‐7. [DOI: 10.1016/j.jaci.2008.04.021; PUBMED: 18539195] vonBergA , KoletzkoS , Filipiak‐PittroffB , LaubereauB , GrublA , WichmannHE , et al. German Infant Nutritional Intervention Study Group. Certain hydrolyzed formulas reduce the incidence of atopic dermatitis but not that of asthma: three‐year results of the German Infant Nutritional Intervention Study. Journal of Allergy and Clinical Immunology2007;119(3):718‐25. [DOI: 10.1016/j.jaci.2006.11.017; PUBMED: 17240440] vonBergA , KoletzkoS , GrublA , Filipiak‐PittroffB , WichmannHE , BauerCP , et al. German Infant Nutritional Intervention Study Group. The effect of hydrolyzed cow's milk formula for allergy prevention in the first year of life: the German Infant Nutritional Intervention Study, a randomized double‐blind trial. Journal of Allergy and Clinical Immunology2003;111(3):533‐40. [PUBMED: 12642834] ">von Berg 2003</a>) compared an extensively hydrolysed whey formula versus CMF. </p> </section> <section id="CD003664-sec-0088"> <h6 class="title">Prolonged feeding: extensively hydrolysed casein formula versus extensively hydrolysed whey formula </h6> <p>Two studies (<a href="./references#CD003664-bbs2-0003" title="HalkenS , HansenKS , JacobsenHP , EstmannA , FaellingAE , HansenLG , et al. Comparison of a partially hydrolyzed infant formula with two extensively hydrolyzed formulas for allergy prevention: a prospective, randomized study. Pediatric Allergy and Immunology2000;11(3):149‐61. [PUBMED: 10981524] ">Halken 2000</a>; <a href="./references#CD003664-bbs2-0015" title="BergA , KramerU , LinkE , BollrathC , HeinrichJ , BrockowI , et al. GINIplus study group. Impact of early feeding on childhood eczema: development after nutritional intervention compared with the natural course ‐ the GINIplus study up to the age of 6 years. Clinical and Experimental Allergy2010;40(4):627‐36. [DOI: 10.1111/j.1365‐2222.2009.03444.x; PUBMED: 20082618] BrockowI , ZutavernA , HoffmannU , GrublA , vonBergA , KoletzkoS , et al. GINIplus Study Group. Early allergic sensitizations and their relevance to atopic diseases in children aged 6 years: results of the GINI study. Journal of Investigational Allergology &amp; Clinical Immunology2009;19(3):180‐7. [DOI: 19610260] LaubereauB , BrockowI , ZirngiblA , KoletzkoS , GrueblA , vonBergA , et al. GINI Study Group. Effect of breast‐feeding on the development of atopic dermatitis during the first 3 years of life ‐ results from the GINI‐birth cohort study. Journal of Pediatrics2004;144(5):602‐7. [DOI: 10.1016/j.jpeds.2003.12.029; PUBMED: 15126993] LaubereauB , Filipiak‐PittroffB , vonBergA , GrublA , ReinhardtD , WichmannHE , et al. Caesarean section and gastrointestinal symptoms, atopic dermatitis, and sensitisation during the first year of life. Archives of Disease in Childhood2004;89(11):993‐7. [DOI: 10.1136/adc.2003.043265; PUBMED: 15499049] RzehakP , SausenthalerS , KoletzkoS , BauerCP , SchaafB , vonBergA , et al. Period‐specific growth, overweight and modification by breastfeeding in the GINI and LISA birth cohorts up to age 6 years. European Journal of Epidemiology2009;24(8):449‐67. [DOI: 10.1007/s10654‐009‐9356‐5; PUBMED: 19521784] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. GINI‐plus Study Group. Long‐term effects of hydrolyzed protein infant formulas on growth ‐ extended follow‐up to 10 y of age: results from the German Infant Nutritional Intervention (GINI) study. American Journal of Clinical Nutrition2011;94(6 Suppl):1803S‐7S. [DOI: 10.3945/ajcn.110.000679; PUBMED: 21849601] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. German Infant Nutritional Intervention Study Group. Short‐ and long‐term effects of feeding hydrolyzed protein infant formulas on growth at &lt; or = 6 y of age: results from the German Infant Nutritional Intervention Study. American Journal of Clinical Nutrition2009;89(6):1846‐56. [DOI: 10.3945/ajcn.2008.27373; PUBMED: 19369380] SausenthalerS , KoletzkoS , KoletzkoB , ReinhardtD , KramerU , vonBergA , et al. GINIplus study group. Effect of hydrolysed formula feeding on taste preferences at 10 years. Data from the German Infant Nutritional Intervention Program Plus Study. Clinical Nutrition2010;29(3):304‐6. [DOI: 10.1016/j.clnu.2010.01.007; PUBMED: 20110140] SchoetzauA , Filipiak‐PittroffB , FrankeK , KoletzkoS , VonBergA , GrueblA , et al. German Infant Nutritional Intervention Study Group. Effect of exclusive breast‐feeding and early solid food avoidance on the incidence of atopic dermatitis in high‐risk infants at 1 year of age. Pediatric Allergy and Immunology2002;13(4):234‐42. [PUBMED: 12390439] SchoetzauA , GehringU , FrankeK , GrublA , KoletzkoS , vonBergA , et al. Gini Study Group. Maternal compliance with nutritional recommendations in an allergy preventive programme. Archives of Disease in Childhood2002;86(3):180‐4. [PUBMED: 11861235] VonBergA , Filipiak‐PittroffB , KrämerU , LinkE , HeinrichJ , KoletzkoS , et al. The German Infant Nutritional Intervention Study (GINI) for the preventive effect of hydrolysed infant formulas in infants at high risk for allergic diseases. Design and selected results. Allergologie2012;35(1):32‐43. VonBergA , Filipiak‐PittroffB , SchulzH , HoffmannU , LinkE , SussmannM , et al. GINIplus study group. Allergic manifestation 15 years after early intervention with hydrolyzed formulas ‐ the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2016;71(2):210‐9. [DOI: 10.1111/all.12790; PUBMED: 26465137] vonBergA , FilipiakB , KoletzkoS , KrämerU , HoffmannB , LinkE , et al. Long‐term effect of cow milk protein hydrolysates in high‐risk children. Results from the 10‐years follow‐up of the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2013;68:295‐6. vonBergA , Filipiak‐PittroffB , KramerU , HoffmannB , LinkE , BeckmannC , et al. GINIplus study group. Allergies in high‐risk schoolchildren after early intervention with cow's milk protein hydrolysates: 10‐year results from the German Infant Nutritional Intervention (GINI) study. Journal of Allergy and Clinical Immunology2013;131(6):1565‐73. [DOI: 10.1016/j.jaci.2013.01.006; PUBMED: 23506844] vonBergA , Filipiak‐PittroffB , KramerU , LinkE , BollrathC , BrockowI , et al. GINIplus study group. Preventive effect of hydrolyzed infant formulas persists until age 6 years: long‐term results from the German Infant Nutritional Intervention Study (GINI). Journal of Allergy and Clinical Immunology2008;121(6):1442‐7. [DOI: 10.1016/j.jaci.2008.04.021; PUBMED: 18539195] vonBergA , KoletzkoS , Filipiak‐PittroffB , LaubereauB , GrublA , WichmannHE , et al. German Infant Nutritional Intervention Study Group. Certain hydrolyzed formulas reduce the incidence of atopic dermatitis but not that of asthma: three‐year results of the German Infant Nutritional Intervention Study. Journal of Allergy and Clinical Immunology2007;119(3):718‐25. [DOI: 10.1016/j.jaci.2006.11.017; PUBMED: 17240440] vonBergA , KoletzkoS , GrublA , Filipiak‐PittroffB , WichmannHE , BauerCP , et al. German Infant Nutritional Intervention Study Group. The effect of hydrolyzed cow's milk formula for allergy prevention in the first year of life: the German Infant Nutritional Intervention Study, a randomized double‐blind trial. Journal of Allergy and Clinical Immunology2003;111(3):533‐40. [PUBMED: 12642834] ">von Berg 2003</a>) compared an extensively hydrolysed casein formula versus CMF. </p> <p>No study compared a hydrolysed soy formula versus CMF. No study compared a hydrolysed soy formula versus hydrolysed CMF. </p> </section> </section> <section id="CD003664-sec-0089"> <h5 class="title">Types of outcomes</h5> <p>Definitions for allergic disease varied between studies, but usually required persistent or recurring symptoms and signs in the absence of another obvious clinical explanation. For definitions of 'all allergic disease' and type of allergic disease for each study, see <a href="./references#CD003664-sec-0158" title="">Characteristics of included studies</a>. </p> <p>Studies (with timing) reporting clinician‐diagnosed allergic disease included <a href="./references#CD003664-bbs2-0001" title="ChiricoG , GasparoniA , CiardelliL , DeAmiciM , ColomboA , RondiniG . Immunogenicity and antigenicity of a partially hydrolyzed cow's milk infant formula. Allergy1997;52(1):82‐8. [PUBMED: 9062633] ">Chirico 1997</a> (six months); <a href="./references#CD003664-bbs2-0002" title="deSetaL , SianiP , CirilloG , DiGruttolaM , CimaduomoL , ColettaS . The prevention of allergic diseases with a hypoallergenic formula: a follow‐up at 24 months. The preliminary results. [Italian]. La Pediatria Medica e Chirurgica: Medical and Surgical Pediatrics1994;16(3):251‐4. [PUBMED: 7971447] ">de Seta 1994</a> (six and 24 months); <a href="./references#CD003664-bbs2-0003" title="HalkenS , HansenKS , JacobsenHP , EstmannA , FaellingAE , HansenLG , et al. Comparison of a partially hydrolyzed infant formula with two extensively hydrolyzed formulas for allergy prevention: a prospective, randomized study. Pediatric Allergy and Immunology2000;11(3):149‐61. [PUBMED: 10981524] ">Halken 2000</a> (six, 12 and 18 months); <a href="./references#CD003664-bbs2-0004" title="HillD . A report on the analysis of the Melbourne Atopy Cohort Study. A study designed to test the effectiveness of different formula types on the development of atopic symptoms and signs on a cohort of atopy‐at‐risk infants. Report at year 2. Nestec Internal Report. HillDJ , SporikR , ThorburnJ , HoskingCS . The association of atopic dermatitis in infancy with immunoglobulin E food sensitization. Journal of Pediatrics2000;137(4):475‐9. [DOI: 10.1067/mpd.2000.108207; PUBMED: 11035824] KoplinJ , DharmageSC , GurrinL , OsborneN , TangML , LoweAJ , et al. Soy consumption is not a risk factor for peanut sensitization. Journal of Allergy and Clinical Immunology2008;121(6):1455‐9. [DOI: 10.1016/j.jaci.2008.03.017; PUBMED: 18436294] LoweA , HoskingC , BennettC , AllenK , CarlinJ , DharmageS , et al. The Melbourne Atopy Cohort Study: a RCT of a partially hydrolysed whey formula for the prevention of allergic disease. Internal Medicine Journal2008;38:A158. LoweAJ , AbramsonMJ , HoskingCS , CarlinJB , BennettCM , DharmageSC , et al. The temporal sequence of allergic sensitization and onset of infantile eczema. Clinical &amp; Experimental Allergy2007;37(4):536‐42; Erratum in: Clinical &amp; Experimental Allergy 2007; 37(12);1895. [DOI: 10.1111/j.1365‐2222.2007.02691.x; PUBMED: 17430350] LoweAJ , CarlinJB , BennettCM , HoskingCS , AllenKJ , RobertsonCF , et al. Paracetamol use in early life and asthma: prospective birth cohort study. BMJ2010;341:c4616. [PUBMED: 20843914] LoweAJ , HoskingCS , BennettCM , AllenKJ , AxelradC , CarlinJB , et al. Effect of a partially hydrolyzed whey infant formula at weaning on risk of allergic disease in high‐risk children: a randomized controlled trial. Journal of Allergy and Clinical Immunology2011;128(2):360‐5.e4. [DOI: 10.1016/j.jaci.2010.05.006; PUBMED: 21696814] StoneyRM , WoodsRK , HoskingCS , HillDJ , AbramsonMJ , ThienFC . Maternal breast milk long‐chain n‐3 fatty acids are associated with increased risk of atopy in breastfed infants. Clinical and Experimental Allergy2004;34(2):194‐200; Erratum in: Clinical &amp; Experimental Allergy 2007; 37(12);1895. [PUBMED: 14987297] ThomsonJA , WidjajaC , DarmaputraAA , LoweA , MathesonMC , BennettCM , et al. Early childhood infections and immunisation and the development of allergic disease in particular asthma in a high‐risk cohort: a prospective study of allergy‐prone children from birth to six years. Pediatric Allergy and Immunology2010;21(7):1076‐85. [DOI: 10.1111/j.1399‐3038.2010.01018.x; PUBMED: 20337970] ">Hill 2000</a> (two and six to seven years); <a href="./references#CD003664-bbs2-0005" title="JuvonenP , ManssonM , AnderssonC , JakobssonI . Allergy development and macromolecular absorption in infants with different feeding regimens during the first three days of life. A three‐year prospective follow‐up. Acta Paediatrica1996;85(9):1047‐52. [PUBMED: 8888916] JuvonenP , ManssonM , JakobssonI . Does early diet have an effect on subsequent macromolecular absorption and serum IgE?. Journal of Pediatric Gastroenterology and Nutrition1994;18(3):344‐9. [PUBMED: 8057219] JuvonenP , ManssonM , KjellmanNI , BjorkstenB , JakobssonI . Development of immunoglobulin G and immunoglobulin E antibodies to cow's milk proteins and ovalbumin after a temporary neonatal exposure to hydrolyzed and whole cow's milk proteins. Pediatric Allergy and Immunology1999;10(3):191‐8. [PUBMED: 10565560] ">Juvonen 1996</a> (three years); <a href="./references#CD003664-bbs2-0006" title="KwintaP , SawiecP , KlimekM , LisG , Cichocka‐JaroszE , PietrzykJJ . Correlation between early neonatal diet and atopic symptoms up to 5‐7 years of age in very low birth weight infants: follow‐up of randomized, double‐blind study. Pediatric Allergy and Immunology2009;20(5):458‐66. [DOI: 10.1111/j.1399‐3038.2008.00814.x; PUBMED: 19490477] ">Kwinta 2009</a> (five to seven years); <a href="./references#CD003664-bbs2-0007" title="LamBC , YeungCY . The effect of breast milk, infant formula and hypoallergenic formula on incidence of atopic manifestation in high risk infants. Nestle Internal Report1992. ">Lam 1992</a> (six months); <a href="./references#CD003664-bbs2-0008" title="MalletE , HenocqA . Long‐term prevention of allergic diseases by using protein hydrolysate formula in at‐risk infants. Journal of Pediatrics1992;121(5 Pt 2):S95‐100. [PUBMED: 1447641] ">Mallet 1992</a> (one, two and four years); <a href="./references#CD003664-bbs2-0009" title="MariniA , AgostiM , MottaG , MoscaF . Effects of a dietary and environmental prevention programme on the incidence of allergic symptoms in high atopic risk infants: three years' follow‐up. Acta Paediatrica Supplement1996;414:1‐21. [PUBMED: 8831855] ">Marini 1996</a> (six months, one and three years); <a href="./references#CD003664-bbs2-0010" title="NentwichI , MichkovaE , NevoralJ , UrbanekR , SzepfalusiZ . Cow's milk‐specific cellular and humoral immune responses and atopy skin symptoms in infants from atopic families fed a partially (pHF) or extensively (eHF) hydrolyzed infant formula. Allergy2001;56(12):1144‐56. [PUBMED: 11736743] ">Nentwich 2001</a> (six and 12 months); <a href="./references#CD003664-bbs2-0011" title="OldaeusG , AnjouK , BjorkstenB , MoranJR , KjellmanNI . Extensively and partially hydrolysed infant formulas for allergy prophylaxis. Archives of Disease in Childhood1997;77(1):4‐10. [PUBMED: 9279143] OldaeusG , BjorkstenB , JenmalmMC , KjellmanNI . Cow's milk IgE and IgG antibody responses to cow's milk formulas. Allergy1999;54(4):352‐7. [PUBMED: 10371094] ">Oldaeus 1997</a> (nurse examination at three, six, nine, 12 and 18 months and doctor visit at 18 months); <a href="./references#CD003664-bbs2-0012" title="SaarinenKM , Juntunen‐BackmanK , JarvenpaaAL , KlemettiP , KuitunenP , LopeL , et al. Breast‐feeding and the development of cows' milk protein allergy. Advances in Experimental Medicine and Biology2000;478:121‐30. [DOI: 10.1007/0‐306‐46830‐1_10; PUBMED: 11065065] SaarinenKM , Juntunen‐BackmanK , JarvenpaaAL , KuitunenP , LopeL , RenlundM , et al. Supplementary feeding in maternity hospitals and the risk of cow's milk allergy: a prospective study of 6209 infants. Journal of Allergy and Clinical Immunology1999;104(2 Pt 1):457‐61. [PUBMED: 10452771] SaarinenKM , SavilahtiE . Infant feeding patterns affect the subsequent immunological features in cow's milk allergy. Clinical and Experimental Allergy2000;30(3):400‐6. [DOI: 10691899] SaarinenKM , SuomalainenH , SavilahtiE . Diagnostic value of skin‐prick and patch tests and serum eosinophil cationic protein and cow's milk‐specific IgE in infants with cow's milk allergy. Clinical and Experimental Allergy2001;31(3):423‐9. [PUBMED: 11260154] SaarinenKM , VaaralaO , KlemettiP , SavilahtiE . Transforming growth factor‐beta1 in mothers' colostrum and immune responses to cows' milk proteins in infants with cows' milk allergy. Journal of Allergy and Clinical Immunology1999;104(5):1093‐8. [PUBMED: 10550758] SavilahtiE , SaarinenKM . Early infant feeding and type 1 diabetes. European Journal of Nutrition2009;48(4):243‐9. [DOI: 10.1007/s00394‐009‐0008‐z; PUBMED: 19263185] SavilahtiEM , SaarinenKM , SavilahtiE . Specific antibodies to cow's milk proteins in infants: effect of early feeding and diagnosis of cow's milk allergy. European Journal of Nutrition2010;49(8):501‐4. [DOI: 10.1007/s00394‐010‐0109‐8; PUBMED: 20405136] SiltanenM , KajosaariM , PoussaT , SaarinenKM , SavilahtiE . A dual long‐term effect of breastfeeding on atopy in relation to heredity in children at 4 years of age. Allergy2003;58(6):524‐30. [PUBMED: 12757455] ">Saarinen 1999</a> (mean age at follow‐up of 27 months, range 18 to 34 months); <a href="./references#CD003664-bbs2-0013" title="TsaiYT , ChouCC , HsiehKH . The effect of hypoallergenic formula on the occurrence of allergic diseases in high risk infants. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi1991;32(3):137‐44. [PUBMED: 1776437] ">Tsai 1991</a> (one, two, four, six and 12 months); <a href="./references#CD003664-bbs2-0014" title="VandenplasY . Atopy at 3 years in high‐risk infants fed whey hydrolysate or conventional formula. Lancet1992;339(8801):1118. [PUBMED: 1349137] VandenplasY , HauserB , Van denBorreC , ClybouwC , MahlerT , Hachimi‐IdrissiS , et al. The long‐term effect of a partial whey hydrolysate formula on the prophylaxis of atopic disease. European Journal of Pediatrics1995;154(6):488‐94. [PUBMED: 7671948] VandenplasY , HauserB , Van denBorreC , SacreL , DabI . Effect of a whey hydrolysate prophylaxis of atopic disease. Annals of Allergy1992;68(5):419‐24. [PUBMED: 1586005] ">Vandenplas 1992</a> (12 months); and <a href="./references#CD003664-bbs2-0015" title="BergA , KramerU , LinkE , BollrathC , HeinrichJ , BrockowI , et al. GINIplus study group. Impact of early feeding on childhood eczema: development after nutritional intervention compared with the natural course ‐ the GINIplus study up to the age of 6 years. Clinical and Experimental Allergy2010;40(4):627‐36. [DOI: 10.1111/j.1365‐2222.2009.03444.x; PUBMED: 20082618] BrockowI , ZutavernA , HoffmannU , GrublA , vonBergA , KoletzkoS , et al. GINIplus Study Group. Early allergic sensitizations and their relevance to atopic diseases in children aged 6 years: results of the GINI study. Journal of Investigational Allergology &amp; Clinical Immunology2009;19(3):180‐7. [DOI: 19610260] LaubereauB , BrockowI , ZirngiblA , KoletzkoS , GrueblA , vonBergA , et al. GINI Study Group. Effect of breast‐feeding on the development of atopic dermatitis during the first 3 years of life ‐ results from the GINI‐birth cohort study. Journal of Pediatrics2004;144(5):602‐7. [DOI: 10.1016/j.jpeds.2003.12.029; PUBMED: 15126993] LaubereauB , Filipiak‐PittroffB , vonBergA , GrublA , ReinhardtD , WichmannHE , et al. Caesarean section and gastrointestinal symptoms, atopic dermatitis, and sensitisation during the first year of life. Archives of Disease in Childhood2004;89(11):993‐7. [DOI: 10.1136/adc.2003.043265; PUBMED: 15499049] RzehakP , SausenthalerS , KoletzkoS , BauerCP , SchaafB , vonBergA , et al. Period‐specific growth, overweight and modification by breastfeeding in the GINI and LISA birth cohorts up to age 6 years. European Journal of Epidemiology2009;24(8):449‐67. [DOI: 10.1007/s10654‐009‐9356‐5; PUBMED: 19521784] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. GINI‐plus Study Group. Long‐term effects of hydrolyzed protein infant formulas on growth ‐ extended follow‐up to 10 y of age: results from the German Infant Nutritional Intervention (GINI) study. American Journal of Clinical Nutrition2011;94(6 Suppl):1803S‐7S. [DOI: 10.3945/ajcn.110.000679; PUBMED: 21849601] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. German Infant Nutritional Intervention Study Group. Short‐ and long‐term effects of feeding hydrolyzed protein infant formulas on growth at &lt; or = 6 y of age: results from the German Infant Nutritional Intervention Study. American Journal of Clinical Nutrition2009;89(6):1846‐56. [DOI: 10.3945/ajcn.2008.27373; PUBMED: 19369380] SausenthalerS , KoletzkoS , KoletzkoB , ReinhardtD , KramerU , vonBergA , et al. GINIplus study group. Effect of hydrolysed formula feeding on taste preferences at 10 years. Data from the German Infant Nutritional Intervention Program Plus Study. Clinical Nutrition2010;29(3):304‐6. [DOI: 10.1016/j.clnu.2010.01.007; PUBMED: 20110140] SchoetzauA , Filipiak‐PittroffB , FrankeK , KoletzkoS , VonBergA , GrueblA , et al. German Infant Nutritional Intervention Study Group. Effect of exclusive breast‐feeding and early solid food avoidance on the incidence of atopic dermatitis in high‐risk infants at 1 year of age. Pediatric Allergy and Immunology2002;13(4):234‐42. [PUBMED: 12390439] SchoetzauA , GehringU , FrankeK , GrublA , KoletzkoS , vonBergA , et al. Gini Study Group. Maternal compliance with nutritional recommendations in an allergy preventive programme. Archives of Disease in Childhood2002;86(3):180‐4. [PUBMED: 11861235] VonBergA , Filipiak‐PittroffB , KrämerU , LinkE , HeinrichJ , KoletzkoS , et al. The German Infant Nutritional Intervention Study (GINI) for the preventive effect of hydrolysed infant formulas in infants at high risk for allergic diseases. Design and selected results. Allergologie2012;35(1):32‐43. VonBergA , Filipiak‐PittroffB , SchulzH , HoffmannU , LinkE , SussmannM , et al. GINIplus study group. Allergic manifestation 15 years after early intervention with hydrolyzed formulas ‐ the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2016;71(2):210‐9. [DOI: 10.1111/all.12790; PUBMED: 26465137] vonBergA , FilipiakB , KoletzkoS , KrämerU , HoffmannB , LinkE , et al. Long‐term effect of cow milk protein hydrolysates in high‐risk children. Results from the 10‐years follow‐up of the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2013;68:295‐6. vonBergA , Filipiak‐PittroffB , KramerU , HoffmannB , LinkE , BeckmannC , et al. GINIplus study group. Allergies in high‐risk schoolchildren after early intervention with cow's milk protein hydrolysates: 10‐year results from the German Infant Nutritional Intervention (GINI) study. Journal of Allergy and Clinical Immunology2013;131(6):1565‐73. [DOI: 10.1016/j.jaci.2013.01.006; PUBMED: 23506844] vonBergA , Filipiak‐PittroffB , KramerU , LinkE , BollrathC , BrockowI , et al. GINIplus study group. Preventive effect of hydrolyzed infant formulas persists until age 6 years: long‐term results from the German Infant Nutritional Intervention Study (GINI). Journal of Allergy and Clinical Immunology2008;121(6):1442‐7. [DOI: 10.1016/j.jaci.2008.04.021; PUBMED: 18539195] vonBergA , KoletzkoS , Filipiak‐PittroffB , LaubereauB , GrublA , WichmannHE , et al. German Infant Nutritional Intervention Study Group. Certain hydrolyzed formulas reduce the incidence of atopic dermatitis but not that of asthma: three‐year results of the German Infant Nutritional Intervention Study. Journal of Allergy and Clinical Immunology2007;119(3):718‐25. [DOI: 10.1016/j.jaci.2006.11.017; PUBMED: 17240440] vonBergA , KoletzkoS , GrublA , Filipiak‐PittroffB , WichmannHE , BauerCP , et al. German Infant Nutritional Intervention Study Group. The effect of hydrolyzed cow's milk formula for allergy prevention in the first year of life: the German Infant Nutritional Intervention Study, a randomized double‐blind trial. Journal of Allergy and Clinical Immunology2003;111(3):533‐40. [PUBMED: 12642834] ">von Berg 2003</a> (12 months and three, six, 10 and 15 years ‐ note excess losses from three years of age). </p> <p>Three studies reported using questionnaire‐diagnosed allergic disease: <a href="./references#CD003664-bbs2-0004" title="HillD . A report on the analysis of the Melbourne Atopy Cohort Study. A study designed to test the effectiveness of different formula types on the development of atopic symptoms and signs on a cohort of atopy‐at‐risk infants. Report at year 2. Nestec Internal Report. HillDJ , SporikR , ThorburnJ , HoskingCS . The association of atopic dermatitis in infancy with immunoglobulin E food sensitization. Journal of Pediatrics2000;137(4):475‐9. [DOI: 10.1067/mpd.2000.108207; PUBMED: 11035824] KoplinJ , DharmageSC , GurrinL , OsborneN , TangML , LoweAJ , et al. Soy consumption is not a risk factor for peanut sensitization. Journal of Allergy and Clinical Immunology2008;121(6):1455‐9. [DOI: 10.1016/j.jaci.2008.03.017; PUBMED: 18436294] LoweA , HoskingC , BennettC , AllenK , CarlinJ , DharmageS , et al. The Melbourne Atopy Cohort Study: a RCT of a partially hydrolysed whey formula for the prevention of allergic disease. Internal Medicine Journal2008;38:A158. LoweAJ , AbramsonMJ , HoskingCS , CarlinJB , BennettCM , DharmageSC , et al. The temporal sequence of allergic sensitization and onset of infantile eczema. Clinical &amp; Experimental Allergy2007;37(4):536‐42; Erratum in: Clinical &amp; Experimental Allergy 2007; 37(12);1895. [DOI: 10.1111/j.1365‐2222.2007.02691.x; PUBMED: 17430350] LoweAJ , CarlinJB , BennettCM , HoskingCS , AllenKJ , RobertsonCF , et al. Paracetamol use in early life and asthma: prospective birth cohort study. BMJ2010;341:c4616. [PUBMED: 20843914] LoweAJ , HoskingCS , BennettCM , AllenKJ , AxelradC , CarlinJB , et al. Effect of a partially hydrolyzed whey infant formula at weaning on risk of allergic disease in high‐risk children: a randomized controlled trial. Journal of Allergy and Clinical Immunology2011;128(2):360‐5.e4. [DOI: 10.1016/j.jaci.2010.05.006; PUBMED: 21696814] StoneyRM , WoodsRK , HoskingCS , HillDJ , AbramsonMJ , ThienFC . Maternal breast milk long‐chain n‐3 fatty acids are associated with increased risk of atopy in breastfed infants. Clinical and Experimental Allergy2004;34(2):194‐200; Erratum in: Clinical &amp; Experimental Allergy 2007; 37(12);1895. [PUBMED: 14987297] ThomsonJA , WidjajaC , DarmaputraAA , LoweA , MathesonMC , BennettCM , et al. Early childhood infections and immunisation and the development of allergic disease in particular asthma in a high‐risk cohort: a prospective study of allergy‐prone children from birth to six years. Pediatric Allergy and Immunology2010;21(7):1076‐85. [DOI: 10.1111/j.1399‐3038.2010.01018.x; PUBMED: 20337970] ">Hill 2000</a> (six to seven years); <a href="./references#CD003664-bbs2-0006" title="KwintaP , SawiecP , KlimekM , LisG , Cichocka‐JaroszE , PietrzykJJ . Correlation between early neonatal diet and atopic symptoms up to 5‐7 years of age in very low birth weight infants: follow‐up of randomized, double‐blind study. Pediatric Allergy and Immunology2009;20(5):458‐66. [DOI: 10.1111/j.1399‐3038.2008.00814.x; PUBMED: 19490477] ">Kwinta 2009</a> (five to seven years); and <a href="./references#CD003664-bbs2-0016" title="WillemsR , DuchateauJ , MagrezP , DenisR , CasimirG . Influence of hypoallergenic milk formula on the incidence of early allergic manifestations in infants predisposed to atopic diseases. Annals of Allergy1993;71(2):147‐50. [PUBMED: 8346868] ">Willems 1993</a> (three months and one year). </p> <p>Seven studies reported specific food allergy (<a href="./references#CD003664-bbs2-0003" title="HalkenS , HansenKS , JacobsenHP , EstmannA , FaellingAE , HansenLG , et al. Comparison of a partially hydrolyzed infant formula with two extensively hydrolyzed formulas for allergy prevention: a prospective, randomized study. Pediatric Allergy and Immunology2000;11(3):149‐61. [PUBMED: 10981524] ">Halken 2000</a>; <a href="./references#CD003664-bbs2-0004" title="HillD . A report on the analysis of the Melbourne Atopy Cohort Study. A study designed to test the effectiveness of different formula types on the development of atopic symptoms and signs on a cohort of atopy‐at‐risk infants. Report at year 2. Nestec Internal Report. HillDJ , SporikR , ThorburnJ , HoskingCS . The association of atopic dermatitis in infancy with immunoglobulin E food sensitization. Journal of Pediatrics2000;137(4):475‐9. [DOI: 10.1067/mpd.2000.108207; PUBMED: 11035824] KoplinJ , DharmageSC , GurrinL , OsborneN , TangML , LoweAJ , et al. Soy consumption is not a risk factor for peanut sensitization. Journal of Allergy and Clinical Immunology2008;121(6):1455‐9. [DOI: 10.1016/j.jaci.2008.03.017; PUBMED: 18436294] LoweA , HoskingC , BennettC , AllenK , CarlinJ , DharmageS , et al. The Melbourne Atopy Cohort Study: a RCT of a partially hydrolysed whey formula for the prevention of allergic disease. Internal Medicine Journal2008;38:A158. LoweAJ , AbramsonMJ , HoskingCS , CarlinJB , BennettCM , DharmageSC , et al. The temporal sequence of allergic sensitization and onset of infantile eczema. Clinical &amp; Experimental Allergy2007;37(4):536‐42; Erratum in: Clinical &amp; Experimental Allergy 2007; 37(12);1895. [DOI: 10.1111/j.1365‐2222.2007.02691.x; PUBMED: 17430350] LoweAJ , CarlinJB , BennettCM , HoskingCS , AllenKJ , RobertsonCF , et al. Paracetamol use in early life and asthma: prospective birth cohort study. BMJ2010;341:c4616. [PUBMED: 20843914] LoweAJ , HoskingCS , BennettCM , AllenKJ , AxelradC , CarlinJB , et al. Effect of a partially hydrolyzed whey infant formula at weaning on risk of allergic disease in high‐risk children: a randomized controlled trial. Journal of Allergy and Clinical Immunology2011;128(2):360‐5.e4. [DOI: 10.1016/j.jaci.2010.05.006; PUBMED: 21696814] StoneyRM , WoodsRK , HoskingCS , HillDJ , AbramsonMJ , ThienFC . Maternal breast milk long‐chain n‐3 fatty acids are associated with increased risk of atopy in breastfed infants. Clinical and Experimental Allergy2004;34(2):194‐200; Erratum in: Clinical &amp; Experimental Allergy 2007; 37(12);1895. [PUBMED: 14987297] ThomsonJA , WidjajaC , DarmaputraAA , LoweA , MathesonMC , BennettCM , et al. Early childhood infections and immunisation and the development of allergic disease in particular asthma in a high‐risk cohort: a prospective study of allergy‐prone children from birth to six years. Pediatric Allergy and Immunology2010;21(7):1076‐85. [DOI: 10.1111/j.1399‐3038.2010.01018.x; PUBMED: 20337970] ">Hill 2000</a>; <a href="./references#CD003664-bbs2-0005" title="JuvonenP , ManssonM , AnderssonC , JakobssonI . Allergy development and macromolecular absorption in infants with different feeding regimens during the first three days of life. A three‐year prospective follow‐up. Acta Paediatrica1996;85(9):1047‐52. [PUBMED: 8888916] JuvonenP , ManssonM , JakobssonI . Does early diet have an effect on subsequent macromolecular absorption and serum IgE?. Journal of Pediatric Gastroenterology and Nutrition1994;18(3):344‐9. [PUBMED: 8057219] JuvonenP , ManssonM , KjellmanNI , BjorkstenB , JakobssonI . Development of immunoglobulin G and immunoglobulin E antibodies to cow's milk proteins and ovalbumin after a temporary neonatal exposure to hydrolyzed and whole cow's milk proteins. Pediatric Allergy and Immunology1999;10(3):191‐8. [PUBMED: 10565560] ">Juvonen 1996</a>; <a href="./references#CD003664-bbs2-0011" title="OldaeusG , AnjouK , BjorkstenB , MoranJR , KjellmanNI . Extensively and partially hydrolysed infant formulas for allergy prophylaxis. Archives of Disease in Childhood1997;77(1):4‐10. [PUBMED: 9279143] OldaeusG , BjorkstenB , JenmalmMC , KjellmanNI . Cow's milk IgE and IgG antibody responses to cow's milk formulas. Allergy1999;54(4):352‐7. [PUBMED: 10371094] ">Oldaeus 1997</a>; <a href="./references#CD003664-bbs2-0012" title="SaarinenKM , Juntunen‐BackmanK , JarvenpaaAL , KlemettiP , KuitunenP , LopeL , et al. Breast‐feeding and the development of cows' milk protein allergy. Advances in Experimental Medicine and Biology2000;478:121‐30. [DOI: 10.1007/0‐306‐46830‐1_10; PUBMED: 11065065] SaarinenKM , Juntunen‐BackmanK , JarvenpaaAL , KuitunenP , LopeL , RenlundM , et al. Supplementary feeding in maternity hospitals and the risk of cow's milk allergy: a prospective study of 6209 infants. Journal of Allergy and Clinical Immunology1999;104(2 Pt 1):457‐61. [PUBMED: 10452771] SaarinenKM , SavilahtiE . Infant feeding patterns affect the subsequent immunological features in cow's milk allergy. Clinical and Experimental Allergy2000;30(3):400‐6. [DOI: 10691899] SaarinenKM , SuomalainenH , SavilahtiE . Diagnostic value of skin‐prick and patch tests and serum eosinophil cationic protein and cow's milk‐specific IgE in infants with cow's milk allergy. Clinical and Experimental Allergy2001;31(3):423‐9. [PUBMED: 11260154] SaarinenKM , VaaralaO , KlemettiP , SavilahtiE . Transforming growth factor‐beta1 in mothers' colostrum and immune responses to cows' milk proteins in infants with cows' milk allergy. Journal of Allergy and Clinical Immunology1999;104(5):1093‐8. [PUBMED: 10550758] SavilahtiE , SaarinenKM . Early infant feeding and type 1 diabetes. European Journal of Nutrition2009;48(4):243‐9. [DOI: 10.1007/s00394‐009‐0008‐z; PUBMED: 19263185] SavilahtiEM , SaarinenKM , SavilahtiE . Specific antibodies to cow's milk proteins in infants: effect of early feeding and diagnosis of cow's milk allergy. European Journal of Nutrition2010;49(8):501‐4. [DOI: 10.1007/s00394‐010‐0109‐8; PUBMED: 20405136] SiltanenM , KajosaariM , PoussaT , SaarinenKM , SavilahtiE . A dual long‐term effect of breastfeeding on atopy in relation to heredity in children at 4 years of age. Allergy2003;58(6):524‐30. [PUBMED: 12757455] ">Saarinen 1999</a>; <a href="./references#CD003664-bbs2-0014" title="VandenplasY . Atopy at 3 years in high‐risk infants fed whey hydrolysate or conventional formula. Lancet1992;339(8801):1118. [PUBMED: 1349137] VandenplasY , HauserB , Van denBorreC , ClybouwC , MahlerT , Hachimi‐IdrissiS , et al. The long‐term effect of a partial whey hydrolysate formula on the prophylaxis of atopic disease. European Journal of Pediatrics1995;154(6):488‐94. [PUBMED: 7671948] VandenplasY , HauserB , Van denBorreC , SacreL , DabI . Effect of a whey hydrolysate prophylaxis of atopic disease. Annals of Allergy1992;68(5):419‐24. [PUBMED: 1586005] ">Vandenplas 1992</a>; <a href="./references#CD003664-bbs2-0015" title="BergA , KramerU , LinkE , BollrathC , HeinrichJ , BrockowI , et al. GINIplus study group. Impact of early feeding on childhood eczema: development after nutritional intervention compared with the natural course ‐ the GINIplus study up to the age of 6 years. Clinical and Experimental Allergy2010;40(4):627‐36. [DOI: 10.1111/j.1365‐2222.2009.03444.x; PUBMED: 20082618] BrockowI , ZutavernA , HoffmannU , GrublA , vonBergA , KoletzkoS , et al. GINIplus Study Group. Early allergic sensitizations and their relevance to atopic diseases in children aged 6 years: results of the GINI study. Journal of Investigational Allergology &amp; Clinical Immunology2009;19(3):180‐7. [DOI: 19610260] LaubereauB , BrockowI , ZirngiblA , KoletzkoS , GrueblA , vonBergA , et al. GINI Study Group. Effect of breast‐feeding on the development of atopic dermatitis during the first 3 years of life ‐ results from the GINI‐birth cohort study. Journal of Pediatrics2004;144(5):602‐7. [DOI: 10.1016/j.jpeds.2003.12.029; PUBMED: 15126993] LaubereauB , Filipiak‐PittroffB , vonBergA , GrublA , ReinhardtD , WichmannHE , et al. Caesarean section and gastrointestinal symptoms, atopic dermatitis, and sensitisation during the first year of life. Archives of Disease in Childhood2004;89(11):993‐7. [DOI: 10.1136/adc.2003.043265; PUBMED: 15499049] RzehakP , SausenthalerS , KoletzkoS , BauerCP , SchaafB , vonBergA , et al. Period‐specific growth, overweight and modification by breastfeeding in the GINI and LISA birth cohorts up to age 6 years. European Journal of Epidemiology2009;24(8):449‐67. [DOI: 10.1007/s10654‐009‐9356‐5; PUBMED: 19521784] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. GINI‐plus Study Group. Long‐term effects of hydrolyzed protein infant formulas on growth ‐ extended follow‐up to 10 y of age: results from the German Infant Nutritional Intervention (GINI) study. American Journal of Clinical Nutrition2011;94(6 Suppl):1803S‐7S. [DOI: 10.3945/ajcn.110.000679; PUBMED: 21849601] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. German Infant Nutritional Intervention Study Group. Short‐ and long‐term effects of feeding hydrolyzed protein infant formulas on growth at &lt; or = 6 y of age: results from the German Infant Nutritional Intervention Study. American Journal of Clinical Nutrition2009;89(6):1846‐56. [DOI: 10.3945/ajcn.2008.27373; PUBMED: 19369380] SausenthalerS , KoletzkoS , KoletzkoB , ReinhardtD , KramerU , vonBergA , et al. GINIplus study group. Effect of hydrolysed formula feeding on taste preferences at 10 years. Data from the German Infant Nutritional Intervention Program Plus Study. Clinical Nutrition2010;29(3):304‐6. [DOI: 10.1016/j.clnu.2010.01.007; PUBMED: 20110140] SchoetzauA , Filipiak‐PittroffB , FrankeK , KoletzkoS , VonBergA , GrueblA , et al. German Infant Nutritional Intervention Study Group. Effect of exclusive breast‐feeding and early solid food avoidance on the incidence of atopic dermatitis in high‐risk infants at 1 year of age. Pediatric Allergy and Immunology2002;13(4):234‐42. [PUBMED: 12390439] SchoetzauA , GehringU , FrankeK , GrublA , KoletzkoS , vonBergA , et al. Gini Study Group. Maternal compliance with nutritional recommendations in an allergy preventive programme. Archives of Disease in Childhood2002;86(3):180‐4. [PUBMED: 11861235] VonBergA , Filipiak‐PittroffB , KrämerU , LinkE , HeinrichJ , KoletzkoS , et al. The German Infant Nutritional Intervention Study (GINI) for the preventive effect of hydrolysed infant formulas in infants at high risk for allergic diseases. Design and selected results. Allergologie2012;35(1):32‐43. VonBergA , Filipiak‐PittroffB , SchulzH , HoffmannU , LinkE , SussmannM , et al. GINIplus study group. Allergic manifestation 15 years after early intervention with hydrolyzed formulas ‐ the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2016;71(2):210‐9. [DOI: 10.1111/all.12790; PUBMED: 26465137] vonBergA , FilipiakB , KoletzkoS , KrämerU , HoffmannB , LinkE , et al. Long‐term effect of cow milk protein hydrolysates in high‐risk children. Results from the 10‐years follow‐up of the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2013;68:295‐6. vonBergA , Filipiak‐PittroffB , KramerU , HoffmannB , LinkE , BeckmannC , et al. GINIplus study group. Allergies in high‐risk schoolchildren after early intervention with cow's milk protein hydrolysates: 10‐year results from the German Infant Nutritional Intervention (GINI) study. Journal of Allergy and Clinical Immunology2013;131(6):1565‐73. [DOI: 10.1016/j.jaci.2013.01.006; PUBMED: 23506844] vonBergA , Filipiak‐PittroffB , KramerU , LinkE , BollrathC , BrockowI , et al. GINIplus study group. Preventive effect of hydrolyzed infant formulas persists until age 6 years: long‐term results from the German Infant Nutritional Intervention Study (GINI). Journal of Allergy and Clinical Immunology2008;121(6):1442‐7. [DOI: 10.1016/j.jaci.2008.04.021; PUBMED: 18539195] vonBergA , KoletzkoS , Filipiak‐PittroffB , LaubereauB , GrublA , WichmannHE , et al. German Infant Nutritional Intervention Study Group. Certain hydrolyzed formulas reduce the incidence of atopic dermatitis but not that of asthma: three‐year results of the German Infant Nutritional Intervention Study. Journal of Allergy and Clinical Immunology2007;119(3):718‐25. [DOI: 10.1016/j.jaci.2006.11.017; PUBMED: 17240440] vonBergA , KoletzkoS , GrublA , Filipiak‐PittroffB , WichmannHE , BauerCP , et al. German Infant Nutritional Intervention Study Group. The effect of hydrolyzed cow's milk formula for allergy prevention in the first year of life: the German Infant Nutritional Intervention Study, a randomized double‐blind trial. Journal of Allergy and Clinical Immunology2003;111(3):533‐40. [PUBMED: 12642834] ">von Berg 2003</a>). </p> </section> </section> <section id="CD003664-sec-0090"> <h4 class="title">Excluded studies</h4> <p>We excluded 86 studies and documented reasons for exclusion in the <a href="./references#CD003664-sec-0159" title="">Characteristics of excluded studies</a> table. Here, we document controlled trials of hydrolysed formula according to types of participants and reasons for exclusion. </p> <section id="CD003664-sec-0091"> <h5 class="title">Preterm or low birth weight infants</h5> <p>The following studies did not report allergic disease: <a href="./references#CD003664-bbs2-0017" title="AgostiM , PugniL , RamenghiLA , MoscaF , MariniA . Hydrolysed proteins in preterm formula: influence on plasma aminoacids, blood fatty acids and insulinaemia. Acta Paediatrica Supplement2003;91(441):34‐8. [14599039] ">Agosti 2003</a>; <a href="./references#CD003664-bbs2-0023" title="BaldassarreME , DiMauroA , FanelliM , MontagnaO , WamplerJ , CooperT , et al. Shorter time to full enteral feedings among infants fed an intact protein (IP) vs an extensively hydrolyzed (EH) formula does not appear to be related to differences in gastric emptying. Journal of Pediatric Gastroenterology and Nutrition2017;64(Suppl 1):920‐1. ">Baldassarre 2017</a>; <a href="./references#CD003664-bbs2-0043" title="FlorendoKN , BellflowerB , vanZwolA , CookeRJ . Growth in preterm infants fed either a partially hydrolyzed whey or an intact casein/whey preterm infant formula. Journal of Perinatology2009;29(2):106‐11. [DOI: 10.1038/jp.2008.124; PUBMED: 18716627] ">Florendo 2009</a>; <a href="./references#CD003664-bbs2-0059" title="MaggioL , ZuppaAA , SawatzkiG , ValsasinaR , SchubertW , TortoroloG . Higher urinary excretion of essential amino acids in preterm infants fed protein hydrolysates. Acta Paediatrica2005;94(1):75‐84. [PUBMED: 15858965] ZuppaAA , GirlandoP , ScapillatiME , MaggioL , RomagnoliC , TortoroloG . [Effects on growth, tolerability and biochemical parameters of two different human milk fortifiers in very low birth‐weight newborns]. Pediatria Medica e Chirurgica2004;26(1):45‐9. [PUBMED: 15529811] ">Maggio 2005</a>; <a href="./references#CD003664-bbs2-0063" title="MihatschWA , HogelJ , PohlandtF . Hydrolysed protein accelerates the gastrointestinal transport of formula in preterm infants. Acta Paediatrica2001;90(2):196‐8. [PUBMED: 11236051] MihatschWA , PohlandtF . Protein hydrolysate formula maintains homeostasis of plasma amino acids in preterm infants. Journal of Pediatric Gastroenterology and Nutrition1999;29(4):406‐10. [PUBMED: 10512399] ">Mihatsch 1999</a> (cross‐over trial); <a href="./references#CD003664-bbs2-0064" title="MihatschWA , FranzAR , HogelJ , PohlandtF . Hydrolyzed protein accelerates feeding advancement in very low birth weight infants. Pediatrics2002;110(6):1199‐203. [PUBMED: 12456919] ">Mihatsch 2002</a> (excess losses); <a href="./references#CD003664-bbs2-0073" title="PaulsJ , BauerK , VersmoldH . Randomized controlled trial of formulas with hydrolyzed versus non‐hydrolyzed protein for starting enteral feedings in preterm infants &lt;1500g body weight. Journal of Pediatric Gastroenterology and Nutrition1996;22:450 (abstract 164). ">Pauls 1996</a> (abstract format only); <a href="./references#CD003664-bbs2-0074" title="PicaudJC , LapillonneA , RigoJ , NormandS , ReygrobelletB , ClarisO , et al. Nitrogen utilization and bone mineralization in very low birth weight infants fed partially hydrolyzed preterm formula. Seminars in Perinatology2002;26(6):439‐46; Retraction in: Seminars in Perinatology 2013; 37(2):138. [PUBMED: 12537316] PicaudJC , RigoJ , NormandS , LapillonneA , ReygrobelletB , ClarisO , et al. Nutritional efficacy of preterm formula with a partially hydrolyzed protein source: a randomized pilot study. Journal of Pediatric Gastroenterology and Nutrition2001;32(5):555‐61. [PUBMED: 11429516] ">Picaud 2001</a>; <a href="./references#CD003664-bbs2-0076" title="RauppP , VonKriesR , GobelC , FoxA , LemburgP , SchmidtE , et al. Bone density and biochemical parameters of bone mineral metabolism and acid load in preterm infants. Cow's milk formula versus hydrolysed protein preparation. Monatsschr Kinderheilkd1995;143(7 (Suppl 2)):S140‐6. ">Raupp 1995</a>; <a href="./references#CD003664-bbs2-0077" title="RiezzoG , IndrioF , MontagnaO , TripaldiC , LaforgiaN , ChiloiroM , et al. Gastric electrical activity and gastric emptying in preterm newborns fed standard and hydrolysate formulas. Journal of Pediatric Gastroenterology and Nutrition2001;33(3):290‐5. [PUBMED: 11593124] ">Riezzo 2001</a>; <a href="./references#CD003664-bbs2-0079" title="RigoJ , SenterreJ . Metabolic balance studies and plasma amino acid concentrations in preterm infants fed experimental protein hydrolysate preterm formulas. Acta Paediatrica Supplement1994;405:98‐104. [PUBMED: 7734800] ">Rigo 1994b</a> (unclear allocation); <a href="./references#CD003664-bbs2-0091" title="SzajewskaH , AlbrechtP , StoinskaB , ProchowskaA , GaweckaA , Laskowska‐KlitaT . Extensive and partial protein hydrolysate preterm formulas: the effect on growth rate, protein metabolism indices, and plasma amino acid concentrations. Journal of Pediatric Gastroenterology and Nutrition2001;32(3):303‐9. [PUBMED: 11345180] ">Szajewska 2001</a>; and <a href="./references#CD003664-bbs2-0101" title="YuMX , ZhuangSQ , WangDH , ZhouXY , LiuXH , ShiLP , et al. Effects of extensively hydrolyzed protein formula on feeding and growth in preterm infants: a multicenter controlled clinical study. Zhongguo Dang Dai Er Ke za Zhi [Chinese Journal of Contemporary Pediatrics]2014;16(7):684‐90. [PUBMED: 25008873] ">Yu 2014</a> (likely non‐random, cross‐over). </p> </section> <section id="CD003664-sec-0092"> <h5 class="title">Term healthy infants</h5> <p><a href="./references#CD003664-bbs2-0018" title="AkerblomHK , VirtanenSM , IlonenJ , SavilahtiE , VaaralaO , ReunanenA , et al. National TRIGR Study Groups. Dietary manipulation of beta cell autoimmunity in infants at increased risk of type 1 diabetes: A pilot study. Diabetologia2005;48(5):829‐37; Erratum in: Diabetologia 2005; Aug;48(8):1676. [DOI: 10.1007/s00125‐005‐1733‐3; PUBMED: 15838685] VirtanenSM , BarlundS , SalonenM , SavilahtiE , ReunanenA , ParonenJ , et al. Finnish TRIGR Study Group. Feasibility and compliance in a nutritional primary prevention trial in infants at increased risk for type 1 diabetes. Acta Paediatrica2011;100(4):557‐64. [DOI: 10.1111/j.1651‐2227.2010.02107.x; PUBMED: 21114527] ">Akerblom 2005</a> enrolled infants at high risk of diabetes and did not report allergic disease; <a href="./references#CD003664-bbs2-0019" title="AkimotoK , SaitoH , AkasawaA , IikuraY . [Preventative effect of a whey hydrolyzed formula (Nestle, NAN H.A.) on the development of allergic symptoms in infants]. Arerugi [Allergy]1997;46(10):1044‐51. [PUBMED: 9404092] ">Akimoto 1997</a> reported allergic disease (non‐random); <a href="./references#CD003664-bbs2-0067" title="NCT00936637 . Effects on growth of an extensively hydrolyzed formula fed to term [A 16‐week growth study of an extensively hydrolyzed infant formula, 3 Months treatment and 1 month follow‐up for a duration of 4 months]. clinicaltrials.gov/show/NCT00936637 (first received 10 July 2009). ">NCT00936637</a> did not report allergic disease; <a href="./references#CD003664-bbs2-0026" title="BersethCL , MitmesserSH , ZieglerEE , MarunyczJD , VanderhoofJ . Tolerance of a standard intact protein formula versus a partially hydrolyzed formula in healthy, term infants. Nutrition Journal2009;8:27. [DOI: 10.1186/1475‐2891‐8‐27; PUBMED: 19545360] ">Berseth 2009</a> (multiple formula differences) did not report allergic disease; <a href="./references#CD003664-bbs2-0027" title="BorschelMW , ZieglerEE , WedigRT , OliverJS . Growth of healthy term infants fed an extensively hydrolyzed casein‐based or free amino acid‐based infant formula: a randomized, double‐blind, controlled trial. Clinical Pediatrics2013;52(10):910‐7. [DOI: 10.1177/0009922813492883; PUBMED: 23820000] ">Borschel 2013</a> did not report allergic disease; <a href="./references#CD003664-bbs2-0028" title="BorschelMW , ChoeYS , KajzerJA . Growth of healthy term infants fed partially hydrolyzed whey‐based infant formula: a randomized, blinded, controlled trial. Clinical Pediatrics2014;53(14):1375‐82. [DOI: 10.1177/0009922814541804; PUBMED: 25009115] ">Borschel 2014a</a> (multiple formula differences) did not report allergic disease; <a href="./references#CD003664-bbs2-0029" title="BorschelMW , BaggsGE , Barrett‐ReisB . Growth of healthy term infants fed ready‐to‐feed and powdered forms of an extensively hydrolyzed casein‐based infant formula: a randomized, blinded, controlled trial. Clinical Pediatrics2014;53(6):585‐92. [DOI: 10.1177/0009922814528036; PUBMED: 24662422] ">Borschel 2014b</a> (multiple formula differences) did not report allergic disease; <a href="./references#CD003664-bbs2-0031" title="BurksW , JonesSM , BersethCL , HarrisC , SampsonHA , ScalabrinDM . Hypoallergenicity and effects on growth and tolerance of a new amino acid‐based formula with docosahexaenoic acid and arachidonic acid. Journal of Pediatrics2008;153(2):266‐71. [DOI: 10.1016/j.jpeds.2008.02.043; PUBMED: 18534230] ">Burks 2008</a> (excess losses) did not report allergic disease; <a href="./references#CD003664-bbs2-0041" title="deJongMH , Scharp‐Van Der LindenVT , AalberseR , HeymansHS , BrunekreefB . The effect of brief neonatal exposure to cows' milk on atopic symptoms up to age 5. Archives of Disease in Childhood2002;86(5):365‐9. [PUBMED: 11970933] deJongMH , Scharp‐van der LindenVT , AalberseRC , OostingJ , TijssenJG , deGrootCJ . Randomised controlled trial of brief neonatal exposure to cows' milk on the development of atopy. Archives of Disease in Childhood1998;79(2):126‐30. [PUBMED: 9797592] ">de Jong 1998</a> used protein‐free formula; <a href="./references#CD003664-bbs2-0039" title="DecsiT , VolkerV , SzaszM , EzerE , MehesK . [Comparison of human milk with 3 different types of infant food in the nutrition of full‐term neonates]. Orvosi Hetilap1992;133(33):2087‐91. [PUBMED: 1501859] ">Decsi 1992</a> did not report allergic disease; <a href="./references#CD003664-bbs2-0040" title="DecsiT , VeitlV , BurusI . Plasma amino acid concentrations, indexes of protein metabolism and growth in healthy, full‐term infants fed partially hydrolyzed infant formula. Journal of Pediatric Gastroenterology and Nutrition1998;27(1):12‐6. [PUBMED: 9669720] ">Decsi 1998</a> did not report allergic disease; <a href="./references#CD003664-bbs2-0042" title="ExlBM , DelandU , SecretinMC , PreyschU , WallM , ShmerlingDH . Improved general health status in an unselected infant population following an allergen reduced dietary intervention programme. The ZUFF‐study‐programme. Part I: study design and 6‐month nutritional behaviour. European Journal of Nutrition2000;39(3):89‐102. [PUBMED: 10918990] ExlBM , DelandU , SecretinMC , PreyschU , WallM , ShmerlingDH . Improved general health status in an unselected infant population following an allergen‐reduced dietary intervention programme: the ZUFF‐STUDY‐PROGRAMME. Part II: infant growth and health status to age 6 months. European Journal of Nutrition2000;39(4):145‐56. [PUBMED: 11079734] ExlBM , DelandU , WallM , PreyschU , SecretinMC , ShmerlingDH . Zug‐Frauenfeld Nutritional Survey ('Zuff Study'): allergen‐reduced nutrition in a normal infant population and its health‐related effects. Results at the age of six months. Nutrition Research1998;18(8):1443‐62. [DOI: 10.1016/S0271‐5317(98)00121‐3] ">Exl 1998</a> reported allergic disease (non‐random); <a href="./references#CD003664-bbs2-0044" title="FukushimaY , IwamotoK , Takeuchi‐NakashimaA , AkamatsuN , Fujino‐NumataN , YoshikoshiM , et al. Preventive effect of whey hydrolysate formulas for mothers and infants against allergy development in infants for the first 2 years. Journal of Nutritional Science and Vitaminology1997;43(3):397‐411. [PUBMED: 9268927] ">Fukushima 1997</a> reported allergic disease (excess losses); <a href="./references#CD003664-bbs2-0047" title="HartmanCT , FredericksGL , KatzES , BrownCA . Prevalence of symptomatic formula intolerance and allergy in a general infant population. Journal of Allergy and Clinical Immunology1994;93(1):210. [(A286)] ">Hartman 1994</a> reported intolerance not allergic disease and reported unclear losses (abstract format only); <a href="./references#CD003664-bbs2-0049" title="HernellO , LonnerdalB . Nutritional evaluation of protein hydrolysate formulas in healthy term infants: plasma amino acids, hematology, and trace elements. American Journal of Clinical Nutrition2003;78(2):296‐301. [DOI: 10.1093/ajcn/78.2.296; PUBMED: 12885712] ">Hernell 2003</a> (unclear allocation) did not report allergic disease; <a href="./references#CD003664-bbs2-0053" title="KellerKM , Burgin‐WolffA , LippoldR , WirthS , LentzeMJ . The diagnostic significance of IgG cow's milk protein antibodies re‐evaluated. European Journal of Pediatrics1996;155(4):331‐7. [PUBMED: 8777930] ">Keller 1996</a> (unclear allocation) reported allergic disease; <a href="./references#CD003664-bbs2-0054" title="HyytinenM , SavilahtiE , VirtanenSM , HarkonenT , IlonenJ , LuopajarviK , et al. Finnish TRIGR Pilot Study Group. Avoidance of cow's milk‐based formula for at‐risk infants does not reduce development of celiac disease: a randomized controlled trial. Gastroenterology2017;153(4):961‐70.e3. KnipM , VirtanenSM , SeppaK , IlonenJ , SavilahtiE , VaaralaO , et al. Finnish TRIGR Study Group. Dietary intervention in infancy and later signs of beta‐cell autoimmunity. New England Journal of Medicine2010;363(20):1900‐8. [DOI: 10.1056/NEJMoa1004809; PUBMED: 21067382] ">Knip 2010</a> enrolled infants at high risk of diabetes and did not report allergic disease; <a href="./references#CD003664-bbs2-0057" title="LasekanJB , KooWW , WaltersJ , NeylanM , LuebbersS . Growth, tolerance and biochemical measures in healthy infants fed a partially hydrolyzed rice protein‐based formula: a randomized, blinded, prospective trial. Journal of the American College of Nutrition2006;25(1):12‐9. [PUBMED: 16522927] ">Lasekan 2006</a> did not report allergic disease; <a href="./references#CD003664-bbs2-0061" title="Medjad‐GuillouN , HenocqA , Arnaud‐BattandierF . Does the hydrolysis of proteins change the acceptability and the digestive tolerance of milk for infants? The results of a comparative and randomized prospective study. Annales de Pediatrie1992;39(3):202‐6. [PUBMED: 1570949] ">Medjad‐Guillou 1992</a> (cross‐over trial) did not report allergic disease; <a href="./references#CD003664-bbs2-0062" title="MennellaJA , CastorSM . Sensitive period in flavor learning: effects of duration of exposure to formula flavors on food likes during infancy. Clinical Nutrition2012;31(6):1022‐5. [DOI: 10.1016/j.clnu.2012.05.005; PUBMED: 22652361] MennellaJA , ForestellCA , MorganLK , BeauchampGK . Early milk feeding influences taste acceptance and liking during infancy. American Journal of Clinical Nutrition2009;90(3):780S‐8S. [DOI: 10.3945/ajcn.2009.27462O; PUBMED: 19605570] MennellaJA , LukasewyczLD , CastorSM , BeauchampGK . The timing and duration of a sensitive period in human flavor learning: a randomized trial. American Journal of Clinical Nutrition2011;93(5):1019‐24. [DOI: 10.3945/ajcn.110.003541; 21310829; NCT00994747] MennellaJA , TrabulsiJC , PapasMA . Effects of cow milk versus extensive protein hydrolysate formulas on infant cognitive development. Amino Acids2016;48(3):697‐705. [DOI: 10.1007/s00726‐015‐2118‐7; NCT00994747; PUBMED: 26497857] ">Mennella 2011a</a> did not report allergic disease; <a href="./references#CD003664-bbs2-0066" title="MoranJR . Effects of prolonged exposure to partially hydrolyzed milk protein. Journal of Pediatrics1992;121(5 Pt 2):S90‐4. [PUBMED: 1447640] ">Moran 1992</a> reported excess losses; <a href="./references#CD003664-bbs2-0072" title="ParonenJ , KnipM , SavilahtiE , VirtanenSM , IlonenJ , AkerblomHK , et al. Effect of cow's milk exposure and maternal type 1 diabetes on cellular and humoral immunization to dietary insulin in infants at genetic risk for type 1 diabetes. Finnish Trial to Reduce IDDM in the Genetically at Risk Study Group. Diabetes2000;49(10):1657‐65. [PUBMED: 11016449] ">Paronen 2000</a> enrolled infants at risk of diabetes and did not report allergic disease; <a href="./references#CD003664-bbs2-0078" title="RigoJ , SalleBL , PicaudJC , PutetG , SenterreJ . Nutritional evaluation of protein hydrolysate formulas. European Journal of Clinical Nutrition1995;49(Suppl 1):S26‐38. [PUBMED: 8647061] RigoJ , SalleBL , PutetG , SenterreJ . Nutritional evaluation of various protein hydrolysate formulae in term infants during the first month of life. Acta Paediatrica Supplement1994;402:100‐4. [PUBMED: 7841611] ">Rigo 1994a</a> (unclear allocation) did not report allergic disease; <a href="./references#CD003664-bbs2-0082" title="ScalabrinD , BersethC , MarunyczJ , MitmesserS . Long term safety, growth, and health effects of lactobacillus GG (LGG) added to partially and extensively hydrolyzed infant formulas. Allergy: European Journal of Allergy and Clinical Immunology2009;64(1171):447. ScalabrinD , HarrisC , JohnstonWH , BersethCL . Long‐term safety assessment in children who received hydrolyzed protein formulas with Lactobacillus rhamnosus GG: a 5‐year follow‐up. European Journal of Pediatrics2017;176(2):217‐24. [DOI: 10.1007/s00431‐016‐2825‐4; PUBMED: 27975116] ScalabrinDM , JohnstonWH , HoffmanDR , P'PoolVL , HarrisCL , MitmesserSH . Growth and tolerance of healthy term infants receiving hydrolyzed infant formulas supplemented with Lactobacillus rhamnosus GG: randomized, double‐blind, controlled trial. Clinical Pediatrics2009;48(7):734‐44. [DOI: 10.1177/0009922809332682; NCT00655720; PUBMED: 19264721] ScalabrinDMF , HarrisC , StrongPV , LiuB , BersethCL . Infant supplementation with Lactobacillus rhamnosus GG (LGG) and long‐term growth and health: a 5‐year follow‐up. Allergy: European Journal of Allergy and Clinical Immunology2014;69(451):196‐7. ">Scalabrin 2009</a> (excess losses) reported adverse events including allergic disease; <a href="./references#CD003664-bbs2-0083" title="SchmelzleH , WirthS , SkopnikH , RadkeM , KnolJ , BocklerHM , et al. Randomized double‐blind study of the nutritional efficacy and bifidogenicity of a new infant formula containing partially hydrolyzed protein, a high beta‐palmitic acid level, and nondigestible oligosaccharides. Journal of Pediatric Gastroenterology and Nutrition2003;36(3):343‐51. [PUBMED: 12604972] ">Schmelzle 2003</a> (excess losses) did not report allergic disease; <a href="./references#CD003664-bbs2-0085" title="SchmitzJ , DigeonB , ChastangC , DupouyD , LerouxB , RobillardP , et al. Effects of brief early exposure to partially hydrolyzed and whole cow milk proteins. Journal of Pediatrics1992;121(5 Pt 2):S85‐9. [PUBMED: 1447639] ">Schmitz 1992</a> did not report allergic disease (excess losses); <a href="./references#CD003664-bbs2-0086" title="SchranderJJ , van denBogartJP , ForgetPP , Schrander‐StumpelCT , KuijtenRH , KesterAD . Cow's milk protein intolerance in infants under 1 year of age: a prospective epidemiological study. European Journal of Pediatrics1993;152(8):640‐4. [PUBMED: 8404966] ">Schrander 1993</a> was observational; <a href="./references#CD003664-bbs2-0088" title="Silva ReyAL , GarciaG , NogalesA . Preventatibve Effect of a Partially Hydrolyzed Milk Formula [Thesis]. Madrid, Spain, 1996. ">Silva Rey 1996</a> (unclear allocation; excess losses) reported in a thesis only; <a href="./references#CD003664-bbs2-0090" title="StaelensS , Van denDriesscheM , BarclayD , Carrie‐FaesslerAL , HaschkeF , VerbekeK , et al. Gastric emptying in healthy newborns fed an intact protein formula, a partially and an extensively hydrolysed formula. Clinical Nutrition2008;27(2):264‐8. [DOI: 10.1016/j.clnu.2007.12.009; PUBMED: 18280619] ">Staelens 2008</a> did not report allergic disease; <a href="./references#CD003664-bbs2-0093" title="TariqSM , MatthewsSM , HakimEA , StevensM , ArshadSH , HideDW . The prevalence of and risk factors for atopy in early childhood: a whole population birth cohort study. Journal of Allergy and Clinical Immunology1998;101(5):587‐93. [DOI: 10.1016/S0091‐6749(98)70164‐2; PUBMED: 9600493] ">Tariq 1998</a> was an observational trial; <a href="./references#CD003664-bbs2-0055" title="KnipM , AkerblomHK , BeckerD , DoschHM , DupreJ , FraserW , et al. TRIGR Study Group. Hydrolyzed infant formula and early beta‐cell autoimmunity: a randomized clinical trial. JAMA2014;311(22):2279‐87. [DOI: 10.1001/jama.2014.5610; PUBMED: 24915259] KnipM , VirtanenSM , BeckerD , DupreJ , KrischerJP , AkerblomHK , TRIGR Study Group. Early feeding and risk of type 1 diabetes: experiences from the Trial to Reduce Insulin‐dependent diabetes mellitus in the Genetically at Risk (TRIGR). American Journal of Clinical Nutrition2011;94(6 Suppl):1814S‐20S. [DOI: 10.3945/ajcn.110.000711; PUBMED: 21653795] KrischerJP . Hydrolyzed infant formula and early beta‐cell autoimmunity. Diabetes2014;63:A7. NCT00179777 . TRIGR ‐ Primary prevention study for Type 1 Diabetes in children at risk [TRIGR ‐ Trial to Reduce IDDM in the Genetically at Risk]. clinicaltrials.gov/show/NCT00179777 (first received 16 September 2005). TRIGR Study Group, AkerblomHK , KrischerJ , VirtanenSM , BersethC , BeckerD , DupreJ , et al. The trial to reduce IDDM in the genetically at risk (TRIGR) study: recruitment, intervention and follow‐up. Diabetologia2011;54(3):627‐33; Erratum in: Diabetologia. 2011;54(8):2210. [DOI: 10.1007/s00125‐010‐1964‐9; NCT00179777; PUBMED: 21153533] Writing Group for the TRIGR Study Group, KnipM , ÅkerblomHK , Al TajiE , BeckerD , BruiningJ , CastanoL , et al. Effect of hydrolyzed infant formula vs conventional formula on risk of Type 1 diabetes: The TRIGR randomized clinical trial. JAMA2018;319(1):38‐48. [DOI: 10.1001/jama.2017.19826; NCT00179777; PUBMED: 29297078] ">Knip 2011</a> enrolled infants at high risk of diabetes and reported adverse events at 10 years including asthma and other allergic disease (excess losses); <a href="./references#CD003664-bbs2-0095" title="ParonenJ , VaaralaO , SavilahtiE , SaukkonenT , AkerblomHK . Soluble adhesion molecules and oral antigen feeding in infants. Pediatric Research1996;40(2):276‐9. [DOI: 10.1203/00006450‐199608000‐00014; PUBMED: 8827777] VaaralaO , SaukkonenT , SavilahtiE , KlemolaT , AkerblomHK . Development of immune response to cow's milk proteins in infants receiving cow's milk or hydrolyzed formula. Journal of Allergy and Clinical Immunology1995;96(6 Pt 1):917‐23. [PUBMED: 8543750] ">Vaarala 1995</a> did not report allergic disease; <a href="./references#CD003664-bbs2-0096" title="VaaralaO , IlonenJ , RuohtulaT , PesolaJ , VirtanenSM , HarkonenT , et al. Removal of bovine insulin from cow's milk formula and early initiation of beta‐cell autoimmunity in the FINDIA pilot study. Archives of Pediatrics &amp; Adolescent Medicine2012;166(7):608‐14. [DOI: 10.1001/archpediatrics.2011.1559; PUBMED: 22393174] ">Vaarala 2012</a> (enrolled infants at risk of diabetes) did not report allergic disease; and <a href="./references#CD003664-bbs2-0098" title="HauserB , BleckerU , KeymolenK , SuysB , GerloE , VandenplasY . Plasma amino acid concentrations in term‐born infants fed a whey predominant or a whey hydrolysate formula. JPEN. Journal of Parenteral and Enteral Nutrition1997;21(1):27‐30. [DOI: 10.1177/014860719702100127; PUBMED: 9002081] HauserB , KeymolenK , BleckerU , SuysB , BougatefA , LoebH , et al. A comparative evaluation of whey hydrolysate and whey‐predominant formulas. How well do infants accept and tolerate them?. Clinical Pediatrics1993;62:433‐7. VandenplasY , HauserB , BleckerU , SuysB , PeetersS , KeymolenK , et al. The nutritional value of a whey hydrolysate formula compared with a whey‐predominant formula in healthy infants. Journal of Pediatric Gastroenterology and Nutrition1993;17(1):92‐6. [PUBMED: 8350218] ">Vandenplas 1993</a> did not report allergic disease. </p> </section> <section id="CD003664-sec-0093"> <h5 class="title">Term infants at high risk of allergic disease</h5> <p><a href="./references#CD003664-bbs2-0021" title="ArshadSH . Randomised controlled trial of cow’s milk formula versus hydrolysed formula for the prevention of allergy. Author email communication November 2017. ">Arshad 1990</a> was unable to get approval from the study sponsor to release data so remains unpublished. <a href="./references#CD003664-bbs2-0022" title="ArshadSH , BatemanB , MatthewsSM . Primary prevention of asthma and atopy during childhood by allergen avoidance in infancy: a randomised controlled study. Thorax2003;58(6):489‐93. [PUBMED: 12775858] ArshadSH , MatthewsS , GantC , HideDW . Effect of allergen avoidance on development of allergic disorders in infancy. Lancet1992;339(8808):1493‐7. [PUBMED: 1351183] HideDW , MatthewsS , MatthewsL , StevensM , RidoutS , TwiseltonR , et al. Effect of allergen avoidance in infancy on allergic manifestations at age two years. Journal of Allergy and Clinical Immunology1994;93(5):842‐6. [PUBMED: 8182225] HideDW , MatthewsS , TariqS , ArshadSH . Allergen avoidance in infancy and allergy at 4 years of age. Allergy1996;51(2):89‐93. [PUBMED: 8738513] ScottM , KurukulaaratchyR , RobertsG , ClaytonB , MatthewsS , ArshadS . Primary prevention of asthma, outcomes at 17 year follow up. Allergy2010;65(S92):315. ScottM , RobertsG , KurukulaaratchyR , ClaytonB , MatthewsS , ArshadS . Primary prevention of eczema, outcomes at 17 year follow up. Allergy2010;65(S92):314. ScottM , RobertsG , KurukulaaratchyRJ , MatthewsS , NoveA , ArshadSH . Multifaceted allergen avoidance during infancy reduces asthma during childhood with the effect persisting until age 18 years. Thorax2012;67(12):1046‐51. [DOI: 10.1136/thoraxjnl‐2012‐202150; PUBMED: 22858926] ">Arshad 1992a</a> reported multiple differential allergic disease‐reducing co‐interventions; <a href="./references#CD003664-bbs2-0024" title="BarberiI , SalpietroDC , CataliotoG , FuliaF . Clinical trial of a new hypoallergenic formula for risk infants. 2nd World Congress of Perinatal Medicine; 1993 Sep 19‐24; Rome (Italy). 1993. ">Barberi 1993</a> reported unclear allocation, excess losses, and allergic disease (abstract format only); <a href="./references#CD003664-bbs2-0025" title="BergmannRL , DannemannA , EdenharterG , BergmannKE , MonchE , DudenhausenJW , et al. Influence of ultrafiltrated, partially hydrolysed formula on growth and health of young infants. Monatsschrift fur Kinderheilkunde1996;144(2):152‐8. ">Bergmann 1996a</a> reported allergic disease and non‐random allocation; <a href="./references#CD003664-bbs2-0030" title="BoyleRJ , TangMLK , ChiangWC , ChuaMC , IsmailI , NautaA , et al. PATCH study investigators. Prebiotic‐supplemented partially hydrolysed cow's milk formula for the prevention of eczema in high‐risk infants: a randomized controlled trial. Allergy2016;71(5):701‐10. [DOI: 10.1111/all.12848; PUBMED: 27111273] TangM , RijnierseA , NautaA , BoyleR , HourihaneJ , ChiangW , et al. Influence of early feeding patterns on eczema development in high‐risk infants. Allergy2017;72:15. ">Boyle 2016</a> reported multiple differential allergic disease‐reducing co‐interventions (prebiotic and hydrolysed formula) and reported allergic disease; <a href="./references#CD003664-bbs2-0033" title="ChanYH , ShekLP , AwM , QuakSH , LeeBW . Use of hypoallergenic formula in the prevention of atopic disease among Asian children. Journal of Paediatrics and Child Health2002;38(1):84‐8. [PUBMED: 11869407] ">Chan 2002</a> reported allergic disease and excess losses; <a href="./references#CD003664-bbs2-0036" title="BeckerA , WatsonW , FergusonA , Dimich‐WardH , Chan‐YeungM . The Canadian asthma primary prevention study: outcomes at 2 years of age. Journal of Allergy and Clinical Immunology2004;113(4):650‐6. [DOI: 10.1016/j.jaci.2004.01.754; PUBMED: 15100668] Chan‐YeungM , ManfredaJ , Dimich‐WardH , FergusonA , WatsonW , BeckerA . A randomized controlled study on the effectiveness of a multifaceted intervention program in the primary prevention of asthma in high‐risk infants. Archives of Pediatrics &amp; Adolescent Medicine2000;154(7):657‐63. [PUBMED: 10891016] ">Chan‐Yeung 2000</a> reported multiple differential allergic disease‐reducing co‐interventions; <a href="./references#CD003664-bbs2-0034" title="ChandraRK , PuriS , HamedA . Influence of maternal diet during lactation and use of formula feeds on development of atopic eczema in high risk infants. BMJ1989;299(6693):228‐30; Erratum in: BMJ 1989;299(6704):896; Retraction in: BMJ 2015; 351(h5682). ">Chandra 1989a</a> reported data that could not be verified after allegations of fraud; <a href="./references#CD003664-bbs2-0035" title="ChandraRK . Five‐year follow‐up of high‐risk infants with family history of allergy who were exclusively breast‐fed or fed partial whey hydrolysate, soy, and conventional cow's milk formulas. Journal of Pediatric Gastroenterology and Nutrition1997;24(4):380‐8; Expression of concern in: Journal of Pediatric Gastroenterology and Nutrition 2016; 63(2):307. [PUBMED: 9144119] ChandraRK , HamedA . Cumulative incidence of atopic disorders in high risk infants fed whey hydrolysate, soy, and conventional cow milk formulas. Annals of Allergy1991;67(2 Pt 1):129‐32. [PUBMED: 1867449] ChandraRK , SinghG , ShridharaB . Effect of feeding whey hydrolysate, soy and conventional cow milk formulas on incidence of atopic disease in high risk infants. Annals of Allergy1989;63(2):102‐6. [PUBMED: 2669565] ">Chandra 1989b</a> reported data that could not be verified after allegations of fraud; <a href="./references#CD003664-bbs2-0038" title="D'AgataA , BettaP , SciaccaP , MoranoC , PraticoG , CurreriR , et al. Role of dietary prevention in newborns at risk for atopy. Results of a follow‐up study. Pediatria Medica e Chirurgica1996;18(5):469‐72. [PUBMED: 9053884] ">D'Agata 1996</a> reported unclear allocation, imbalances between groups and allergic disease; <a href="./references#CD003664-bbs2-0045" title="GiovanniniM , AgostoniC , FiocchiA , BelluR , TrojanS , RivaE . Antigen‐reduced infant formulas versus human milk: growth and metabolic parameters in the first 6 months of life. Journal of the American College of Nutrition1994;13(4):357‐63. [PUBMED: 7963141] ">Giovannini 1994</a> reported excess losses and did not report allergic disease; <a href="./references#CD003664-bbs2-0046" title='HalkenS , HostA , HansenLG , OsterballeO . Effect of an allergy prevention programme on incidence of atopic symptoms in infancy. A prospective study of 159 "high‐risk" infants. Allergy1992;47(5):545‐53. [PUBMED: 1485660] HalkenS , HostA , HansenLG , OsterballeO . Prevention of allergy in infants. A prospective study of 159 high‐risk children. Ugeskrift for Laeger1994;156(3):308‐12. [PUBMED: 8296423] HalkenS , HostA , HansenLG , OsterballeO . Preventive effect of feeding high‐risk infants a casein hydrolysate formula or an ultrafiltrated whey hydrolysate formula. A prospective, randomized, comparative clinical study. Pediatric Allergy and Immunology1993;4(4):173‐81. [PUBMED: 8298708] '>Halken 1992</a> reported allergic disease and excess losses; <a href="./references#CD003664-bbs2-0048" title="HattevigG , KjellmanB , SigursN , BjorkstenB , KjellmanNI . Effect of maternal avoidance of eggs, cow's milk and fish during lactation upon allergic manifestations in infants. Clinical and Experimental Allergy1989;19(1):27‐32. [PUBMED: 2702510] HattevigG , KjellmanB , SigursN , GrodzinskyE , HedJ , BjorkstenB . The effect of maternal avoidance of eggs, cow's milk, and fish during lactation on the development of IgE, IgG, and IgA antibodies in infants. Journal of Allergy and Clinical Immunology1990;85(1 Pt 1):108‐15. [PUBMED: 2299096] HattevigG , SigursN , KjellmanB . Effects of maternal dietary avoidance during lactation on allergy in children at 10 years of age. Acta Paediatrica1999;88(1):7‐12. [PUBMED: 10090539] ParonenJ , BjorkstenB , HattevigG , AkerblomHK , VaaralaO . Effect of maternal diet during lactation on development of bovine insulin‐binding antibodies in children at risk for allergy. Journal of Allergy and Clinical Immunology2000;106(2):302‐6. [DOI: 10.1067/mai.2000.108110; PUBMED: 10932074] SigursN , HattevigG , KjellmanB . Maternal avoidance of eggs, cow's milk, and fish during lactation: effect on allergic manifestations, skin‐prick tests, and specific IgE antibodies in children at age 4 years. Pediatrics1992;89(4 Pt 2):735‐9. [PUBMED: 1557270] ">Hattevig 1989</a> trial of maternal allergen avoidance only; <a href="./references#CD003664-bbs2-0056" title="KuoHC , LiuCA , OuCY , HsuTY , WangCL , HuangHC , et al. Partial protein‐hydrolyzed infant formula decreased food sensitization but not allergic diseases in a prospective birth cohort study. International Archives of Allergy and Immunology2011;154(4):310‐7. [DOI: 10.1159/000321823; PUBMED: 20975282] ">Kuo 2011</a> was observational; <a href="./references#CD003664-bbs2-0052" title="IikuraY , AkimotoK , EbisawaM , OndaT , AkazawaA , SaitoH , et al. Effect of hydrolyzed whey protein formula for babies on development of allergic symptoms during infancy. Nestle Nutrition Workshop Series. Vol. 34, Baltimore, Maryland: Raven Press, 1995:269‐75. ">Iikura 1995</a> reported unclear allocation and imbalances between groups (abstract format only); <a href="./references#CD003664-bbs2-0060" title="Martinenez‐ValverdeA , Aljma‐GarciaJM . Study and evaluation of serum IgE and specific total IgE against alpha‐lactalbumin, beta‐lactoglobulin and casein with hypoallergenic formulas (HA) and other types of feeding [Thesis]. Spain: Universidad de Malaga, 1993. ">Martinez‐Valverde 1993</a> unclear allocation reported in thesis only; <a href="./references#CD003664-bbs2-0066" title="MoranJR . Effects of prolonged exposure to partially hydrolyzed milk protein. Journal of Pediatrics1992;121(5 Pt 2):S90‐4. [PUBMED: 1447640] ">Moran 1992</a> reported excess losses and allergic disease; <a href="./references#CD003664-bbs2-0069" title="NentwichI , PazdirkovaA , KoberskaI , PokojskaE , SzepfalusiZ , LokajJ . Cow milk‐specific humoral and cellular immune response in infants with high risk of atopy under feeding a whey hydrolysate infant formula. Klinische Padiatrie2003;215(5):275‐9. [DOI: 10.1055/s‐2003‐42664; PUBMED: 14520590] ">Nentwich 2003</a> was an observational trial; <a href="./references#CD003664-bbs2-0071" title="OdelramH , VantoT , JacobsenL , KjellmanNI . Whey hydrolysate compared with cow's milk‐based formula for weaning at about 6 months of age in high allergy‐risk infants: effects on atopic disease and sensitization. Allergy1996;51(3):192‐5. [PUBMED: 8781676] ">Odelram 1996</a> reported excess losses and allergic disease; <a href="./references#CD003664-bbs2-0075" title="PorchMC , ShahaneAD , LeivaLE , ElstonRC , SorensenRU . Influence of breast milk, soy or two hydrolyzed formulas on the development of allergic manifestations in infants at risk. Nutrition Research1998;18(8):1413‐24. ">Porch 1998</a> reported excess losses; <a href="./references#CD003664-bbs2-0084" title="SchmidtE , Eden‐KohlerJ , TonkaboniF , TolleJ . Alimentary allergy prevention in infants with increased allergic risk: the effect of different feeding regimens in the first 6 months on atopic manifestations during the first year of life. A large scale feeding trial. Nestle Nutritional Workshop Series. Vol. 34, Baltimore, Maryland: Raven Press, 1995:231‐48. ">Schmidt 1995</a> was an observational trial; <a href="./references#CD003664-bbs2-0087" title="ShaoJ , ShengJ , DongW , LiYZ , YuSC . Effects of feeding intervention on development of eczema in atopy high‐risk infants: an 18‐month follow‐up study. Zhonghua Er Ke Za Zhi2006;44(9):684‐7. [PUBMED: 17217664] ">Shao 2006</a> reported multiple differential allergic disease‐reducing co‐interventions; <a href="./references#CD003664-bbs2-0089" title="SorensenRU , InostrozaJ , HebalE , VinetAM , FierroJ . Weaning to a partially hydrolyzed whey formula at three months of age protects against the later development of anti‐cow milk lgE antibodies in comparison to whole cows milk or extensively hydrolyzed whey formulas. Journal of Allergy and Clinical Immunology2007;119(1):S120. ">Sorensen 2007</a> has not reported allergic disease data to date; <a href="./references#CD003664-bbs2-0092" title="SzajewskaH , MrukowiczJZ , StoinskaB , ProchowskaA . Extensively and partially hydrolysed preterm formulas in the prevention of allergic diseases in preterm infants: a randomized, double‐blind trial. Acta Paediatrica2004;93(9):1159‐65. [PUBMED: 15384877] ">Szajewska 2004</a> reported excess losses and allergic disease; <a href="./references#CD003664-bbs2-0097" title="VandenplasY , DeneyerM , SacreL , LoebH . Preliminary data on a field study with a new hypo‐allergenic formula. European Journal of Pediatrics1988;148(3):274‐7. [PUBMED: 3215202] VandenplasY , MalfrootA , DabI . Short‐term prevention of cow's milk protein allergy in infants. Immunology and Allergy Practice1989;11:430‐7. ">Vandenplas 1988</a> reported unclear allocation and losses; <a href="./references#CD003664-bbs2-0099" title="WopereisH , SimK , ShawA , MartinR , OozeerR , WarnerJO , et al. The developmental gut microbiota is modulated towards a pattern closer to breastfed infants by a partially hydrolyzed cow's milk formula supplemented with specific prebiotic oligosaccharides. Allergy: European Journal of Allergy and Clinical Immunology2014;69:315. ">Wopereis 2014</a> has not reported allergic disease to date (abstract format only); and <a href="./references#CD003664-bbs2-0102" title="ZeigerRS , HellerS . Development of nasal basophilic cells and nasal eosinophils from age 4 months through 4 years in children of atopic parents. Journal of Allergy and Clinical Immunology1993;91(3):723‐34. [PUBMED: 8454794] ZeigerRS , HellerS . The development and prediction of atopy in high‐risk children: follow‐up at age seven years in a prospective randomized study of combined maternal and infant food allergen avoidance. Journal of Allergy and Clinical Immunology1995;95(6):1179‐90. [PUBMED: 7797786] ZeigerRS , HellerS , MellonMH , ForsytheAB , O'ConnorRD , HamburgerRN , et al. Effect of combined maternal and infant food‐allergen avoidance on development of atopy in early infancy: a randomized study. Journal of Allergy and Clinical Immunology1989;84:72‐89. ZeigerRS , HellerS , MellonMH , HalseyJF , HamburgerRN , SampsonHA . Genetic and environmental factors affecting the development of atopy through age 4 in children of atopic parents: a prospective randomized study of food allergen avoidance. Pediatric Allergy and Immunology1992;3(3):110‐27. ">Zeiger 1989</a> reported multiple co‐interventions and excess losses. </p> </section> <section id="CD003664-sec-0094"> <h5 class="title">Infants with allergic disease, infantile colic, gastro‐oesophageal reflux symptoms or feed intolerance </h5> <p><a href="./references#CD003664-bbs2-0020" title="ArikanD , AlpH , GozumS , OrbakZ , CifciEK . Effectiveness of massage, sucrose solution, herbal tea or hydrolysed formula in the treatment of infantile colic. Journal of Clinical Nursing2008;17(13):1754‐61. [PUBMED: 18592627] ">Arikan 2008</a> did not report allergic disease; <a href="./references#CD003664-bbs2-0068" title="NCT01987154 . Tolerance of an extensively hydrolyzed protein infant formula versus a premature infant formula. clinicaltrials.gov/show/NCT01987154 (first received 19 November 2013). ">NCT01987154</a> enrolled infants with CMPI; <a href="./references#CD003664-bbs2-0032" title="CampbellJP . Dietary therapy of infant colic: a double‐blind study. Ceskoslovenska Pediatrie1993;48(4):199‐202. [PUBMED: 8495532] CampbellJP . Dietary treatment of infant colic: a double‐blind study. Journal of the Royal College of General Practitioners1989;39(318):11‐4. [PUBMED: 2553940] ">Campbell 1989</a> did not report allergic disease (non‐random); <a href="./references#CD003664-bbs2-0037" title="CorvagliaL , MarianiE , AcetiA , GallettiS , FaldellaG . Extensively hydrolyzed protein formula reduces acid gastro‐esophageal reflux in symptomatic preterm infants. Early Human Development2013;89(7):453‐5. [DOI: 10.1016/j.earlhumdev.2013.04.003; PUBMED: 23642476] ">Corvaglia 2013</a> did not report allergic disease; <a href="./references#CD003664-bbs2-0050" title="HillDJ , HudsonIL , SheffieldLJ , SheltonMJ , MenahemS , HoskingCS . A low allergen diet is a significant intervention in infantile colic: results of a community‐based study. Journal of Allergy and Clinical Immunology1995;96(6 Pt 1):886‐92. [PUBMED: 8543745] ">Hill 1995b</a> did not report allergic disease; <a href="./references#CD003664-bbs2-0051" title="HøstA . Importance of the first meal on the development of cow's milk allergy and intolerance. Allergy Proceedings1991;12(4):227‐32. [PUBMED: 1936970] ">Høst 1991</a> challenge test in infants with reactions ‐ observational study; <a href="./references#CD003664-bbs2-0058" title="LucassenPL , AssendelftWJ , GubbelsJW , vanEijkJT , DouwesAC . Infantile colic: crying time reduction with a whey hydrolysate. A double‐blind, randomized, placebo‐controlled trial. Pediatrics2000;106(6):1349‐54. [PUBMED: 11099588] ">Lucassen 2000</a> did not report allergic disease; <a href="./references#CD003664-bbs2-0070" title="NocerinoR , DeMarcoG , CosenzaL , PezzellaV , PassarielloA , TerrinG , et al. Efficacy of a new partially hydrolyzed whey formula on infant colic: a randomized controlled trial. Digestive and Liver Disease2012;44:S272. ">Nocerino 2012</a> did not report allergic disease (abstract format only); <a href="./references#CD003664-bbs2-0080" title='SavinoF , CresiF , MaccarioS , CavalloF , DalmassoP , FanaroS , et al. "Minor" feeding problems during the first months of life: effect of a partially hydrolysed milk formula containing fructo‐ and galacto‐oligosaccharides. Acta Paediatrica Supplement2003;91(441):86‐90. [PUBMED: 14599049] '>Savino 2003</a> was observational; <a href="./references#CD003664-bbs2-0081" title="SavinoF , PalumeriE , CastagnoE , CresiF , DalmassoP , CavalloF , et al. Reduction of crying episodes owing to infantile colic: a randomized controlled study on the efficacy of a new infant formula. European Journal of Clinical Nutrition2006;60(11):1304‐10. [DOI: 10.1038/sj.ejcn.1602457; PUBMED: 16736065] ">Savino 2006</a> reported multiple formula differences; <a href="./references#CD003664-bbs2-0094" title="TaubmanB . Parental counseling compared with elimination of cow's milk or soy milk protein for the treatment of infant colic syndrome: a randomized trial. Pediatrics1988;81(6):756‐61. [PUBMED: 3285312] ">Taubman 1988</a> did not report allergic disease; <a href="./references#CD003664-bbs2-0100" title="XiniasI , AnalitisA , VandenplasY . A synbiotic partial whey hydrolysate with reduced lactose decreases infantile colic and improves quality of life; A randomized open pilot study. Journal of Pediatric Gastroenterology and Nutrition2017;64:143. ">Xinias 2017</a> did not report allergic disease; and <a href="./references#CD003664-bbs2-0102" title="ZeigerRS , HellerS . Development of nasal basophilic cells and nasal eosinophils from age 4 months through 4 years in children of atopic parents. Journal of Allergy and Clinical Immunology1993;91(3):723‐34. [PUBMED: 8454794] ZeigerRS , HellerS . The development and prediction of atopy in high‐risk children: follow‐up at age seven years in a prospective randomized study of combined maternal and infant food allergen avoidance. Journal of Allergy and Clinical Immunology1995;95(6):1179‐90. [PUBMED: 7797786] ZeigerRS , HellerS , MellonMH , ForsytheAB , O'ConnorRD , HamburgerRN , et al. Effect of combined maternal and infant food‐allergen avoidance on development of atopy in early infancy: a randomized study. Journal of Allergy and Clinical Immunology1989;84:72‐89. ZeigerRS , HellerS , MellonMH , HalseyJF , HamburgerRN , SampsonHA . Genetic and environmental factors affecting the development of atopy through age 4 in children of atopic parents: a prospective randomized study of food allergen avoidance. Pediatric Allergy and Immunology1992;3(3):110‐27. ">Zeiger 1989</a> reported allergic disease and excess losses. </p> </section> </section> </section> <section id="CD003664-sec-0095"> <h3 class="title">Risk of bias in included studies</h3> <p>We have summarised risk of bias in included studies in <a href="#CD003664-fig-0002">Figure 2</a>; and <a href="#CD003664-fig-0003">Figure 3</a>. Overall, we considered no studies to be at 'low risk' of bias. </p> <div class="figure" id="CD003664-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD003664-fig-0002" src="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD003664-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study." data-id="CD003664-fig-0003" src="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD003664-sec-0096"> <h4 class="title">Allocation</h4> <section id="CD003664-sec-0097"> <h5 class="title">Randomisation</h5> <p>Two studies reported an adequate method of randomisation (<a href="./references#CD003664-bbs2-0004" title="HillD . A report on the analysis of the Melbourne Atopy Cohort Study. A study designed to test the effectiveness of different formula types on the development of atopic symptoms and signs on a cohort of atopy‐at‐risk infants. Report at year 2. Nestec Internal Report. HillDJ , SporikR , ThorburnJ , HoskingCS . The association of atopic dermatitis in infancy with immunoglobulin E food sensitization. Journal of Pediatrics2000;137(4):475‐9. [DOI: 10.1067/mpd.2000.108207; PUBMED: 11035824] KoplinJ , DharmageSC , GurrinL , OsborneN , TangML , LoweAJ , et al. Soy consumption is not a risk factor for peanut sensitization. Journal of Allergy and Clinical Immunology2008;121(6):1455‐9. [DOI: 10.1016/j.jaci.2008.03.017; PUBMED: 18436294] LoweA , HoskingC , BennettC , AllenK , CarlinJ , DharmageS , et al. The Melbourne Atopy Cohort Study: a RCT of a partially hydrolysed whey formula for the prevention of allergic disease. Internal Medicine Journal2008;38:A158. LoweAJ , AbramsonMJ , HoskingCS , CarlinJB , BennettCM , DharmageSC , et al. The temporal sequence of allergic sensitization and onset of infantile eczema. Clinical &amp; Experimental Allergy2007;37(4):536‐42; Erratum in: Clinical &amp; Experimental Allergy 2007; 37(12);1895. [DOI: 10.1111/j.1365‐2222.2007.02691.x; PUBMED: 17430350] LoweAJ , CarlinJB , BennettCM , HoskingCS , AllenKJ , RobertsonCF , et al. Paracetamol use in early life and asthma: prospective birth cohort study. BMJ2010;341:c4616. [PUBMED: 20843914] LoweAJ , HoskingCS , BennettCM , AllenKJ , AxelradC , CarlinJB , et al. Effect of a partially hydrolyzed whey infant formula at weaning on risk of allergic disease in high‐risk children: a randomized controlled trial. Journal of Allergy and Clinical Immunology2011;128(2):360‐5.e4. [DOI: 10.1016/j.jaci.2010.05.006; PUBMED: 21696814] StoneyRM , WoodsRK , HoskingCS , HillDJ , AbramsonMJ , ThienFC . Maternal breast milk long‐chain n‐3 fatty acids are associated with increased risk of atopy in breastfed infants. Clinical and Experimental Allergy2004;34(2):194‐200; Erratum in: Clinical &amp; Experimental Allergy 2007; 37(12);1895. [PUBMED: 14987297] ThomsonJA , WidjajaC , DarmaputraAA , LoweA , MathesonMC , BennettCM , et al. Early childhood infections and immunisation and the development of allergic disease in particular asthma in a high‐risk cohort: a prospective study of allergy‐prone children from birth to six years. Pediatric Allergy and Immunology2010;21(7):1076‐85. [DOI: 10.1111/j.1399‐3038.2010.01018.x; PUBMED: 20337970] ">Hill 2000</a>; <a href="./references#CD003664-bbs2-0015" title="BergA , KramerU , LinkE , BollrathC , HeinrichJ , BrockowI , et al. GINIplus study group. Impact of early feeding on childhood eczema: development after nutritional intervention compared with the natural course ‐ the GINIplus study up to the age of 6 years. Clinical and Experimental Allergy2010;40(4):627‐36. [DOI: 10.1111/j.1365‐2222.2009.03444.x; PUBMED: 20082618] BrockowI , ZutavernA , HoffmannU , GrublA , vonBergA , KoletzkoS , et al. GINIplus Study Group. Early allergic sensitizations and their relevance to atopic diseases in children aged 6 years: results of the GINI study. Journal of Investigational Allergology &amp; Clinical Immunology2009;19(3):180‐7. [DOI: 19610260] LaubereauB , BrockowI , ZirngiblA , KoletzkoS , GrueblA , vonBergA , et al. GINI Study Group. Effect of breast‐feeding on the development of atopic dermatitis during the first 3 years of life ‐ results from the GINI‐birth cohort study. Journal of Pediatrics2004;144(5):602‐7. [DOI: 10.1016/j.jpeds.2003.12.029; PUBMED: 15126993] LaubereauB , Filipiak‐PittroffB , vonBergA , GrublA , ReinhardtD , WichmannHE , et al. Caesarean section and gastrointestinal symptoms, atopic dermatitis, and sensitisation during the first year of life. Archives of Disease in Childhood2004;89(11):993‐7. [DOI: 10.1136/adc.2003.043265; PUBMED: 15499049] RzehakP , SausenthalerS , KoletzkoS , BauerCP , SchaafB , vonBergA , et al. Period‐specific growth, overweight and modification by breastfeeding in the GINI and LISA birth cohorts up to age 6 years. European Journal of Epidemiology2009;24(8):449‐67. [DOI: 10.1007/s10654‐009‐9356‐5; PUBMED: 19521784] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. GINI‐plus Study Group. Long‐term effects of hydrolyzed protein infant formulas on growth ‐ extended follow‐up to 10 y of age: results from the German Infant Nutritional Intervention (GINI) study. American Journal of Clinical Nutrition2011;94(6 Suppl):1803S‐7S. [DOI: 10.3945/ajcn.110.000679; PUBMED: 21849601] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. German Infant Nutritional Intervention Study Group. Short‐ and long‐term effects of feeding hydrolyzed protein infant formulas on growth at &lt; or = 6 y of age: results from the German Infant Nutritional Intervention Study. American Journal of Clinical Nutrition2009;89(6):1846‐56. [DOI: 10.3945/ajcn.2008.27373; PUBMED: 19369380] SausenthalerS , KoletzkoS , KoletzkoB , ReinhardtD , KramerU , vonBergA , et al. GINIplus study group. Effect of hydrolysed formula feeding on taste preferences at 10 years. Data from the German Infant Nutritional Intervention Program Plus Study. Clinical Nutrition2010;29(3):304‐6. [DOI: 10.1016/j.clnu.2010.01.007; PUBMED: 20110140] SchoetzauA , Filipiak‐PittroffB , FrankeK , KoletzkoS , VonBergA , GrueblA , et al. German Infant Nutritional Intervention Study Group. Effect of exclusive breast‐feeding and early solid food avoidance on the incidence of atopic dermatitis in high‐risk infants at 1 year of age. Pediatric Allergy and Immunology2002;13(4):234‐42. [PUBMED: 12390439] SchoetzauA , GehringU , FrankeK , GrublA , KoletzkoS , vonBergA , et al. Gini Study Group. Maternal compliance with nutritional recommendations in an allergy preventive programme. Archives of Disease in Childhood2002;86(3):180‐4. [PUBMED: 11861235] VonBergA , Filipiak‐PittroffB , KrämerU , LinkE , HeinrichJ , KoletzkoS , et al. The German Infant Nutritional Intervention Study (GINI) for the preventive effect of hydrolysed infant formulas in infants at high risk for allergic diseases. Design and selected results. Allergologie2012;35(1):32‐43. VonBergA , Filipiak‐PittroffB , SchulzH , HoffmannU , LinkE , SussmannM , et al. GINIplus study group. Allergic manifestation 15 years after early intervention with hydrolyzed formulas ‐ the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2016;71(2):210‐9. [DOI: 10.1111/all.12790; PUBMED: 26465137] vonBergA , FilipiakB , KoletzkoS , KrämerU , HoffmannB , LinkE , et al. Long‐term effect of cow milk protein hydrolysates in high‐risk children. Results from the 10‐years follow‐up of the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2013;68:295‐6. vonBergA , Filipiak‐PittroffB , KramerU , HoffmannB , LinkE , BeckmannC , et al. GINIplus study group. Allergies in high‐risk schoolchildren after early intervention with cow's milk protein hydrolysates: 10‐year results from the German Infant Nutritional Intervention (GINI) study. Journal of Allergy and Clinical Immunology2013;131(6):1565‐73. [DOI: 10.1016/j.jaci.2013.01.006; PUBMED: 23506844] vonBergA , Filipiak‐PittroffB , KramerU , LinkE , BollrathC , BrockowI , et al. GINIplus study group. Preventive effect of hydrolyzed infant formulas persists until age 6 years: long‐term results from the German Infant Nutritional Intervention Study (GINI). Journal of Allergy and Clinical Immunology2008;121(6):1442‐7. [DOI: 10.1016/j.jaci.2008.04.021; PUBMED: 18539195] vonBergA , KoletzkoS , Filipiak‐PittroffB , LaubereauB , GrublA , WichmannHE , et al. German Infant Nutritional Intervention Study Group. Certain hydrolyzed formulas reduce the incidence of atopic dermatitis but not that of asthma: three‐year results of the German Infant Nutritional Intervention Study. Journal of Allergy and Clinical Immunology2007;119(3):718‐25. [DOI: 10.1016/j.jaci.2006.11.017; PUBMED: 17240440] vonBergA , KoletzkoS , GrublA , Filipiak‐PittroffB , WichmannHE , BauerCP , et al. German Infant Nutritional Intervention Study Group. The effect of hydrolyzed cow's milk formula for allergy prevention in the first year of life: the German Infant Nutritional Intervention Study, a randomized double‐blind trial. Journal of Allergy and Clinical Immunology2003;111(3):533‐40. [PUBMED: 12642834] ">von Berg 2003</a>). Nine studies reported random allocation of infants but not the method of randomisation used (<a href="./references#CD003664-bbs2-0001" title="ChiricoG , GasparoniA , CiardelliL , DeAmiciM , ColomboA , RondiniG . Immunogenicity and antigenicity of a partially hydrolyzed cow's milk infant formula. Allergy1997;52(1):82‐8. [PUBMED: 9062633] ">Chirico 1997</a>; <a href="./references#CD003664-bbs2-0002" title="deSetaL , SianiP , CirilloG , DiGruttolaM , CimaduomoL , ColettaS . The prevention of allergic diseases with a hypoallergenic formula: a follow‐up at 24 months. The preliminary results. [Italian]. La Pediatria Medica e Chirurgica: Medical and Surgical Pediatrics1994;16(3):251‐4. [PUBMED: 7971447] ">de Seta 1994</a>; <a href="./references#CD003664-bbs2-0006" title="KwintaP , SawiecP , KlimekM , LisG , Cichocka‐JaroszE , PietrzykJJ . Correlation between early neonatal diet and atopic symptoms up to 5‐7 years of age in very low birth weight infants: follow‐up of randomized, double‐blind study. Pediatric Allergy and Immunology2009;20(5):458‐66. [DOI: 10.1111/j.1399‐3038.2008.00814.x; PUBMED: 19490477] ">Kwinta 2009</a>; <a href="./references#CD003664-bbs2-0007" title="LamBC , YeungCY . The effect of breast milk, infant formula and hypoallergenic formula on incidence of atopic manifestation in high risk infants. Nestle Internal Report1992. ">Lam 1992</a>; <a href="./references#CD003664-bbs2-0008" title="MalletE , HenocqA . Long‐term prevention of allergic diseases by using protein hydrolysate formula in at‐risk infants. Journal of Pediatrics1992;121(5 Pt 2):S95‐100. [PUBMED: 1447641] ">Mallet 1992</a>; <a href="./references#CD003664-bbs2-0009" title="MariniA , AgostiM , MottaG , MoscaF . Effects of a dietary and environmental prevention programme on the incidence of allergic symptoms in high atopic risk infants: three years' follow‐up. Acta Paediatrica Supplement1996;414:1‐21. [PUBMED: 8831855] ">Marini 1996</a>; <a href="./references#CD003664-bbs2-0011" title="OldaeusG , AnjouK , BjorkstenB , MoranJR , KjellmanNI . Extensively and partially hydrolysed infant formulas for allergy prophylaxis. Archives of Disease in Childhood1997;77(1):4‐10. [PUBMED: 9279143] OldaeusG , BjorkstenB , JenmalmMC , KjellmanNI . Cow's milk IgE and IgG antibody responses to cow's milk formulas. Allergy1999;54(4):352‐7. [PUBMED: 10371094] ">Oldaeus 1997</a>; <a href="./references#CD003664-bbs2-0013" title="TsaiYT , ChouCC , HsiehKH . The effect of hypoallergenic formula on the occurrence of allergic diseases in high risk infants. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi1991;32(3):137‐44. [PUBMED: 1776437] ">Tsai 1991</a>; <a href="./references#CD003664-bbs2-0014" title="VandenplasY . Atopy at 3 years in high‐risk infants fed whey hydrolysate or conventional formula. Lancet1992;339(8801):1118. [PUBMED: 1349137] VandenplasY , HauserB , Van denBorreC , ClybouwC , MahlerT , Hachimi‐IdrissiS , et al. The long‐term effect of a partial whey hydrolysate formula on the prophylaxis of atopic disease. European Journal of Pediatrics1995;154(6):488‐94. [PUBMED: 7671948] VandenplasY , HauserB , Van denBorreC , SacreL , DabI . Effect of a whey hydrolysate prophylaxis of atopic disease. Annals of Allergy1992;68(5):419‐24. [PUBMED: 1586005] ">Vandenplas 1992</a>), so we assessed their risk as 'unclear'. Five studies reported quasi‐random methods of participant allocation, including <a href="./references#CD003664-bbs2-0003" title="HalkenS , HansenKS , JacobsenHP , EstmannA , FaellingAE , HansenLG , et al. Comparison of a partially hydrolyzed infant formula with two extensively hydrolyzed formulas for allergy prevention: a prospective, randomized study. Pediatric Allergy and Immunology2000;11(3):149‐61. [PUBMED: 10981524] ">Halken 2000</a> (by date of birth), <a href="./references#CD003664-bbs2-0005" title="JuvonenP , ManssonM , AnderssonC , JakobssonI . Allergy development and macromolecular absorption in infants with different feeding regimens during the first three days of life. A three‐year prospective follow‐up. Acta Paediatrica1996;85(9):1047‐52. [PUBMED: 8888916] JuvonenP , ManssonM , JakobssonI . Does early diet have an effect on subsequent macromolecular absorption and serum IgE?. Journal of Pediatric Gastroenterology and Nutrition1994;18(3):344‐9. [PUBMED: 8057219] JuvonenP , ManssonM , KjellmanNI , BjorkstenB , JakobssonI . Development of immunoglobulin G and immunoglobulin E antibodies to cow's milk proteins and ovalbumin after a temporary neonatal exposure to hydrolyzed and whole cow's milk proteins. Pediatric Allergy and Immunology1999;10(3):191‐8. [PUBMED: 10565560] ">Juvonen 1996</a> (by day of month), <a href="./references#CD003664-bbs2-0010" title="NentwichI , MichkovaE , NevoralJ , UrbanekR , SzepfalusiZ . Cow's milk‐specific cellular and humoral immune responses and atopy skin symptoms in infants from atopic families fed a partially (pHF) or extensively (eHF) hydrolyzed infant formula. Allergy2001;56(12):1144‐56. [PUBMED: 11736743] ">Nentwich 2001</a> (odd and even numbers), <a href="./references#CD003664-bbs2-0012" title="SaarinenKM , Juntunen‐BackmanK , JarvenpaaAL , KlemettiP , KuitunenP , LopeL , et al. Breast‐feeding and the development of cows' milk protein allergy. Advances in Experimental Medicine and Biology2000;478:121‐30. [DOI: 10.1007/0‐306‐46830‐1_10; PUBMED: 11065065] SaarinenKM , Juntunen‐BackmanK , JarvenpaaAL , KuitunenP , LopeL , RenlundM , et al. Supplementary feeding in maternity hospitals and the risk of cow's milk allergy: a prospective study of 6209 infants. Journal of Allergy and Clinical Immunology1999;104(2 Pt 1):457‐61. [PUBMED: 10452771] SaarinenKM , SavilahtiE . Infant feeding patterns affect the subsequent immunological features in cow's milk allergy. Clinical and Experimental Allergy2000;30(3):400‐6. [DOI: 10691899] SaarinenKM , SuomalainenH , SavilahtiE . Diagnostic value of skin‐prick and patch tests and serum eosinophil cationic protein and cow's milk‐specific IgE in infants with cow's milk allergy. Clinical and Experimental Allergy2001;31(3):423‐9. [PUBMED: 11260154] SaarinenKM , VaaralaO , KlemettiP , SavilahtiE . Transforming growth factor‐beta1 in mothers' colostrum and immune responses to cows' milk proteins in infants with cows' milk allergy. Journal of Allergy and Clinical Immunology1999;104(5):1093‐8. [PUBMED: 10550758] SavilahtiE , SaarinenKM . Early infant feeding and type 1 diabetes. European Journal of Nutrition2009;48(4):243‐9. [DOI: 10.1007/s00394‐009‐0008‐z; PUBMED: 19263185] SavilahtiEM , SaarinenKM , SavilahtiE . Specific antibodies to cow's milk proteins in infants: effect of early feeding and diagnosis of cow's milk allergy. European Journal of Nutrition2010;49(8):501‐4. [DOI: 10.1007/s00394‐010‐0109‐8; PUBMED: 20405136] SiltanenM , KajosaariM , PoussaT , SaarinenKM , SavilahtiE . A dual long‐term effect of breastfeeding on atopy in relation to heredity in children at 4 years of age. Allergy2003;58(6):524‐30. [PUBMED: 12757455] ">Saarinen 1999</a> and <a href="./references#CD003664-bbs2-0016" title="WillemsR , DuchateauJ , MagrezP , DenisR , CasimirG . Influence of hypoallergenic milk formula on the incidence of early allergic manifestations in infants predisposed to atopic diseases. Annals of Allergy1993;71(2):147‐50. [PUBMED: 8346868] ">Willems 1993</a> (month of birth), so were assessed as at 'high risk' of bias. </p> </section> <section id="CD003664-sec-0098"> <h5 class="title">Allocation concealment</h5> <p>Three studies are at 'low risk' of bias due to allocation concealment (<a href="./references#CD003664-bbs2-0001" title="ChiricoG , GasparoniA , CiardelliL , DeAmiciM , ColomboA , RondiniG . Immunogenicity and antigenicity of a partially hydrolyzed cow's milk infant formula. Allergy1997;52(1):82‐8. [PUBMED: 9062633] ">Chirico 1997</a>; <a href="./references#CD003664-bbs2-0004" title="HillD . A report on the analysis of the Melbourne Atopy Cohort Study. A study designed to test the effectiveness of different formula types on the development of atopic symptoms and signs on a cohort of atopy‐at‐risk infants. Report at year 2. Nestec Internal Report. HillDJ , SporikR , ThorburnJ , HoskingCS . The association of atopic dermatitis in infancy with immunoglobulin E food sensitization. Journal of Pediatrics2000;137(4):475‐9. [DOI: 10.1067/mpd.2000.108207; PUBMED: 11035824] KoplinJ , DharmageSC , GurrinL , OsborneN , TangML , LoweAJ , et al. Soy consumption is not a risk factor for peanut sensitization. Journal of Allergy and Clinical Immunology2008;121(6):1455‐9. [DOI: 10.1016/j.jaci.2008.03.017; PUBMED: 18436294] LoweA , HoskingC , BennettC , AllenK , CarlinJ , DharmageS , et al. The Melbourne Atopy Cohort Study: a RCT of a partially hydrolysed whey formula for the prevention of allergic disease. Internal Medicine Journal2008;38:A158. LoweAJ , AbramsonMJ , HoskingCS , CarlinJB , BennettCM , DharmageSC , et al. The temporal sequence of allergic sensitization and onset of infantile eczema. Clinical &amp; Experimental Allergy2007;37(4):536‐42; Erratum in: Clinical &amp; Experimental Allergy 2007; 37(12);1895. [DOI: 10.1111/j.1365‐2222.2007.02691.x; PUBMED: 17430350] LoweAJ , CarlinJB , BennettCM , HoskingCS , AllenKJ , RobertsonCF , et al. Paracetamol use in early life and asthma: prospective birth cohort study. BMJ2010;341:c4616. [PUBMED: 20843914] LoweAJ , HoskingCS , BennettCM , AllenKJ , AxelradC , CarlinJB , et al. Effect of a partially hydrolyzed whey infant formula at weaning on risk of allergic disease in high‐risk children: a randomized controlled trial. Journal of Allergy and Clinical Immunology2011;128(2):360‐5.e4. [DOI: 10.1016/j.jaci.2010.05.006; PUBMED: 21696814] StoneyRM , WoodsRK , HoskingCS , HillDJ , AbramsonMJ , ThienFC . Maternal breast milk long‐chain n‐3 fatty acids are associated with increased risk of atopy in breastfed infants. Clinical and Experimental Allergy2004;34(2):194‐200; Erratum in: Clinical &amp; Experimental Allergy 2007; 37(12);1895. [PUBMED: 14987297] ThomsonJA , WidjajaC , DarmaputraAA , LoweA , MathesonMC , BennettCM , et al. Early childhood infections and immunisation and the development of allergic disease in particular asthma in a high‐risk cohort: a prospective study of allergy‐prone children from birth to six years. Pediatric Allergy and Immunology2010;21(7):1076‐85. [DOI: 10.1111/j.1399‐3038.2010.01018.x; PUBMED: 20337970] ">Hill 2000</a>; <a href="./references#CD003664-bbs2-0015" title="BergA , KramerU , LinkE , BollrathC , HeinrichJ , BrockowI , et al. GINIplus study group. Impact of early feeding on childhood eczema: development after nutritional intervention compared with the natural course ‐ the GINIplus study up to the age of 6 years. Clinical and Experimental Allergy2010;40(4):627‐36. [DOI: 10.1111/j.1365‐2222.2009.03444.x; PUBMED: 20082618] BrockowI , ZutavernA , HoffmannU , GrublA , vonBergA , KoletzkoS , et al. GINIplus Study Group. Early allergic sensitizations and their relevance to atopic diseases in children aged 6 years: results of the GINI study. Journal of Investigational Allergology &amp; Clinical Immunology2009;19(3):180‐7. [DOI: 19610260] LaubereauB , BrockowI , ZirngiblA , KoletzkoS , GrueblA , vonBergA , et al. GINI Study Group. Effect of breast‐feeding on the development of atopic dermatitis during the first 3 years of life ‐ results from the GINI‐birth cohort study. Journal of Pediatrics2004;144(5):602‐7. [DOI: 10.1016/j.jpeds.2003.12.029; PUBMED: 15126993] LaubereauB , Filipiak‐PittroffB , vonBergA , GrublA , ReinhardtD , WichmannHE , et al. Caesarean section and gastrointestinal symptoms, atopic dermatitis, and sensitisation during the first year of life. Archives of Disease in Childhood2004;89(11):993‐7. [DOI: 10.1136/adc.2003.043265; PUBMED: 15499049] RzehakP , SausenthalerS , KoletzkoS , BauerCP , SchaafB , vonBergA , et al. Period‐specific growth, overweight and modification by breastfeeding in the GINI and LISA birth cohorts up to age 6 years. European Journal of Epidemiology2009;24(8):449‐67. [DOI: 10.1007/s10654‐009‐9356‐5; PUBMED: 19521784] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. GINI‐plus Study Group. Long‐term effects of hydrolyzed protein infant formulas on growth ‐ extended follow‐up to 10 y of age: results from the German Infant Nutritional Intervention (GINI) study. American Journal of Clinical Nutrition2011;94(6 Suppl):1803S‐7S. [DOI: 10.3945/ajcn.110.000679; PUBMED: 21849601] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. German Infant Nutritional Intervention Study Group. Short‐ and long‐term effects of feeding hydrolyzed protein infant formulas on growth at &lt; or = 6 y of age: results from the German Infant Nutritional Intervention Study. American Journal of Clinical Nutrition2009;89(6):1846‐56. [DOI: 10.3945/ajcn.2008.27373; PUBMED: 19369380] SausenthalerS , KoletzkoS , KoletzkoB , ReinhardtD , KramerU , vonBergA , et al. GINIplus study group. Effect of hydrolysed formula feeding on taste preferences at 10 years. Data from the German Infant Nutritional Intervention Program Plus Study. Clinical Nutrition2010;29(3):304‐6. [DOI: 10.1016/j.clnu.2010.01.007; PUBMED: 20110140] SchoetzauA , Filipiak‐PittroffB , FrankeK , KoletzkoS , VonBergA , GrueblA , et al. German Infant Nutritional Intervention Study Group. Effect of exclusive breast‐feeding and early solid food avoidance on the incidence of atopic dermatitis in high‐risk infants at 1 year of age. Pediatric Allergy and Immunology2002;13(4):234‐42. [PUBMED: 12390439] SchoetzauA , GehringU , FrankeK , GrublA , KoletzkoS , vonBergA , et al. Gini Study Group. Maternal compliance with nutritional recommendations in an allergy preventive programme. Archives of Disease in Childhood2002;86(3):180‐4. [PUBMED: 11861235] VonBergA , Filipiak‐PittroffB , KrämerU , LinkE , HeinrichJ , KoletzkoS , et al. The German Infant Nutritional Intervention Study (GINI) for the preventive effect of hydrolysed infant formulas in infants at high risk for allergic diseases. Design and selected results. Allergologie2012;35(1):32‐43. VonBergA , Filipiak‐PittroffB , SchulzH , HoffmannU , LinkE , SussmannM , et al. GINIplus study group. Allergic manifestation 15 years after early intervention with hydrolyzed formulas ‐ the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2016;71(2):210‐9. [DOI: 10.1111/all.12790; PUBMED: 26465137] vonBergA , FilipiakB , KoletzkoS , KrämerU , HoffmannB , LinkE , et al. Long‐term effect of cow milk protein hydrolysates in high‐risk children. Results from the 10‐years follow‐up of the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2013;68:295‐6. vonBergA , Filipiak‐PittroffB , KramerU , HoffmannB , LinkE , BeckmannC , et al. GINIplus study group. Allergies in high‐risk schoolchildren after early intervention with cow's milk protein hydrolysates: 10‐year results from the German Infant Nutritional Intervention (GINI) study. Journal of Allergy and Clinical Immunology2013;131(6):1565‐73. [DOI: 10.1016/j.jaci.2013.01.006; PUBMED: 23506844] vonBergA , Filipiak‐PittroffB , KramerU , LinkE , BollrathC , BrockowI , et al. GINIplus study group. Preventive effect of hydrolyzed infant formulas persists until age 6 years: long‐term results from the German Infant Nutritional Intervention Study (GINI). Journal of Allergy and Clinical Immunology2008;121(6):1442‐7. [DOI: 10.1016/j.jaci.2008.04.021; PUBMED: 18539195] vonBergA , KoletzkoS , Filipiak‐PittroffB , LaubereauB , GrublA , WichmannHE , et al. German Infant Nutritional Intervention Study Group. Certain hydrolyzed formulas reduce the incidence of atopic dermatitis but not that of asthma: three‐year results of the German Infant Nutritional Intervention Study. Journal of Allergy and Clinical Immunology2007;119(3):718‐25. [DOI: 10.1016/j.jaci.2006.11.017; PUBMED: 17240440] vonBergA , KoletzkoS , GrublA , Filipiak‐PittroffB , WichmannHE , BauerCP , et al. German Infant Nutritional Intervention Study Group. The effect of hydrolyzed cow's milk formula for allergy prevention in the first year of life: the German Infant Nutritional Intervention Study, a randomized double‐blind trial. Journal of Allergy and Clinical Immunology2003;111(3):533‐40. [PUBMED: 12642834] ">von Berg 2003</a>). Nine studies were at 'unclear' risk including <a href="./references#CD003664-bbs2-0002" title="deSetaL , SianiP , CirilloG , DiGruttolaM , CimaduomoL , ColettaS . The prevention of allergic diseases with a hypoallergenic formula: a follow‐up at 24 months. The preliminary results. [Italian]. La Pediatria Medica e Chirurgica: Medical and Surgical Pediatrics1994;16(3):251‐4. [PUBMED: 7971447] ">de Seta 1994</a> did not report method of allocation, <a href="./references#CD003664-bbs2-0003" title="HalkenS , HansenKS , JacobsenHP , EstmannA , FaellingAE , HansenLG , et al. Comparison of a partially hydrolyzed infant formula with two extensively hydrolyzed formulas for allergy prevention: a prospective, randomized study. Pediatric Allergy and Immunology2000;11(3):149‐61. [PUBMED: 10981524] ">Halken 2000</a> used quasi‐random allocation method but blinded intervention, <a href="./references#CD003664-bbs2-0006" title="KwintaP , SawiecP , KlimekM , LisG , Cichocka‐JaroszE , PietrzykJJ . Correlation between early neonatal diet and atopic symptoms up to 5‐7 years of age in very low birth weight infants: follow‐up of randomized, double‐blind study. Pediatric Allergy and Immunology2009;20(5):458‐66. [DOI: 10.1111/j.1399‐3038.2008.00814.x; PUBMED: 19490477] ">Kwinta 2009</a> used unclear allocation method, <a href="./references#CD003664-bbs2-0007" title="LamBC , YeungCY . The effect of breast milk, infant formula and hypoallergenic formula on incidence of atopic manifestation in high risk infants. Nestle Internal Report1992. ">Lam 1992</a> did not report method, <a href="./references#CD003664-bbs2-0008" title="MalletE , HenocqA . Long‐term prevention of allergic diseases by using protein hydrolysate formula in at‐risk infants. Journal of Pediatrics1992;121(5 Pt 2):S95‐100. [PUBMED: 1447641] ">Mallet 1992</a> did not report method, <a href="./references#CD003664-bbs2-0009" title="MariniA , AgostiM , MottaG , MoscaF . Effects of a dietary and environmental prevention programme on the incidence of allergic symptoms in high atopic risk infants: three years' follow‐up. Acta Paediatrica Supplement1996;414:1‐21. [PUBMED: 8831855] ">Marini 1996</a> did not report method, <a href="./references#CD003664-bbs2-0011" title="OldaeusG , AnjouK , BjorkstenB , MoranJR , KjellmanNI . Extensively and partially hydrolysed infant formulas for allergy prophylaxis. Archives of Disease in Childhood1997;77(1):4‐10. [PUBMED: 9279143] OldaeusG , BjorkstenB , JenmalmMC , KjellmanNI . Cow's milk IgE and IgG antibody responses to cow's milk formulas. Allergy1999;54(4):352‐7. [PUBMED: 10371094] ">Oldaeus 1997</a> did not report method, <a href="./references#CD003664-bbs2-0012" title="SaarinenKM , Juntunen‐BackmanK , JarvenpaaAL , KlemettiP , KuitunenP , LopeL , et al. Breast‐feeding and the development of cows' milk protein allergy. Advances in Experimental Medicine and Biology2000;478:121‐30. [DOI: 10.1007/0‐306‐46830‐1_10; PUBMED: 11065065] SaarinenKM , Juntunen‐BackmanK , JarvenpaaAL , KuitunenP , LopeL , RenlundM , et al. Supplementary feeding in maternity hospitals and the risk of cow's milk allergy: a prospective study of 6209 infants. Journal of Allergy and Clinical Immunology1999;104(2 Pt 1):457‐61. [PUBMED: 10452771] SaarinenKM , SavilahtiE . Infant feeding patterns affect the subsequent immunological features in cow's milk allergy. Clinical and Experimental Allergy2000;30(3):400‐6. [DOI: 10691899] SaarinenKM , SuomalainenH , SavilahtiE . Diagnostic value of skin‐prick and patch tests and serum eosinophil cationic protein and cow's milk‐specific IgE in infants with cow's milk allergy. Clinical and Experimental Allergy2001;31(3):423‐9. [PUBMED: 11260154] SaarinenKM , VaaralaO , KlemettiP , SavilahtiE . Transforming growth factor‐beta1 in mothers' colostrum and immune responses to cows' milk proteins in infants with cows' milk allergy. Journal of Allergy and Clinical Immunology1999;104(5):1093‐8. [PUBMED: 10550758] SavilahtiE , SaarinenKM . Early infant feeding and type 1 diabetes. European Journal of Nutrition2009;48(4):243‐9. [DOI: 10.1007/s00394‐009‐0008‐z; PUBMED: 19263185] SavilahtiEM , SaarinenKM , SavilahtiE . Specific antibodies to cow's milk proteins in infants: effect of early feeding and diagnosis of cow's milk allergy. European Journal of Nutrition2010;49(8):501‐4. [DOI: 10.1007/s00394‐010‐0109‐8; PUBMED: 20405136] SiltanenM , KajosaariM , PoussaT , SaarinenKM , SavilahtiE . A dual long‐term effect of breastfeeding on atopy in relation to heredity in children at 4 years of age. Allergy2003;58(6):524‐30. [PUBMED: 12757455] ">Saarinen 1999</a> used quasi‐random allocation method but blinded intervention, <a href="./references#CD003664-bbs2-0013" title="TsaiYT , ChouCC , HsiehKH . The effect of hypoallergenic formula on the occurrence of allergic diseases in high risk infants. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi1991;32(3):137‐44. [PUBMED: 1776437] ">Tsai 1991</a> did not report method, and <a href="./references#CD003664-bbs2-0014" title="VandenplasY . Atopy at 3 years in high‐risk infants fed whey hydrolysate or conventional formula. Lancet1992;339(8801):1118. [PUBMED: 1349137] VandenplasY , HauserB , Van denBorreC , ClybouwC , MahlerT , Hachimi‐IdrissiS , et al. The long‐term effect of a partial whey hydrolysate formula on the prophylaxis of atopic disease. European Journal of Pediatrics1995;154(6):488‐94. [PUBMED: 7671948] VandenplasY , HauserB , Van denBorreC , SacreL , DabI . Effect of a whey hydrolysate prophylaxis of atopic disease. Annals of Allergy1992;68(5):419‐24. [PUBMED: 1586005] ">Vandenplas 1992</a> (used unclear allocation method). We assessed three studies as having 'high risk' for allocation concealment ‐ <a href="./references#CD003664-bbs2-0005" title="JuvonenP , ManssonM , AnderssonC , JakobssonI . Allergy development and macromolecular absorption in infants with different feeding regimens during the first three days of life. A three‐year prospective follow‐up. Acta Paediatrica1996;85(9):1047‐52. [PUBMED: 8888916] JuvonenP , ManssonM , JakobssonI . Does early diet have an effect on subsequent macromolecular absorption and serum IgE?. Journal of Pediatric Gastroenterology and Nutrition1994;18(3):344‐9. [PUBMED: 8057219] JuvonenP , ManssonM , KjellmanNI , BjorkstenB , JakobssonI . Development of immunoglobulin G and immunoglobulin E antibodies to cow's milk proteins and ovalbumin after a temporary neonatal exposure to hydrolyzed and whole cow's milk proteins. Pediatric Allergy and Immunology1999;10(3):191‐8. [PUBMED: 10565560] ">Juvonen 1996</a> quasi‐random allocation, unblinded study, <a href="./references#CD003664-bbs2-0010" title="NentwichI , MichkovaE , NevoralJ , UrbanekR , SzepfalusiZ . Cow's milk‐specific cellular and humoral immune responses and atopy skin symptoms in infants from atopic families fed a partially (pHF) or extensively (eHF) hydrolyzed infant formula. Allergy2001;56(12):1144‐56. [PUBMED: 11736743] ">Nentwich 2001</a> quasi‐random allocation, unblinded prescribing and <a href="./references#CD003664-bbs2-0016" title="WillemsR , DuchateauJ , MagrezP , DenisR , CasimirG . Influence of hypoallergenic milk formula on the incidence of early allergic manifestations in infants predisposed to atopic diseases. Annals of Allergy1993;71(2):147‐50. [PUBMED: 8346868] ">Willems 1993</a> quasi‐random allocation, unblinded study. </p> </section> </section> <section id="CD003664-sec-0099"> <h4 class="title">Blinding</h4> <p>Six studies reported blinding of participants and personnel (<a href="./references#CD003664-bbs2-0003" title="HalkenS , HansenKS , JacobsenHP , EstmannA , FaellingAE , HansenLG , et al. Comparison of a partially hydrolyzed infant formula with two extensively hydrolyzed formulas for allergy prevention: a prospective, randomized study. Pediatric Allergy and Immunology2000;11(3):149‐61. [PUBMED: 10981524] ">Halken 2000</a>; <a href="./references#CD003664-bbs2-0004" title="HillD . A report on the analysis of the Melbourne Atopy Cohort Study. A study designed to test the effectiveness of different formula types on the development of atopic symptoms and signs on a cohort of atopy‐at‐risk infants. Report at year 2. Nestec Internal Report. HillDJ , SporikR , ThorburnJ , HoskingCS . The association of atopic dermatitis in infancy with immunoglobulin E food sensitization. Journal of Pediatrics2000;137(4):475‐9. [DOI: 10.1067/mpd.2000.108207; PUBMED: 11035824] KoplinJ , DharmageSC , GurrinL , OsborneN , TangML , LoweAJ , et al. Soy consumption is not a risk factor for peanut sensitization. Journal of Allergy and Clinical Immunology2008;121(6):1455‐9. [DOI: 10.1016/j.jaci.2008.03.017; PUBMED: 18436294] LoweA , HoskingC , BennettC , AllenK , CarlinJ , DharmageS , et al. The Melbourne Atopy Cohort Study: a RCT of a partially hydrolysed whey formula for the prevention of allergic disease. Internal Medicine Journal2008;38:A158. LoweAJ , AbramsonMJ , HoskingCS , CarlinJB , BennettCM , DharmageSC , et al. The temporal sequence of allergic sensitization and onset of infantile eczema. Clinical &amp; Experimental Allergy2007;37(4):536‐42; Erratum in: Clinical &amp; Experimental Allergy 2007; 37(12);1895. [DOI: 10.1111/j.1365‐2222.2007.02691.x; PUBMED: 17430350] LoweAJ , CarlinJB , BennettCM , HoskingCS , AllenKJ , RobertsonCF , et al. Paracetamol use in early life and asthma: prospective birth cohort study. BMJ2010;341:c4616. [PUBMED: 20843914] LoweAJ , HoskingCS , BennettCM , AllenKJ , AxelradC , CarlinJB , et al. Effect of a partially hydrolyzed whey infant formula at weaning on risk of allergic disease in high‐risk children: a randomized controlled trial. Journal of Allergy and Clinical Immunology2011;128(2):360‐5.e4. [DOI: 10.1016/j.jaci.2010.05.006; PUBMED: 21696814] StoneyRM , WoodsRK , HoskingCS , HillDJ , AbramsonMJ , ThienFC . Maternal breast milk long‐chain n‐3 fatty acids are associated with increased risk of atopy in breastfed infants. Clinical and Experimental Allergy2004;34(2):194‐200; Erratum in: Clinical &amp; Experimental Allergy 2007; 37(12);1895. [PUBMED: 14987297] ThomsonJA , WidjajaC , DarmaputraAA , LoweA , MathesonMC , BennettCM , et al. Early childhood infections and immunisation and the development of allergic disease in particular asthma in a high‐risk cohort: a prospective study of allergy‐prone children from birth to six years. Pediatric Allergy and Immunology2010;21(7):1076‐85. [DOI: 10.1111/j.1399‐3038.2010.01018.x; PUBMED: 20337970] ">Hill 2000</a>; <a href="./references#CD003664-bbs2-0006" title="KwintaP , SawiecP , KlimekM , LisG , Cichocka‐JaroszE , PietrzykJJ . Correlation between early neonatal diet and atopic symptoms up to 5‐7 years of age in very low birth weight infants: follow‐up of randomized, double‐blind study. Pediatric Allergy and Immunology2009;20(5):458‐66. [DOI: 10.1111/j.1399‐3038.2008.00814.x; PUBMED: 19490477] ">Kwinta 2009</a>; <a href="./references#CD003664-bbs2-0012" title="SaarinenKM , Juntunen‐BackmanK , JarvenpaaAL , KlemettiP , KuitunenP , LopeL , et al. Breast‐feeding and the development of cows' milk protein allergy. Advances in Experimental Medicine and Biology2000;478:121‐30. [DOI: 10.1007/0‐306‐46830‐1_10; PUBMED: 11065065] SaarinenKM , Juntunen‐BackmanK , JarvenpaaAL , KuitunenP , LopeL , RenlundM , et al. Supplementary feeding in maternity hospitals and the risk of cow's milk allergy: a prospective study of 6209 infants. Journal of Allergy and Clinical Immunology1999;104(2 Pt 1):457‐61. [PUBMED: 10452771] SaarinenKM , SavilahtiE . Infant feeding patterns affect the subsequent immunological features in cow's milk allergy. Clinical and Experimental Allergy2000;30(3):400‐6. [DOI: 10691899] SaarinenKM , SuomalainenH , SavilahtiE . Diagnostic value of skin‐prick and patch tests and serum eosinophil cationic protein and cow's milk‐specific IgE in infants with cow's milk allergy. Clinical and Experimental Allergy2001;31(3):423‐9. [PUBMED: 11260154] SaarinenKM , VaaralaO , KlemettiP , SavilahtiE . Transforming growth factor‐beta1 in mothers' colostrum and immune responses to cows' milk proteins in infants with cows' milk allergy. Journal of Allergy and Clinical Immunology1999;104(5):1093‐8. [PUBMED: 10550758] SavilahtiE , SaarinenKM . Early infant feeding and type 1 diabetes. European Journal of Nutrition2009;48(4):243‐9. [DOI: 10.1007/s00394‐009‐0008‐z; PUBMED: 19263185] SavilahtiEM , SaarinenKM , SavilahtiE . Specific antibodies to cow's milk proteins in infants: effect of early feeding and diagnosis of cow's milk allergy. European Journal of Nutrition2010;49(8):501‐4. [DOI: 10.1007/s00394‐010‐0109‐8; PUBMED: 20405136] SiltanenM , KajosaariM , PoussaT , SaarinenKM , SavilahtiE . A dual long‐term effect of breastfeeding on atopy in relation to heredity in children at 4 years of age. Allergy2003;58(6):524‐30. [PUBMED: 12757455] ">Saarinen 1999</a>; <a href="./references#CD003664-bbs2-0014" title="VandenplasY . Atopy at 3 years in high‐risk infants fed whey hydrolysate or conventional formula. Lancet1992;339(8801):1118. [PUBMED: 1349137] VandenplasY , HauserB , Van denBorreC , ClybouwC , MahlerT , Hachimi‐IdrissiS , et al. The long‐term effect of a partial whey hydrolysate formula on the prophylaxis of atopic disease. European Journal of Pediatrics1995;154(6):488‐94. [PUBMED: 7671948] VandenplasY , HauserB , Van denBorreC , SacreL , DabI . Effect of a whey hydrolysate prophylaxis of atopic disease. Annals of Allergy1992;68(5):419‐24. [PUBMED: 1586005] ">Vandenplas 1992</a>; <a href="./references#CD003664-bbs2-0015" title="BergA , KramerU , LinkE , BollrathC , HeinrichJ , BrockowI , et al. GINIplus study group. Impact of early feeding on childhood eczema: development after nutritional intervention compared with the natural course ‐ the GINIplus study up to the age of 6 years. Clinical and Experimental Allergy2010;40(4):627‐36. [DOI: 10.1111/j.1365‐2222.2009.03444.x; PUBMED: 20082618] BrockowI , ZutavernA , HoffmannU , GrublA , vonBergA , KoletzkoS , et al. GINIplus Study Group. Early allergic sensitizations and their relevance to atopic diseases in children aged 6 years: results of the GINI study. Journal of Investigational Allergology &amp; Clinical Immunology2009;19(3):180‐7. [DOI: 19610260] LaubereauB , BrockowI , ZirngiblA , KoletzkoS , GrueblA , vonBergA , et al. GINI Study Group. Effect of breast‐feeding on the development of atopic dermatitis during the first 3 years of life ‐ results from the GINI‐birth cohort study. Journal of Pediatrics2004;144(5):602‐7. [DOI: 10.1016/j.jpeds.2003.12.029; PUBMED: 15126993] LaubereauB , Filipiak‐PittroffB , vonBergA , GrublA , ReinhardtD , WichmannHE , et al. Caesarean section and gastrointestinal symptoms, atopic dermatitis, and sensitisation during the first year of life. Archives of Disease in Childhood2004;89(11):993‐7. [DOI: 10.1136/adc.2003.043265; PUBMED: 15499049] RzehakP , SausenthalerS , KoletzkoS , BauerCP , SchaafB , vonBergA , et al. Period‐specific growth, overweight and modification by breastfeeding in the GINI and LISA birth cohorts up to age 6 years. European Journal of Epidemiology2009;24(8):449‐67. [DOI: 10.1007/s10654‐009‐9356‐5; PUBMED: 19521784] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. GINI‐plus Study Group. Long‐term effects of hydrolyzed protein infant formulas on growth ‐ extended follow‐up to 10 y of age: results from the German Infant Nutritional Intervention (GINI) study. American Journal of Clinical Nutrition2011;94(6 Suppl):1803S‐7S. [DOI: 10.3945/ajcn.110.000679; PUBMED: 21849601] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. German Infant Nutritional Intervention Study Group. Short‐ and long‐term effects of feeding hydrolyzed protein infant formulas on growth at &lt; or = 6 y of age: results from the German Infant Nutritional Intervention Study. American Journal of Clinical Nutrition2009;89(6):1846‐56. [DOI: 10.3945/ajcn.2008.27373; PUBMED: 19369380] SausenthalerS , KoletzkoS , KoletzkoB , ReinhardtD , KramerU , vonBergA , et al. GINIplus study group. Effect of hydrolysed formula feeding on taste preferences at 10 years. Data from the German Infant Nutritional Intervention Program Plus Study. Clinical Nutrition2010;29(3):304‐6. [DOI: 10.1016/j.clnu.2010.01.007; PUBMED: 20110140] SchoetzauA , Filipiak‐PittroffB , FrankeK , KoletzkoS , VonBergA , GrueblA , et al. German Infant Nutritional Intervention Study Group. Effect of exclusive breast‐feeding and early solid food avoidance on the incidence of atopic dermatitis in high‐risk infants at 1 year of age. Pediatric Allergy and Immunology2002;13(4):234‐42. [PUBMED: 12390439] SchoetzauA , GehringU , FrankeK , GrublA , KoletzkoS , vonBergA , et al. Gini Study Group. Maternal compliance with nutritional recommendations in an allergy preventive programme. Archives of Disease in Childhood2002;86(3):180‐4. [PUBMED: 11861235] VonBergA , Filipiak‐PittroffB , KrämerU , LinkE , HeinrichJ , KoletzkoS , et al. The German Infant Nutritional Intervention Study (GINI) for the preventive effect of hydrolysed infant formulas in infants at high risk for allergic diseases. Design and selected results. Allergologie2012;35(1):32‐43. VonBergA , Filipiak‐PittroffB , SchulzH , HoffmannU , LinkE , SussmannM , et al. GINIplus study group. Allergic manifestation 15 years after early intervention with hydrolyzed formulas ‐ the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2016;71(2):210‐9. [DOI: 10.1111/all.12790; PUBMED: 26465137] vonBergA , FilipiakB , KoletzkoS , KrämerU , HoffmannB , LinkE , et al. Long‐term effect of cow milk protein hydrolysates in high‐risk children. Results from the 10‐years follow‐up of the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2013;68:295‐6. vonBergA , Filipiak‐PittroffB , KramerU , HoffmannB , LinkE , BeckmannC , et al. GINIplus study group. Allergies in high‐risk schoolchildren after early intervention with cow's milk protein hydrolysates: 10‐year results from the German Infant Nutritional Intervention (GINI) study. Journal of Allergy and Clinical Immunology2013;131(6):1565‐73. [DOI: 10.1016/j.jaci.2013.01.006; PUBMED: 23506844] vonBergA , Filipiak‐PittroffB , KramerU , LinkE , BollrathC , BrockowI , et al. GINIplus study group. Preventive effect of hydrolyzed infant formulas persists until age 6 years: long‐term results from the German Infant Nutritional Intervention Study (GINI). Journal of Allergy and Clinical Immunology2008;121(6):1442‐7. [DOI: 10.1016/j.jaci.2008.04.021; PUBMED: 18539195] vonBergA , KoletzkoS , Filipiak‐PittroffB , LaubereauB , GrublA , WichmannHE , et al. German Infant Nutritional Intervention Study Group. Certain hydrolyzed formulas reduce the incidence of atopic dermatitis but not that of asthma: three‐year results of the German Infant Nutritional Intervention Study. Journal of Allergy and Clinical Immunology2007;119(3):718‐25. [DOI: 10.1016/j.jaci.2006.11.017; PUBMED: 17240440] vonBergA , KoletzkoS , GrublA , Filipiak‐PittroffB , WichmannHE , BauerCP , et al. German Infant Nutritional Intervention Study Group. The effect of hydrolyzed cow's milk formula for allergy prevention in the first year of life: the German Infant Nutritional Intervention Study, a randomized double‐blind trial. Journal of Allergy and Clinical Immunology2003;111(3):533‐40. [PUBMED: 12642834] ">von Berg 2003</a>); we assessed four studies as having 'unclear' risk, as they did not report details (<a href="./references#CD003664-bbs2-0001" title="ChiricoG , GasparoniA , CiardelliL , DeAmiciM , ColomboA , RondiniG . Immunogenicity and antigenicity of a partially hydrolyzed cow's milk infant formula. Allergy1997;52(1):82‐8. [PUBMED: 9062633] ">Chirico 1997</a>; <a href="./references#CD003664-bbs2-0002" title="deSetaL , SianiP , CirilloG , DiGruttolaM , CimaduomoL , ColettaS . The prevention of allergic diseases with a hypoallergenic formula: a follow‐up at 24 months. The preliminary results. [Italian]. La Pediatria Medica e Chirurgica: Medical and Surgical Pediatrics1994;16(3):251‐4. [PUBMED: 7971447] ">de Seta 1994</a>; <a href="./references#CD003664-bbs2-0005" title="JuvonenP , ManssonM , AnderssonC , JakobssonI . Allergy development and macromolecular absorption in infants with different feeding regimens during the first three days of life. A three‐year prospective follow‐up. Acta Paediatrica1996;85(9):1047‐52. [PUBMED: 8888916] JuvonenP , ManssonM , JakobssonI . Does early diet have an effect on subsequent macromolecular absorption and serum IgE?. Journal of Pediatric Gastroenterology and Nutrition1994;18(3):344‐9. [PUBMED: 8057219] JuvonenP , ManssonM , KjellmanNI , BjorkstenB , JakobssonI . Development of immunoglobulin G and immunoglobulin E antibodies to cow's milk proteins and ovalbumin after a temporary neonatal exposure to hydrolyzed and whole cow's milk proteins. Pediatric Allergy and Immunology1999;10(3):191‐8. [PUBMED: 10565560] ">Juvonen 1996</a>; <a href="./references#CD003664-bbs2-0007" title="LamBC , YeungCY . The effect of breast milk, infant formula and hypoallergenic formula on incidence of atopic manifestation in high risk infants. Nestle Internal Report1992. ">Lam 1992</a>) and six studies as 'high risk as they were unblinded (<a href="./references#CD003664-bbs2-0008" title="MalletE , HenocqA . Long‐term prevention of allergic diseases by using protein hydrolysate formula in at‐risk infants. Journal of Pediatrics1992;121(5 Pt 2):S95‐100. [PUBMED: 1447641] ">Mallet 1992</a>; <a href="./references#CD003664-bbs2-0009" title="MariniA , AgostiM , MottaG , MoscaF . Effects of a dietary and environmental prevention programme on the incidence of allergic symptoms in high atopic risk infants: three years' follow‐up. Acta Paediatrica Supplement1996;414:1‐21. [PUBMED: 8831855] ">Marini 1996</a>; <a href="./references#CD003664-bbs2-0010" title="NentwichI , MichkovaE , NevoralJ , UrbanekR , SzepfalusiZ . Cow's milk‐specific cellular and humoral immune responses and atopy skin symptoms in infants from atopic families fed a partially (pHF) or extensively (eHF) hydrolyzed infant formula. Allergy2001;56(12):1144‐56. [PUBMED: 11736743] ">Nentwich 2001</a>; <a href="./references#CD003664-bbs2-0011" title="OldaeusG , AnjouK , BjorkstenB , MoranJR , KjellmanNI . Extensively and partially hydrolysed infant formulas for allergy prophylaxis. Archives of Disease in Childhood1997;77(1):4‐10. [PUBMED: 9279143] OldaeusG , BjorkstenB , JenmalmMC , KjellmanNI . Cow's milk IgE and IgG antibody responses to cow's milk formulas. Allergy1999;54(4):352‐7. [PUBMED: 10371094] ">Oldaeus 1997</a>; <a href="./references#CD003664-bbs2-0013" title="TsaiYT , ChouCC , HsiehKH . The effect of hypoallergenic formula on the occurrence of allergic diseases in high risk infants. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi1991;32(3):137‐44. [PUBMED: 1776437] ">Tsai 1991</a>; <a href="./references#CD003664-bbs2-0016" title="WillemsR , DuchateauJ , MagrezP , DenisR , CasimirG . Influence of hypoallergenic milk formula on the incidence of early allergic manifestations in infants predisposed to atopic diseases. Annals of Allergy1993;71(2):147‐50. [PUBMED: 8346868] ">Willems 1993</a>). </p> <p>Six studies reported blinding of measurement (<a href="./references#CD003664-bbs2-0003" title="HalkenS , HansenKS , JacobsenHP , EstmannA , FaellingAE , HansenLG , et al. Comparison of a partially hydrolyzed infant formula with two extensively hydrolyzed formulas for allergy prevention: a prospective, randomized study. Pediatric Allergy and Immunology2000;11(3):149‐61. [PUBMED: 10981524] ">Halken 2000</a>; <a href="./references#CD003664-bbs2-0006" title="KwintaP , SawiecP , KlimekM , LisG , Cichocka‐JaroszE , PietrzykJJ . Correlation between early neonatal diet and atopic symptoms up to 5‐7 years of age in very low birth weight infants: follow‐up of randomized, double‐blind study. Pediatric Allergy and Immunology2009;20(5):458‐66. [DOI: 10.1111/j.1399‐3038.2008.00814.x; PUBMED: 19490477] ">Kwinta 2009</a>; <a href="./references#CD003664-bbs2-0010" title="NentwichI , MichkovaE , NevoralJ , UrbanekR , SzepfalusiZ . Cow's milk‐specific cellular and humoral immune responses and atopy skin symptoms in infants from atopic families fed a partially (pHF) or extensively (eHF) hydrolyzed infant formula. Allergy2001;56(12):1144‐56. [PUBMED: 11736743] ">Nentwich 2001</a>; <a href="./references#CD003664-bbs2-0011" title="OldaeusG , AnjouK , BjorkstenB , MoranJR , KjellmanNI . Extensively and partially hydrolysed infant formulas for allergy prophylaxis. Archives of Disease in Childhood1997;77(1):4‐10. [PUBMED: 9279143] OldaeusG , BjorkstenB , JenmalmMC , KjellmanNI . Cow's milk IgE and IgG antibody responses to cow's milk formulas. Allergy1999;54(4):352‐7. [PUBMED: 10371094] ">Oldaeus 1997</a>; <a href="./references#CD003664-bbs2-0012" title="SaarinenKM , Juntunen‐BackmanK , JarvenpaaAL , KlemettiP , KuitunenP , LopeL , et al. Breast‐feeding and the development of cows' milk protein allergy. Advances in Experimental Medicine and Biology2000;478:121‐30. [DOI: 10.1007/0‐306‐46830‐1_10; PUBMED: 11065065] SaarinenKM , Juntunen‐BackmanK , JarvenpaaAL , KuitunenP , LopeL , RenlundM , et al. Supplementary feeding in maternity hospitals and the risk of cow's milk allergy: a prospective study of 6209 infants. Journal of Allergy and Clinical Immunology1999;104(2 Pt 1):457‐61. [PUBMED: 10452771] SaarinenKM , SavilahtiE . Infant feeding patterns affect the subsequent immunological features in cow's milk allergy. Clinical and Experimental Allergy2000;30(3):400‐6. [DOI: 10691899] SaarinenKM , SuomalainenH , SavilahtiE . Diagnostic value of skin‐prick and patch tests and serum eosinophil cationic protein and cow's milk‐specific IgE in infants with cow's milk allergy. Clinical and Experimental Allergy2001;31(3):423‐9. [PUBMED: 11260154] SaarinenKM , VaaralaO , KlemettiP , SavilahtiE . Transforming growth factor‐beta1 in mothers' colostrum and immune responses to cows' milk proteins in infants with cows' milk allergy. Journal of Allergy and Clinical Immunology1999;104(5):1093‐8. [PUBMED: 10550758] SavilahtiE , SaarinenKM . Early infant feeding and type 1 diabetes. European Journal of Nutrition2009;48(4):243‐9. [DOI: 10.1007/s00394‐009‐0008‐z; PUBMED: 19263185] SavilahtiEM , SaarinenKM , SavilahtiE . Specific antibodies to cow's milk proteins in infants: effect of early feeding and diagnosis of cow's milk allergy. European Journal of Nutrition2010;49(8):501‐4. [DOI: 10.1007/s00394‐010‐0109‐8; PUBMED: 20405136] SiltanenM , KajosaariM , PoussaT , SaarinenKM , SavilahtiE . A dual long‐term effect of breastfeeding on atopy in relation to heredity in children at 4 years of age. Allergy2003;58(6):524‐30. [PUBMED: 12757455] ">Saarinen 1999</a>; <a href="./references#CD003664-bbs2-0014" title="VandenplasY . Atopy at 3 years in high‐risk infants fed whey hydrolysate or conventional formula. Lancet1992;339(8801):1118. [PUBMED: 1349137] VandenplasY , HauserB , Van denBorreC , ClybouwC , MahlerT , Hachimi‐IdrissiS , et al. The long‐term effect of a partial whey hydrolysate formula on the prophylaxis of atopic disease. European Journal of Pediatrics1995;154(6):488‐94. [PUBMED: 7671948] VandenplasY , HauserB , Van denBorreC , SacreL , DabI . Effect of a whey hydrolysate prophylaxis of atopic disease. Annals of Allergy1992;68(5):419‐24. [PUBMED: 1586005] ">Vandenplas 1992</a>). Eight studies did not report blinding of measurement of clinical allergic disease (<a href="./references#CD003664-bbs2-0001" title="ChiricoG , GasparoniA , CiardelliL , DeAmiciM , ColomboA , RondiniG . Immunogenicity and antigenicity of a partially hydrolyzed cow's milk infant formula. Allergy1997;52(1):82‐8. [PUBMED: 9062633] ">Chirico 1997</a>; <a href="./references#CD003664-bbs2-0002" title="deSetaL , SianiP , CirilloG , DiGruttolaM , CimaduomoL , ColettaS . The prevention of allergic diseases with a hypoallergenic formula: a follow‐up at 24 months. The preliminary results. [Italian]. La Pediatria Medica e Chirurgica: Medical and Surgical Pediatrics1994;16(3):251‐4. [PUBMED: 7971447] ">de Seta 1994</a>; <a href="./references#CD003664-bbs2-0004" title="HillD . A report on the analysis of the Melbourne Atopy Cohort Study. A study designed to test the effectiveness of different formula types on the development of atopic symptoms and signs on a cohort of atopy‐at‐risk infants. Report at year 2. Nestec Internal Report. HillDJ , SporikR , ThorburnJ , HoskingCS . The association of atopic dermatitis in infancy with immunoglobulin E food sensitization. Journal of Pediatrics2000;137(4):475‐9. [DOI: 10.1067/mpd.2000.108207; PUBMED: 11035824] KoplinJ , DharmageSC , GurrinL , OsborneN , TangML , LoweAJ , et al. Soy consumption is not a risk factor for peanut sensitization. Journal of Allergy and Clinical Immunology2008;121(6):1455‐9. [DOI: 10.1016/j.jaci.2008.03.017; PUBMED: 18436294] LoweA , HoskingC , BennettC , AllenK , CarlinJ , DharmageS , et al. The Melbourne Atopy Cohort Study: a RCT of a partially hydrolysed whey formula for the prevention of allergic disease. Internal Medicine Journal2008;38:A158. LoweAJ , AbramsonMJ , HoskingCS , CarlinJB , BennettCM , DharmageSC , et al. The temporal sequence of allergic sensitization and onset of infantile eczema. Clinical &amp; Experimental Allergy2007;37(4):536‐42; Erratum in: Clinical &amp; Experimental Allergy 2007; 37(12);1895. [DOI: 10.1111/j.1365‐2222.2007.02691.x; PUBMED: 17430350] LoweAJ , CarlinJB , BennettCM , HoskingCS , AllenKJ , RobertsonCF , et al. Paracetamol use in early life and asthma: prospective birth cohort study. BMJ2010;341:c4616. [PUBMED: 20843914] LoweAJ , HoskingCS , BennettCM , AllenKJ , AxelradC , CarlinJB , et al. Effect of a partially hydrolyzed whey infant formula at weaning on risk of allergic disease in high‐risk children: a randomized controlled trial. Journal of Allergy and Clinical Immunology2011;128(2):360‐5.e4. [DOI: 10.1016/j.jaci.2010.05.006; PUBMED: 21696814] StoneyRM , WoodsRK , HoskingCS , HillDJ , AbramsonMJ , ThienFC . Maternal breast milk long‐chain n‐3 fatty acids are associated with increased risk of atopy in breastfed infants. Clinical and Experimental Allergy2004;34(2):194‐200; Erratum in: Clinical &amp; Experimental Allergy 2007; 37(12);1895. [PUBMED: 14987297] ThomsonJA , WidjajaC , DarmaputraAA , LoweA , MathesonMC , BennettCM , et al. Early childhood infections and immunisation and the development of allergic disease in particular asthma in a high‐risk cohort: a prospective study of allergy‐prone children from birth to six years. Pediatric Allergy and Immunology2010;21(7):1076‐85. [DOI: 10.1111/j.1399‐3038.2010.01018.x; PUBMED: 20337970] ">Hill 2000</a>; <a href="./references#CD003664-bbs2-0005" title="JuvonenP , ManssonM , AnderssonC , JakobssonI . Allergy development and macromolecular absorption in infants with different feeding regimens during the first three days of life. A three‐year prospective follow‐up. Acta Paediatrica1996;85(9):1047‐52. [PUBMED: 8888916] JuvonenP , ManssonM , JakobssonI . Does early diet have an effect on subsequent macromolecular absorption and serum IgE?. Journal of Pediatric Gastroenterology and Nutrition1994;18(3):344‐9. [PUBMED: 8057219] JuvonenP , ManssonM , KjellmanNI , BjorkstenB , JakobssonI . Development of immunoglobulin G and immunoglobulin E antibodies to cow's milk proteins and ovalbumin after a temporary neonatal exposure to hydrolyzed and whole cow's milk proteins. Pediatric Allergy and Immunology1999;10(3):191‐8. [PUBMED: 10565560] ">Juvonen 1996</a>; <a href="./references#CD003664-bbs2-0007" title="LamBC , YeungCY . The effect of breast milk, infant formula and hypoallergenic formula on incidence of atopic manifestation in high risk infants. Nestle Internal Report1992. ">Lam 1992</a>; <a href="./references#CD003664-bbs2-0009" title="MariniA , AgostiM , MottaG , MoscaF . Effects of a dietary and environmental prevention programme on the incidence of allergic symptoms in high atopic risk infants: three years' follow‐up. Acta Paediatrica Supplement1996;414:1‐21. [PUBMED: 8831855] ">Marini 1996</a>; <a href="./references#CD003664-bbs2-0013" title="TsaiYT , ChouCC , HsiehKH . The effect of hypoallergenic formula on the occurrence of allergic diseases in high risk infants. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi1991;32(3):137‐44. [PUBMED: 1776437] ">Tsai 1991</a>; <a href="./references#CD003664-bbs2-0015" title="BergA , KramerU , LinkE , BollrathC , HeinrichJ , BrockowI , et al. GINIplus study group. Impact of early feeding on childhood eczema: development after nutritional intervention compared with the natural course ‐ the GINIplus study up to the age of 6 years. Clinical and Experimental Allergy2010;40(4):627‐36. [DOI: 10.1111/j.1365‐2222.2009.03444.x; PUBMED: 20082618] BrockowI , ZutavernA , HoffmannU , GrublA , vonBergA , KoletzkoS , et al. GINIplus Study Group. Early allergic sensitizations and their relevance to atopic diseases in children aged 6 years: results of the GINI study. Journal of Investigational Allergology &amp; Clinical Immunology2009;19(3):180‐7. [DOI: 19610260] LaubereauB , BrockowI , ZirngiblA , KoletzkoS , GrueblA , vonBergA , et al. GINI Study Group. Effect of breast‐feeding on the development of atopic dermatitis during the first 3 years of life ‐ results from the GINI‐birth cohort study. Journal of Pediatrics2004;144(5):602‐7. [DOI: 10.1016/j.jpeds.2003.12.029; PUBMED: 15126993] LaubereauB , Filipiak‐PittroffB , vonBergA , GrublA , ReinhardtD , WichmannHE , et al. Caesarean section and gastrointestinal symptoms, atopic dermatitis, and sensitisation during the first year of life. Archives of Disease in Childhood2004;89(11):993‐7. [DOI: 10.1136/adc.2003.043265; PUBMED: 15499049] RzehakP , SausenthalerS , KoletzkoS , BauerCP , SchaafB , vonBergA , et al. Period‐specific growth, overweight and modification by breastfeeding in the GINI and LISA birth cohorts up to age 6 years. European Journal of Epidemiology2009;24(8):449‐67. [DOI: 10.1007/s10654‐009‐9356‐5; PUBMED: 19521784] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. GINI‐plus Study Group. Long‐term effects of hydrolyzed protein infant formulas on growth ‐ extended follow‐up to 10 y of age: results from the German Infant Nutritional Intervention (GINI) study. American Journal of Clinical Nutrition2011;94(6 Suppl):1803S‐7S. [DOI: 10.3945/ajcn.110.000679; PUBMED: 21849601] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. German Infant Nutritional Intervention Study Group. Short‐ and long‐term effects of feeding hydrolyzed protein infant formulas on growth at &lt; or = 6 y of age: results from the German Infant Nutritional Intervention Study. American Journal of Clinical Nutrition2009;89(6):1846‐56. [DOI: 10.3945/ajcn.2008.27373; PUBMED: 19369380] SausenthalerS , KoletzkoS , KoletzkoB , ReinhardtD , KramerU , vonBergA , et al. GINIplus study group. Effect of hydrolysed formula feeding on taste preferences at 10 years. Data from the German Infant Nutritional Intervention Program Plus Study. Clinical Nutrition2010;29(3):304‐6. [DOI: 10.1016/j.clnu.2010.01.007; PUBMED: 20110140] SchoetzauA , Filipiak‐PittroffB , FrankeK , KoletzkoS , VonBergA , GrueblA , et al. German Infant Nutritional Intervention Study Group. Effect of exclusive breast‐feeding and early solid food avoidance on the incidence of atopic dermatitis in high‐risk infants at 1 year of age. Pediatric Allergy and Immunology2002;13(4):234‐42. [PUBMED: 12390439] SchoetzauA , GehringU , FrankeK , GrublA , KoletzkoS , vonBergA , et al. Gini Study Group. Maternal compliance with nutritional recommendations in an allergy preventive programme. Archives of Disease in Childhood2002;86(3):180‐4. [PUBMED: 11861235] VonBergA , Filipiak‐PittroffB , KrämerU , LinkE , HeinrichJ , KoletzkoS , et al. The German Infant Nutritional Intervention Study (GINI) for the preventive effect of hydrolysed infant formulas in infants at high risk for allergic diseases. Design and selected results. Allergologie2012;35(1):32‐43. VonBergA , Filipiak‐PittroffB , SchulzH , HoffmannU , LinkE , SussmannM , et al. GINIplus study group. Allergic manifestation 15 years after early intervention with hydrolyzed formulas ‐ the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2016;71(2):210‐9. [DOI: 10.1111/all.12790; PUBMED: 26465137] vonBergA , FilipiakB , KoletzkoS , KrämerU , HoffmannB , LinkE , et al. Long‐term effect of cow milk protein hydrolysates in high‐risk children. Results from the 10‐years follow‐up of the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2013;68:295‐6. vonBergA , Filipiak‐PittroffB , KramerU , HoffmannB , LinkE , BeckmannC , et al. GINIplus study group. Allergies in high‐risk schoolchildren after early intervention with cow's milk protein hydrolysates: 10‐year results from the German Infant Nutritional Intervention (GINI) study. Journal of Allergy and Clinical Immunology2013;131(6):1565‐73. [DOI: 10.1016/j.jaci.2013.01.006; PUBMED: 23506844] vonBergA , Filipiak‐PittroffB , KramerU , LinkE , BollrathC , BrockowI , et al. GINIplus study group. Preventive effect of hydrolyzed infant formulas persists until age 6 years: long‐term results from the German Infant Nutritional Intervention Study (GINI). Journal of Allergy and Clinical Immunology2008;121(6):1442‐7. [DOI: 10.1016/j.jaci.2008.04.021; PUBMED: 18539195] vonBergA , KoletzkoS , Filipiak‐PittroffB , LaubereauB , GrublA , WichmannHE , et al. German Infant Nutritional Intervention Study Group. Certain hydrolyzed formulas reduce the incidence of atopic dermatitis but not that of asthma: three‐year results of the German Infant Nutritional Intervention Study. Journal of Allergy and Clinical Immunology2007;119(3):718‐25. [DOI: 10.1016/j.jaci.2006.11.017; PUBMED: 17240440] vonBergA , KoletzkoS , GrublA , Filipiak‐PittroffB , WichmannHE , BauerCP , et al. German Infant Nutritional Intervention Study Group. The effect of hydrolyzed cow's milk formula for allergy prevention in the first year of life: the German Infant Nutritional Intervention Study, a randomized double‐blind trial. Journal of Allergy and Clinical Immunology2003;111(3):533‐40. [PUBMED: 12642834] ">von Berg 2003</a>). <a href="./references#CD003664-bbs2-0008" title="MalletE , HenocqA . Long‐term prevention of allergic diseases by using protein hydrolysate formula in at‐risk infants. Journal of Pediatrics1992;121(5 Pt 2):S95‐100. [PUBMED: 1447641] ">Mallet 1992</a> and <a href="./references#CD003664-bbs2-0016" title="WillemsR , DuchateauJ , MagrezP , DenisR , CasimirG . Influence of hypoallergenic milk formula on the incidence of early allergic manifestations in infants predisposed to atopic diseases. Annals of Allergy1993;71(2):147‐50. [PUBMED: 8346868] ">Willems 1993</a> performed unblinded measurements. </p> </section> <section id="CD003664-sec-0100"> <h4 class="title">Incomplete outcome data</h4> <p>We included in this review only studies that reported &lt; 20% loss to follow‐up. Studies reported the following losses to follow‐up: <a href="./references#CD003664-bbs2-0001" title="ChiricoG , GasparoniA , CiardelliL , DeAmiciM , ColomboA , RondiniG . Immunogenicity and antigenicity of a partially hydrolyzed cow's milk infant formula. Allergy1997;52(1):82‐8. [PUBMED: 9062633] ">Chirico 1997</a> ‐ unclear; <a href="./references#CD003664-bbs2-0002" title="deSetaL , SianiP , CirilloG , DiGruttolaM , CimaduomoL , ColettaS . The prevention of allergic diseases with a hypoallergenic formula: a follow‐up at 24 months. The preliminary results. [Italian]. La Pediatria Medica e Chirurgica: Medical and Surgical Pediatrics1994;16(3):251‐4. [PUBMED: 7971447] ">de Seta 1994</a> ‐ none reported; <a href="./references#CD003664-bbs2-0003" title="HalkenS , HansenKS , JacobsenHP , EstmannA , FaellingAE , HansenLG , et al. Comparison of a partially hydrolyzed infant formula with two extensively hydrolyzed formulas for allergy prevention: a prospective, randomized study. Pediatric Allergy and Immunology2000;11(3):149‐61. [PUBMED: 10981524] ">Halken 2000</a> ‐ 20% at 18 months; <a href="./references#CD003664-bbs2-0004" title="HillD . A report on the analysis of the Melbourne Atopy Cohort Study. A study designed to test the effectiveness of different formula types on the development of atopic symptoms and signs on a cohort of atopy‐at‐risk infants. Report at year 2. Nestec Internal Report. HillDJ , SporikR , ThorburnJ , HoskingCS . The association of atopic dermatitis in infancy with immunoglobulin E food sensitization. Journal of Pediatrics2000;137(4):475‐9. [DOI: 10.1067/mpd.2000.108207; PUBMED: 11035824] KoplinJ , DharmageSC , GurrinL , OsborneN , TangML , LoweAJ , et al. Soy consumption is not a risk factor for peanut sensitization. Journal of Allergy and Clinical Immunology2008;121(6):1455‐9. [DOI: 10.1016/j.jaci.2008.03.017; PUBMED: 18436294] LoweA , HoskingC , BennettC , AllenK , CarlinJ , DharmageS , et al. The Melbourne Atopy Cohort Study: a RCT of a partially hydrolysed whey formula for the prevention of allergic disease. Internal Medicine Journal2008;38:A158. LoweAJ , AbramsonMJ , HoskingCS , CarlinJB , BennettCM , DharmageSC , et al. The temporal sequence of allergic sensitization and onset of infantile eczema. Clinical &amp; Experimental Allergy2007;37(4):536‐42; Erratum in: Clinical &amp; Experimental Allergy 2007; 37(12);1895. [DOI: 10.1111/j.1365‐2222.2007.02691.x; PUBMED: 17430350] LoweAJ , CarlinJB , BennettCM , HoskingCS , AllenKJ , RobertsonCF , et al. Paracetamol use in early life and asthma: prospective birth cohort study. BMJ2010;341:c4616. [PUBMED: 20843914] LoweAJ , HoskingCS , BennettCM , AllenKJ , AxelradC , CarlinJB , et al. Effect of a partially hydrolyzed whey infant formula at weaning on risk of allergic disease in high‐risk children: a randomized controlled trial. Journal of Allergy and Clinical Immunology2011;128(2):360‐5.e4. [DOI: 10.1016/j.jaci.2010.05.006; PUBMED: 21696814] StoneyRM , WoodsRK , HoskingCS , HillDJ , AbramsonMJ , ThienFC . Maternal breast milk long‐chain n‐3 fatty acids are associated with increased risk of atopy in breastfed infants. Clinical and Experimental Allergy2004;34(2):194‐200; Erratum in: Clinical &amp; Experimental Allergy 2007; 37(12);1895. [PUBMED: 14987297] ThomsonJA , WidjajaC , DarmaputraAA , LoweA , MathesonMC , BennettCM , et al. Early childhood infections and immunisation and the development of allergic disease in particular asthma in a high‐risk cohort: a prospective study of allergy‐prone children from birth to six years. Pediatric Allergy and Immunology2010;21(7):1076‐85. [DOI: 10.1111/j.1399‐3038.2010.01018.x; PUBMED: 20337970] ">Hill 2000</a> ‐ 7.3% at two years and 20% at six to seven years; <a href="./references#CD003664-bbs2-0005" title="JuvonenP , ManssonM , AnderssonC , JakobssonI . Allergy development and macromolecular absorption in infants with different feeding regimens during the first three days of life. A three‐year prospective follow‐up. Acta Paediatrica1996;85(9):1047‐52. [PUBMED: 8888916] JuvonenP , ManssonM , JakobssonI . Does early diet have an effect on subsequent macromolecular absorption and serum IgE?. Journal of Pediatric Gastroenterology and Nutrition1994;18(3):344‐9. [PUBMED: 8057219] JuvonenP , ManssonM , KjellmanNI , BjorkstenB , JakobssonI . Development of immunoglobulin G and immunoglobulin E antibodies to cow's milk proteins and ovalbumin after a temporary neonatal exposure to hydrolyzed and whole cow's milk proteins. Pediatric Allergy and Immunology1999;10(3):191‐8. [PUBMED: 10565560] ">Juvonen 1996</a> ‐ 10% at three years; <a href="./references#CD003664-bbs2-0006" title="KwintaP , SawiecP , KlimekM , LisG , Cichocka‐JaroszE , PietrzykJJ . Correlation between early neonatal diet and atopic symptoms up to 5‐7 years of age in very low birth weight infants: follow‐up of randomized, double‐blind study. Pediatric Allergy and Immunology2009;20(5):458‐66. [DOI: 10.1111/j.1399‐3038.2008.00814.x; PUBMED: 19490477] ">Kwinta 2009</a> ‐ 16% at five to seven years; <a href="./references#CD003664-bbs2-0007" title="LamBC , YeungCY . The effect of breast milk, infant formula and hypoallergenic formula on incidence of atopic manifestation in high risk infants. Nestle Internal Report1992. ">Lam 1992</a> ‐ 8% at six months; <a href="./references#CD003664-bbs2-0008" title="MalletE , HenocqA . Long‐term prevention of allergic diseases by using protein hydrolysate formula in at‐risk infants. Journal of Pediatrics1992;121(5 Pt 2):S95‐100. [PUBMED: 1447641] ">Mallet 1992</a> ‐ 5% to 8% at four months but &gt; 20% at one to four years; <a href="./references#CD003664-bbs2-0009" title="MariniA , AgostiM , MottaG , MoscaF . Effects of a dietary and environmental prevention programme on the incidence of allergic symptoms in high atopic risk infants: three years' follow‐up. Acta Paediatrica Supplement1996;414:1‐21. [PUBMED: 8831855] ">Marini 1996</a> ‐ 13% at two years and 19% at three years; <a href="./references#CD003664-bbs2-0010" title="NentwichI , MichkovaE , NevoralJ , UrbanekR , SzepfalusiZ . Cow's milk‐specific cellular and humoral immune responses and atopy skin symptoms in infants from atopic families fed a partially (pHF) or extensively (eHF) hydrolyzed infant formula. Allergy2001;56(12):1144‐56. [PUBMED: 11736743] ">Nentwich 2001</a> ‐ 19% at 12 months; <a href="./references#CD003664-bbs2-0011" title="OldaeusG , AnjouK , BjorkstenB , MoranJR , KjellmanNI . Extensively and partially hydrolysed infant formulas for allergy prophylaxis. Archives of Disease in Childhood1997;77(1):4‐10. [PUBMED: 9279143] OldaeusG , BjorkstenB , JenmalmMC , KjellmanNI . Cow's milk IgE and IgG antibody responses to cow's milk formulas. Allergy1999;54(4):352‐7. [PUBMED: 10371094] ">Oldaeus 1997</a> ‐ 9% at 18 months; <a href="./references#CD003664-bbs2-0012" title="SaarinenKM , Juntunen‐BackmanK , JarvenpaaAL , KlemettiP , KuitunenP , LopeL , et al. Breast‐feeding and the development of cows' milk protein allergy. Advances in Experimental Medicine and Biology2000;478:121‐30. [DOI: 10.1007/0‐306‐46830‐1_10; PUBMED: 11065065] SaarinenKM , Juntunen‐BackmanK , JarvenpaaAL , KuitunenP , LopeL , RenlundM , et al. Supplementary feeding in maternity hospitals and the risk of cow's milk allergy: a prospective study of 6209 infants. Journal of Allergy and Clinical Immunology1999;104(2 Pt 1):457‐61. [PUBMED: 10452771] SaarinenKM , SavilahtiE . Infant feeding patterns affect the subsequent immunological features in cow's milk allergy. Clinical and Experimental Allergy2000;30(3):400‐6. [DOI: 10691899] SaarinenKM , SuomalainenH , SavilahtiE . Diagnostic value of skin‐prick and patch tests and serum eosinophil cationic protein and cow's milk‐specific IgE in infants with cow's milk allergy. Clinical and Experimental Allergy2001;31(3):423‐9. [PUBMED: 11260154] SaarinenKM , VaaralaO , KlemettiP , SavilahtiE . Transforming growth factor‐beta1 in mothers' colostrum and immune responses to cows' milk proteins in infants with cows' milk allergy. Journal of Allergy and Clinical Immunology1999;104(5):1093‐8. [PUBMED: 10550758] SavilahtiE , SaarinenKM . Early infant feeding and type 1 diabetes. European Journal of Nutrition2009;48(4):243‐9. [DOI: 10.1007/s00394‐009‐0008‐z; PUBMED: 19263185] SavilahtiEM , SaarinenKM , SavilahtiE . Specific antibodies to cow's milk proteins in infants: effect of early feeding and diagnosis of cow's milk allergy. European Journal of Nutrition2010;49(8):501‐4. [DOI: 10.1007/s00394‐010‐0109‐8; PUBMED: 20405136] SiltanenM , KajosaariM , PoussaT , SaarinenKM , SavilahtiE . A dual long‐term effect of breastfeeding on atopy in relation to heredity in children at 4 years of age. Allergy2003;58(6):524‐30. [PUBMED: 12757455] ">Saarinen 1999</a> ‐ unclear, although all infants were reported to be seen routinely in well‐baby clinics; <a href="./references#CD003664-bbs2-0013" title="TsaiYT , ChouCC , HsiehKH . The effect of hypoallergenic formula on the occurrence of allergic diseases in high risk infants. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi1991;32(3):137‐44. [PUBMED: 1776437] ">Tsai 1991</a> ‐ 9% at 12 months; <a href="./references#CD003664-bbs2-0014" title="VandenplasY . Atopy at 3 years in high‐risk infants fed whey hydrolysate or conventional formula. Lancet1992;339(8801):1118. [PUBMED: 1349137] VandenplasY , HauserB , Van denBorreC , ClybouwC , MahlerT , Hachimi‐IdrissiS , et al. The long‐term effect of a partial whey hydrolysate formula on the prophylaxis of atopic disease. European Journal of Pediatrics1995;154(6):488‐94. [PUBMED: 7671948] VandenplasY , HauserB , Van denBorreC , SacreL , DabI . Effect of a whey hydrolysate prophylaxis of atopic disease. Annals of Allergy1992;68(5):419‐24. [PUBMED: 1586005] ">Vandenplas 1992</a> ‐ 11% at 12 months and &gt; 20% at three and five years; <a href="./references#CD003664-bbs2-0015" title="BergA , KramerU , LinkE , BollrathC , HeinrichJ , BrockowI , et al. GINIplus study group. Impact of early feeding on childhood eczema: development after nutritional intervention compared with the natural course ‐ the GINIplus study up to the age of 6 years. Clinical and Experimental Allergy2010;40(4):627‐36. [DOI: 10.1111/j.1365‐2222.2009.03444.x; PUBMED: 20082618] BrockowI , ZutavernA , HoffmannU , GrublA , vonBergA , KoletzkoS , et al. GINIplus Study Group. Early allergic sensitizations and their relevance to atopic diseases in children aged 6 years: results of the GINI study. Journal of Investigational Allergology &amp; Clinical Immunology2009;19(3):180‐7. [DOI: 19610260] LaubereauB , BrockowI , ZirngiblA , KoletzkoS , GrueblA , vonBergA , et al. GINI Study Group. Effect of breast‐feeding on the development of atopic dermatitis during the first 3 years of life ‐ results from the GINI‐birth cohort study. Journal of Pediatrics2004;144(5):602‐7. [DOI: 10.1016/j.jpeds.2003.12.029; PUBMED: 15126993] LaubereauB , Filipiak‐PittroffB , vonBergA , GrublA , ReinhardtD , WichmannHE , et al. Caesarean section and gastrointestinal symptoms, atopic dermatitis, and sensitisation during the first year of life. Archives of Disease in Childhood2004;89(11):993‐7. [DOI: 10.1136/adc.2003.043265; PUBMED: 15499049] RzehakP , SausenthalerS , KoletzkoS , BauerCP , SchaafB , vonBergA , et al. Period‐specific growth, overweight and modification by breastfeeding in the GINI and LISA birth cohorts up to age 6 years. European Journal of Epidemiology2009;24(8):449‐67. [DOI: 10.1007/s10654‐009‐9356‐5; PUBMED: 19521784] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. GINI‐plus Study Group. Long‐term effects of hydrolyzed protein infant formulas on growth ‐ extended follow‐up to 10 y of age: results from the German Infant Nutritional Intervention (GINI) study. American Journal of Clinical Nutrition2011;94(6 Suppl):1803S‐7S. [DOI: 10.3945/ajcn.110.000679; PUBMED: 21849601] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. German Infant Nutritional Intervention Study Group. Short‐ and long‐term effects of feeding hydrolyzed protein infant formulas on growth at &lt; or = 6 y of age: results from the German Infant Nutritional Intervention Study. American Journal of Clinical Nutrition2009;89(6):1846‐56. [DOI: 10.3945/ajcn.2008.27373; PUBMED: 19369380] SausenthalerS , KoletzkoS , KoletzkoB , ReinhardtD , KramerU , vonBergA , et al. GINIplus study group. Effect of hydrolysed formula feeding on taste preferences at 10 years. Data from the German Infant Nutritional Intervention Program Plus Study. Clinical Nutrition2010;29(3):304‐6. [DOI: 10.1016/j.clnu.2010.01.007; PUBMED: 20110140] SchoetzauA , Filipiak‐PittroffB , FrankeK , KoletzkoS , VonBergA , GrueblA , et al. German Infant Nutritional Intervention Study Group. Effect of exclusive breast‐feeding and early solid food avoidance on the incidence of atopic dermatitis in high‐risk infants at 1 year of age. Pediatric Allergy and Immunology2002;13(4):234‐42. [PUBMED: 12390439] SchoetzauA , GehringU , FrankeK , GrublA , KoletzkoS , vonBergA , et al. Gini Study Group. Maternal compliance with nutritional recommendations in an allergy preventive programme. Archives of Disease in Childhood2002;86(3):180‐4. [PUBMED: 11861235] VonBergA , Filipiak‐PittroffB , KrämerU , LinkE , HeinrichJ , KoletzkoS , et al. The German Infant Nutritional Intervention Study (GINI) for the preventive effect of hydrolysed infant formulas in infants at high risk for allergic diseases. Design and selected results. Allergologie2012;35(1):32‐43. VonBergA , Filipiak‐PittroffB , SchulzH , HoffmannU , LinkE , SussmannM , et al. GINIplus study group. Allergic manifestation 15 years after early intervention with hydrolyzed formulas ‐ the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2016;71(2):210‐9. [DOI: 10.1111/all.12790; PUBMED: 26465137] vonBergA , FilipiakB , KoletzkoS , KrämerU , HoffmannB , LinkE , et al. Long‐term effect of cow milk protein hydrolysates in high‐risk children. Results from the 10‐years follow‐up of the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2013;68:295‐6. vonBergA , Filipiak‐PittroffB , KramerU , HoffmannB , LinkE , BeckmannC , et al. GINIplus study group. Allergies in high‐risk schoolchildren after early intervention with cow's milk protein hydrolysates: 10‐year results from the German Infant Nutritional Intervention (GINI) study. Journal of Allergy and Clinical Immunology2013;131(6):1565‐73. [DOI: 10.1016/j.jaci.2013.01.006; PUBMED: 23506844] vonBergA , Filipiak‐PittroffB , KramerU , LinkE , BollrathC , BrockowI , et al. GINIplus study group. Preventive effect of hydrolyzed infant formulas persists until age 6 years: long‐term results from the German Infant Nutritional Intervention Study (GINI). Journal of Allergy and Clinical Immunology2008;121(6):1442‐7. [DOI: 10.1016/j.jaci.2008.04.021; PUBMED: 18539195] vonBergA , KoletzkoS , Filipiak‐PittroffB , LaubereauB , GrublA , WichmannHE , et al. German Infant Nutritional Intervention Study Group. Certain hydrolyzed formulas reduce the incidence of atopic dermatitis but not that of asthma: three‐year results of the German Infant Nutritional Intervention Study. Journal of Allergy and Clinical Immunology2007;119(3):718‐25. [DOI: 10.1016/j.jaci.2006.11.017; PUBMED: 17240440] vonBergA , KoletzkoS , GrublA , Filipiak‐PittroffB , WichmannHE , BauerCP , et al. German Infant Nutritional Intervention Study Group. The effect of hydrolyzed cow's milk formula for allergy prevention in the first year of life: the German Infant Nutritional Intervention Study, a randomized double‐blind trial. Journal of Allergy and Clinical Immunology2003;111(3):533‐40. [PUBMED: 12642834] ">von Berg 2003</a> ‐ for infants born in Wesel: 14.5% at one year and 19% at three years (all other analyses and time points &gt; 20%); and <a href="./references#CD003664-bbs2-0016" title="WillemsR , DuchateauJ , MagrezP , DenisR , CasimirG . Influence of hypoallergenic milk formula on the incidence of early allergic manifestations in infants predisposed to atopic diseases. Annals of Allergy1993;71(2):147‐50. [PUBMED: 8346868] ">Willems 1993</a> ‐ 13% at one year. </p> <p>Studies with &lt; 10% loss to follow‐up included <a href="./references#CD003664-bbs2-0002" title="deSetaL , SianiP , CirilloG , DiGruttolaM , CimaduomoL , ColettaS . The prevention of allergic diseases with a hypoallergenic formula: a follow‐up at 24 months. The preliminary results. [Italian]. La Pediatria Medica e Chirurgica: Medical and Surgical Pediatrics1994;16(3):251‐4. [PUBMED: 7971447] ">de Seta 1994</a> ‐ none reported, <a href="./references#CD003664-bbs2-0004" title="HillD . A report on the analysis of the Melbourne Atopy Cohort Study. A study designed to test the effectiveness of different formula types on the development of atopic symptoms and signs on a cohort of atopy‐at‐risk infants. Report at year 2. Nestec Internal Report. HillDJ , SporikR , ThorburnJ , HoskingCS . The association of atopic dermatitis in infancy with immunoglobulin E food sensitization. Journal of Pediatrics2000;137(4):475‐9. [DOI: 10.1067/mpd.2000.108207; PUBMED: 11035824] KoplinJ , DharmageSC , GurrinL , OsborneN , TangML , LoweAJ , et al. Soy consumption is not a risk factor for peanut sensitization. Journal of Allergy and Clinical Immunology2008;121(6):1455‐9. [DOI: 10.1016/j.jaci.2008.03.017; PUBMED: 18436294] LoweA , HoskingC , BennettC , AllenK , CarlinJ , DharmageS , et al. The Melbourne Atopy Cohort Study: a RCT of a partially hydrolysed whey formula for the prevention of allergic disease. Internal Medicine Journal2008;38:A158. LoweAJ , AbramsonMJ , HoskingCS , CarlinJB , BennettCM , DharmageSC , et al. The temporal sequence of allergic sensitization and onset of infantile eczema. Clinical &amp; Experimental Allergy2007;37(4):536‐42; Erratum in: Clinical &amp; Experimental Allergy 2007; 37(12);1895. [DOI: 10.1111/j.1365‐2222.2007.02691.x; PUBMED: 17430350] LoweAJ , CarlinJB , BennettCM , HoskingCS , AllenKJ , RobertsonCF , et al. Paracetamol use in early life and asthma: prospective birth cohort study. BMJ2010;341:c4616. [PUBMED: 20843914] LoweAJ , HoskingCS , BennettCM , AllenKJ , AxelradC , CarlinJB , et al. Effect of a partially hydrolyzed whey infant formula at weaning on risk of allergic disease in high‐risk children: a randomized controlled trial. Journal of Allergy and Clinical Immunology2011;128(2):360‐5.e4. [DOI: 10.1016/j.jaci.2010.05.006; PUBMED: 21696814] StoneyRM , WoodsRK , HoskingCS , HillDJ , AbramsonMJ , ThienFC . Maternal breast milk long‐chain n‐3 fatty acids are associated with increased risk of atopy in breastfed infants. Clinical and Experimental Allergy2004;34(2):194‐200; Erratum in: Clinical &amp; Experimental Allergy 2007; 37(12);1895. [PUBMED: 14987297] ThomsonJA , WidjajaC , DarmaputraAA , LoweA , MathesonMC , BennettCM , et al. Early childhood infections and immunisation and the development of allergic disease in particular asthma in a high‐risk cohort: a prospective study of allergy‐prone children from birth to six years. Pediatric Allergy and Immunology2010;21(7):1076‐85. [DOI: 10.1111/j.1399‐3038.2010.01018.x; PUBMED: 20337970] ">Hill 2000</a> ‐ 7.3% at two years, <a href="./references#CD003664-bbs2-0007" title="LamBC , YeungCY . The effect of breast milk, infant formula and hypoallergenic formula on incidence of atopic manifestation in high risk infants. Nestle Internal Report1992. ">Lam 1992</a> ‐ 8% at six months, <a href="./references#CD003664-bbs2-0008" title="MalletE , HenocqA . Long‐term prevention of allergic diseases by using protein hydrolysate formula in at‐risk infants. Journal of Pediatrics1992;121(5 Pt 2):S95‐100. [PUBMED: 1447641] ">Mallet 1992</a> ‐ 5% to 8% at four months, <a href="./references#CD003664-bbs2-0011" title="OldaeusG , AnjouK , BjorkstenB , MoranJR , KjellmanNI . Extensively and partially hydrolysed infant formulas for allergy prophylaxis. Archives of Disease in Childhood1997;77(1):4‐10. [PUBMED: 9279143] OldaeusG , BjorkstenB , JenmalmMC , KjellmanNI . Cow's milk IgE and IgG antibody responses to cow's milk formulas. Allergy1999;54(4):352‐7. [PUBMED: 10371094] ">Oldaeus 1997</a> ‐ 9% at 18 months and <a href="./references#CD003664-bbs2-0013" title="TsaiYT , ChouCC , HsiehKH . The effect of hypoallergenic formula on the occurrence of allergic diseases in high risk infants. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi1991;32(3):137‐44. [PUBMED: 1776437] ">Tsai 1991</a> ‐ 9% at 12 months. </p> </section> <section id="CD003664-sec-0101"> <h4 class="title">Selective reporting</h4> <p>Eight studies were at 'low risk' of reporting bias with prespecified primary outcomes reported (<a href="./references#CD003664-bbs2-0002" title="deSetaL , SianiP , CirilloG , DiGruttolaM , CimaduomoL , ColettaS . The prevention of allergic diseases with a hypoallergenic formula: a follow‐up at 24 months. The preliminary results. [Italian]. La Pediatria Medica e Chirurgica: Medical and Surgical Pediatrics1994;16(3):251‐4. [PUBMED: 7971447] ">de Seta 1994</a>; <a href="./references#CD003664-bbs2-0004" title="HillD . A report on the analysis of the Melbourne Atopy Cohort Study. A study designed to test the effectiveness of different formula types on the development of atopic symptoms and signs on a cohort of atopy‐at‐risk infants. Report at year 2. Nestec Internal Report. HillDJ , SporikR , ThorburnJ , HoskingCS . The association of atopic dermatitis in infancy with immunoglobulin E food sensitization. Journal of Pediatrics2000;137(4):475‐9. [DOI: 10.1067/mpd.2000.108207; PUBMED: 11035824] KoplinJ , DharmageSC , GurrinL , OsborneN , TangML , LoweAJ , et al. Soy consumption is not a risk factor for peanut sensitization. Journal of Allergy and Clinical Immunology2008;121(6):1455‐9. [DOI: 10.1016/j.jaci.2008.03.017; PUBMED: 18436294] LoweA , HoskingC , BennettC , AllenK , CarlinJ , DharmageS , et al. The Melbourne Atopy Cohort Study: a RCT of a partially hydrolysed whey formula for the prevention of allergic disease. Internal Medicine Journal2008;38:A158. LoweAJ , AbramsonMJ , HoskingCS , CarlinJB , BennettCM , DharmageSC , et al. The temporal sequence of allergic sensitization and onset of infantile eczema. Clinical &amp; Experimental Allergy2007;37(4):536‐42; Erratum in: Clinical &amp; Experimental Allergy 2007; 37(12);1895. [DOI: 10.1111/j.1365‐2222.2007.02691.x; PUBMED: 17430350] LoweAJ , CarlinJB , BennettCM , HoskingCS , AllenKJ , RobertsonCF , et al. Paracetamol use in early life and asthma: prospective birth cohort study. BMJ2010;341:c4616. [PUBMED: 20843914] LoweAJ , HoskingCS , BennettCM , AllenKJ , AxelradC , CarlinJB , et al. Effect of a partially hydrolyzed whey infant formula at weaning on risk of allergic disease in high‐risk children: a randomized controlled trial. Journal of Allergy and Clinical Immunology2011;128(2):360‐5.e4. [DOI: 10.1016/j.jaci.2010.05.006; PUBMED: 21696814] StoneyRM , WoodsRK , HoskingCS , HillDJ , AbramsonMJ , ThienFC . Maternal breast milk long‐chain n‐3 fatty acids are associated with increased risk of atopy in breastfed infants. Clinical and Experimental Allergy2004;34(2):194‐200; Erratum in: Clinical &amp; Experimental Allergy 2007; 37(12);1895. [PUBMED: 14987297] ThomsonJA , WidjajaC , DarmaputraAA , LoweA , MathesonMC , BennettCM , et al. Early childhood infections and immunisation and the development of allergic disease in particular asthma in a high‐risk cohort: a prospective study of allergy‐prone children from birth to six years. Pediatric Allergy and Immunology2010;21(7):1076‐85. [DOI: 10.1111/j.1399‐3038.2010.01018.x; PUBMED: 20337970] ">Hill 2000</a>; <a href="./references#CD003664-bbs2-0009" title="MariniA , AgostiM , MottaG , MoscaF . Effects of a dietary and environmental prevention programme on the incidence of allergic symptoms in high atopic risk infants: three years' follow‐up. Acta Paediatrica Supplement1996;414:1‐21. [PUBMED: 8831855] ">Marini 1996</a>; <a href="./references#CD003664-bbs2-0010" title="NentwichI , MichkovaE , NevoralJ , UrbanekR , SzepfalusiZ . Cow's milk‐specific cellular and humoral immune responses and atopy skin symptoms in infants from atopic families fed a partially (pHF) or extensively (eHF) hydrolyzed infant formula. Allergy2001;56(12):1144‐56. [PUBMED: 11736743] ">Nentwich 2001</a>; <a href="./references#CD003664-bbs2-0011" title="OldaeusG , AnjouK , BjorkstenB , MoranJR , KjellmanNI . Extensively and partially hydrolysed infant formulas for allergy prophylaxis. Archives of Disease in Childhood1997;77(1):4‐10. [PUBMED: 9279143] OldaeusG , BjorkstenB , JenmalmMC , KjellmanNI . Cow's milk IgE and IgG antibody responses to cow's milk formulas. Allergy1999;54(4):352‐7. [PUBMED: 10371094] ">Oldaeus 1997</a>; <a href="./references#CD003664-bbs2-0012" title="SaarinenKM , Juntunen‐BackmanK , JarvenpaaAL , KlemettiP , KuitunenP , LopeL , et al. Breast‐feeding and the development of cows' milk protein allergy. Advances in Experimental Medicine and Biology2000;478:121‐30. [DOI: 10.1007/0‐306‐46830‐1_10; PUBMED: 11065065] SaarinenKM , Juntunen‐BackmanK , JarvenpaaAL , KuitunenP , LopeL , RenlundM , et al. Supplementary feeding in maternity hospitals and the risk of cow's milk allergy: a prospective study of 6209 infants. Journal of Allergy and Clinical Immunology1999;104(2 Pt 1):457‐61. [PUBMED: 10452771] SaarinenKM , SavilahtiE . Infant feeding patterns affect the subsequent immunological features in cow's milk allergy. Clinical and Experimental Allergy2000;30(3):400‐6. [DOI: 10691899] SaarinenKM , SuomalainenH , SavilahtiE . Diagnostic value of skin‐prick and patch tests and serum eosinophil cationic protein and cow's milk‐specific IgE in infants with cow's milk allergy. Clinical and Experimental Allergy2001;31(3):423‐9. [PUBMED: 11260154] SaarinenKM , VaaralaO , KlemettiP , SavilahtiE . Transforming growth factor‐beta1 in mothers' colostrum and immune responses to cows' milk proteins in infants with cows' milk allergy. Journal of Allergy and Clinical Immunology1999;104(5):1093‐8. [PUBMED: 10550758] SavilahtiE , SaarinenKM . Early infant feeding and type 1 diabetes. European Journal of Nutrition2009;48(4):243‐9. [DOI: 10.1007/s00394‐009‐0008‐z; PUBMED: 19263185] SavilahtiEM , SaarinenKM , SavilahtiE . Specific antibodies to cow's milk proteins in infants: effect of early feeding and diagnosis of cow's milk allergy. European Journal of Nutrition2010;49(8):501‐4. [DOI: 10.1007/s00394‐010‐0109‐8; PUBMED: 20405136] SiltanenM , KajosaariM , PoussaT , SaarinenKM , SavilahtiE . A dual long‐term effect of breastfeeding on atopy in relation to heredity in children at 4 years of age. Allergy2003;58(6):524‐30. [PUBMED: 12757455] ">Saarinen 1999</a>; <a href="./references#CD003664-bbs2-0015" title="BergA , KramerU , LinkE , BollrathC , HeinrichJ , BrockowI , et al. GINIplus study group. Impact of early feeding on childhood eczema: development after nutritional intervention compared with the natural course ‐ the GINIplus study up to the age of 6 years. Clinical and Experimental Allergy2010;40(4):627‐36. [DOI: 10.1111/j.1365‐2222.2009.03444.x; PUBMED: 20082618] BrockowI , ZutavernA , HoffmannU , GrublA , vonBergA , KoletzkoS , et al. GINIplus Study Group. Early allergic sensitizations and their relevance to atopic diseases in children aged 6 years: results of the GINI study. Journal of Investigational Allergology &amp; Clinical Immunology2009;19(3):180‐7. [DOI: 19610260] LaubereauB , BrockowI , ZirngiblA , KoletzkoS , GrueblA , vonBergA , et al. GINI Study Group. Effect of breast‐feeding on the development of atopic dermatitis during the first 3 years of life ‐ results from the GINI‐birth cohort study. Journal of Pediatrics2004;144(5):602‐7. [DOI: 10.1016/j.jpeds.2003.12.029; PUBMED: 15126993] LaubereauB , Filipiak‐PittroffB , vonBergA , GrublA , ReinhardtD , WichmannHE , et al. Caesarean section and gastrointestinal symptoms, atopic dermatitis, and sensitisation during the first year of life. Archives of Disease in Childhood2004;89(11):993‐7. [DOI: 10.1136/adc.2003.043265; PUBMED: 15499049] RzehakP , SausenthalerS , KoletzkoS , BauerCP , SchaafB , vonBergA , et al. Period‐specific growth, overweight and modification by breastfeeding in the GINI and LISA birth cohorts up to age 6 years. European Journal of Epidemiology2009;24(8):449‐67. [DOI: 10.1007/s10654‐009‐9356‐5; PUBMED: 19521784] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. GINI‐plus Study Group. Long‐term effects of hydrolyzed protein infant formulas on growth ‐ extended follow‐up to 10 y of age: results from the German Infant Nutritional Intervention (GINI) study. American Journal of Clinical Nutrition2011;94(6 Suppl):1803S‐7S. [DOI: 10.3945/ajcn.110.000679; PUBMED: 21849601] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. German Infant Nutritional Intervention Study Group. Short‐ and long‐term effects of feeding hydrolyzed protein infant formulas on growth at &lt; or = 6 y of age: results from the German Infant Nutritional Intervention Study. American Journal of Clinical Nutrition2009;89(6):1846‐56. [DOI: 10.3945/ajcn.2008.27373; PUBMED: 19369380] SausenthalerS , KoletzkoS , KoletzkoB , ReinhardtD , KramerU , vonBergA , et al. GINIplus study group. Effect of hydrolysed formula feeding on taste preferences at 10 years. Data from the German Infant Nutritional Intervention Program Plus Study. Clinical Nutrition2010;29(3):304‐6. [DOI: 10.1016/j.clnu.2010.01.007; PUBMED: 20110140] SchoetzauA , Filipiak‐PittroffB , FrankeK , KoletzkoS , VonBergA , GrueblA , et al. German Infant Nutritional Intervention Study Group. Effect of exclusive breast‐feeding and early solid food avoidance on the incidence of atopic dermatitis in high‐risk infants at 1 year of age. Pediatric Allergy and Immunology2002;13(4):234‐42. [PUBMED: 12390439] SchoetzauA , GehringU , FrankeK , GrublA , KoletzkoS , vonBergA , et al. Gini Study Group. Maternal compliance with nutritional recommendations in an allergy preventive programme. Archives of Disease in Childhood2002;86(3):180‐4. [PUBMED: 11861235] VonBergA , Filipiak‐PittroffB , KrämerU , LinkE , HeinrichJ , KoletzkoS , et al. The German Infant Nutritional Intervention Study (GINI) for the preventive effect of hydrolysed infant formulas in infants at high risk for allergic diseases. Design and selected results. Allergologie2012;35(1):32‐43. VonBergA , Filipiak‐PittroffB , SchulzH , HoffmannU , LinkE , SussmannM , et al. GINIplus study group. Allergic manifestation 15 years after early intervention with hydrolyzed formulas ‐ the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2016;71(2):210‐9. [DOI: 10.1111/all.12790; PUBMED: 26465137] vonBergA , FilipiakB , KoletzkoS , KrämerU , HoffmannB , LinkE , et al. Long‐term effect of cow milk protein hydrolysates in high‐risk children. Results from the 10‐years follow‐up of the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2013;68:295‐6. vonBergA , Filipiak‐PittroffB , KramerU , HoffmannB , LinkE , BeckmannC , et al. GINIplus study group. Allergies in high‐risk schoolchildren after early intervention with cow's milk protein hydrolysates: 10‐year results from the German Infant Nutritional Intervention (GINI) study. Journal of Allergy and Clinical Immunology2013;131(6):1565‐73. [DOI: 10.1016/j.jaci.2013.01.006; PUBMED: 23506844] vonBergA , Filipiak‐PittroffB , KramerU , LinkE , BollrathC , BrockowI , et al. GINIplus study group. Preventive effect of hydrolyzed infant formulas persists until age 6 years: long‐term results from the German Infant Nutritional Intervention Study (GINI). Journal of Allergy and Clinical Immunology2008;121(6):1442‐7. [DOI: 10.1016/j.jaci.2008.04.021; PUBMED: 18539195] vonBergA , KoletzkoS , Filipiak‐PittroffB , LaubereauB , GrublA , WichmannHE , et al. German Infant Nutritional Intervention Study Group. Certain hydrolyzed formulas reduce the incidence of atopic dermatitis but not that of asthma: three‐year results of the German Infant Nutritional Intervention Study. Journal of Allergy and Clinical Immunology2007;119(3):718‐25. [DOI: 10.1016/j.jaci.2006.11.017; PUBMED: 17240440] vonBergA , KoletzkoS , GrublA , Filipiak‐PittroffB , WichmannHE , BauerCP , et al. German Infant Nutritional Intervention Study Group. The effect of hydrolyzed cow's milk formula for allergy prevention in the first year of life: the German Infant Nutritional Intervention Study, a randomized double‐blind trial. Journal of Allergy and Clinical Immunology2003;111(3):533‐40. [PUBMED: 12642834] ">von Berg 2003</a>; <a href="./references#CD003664-bbs2-0016" title="WillemsR , DuchateauJ , MagrezP , DenisR , CasimirG . Influence of hypoallergenic milk formula on the incidence of early allergic manifestations in infants predisposed to atopic diseases. Annals of Allergy1993;71(2):147‐50. [PUBMED: 8346868] ">Willems 1993</a>). We assessed five studies as being at 'unclear' risk of reporting bias (<a href="./references#CD003664-bbs2-0001" title="ChiricoG , GasparoniA , CiardelliL , DeAmiciM , ColomboA , RondiniG . Immunogenicity and antigenicity of a partially hydrolyzed cow's milk infant formula. Allergy1997;52(1):82‐8. [PUBMED: 9062633] ">Chirico 1997</a>; <a href="./references#CD003664-bbs2-0005" title="JuvonenP , ManssonM , AnderssonC , JakobssonI . Allergy development and macromolecular absorption in infants with different feeding regimens during the first three days of life. A three‐year prospective follow‐up. Acta Paediatrica1996;85(9):1047‐52. [PUBMED: 8888916] JuvonenP , ManssonM , JakobssonI . Does early diet have an effect on subsequent macromolecular absorption and serum IgE?. Journal of Pediatric Gastroenterology and Nutrition1994;18(3):344‐9. [PUBMED: 8057219] JuvonenP , ManssonM , KjellmanNI , BjorkstenB , JakobssonI . Development of immunoglobulin G and immunoglobulin E antibodies to cow's milk proteins and ovalbumin after a temporary neonatal exposure to hydrolyzed and whole cow's milk proteins. Pediatric Allergy and Immunology1999;10(3):191‐8. [PUBMED: 10565560] ">Juvonen 1996</a>; <a href="./references#CD003664-bbs2-0007" title="LamBC , YeungCY . The effect of breast milk, infant formula and hypoallergenic formula on incidence of atopic manifestation in high risk infants. Nestle Internal Report1992. ">Lam 1992</a>; <a href="./references#CD003664-bbs2-0013" title="TsaiYT , ChouCC , HsiehKH . The effect of hypoallergenic formula on the occurrence of allergic diseases in high risk infants. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi1991;32(3):137‐44. [PUBMED: 1776437] ">Tsai 1991</a>; <a href="./references#CD003664-bbs2-0014" title="VandenplasY . Atopy at 3 years in high‐risk infants fed whey hydrolysate or conventional formula. Lancet1992;339(8801):1118. [PUBMED: 1349137] VandenplasY , HauserB , Van denBorreC , ClybouwC , MahlerT , Hachimi‐IdrissiS , et al. The long‐term effect of a partial whey hydrolysate formula on the prophylaxis of atopic disease. European Journal of Pediatrics1995;154(6):488‐94. [PUBMED: 7671948] VandenplasY , HauserB , Van denBorreC , SacreL , DabI . Effect of a whey hydrolysate prophylaxis of atopic disease. Annals of Allergy1992;68(5):419‐24. [PUBMED: 1586005] ">Vandenplas 1992</a>), and three as being at 'high risk' (<a href="./references#CD003664-bbs2-0003" title="HalkenS , HansenKS , JacobsenHP , EstmannA , FaellingAE , HansenLG , et al. Comparison of a partially hydrolyzed infant formula with two extensively hydrolyzed formulas for allergy prevention: a prospective, randomized study. Pediatric Allergy and Immunology2000;11(3):149‐61. [PUBMED: 10981524] ">Halken 2000</a>; <a href="./references#CD003664-bbs2-0006" title="KwintaP , SawiecP , KlimekM , LisG , Cichocka‐JaroszE , PietrzykJJ . Correlation between early neonatal diet and atopic symptoms up to 5‐7 years of age in very low birth weight infants: follow‐up of randomized, double‐blind study. Pediatric Allergy and Immunology2009;20(5):458‐66. [DOI: 10.1111/j.1399‐3038.2008.00814.x; PUBMED: 19490477] ">Kwinta 2009</a>; <a href="./references#CD003664-bbs2-0008" title="MalletE , HenocqA . Long‐term prevention of allergic diseases by using protein hydrolysate formula in at‐risk infants. Journal of Pediatrics1992;121(5 Pt 2):S95‐100. [PUBMED: 1447641] ">Mallet 1992</a>). </p> </section> <section id="CD003664-sec-0102"> <h4 class="title">Other potential sources of bias</h4> <p>Six studies had imbalances between groups after randomisation, so we considered them to be at 'high risk' of bias (<a href="./references#CD003664-bbs2-0001" title="ChiricoG , GasparoniA , CiardelliL , DeAmiciM , ColomboA , RondiniG . Immunogenicity and antigenicity of a partially hydrolyzed cow's milk infant formula. Allergy1997;52(1):82‐8. [PUBMED: 9062633] ">Chirico 1997</a>; <a href="./references#CD003664-bbs2-0002" title="deSetaL , SianiP , CirilloG , DiGruttolaM , CimaduomoL , ColettaS . The prevention of allergic diseases with a hypoallergenic formula: a follow‐up at 24 months. The preliminary results. [Italian]. La Pediatria Medica e Chirurgica: Medical and Surgical Pediatrics1994;16(3):251‐4. [PUBMED: 7971447] ">de Seta 1994</a>; <a href="./references#CD003664-bbs2-0003" title="HalkenS , HansenKS , JacobsenHP , EstmannA , FaellingAE , HansenLG , et al. Comparison of a partially hydrolyzed infant formula with two extensively hydrolyzed formulas for allergy prevention: a prospective, randomized study. Pediatric Allergy and Immunology2000;11(3):149‐61. [PUBMED: 10981524] ">Halken 2000</a>; <a href="./references#CD003664-bbs2-0005" title="JuvonenP , ManssonM , AnderssonC , JakobssonI . Allergy development and macromolecular absorption in infants with different feeding regimens during the first three days of life. A three‐year prospective follow‐up. Acta Paediatrica1996;85(9):1047‐52. [PUBMED: 8888916] JuvonenP , ManssonM , JakobssonI . Does early diet have an effect on subsequent macromolecular absorption and serum IgE?. Journal of Pediatric Gastroenterology and Nutrition1994;18(3):344‐9. [PUBMED: 8057219] JuvonenP , ManssonM , KjellmanNI , BjorkstenB , JakobssonI . Development of immunoglobulin G and immunoglobulin E antibodies to cow's milk proteins and ovalbumin after a temporary neonatal exposure to hydrolyzed and whole cow's milk proteins. Pediatric Allergy and Immunology1999;10(3):191‐8. [PUBMED: 10565560] ">Juvonen 1996</a>; <a href="./references#CD003664-bbs2-0010" title="NentwichI , MichkovaE , NevoralJ , UrbanekR , SzepfalusiZ . Cow's milk‐specific cellular and humoral immune responses and atopy skin symptoms in infants from atopic families fed a partially (pHF) or extensively (eHF) hydrolyzed infant formula. Allergy2001;56(12):1144‐56. [PUBMED: 11736743] ">Nentwich 2001</a>; <a href="./references#CD003664-bbs2-0015" title="BergA , KramerU , LinkE , BollrathC , HeinrichJ , BrockowI , et al. GINIplus study group. Impact of early feeding on childhood eczema: development after nutritional intervention compared with the natural course ‐ the GINIplus study up to the age of 6 years. Clinical and Experimental Allergy2010;40(4):627‐36. [DOI: 10.1111/j.1365‐2222.2009.03444.x; PUBMED: 20082618] BrockowI , ZutavernA , HoffmannU , GrublA , vonBergA , KoletzkoS , et al. GINIplus Study Group. Early allergic sensitizations and their relevance to atopic diseases in children aged 6 years: results of the GINI study. Journal of Investigational Allergology &amp; Clinical Immunology2009;19(3):180‐7. [DOI: 19610260] LaubereauB , BrockowI , ZirngiblA , KoletzkoS , GrueblA , vonBergA , et al. GINI Study Group. Effect of breast‐feeding on the development of atopic dermatitis during the first 3 years of life ‐ results from the GINI‐birth cohort study. Journal of Pediatrics2004;144(5):602‐7. [DOI: 10.1016/j.jpeds.2003.12.029; PUBMED: 15126993] LaubereauB , Filipiak‐PittroffB , vonBergA , GrublA , ReinhardtD , WichmannHE , et al. Caesarean section and gastrointestinal symptoms, atopic dermatitis, and sensitisation during the first year of life. Archives of Disease in Childhood2004;89(11):993‐7. [DOI: 10.1136/adc.2003.043265; PUBMED: 15499049] RzehakP , SausenthalerS , KoletzkoS , BauerCP , SchaafB , vonBergA , et al. Period‐specific growth, overweight and modification by breastfeeding in the GINI and LISA birth cohorts up to age 6 years. European Journal of Epidemiology2009;24(8):449‐67. [DOI: 10.1007/s10654‐009‐9356‐5; PUBMED: 19521784] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. GINI‐plus Study Group. Long‐term effects of hydrolyzed protein infant formulas on growth ‐ extended follow‐up to 10 y of age: results from the German Infant Nutritional Intervention (GINI) study. American Journal of Clinical Nutrition2011;94(6 Suppl):1803S‐7S. [DOI: 10.3945/ajcn.110.000679; PUBMED: 21849601] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. German Infant Nutritional Intervention Study Group. Short‐ and long‐term effects of feeding hydrolyzed protein infant formulas on growth at &lt; or = 6 y of age: results from the German Infant Nutritional Intervention Study. American Journal of Clinical Nutrition2009;89(6):1846‐56. [DOI: 10.3945/ajcn.2008.27373; PUBMED: 19369380] SausenthalerS , KoletzkoS , KoletzkoB , ReinhardtD , KramerU , vonBergA , et al. GINIplus study group. Effect of hydrolysed formula feeding on taste preferences at 10 years. Data from the German Infant Nutritional Intervention Program Plus Study. Clinical Nutrition2010;29(3):304‐6. [DOI: 10.1016/j.clnu.2010.01.007; PUBMED: 20110140] SchoetzauA , Filipiak‐PittroffB , FrankeK , KoletzkoS , VonBergA , GrueblA , et al. German Infant Nutritional Intervention Study Group. Effect of exclusive breast‐feeding and early solid food avoidance on the incidence of atopic dermatitis in high‐risk infants at 1 year of age. Pediatric Allergy and Immunology2002;13(4):234‐42. [PUBMED: 12390439] SchoetzauA , GehringU , FrankeK , GrublA , KoletzkoS , vonBergA , et al. Gini Study Group. Maternal compliance with nutritional recommendations in an allergy preventive programme. Archives of Disease in Childhood2002;86(3):180‐4. [PUBMED: 11861235] VonBergA , Filipiak‐PittroffB , KrämerU , LinkE , HeinrichJ , KoletzkoS , et al. The German Infant Nutritional Intervention Study (GINI) for the preventive effect of hydrolysed infant formulas in infants at high risk for allergic diseases. Design and selected results. Allergologie2012;35(1):32‐43. VonBergA , Filipiak‐PittroffB , SchulzH , HoffmannU , LinkE , SussmannM , et al. GINIplus study group. Allergic manifestation 15 years after early intervention with hydrolyzed formulas ‐ the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2016;71(2):210‐9. [DOI: 10.1111/all.12790; PUBMED: 26465137] vonBergA , FilipiakB , KoletzkoS , KrämerU , HoffmannB , LinkE , et al. Long‐term effect of cow milk protein hydrolysates in high‐risk children. Results from the 10‐years follow‐up of the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2013;68:295‐6. vonBergA , Filipiak‐PittroffB , KramerU , HoffmannB , LinkE , BeckmannC , et al. GINIplus study group. Allergies in high‐risk schoolchildren after early intervention with cow's milk protein hydrolysates: 10‐year results from the German Infant Nutritional Intervention (GINI) study. Journal of Allergy and Clinical Immunology2013;131(6):1565‐73. [DOI: 10.1016/j.jaci.2013.01.006; PUBMED: 23506844] vonBergA , Filipiak‐PittroffB , KramerU , LinkE , BollrathC , BrockowI , et al. GINIplus study group. Preventive effect of hydrolyzed infant formulas persists until age 6 years: long‐term results from the German Infant Nutritional Intervention Study (GINI). Journal of Allergy and Clinical Immunology2008;121(6):1442‐7. [DOI: 10.1016/j.jaci.2008.04.021; PUBMED: 18539195] vonBergA , KoletzkoS , Filipiak‐PittroffB , LaubereauB , GrublA , WichmannHE , et al. German Infant Nutritional Intervention Study Group. Certain hydrolyzed formulas reduce the incidence of atopic dermatitis but not that of asthma: three‐year results of the German Infant Nutritional Intervention Study. Journal of Allergy and Clinical Immunology2007;119(3):718‐25. [DOI: 10.1016/j.jaci.2006.11.017; PUBMED: 17240440] vonBergA , KoletzkoS , GrublA , Filipiak‐PittroffB , WichmannHE , BauerCP , et al. German Infant Nutritional Intervention Study Group. The effect of hydrolyzed cow's milk formula for allergy prevention in the first year of life: the German Infant Nutritional Intervention Study, a randomized double‐blind trial. Journal of Allergy and Clinical Immunology2003;111(3):533‐40. [PUBMED: 12642834] ">von Berg 2003</a>). Six studies did not report sufficient details of baseline characteristics or described differences of 'unclear' importance (<a href="./references#CD003664-bbs2-0006" title="KwintaP , SawiecP , KlimekM , LisG , Cichocka‐JaroszE , PietrzykJJ . Correlation between early neonatal diet and atopic symptoms up to 5‐7 years of age in very low birth weight infants: follow‐up of randomized, double‐blind study. Pediatric Allergy and Immunology2009;20(5):458‐66. [DOI: 10.1111/j.1399‐3038.2008.00814.x; PUBMED: 19490477] ">Kwinta 2009</a>; <a href="./references#CD003664-bbs2-0007" title="LamBC , YeungCY . The effect of breast milk, infant formula and hypoallergenic formula on incidence of atopic manifestation in high risk infants. Nestle Internal Report1992. ">Lam 1992</a>; <a href="./references#CD003664-bbs2-0009" title="MariniA , AgostiM , MottaG , MoscaF . Effects of a dietary and environmental prevention programme on the incidence of allergic symptoms in high atopic risk infants: three years' follow‐up. Acta Paediatrica Supplement1996;414:1‐21. [PUBMED: 8831855] ">Marini 1996</a>; <a href="./references#CD003664-bbs2-0011" title="OldaeusG , AnjouK , BjorkstenB , MoranJR , KjellmanNI . Extensively and partially hydrolysed infant formulas for allergy prophylaxis. Archives of Disease in Childhood1997;77(1):4‐10. [PUBMED: 9279143] OldaeusG , BjorkstenB , JenmalmMC , KjellmanNI . Cow's milk IgE and IgG antibody responses to cow's milk formulas. Allergy1999;54(4):352‐7. [PUBMED: 10371094] ">Oldaeus 1997</a>; <a href="./references#CD003664-bbs2-0012" title="SaarinenKM , Juntunen‐BackmanK , JarvenpaaAL , KlemettiP , KuitunenP , LopeL , et al. Breast‐feeding and the development of cows' milk protein allergy. Advances in Experimental Medicine and Biology2000;478:121‐30. [DOI: 10.1007/0‐306‐46830‐1_10; PUBMED: 11065065] SaarinenKM , Juntunen‐BackmanK , JarvenpaaAL , KuitunenP , LopeL , RenlundM , et al. Supplementary feeding in maternity hospitals and the risk of cow's milk allergy: a prospective study of 6209 infants. Journal of Allergy and Clinical Immunology1999;104(2 Pt 1):457‐61. [PUBMED: 10452771] SaarinenKM , SavilahtiE . Infant feeding patterns affect the subsequent immunological features in cow's milk allergy. Clinical and Experimental Allergy2000;30(3):400‐6. [DOI: 10691899] SaarinenKM , SuomalainenH , SavilahtiE . Diagnostic value of skin‐prick and patch tests and serum eosinophil cationic protein and cow's milk‐specific IgE in infants with cow's milk allergy. Clinical and Experimental Allergy2001;31(3):423‐9. [PUBMED: 11260154] SaarinenKM , VaaralaO , KlemettiP , SavilahtiE . Transforming growth factor‐beta1 in mothers' colostrum and immune responses to cows' milk proteins in infants with cows' milk allergy. Journal of Allergy and Clinical Immunology1999;104(5):1093‐8. [PUBMED: 10550758] SavilahtiE , SaarinenKM . Early infant feeding and type 1 diabetes. European Journal of Nutrition2009;48(4):243‐9. [DOI: 10.1007/s00394‐009‐0008‐z; PUBMED: 19263185] SavilahtiEM , SaarinenKM , SavilahtiE . Specific antibodies to cow's milk proteins in infants: effect of early feeding and diagnosis of cow's milk allergy. European Journal of Nutrition2010;49(8):501‐4. [DOI: 10.1007/s00394‐010‐0109‐8; PUBMED: 20405136] SiltanenM , KajosaariM , PoussaT , SaarinenKM , SavilahtiE . A dual long‐term effect of breastfeeding on atopy in relation to heredity in children at 4 years of age. Allergy2003;58(6):524‐30. [PUBMED: 12757455] ">Saarinen 1999</a>; <a href="./references#CD003664-bbs2-0016" title="WillemsR , DuchateauJ , MagrezP , DenisR , CasimirG . Influence of hypoallergenic milk formula on the incidence of early allergic manifestations in infants predisposed to atopic diseases. Annals of Allergy1993;71(2):147‐50. [PUBMED: 8346868] ">Willems 1993</a>). We considered four studies to have well‐balanced groups after randomisation with no other identified source of bias (<a href="./references#CD003664-bbs2-0004" title="HillD . A report on the analysis of the Melbourne Atopy Cohort Study. A study designed to test the effectiveness of different formula types on the development of atopic symptoms and signs on a cohort of atopy‐at‐risk infants. Report at year 2. Nestec Internal Report. HillDJ , SporikR , ThorburnJ , HoskingCS . The association of atopic dermatitis in infancy with immunoglobulin E food sensitization. Journal of Pediatrics2000;137(4):475‐9. [DOI: 10.1067/mpd.2000.108207; PUBMED: 11035824] KoplinJ , DharmageSC , GurrinL , OsborneN , TangML , LoweAJ , et al. Soy consumption is not a risk factor for peanut sensitization. Journal of Allergy and Clinical Immunology2008;121(6):1455‐9. [DOI: 10.1016/j.jaci.2008.03.017; PUBMED: 18436294] LoweA , HoskingC , BennettC , AllenK , CarlinJ , DharmageS , et al. The Melbourne Atopy Cohort Study: a RCT of a partially hydrolysed whey formula for the prevention of allergic disease. Internal Medicine Journal2008;38:A158. LoweAJ , AbramsonMJ , HoskingCS , CarlinJB , BennettCM , DharmageSC , et al. The temporal sequence of allergic sensitization and onset of infantile eczema. Clinical &amp; Experimental Allergy2007;37(4):536‐42; Erratum in: Clinical &amp; Experimental Allergy 2007; 37(12);1895. [DOI: 10.1111/j.1365‐2222.2007.02691.x; PUBMED: 17430350] LoweAJ , CarlinJB , BennettCM , HoskingCS , AllenKJ , RobertsonCF , et al. Paracetamol use in early life and asthma: prospective birth cohort study. BMJ2010;341:c4616. [PUBMED: 20843914] LoweAJ , HoskingCS , BennettCM , AllenKJ , AxelradC , CarlinJB , et al. Effect of a partially hydrolyzed whey infant formula at weaning on risk of allergic disease in high‐risk children: a randomized controlled trial. Journal of Allergy and Clinical Immunology2011;128(2):360‐5.e4. [DOI: 10.1016/j.jaci.2010.05.006; PUBMED: 21696814] StoneyRM , WoodsRK , HoskingCS , HillDJ , AbramsonMJ , ThienFC . Maternal breast milk long‐chain n‐3 fatty acids are associated with increased risk of atopy in breastfed infants. Clinical and Experimental Allergy2004;34(2):194‐200; Erratum in: Clinical &amp; Experimental Allergy 2007; 37(12);1895. [PUBMED: 14987297] ThomsonJA , WidjajaC , DarmaputraAA , LoweA , MathesonMC , BennettCM , et al. Early childhood infections and immunisation and the development of allergic disease in particular asthma in a high‐risk cohort: a prospective study of allergy‐prone children from birth to six years. Pediatric Allergy and Immunology2010;21(7):1076‐85. [DOI: 10.1111/j.1399‐3038.2010.01018.x; PUBMED: 20337970] ">Hill 2000</a>; <a href="./references#CD003664-bbs2-0008" title="MalletE , HenocqA . Long‐term prevention of allergic diseases by using protein hydrolysate formula in at‐risk infants. Journal of Pediatrics1992;121(5 Pt 2):S95‐100. [PUBMED: 1447641] ">Mallet 1992</a>; <a href="./references#CD003664-bbs2-0013" title="TsaiYT , ChouCC , HsiehKH . The effect of hypoallergenic formula on the occurrence of allergic diseases in high risk infants. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi1991;32(3):137‐44. [PUBMED: 1776437] ">Tsai 1991</a>; <a href="./references#CD003664-bbs2-0014" title="VandenplasY . Atopy at 3 years in high‐risk infants fed whey hydrolysate or conventional formula. Lancet1992;339(8801):1118. [PUBMED: 1349137] VandenplasY , HauserB , Van denBorreC , ClybouwC , MahlerT , Hachimi‐IdrissiS , et al. The long‐term effect of a partial whey hydrolysate formula on the prophylaxis of atopic disease. European Journal of Pediatrics1995;154(6):488‐94. [PUBMED: 7671948] VandenplasY , HauserB , Van denBorreC , SacreL , DabI . Effect of a whey hydrolysate prophylaxis of atopic disease. Annals of Allergy1992;68(5):419‐24. [PUBMED: 1586005] ">Vandenplas 1992</a>). </p> <p>We assessed no studies as having 'low risk' of bias overall ('low risk' of selection bias, performance and measurement bias and attrition bias with &lt; 10% loss to follow‐up). </p> </section> </section> <section id="CD003664-sec-0103"> <h3 class="title" id="CD003664-sec-0103">Effects of interventions</h3> <p>See: <a href="./full#CD003664-tbl-0001"><b>Summary of findings for the main comparison</b> Early short‐term feeding: hydrolysed formula versus human milk feeding ‐ low‐risk infants for prevention of allergic disease</a>; <a href="./full#CD003664-tbl-0002"><b>Summary of findings 2</b> Early short‐term feeding: hydrolysed formula versus cow's milk formula ‐ low‐risk infants for prevention of allergic disease and food allergy</a>; <a href="./full#CD003664-tbl-0003"><b>Summary of findings 3</b> Prolonged feeding: hydrolysed formula versus cow's milk formula for prevention of allergic disease</a> </p> <section id="CD003664-sec-0104"> <h4 class="title">Analyses</h4> <section id="CD003664-sec-0105"> <h5 class="title">Comparison 1. Early short‐term feeding: hydrolysed formula versus human milk feeding ‐ low‐risk infants </h5> <p>We included two studies (<a href="./references#CD003664-bbs2-0005" title="JuvonenP , ManssonM , AnderssonC , JakobssonI . Allergy development and macromolecular absorption in infants with different feeding regimens during the first three days of life. A three‐year prospective follow‐up. Acta Paediatrica1996;85(9):1047‐52. [PUBMED: 8888916] JuvonenP , ManssonM , JakobssonI . Does early diet have an effect on subsequent macromolecular absorption and serum IgE?. Journal of Pediatric Gastroenterology and Nutrition1994;18(3):344‐9. [PUBMED: 8057219] JuvonenP , ManssonM , KjellmanNI , BjorkstenB , JakobssonI . Development of immunoglobulin G and immunoglobulin E antibodies to cow's milk proteins and ovalbumin after a temporary neonatal exposure to hydrolyzed and whole cow's milk proteins. Pediatric Allergy and Immunology1999;10(3):191‐8. [PUBMED: 10565560] ">Juvonen 1996</a>; <a href="./references#CD003664-bbs2-0012" title="SaarinenKM , Juntunen‐BackmanK , JarvenpaaAL , KlemettiP , KuitunenP , LopeL , et al. Breast‐feeding and the development of cows' milk protein allergy. Advances in Experimental Medicine and Biology2000;478:121‐30. [DOI: 10.1007/0‐306‐46830‐1_10; PUBMED: 11065065] SaarinenKM , Juntunen‐BackmanK , JarvenpaaAL , KuitunenP , LopeL , RenlundM , et al. Supplementary feeding in maternity hospitals and the risk of cow's milk allergy: a prospective study of 6209 infants. Journal of Allergy and Clinical Immunology1999;104(2 Pt 1):457‐61. [PUBMED: 10452771] SaarinenKM , SavilahtiE . Infant feeding patterns affect the subsequent immunological features in cow's milk allergy. Clinical and Experimental Allergy2000;30(3):400‐6. [DOI: 10691899] SaarinenKM , SuomalainenH , SavilahtiE . Diagnostic value of skin‐prick and patch tests and serum eosinophil cationic protein and cow's milk‐specific IgE in infants with cow's milk allergy. Clinical and Experimental Allergy2001;31(3):423‐9. [PUBMED: 11260154] SaarinenKM , VaaralaO , KlemettiP , SavilahtiE . Transforming growth factor‐beta1 in mothers' colostrum and immune responses to cows' milk proteins in infants with cows' milk allergy. Journal of Allergy and Clinical Immunology1999;104(5):1093‐8. [PUBMED: 10550758] SavilahtiE , SaarinenKM . Early infant feeding and type 1 diabetes. European Journal of Nutrition2009;48(4):243‐9. [DOI: 10.1007/s00394‐009‐0008‐z; PUBMED: 19263185] SavilahtiEM , SaarinenKM , SavilahtiE . Specific antibodies to cow's milk proteins in infants: effect of early feeding and diagnosis of cow's milk allergy. European Journal of Nutrition2010;49(8):501‐4. [DOI: 10.1007/s00394‐010‐0109‐8; PUBMED: 20405136] SiltanenM , KajosaariM , PoussaT , SaarinenKM , SavilahtiE . A dual long‐term effect of breastfeeding on atopy in relation to heredity in children at 4 years of age. Allergy2003;58(6):524‐30. [PUBMED: 12757455] ">Saarinen 1999</a>) that compared a short duration (three to four days whilst in hospital) of early supplemental or sole hydrolysed formula versus donor human milk feeds in infants who were subsequently encouraged to breast feed. </p> <p><a href="./references#CD003664-bbs2-0005" title="JuvonenP , ManssonM , AnderssonC , JakobssonI . Allergy development and macromolecular absorption in infants with different feeding regimens during the first three days of life. A three‐year prospective follow‐up. Acta Paediatrica1996;85(9):1047‐52. [PUBMED: 8888916] JuvonenP , ManssonM , JakobssonI . Does early diet have an effect on subsequent macromolecular absorption and serum IgE?. Journal of Pediatric Gastroenterology and Nutrition1994;18(3):344‐9. [PUBMED: 8057219] JuvonenP , ManssonM , KjellmanNI , BjorkstenB , JakobssonI . Development of immunoglobulin G and immunoglobulin E antibodies to cow's milk proteins and ovalbumin after a temporary neonatal exposure to hydrolyzed and whole cow's milk proteins. Pediatric Allergy and Immunology1999;10(3):191‐8. [PUBMED: 10565560] ">Juvonen 1996</a> (90 infants) reported no difference in childhood incidence of allergic disease (risk ratio (RR) 1.43, 95% confidence interval (CI) 0.38 to 5.37), asthma (RR 0.48, 95% CI 0.05 to 4.41), eczema (RR 0.48, 95% CI 0.05 to 4.41), no difference in food allergy (RR 1.43, 95% CI 0.38 to 5.37) and no difference in cow's milk allergy (CMA) (RR 7.11, 95% CI 0.35 to 143.84) at three years. <a href="./references#CD003664-bbs2-0012" title="SaarinenKM , Juntunen‐BackmanK , JarvenpaaAL , KlemettiP , KuitunenP , LopeL , et al. Breast‐feeding and the development of cows' milk protein allergy. Advances in Experimental Medicine and Biology2000;478:121‐30. [DOI: 10.1007/0‐306‐46830‐1_10; PUBMED: 11065065] SaarinenKM , Juntunen‐BackmanK , JarvenpaaAL , KuitunenP , LopeL , RenlundM , et al. Supplementary feeding in maternity hospitals and the risk of cow's milk allergy: a prospective study of 6209 infants. Journal of Allergy and Clinical Immunology1999;104(2 Pt 1):457‐61. [PUBMED: 10452771] SaarinenKM , SavilahtiE . Infant feeding patterns affect the subsequent immunological features in cow's milk allergy. Clinical and Experimental Allergy2000;30(3):400‐6. [DOI: 10691899] SaarinenKM , SuomalainenH , SavilahtiE . Diagnostic value of skin‐prick and patch tests and serum eosinophil cationic protein and cow's milk‐specific IgE in infants with cow's milk allergy. Clinical and Experimental Allergy2001;31(3):423‐9. [PUBMED: 11260154] SaarinenKM , VaaralaO , KlemettiP , SavilahtiE . Transforming growth factor‐beta1 in mothers' colostrum and immune responses to cows' milk proteins in infants with cows' milk allergy. Journal of Allergy and Clinical Immunology1999;104(5):1093‐8. [PUBMED: 10550758] SavilahtiE , SaarinenKM . Early infant feeding and type 1 diabetes. European Journal of Nutrition2009;48(4):243‐9. [DOI: 10.1007/s00394‐009‐0008‐z; PUBMED: 19263185] SavilahtiEM , SaarinenKM , SavilahtiE . Specific antibodies to cow's milk proteins in infants: effect of early feeding and diagnosis of cow's milk allergy. European Journal of Nutrition2010;49(8):501‐4. [DOI: 10.1007/s00394‐010‐0109‐8; PUBMED: 20405136] SiltanenM , KajosaariM , PoussaT , SaarinenKM , SavilahtiE . A dual long‐term effect of breastfeeding on atopy in relation to heredity in children at 4 years of age. Allergy2003;58(6):524‐30. [PUBMED: 12757455] ">Saarinen 1999</a> reported no difference in childhood incidence of CMA (3559 infants; RR 0.87, 95% CI 0.52 to 1.46) up to a mean age of 27 months. Quality of evidence was assessed as 'very low' for all outcomes (see <a href="./full#CD003664-tbl-0001">summary of findings Table for the main comparison</a>). </p> <p>We considered the following subgroup analyses, but as no significant benefits were reported, we did not wish to duplicate the results. </p> <p> <ul id="CD003664-list-0034"> <li> <p>Both studies enrolled infants irrespective of family history of allergic disease or food allergy in first‐degree relatives. </p> </li> <li> <p>Extent of protein hydrolysis: <a href="./references#CD003664-bbs2-0005" title="JuvonenP , ManssonM , AnderssonC , JakobssonI . Allergy development and macromolecular absorption in infants with different feeding regimens during the first three days of life. A three‐year prospective follow‐up. Acta Paediatrica1996;85(9):1047‐52. [PUBMED: 8888916] JuvonenP , ManssonM , JakobssonI . Does early diet have an effect on subsequent macromolecular absorption and serum IgE?. Journal of Pediatric Gastroenterology and Nutrition1994;18(3):344‐9. [PUBMED: 8057219] JuvonenP , ManssonM , KjellmanNI , BjorkstenB , JakobssonI . Development of immunoglobulin G and immunoglobulin E antibodies to cow's milk proteins and ovalbumin after a temporary neonatal exposure to hydrolyzed and whole cow's milk proteins. Pediatric Allergy and Immunology1999;10(3):191‐8. [PUBMED: 10565560] ">Juvonen 1996</a> and <a href="./references#CD003664-bbs2-0012" title="SaarinenKM , Juntunen‐BackmanK , JarvenpaaAL , KlemettiP , KuitunenP , LopeL , et al. Breast‐feeding and the development of cows' milk protein allergy. Advances in Experimental Medicine and Biology2000;478:121‐30. [DOI: 10.1007/0‐306‐46830‐1_10; PUBMED: 11065065] SaarinenKM , Juntunen‐BackmanK , JarvenpaaAL , KuitunenP , LopeL , RenlundM , et al. Supplementary feeding in maternity hospitals and the risk of cow's milk allergy: a prospective study of 6209 infants. Journal of Allergy and Clinical Immunology1999;104(2 Pt 1):457‐61. [PUBMED: 10452771] SaarinenKM , SavilahtiE . Infant feeding patterns affect the subsequent immunological features in cow's milk allergy. Clinical and Experimental Allergy2000;30(3):400‐6. [DOI: 10691899] SaarinenKM , SuomalainenH , SavilahtiE . Diagnostic value of skin‐prick and patch tests and serum eosinophil cationic protein and cow's milk‐specific IgE in infants with cow's milk allergy. Clinical and Experimental Allergy2001;31(3):423‐9. [PUBMED: 11260154] SaarinenKM , VaaralaO , KlemettiP , SavilahtiE . Transforming growth factor‐beta1 in mothers' colostrum and immune responses to cows' milk proteins in infants with cows' milk allergy. Journal of Allergy and Clinical Immunology1999;104(5):1093‐8. [PUBMED: 10550758] SavilahtiE , SaarinenKM . Early infant feeding and type 1 diabetes. European Journal of Nutrition2009;48(4):243‐9. [DOI: 10.1007/s00394‐009‐0008‐z; PUBMED: 19263185] SavilahtiEM , SaarinenKM , SavilahtiE . Specific antibodies to cow's milk proteins in infants: effect of early feeding and diagnosis of cow's milk allergy. European Journal of Nutrition2010;49(8):501‐4. [DOI: 10.1007/s00394‐010‐0109‐8; PUBMED: 20405136] SiltanenM , KajosaariM , PoussaT , SaarinenKM , SavilahtiE . A dual long‐term effect of breastfeeding on atopy in relation to heredity in children at 4 years of age. Allergy2003;58(6):524‐30. [PUBMED: 12757455] ">Saarinen 1999</a> compared an extensively hydrolysed formula (EHF) versus pasteurised donor human milk. </p> </li> <li> <p>Indication for use: both studies used formula for early short‐term infant formula feeding. </p> </li> <li> <p>Method of ascertainment of allergic disease: <a href="./references#CD003664-bbs2-0012" title="SaarinenKM , Juntunen‐BackmanK , JarvenpaaAL , KlemettiP , KuitunenP , LopeL , et al. Breast‐feeding and the development of cows' milk protein allergy. Advances in Experimental Medicine and Biology2000;478:121‐30. [DOI: 10.1007/0‐306‐46830‐1_10; PUBMED: 11065065] SaarinenKM , Juntunen‐BackmanK , JarvenpaaAL , KuitunenP , LopeL , RenlundM , et al. Supplementary feeding in maternity hospitals and the risk of cow's milk allergy: a prospective study of 6209 infants. Journal of Allergy and Clinical Immunology1999;104(2 Pt 1):457‐61. [PUBMED: 10452771] SaarinenKM , SavilahtiE . Infant feeding patterns affect the subsequent immunological features in cow's milk allergy. Clinical and Experimental Allergy2000;30(3):400‐6. [DOI: 10691899] SaarinenKM , SuomalainenH , SavilahtiE . Diagnostic value of skin‐prick and patch tests and serum eosinophil cationic protein and cow's milk‐specific IgE in infants with cow's milk allergy. Clinical and Experimental Allergy2001;31(3):423‐9. [PUBMED: 11260154] SaarinenKM , VaaralaO , KlemettiP , SavilahtiE . Transforming growth factor‐beta1 in mothers' colostrum and immune responses to cows' milk proteins in infants with cows' milk allergy. Journal of Allergy and Clinical Immunology1999;104(5):1093‐8. [PUBMED: 10550758] SavilahtiE , SaarinenKM . Early infant feeding and type 1 diabetes. European Journal of Nutrition2009;48(4):243‐9. [DOI: 10.1007/s00394‐009‐0008‐z; PUBMED: 19263185] SavilahtiEM , SaarinenKM , SavilahtiE . Specific antibodies to cow's milk proteins in infants: effect of early feeding and diagnosis of cow's milk allergy. European Journal of Nutrition2010;49(8):501‐4. [DOI: 10.1007/s00394‐010‐0109‐8; PUBMED: 20405136] SiltanenM , KajosaariM , PoussaT , SaarinenKM , SavilahtiE . A dual long‐term effect of breastfeeding on atopy in relation to heredity in children at 4 years of age. Allergy2003;58(6):524‐30. [PUBMED: 12757455] ">Saarinen 1999</a> reported outcomes of an unblinded elimination/challenge for CMA. <a href="./references#CD003664-bbs2-0005" title="JuvonenP , ManssonM , AnderssonC , JakobssonI . Allergy development and macromolecular absorption in infants with different feeding regimens during the first three days of life. A three‐year prospective follow‐up. Acta Paediatrica1996;85(9):1047‐52. [PUBMED: 8888916] JuvonenP , ManssonM , JakobssonI . Does early diet have an effect on subsequent macromolecular absorption and serum IgE?. Journal of Pediatric Gastroenterology and Nutrition1994;18(3):344‐9. [PUBMED: 8057219] JuvonenP , ManssonM , KjellmanNI , BjorkstenB , JakobssonI . Development of immunoglobulin G and immunoglobulin E antibodies to cow's milk proteins and ovalbumin after a temporary neonatal exposure to hydrolyzed and whole cow's milk proteins. Pediatric Allergy and Immunology1999;10(3):191‐8. [PUBMED: 10565560] ">Juvonen 1996</a> did not report criteria for diagnosis of allergic disease. </p> </li> <li> <p>Type of protein hydrolysate used: <a href="./references#CD003664-bbs2-0005" title="JuvonenP , ManssonM , AnderssonC , JakobssonI . Allergy development and macromolecular absorption in infants with different feeding regimens during the first three days of life. A three‐year prospective follow‐up. Acta Paediatrica1996;85(9):1047‐52. [PUBMED: 8888916] JuvonenP , ManssonM , JakobssonI . Does early diet have an effect on subsequent macromolecular absorption and serum IgE?. Journal of Pediatric Gastroenterology and Nutrition1994;18(3):344‐9. [PUBMED: 8057219] JuvonenP , ManssonM , KjellmanNI , BjorkstenB , JakobssonI . Development of immunoglobulin G and immunoglobulin E antibodies to cow's milk proteins and ovalbumin after a temporary neonatal exposure to hydrolyzed and whole cow's milk proteins. Pediatric Allergy and Immunology1999;10(3):191‐8. [PUBMED: 10565560] ">Juvonen 1996</a> compared an extensively hydrolysed casein formula versus pasteurised donor human milk. <a href="./references#CD003664-bbs2-0012" title="SaarinenKM , Juntunen‐BackmanK , JarvenpaaAL , KlemettiP , KuitunenP , LopeL , et al. Breast‐feeding and the development of cows' milk protein allergy. Advances in Experimental Medicine and Biology2000;478:121‐30. [DOI: 10.1007/0‐306‐46830‐1_10; PUBMED: 11065065] SaarinenKM , Juntunen‐BackmanK , JarvenpaaAL , KuitunenP , LopeL , RenlundM , et al. Supplementary feeding in maternity hospitals and the risk of cow's milk allergy: a prospective study of 6209 infants. Journal of Allergy and Clinical Immunology1999;104(2 Pt 1):457‐61. [PUBMED: 10452771] SaarinenKM , SavilahtiE . Infant feeding patterns affect the subsequent immunological features in cow's milk allergy. Clinical and Experimental Allergy2000;30(3):400‐6. [DOI: 10691899] SaarinenKM , SuomalainenH , SavilahtiE . Diagnostic value of skin‐prick and patch tests and serum eosinophil cationic protein and cow's milk‐specific IgE in infants with cow's milk allergy. Clinical and Experimental Allergy2001;31(3):423‐9. [PUBMED: 11260154] SaarinenKM , VaaralaO , KlemettiP , SavilahtiE . Transforming growth factor‐beta1 in mothers' colostrum and immune responses to cows' milk proteins in infants with cows' milk allergy. Journal of Allergy and Clinical Immunology1999;104(5):1093‐8. [PUBMED: 10550758] SavilahtiE , SaarinenKM . Early infant feeding and type 1 diabetes. European Journal of Nutrition2009;48(4):243‐9. [DOI: 10.1007/s00394‐009‐0008‐z; PUBMED: 19263185] SavilahtiEM , SaarinenKM , SavilahtiE . Specific antibodies to cow's milk proteins in infants: effect of early feeding and diagnosis of cow's milk allergy. European Journal of Nutrition2010;49(8):501‐4. [DOI: 10.1007/s00394‐010‐0109‐8; PUBMED: 20405136] SiltanenM , KajosaariM , PoussaT , SaarinenKM , SavilahtiE . A dual long‐term effect of breastfeeding on atopy in relation to heredity in children at 4 years of age. Allergy2003;58(6):524‐30. [PUBMED: 12757455] ">Saarinen 1999</a> compared an extensively hydrolysed whey formula versus pasteurised donor human milk. </p> </li> </ul> </p> <section id="CD003664-sec-0106"> <h6 class="title">Sensitivity analysis</h6> <p>We considered neither study to be at 'low risk' of bias.</p> </section> </section> <section id="CD003664-sec-0107"> <h5 class="title">Comparison 2. Early short‐term feeding: hydrolysed formula versus cow's milk formula (CMF) ‐ low‐risk infants </h5> <p>Two studies (<a href="./references#CD003664-bbs2-0005" title="JuvonenP , ManssonM , AnderssonC , JakobssonI . Allergy development and macromolecular absorption in infants with different feeding regimens during the first three days of life. A three‐year prospective follow‐up. Acta Paediatrica1996;85(9):1047‐52. [PUBMED: 8888916] JuvonenP , ManssonM , JakobssonI . Does early diet have an effect on subsequent macromolecular absorption and serum IgE?. Journal of Pediatric Gastroenterology and Nutrition1994;18(3):344‐9. [PUBMED: 8057219] JuvonenP , ManssonM , KjellmanNI , BjorkstenB , JakobssonI . Development of immunoglobulin G and immunoglobulin E antibodies to cow's milk proteins and ovalbumin after a temporary neonatal exposure to hydrolyzed and whole cow's milk proteins. Pediatric Allergy and Immunology1999;10(3):191‐8. [PUBMED: 10565560] ">Juvonen 1996</a>; <a href="./references#CD003664-bbs2-0012" title="SaarinenKM , Juntunen‐BackmanK , JarvenpaaAL , KlemettiP , KuitunenP , LopeL , et al. Breast‐feeding and the development of cows' milk protein allergy. Advances in Experimental Medicine and Biology2000;478:121‐30. [DOI: 10.1007/0‐306‐46830‐1_10; PUBMED: 11065065] SaarinenKM , Juntunen‐BackmanK , JarvenpaaAL , KuitunenP , LopeL , RenlundM , et al. Supplementary feeding in maternity hospitals and the risk of cow's milk allergy: a prospective study of 6209 infants. Journal of Allergy and Clinical Immunology1999;104(2 Pt 1):457‐61. [PUBMED: 10452771] SaarinenKM , SavilahtiE . Infant feeding patterns affect the subsequent immunological features in cow's milk allergy. Clinical and Experimental Allergy2000;30(3):400‐6. [DOI: 10691899] SaarinenKM , SuomalainenH , SavilahtiE . Diagnostic value of skin‐prick and patch tests and serum eosinophil cationic protein and cow's milk‐specific IgE in infants with cow's milk allergy. Clinical and Experimental Allergy2001;31(3):423‐9. [PUBMED: 11260154] SaarinenKM , VaaralaO , KlemettiP , SavilahtiE . Transforming growth factor‐beta1 in mothers' colostrum and immune responses to cows' milk proteins in infants with cows' milk allergy. Journal of Allergy and Clinical Immunology1999;104(5):1093‐8. [PUBMED: 10550758] SavilahtiE , SaarinenKM . Early infant feeding and type 1 diabetes. European Journal of Nutrition2009;48(4):243‐9. [DOI: 10.1007/s00394‐009‐0008‐z; PUBMED: 19263185] SavilahtiEM , SaarinenKM , SavilahtiE . Specific antibodies to cow's milk proteins in infants: effect of early feeding and diagnosis of cow's milk allergy. European Journal of Nutrition2010;49(8):501‐4. [DOI: 10.1007/s00394‐010‐0109‐8; PUBMED: 20405136] SiltanenM , KajosaariM , PoussaT , SaarinenKM , SavilahtiE . A dual long‐term effect of breastfeeding on atopy in relation to heredity in children at 4 years of age. Allergy2003;58(6):524‐30. [PUBMED: 12757455] ">Saarinen 1999</a>) compared a short duration (three to four days whilst in hospital) of early supplemental or sole feeding with a hydrolysed formula versus CMF. Both trials subsequently encouraged all mothers to breast feed. </p> <p><a href="./references#CD003664-bbs2-0005" title="JuvonenP , ManssonM , AnderssonC , JakobssonI . Allergy development and macromolecular absorption in infants with different feeding regimens during the first three days of life. A three‐year prospective follow‐up. Acta Paediatrica1996;85(9):1047‐52. [PUBMED: 8888916] JuvonenP , ManssonM , JakobssonI . Does early diet have an effect on subsequent macromolecular absorption and serum IgE?. Journal of Pediatric Gastroenterology and Nutrition1994;18(3):344‐9. [PUBMED: 8057219] JuvonenP , ManssonM , KjellmanNI , BjorkstenB , JakobssonI . Development of immunoglobulin G and immunoglobulin E antibodies to cow's milk proteins and ovalbumin after a temporary neonatal exposure to hydrolyzed and whole cow's milk proteins. Pediatric Allergy and Immunology1999;10(3):191‐8. [PUBMED: 10565560] ">Juvonen 1996</a> (77 infants) reported no difference in childhood allergic disease incidence (RR 1.37, 95% CI 0.33 to 5.71), no difference in childhood asthma incidence (RR 3.08, 95% CI 0.13 to 73.26), no difference in childhood eczema incidence (RR 0.34, 95% CI 0.04 to 3.15), no difference in childhood food allergy (RR 1.37, 95% CI 0.33 to 5.71) and no difference in childhood CMA (RR 5.13, 95% CI 0.25 to 103.43). <a href="./references#CD003664-bbs2-0012" title="SaarinenKM , Juntunen‐BackmanK , JarvenpaaAL , KlemettiP , KuitunenP , LopeL , et al. Breast‐feeding and the development of cows' milk protein allergy. Advances in Experimental Medicine and Biology2000;478:121‐30. [DOI: 10.1007/0‐306‐46830‐1_10; PUBMED: 11065065] SaarinenKM , Juntunen‐BackmanK , JarvenpaaAL , KuitunenP , LopeL , RenlundM , et al. Supplementary feeding in maternity hospitals and the risk of cow's milk allergy: a prospective study of 6209 infants. Journal of Allergy and Clinical Immunology1999;104(2 Pt 1):457‐61. [PUBMED: 10452771] SaarinenKM , SavilahtiE . Infant feeding patterns affect the subsequent immunological features in cow's milk allergy. Clinical and Experimental Allergy2000;30(3):400‐6. [DOI: 10691899] SaarinenKM , SuomalainenH , SavilahtiE . Diagnostic value of skin‐prick and patch tests and serum eosinophil cationic protein and cow's milk‐specific IgE in infants with cow's milk allergy. Clinical and Experimental Allergy2001;31(3):423‐9. [PUBMED: 11260154] SaarinenKM , VaaralaO , KlemettiP , SavilahtiE . Transforming growth factor‐beta1 in mothers' colostrum and immune responses to cows' milk proteins in infants with cows' milk allergy. Journal of Allergy and Clinical Immunology1999;104(5):1093‐8. [PUBMED: 10550758] SavilahtiE , SaarinenKM . Early infant feeding and type 1 diabetes. European Journal of Nutrition2009;48(4):243‐9. [DOI: 10.1007/s00394‐009‐0008‐z; PUBMED: 19263185] SavilahtiEM , SaarinenKM , SavilahtiE . Specific antibodies to cow's milk proteins in infants: effect of early feeding and diagnosis of cow's milk allergy. European Journal of Nutrition2010;49(8):501‐4. [DOI: 10.1007/s00394‐010‐0109‐8; PUBMED: 20405136] SiltanenM , KajosaariM , PoussaT , SaarinenKM , SavilahtiE . A dual long‐term effect of breastfeeding on atopy in relation to heredity in children at 4 years of age. Allergy2003;58(6):524‐30. [PUBMED: 12757455] ">Saarinen 1999</a> reported a reduction in infant CMA incidence of borderline significance (3473 infants; RR 0.62, 95% CI 0.38 to 1.00; risk difference ‐0.01, 95% CI ‐0.02 to 0.00; P = 0.05). Quality of evidence was assessed as 'very low' for all outcomes (see <a href="./full#CD003664-tbl-0002">summary of findings Table 2</a>). </p> <p>We considered the following subgroup analyses, but as no significant benefits were reported, we did not wish to duplicate the results. </p> <p> <ul id="CD003664-list-0035"> <li> <p>Both studies enrolled infants irrespective of family history allergic disease in first‐degree relatives. </p> </li> <li> <p>Extent of protein hydrolysis: <a href="./references#CD003664-bbs2-0005" title="JuvonenP , ManssonM , AnderssonC , JakobssonI . Allergy development and macromolecular absorption in infants with different feeding regimens during the first three days of life. A three‐year prospective follow‐up. Acta Paediatrica1996;85(9):1047‐52. [PUBMED: 8888916] JuvonenP , ManssonM , JakobssonI . Does early diet have an effect on subsequent macromolecular absorption and serum IgE?. Journal of Pediatric Gastroenterology and Nutrition1994;18(3):344‐9. [PUBMED: 8057219] JuvonenP , ManssonM , KjellmanNI , BjorkstenB , JakobssonI . Development of immunoglobulin G and immunoglobulin E antibodies to cow's milk proteins and ovalbumin after a temporary neonatal exposure to hydrolyzed and whole cow's milk proteins. Pediatric Allergy and Immunology1999;10(3):191‐8. [PUBMED: 10565560] ">Juvonen 1996</a> and <a href="./references#CD003664-bbs2-0012" title="SaarinenKM , Juntunen‐BackmanK , JarvenpaaAL , KlemettiP , KuitunenP , LopeL , et al. Breast‐feeding and the development of cows' milk protein allergy. Advances in Experimental Medicine and Biology2000;478:121‐30. [DOI: 10.1007/0‐306‐46830‐1_10; PUBMED: 11065065] SaarinenKM , Juntunen‐BackmanK , JarvenpaaAL , KuitunenP , LopeL , RenlundM , et al. Supplementary feeding in maternity hospitals and the risk of cow's milk allergy: a prospective study of 6209 infants. Journal of Allergy and Clinical Immunology1999;104(2 Pt 1):457‐61. [PUBMED: 10452771] SaarinenKM , SavilahtiE . Infant feeding patterns affect the subsequent immunological features in cow's milk allergy. Clinical and Experimental Allergy2000;30(3):400‐6. [DOI: 10691899] SaarinenKM , SuomalainenH , SavilahtiE . Diagnostic value of skin‐prick and patch tests and serum eosinophil cationic protein and cow's milk‐specific IgE in infants with cow's milk allergy. Clinical and Experimental Allergy2001;31(3):423‐9. [PUBMED: 11260154] SaarinenKM , VaaralaO , KlemettiP , SavilahtiE . Transforming growth factor‐beta1 in mothers' colostrum and immune responses to cows' milk proteins in infants with cows' milk allergy. Journal of Allergy and Clinical Immunology1999;104(5):1093‐8. [PUBMED: 10550758] SavilahtiE , SaarinenKM . Early infant feeding and type 1 diabetes. European Journal of Nutrition2009;48(4):243‐9. [DOI: 10.1007/s00394‐009‐0008‐z; PUBMED: 19263185] SavilahtiEM , SaarinenKM , SavilahtiE . Specific antibodies to cow's milk proteins in infants: effect of early feeding and diagnosis of cow's milk allergy. European Journal of Nutrition2010;49(8):501‐4. [DOI: 10.1007/s00394‐010‐0109‐8; PUBMED: 20405136] SiltanenM , KajosaariM , PoussaT , SaarinenKM , SavilahtiE . A dual long‐term effect of breastfeeding on atopy in relation to heredity in children at 4 years of age. Allergy2003;58(6):524‐30. [PUBMED: 12757455] ">Saarinen 1999</a> compared an EHF versus CMF. </p> </li> <li> <p>Indication for use: both studies used formula for early short‐term infant formula feeding. </p> </li> <li> <p>Method of ascertainment of allergic disease: <a href="./references#CD003664-bbs2-0012" title="SaarinenKM , Juntunen‐BackmanK , JarvenpaaAL , KlemettiP , KuitunenP , LopeL , et al. Breast‐feeding and the development of cows' milk protein allergy. Advances in Experimental Medicine and Biology2000;478:121‐30. [DOI: 10.1007/0‐306‐46830‐1_10; PUBMED: 11065065] SaarinenKM , Juntunen‐BackmanK , JarvenpaaAL , KuitunenP , LopeL , RenlundM , et al. Supplementary feeding in maternity hospitals and the risk of cow's milk allergy: a prospective study of 6209 infants. Journal of Allergy and Clinical Immunology1999;104(2 Pt 1):457‐61. [PUBMED: 10452771] SaarinenKM , SavilahtiE . Infant feeding patterns affect the subsequent immunological features in cow's milk allergy. Clinical and Experimental Allergy2000;30(3):400‐6. [DOI: 10691899] SaarinenKM , SuomalainenH , SavilahtiE . Diagnostic value of skin‐prick and patch tests and serum eosinophil cationic protein and cow's milk‐specific IgE in infants with cow's milk allergy. Clinical and Experimental Allergy2001;31(3):423‐9. [PUBMED: 11260154] SaarinenKM , VaaralaO , KlemettiP , SavilahtiE . Transforming growth factor‐beta1 in mothers' colostrum and immune responses to cows' milk proteins in infants with cows' milk allergy. Journal of Allergy and Clinical Immunology1999;104(5):1093‐8. [PUBMED: 10550758] SavilahtiE , SaarinenKM . Early infant feeding and type 1 diabetes. European Journal of Nutrition2009;48(4):243‐9. [DOI: 10.1007/s00394‐009‐0008‐z; PUBMED: 19263185] SavilahtiEM , SaarinenKM , SavilahtiE . Specific antibodies to cow's milk proteins in infants: effect of early feeding and diagnosis of cow's milk allergy. European Journal of Nutrition2010;49(8):501‐4. [DOI: 10.1007/s00394‐010‐0109‐8; PUBMED: 20405136] SiltanenM , KajosaariM , PoussaT , SaarinenKM , SavilahtiE . A dual long‐term effect of breastfeeding on atopy in relation to heredity in children at 4 years of age. Allergy2003;58(6):524‐30. [PUBMED: 12757455] ">Saarinen 1999</a> reported outcomes of an unblinded elimination/challenge for CMA. <a href="./references#CD003664-bbs2-0005" title="JuvonenP , ManssonM , AnderssonC , JakobssonI . Allergy development and macromolecular absorption in infants with different feeding regimens during the first three days of life. A three‐year prospective follow‐up. Acta Paediatrica1996;85(9):1047‐52. [PUBMED: 8888916] JuvonenP , ManssonM , JakobssonI . Does early diet have an effect on subsequent macromolecular absorption and serum IgE?. Journal of Pediatric Gastroenterology and Nutrition1994;18(3):344‐9. [PUBMED: 8057219] JuvonenP , ManssonM , KjellmanNI , BjorkstenB , JakobssonI . Development of immunoglobulin G and immunoglobulin E antibodies to cow's milk proteins and ovalbumin after a temporary neonatal exposure to hydrolyzed and whole cow's milk proteins. Pediatric Allergy and Immunology1999;10(3):191‐8. [PUBMED: 10565560] ">Juvonen 1996</a> did not report criteria for diagnosis of allergic disease. </p> </li> <li> <p>Type of protein hydrolysate used: <a href="./references#CD003664-bbs2-0005" title="JuvonenP , ManssonM , AnderssonC , JakobssonI . Allergy development and macromolecular absorption in infants with different feeding regimens during the first three days of life. A three‐year prospective follow‐up. Acta Paediatrica1996;85(9):1047‐52. [PUBMED: 8888916] JuvonenP , ManssonM , JakobssonI . Does early diet have an effect on subsequent macromolecular absorption and serum IgE?. Journal of Pediatric Gastroenterology and Nutrition1994;18(3):344‐9. [PUBMED: 8057219] JuvonenP , ManssonM , KjellmanNI , BjorkstenB , JakobssonI . Development of immunoglobulin G and immunoglobulin E antibodies to cow's milk proteins and ovalbumin after a temporary neonatal exposure to hydrolyzed and whole cow's milk proteins. Pediatric Allergy and Immunology1999;10(3):191‐8. [PUBMED: 10565560] ">Juvonen 1996</a> compared an extensively hydrolysed casein formula versus CMF. <a href="./references#CD003664-bbs2-0012" title="SaarinenKM , Juntunen‐BackmanK , JarvenpaaAL , KlemettiP , KuitunenP , LopeL , et al. Breast‐feeding and the development of cows' milk protein allergy. Advances in Experimental Medicine and Biology2000;478:121‐30. [DOI: 10.1007/0‐306‐46830‐1_10; PUBMED: 11065065] SaarinenKM , Juntunen‐BackmanK , JarvenpaaAL , KuitunenP , LopeL , RenlundM , et al. Supplementary feeding in maternity hospitals and the risk of cow's milk allergy: a prospective study of 6209 infants. Journal of Allergy and Clinical Immunology1999;104(2 Pt 1):457‐61. [PUBMED: 10452771] SaarinenKM , SavilahtiE . Infant feeding patterns affect the subsequent immunological features in cow's milk allergy. Clinical and Experimental Allergy2000;30(3):400‐6. [DOI: 10691899] SaarinenKM , SuomalainenH , SavilahtiE . Diagnostic value of skin‐prick and patch tests and serum eosinophil cationic protein and cow's milk‐specific IgE in infants with cow's milk allergy. Clinical and Experimental Allergy2001;31(3):423‐9. [PUBMED: 11260154] SaarinenKM , VaaralaO , KlemettiP , SavilahtiE . Transforming growth factor‐beta1 in mothers' colostrum and immune responses to cows' milk proteins in infants with cows' milk allergy. Journal of Allergy and Clinical Immunology1999;104(5):1093‐8. [PUBMED: 10550758] SavilahtiE , SaarinenKM . Early infant feeding and type 1 diabetes. European Journal of Nutrition2009;48(4):243‐9. [DOI: 10.1007/s00394‐009‐0008‐z; PUBMED: 19263185] SavilahtiEM , SaarinenKM , SavilahtiE . Specific antibodies to cow's milk proteins in infants: effect of early feeding and diagnosis of cow's milk allergy. European Journal of Nutrition2010;49(8):501‐4. [DOI: 10.1007/s00394‐010‐0109‐8; PUBMED: 20405136] SiltanenM , KajosaariM , PoussaT , SaarinenKM , SavilahtiE . A dual long‐term effect of breastfeeding on atopy in relation to heredity in children at 4 years of age. Allergy2003;58(6):524‐30. [PUBMED: 12757455] ">Saarinen 1999</a> compared an extensively hydrolysed whey formula versus CMF. </p> </li> </ul> </p> <section id="CD003664-sec-0108"> <h6 class="title">Sensitivity analysis</h6> <p>We considered both studies to be at high risk of bias.</p> </section> </section> <section id="CD003664-sec-0109"> <h5 class="title">Comparison 3. Prolonged feeding: hydrolysed formula versus human milk feeding</h5> <p>We found no studies that compared prolonged feeding with hydrolysed formula versus human milk feeding. </p> </section> <section id="CD003664-sec-0110"> <h5 class="title">Comparison 4. Prolonged feeding: hydrolysed formula versus cow's milk formula (CMF)</h5> <p>Twelve studies (<a href="./references#CD003664-bbs2-0001" title="ChiricoG , GasparoniA , CiardelliL , DeAmiciM , ColomboA , RondiniG . Immunogenicity and antigenicity of a partially hydrolyzed cow's milk infant formula. Allergy1997;52(1):82‐8. [PUBMED: 9062633] ">Chirico 1997</a>; <a href="./references#CD003664-bbs2-0002" title="deSetaL , SianiP , CirilloG , DiGruttolaM , CimaduomoL , ColettaS . The prevention of allergic diseases with a hypoallergenic formula: a follow‐up at 24 months. The preliminary results. [Italian]. La Pediatria Medica e Chirurgica: Medical and Surgical Pediatrics1994;16(3):251‐4. [PUBMED: 7971447] ">de Seta 1994</a>; <a href="./references#CD003664-bbs2-0004" title="HillD . A report on the analysis of the Melbourne Atopy Cohort Study. A study designed to test the effectiveness of different formula types on the development of atopic symptoms and signs on a cohort of atopy‐at‐risk infants. Report at year 2. Nestec Internal Report. HillDJ , SporikR , ThorburnJ , HoskingCS . The association of atopic dermatitis in infancy with immunoglobulin E food sensitization. Journal of Pediatrics2000;137(4):475‐9. [DOI: 10.1067/mpd.2000.108207; PUBMED: 11035824] KoplinJ , DharmageSC , GurrinL , OsborneN , TangML , LoweAJ , et al. Soy consumption is not a risk factor for peanut sensitization. Journal of Allergy and Clinical Immunology2008;121(6):1455‐9. [DOI: 10.1016/j.jaci.2008.03.017; PUBMED: 18436294] LoweA , HoskingC , BennettC , AllenK , CarlinJ , DharmageS , et al. The Melbourne Atopy Cohort Study: a RCT of a partially hydrolysed whey formula for the prevention of allergic disease. Internal Medicine Journal2008;38:A158. LoweAJ , AbramsonMJ , HoskingCS , CarlinJB , BennettCM , DharmageSC , et al. The temporal sequence of allergic sensitization and onset of infantile eczema. Clinical &amp; Experimental Allergy2007;37(4):536‐42; Erratum in: Clinical &amp; Experimental Allergy 2007; 37(12);1895. [DOI: 10.1111/j.1365‐2222.2007.02691.x; PUBMED: 17430350] LoweAJ , CarlinJB , BennettCM , HoskingCS , AllenKJ , RobertsonCF , et al. Paracetamol use in early life and asthma: prospective birth cohort study. BMJ2010;341:c4616. [PUBMED: 20843914] LoweAJ , HoskingCS , BennettCM , AllenKJ , AxelradC , CarlinJB , et al. Effect of a partially hydrolyzed whey infant formula at weaning on risk of allergic disease in high‐risk children: a randomized controlled trial. Journal of Allergy and Clinical Immunology2011;128(2):360‐5.e4. [DOI: 10.1016/j.jaci.2010.05.006; PUBMED: 21696814] StoneyRM , WoodsRK , HoskingCS , HillDJ , AbramsonMJ , ThienFC . Maternal breast milk long‐chain n‐3 fatty acids are associated with increased risk of atopy in breastfed infants. Clinical and Experimental Allergy2004;34(2):194‐200; Erratum in: Clinical &amp; Experimental Allergy 2007; 37(12);1895. [PUBMED: 14987297] ThomsonJA , WidjajaC , DarmaputraAA , LoweA , MathesonMC , BennettCM , et al. Early childhood infections and immunisation and the development of allergic disease in particular asthma in a high‐risk cohort: a prospective study of allergy‐prone children from birth to six years. Pediatric Allergy and Immunology2010;21(7):1076‐85. [DOI: 10.1111/j.1399‐3038.2010.01018.x; PUBMED: 20337970] ">Hill 2000</a>; <a href="./references#CD003664-bbs2-0006" title="KwintaP , SawiecP , KlimekM , LisG , Cichocka‐JaroszE , PietrzykJJ . Correlation between early neonatal diet and atopic symptoms up to 5‐7 years of age in very low birth weight infants: follow‐up of randomized, double‐blind study. Pediatric Allergy and Immunology2009;20(5):458‐66. [DOI: 10.1111/j.1399‐3038.2008.00814.x; PUBMED: 19490477] ">Kwinta 2009</a>; <a href="./references#CD003664-bbs2-0007" title="LamBC , YeungCY . The effect of breast milk, infant formula and hypoallergenic formula on incidence of atopic manifestation in high risk infants. Nestle Internal Report1992. ">Lam 1992</a>; <a href="./references#CD003664-bbs2-0008" title="MalletE , HenocqA . Long‐term prevention of allergic diseases by using protein hydrolysate formula in at‐risk infants. Journal of Pediatrics1992;121(5 Pt 2):S95‐100. [PUBMED: 1447641] ">Mallet 1992</a>; <a href="./references#CD003664-bbs2-0009" title="MariniA , AgostiM , MottaG , MoscaF . Effects of a dietary and environmental prevention programme on the incidence of allergic symptoms in high atopic risk infants: three years' follow‐up. Acta Paediatrica Supplement1996;414:1‐21. [PUBMED: 8831855] ">Marini 1996</a>; <a href="./references#CD003664-bbs2-0011" title="OldaeusG , AnjouK , BjorkstenB , MoranJR , KjellmanNI . Extensively and partially hydrolysed infant formulas for allergy prophylaxis. Archives of Disease in Childhood1997;77(1):4‐10. [PUBMED: 9279143] OldaeusG , BjorkstenB , JenmalmMC , KjellmanNI . Cow's milk IgE and IgG antibody responses to cow's milk formulas. Allergy1999;54(4):352‐7. [PUBMED: 10371094] ">Oldaeus 1997</a>; <a href="./references#CD003664-bbs2-0013" title="TsaiYT , ChouCC , HsiehKH . The effect of hypoallergenic formula on the occurrence of allergic diseases in high risk infants. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi1991;32(3):137‐44. [PUBMED: 1776437] ">Tsai 1991</a>; <a href="./references#CD003664-bbs2-0014" title="VandenplasY . Atopy at 3 years in high‐risk infants fed whey hydrolysate or conventional formula. Lancet1992;339(8801):1118. [PUBMED: 1349137] VandenplasY , HauserB , Van denBorreC , ClybouwC , MahlerT , Hachimi‐IdrissiS , et al. The long‐term effect of a partial whey hydrolysate formula on the prophylaxis of atopic disease. European Journal of Pediatrics1995;154(6):488‐94. [PUBMED: 7671948] VandenplasY , HauserB , Van denBorreC , SacreL , DabI . Effect of a whey hydrolysate prophylaxis of atopic disease. Annals of Allergy1992;68(5):419‐24. [PUBMED: 1586005] ">Vandenplas 1992</a>; <a href="./references#CD003664-bbs2-0015" title="BergA , KramerU , LinkE , BollrathC , HeinrichJ , BrockowI , et al. GINIplus study group. Impact of early feeding on childhood eczema: development after nutritional intervention compared with the natural course ‐ the GINIplus study up to the age of 6 years. Clinical and Experimental Allergy2010;40(4):627‐36. [DOI: 10.1111/j.1365‐2222.2009.03444.x; PUBMED: 20082618] BrockowI , ZutavernA , HoffmannU , GrublA , vonBergA , KoletzkoS , et al. GINIplus Study Group. Early allergic sensitizations and their relevance to atopic diseases in children aged 6 years: results of the GINI study. Journal of Investigational Allergology &amp; Clinical Immunology2009;19(3):180‐7. [DOI: 19610260] LaubereauB , BrockowI , ZirngiblA , KoletzkoS , GrueblA , vonBergA , et al. GINI Study Group. Effect of breast‐feeding on the development of atopic dermatitis during the first 3 years of life ‐ results from the GINI‐birth cohort study. Journal of Pediatrics2004;144(5):602‐7. [DOI: 10.1016/j.jpeds.2003.12.029; PUBMED: 15126993] LaubereauB , Filipiak‐PittroffB , vonBergA , GrublA , ReinhardtD , WichmannHE , et al. Caesarean section and gastrointestinal symptoms, atopic dermatitis, and sensitisation during the first year of life. Archives of Disease in Childhood2004;89(11):993‐7. [DOI: 10.1136/adc.2003.043265; PUBMED: 15499049] RzehakP , SausenthalerS , KoletzkoS , BauerCP , SchaafB , vonBergA , et al. Period‐specific growth, overweight and modification by breastfeeding in the GINI and LISA birth cohorts up to age 6 years. European Journal of Epidemiology2009;24(8):449‐67. [DOI: 10.1007/s10654‐009‐9356‐5; PUBMED: 19521784] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. GINI‐plus Study Group. Long‐term effects of hydrolyzed protein infant formulas on growth ‐ extended follow‐up to 10 y of age: results from the German Infant Nutritional Intervention (GINI) study. American Journal of Clinical Nutrition2011;94(6 Suppl):1803S‐7S. [DOI: 10.3945/ajcn.110.000679; PUBMED: 21849601] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. German Infant Nutritional Intervention Study Group. Short‐ and long‐term effects of feeding hydrolyzed protein infant formulas on growth at &lt; or = 6 y of age: results from the German Infant Nutritional Intervention Study. American Journal of Clinical Nutrition2009;89(6):1846‐56. [DOI: 10.3945/ajcn.2008.27373; PUBMED: 19369380] SausenthalerS , KoletzkoS , KoletzkoB , ReinhardtD , KramerU , vonBergA , et al. GINIplus study group. Effect of hydrolysed formula feeding on taste preferences at 10 years. Data from the German Infant Nutritional Intervention Program Plus Study. Clinical Nutrition2010;29(3):304‐6. [DOI: 10.1016/j.clnu.2010.01.007; PUBMED: 20110140] SchoetzauA , Filipiak‐PittroffB , FrankeK , KoletzkoS , VonBergA , GrueblA , et al. German Infant Nutritional Intervention Study Group. Effect of exclusive breast‐feeding and early solid food avoidance on the incidence of atopic dermatitis in high‐risk infants at 1 year of age. Pediatric Allergy and Immunology2002;13(4):234‐42. [PUBMED: 12390439] SchoetzauA , GehringU , FrankeK , GrublA , KoletzkoS , vonBergA , et al. Gini Study Group. Maternal compliance with nutritional recommendations in an allergy preventive programme. Archives of Disease in Childhood2002;86(3):180‐4. [PUBMED: 11861235] VonBergA , Filipiak‐PittroffB , KrämerU , LinkE , HeinrichJ , KoletzkoS , et al. The German Infant Nutritional Intervention Study (GINI) for the preventive effect of hydrolysed infant formulas in infants at high risk for allergic diseases. Design and selected results. Allergologie2012;35(1):32‐43. VonBergA , Filipiak‐PittroffB , SchulzH , HoffmannU , LinkE , SussmannM , et al. GINIplus study group. Allergic manifestation 15 years after early intervention with hydrolyzed formulas ‐ the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2016;71(2):210‐9. [DOI: 10.1111/all.12790; PUBMED: 26465137] vonBergA , FilipiakB , KoletzkoS , KrämerU , HoffmannB , LinkE , et al. Long‐term effect of cow milk protein hydrolysates in high‐risk children. Results from the 10‐years follow‐up of the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2013;68:295‐6. vonBergA , Filipiak‐PittroffB , KramerU , HoffmannB , LinkE , BeckmannC , et al. GINIplus study group. Allergies in high‐risk schoolchildren after early intervention with cow's milk protein hydrolysates: 10‐year results from the German Infant Nutritional Intervention (GINI) study. Journal of Allergy and Clinical Immunology2013;131(6):1565‐73. [DOI: 10.1016/j.jaci.2013.01.006; PUBMED: 23506844] vonBergA , Filipiak‐PittroffB , KramerU , LinkE , BollrathC , BrockowI , et al. GINIplus study group. Preventive effect of hydrolyzed infant formulas persists until age 6 years: long‐term results from the German Infant Nutritional Intervention Study (GINI). Journal of Allergy and Clinical Immunology2008;121(6):1442‐7. [DOI: 10.1016/j.jaci.2008.04.021; PUBMED: 18539195] vonBergA , KoletzkoS , Filipiak‐PittroffB , LaubereauB , GrublA , WichmannHE , et al. German Infant Nutritional Intervention Study Group. Certain hydrolyzed formulas reduce the incidence of atopic dermatitis but not that of asthma: three‐year results of the German Infant Nutritional Intervention Study. Journal of Allergy and Clinical Immunology2007;119(3):718‐25. [DOI: 10.1016/j.jaci.2006.11.017; PUBMED: 17240440] vonBergA , KoletzkoS , GrublA , Filipiak‐PittroffB , WichmannHE , BauerCP , et al. German Infant Nutritional Intervention Study Group. The effect of hydrolyzed cow's milk formula for allergy prevention in the first year of life: the German Infant Nutritional Intervention Study, a randomized double‐blind trial. Journal of Allergy and Clinical Immunology2003;111(3):533‐40. [PUBMED: 12642834] ">von Berg 2003</a>; <a href="./references#CD003664-bbs2-0016" title="WillemsR , DuchateauJ , MagrezP , DenisR , CasimirG . Influence of hypoallergenic milk formula on the incidence of early allergic manifestations in infants predisposed to atopic diseases. Annals of Allergy1993;71(2):147‐50. [PUBMED: 8346868] ">Willems 1993</a>) reported outcomes comparing prolonged hydrolysed formula versus CMF feeding. </p> <p>Meta‐analysis found no difference in infant allergic disease (typical RR 0.88, 95% CI 0.76 to 1.01; participants = 2852; studies = 8; I<sup>2</sup> = 48% [heterogeneity low]). Meta‐analysis found no difference in childhood allergic disease incidence (typical RR 0.85, 95% CI 0.69 to 1.05; participants = 950; studies = 2; I<sup>2</sup> = 73% [heterogeneity moderate]). One study (<a href="./references#CD003664-bbs2-0006" title="KwintaP , SawiecP , KlimekM , LisG , Cichocka‐JaroszE , PietrzykJJ . Correlation between early neonatal diet and atopic symptoms up to 5‐7 years of age in very low birth weight infants: follow‐up of randomized, double‐blind study. Pediatric Allergy and Immunology2009;20(5):458‐66. [DOI: 10.1111/j.1399‐3038.2008.00814.x; PUBMED: 19490477] ">Kwinta 2009</a>) reported no difference in childhood allergic disease prevalence (RR 1.76, 95% CI 0.76 to 4.09; participants = 62). See <a href="#CD003664-fig-0004">Figure 4</a> for funnel plot. </p> <div class="figure" id="CD003664-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 4 Prolonged feeding: hydrolysed formula versus cow's milk formula, outcome: 4.1 All allergic disease." data-id="CD003664-fig-0004" src="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 4 Prolonged feeding: hydrolysed formula versus cow's milk formula, outcome: 4.1 All allergic disease. </p> </div> </div> </div> <p>Meta‐analysis found no difference in infant asthma (typical RR 0.57, 95% CI 0.31 to 1.04; participants = 318; studies = 4; I<sup>2</sup> = 0%). <a href="./references#CD003664-bbs2-0009" title="MariniA , AgostiM , MottaG , MoscaF . Effects of a dietary and environmental prevention programme on the incidence of allergic symptoms in high atopic risk infants: three years' follow‐up. Acta Paediatrica Supplement1996;414:1‐21. [PUBMED: 8831855] ">Marini 1996</a> reported no difference in childhood asthma incidence (RR 0.38, 95% CI 0.08 to 1.84; participants = 78). Meta‐analysis found no difference in childhood asthma prevalence (typical RR 1.03, 95% CI 0.79 to 1.33; participants = 1229; studies = 3; I<sup>2</sup> = 26% [heterogeneity low]). </p> <p>Meta‐analysis found no difference in infant eczema (typical RR 0.93, 95% CI 0.79 to 1.09; participants = 2896; studies = 9; I<sup>2</sup> = 9%). Meta‐analysis found no difference in childhood eczema incidence (typical RR 0.83, 95% CI 0.63 to 1.10; participants = 950; studies = 2; I<sup>2</sup> = 40% [heterogeneity low]). Meta‐analysis found no difference in childhood eczema prevalence (typical RR 0.86, 95% CI 0.66 to 1.12; participants = 1228; studies = 3; I<sup>2</sup> = 53% [heterogeneity moderate]). (See <a href="#CD003664-fig-0005">Figure 5</a> for funnel plot.) </p> <div class="figure" id="CD003664-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 4 Prolonged feeding: hydrolysed formula versus cow's milk formula, outcome: 4.3 Eczema." data-id="CD003664-fig-0005" src="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-AFig-FIG05.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 4 Prolonged feeding: hydrolysed formula versus cow's milk formula, outcome: 4.3 Eczema. </p> </div> </div> </div> <p>Meta‐analysis found no difference in infant rhinitis (typical RR 0.52, 95% CI 0.14 to 1.85; participants = 256; studies = 3; I<sup>2</sup> = 0%). <a href="./references#CD003664-bbs2-0009" title="MariniA , AgostiM , MottaG , MoscaF . Effects of a dietary and environmental prevention programme on the incidence of allergic symptoms in high atopic risk infants: three years' follow‐up. Acta Paediatrica Supplement1996;414:1‐21. [PUBMED: 8831855] ">Marini 1996</a> reported no difference in childhood rhinitis incidence (RR 0.47, 95% CI 0.04 to 5.03; participants = 78). Meta‐analysis found no difference in childhood rhinitis prevalence (typical RR 0.97, 95% CI 0.66 to 1.41; participants = 357; studies = 2; I<sup>2</sup> = 0%). </p> <p>Meta‐analysis found no difference in infant food allergy (typical RR 1.42, 95% CI 0.87 to 2.33; participants = 479; studies = 2; I<sup>2</sup> = 0%). <a href="./references#CD003664-bbs2-0004" title="HillD . A report on the analysis of the Melbourne Atopy Cohort Study. A study designed to test the effectiveness of different formula types on the development of atopic symptoms and signs on a cohort of atopy‐at‐risk infants. Report at year 2. Nestec Internal Report. HillDJ , SporikR , ThorburnJ , HoskingCS . The association of atopic dermatitis in infancy with immunoglobulin E food sensitization. Journal of Pediatrics2000;137(4):475‐9. [DOI: 10.1067/mpd.2000.108207; PUBMED: 11035824] KoplinJ , DharmageSC , GurrinL , OsborneN , TangML , LoweAJ , et al. Soy consumption is not a risk factor for peanut sensitization. Journal of Allergy and Clinical Immunology2008;121(6):1455‐9. [DOI: 10.1016/j.jaci.2008.03.017; PUBMED: 18436294] LoweA , HoskingC , BennettC , AllenK , CarlinJ , DharmageS , et al. The Melbourne Atopy Cohort Study: a RCT of a partially hydrolysed whey formula for the prevention of allergic disease. Internal Medicine Journal2008;38:A158. LoweAJ , AbramsonMJ , HoskingCS , CarlinJB , BennettCM , DharmageSC , et al. The temporal sequence of allergic sensitization and onset of infantile eczema. Clinical &amp; Experimental Allergy2007;37(4):536‐42; Erratum in: Clinical &amp; Experimental Allergy 2007; 37(12);1895. [DOI: 10.1111/j.1365‐2222.2007.02691.x; PUBMED: 17430350] LoweAJ , CarlinJB , BennettCM , HoskingCS , AllenKJ , RobertsonCF , et al. Paracetamol use in early life and asthma: prospective birth cohort study. BMJ2010;341:c4616. [PUBMED: 20843914] LoweAJ , HoskingCS , BennettCM , AllenKJ , AxelradC , CarlinJB , et al. Effect of a partially hydrolyzed whey infant formula at weaning on risk of allergic disease in high‐risk children: a randomized controlled trial. Journal of Allergy and Clinical Immunology2011;128(2):360‐5.e4. [DOI: 10.1016/j.jaci.2010.05.006; PUBMED: 21696814] StoneyRM , WoodsRK , HoskingCS , HillDJ , AbramsonMJ , ThienFC . Maternal breast milk long‐chain n‐3 fatty acids are associated with increased risk of atopy in breastfed infants. Clinical and Experimental Allergy2004;34(2):194‐200; Erratum in: Clinical &amp; Experimental Allergy 2007; 37(12);1895. [PUBMED: 14987297] ThomsonJA , WidjajaC , DarmaputraAA , LoweA , MathesonMC , BennettCM , et al. Early childhood infections and immunisation and the development of allergic disease in particular asthma in a high‐risk cohort: a prospective study of allergy‐prone children from birth to six years. Pediatric Allergy and Immunology2010;21(7):1076‐85. [DOI: 10.1111/j.1399‐3038.2010.01018.x; PUBMED: 20337970] ">Hill 2000</a> reported no difference in infant CMA (RR 2.31, 95% CI 0.24 to 21.97; participants = 338). Another study (<a href="./references#CD003664-bbs2-0014" title="VandenplasY . Atopy at 3 years in high‐risk infants fed whey hydrolysate or conventional formula. Lancet1992;339(8801):1118. [PUBMED: 1349137] VandenplasY , HauserB , Van denBorreC , ClybouwC , MahlerT , Hachimi‐IdrissiS , et al. The long‐term effect of a partial whey hydrolysate formula on the prophylaxis of atopic disease. European Journal of Pediatrics1995;154(6):488‐94. [PUBMED: 7671948] VandenplasY , HauserB , Van denBorreC , SacreL , DabI . Effect of a whey hydrolysate prophylaxis of atopic disease. Annals of Allergy1992;68(5):419‐24. [PUBMED: 1586005] ">Vandenplas 1992</a>) previously included in this analysis is no longer included as it did not report IgE‐mediated CMA consistent with WHO criteria (<a href="./references#CD003664-bbs2-0135" title="JohanssonSG , BieberT , DahlR , FriedmannPS , LanierBQ , LockeyRF , et al. Revised nomenclature for allergy for global use. Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. Journal of Allergy and Clinical Immunology2004;113(5):832‐6. [DOI: 10.1016/j.jaci.2003.12.591; PUBMED: 15131563] ">Johansson 2004</a>). </p> <p>Quality of evidence was assessed as 'very low' for all outcomes (see <a href="./full#CD003664-tbl-0003">summary of findings Table 3</a>). </p> </section> </section> <section id="CD003664-sec-0111"> <h4 class="title">Subgroup analyses (Comparisons 5 to 10)</h4> <section id="CD003664-sec-0112"> <h5 class="title">Comparison 5. Prolonged feeding: hydrolysed formula versus cow's milk formula (CMF) ‐ low‐risk infants </h5> <p><a href="./references#CD003664-bbs2-0006" title="KwintaP , SawiecP , KlimekM , LisG , Cichocka‐JaroszE , PietrzykJJ . Correlation between early neonatal diet and atopic symptoms up to 5‐7 years of age in very low birth weight infants: follow‐up of randomized, double‐blind study. Pediatric Allergy and Immunology2009;20(5):458‐66. [DOI: 10.1111/j.1399‐3038.2008.00814.x; PUBMED: 19490477] ">Kwinta 2009</a> compared prolonged feeding with a hydrolysed formula versus CMF in low‐risk infants. <a href="./references#CD003664-bbs2-0006" title="KwintaP , SawiecP , KlimekM , LisG , Cichocka‐JaroszE , PietrzykJJ . Correlation between early neonatal diet and atopic symptoms up to 5‐7 years of age in very low birth weight infants: follow‐up of randomized, double‐blind study. Pediatric Allergy and Immunology2009;20(5):458‐66. [DOI: 10.1111/j.1399‐3038.2008.00814.x; PUBMED: 19490477] ">Kwinta 2009</a> reported no difference in childhood prevalence of allergic disease (RR 1.76, 95% CI 0.76 to 4.09; participants = 62), asthma (RR 2.20, 95% CI 0.77 to 6.26; participants = 62), eczema (RR 0.29, 95% CI 0.03 to 2.66; participants = 62) and rhinitis (RR 1.32, 95% CI 0.53 to 3.26; participants = 62). </p> </section> <section id="CD003664-sec-0113"> <h5 class="title">Comparison 6. Prolonged feeding: hydrolysed formula versus cow's milk formula (CMF) ‐ high‐risk infants </h5> <p>Eight studies (<a href="./references#CD003664-bbs2-0002" title="deSetaL , SianiP , CirilloG , DiGruttolaM , CimaduomoL , ColettaS . The prevention of allergic diseases with a hypoallergenic formula: a follow‐up at 24 months. The preliminary results. [Italian]. La Pediatria Medica e Chirurgica: Medical and Surgical Pediatrics1994;16(3):251‐4. [PUBMED: 7971447] ">de Seta 1994</a>; <a href="./references#CD003664-bbs2-0004" title="HillD . A report on the analysis of the Melbourne Atopy Cohort Study. A study designed to test the effectiveness of different formula types on the development of atopic symptoms and signs on a cohort of atopy‐at‐risk infants. Report at year 2. Nestec Internal Report. HillDJ , SporikR , ThorburnJ , HoskingCS . The association of atopic dermatitis in infancy with immunoglobulin E food sensitization. Journal of Pediatrics2000;137(4):475‐9. [DOI: 10.1067/mpd.2000.108207; PUBMED: 11035824] KoplinJ , DharmageSC , GurrinL , OsborneN , TangML , LoweAJ , et al. Soy consumption is not a risk factor for peanut sensitization. Journal of Allergy and Clinical Immunology2008;121(6):1455‐9. [DOI: 10.1016/j.jaci.2008.03.017; PUBMED: 18436294] LoweA , HoskingC , BennettC , AllenK , CarlinJ , DharmageS , et al. The Melbourne Atopy Cohort Study: a RCT of a partially hydrolysed whey formula for the prevention of allergic disease. Internal Medicine Journal2008;38:A158. LoweAJ , AbramsonMJ , HoskingCS , CarlinJB , BennettCM , DharmageSC , et al. The temporal sequence of allergic sensitization and onset of infantile eczema. Clinical &amp; Experimental Allergy2007;37(4):536‐42; Erratum in: Clinical &amp; Experimental Allergy 2007; 37(12);1895. [DOI: 10.1111/j.1365‐2222.2007.02691.x; PUBMED: 17430350] LoweAJ , CarlinJB , BennettCM , HoskingCS , AllenKJ , RobertsonCF , et al. Paracetamol use in early life and asthma: prospective birth cohort study. BMJ2010;341:c4616. [PUBMED: 20843914] LoweAJ , HoskingCS , BennettCM , AllenKJ , AxelradC , CarlinJB , et al. Effect of a partially hydrolyzed whey infant formula at weaning on risk of allergic disease in high‐risk children: a randomized controlled trial. Journal of Allergy and Clinical Immunology2011;128(2):360‐5.e4. [DOI: 10.1016/j.jaci.2010.05.006; PUBMED: 21696814] StoneyRM , WoodsRK , HoskingCS , HillDJ , AbramsonMJ , ThienFC . Maternal breast milk long‐chain n‐3 fatty acids are associated with increased risk of atopy in breastfed infants. Clinical and Experimental Allergy2004;34(2):194‐200; Erratum in: Clinical &amp; Experimental Allergy 2007; 37(12);1895. [PUBMED: 14987297] ThomsonJA , WidjajaC , DarmaputraAA , LoweA , MathesonMC , BennettCM , et al. Early childhood infections and immunisation and the development of allergic disease in particular asthma in a high‐risk cohort: a prospective study of allergy‐prone children from birth to six years. Pediatric Allergy and Immunology2010;21(7):1076‐85. [DOI: 10.1111/j.1399‐3038.2010.01018.x; PUBMED: 20337970] ">Hill 2000</a>; <a href="./references#CD003664-bbs2-0007" title="LamBC , YeungCY . The effect of breast milk, infant formula and hypoallergenic formula on incidence of atopic manifestation in high risk infants. Nestle Internal Report1992. ">Lam 1992</a>; <a href="./references#CD003664-bbs2-0009" title="MariniA , AgostiM , MottaG , MoscaF . Effects of a dietary and environmental prevention programme on the incidence of allergic symptoms in high atopic risk infants: three years' follow‐up. Acta Paediatrica Supplement1996;414:1‐21. [PUBMED: 8831855] ">Marini 1996</a>; <a href="./references#CD003664-bbs2-0011" title="OldaeusG , AnjouK , BjorkstenB , MoranJR , KjellmanNI . Extensively and partially hydrolysed infant formulas for allergy prophylaxis. Archives of Disease in Childhood1997;77(1):4‐10. [PUBMED: 9279143] OldaeusG , BjorkstenB , JenmalmMC , KjellmanNI . Cow's milk IgE and IgG antibody responses to cow's milk formulas. Allergy1999;54(4):352‐7. [PUBMED: 10371094] ">Oldaeus 1997</a>; <a href="./references#CD003664-bbs2-0014" title="VandenplasY . Atopy at 3 years in high‐risk infants fed whey hydrolysate or conventional formula. Lancet1992;339(8801):1118. [PUBMED: 1349137] VandenplasY , HauserB , Van denBorreC , ClybouwC , MahlerT , Hachimi‐IdrissiS , et al. The long‐term effect of a partial whey hydrolysate formula on the prophylaxis of atopic disease. European Journal of Pediatrics1995;154(6):488‐94. [PUBMED: 7671948] VandenplasY , HauserB , Van denBorreC , SacreL , DabI . Effect of a whey hydrolysate prophylaxis of atopic disease. Annals of Allergy1992;68(5):419‐24. [PUBMED: 1586005] ">Vandenplas 1992</a>; <a href="./references#CD003664-bbs2-0015" title="BergA , KramerU , LinkE , BollrathC , HeinrichJ , BrockowI , et al. GINIplus study group. Impact of early feeding on childhood eczema: development after nutritional intervention compared with the natural course ‐ the GINIplus study up to the age of 6 years. Clinical and Experimental Allergy2010;40(4):627‐36. [DOI: 10.1111/j.1365‐2222.2009.03444.x; PUBMED: 20082618] BrockowI , ZutavernA , HoffmannU , GrublA , vonBergA , KoletzkoS , et al. GINIplus Study Group. Early allergic sensitizations and their relevance to atopic diseases in children aged 6 years: results of the GINI study. Journal of Investigational Allergology &amp; Clinical Immunology2009;19(3):180‐7. [DOI: 19610260] LaubereauB , BrockowI , ZirngiblA , KoletzkoS , GrueblA , vonBergA , et al. GINI Study Group. Effect of breast‐feeding on the development of atopic dermatitis during the first 3 years of life ‐ results from the GINI‐birth cohort study. Journal of Pediatrics2004;144(5):602‐7. [DOI: 10.1016/j.jpeds.2003.12.029; PUBMED: 15126993] LaubereauB , Filipiak‐PittroffB , vonBergA , GrublA , ReinhardtD , WichmannHE , et al. Caesarean section and gastrointestinal symptoms, atopic dermatitis, and sensitisation during the first year of life. Archives of Disease in Childhood2004;89(11):993‐7. [DOI: 10.1136/adc.2003.043265; PUBMED: 15499049] RzehakP , SausenthalerS , KoletzkoS , BauerCP , SchaafB , vonBergA , et al. Period‐specific growth, overweight and modification by breastfeeding in the GINI and LISA birth cohorts up to age 6 years. European Journal of Epidemiology2009;24(8):449‐67. [DOI: 10.1007/s10654‐009‐9356‐5; PUBMED: 19521784] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. GINI‐plus Study Group. Long‐term effects of hydrolyzed protein infant formulas on growth ‐ extended follow‐up to 10 y of age: results from the German Infant Nutritional Intervention (GINI) study. American Journal of Clinical Nutrition2011;94(6 Suppl):1803S‐7S. [DOI: 10.3945/ajcn.110.000679; PUBMED: 21849601] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. German Infant Nutritional Intervention Study Group. Short‐ and long‐term effects of feeding hydrolyzed protein infant formulas on growth at &lt; or = 6 y of age: results from the German Infant Nutritional Intervention Study. American Journal of Clinical Nutrition2009;89(6):1846‐56. [DOI: 10.3945/ajcn.2008.27373; PUBMED: 19369380] SausenthalerS , KoletzkoS , KoletzkoB , ReinhardtD , KramerU , vonBergA , et al. GINIplus study group. Effect of hydrolysed formula feeding on taste preferences at 10 years. Data from the German Infant Nutritional Intervention Program Plus Study. Clinical Nutrition2010;29(3):304‐6. [DOI: 10.1016/j.clnu.2010.01.007; PUBMED: 20110140] SchoetzauA , Filipiak‐PittroffB , FrankeK , KoletzkoS , VonBergA , GrueblA , et al. German Infant Nutritional Intervention Study Group. Effect of exclusive breast‐feeding and early solid food avoidance on the incidence of atopic dermatitis in high‐risk infants at 1 year of age. Pediatric Allergy and Immunology2002;13(4):234‐42. [PUBMED: 12390439] SchoetzauA , GehringU , FrankeK , GrublA , KoletzkoS , vonBergA , et al. Gini Study Group. Maternal compliance with nutritional recommendations in an allergy preventive programme. Archives of Disease in Childhood2002;86(3):180‐4. [PUBMED: 11861235] VonBergA , Filipiak‐PittroffB , KrämerU , LinkE , HeinrichJ , KoletzkoS , et al. The German Infant Nutritional Intervention Study (GINI) for the preventive effect of hydrolysed infant formulas in infants at high risk for allergic diseases. Design and selected results. Allergologie2012;35(1):32‐43. VonBergA , Filipiak‐PittroffB , SchulzH , HoffmannU , LinkE , SussmannM , et al. GINIplus study group. Allergic manifestation 15 years after early intervention with hydrolyzed formulas ‐ the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2016;71(2):210‐9. [DOI: 10.1111/all.12790; PUBMED: 26465137] vonBergA , FilipiakB , KoletzkoS , KrämerU , HoffmannB , LinkE , et al. Long‐term effect of cow milk protein hydrolysates in high‐risk children. Results from the 10‐years follow‐up of the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2013;68:295‐6. vonBergA , Filipiak‐PittroffB , KramerU , HoffmannB , LinkE , BeckmannC , et al. GINIplus study group. Allergies in high‐risk schoolchildren after early intervention with cow's milk protein hydrolysates: 10‐year results from the German Infant Nutritional Intervention (GINI) study. Journal of Allergy and Clinical Immunology2013;131(6):1565‐73. [DOI: 10.1016/j.jaci.2013.01.006; PUBMED: 23506844] vonBergA , Filipiak‐PittroffB , KramerU , LinkE , BollrathC , BrockowI , et al. GINIplus study group. Preventive effect of hydrolyzed infant formulas persists until age 6 years: long‐term results from the German Infant Nutritional Intervention Study (GINI). Journal of Allergy and Clinical Immunology2008;121(6):1442‐7. [DOI: 10.1016/j.jaci.2008.04.021; PUBMED: 18539195] vonBergA , KoletzkoS , Filipiak‐PittroffB , LaubereauB , GrublA , WichmannHE , et al. German Infant Nutritional Intervention Study Group. Certain hydrolyzed formulas reduce the incidence of atopic dermatitis but not that of asthma: three‐year results of the German Infant Nutritional Intervention Study. Journal of Allergy and Clinical Immunology2007;119(3):718‐25. [DOI: 10.1016/j.jaci.2006.11.017; PUBMED: 17240440] vonBergA , KoletzkoS , GrublA , Filipiak‐PittroffB , WichmannHE , BauerCP , et al. German Infant Nutritional Intervention Study Group. The effect of hydrolyzed cow's milk formula for allergy prevention in the first year of life: the German Infant Nutritional Intervention Study, a randomized double‐blind trial. Journal of Allergy and Clinical Immunology2003;111(3):533‐40. [PUBMED: 12642834] ">von Berg 2003</a>; <a href="./references#CD003664-bbs2-0016" title="WillemsR , DuchateauJ , MagrezP , DenisR , CasimirG . Influence of hypoallergenic milk formula on the incidence of early allergic manifestations in infants predisposed to atopic diseases. Annals of Allergy1993;71(2):147‐50. [PUBMED: 8346868] ">Willems 1993</a>) compared prolonged hydrolysed formula feeding versus CMF feeding in high‐risk infants. </p> <p>Meta‐analysis found no difference in infant allergic disease incidence (typical RR 0.88, 95% CI 0.76 to 1.01; participants = 2852; studies = 8; I<sup>2</sup> = 48% [heterogeneity low]). Meta‐analysis found no difference in childhood allergic disease incidence (typical RR 0.85, 95% CI 0.69 to 1.05; participants = 950; studies = 2; I<sup>2</sup> = 73% [heterogeneity moderate]). </p> <p>Meta‐analysis found no difference in infant asthma incidence (typical RR 0.57, 95% CI 0.31 to 1.04; participants = 318; studies = 4; I<sup>2</sup> = 0%). <a href="./references#CD003664-bbs2-0009" title="MariniA , AgostiM , MottaG , MoscaF . Effects of a dietary and environmental prevention programme on the incidence of allergic symptoms in high atopic risk infants: three years' follow‐up. Acta Paediatrica Supplement1996;414:1‐21. [PUBMED: 8831855] ">Marini 1996</a> reported no difference in childhood asthma incidence (RR 0.38, 95% CI 0.08 to 1.84; participants = 78). Meta‐analysis found no difference in childhood asthma prevalence (typical RR 0.97, 95% CI 0.74 to 1.27; participants = 1167; studies = 2; I<sup>2</sup> = 0%). </p> <p>Meta‐analysis found no difference in infant eczema incidence (typical RR 0.93, 95% CI 0.79 to 1.09; participants = 2896; studies = 9; I<sup>2</sup> = 9%), no difference in childhood eczema incidence (typical RR 0.83, 95% CI 0.63 to 1.10; participants = 950; studies = 2; I<sup>2</sup> = 40% [heterogeneity low]) and no difference in childhood eczema prevalence (typical RR 0.89, 95% CI 0.68 to 1.15; participants = 1166; studies = 2; I<sup>2</sup> = 69% [heterogeneity moderate]). </p> <p>Meta‐analysis found no difference in infant rhinitis incidence (typical RR 0.52, 95% CI 0.14 to 1.85; participants = 256; studies = 3; I<sup>2</sup> = 0%). <a href="./references#CD003664-bbs2-0009" title="MariniA , AgostiM , MottaG , MoscaF . Effects of a dietary and environmental prevention programme on the incidence of allergic symptoms in high atopic risk infants: three years' follow‐up. Acta Paediatrica Supplement1996;414:1‐21. [PUBMED: 8831855] ">Marini 1996</a> reported no difference in childhood rhinitis incidence (RR 0.47, 95% CI 0.04 to 5.03; participants = 78). <a href="./references#CD003664-bbs2-0004" title="HillD . A report on the analysis of the Melbourne Atopy Cohort Study. A study designed to test the effectiveness of different formula types on the development of atopic symptoms and signs on a cohort of atopy‐at‐risk infants. Report at year 2. Nestec Internal Report. HillDJ , SporikR , ThorburnJ , HoskingCS . The association of atopic dermatitis in infancy with immunoglobulin E food sensitization. Journal of Pediatrics2000;137(4):475‐9. [DOI: 10.1067/mpd.2000.108207; PUBMED: 11035824] KoplinJ , DharmageSC , GurrinL , OsborneN , TangML , LoweAJ , et al. Soy consumption is not a risk factor for peanut sensitization. Journal of Allergy and Clinical Immunology2008;121(6):1455‐9. [DOI: 10.1016/j.jaci.2008.03.017; PUBMED: 18436294] LoweA , HoskingC , BennettC , AllenK , CarlinJ , DharmageS , et al. The Melbourne Atopy Cohort Study: a RCT of a partially hydrolysed whey formula for the prevention of allergic disease. Internal Medicine Journal2008;38:A158. LoweAJ , AbramsonMJ , HoskingCS , CarlinJB , BennettCM , DharmageSC , et al. The temporal sequence of allergic sensitization and onset of infantile eczema. Clinical &amp; Experimental Allergy2007;37(4):536‐42; Erratum in: Clinical &amp; Experimental Allergy 2007; 37(12);1895. [DOI: 10.1111/j.1365‐2222.2007.02691.x; PUBMED: 17430350] LoweAJ , CarlinJB , BennettCM , HoskingCS , AllenKJ , RobertsonCF , et al. Paracetamol use in early life and asthma: prospective birth cohort study. BMJ2010;341:c4616. [PUBMED: 20843914] LoweAJ , HoskingCS , BennettCM , AllenKJ , AxelradC , CarlinJB , et al. Effect of a partially hydrolyzed whey infant formula at weaning on risk of allergic disease in high‐risk children: a randomized controlled trial. Journal of Allergy and Clinical Immunology2011;128(2):360‐5.e4. [DOI: 10.1016/j.jaci.2010.05.006; PUBMED: 21696814] StoneyRM , WoodsRK , HoskingCS , HillDJ , AbramsonMJ , ThienFC . Maternal breast milk long‐chain n‐3 fatty acids are associated with increased risk of atopy in breastfed infants. Clinical and Experimental Allergy2004;34(2):194‐200; Erratum in: Clinical &amp; Experimental Allergy 2007; 37(12);1895. [PUBMED: 14987297] ThomsonJA , WidjajaC , DarmaputraAA , LoweA , MathesonMC , BennettCM , et al. Early childhood infections and immunisation and the development of allergic disease in particular asthma in a high‐risk cohort: a prospective study of allergy‐prone children from birth to six years. Pediatric Allergy and Immunology2010;21(7):1076‐85. [DOI: 10.1111/j.1399‐3038.2010.01018.x; PUBMED: 20337970] ">Hill 2000</a> reported no difference in childhood rhinitis prevalence (RR 0.90, 95% CI 0.59 to 1.37; participants = 295). </p> <p>Meta‐analysis found no difference in infant food allergic disease incidence (typical RR 1.42, 95% CI 0.87 to 2.33; participants = 479; studies = 2; I<sup>2</sup> = 0%). </p> <p><a href="./references#CD003664-bbs2-0004" title="HillD . A report on the analysis of the Melbourne Atopy Cohort Study. A study designed to test the effectiveness of different formula types on the development of atopic symptoms and signs on a cohort of atopy‐at‐risk infants. Report at year 2. Nestec Internal Report. HillDJ , SporikR , ThorburnJ , HoskingCS . The association of atopic dermatitis in infancy with immunoglobulin E food sensitization. Journal of Pediatrics2000;137(4):475‐9. [DOI: 10.1067/mpd.2000.108207; PUBMED: 11035824] KoplinJ , DharmageSC , GurrinL , OsborneN , TangML , LoweAJ , et al. Soy consumption is not a risk factor for peanut sensitization. Journal of Allergy and Clinical Immunology2008;121(6):1455‐9. [DOI: 10.1016/j.jaci.2008.03.017; PUBMED: 18436294] LoweA , HoskingC , BennettC , AllenK , CarlinJ , DharmageS , et al. The Melbourne Atopy Cohort Study: a RCT of a partially hydrolysed whey formula for the prevention of allergic disease. Internal Medicine Journal2008;38:A158. LoweAJ , AbramsonMJ , HoskingCS , CarlinJB , BennettCM , DharmageSC , et al. The temporal sequence of allergic sensitization and onset of infantile eczema. Clinical &amp; Experimental Allergy2007;37(4):536‐42; Erratum in: Clinical &amp; Experimental Allergy 2007; 37(12);1895. [DOI: 10.1111/j.1365‐2222.2007.02691.x; PUBMED: 17430350] LoweAJ , CarlinJB , BennettCM , HoskingCS , AllenKJ , RobertsonCF , et al. Paracetamol use in early life and asthma: prospective birth cohort study. BMJ2010;341:c4616. [PUBMED: 20843914] LoweAJ , HoskingCS , BennettCM , AllenKJ , AxelradC , CarlinJB , et al. Effect of a partially hydrolyzed whey infant formula at weaning on risk of allergic disease in high‐risk children: a randomized controlled trial. Journal of Allergy and Clinical Immunology2011;128(2):360‐5.e4. [DOI: 10.1016/j.jaci.2010.05.006; PUBMED: 21696814] StoneyRM , WoodsRK , HoskingCS , HillDJ , AbramsonMJ , ThienFC . Maternal breast milk long‐chain n‐3 fatty acids are associated with increased risk of atopy in breastfed infants. Clinical and Experimental Allergy2004;34(2):194‐200; Erratum in: Clinical &amp; Experimental Allergy 2007; 37(12);1895. [PUBMED: 14987297] ThomsonJA , WidjajaC , DarmaputraAA , LoweA , MathesonMC , BennettCM , et al. Early childhood infections and immunisation and the development of allergic disease in particular asthma in a high‐risk cohort: a prospective study of allergy‐prone children from birth to six years. Pediatric Allergy and Immunology2010;21(7):1076‐85. [DOI: 10.1111/j.1399‐3038.2010.01018.x; PUBMED: 20337970] ">Hill 2000</a> reported no difference in infant CMA incidence (RR 2.31, 95% CI 0.24 to 21.97; participants = 338). </p> </section> <section id="CD003664-sec-0114"> <h5 class="title">Comparison 7. Prolonged feeding: partially hydrolysed formula (PHF) versus cow's milk formula (CMF) </h5> <p>Eleven studies (<a href="./references#CD003664-bbs2-0001" title="ChiricoG , GasparoniA , CiardelliL , DeAmiciM , ColomboA , RondiniG . Immunogenicity and antigenicity of a partially hydrolyzed cow's milk infant formula. Allergy1997;52(1):82‐8. [PUBMED: 9062633] ">Chirico 1997</a>; <a href="./references#CD003664-bbs2-0002" title="deSetaL , SianiP , CirilloG , DiGruttolaM , CimaduomoL , ColettaS . The prevention of allergic diseases with a hypoallergenic formula: a follow‐up at 24 months. The preliminary results. [Italian]. La Pediatria Medica e Chirurgica: Medical and Surgical Pediatrics1994;16(3):251‐4. [PUBMED: 7971447] ">de Seta 1994</a>; <a href="./references#CD003664-bbs2-0006" title="KwintaP , SawiecP , KlimekM , LisG , Cichocka‐JaroszE , PietrzykJJ . Correlation between early neonatal diet and atopic symptoms up to 5‐7 years of age in very low birth weight infants: follow‐up of randomized, double‐blind study. Pediatric Allergy and Immunology2009;20(5):458‐66. [DOI: 10.1111/j.1399‐3038.2008.00814.x; PUBMED: 19490477] ">Kwinta 2009</a>; <a href="./references#CD003664-bbs2-0004" title="HillD . A report on the analysis of the Melbourne Atopy Cohort Study. A study designed to test the effectiveness of different formula types on the development of atopic symptoms and signs on a cohort of atopy‐at‐risk infants. Report at year 2. Nestec Internal Report. HillDJ , SporikR , ThorburnJ , HoskingCS . The association of atopic dermatitis in infancy with immunoglobulin E food sensitization. Journal of Pediatrics2000;137(4):475‐9. [DOI: 10.1067/mpd.2000.108207; PUBMED: 11035824] KoplinJ , DharmageSC , GurrinL , OsborneN , TangML , LoweAJ , et al. Soy consumption is not a risk factor for peanut sensitization. Journal of Allergy and Clinical Immunology2008;121(6):1455‐9. [DOI: 10.1016/j.jaci.2008.03.017; PUBMED: 18436294] LoweA , HoskingC , BennettC , AllenK , CarlinJ , DharmageS , et al. The Melbourne Atopy Cohort Study: a RCT of a partially hydrolysed whey formula for the prevention of allergic disease. Internal Medicine Journal2008;38:A158. LoweAJ , AbramsonMJ , HoskingCS , CarlinJB , BennettCM , DharmageSC , et al. The temporal sequence of allergic sensitization and onset of infantile eczema. Clinical &amp; Experimental Allergy2007;37(4):536‐42; Erratum in: Clinical &amp; Experimental Allergy 2007; 37(12);1895. [DOI: 10.1111/j.1365‐2222.2007.02691.x; PUBMED: 17430350] LoweAJ , CarlinJB , BennettCM , HoskingCS , AllenKJ , RobertsonCF , et al. Paracetamol use in early life and asthma: prospective birth cohort study. BMJ2010;341:c4616. [PUBMED: 20843914] LoweAJ , HoskingCS , BennettCM , AllenKJ , AxelradC , CarlinJB , et al. Effect of a partially hydrolyzed whey infant formula at weaning on risk of allergic disease in high‐risk children: a randomized controlled trial. Journal of Allergy and Clinical Immunology2011;128(2):360‐5.e4. [DOI: 10.1016/j.jaci.2010.05.006; PUBMED: 21696814] StoneyRM , WoodsRK , HoskingCS , HillDJ , AbramsonMJ , ThienFC . Maternal breast milk long‐chain n‐3 fatty acids are associated with increased risk of atopy in breastfed infants. Clinical and Experimental Allergy2004;34(2):194‐200; Erratum in: Clinical &amp; Experimental Allergy 2007; 37(12);1895. [PUBMED: 14987297] ThomsonJA , WidjajaC , DarmaputraAA , LoweA , MathesonMC , BennettCM , et al. Early childhood infections and immunisation and the development of allergic disease in particular asthma in a high‐risk cohort: a prospective study of allergy‐prone children from birth to six years. Pediatric Allergy and Immunology2010;21(7):1076‐85. [DOI: 10.1111/j.1399‐3038.2010.01018.x; PUBMED: 20337970] ">Hill 2000</a>; <a href="./references#CD003664-bbs2-0007" title="LamBC , YeungCY . The effect of breast milk, infant formula and hypoallergenic formula on incidence of atopic manifestation in high risk infants. Nestle Internal Report1992. ">Lam 1992</a>; <a href="./references#CD003664-bbs2-0009" title="MariniA , AgostiM , MottaG , MoscaF . Effects of a dietary and environmental prevention programme on the incidence of allergic symptoms in high atopic risk infants: three years' follow‐up. Acta Paediatrica Supplement1996;414:1‐21. [PUBMED: 8831855] ">Marini 1996</a>; <a href="./references#CD003664-bbs2-0011" title="OldaeusG , AnjouK , BjorkstenB , MoranJR , KjellmanNI . Extensively and partially hydrolysed infant formulas for allergy prophylaxis. Archives of Disease in Childhood1997;77(1):4‐10. [PUBMED: 9279143] OldaeusG , BjorkstenB , JenmalmMC , KjellmanNI . Cow's milk IgE and IgG antibody responses to cow's milk formulas. Allergy1999;54(4):352‐7. [PUBMED: 10371094] ">Oldaeus 1997</a>; <a href="./references#CD003664-bbs2-0013" title="TsaiYT , ChouCC , HsiehKH . The effect of hypoallergenic formula on the occurrence of allergic diseases in high risk infants. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi1991;32(3):137‐44. [PUBMED: 1776437] ">Tsai 1991</a>; <a href="./references#CD003664-bbs2-0014" title="VandenplasY . Atopy at 3 years in high‐risk infants fed whey hydrolysate or conventional formula. Lancet1992;339(8801):1118. [PUBMED: 1349137] VandenplasY , HauserB , Van denBorreC , ClybouwC , MahlerT , Hachimi‐IdrissiS , et al. The long‐term effect of a partial whey hydrolysate formula on the prophylaxis of atopic disease. European Journal of Pediatrics1995;154(6):488‐94. [PUBMED: 7671948] VandenplasY , HauserB , Van denBorreC , SacreL , DabI . Effect of a whey hydrolysate prophylaxis of atopic disease. Annals of Allergy1992;68(5):419‐24. [PUBMED: 1586005] ">Vandenplas 1992</a>; <a href="./references#CD003664-bbs2-0015" title="BergA , KramerU , LinkE , BollrathC , HeinrichJ , BrockowI , et al. GINIplus study group. Impact of early feeding on childhood eczema: development after nutritional intervention compared with the natural course ‐ the GINIplus study up to the age of 6 years. Clinical and Experimental Allergy2010;40(4):627‐36. [DOI: 10.1111/j.1365‐2222.2009.03444.x; PUBMED: 20082618] BrockowI , ZutavernA , HoffmannU , GrublA , vonBergA , KoletzkoS , et al. GINIplus Study Group. Early allergic sensitizations and their relevance to atopic diseases in children aged 6 years: results of the GINI study. Journal of Investigational Allergology &amp; Clinical Immunology2009;19(3):180‐7. [DOI: 19610260] LaubereauB , BrockowI , ZirngiblA , KoletzkoS , GrueblA , vonBergA , et al. GINI Study Group. Effect of breast‐feeding on the development of atopic dermatitis during the first 3 years of life ‐ results from the GINI‐birth cohort study. Journal of Pediatrics2004;144(5):602‐7. [DOI: 10.1016/j.jpeds.2003.12.029; PUBMED: 15126993] LaubereauB , Filipiak‐PittroffB , vonBergA , GrublA , ReinhardtD , WichmannHE , et al. Caesarean section and gastrointestinal symptoms, atopic dermatitis, and sensitisation during the first year of life. Archives of Disease in Childhood2004;89(11):993‐7. [DOI: 10.1136/adc.2003.043265; PUBMED: 15499049] RzehakP , SausenthalerS , KoletzkoS , BauerCP , SchaafB , vonBergA , et al. Period‐specific growth, overweight and modification by breastfeeding in the GINI and LISA birth cohorts up to age 6 years. European Journal of Epidemiology2009;24(8):449‐67. [DOI: 10.1007/s10654‐009‐9356‐5; PUBMED: 19521784] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. GINI‐plus Study Group. Long‐term effects of hydrolyzed protein infant formulas on growth ‐ extended follow‐up to 10 y of age: results from the German Infant Nutritional Intervention (GINI) study. American Journal of Clinical Nutrition2011;94(6 Suppl):1803S‐7S. [DOI: 10.3945/ajcn.110.000679; PUBMED: 21849601] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. German Infant Nutritional Intervention Study Group. Short‐ and long‐term effects of feeding hydrolyzed protein infant formulas on growth at &lt; or = 6 y of age: results from the German Infant Nutritional Intervention Study. American Journal of Clinical Nutrition2009;89(6):1846‐56. [DOI: 10.3945/ajcn.2008.27373; PUBMED: 19369380] SausenthalerS , KoletzkoS , KoletzkoB , ReinhardtD , KramerU , vonBergA , et al. GINIplus study group. Effect of hydrolysed formula feeding on taste preferences at 10 years. Data from the German Infant Nutritional Intervention Program Plus Study. Clinical Nutrition2010;29(3):304‐6. [DOI: 10.1016/j.clnu.2010.01.007; PUBMED: 20110140] SchoetzauA , Filipiak‐PittroffB , FrankeK , KoletzkoS , VonBergA , GrueblA , et al. German Infant Nutritional Intervention Study Group. Effect of exclusive breast‐feeding and early solid food avoidance on the incidence of atopic dermatitis in high‐risk infants at 1 year of age. Pediatric Allergy and Immunology2002;13(4):234‐42. [PUBMED: 12390439] SchoetzauA , GehringU , FrankeK , GrublA , KoletzkoS , vonBergA , et al. Gini Study Group. Maternal compliance with nutritional recommendations in an allergy preventive programme. Archives of Disease in Childhood2002;86(3):180‐4. [PUBMED: 11861235] VonBergA , Filipiak‐PittroffB , KrämerU , LinkE , HeinrichJ , KoletzkoS , et al. The German Infant Nutritional Intervention Study (GINI) for the preventive effect of hydrolysed infant formulas in infants at high risk for allergic diseases. Design and selected results. Allergologie2012;35(1):32‐43. VonBergA , Filipiak‐PittroffB , SchulzH , HoffmannU , LinkE , SussmannM , et al. GINIplus study group. Allergic manifestation 15 years after early intervention with hydrolyzed formulas ‐ the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2016;71(2):210‐9. [DOI: 10.1111/all.12790; PUBMED: 26465137] vonBergA , FilipiakB , KoletzkoS , KrämerU , HoffmannB , LinkE , et al. Long‐term effect of cow milk protein hydrolysates in high‐risk children. Results from the 10‐years follow‐up of the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2013;68:295‐6. vonBergA , Filipiak‐PittroffB , KramerU , HoffmannB , LinkE , BeckmannC , et al. GINIplus study group. Allergies in high‐risk schoolchildren after early intervention with cow's milk protein hydrolysates: 10‐year results from the German Infant Nutritional Intervention (GINI) study. Journal of Allergy and Clinical Immunology2013;131(6):1565‐73. [DOI: 10.1016/j.jaci.2013.01.006; PUBMED: 23506844] vonBergA , Filipiak‐PittroffB , KramerU , LinkE , BollrathC , BrockowI , et al. GINIplus study group. Preventive effect of hydrolyzed infant formulas persists until age 6 years: long‐term results from the German Infant Nutritional Intervention Study (GINI). Journal of Allergy and Clinical Immunology2008;121(6):1442‐7. [DOI: 10.1016/j.jaci.2008.04.021; PUBMED: 18539195] vonBergA , KoletzkoS , Filipiak‐PittroffB , LaubereauB , GrublA , WichmannHE , et al. German Infant Nutritional Intervention Study Group. Certain hydrolyzed formulas reduce the incidence of atopic dermatitis but not that of asthma: three‐year results of the German Infant Nutritional Intervention Study. Journal of Allergy and Clinical Immunology2007;119(3):718‐25. [DOI: 10.1016/j.jaci.2006.11.017; PUBMED: 17240440] vonBergA , KoletzkoS , GrublA , Filipiak‐PittroffB , WichmannHE , BauerCP , et al. German Infant Nutritional Intervention Study Group. The effect of hydrolyzed cow's milk formula for allergy prevention in the first year of life: the German Infant Nutritional Intervention Study, a randomized double‐blind trial. Journal of Allergy and Clinical Immunology2003;111(3):533‐40. [PUBMED: 12642834] ">von Berg 2003</a>; <a href="./references#CD003664-bbs2-0016" title="WillemsR , DuchateauJ , MagrezP , DenisR , CasimirG . Influence of hypoallergenic milk formula on the incidence of early allergic manifestations in infants predisposed to atopic diseases. Annals of Allergy1993;71(2):147‐50. [PUBMED: 8346868] ">Willems 1993</a>) reported outcomes that compared prolonged feeding with a PHF versus a CMF. </p> <p>Meta‐analysis found no difference in infant allergic disease incidence (typical RR 0.89, 95% CI 0.77 to 1.04; participants = 1820; studies = 8; I<sup>2</sup> = 53% [heterogeneity moderate]) and no difference in childhood allergic disease incidence (typical RR 0.86, 95% CI 0.67 to 1.10; participants = 510; studies = 2; I<sup>2</sup> = 75% [heterogeneity high]). <a href="./references#CD003664-bbs2-0009" title="MariniA , AgostiM , MottaG , MoscaF . Effects of a dietary and environmental prevention programme on the incidence of allergic symptoms in high atopic risk infants: three years' follow‐up. Acta Paediatrica Supplement1996;414:1‐21. [PUBMED: 8831855] ">Marini 1996</a> reported a reduction in childhood allergic disease incidence (78 infants; RR 0.42, 95% CI 0.19 to 0.90), whereas <a href="./references#CD003664-bbs2-0015" title="BergA , KramerU , LinkE , BollrathC , HeinrichJ , BrockowI , et al. GINIplus study group. Impact of early feeding on childhood eczema: development after nutritional intervention compared with the natural course ‐ the GINIplus study up to the age of 6 years. Clinical and Experimental Allergy2010;40(4):627‐36. [DOI: 10.1111/j.1365‐2222.2009.03444.x; PUBMED: 20082618] BrockowI , ZutavernA , HoffmannU , GrublA , vonBergA , KoletzkoS , et al. GINIplus Study Group. Early allergic sensitizations and their relevance to atopic diseases in children aged 6 years: results of the GINI study. Journal of Investigational Allergology &amp; Clinical Immunology2009;19(3):180‐7. [DOI: 19610260] LaubereauB , BrockowI , ZirngiblA , KoletzkoS , GrueblA , vonBergA , et al. GINI Study Group. Effect of breast‐feeding on the development of atopic dermatitis during the first 3 years of life ‐ results from the GINI‐birth cohort study. Journal of Pediatrics2004;144(5):602‐7. [DOI: 10.1016/j.jpeds.2003.12.029; PUBMED: 15126993] LaubereauB , Filipiak‐PittroffB , vonBergA , GrublA , ReinhardtD , WichmannHE , et al. Caesarean section and gastrointestinal symptoms, atopic dermatitis, and sensitisation during the first year of life. Archives of Disease in Childhood2004;89(11):993‐7. [DOI: 10.1136/adc.2003.043265; PUBMED: 15499049] RzehakP , SausenthalerS , KoletzkoS , BauerCP , SchaafB , vonBergA , et al. Period‐specific growth, overweight and modification by breastfeeding in the GINI and LISA birth cohorts up to age 6 years. European Journal of Epidemiology2009;24(8):449‐67. [DOI: 10.1007/s10654‐009‐9356‐5; PUBMED: 19521784] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. GINI‐plus Study Group. Long‐term effects of hydrolyzed protein infant formulas on growth ‐ extended follow‐up to 10 y of age: results from the German Infant Nutritional Intervention (GINI) study. American Journal of Clinical Nutrition2011;94(6 Suppl):1803S‐7S. [DOI: 10.3945/ajcn.110.000679; PUBMED: 21849601] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. German Infant Nutritional Intervention Study Group. Short‐ and long‐term effects of feeding hydrolyzed protein infant formulas on growth at &lt; or = 6 y of age: results from the German Infant Nutritional Intervention Study. American Journal of Clinical Nutrition2009;89(6):1846‐56. [DOI: 10.3945/ajcn.2008.27373; PUBMED: 19369380] SausenthalerS , KoletzkoS , KoletzkoB , ReinhardtD , KramerU , vonBergA , et al. GINIplus study group. Effect of hydrolysed formula feeding on taste preferences at 10 years. Data from the German Infant Nutritional Intervention Program Plus Study. Clinical Nutrition2010;29(3):304‐6. [DOI: 10.1016/j.clnu.2010.01.007; PUBMED: 20110140] SchoetzauA , Filipiak‐PittroffB , FrankeK , KoletzkoS , VonBergA , GrueblA , et al. German Infant Nutritional Intervention Study Group. Effect of exclusive breast‐feeding and early solid food avoidance on the incidence of atopic dermatitis in high‐risk infants at 1 year of age. Pediatric Allergy and Immunology2002;13(4):234‐42. [PUBMED: 12390439] SchoetzauA , GehringU , FrankeK , GrublA , KoletzkoS , vonBergA , et al. Gini Study Group. Maternal compliance with nutritional recommendations in an allergy preventive programme. Archives of Disease in Childhood2002;86(3):180‐4. [PUBMED: 11861235] VonBergA , Filipiak‐PittroffB , KrämerU , LinkE , HeinrichJ , KoletzkoS , et al. The German Infant Nutritional Intervention Study (GINI) for the preventive effect of hydrolysed infant formulas in infants at high risk for allergic diseases. Design and selected results. Allergologie2012;35(1):32‐43. VonBergA , Filipiak‐PittroffB , SchulzH , HoffmannU , LinkE , SussmannM , et al. GINIplus study group. Allergic manifestation 15 years after early intervention with hydrolyzed formulas ‐ the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2016;71(2):210‐9. [DOI: 10.1111/all.12790; PUBMED: 26465137] vonBergA , FilipiakB , KoletzkoS , KrämerU , HoffmannB , LinkE , et al. Long‐term effect of cow milk protein hydrolysates in high‐risk children. Results from the 10‐years follow‐up of the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2013;68:295‐6. vonBergA , Filipiak‐PittroffB , KramerU , HoffmannB , LinkE , BeckmannC , et al. GINIplus study group. Allergies in high‐risk schoolchildren after early intervention with cow's milk protein hydrolysates: 10‐year results from the German Infant Nutritional Intervention (GINI) study. Journal of Allergy and Clinical Immunology2013;131(6):1565‐73. [DOI: 10.1016/j.jaci.2013.01.006; PUBMED: 23506844] vonBergA , Filipiak‐PittroffB , KramerU , LinkE , BollrathC , BrockowI , et al. GINIplus study group. Preventive effect of hydrolyzed infant formulas persists until age 6 years: long‐term results from the German Infant Nutritional Intervention Study (GINI). Journal of Allergy and Clinical Immunology2008;121(6):1442‐7. [DOI: 10.1016/j.jaci.2008.04.021; PUBMED: 18539195] vonBergA , KoletzkoS , Filipiak‐PittroffB , LaubereauB , GrublA , WichmannHE , et al. German Infant Nutritional Intervention Study Group. Certain hydrolyzed formulas reduce the incidence of atopic dermatitis but not that of asthma: three‐year results of the German Infant Nutritional Intervention Study. Journal of Allergy and Clinical Immunology2007;119(3):718‐25. [DOI: 10.1016/j.jaci.2006.11.017; PUBMED: 17240440] vonBergA , KoletzkoS , GrublA , Filipiak‐PittroffB , WichmannHE , BauerCP , et al. German Infant Nutritional Intervention Study Group. The effect of hydrolyzed cow's milk formula for allergy prevention in the first year of life: the German Infant Nutritional Intervention Study, a randomized double‐blind trial. Journal of Allergy and Clinical Immunology2003;111(3):533‐40. [PUBMED: 12642834] ">von Berg 2003</a> reported no difference (432 infants; RR 0.95, 95% CI 0.73 to 1.25). </p> <p>Meta‐analysis found no difference in infant asthma (typical RR 0.54, 95% CI 0.28 to 1.04; participants = 268; studies = 4; I<sup>2</sup> = 0%). <a href="./references#CD003664-bbs2-0009" title="MariniA , AgostiM , MottaG , MoscaF . Effects of a dietary and environmental prevention programme on the incidence of allergic symptoms in high atopic risk infants: three years' follow‐up. Acta Paediatrica Supplement1996;414:1‐21. [PUBMED: 8831855] ">Marini 1996</a> reported no difference in childhood asthma incidence (RR 0.38, 95% CI 0.08 to 1.84; participants = 78). Meta‐analysis found no difference in childhood asthma prevalence (typical RR 1.05, 95% CI 0.80 to 1.38; participants = 789; studies = 3; I<sup>2</sup> = 31% [heterogeneity low]). </p> <p>Meta‐analysis found no difference in infant eczema (typical RR 0.98, 95% CI 0.82 to 1.16; participants = 1699; studies = 8; I<sup>2</sup> = 0%), no difference in childhood eczema incidence (typical RR 0.85, 95% CI 0.61 to 1.19; participants = 510; studies = 2; I<sup>2</sup> = 46% [heterogeneity low]) and no difference in childhood eczema prevalence (typical RR 0.92, 95% CI 0.69 to 1.22; participants = 788; studies = 3; I<sup>2</sup> = 32%). </p> <p>Meta‐analysis found no difference in infant rhinitis (typical RR 0.40, 95% CI 0.09 to 1.70; participants = 206; studies = 3; I<sup>2</sup> = 0%). <a href="./references#CD003664-bbs2-0009" title="MariniA , AgostiM , MottaG , MoscaF . Effects of a dietary and environmental prevention programme on the incidence of allergic symptoms in high atopic risk infants: three years' follow‐up. Acta Paediatrica Supplement1996;414:1‐21. [PUBMED: 8831855] ">Marini 1996</a> reported no difference in childhood rhinitis incidence (RR 0.47, 95% CI 0.04 to 5.03; participants = 78). Meta‐analysis found no difference in childhood rhinitis prevalence (typical RR 0.97, 95% CI 0.66 to 1.41; participants = 357; studies = 2; I<sup>2</sup> = 0%). </p> <p>Meta‐analysis found no difference in infant food allergy (typical RR 1.53, 95% CI 0.93 to 2.49; participants = 429; studies = 2; I<sup>2</sup> = 13%). Neither study reported a difference. </p> <p><a href="./references#CD003664-bbs2-0004" title="HillD . A report on the analysis of the Melbourne Atopy Cohort Study. A study designed to test the effectiveness of different formula types on the development of atopic symptoms and signs on a cohort of atopy‐at‐risk infants. Report at year 2. Nestec Internal Report. HillDJ , SporikR , ThorburnJ , HoskingCS . The association of atopic dermatitis in infancy with immunoglobulin E food sensitization. Journal of Pediatrics2000;137(4):475‐9. [DOI: 10.1067/mpd.2000.108207; PUBMED: 11035824] KoplinJ , DharmageSC , GurrinL , OsborneN , TangML , LoweAJ , et al. Soy consumption is not a risk factor for peanut sensitization. Journal of Allergy and Clinical Immunology2008;121(6):1455‐9. [DOI: 10.1016/j.jaci.2008.03.017; PUBMED: 18436294] LoweA , HoskingC , BennettC , AllenK , CarlinJ , DharmageS , et al. The Melbourne Atopy Cohort Study: a RCT of a partially hydrolysed whey formula for the prevention of allergic disease. Internal Medicine Journal2008;38:A158. LoweAJ , AbramsonMJ , HoskingCS , CarlinJB , BennettCM , DharmageSC , et al. The temporal sequence of allergic sensitization and onset of infantile eczema. Clinical &amp; Experimental Allergy2007;37(4):536‐42; Erratum in: Clinical &amp; Experimental Allergy 2007; 37(12);1895. [DOI: 10.1111/j.1365‐2222.2007.02691.x; PUBMED: 17430350] LoweAJ , CarlinJB , BennettCM , HoskingCS , AllenKJ , RobertsonCF , et al. Paracetamol use in early life and asthma: prospective birth cohort study. BMJ2010;341:c4616. [PUBMED: 20843914] LoweAJ , HoskingCS , BennettCM , AllenKJ , AxelradC , CarlinJB , et al. Effect of a partially hydrolyzed whey infant formula at weaning on risk of allergic disease in high‐risk children: a randomized controlled trial. Journal of Allergy and Clinical Immunology2011;128(2):360‐5.e4. [DOI: 10.1016/j.jaci.2010.05.006; PUBMED: 21696814] StoneyRM , WoodsRK , HoskingCS , HillDJ , AbramsonMJ , ThienFC . Maternal breast milk long‐chain n‐3 fatty acids are associated with increased risk of atopy in breastfed infants. Clinical and Experimental Allergy2004;34(2):194‐200; Erratum in: Clinical &amp; Experimental Allergy 2007; 37(12);1895. [PUBMED: 14987297] ThomsonJA , WidjajaC , DarmaputraAA , LoweA , MathesonMC , BennettCM , et al. Early childhood infections and immunisation and the development of allergic disease in particular asthma in a high‐risk cohort: a prospective study of allergy‐prone children from birth to six years. Pediatric Allergy and Immunology2010;21(7):1076‐85. [DOI: 10.1111/j.1399‐3038.2010.01018.x; PUBMED: 20337970] ">Hill 2000</a> reported no difference in infant CMA incidence (RR 2.31, 95% CI 0.24 to 21.97; participants = 338). </p> </section> <section id="CD003664-sec-0115"> <h5 class="title">Comparison 8. Prolonged feeding: extensively hydrolysed formula (EHF) versus cow's milk formula (CMF) </h5> <p>Four studies (<a href="./references#CD003664-bbs2-0006" title="KwintaP , SawiecP , KlimekM , LisG , Cichocka‐JaroszE , PietrzykJJ . Correlation between early neonatal diet and atopic symptoms up to 5‐7 years of age in very low birth weight infants: follow‐up of randomized, double‐blind study. Pediatric Allergy and Immunology2009;20(5):458‐66. [DOI: 10.1111/j.1399‐3038.2008.00814.x; PUBMED: 19490477] ">Kwinta 2009</a>; <a href="./references#CD003664-bbs2-0008" title="MalletE , HenocqA . Long‐term prevention of allergic diseases by using protein hydrolysate formula in at‐risk infants. Journal of Pediatrics1992;121(5 Pt 2):S95‐100. [PUBMED: 1447641] ">Mallet 1992</a>; <a href="./references#CD003664-bbs2-0011" title="OldaeusG , AnjouK , BjorkstenB , MoranJR , KjellmanNI . Extensively and partially hydrolysed infant formulas for allergy prophylaxis. Archives of Disease in Childhood1997;77(1):4‐10. [PUBMED: 9279143] OldaeusG , BjorkstenB , JenmalmMC , KjellmanNI . Cow's milk IgE and IgG antibody responses to cow's milk formulas. Allergy1999;54(4):352‐7. [PUBMED: 10371094] ">Oldaeus 1997</a>; <a href="./references#CD003664-bbs2-0015" title="BergA , KramerU , LinkE , BollrathC , HeinrichJ , BrockowI , et al. GINIplus study group. Impact of early feeding on childhood eczema: development after nutritional intervention compared with the natural course ‐ the GINIplus study up to the age of 6 years. Clinical and Experimental Allergy2010;40(4):627‐36. [DOI: 10.1111/j.1365‐2222.2009.03444.x; PUBMED: 20082618] BrockowI , ZutavernA , HoffmannU , GrublA , vonBergA , KoletzkoS , et al. GINIplus Study Group. Early allergic sensitizations and their relevance to atopic diseases in children aged 6 years: results of the GINI study. Journal of Investigational Allergology &amp; Clinical Immunology2009;19(3):180‐7. [DOI: 19610260] LaubereauB , BrockowI , ZirngiblA , KoletzkoS , GrueblA , vonBergA , et al. GINI Study Group. Effect of breast‐feeding on the development of atopic dermatitis during the first 3 years of life ‐ results from the GINI‐birth cohort study. Journal of Pediatrics2004;144(5):602‐7. [DOI: 10.1016/j.jpeds.2003.12.029; PUBMED: 15126993] LaubereauB , Filipiak‐PittroffB , vonBergA , GrublA , ReinhardtD , WichmannHE , et al. Caesarean section and gastrointestinal symptoms, atopic dermatitis, and sensitisation during the first year of life. Archives of Disease in Childhood2004;89(11):993‐7. [DOI: 10.1136/adc.2003.043265; PUBMED: 15499049] RzehakP , SausenthalerS , KoletzkoS , BauerCP , SchaafB , vonBergA , et al. Period‐specific growth, overweight and modification by breastfeeding in the GINI and LISA birth cohorts up to age 6 years. European Journal of Epidemiology2009;24(8):449‐67. [DOI: 10.1007/s10654‐009‐9356‐5; PUBMED: 19521784] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. GINI‐plus Study Group. Long‐term effects of hydrolyzed protein infant formulas on growth ‐ extended follow‐up to 10 y of age: results from the German Infant Nutritional Intervention (GINI) study. American Journal of Clinical Nutrition2011;94(6 Suppl):1803S‐7S. [DOI: 10.3945/ajcn.110.000679; PUBMED: 21849601] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. German Infant Nutritional Intervention Study Group. Short‐ and long‐term effects of feeding hydrolyzed protein infant formulas on growth at &lt; or = 6 y of age: results from the German Infant Nutritional Intervention Study. American Journal of Clinical Nutrition2009;89(6):1846‐56. [DOI: 10.3945/ajcn.2008.27373; PUBMED: 19369380] SausenthalerS , KoletzkoS , KoletzkoB , ReinhardtD , KramerU , vonBergA , et al. GINIplus study group. Effect of hydrolysed formula feeding on taste preferences at 10 years. Data from the German Infant Nutritional Intervention Program Plus Study. Clinical Nutrition2010;29(3):304‐6. [DOI: 10.1016/j.clnu.2010.01.007; PUBMED: 20110140] SchoetzauA , Filipiak‐PittroffB , FrankeK , KoletzkoS , VonBergA , GrueblA , et al. German Infant Nutritional Intervention Study Group. Effect of exclusive breast‐feeding and early solid food avoidance on the incidence of atopic dermatitis in high‐risk infants at 1 year of age. Pediatric Allergy and Immunology2002;13(4):234‐42. [PUBMED: 12390439] SchoetzauA , GehringU , FrankeK , GrublA , KoletzkoS , vonBergA , et al. Gini Study Group. Maternal compliance with nutritional recommendations in an allergy preventive programme. Archives of Disease in Childhood2002;86(3):180‐4. [PUBMED: 11861235] VonBergA , Filipiak‐PittroffB , KrämerU , LinkE , HeinrichJ , KoletzkoS , et al. The German Infant Nutritional Intervention Study (GINI) for the preventive effect of hydrolysed infant formulas in infants at high risk for allergic diseases. Design and selected results. Allergologie2012;35(1):32‐43. VonBergA , Filipiak‐PittroffB , SchulzH , HoffmannU , LinkE , SussmannM , et al. GINIplus study group. Allergic manifestation 15 years after early intervention with hydrolyzed formulas ‐ the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2016;71(2):210‐9. [DOI: 10.1111/all.12790; PUBMED: 26465137] vonBergA , FilipiakB , KoletzkoS , KrämerU , HoffmannB , LinkE , et al. Long‐term effect of cow milk protein hydrolysates in high‐risk children. Results from the 10‐years follow‐up of the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2013;68:295‐6. vonBergA , Filipiak‐PittroffB , KramerU , HoffmannB , LinkE , BeckmannC , et al. GINIplus study group. Allergies in high‐risk schoolchildren after early intervention with cow's milk protein hydrolysates: 10‐year results from the German Infant Nutritional Intervention (GINI) study. Journal of Allergy and Clinical Immunology2013;131(6):1565‐73. [DOI: 10.1016/j.jaci.2013.01.006; PUBMED: 23506844] vonBergA , Filipiak‐PittroffB , KramerU , LinkE , BollrathC , BrockowI , et al. GINIplus study group. Preventive effect of hydrolyzed infant formulas persists until age 6 years: long‐term results from the German Infant Nutritional Intervention Study (GINI). Journal of Allergy and Clinical Immunology2008;121(6):1442‐7. [DOI: 10.1016/j.jaci.2008.04.021; PUBMED: 18539195] vonBergA , KoletzkoS , Filipiak‐PittroffB , LaubereauB , GrublA , WichmannHE , et al. German Infant Nutritional Intervention Study Group. Certain hydrolyzed formulas reduce the incidence of atopic dermatitis but not that of asthma: three‐year results of the German Infant Nutritional Intervention Study. Journal of Allergy and Clinical Immunology2007;119(3):718‐25. [DOI: 10.1016/j.jaci.2006.11.017; PUBMED: 17240440] vonBergA , KoletzkoS , GrublA , Filipiak‐PittroffB , WichmannHE , BauerCP , et al. German Infant Nutritional Intervention Study Group. The effect of hydrolyzed cow's milk formula for allergy prevention in the first year of life: the German Infant Nutritional Intervention Study, a randomized double‐blind trial. Journal of Allergy and Clinical Immunology2003;111(3):533‐40. [PUBMED: 12642834] ">von Berg 2003</a>) compared prolonged feeding with an EHF versus CMF. </p> <p>Meta‐analysis found no difference in infant allergic disease (typical RR 0.87, 95% CI 0.68 to 1.13; participants = 1561; studies = 2; I<sup>2</sup> = 0%). <a href="./references#CD003664-bbs2-0015" title="BergA , KramerU , LinkE , BollrathC , HeinrichJ , BrockowI , et al. GINIplus study group. Impact of early feeding on childhood eczema: development after nutritional intervention compared with the natural course ‐ the GINIplus study up to the age of 6 years. Clinical and Experimental Allergy2010;40(4):627‐36. [DOI: 10.1111/j.1365‐2222.2009.03444.x; PUBMED: 20082618] BrockowI , ZutavernA , HoffmannU , GrublA , vonBergA , KoletzkoS , et al. GINIplus Study Group. Early allergic sensitizations and their relevance to atopic diseases in children aged 6 years: results of the GINI study. Journal of Investigational Allergology &amp; Clinical Immunology2009;19(3):180‐7. [DOI: 19610260] LaubereauB , BrockowI , ZirngiblA , KoletzkoS , GrueblA , vonBergA , et al. GINI Study Group. Effect of breast‐feeding on the development of atopic dermatitis during the first 3 years of life ‐ results from the GINI‐birth cohort study. Journal of Pediatrics2004;144(5):602‐7. [DOI: 10.1016/j.jpeds.2003.12.029; PUBMED: 15126993] LaubereauB , Filipiak‐PittroffB , vonBergA , GrublA , ReinhardtD , WichmannHE , et al. Caesarean section and gastrointestinal symptoms, atopic dermatitis, and sensitisation during the first year of life. Archives of Disease in Childhood2004;89(11):993‐7. [DOI: 10.1136/adc.2003.043265; PUBMED: 15499049] RzehakP , SausenthalerS , KoletzkoS , BauerCP , SchaafB , vonBergA , et al. Period‐specific growth, overweight and modification by breastfeeding in the GINI and LISA birth cohorts up to age 6 years. European Journal of Epidemiology2009;24(8):449‐67. [DOI: 10.1007/s10654‐009‐9356‐5; PUBMED: 19521784] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. GINI‐plus Study Group. Long‐term effects of hydrolyzed protein infant formulas on growth ‐ extended follow‐up to 10 y of age: results from the German Infant Nutritional Intervention (GINI) study. American Journal of Clinical Nutrition2011;94(6 Suppl):1803S‐7S. [DOI: 10.3945/ajcn.110.000679; PUBMED: 21849601] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. German Infant Nutritional Intervention Study Group. Short‐ and long‐term effects of feeding hydrolyzed protein infant formulas on growth at &lt; or = 6 y of age: results from the German Infant Nutritional Intervention Study. American Journal of Clinical Nutrition2009;89(6):1846‐56. [DOI: 10.3945/ajcn.2008.27373; PUBMED: 19369380] SausenthalerS , KoletzkoS , KoletzkoB , ReinhardtD , KramerU , vonBergA , et al. GINIplus study group. Effect of hydrolysed formula feeding on taste preferences at 10 years. Data from the German Infant Nutritional Intervention Program Plus Study. Clinical Nutrition2010;29(3):304‐6. [DOI: 10.1016/j.clnu.2010.01.007; PUBMED: 20110140] SchoetzauA , Filipiak‐PittroffB , FrankeK , KoletzkoS , VonBergA , GrueblA , et al. German Infant Nutritional Intervention Study Group. Effect of exclusive breast‐feeding and early solid food avoidance on the incidence of atopic dermatitis in high‐risk infants at 1 year of age. Pediatric Allergy and Immunology2002;13(4):234‐42. [PUBMED: 12390439] SchoetzauA , GehringU , FrankeK , GrublA , KoletzkoS , vonBergA , et al. Gini Study Group. Maternal compliance with nutritional recommendations in an allergy preventive programme. Archives of Disease in Childhood2002;86(3):180‐4. [PUBMED: 11861235] VonBergA , Filipiak‐PittroffB , KrämerU , LinkE , HeinrichJ , KoletzkoS , et al. The German Infant Nutritional Intervention Study (GINI) for the preventive effect of hydrolysed infant formulas in infants at high risk for allergic diseases. Design and selected results. Allergologie2012;35(1):32‐43. VonBergA , Filipiak‐PittroffB , SchulzH , HoffmannU , LinkE , SussmannM , et al. GINIplus study group. Allergic manifestation 15 years after early intervention with hydrolyzed formulas ‐ the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2016;71(2):210‐9. [DOI: 10.1111/all.12790; PUBMED: 26465137] vonBergA , FilipiakB , KoletzkoS , KrämerU , HoffmannB , LinkE , et al. Long‐term effect of cow milk protein hydrolysates in high‐risk children. Results from the 10‐years follow‐up of the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2013;68:295‐6. vonBergA , Filipiak‐PittroffB , KramerU , HoffmannB , LinkE , BeckmannC , et al. GINIplus study group. Allergies in high‐risk schoolchildren after early intervention with cow's milk protein hydrolysates: 10‐year results from the German Infant Nutritional Intervention (GINI) study. Journal of Allergy and Clinical Immunology2013;131(6):1565‐73. [DOI: 10.1016/j.jaci.2013.01.006; PUBMED: 23506844] vonBergA , Filipiak‐PittroffB , KramerU , LinkE , BollrathC , BrockowI , et al. GINIplus study group. Preventive effect of hydrolyzed infant formulas persists until age 6 years: long‐term results from the German Infant Nutritional Intervention Study (GINI). Journal of Allergy and Clinical Immunology2008;121(6):1442‐7. [DOI: 10.1016/j.jaci.2008.04.021; PUBMED: 18539195] vonBergA , KoletzkoS , Filipiak‐PittroffB , LaubereauB , GrublA , WichmannHE , et al. German Infant Nutritional Intervention Study Group. Certain hydrolyzed formulas reduce the incidence of atopic dermatitis but not that of asthma: three‐year results of the German Infant Nutritional Intervention Study. Journal of Allergy and Clinical Immunology2007;119(3):718‐25. [DOI: 10.1016/j.jaci.2006.11.017; PUBMED: 17240440] vonBergA , KoletzkoS , GrublA , Filipiak‐PittroffB , WichmannHE , BauerCP , et al. German Infant Nutritional Intervention Study Group. The effect of hydrolyzed cow's milk formula for allergy prevention in the first year of life: the German Infant Nutritional Intervention Study, a randomized double‐blind trial. Journal of Allergy and Clinical Immunology2003;111(3):533‐40. [PUBMED: 12642834] ">von Berg 2003</a> reported no difference in childhood allergic disease incidence (RR 0.89, 95% CI 0.71 to 1.13; participants = 651). <a href="./references#CD003664-bbs2-0006" title="KwintaP , SawiecP , KlimekM , LisG , Cichocka‐JaroszE , PietrzykJJ . Correlation between early neonatal diet and atopic symptoms up to 5‐7 years of age in very low birth weight infants: follow‐up of randomized, double‐blind study. Pediatric Allergy and Immunology2009;20(5):458‐66. [DOI: 10.1111/j.1399‐3038.2008.00814.x; PUBMED: 19490477] ">Kwinta 2009</a> reported no difference in childhood allergic disease prevalence (RR 1.76, 95% CI 0.76 to 4.09; participants = 62). </p> <p><a href="./references#CD003664-bbs2-0011" title="OldaeusG , AnjouK , BjorkstenB , MoranJR , KjellmanNI . Extensively and partially hydrolysed infant formulas for allergy prophylaxis. Archives of Disease in Childhood1997;77(1):4‐10. [PUBMED: 9279143] OldaeusG , BjorkstenB , JenmalmMC , KjellmanNI . Cow's milk IgE and IgG antibody responses to cow's milk formulas. Allergy1999;54(4):352‐7. [PUBMED: 10371094] ">Oldaeus 1997</a> reported no difference in infant asthma (RR 0.61, 95% CI 0.18 to 2.04; participants = 96). Meta‐analysis found no difference in childhood asthma prevalence (typical RR 1.15, 95% CI 0.76 to 1.72; participants = 713; studies = 2; I<sup>2</sup> = 43% [heterogeneity low]). </p> <p>Meta‐analysis found no difference in infant eczema (typical RR 0.83, 95% CI 0.63 to 1.08; participants = 1726; studies = 3; I<sup>2</sup> = 19%). <a href="./references#CD003664-bbs2-0015" title="BergA , KramerU , LinkE , BollrathC , HeinrichJ , BrockowI , et al. GINIplus study group. Impact of early feeding on childhood eczema: development after nutritional intervention compared with the natural course ‐ the GINIplus study up to the age of 6 years. Clinical and Experimental Allergy2010;40(4):627‐36. [DOI: 10.1111/j.1365‐2222.2009.03444.x; PUBMED: 20082618] BrockowI , ZutavernA , HoffmannU , GrublA , vonBergA , KoletzkoS , et al. GINIplus Study Group. Early allergic sensitizations and their relevance to atopic diseases in children aged 6 years: results of the GINI study. Journal of Investigational Allergology &amp; Clinical Immunology2009;19(3):180‐7. [DOI: 19610260] LaubereauB , BrockowI , ZirngiblA , KoletzkoS , GrueblA , vonBergA , et al. GINI Study Group. Effect of breast‐feeding on the development of atopic dermatitis during the first 3 years of life ‐ results from the GINI‐birth cohort study. Journal of Pediatrics2004;144(5):602‐7. [DOI: 10.1016/j.jpeds.2003.12.029; PUBMED: 15126993] LaubereauB , Filipiak‐PittroffB , vonBergA , GrublA , ReinhardtD , WichmannHE , et al. Caesarean section and gastrointestinal symptoms, atopic dermatitis, and sensitisation during the first year of life. Archives of Disease in Childhood2004;89(11):993‐7. [DOI: 10.1136/adc.2003.043265; PUBMED: 15499049] RzehakP , SausenthalerS , KoletzkoS , BauerCP , SchaafB , vonBergA , et al. Period‐specific growth, overweight and modification by breastfeeding in the GINI and LISA birth cohorts up to age 6 years. European Journal of Epidemiology2009;24(8):449‐67. [DOI: 10.1007/s10654‐009‐9356‐5; PUBMED: 19521784] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. GINI‐plus Study Group. Long‐term effects of hydrolyzed protein infant formulas on growth ‐ extended follow‐up to 10 y of age: results from the German Infant Nutritional Intervention (GINI) study. American Journal of Clinical Nutrition2011;94(6 Suppl):1803S‐7S. [DOI: 10.3945/ajcn.110.000679; PUBMED: 21849601] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. German Infant Nutritional Intervention Study Group. Short‐ and long‐term effects of feeding hydrolyzed protein infant formulas on growth at &lt; or = 6 y of age: results from the German Infant Nutritional Intervention Study. American Journal of Clinical Nutrition2009;89(6):1846‐56. [DOI: 10.3945/ajcn.2008.27373; PUBMED: 19369380] SausenthalerS , KoletzkoS , KoletzkoB , ReinhardtD , KramerU , vonBergA , et al. GINIplus study group. Effect of hydrolysed formula feeding on taste preferences at 10 years. Data from the German Infant Nutritional Intervention Program Plus Study. Clinical Nutrition2010;29(3):304‐6. [DOI: 10.1016/j.clnu.2010.01.007; PUBMED: 20110140] SchoetzauA , Filipiak‐PittroffB , FrankeK , KoletzkoS , VonBergA , GrueblA , et al. German Infant Nutritional Intervention Study Group. Effect of exclusive breast‐feeding and early solid food avoidance on the incidence of atopic dermatitis in high‐risk infants at 1 year of age. Pediatric Allergy and Immunology2002;13(4):234‐42. [PUBMED: 12390439] SchoetzauA , GehringU , FrankeK , GrublA , KoletzkoS , vonBergA , et al. Gini Study Group. Maternal compliance with nutritional recommendations in an allergy preventive programme. Archives of Disease in Childhood2002;86(3):180‐4. [PUBMED: 11861235] VonBergA , Filipiak‐PittroffB , KrämerU , LinkE , HeinrichJ , KoletzkoS , et al. The German Infant Nutritional Intervention Study (GINI) for the preventive effect of hydrolysed infant formulas in infants at high risk for allergic diseases. Design and selected results. Allergologie2012;35(1):32‐43. VonBergA , Filipiak‐PittroffB , SchulzH , HoffmannU , LinkE , SussmannM , et al. GINIplus study group. Allergic manifestation 15 years after early intervention with hydrolyzed formulas ‐ the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2016;71(2):210‐9. [DOI: 10.1111/all.12790; PUBMED: 26465137] vonBergA , FilipiakB , KoletzkoS , KrämerU , HoffmannB , LinkE , et al. Long‐term effect of cow milk protein hydrolysates in high‐risk children. Results from the 10‐years follow‐up of the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2013;68:295‐6. vonBergA , Filipiak‐PittroffB , KramerU , HoffmannB , LinkE , BeckmannC , et al. GINIplus study group. Allergies in high‐risk schoolchildren after early intervention with cow's milk protein hydrolysates: 10‐year results from the German Infant Nutritional Intervention (GINI) study. Journal of Allergy and Clinical Immunology2013;131(6):1565‐73. [DOI: 10.1016/j.jaci.2013.01.006; PUBMED: 23506844] vonBergA , Filipiak‐PittroffB , KramerU , LinkE , BollrathC , BrockowI , et al. GINIplus study group. Preventive effect of hydrolyzed infant formulas persists until age 6 years: long‐term results from the German Infant Nutritional Intervention Study (GINI). Journal of Allergy and Clinical Immunology2008;121(6):1442‐7. [DOI: 10.1016/j.jaci.2008.04.021; PUBMED: 18539195] vonBergA , KoletzkoS , Filipiak‐PittroffB , LaubereauB , GrublA , WichmannHE , et al. German Infant Nutritional Intervention Study Group. Certain hydrolyzed formulas reduce the incidence of atopic dermatitis but not that of asthma: three‐year results of the German Infant Nutritional Intervention Study. Journal of Allergy and Clinical Immunology2007;119(3):718‐25. [DOI: 10.1016/j.jaci.2006.11.017; PUBMED: 17240440] vonBergA , KoletzkoS , GrublA , Filipiak‐PittroffB , WichmannHE , BauerCP , et al. German Infant Nutritional Intervention Study Group. The effect of hydrolyzed cow's milk formula for allergy prevention in the first year of life: the German Infant Nutritional Intervention Study, a randomized double‐blind trial. Journal of Allergy and Clinical Immunology2003;111(3):533‐40. [PUBMED: 12642834] ">von Berg 2003</a> reported no difference in childhood eczema incidence (RR 0.86, 95% CI 0.63 to 1.17; participants = 651). Meta‐analysis found a reduction in childhood eczema prevalence (typical RR 0.61, 95% CI 0.39 to 0.97; participants = 713; studies = 2; I<sup>2</sup> = 0%). </p> <p><a href="./references#CD003664-bbs2-0011" title="OldaeusG , AnjouK , BjorkstenB , MoranJR , KjellmanNI . Extensively and partially hydrolysed infant formulas for allergy prophylaxis. Archives of Disease in Childhood1997;77(1):4‐10. [PUBMED: 9279143] OldaeusG , BjorkstenB , JenmalmMC , KjellmanNI . Cow's milk IgE and IgG antibody responses to cow's milk formulas. Allergy1999;54(4):352‐7. [PUBMED: 10371094] ">Oldaeus 1997</a> reported no difference in infant rhinitis incidence (RR 2.76, 95% CI 0.12 to 66.22; participants = 96). <a href="./references#CD003664-bbs2-0006" title="KwintaP , SawiecP , KlimekM , LisG , Cichocka‐JaroszE , PietrzykJJ . Correlation between early neonatal diet and atopic symptoms up to 5‐7 years of age in very low birth weight infants: follow‐up of randomized, double‐blind study. Pediatric Allergy and Immunology2009;20(5):458‐66. [DOI: 10.1111/j.1399‐3038.2008.00814.x; PUBMED: 19490477] ">Kwinta 2009</a> found no difference in childhood rhinitis prevalence (RR 1.32, 95% CI 0.53 to 3.26; participants = 62). </p> <p><a href="./references#CD003664-bbs2-0011" title="OldaeusG , AnjouK , BjorkstenB , MoranJR , KjellmanNI . Extensively and partially hydrolysed infant formulas for allergy prophylaxis. Archives of Disease in Childhood1997;77(1):4‐10. [PUBMED: 9279143] OldaeusG , BjorkstenB , JenmalmMC , KjellmanNI . Cow's milk IgE and IgG antibody responses to cow's milk formulas. Allergy1999;54(4):352‐7. [PUBMED: 10371094] ">Oldaeus 1997</a> reported no difference in food allergy (RR 1.15, 95% CI 0.33 to 4.02; participants = 96). </p> </section> <section id="CD003664-sec-0116"> <h5 class="title">Comparison 9. Prolonged feeding: extensively hydrolysed formula (EHF) versus partially hydrolysed formula (PHF) </h5> <p>Four studies (<a href="./references#CD003664-bbs2-0003" title="HalkenS , HansenKS , JacobsenHP , EstmannA , FaellingAE , HansenLG , et al. Comparison of a partially hydrolyzed infant formula with two extensively hydrolyzed formulas for allergy prevention: a prospective, randomized study. Pediatric Allergy and Immunology2000;11(3):149‐61. [PUBMED: 10981524] ">Halken 2000</a>; <a href="./references#CD003664-bbs2-0010" title="NentwichI , MichkovaE , NevoralJ , UrbanekR , SzepfalusiZ . Cow's milk‐specific cellular and humoral immune responses and atopy skin symptoms in infants from atopic families fed a partially (pHF) or extensively (eHF) hydrolyzed infant formula. Allergy2001;56(12):1144‐56. [PUBMED: 11736743] ">Nentwich 2001</a>; <a href="./references#CD003664-bbs2-0011" title="OldaeusG , AnjouK , BjorkstenB , MoranJR , KjellmanNI . Extensively and partially hydrolysed infant formulas for allergy prophylaxis. Archives of Disease in Childhood1997;77(1):4‐10. [PUBMED: 9279143] OldaeusG , BjorkstenB , JenmalmMC , KjellmanNI . Cow's milk IgE and IgG antibody responses to cow's milk formulas. Allergy1999;54(4):352‐7. [PUBMED: 10371094] ">Oldaeus 1997</a>; <a href="./references#CD003664-bbs2-0015" title="BergA , KramerU , LinkE , BollrathC , HeinrichJ , BrockowI , et al. GINIplus study group. Impact of early feeding on childhood eczema: development after nutritional intervention compared with the natural course ‐ the GINIplus study up to the age of 6 years. Clinical and Experimental Allergy2010;40(4):627‐36. [DOI: 10.1111/j.1365‐2222.2009.03444.x; PUBMED: 20082618] BrockowI , ZutavernA , HoffmannU , GrublA , vonBergA , KoletzkoS , et al. GINIplus Study Group. Early allergic sensitizations and their relevance to atopic diseases in children aged 6 years: results of the GINI study. Journal of Investigational Allergology &amp; Clinical Immunology2009;19(3):180‐7. [DOI: 19610260] LaubereauB , BrockowI , ZirngiblA , KoletzkoS , GrueblA , vonBergA , et al. GINI Study Group. Effect of breast‐feeding on the development of atopic dermatitis during the first 3 years of life ‐ results from the GINI‐birth cohort study. Journal of Pediatrics2004;144(5):602‐7. [DOI: 10.1016/j.jpeds.2003.12.029; PUBMED: 15126993] LaubereauB , Filipiak‐PittroffB , vonBergA , GrublA , ReinhardtD , WichmannHE , et al. Caesarean section and gastrointestinal symptoms, atopic dermatitis, and sensitisation during the first year of life. Archives of Disease in Childhood2004;89(11):993‐7. [DOI: 10.1136/adc.2003.043265; PUBMED: 15499049] RzehakP , SausenthalerS , KoletzkoS , BauerCP , SchaafB , vonBergA , et al. Period‐specific growth, overweight and modification by breastfeeding in the GINI and LISA birth cohorts up to age 6 years. European Journal of Epidemiology2009;24(8):449‐67. [DOI: 10.1007/s10654‐009‐9356‐5; PUBMED: 19521784] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. GINI‐plus Study Group. Long‐term effects of hydrolyzed protein infant formulas on growth ‐ extended follow‐up to 10 y of age: results from the German Infant Nutritional Intervention (GINI) study. American Journal of Clinical Nutrition2011;94(6 Suppl):1803S‐7S. [DOI: 10.3945/ajcn.110.000679; PUBMED: 21849601] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. German Infant Nutritional Intervention Study Group. Short‐ and long‐term effects of feeding hydrolyzed protein infant formulas on growth at &lt; or = 6 y of age: results from the German Infant Nutritional Intervention Study. American Journal of Clinical Nutrition2009;89(6):1846‐56. [DOI: 10.3945/ajcn.2008.27373; PUBMED: 19369380] SausenthalerS , KoletzkoS , KoletzkoB , ReinhardtD , KramerU , vonBergA , et al. GINIplus study group. Effect of hydrolysed formula feeding on taste preferences at 10 years. Data from the German Infant Nutritional Intervention Program Plus Study. Clinical Nutrition2010;29(3):304‐6. [DOI: 10.1016/j.clnu.2010.01.007; PUBMED: 20110140] SchoetzauA , Filipiak‐PittroffB , FrankeK , KoletzkoS , VonBergA , GrueblA , et al. German Infant Nutritional Intervention Study Group. Effect of exclusive breast‐feeding and early solid food avoidance on the incidence of atopic dermatitis in high‐risk infants at 1 year of age. Pediatric Allergy and Immunology2002;13(4):234‐42. [PUBMED: 12390439] SchoetzauA , GehringU , FrankeK , GrublA , KoletzkoS , vonBergA , et al. Gini Study Group. Maternal compliance with nutritional recommendations in an allergy preventive programme. Archives of Disease in Childhood2002;86(3):180‐4. [PUBMED: 11861235] VonBergA , Filipiak‐PittroffB , KrämerU , LinkE , HeinrichJ , KoletzkoS , et al. The German Infant Nutritional Intervention Study (GINI) for the preventive effect of hydrolysed infant formulas in infants at high risk for allergic diseases. Design and selected results. Allergologie2012;35(1):32‐43. VonBergA , Filipiak‐PittroffB , SchulzH , HoffmannU , LinkE , SussmannM , et al. GINIplus study group. Allergic manifestation 15 years after early intervention with hydrolyzed formulas ‐ the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2016;71(2):210‐9. [DOI: 10.1111/all.12790; PUBMED: 26465137] vonBergA , FilipiakB , KoletzkoS , KrämerU , HoffmannB , LinkE , et al. Long‐term effect of cow milk protein hydrolysates in high‐risk children. Results from the 10‐years follow‐up of the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2013;68:295‐6. vonBergA , Filipiak‐PittroffB , KramerU , HoffmannB , LinkE , BeckmannC , et al. GINIplus study group. Allergies in high‐risk schoolchildren after early intervention with cow's milk protein hydrolysates: 10‐year results from the German Infant Nutritional Intervention (GINI) study. Journal of Allergy and Clinical Immunology2013;131(6):1565‐73. [DOI: 10.1016/j.jaci.2013.01.006; PUBMED: 23506844] vonBergA , Filipiak‐PittroffB , KramerU , LinkE , BollrathC , BrockowI , et al. GINIplus study group. Preventive effect of hydrolyzed infant formulas persists until age 6 years: long‐term results from the German Infant Nutritional Intervention Study (GINI). Journal of Allergy and Clinical Immunology2008;121(6):1442‐7. [DOI: 10.1016/j.jaci.2008.04.021; PUBMED: 18539195] vonBergA , KoletzkoS , Filipiak‐PittroffB , LaubereauB , GrublA , WichmannHE , et al. German Infant Nutritional Intervention Study Group. Certain hydrolyzed formulas reduce the incidence of atopic dermatitis but not that of asthma: three‐year results of the German Infant Nutritional Intervention Study. Journal of Allergy and Clinical Immunology2007;119(3):718‐25. [DOI: 10.1016/j.jaci.2006.11.017; PUBMED: 17240440] vonBergA , KoletzkoS , GrublA , Filipiak‐PittroffB , WichmannHE , BauerCP , et al. German Infant Nutritional Intervention Study Group. The effect of hydrolyzed cow's milk formula for allergy prevention in the first year of life: the German Infant Nutritional Intervention Study, a randomized double‐blind trial. Journal of Allergy and Clinical Immunology2003;111(3):533‐40. [PUBMED: 12642834] ">von Berg 2003</a>) compared prolonged feeding with an EHF versus a PHF. </p> <p>Meta‐analysis found no difference in infant allergic disease (three studies, 1806 infants; typical RR 0.93, 95% CI 0.75 to 1.16; I² = 0%). <a href="./references#CD003664-bbs2-0015" title="BergA , KramerU , LinkE , BollrathC , HeinrichJ , BrockowI , et al. GINIplus study group. Impact of early feeding on childhood eczema: development after nutritional intervention compared with the natural course ‐ the GINIplus study up to the age of 6 years. Clinical and Experimental Allergy2010;40(4):627‐36. [DOI: 10.1111/j.1365‐2222.2009.03444.x; PUBMED: 20082618] BrockowI , ZutavernA , HoffmannU , GrublA , vonBergA , KoletzkoS , et al. GINIplus Study Group. Early allergic sensitizations and their relevance to atopic diseases in children aged 6 years: results of the GINI study. Journal of Investigational Allergology &amp; Clinical Immunology2009;19(3):180‐7. [DOI: 19610260] LaubereauB , BrockowI , ZirngiblA , KoletzkoS , GrueblA , vonBergA , et al. GINI Study Group. Effect of breast‐feeding on the development of atopic dermatitis during the first 3 years of life ‐ results from the GINI‐birth cohort study. Journal of Pediatrics2004;144(5):602‐7. [DOI: 10.1016/j.jpeds.2003.12.029; PUBMED: 15126993] LaubereauB , Filipiak‐PittroffB , vonBergA , GrublA , ReinhardtD , WichmannHE , et al. Caesarean section and gastrointestinal symptoms, atopic dermatitis, and sensitisation during the first year of life. Archives of Disease in Childhood2004;89(11):993‐7. [DOI: 10.1136/adc.2003.043265; PUBMED: 15499049] RzehakP , SausenthalerS , KoletzkoS , BauerCP , SchaafB , vonBergA , et al. Period‐specific growth, overweight and modification by breastfeeding in the GINI and LISA birth cohorts up to age 6 years. European Journal of Epidemiology2009;24(8):449‐67. [DOI: 10.1007/s10654‐009‐9356‐5; PUBMED: 19521784] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. GINI‐plus Study Group. Long‐term effects of hydrolyzed protein infant formulas on growth ‐ extended follow‐up to 10 y of age: results from the German Infant Nutritional Intervention (GINI) study. American Journal of Clinical Nutrition2011;94(6 Suppl):1803S‐7S. [DOI: 10.3945/ajcn.110.000679; PUBMED: 21849601] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. German Infant Nutritional Intervention Study Group. Short‐ and long‐term effects of feeding hydrolyzed protein infant formulas on growth at &lt; or = 6 y of age: results from the German Infant Nutritional Intervention Study. American Journal of Clinical Nutrition2009;89(6):1846‐56. [DOI: 10.3945/ajcn.2008.27373; PUBMED: 19369380] SausenthalerS , KoletzkoS , KoletzkoB , ReinhardtD , KramerU , vonBergA , et al. GINIplus study group. Effect of hydrolysed formula feeding on taste preferences at 10 years. Data from the German Infant Nutritional Intervention Program Plus Study. Clinical Nutrition2010;29(3):304‐6. [DOI: 10.1016/j.clnu.2010.01.007; PUBMED: 20110140] SchoetzauA , Filipiak‐PittroffB , FrankeK , KoletzkoS , VonBergA , GrueblA , et al. German Infant Nutritional Intervention Study Group. Effect of exclusive breast‐feeding and early solid food avoidance on the incidence of atopic dermatitis in high‐risk infants at 1 year of age. Pediatric Allergy and Immunology2002;13(4):234‐42. [PUBMED: 12390439] SchoetzauA , GehringU , FrankeK , GrublA , KoletzkoS , vonBergA , et al. Gini Study Group. Maternal compliance with nutritional recommendations in an allergy preventive programme. Archives of Disease in Childhood2002;86(3):180‐4. [PUBMED: 11861235] VonBergA , Filipiak‐PittroffB , KrämerU , LinkE , HeinrichJ , KoletzkoS , et al. The German Infant Nutritional Intervention Study (GINI) for the preventive effect of hydrolysed infant formulas in infants at high risk for allergic diseases. Design and selected results. Allergologie2012;35(1):32‐43. VonBergA , Filipiak‐PittroffB , SchulzH , HoffmannU , LinkE , SussmannM , et al. GINIplus study group. Allergic manifestation 15 years after early intervention with hydrolyzed formulas ‐ the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2016;71(2):210‐9. [DOI: 10.1111/all.12790; PUBMED: 26465137] vonBergA , FilipiakB , KoletzkoS , KrämerU , HoffmannB , LinkE , et al. Long‐term effect of cow milk protein hydrolysates in high‐risk children. Results from the 10‐years follow‐up of the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2013;68:295‐6. vonBergA , Filipiak‐PittroffB , KramerU , HoffmannB , LinkE , BeckmannC , et al. GINIplus study group. Allergies in high‐risk schoolchildren after early intervention with cow's milk protein hydrolysates: 10‐year results from the German Infant Nutritional Intervention (GINI) study. Journal of Allergy and Clinical Immunology2013;131(6):1565‐73. [DOI: 10.1016/j.jaci.2013.01.006; PUBMED: 23506844] vonBergA , Filipiak‐PittroffB , KramerU , LinkE , BollrathC , BrockowI , et al. GINIplus study group. Preventive effect of hydrolyzed infant formulas persists until age 6 years: long‐term results from the German Infant Nutritional Intervention Study (GINI). Journal of Allergy and Clinical Immunology2008;121(6):1442‐7. [DOI: 10.1016/j.jaci.2008.04.021; PUBMED: 18539195] vonBergA , KoletzkoS , Filipiak‐PittroffB , LaubereauB , GrublA , WichmannHE , et al. German Infant Nutritional Intervention Study Group. Certain hydrolyzed formulas reduce the incidence of atopic dermatitis but not that of asthma: three‐year results of the German Infant Nutritional Intervention Study. Journal of Allergy and Clinical Immunology2007;119(3):718‐25. [DOI: 10.1016/j.jaci.2006.11.017; PUBMED: 17240440] vonBergA , KoletzkoS , GrublA , Filipiak‐PittroffB , WichmannHE , BauerCP , et al. German Infant Nutritional Intervention Study Group. The effect of hydrolyzed cow's milk formula for allergy prevention in the first year of life: the German Infant Nutritional Intervention Study, a randomized double‐blind trial. Journal of Allergy and Clinical Immunology2003;111(3):533‐40. [PUBMED: 12642834] ">von Berg 2003</a> reported no difference in childhood allergic disease incidence (RR 0.93, 95% CI 0.74 to 1.18; participants = 661). </p> <p>Meta‐analysis found no difference in infant asthma incidence (typical RR 1.72, 95% CI 0.74 to 3.96; participants = 341; studies = 2; I<sup>2</sup> = 0%). <a href="./references#CD003664-bbs2-0015" title="BergA , KramerU , LinkE , BollrathC , HeinrichJ , BrockowI , et al. GINIplus study group. Impact of early feeding on childhood eczema: development after nutritional intervention compared with the natural course ‐ the GINIplus study up to the age of 6 years. Clinical and Experimental Allergy2010;40(4):627‐36. [DOI: 10.1111/j.1365‐2222.2009.03444.x; PUBMED: 20082618] BrockowI , ZutavernA , HoffmannU , GrublA , vonBergA , KoletzkoS , et al. GINIplus Study Group. Early allergic sensitizations and their relevance to atopic diseases in children aged 6 years: results of the GINI study. Journal of Investigational Allergology &amp; Clinical Immunology2009;19(3):180‐7. [DOI: 19610260] LaubereauB , BrockowI , ZirngiblA , KoletzkoS , GrueblA , vonBergA , et al. GINI Study Group. Effect of breast‐feeding on the development of atopic dermatitis during the first 3 years of life ‐ results from the GINI‐birth cohort study. Journal of Pediatrics2004;144(5):602‐7. [DOI: 10.1016/j.jpeds.2003.12.029; PUBMED: 15126993] LaubereauB , Filipiak‐PittroffB , vonBergA , GrublA , ReinhardtD , WichmannHE , et al. Caesarean section and gastrointestinal symptoms, atopic dermatitis, and sensitisation during the first year of life. Archives of Disease in Childhood2004;89(11):993‐7. [DOI: 10.1136/adc.2003.043265; PUBMED: 15499049] RzehakP , SausenthalerS , KoletzkoS , BauerCP , SchaafB , vonBergA , et al. Period‐specific growth, overweight and modification by breastfeeding in the GINI and LISA birth cohorts up to age 6 years. European Journal of Epidemiology2009;24(8):449‐67. [DOI: 10.1007/s10654‐009‐9356‐5; PUBMED: 19521784] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. GINI‐plus Study Group. Long‐term effects of hydrolyzed protein infant formulas on growth ‐ extended follow‐up to 10 y of age: results from the German Infant Nutritional Intervention (GINI) study. American Journal of Clinical Nutrition2011;94(6 Suppl):1803S‐7S. [DOI: 10.3945/ajcn.110.000679; PUBMED: 21849601] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. German Infant Nutritional Intervention Study Group. Short‐ and long‐term effects of feeding hydrolyzed protein infant formulas on growth at &lt; or = 6 y of age: results from the German Infant Nutritional Intervention Study. American Journal of Clinical Nutrition2009;89(6):1846‐56. [DOI: 10.3945/ajcn.2008.27373; PUBMED: 19369380] SausenthalerS , KoletzkoS , KoletzkoB , ReinhardtD , KramerU , vonBergA , et al. GINIplus study group. Effect of hydrolysed formula feeding on taste preferences at 10 years. Data from the German Infant Nutritional Intervention Program Plus Study. Clinical Nutrition2010;29(3):304‐6. [DOI: 10.1016/j.clnu.2010.01.007; PUBMED: 20110140] SchoetzauA , Filipiak‐PittroffB , FrankeK , KoletzkoS , VonBergA , GrueblA , et al. German Infant Nutritional Intervention Study Group. Effect of exclusive breast‐feeding and early solid food avoidance on the incidence of atopic dermatitis in high‐risk infants at 1 year of age. Pediatric Allergy and Immunology2002;13(4):234‐42. [PUBMED: 12390439] SchoetzauA , GehringU , FrankeK , GrublA , KoletzkoS , vonBergA , et al. Gini Study Group. Maternal compliance with nutritional recommendations in an allergy preventive programme. Archives of Disease in Childhood2002;86(3):180‐4. [PUBMED: 11861235] VonBergA , Filipiak‐PittroffB , KrämerU , LinkE , HeinrichJ , KoletzkoS , et al. The German Infant Nutritional Intervention Study (GINI) for the preventive effect of hydrolysed infant formulas in infants at high risk for allergic diseases. Design and selected results. Allergologie2012;35(1):32‐43. VonBergA , Filipiak‐PittroffB , SchulzH , HoffmannU , LinkE , SussmannM , et al. GINIplus study group. Allergic manifestation 15 years after early intervention with hydrolyzed formulas ‐ the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2016;71(2):210‐9. [DOI: 10.1111/all.12790; PUBMED: 26465137] vonBergA , FilipiakB , KoletzkoS , KrämerU , HoffmannB , LinkE , et al. Long‐term effect of cow milk protein hydrolysates in high‐risk children. Results from the 10‐years follow‐up of the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2013;68:295‐6. vonBergA , Filipiak‐PittroffB , KramerU , HoffmannB , LinkE , BeckmannC , et al. GINIplus study group. Allergies in high‐risk schoolchildren after early intervention with cow's milk protein hydrolysates: 10‐year results from the German Infant Nutritional Intervention (GINI) study. Journal of Allergy and Clinical Immunology2013;131(6):1565‐73. [DOI: 10.1016/j.jaci.2013.01.006; PUBMED: 23506844] vonBergA , Filipiak‐PittroffB , KramerU , LinkE , BollrathC , BrockowI , et al. GINIplus study group. Preventive effect of hydrolyzed infant formulas persists until age 6 years: long‐term results from the German Infant Nutritional Intervention Study (GINI). Journal of Allergy and Clinical Immunology2008;121(6):1442‐7. [DOI: 10.1016/j.jaci.2008.04.021; PUBMED: 18539195] vonBergA , KoletzkoS , Filipiak‐PittroffB , LaubereauB , GrublA , WichmannHE , et al. German Infant Nutritional Intervention Study Group. Certain hydrolyzed formulas reduce the incidence of atopic dermatitis but not that of asthma: three‐year results of the German Infant Nutritional Intervention Study. Journal of Allergy and Clinical Immunology2007;119(3):718‐25. [DOI: 10.1016/j.jaci.2006.11.017; PUBMED: 17240440] vonBergA , KoletzkoS , GrublA , Filipiak‐PittroffB , WichmannHE , BauerCP , et al. German Infant Nutritional Intervention Study Group. The effect of hydrolyzed cow's milk formula for allergy prevention in the first year of life: the German Infant Nutritional Intervention Study, a randomized double‐blind trial. Journal of Allergy and Clinical Immunology2003;111(3):533‐40. [PUBMED: 12642834] ">von Berg 2003</a> reported no difference in childhood asthma prevalence (RR 0.89, 95% CI 0.58 to 1.35; participants = 661). </p> <p>Meta‐analysis found no difference in infant eczema (typical RR 0.89, 95% CI 0.73 to 1.10; participants = 1865; studies = 4; I<sup>2</sup> = 0%). <a href="./references#CD003664-bbs2-0015" title="BergA , KramerU , LinkE , BollrathC , HeinrichJ , BrockowI , et al. GINIplus study group. Impact of early feeding on childhood eczema: development after nutritional intervention compared with the natural course ‐ the GINIplus study up to the age of 6 years. Clinical and Experimental Allergy2010;40(4):627‐36. [DOI: 10.1111/j.1365‐2222.2009.03444.x; PUBMED: 20082618] BrockowI , ZutavernA , HoffmannU , GrublA , vonBergA , KoletzkoS , et al. GINIplus Study Group. Early allergic sensitizations and their relevance to atopic diseases in children aged 6 years: results of the GINI study. Journal of Investigational Allergology &amp; Clinical Immunology2009;19(3):180‐7. [DOI: 19610260] LaubereauB , BrockowI , ZirngiblA , KoletzkoS , GrueblA , vonBergA , et al. GINI Study Group. Effect of breast‐feeding on the development of atopic dermatitis during the first 3 years of life ‐ results from the GINI‐birth cohort study. Journal of Pediatrics2004;144(5):602‐7. [DOI: 10.1016/j.jpeds.2003.12.029; PUBMED: 15126993] LaubereauB , Filipiak‐PittroffB , vonBergA , GrublA , ReinhardtD , WichmannHE , et al. Caesarean section and gastrointestinal symptoms, atopic dermatitis, and sensitisation during the first year of life. Archives of Disease in Childhood2004;89(11):993‐7. [DOI: 10.1136/adc.2003.043265; PUBMED: 15499049] RzehakP , SausenthalerS , KoletzkoS , BauerCP , SchaafB , vonBergA , et al. Period‐specific growth, overweight and modification by breastfeeding in the GINI and LISA birth cohorts up to age 6 years. European Journal of Epidemiology2009;24(8):449‐67. [DOI: 10.1007/s10654‐009‐9356‐5; PUBMED: 19521784] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. GINI‐plus Study Group. Long‐term effects of hydrolyzed protein infant formulas on growth ‐ extended follow‐up to 10 y of age: results from the German Infant Nutritional Intervention (GINI) study. American Journal of Clinical Nutrition2011;94(6 Suppl):1803S‐7S. [DOI: 10.3945/ajcn.110.000679; PUBMED: 21849601] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. German Infant Nutritional Intervention Study Group. Short‐ and long‐term effects of feeding hydrolyzed protein infant formulas on growth at &lt; or = 6 y of age: results from the German Infant Nutritional Intervention Study. American Journal of Clinical Nutrition2009;89(6):1846‐56. [DOI: 10.3945/ajcn.2008.27373; PUBMED: 19369380] SausenthalerS , KoletzkoS , KoletzkoB , ReinhardtD , KramerU , vonBergA , et al. GINIplus study group. Effect of hydrolysed formula feeding on taste preferences at 10 years. Data from the German Infant Nutritional Intervention Program Plus Study. Clinical Nutrition2010;29(3):304‐6. [DOI: 10.1016/j.clnu.2010.01.007; PUBMED: 20110140] SchoetzauA , Filipiak‐PittroffB , FrankeK , KoletzkoS , VonBergA , GrueblA , et al. German Infant Nutritional Intervention Study Group. Effect of exclusive breast‐feeding and early solid food avoidance on the incidence of atopic dermatitis in high‐risk infants at 1 year of age. Pediatric Allergy and Immunology2002;13(4):234‐42. [PUBMED: 12390439] SchoetzauA , GehringU , FrankeK , GrublA , KoletzkoS , vonBergA , et al. Gini Study Group. Maternal compliance with nutritional recommendations in an allergy preventive programme. Archives of Disease in Childhood2002;86(3):180‐4. [PUBMED: 11861235] VonBergA , Filipiak‐PittroffB , KrämerU , LinkE , HeinrichJ , KoletzkoS , et al. The German Infant Nutritional Intervention Study (GINI) for the preventive effect of hydrolysed infant formulas in infants at high risk for allergic diseases. Design and selected results. Allergologie2012;35(1):32‐43. VonBergA , Filipiak‐PittroffB , SchulzH , HoffmannU , LinkE , SussmannM , et al. GINIplus study group. Allergic manifestation 15 years after early intervention with hydrolyzed formulas ‐ the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2016;71(2):210‐9. [DOI: 10.1111/all.12790; PUBMED: 26465137] vonBergA , FilipiakB , KoletzkoS , KrämerU , HoffmannB , LinkE , et al. Long‐term effect of cow milk protein hydrolysates in high‐risk children. Results from the 10‐years follow‐up of the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2013;68:295‐6. vonBergA , Filipiak‐PittroffB , KramerU , HoffmannB , LinkE , BeckmannC , et al. GINIplus study group. Allergies in high‐risk schoolchildren after early intervention with cow's milk protein hydrolysates: 10‐year results from the German Infant Nutritional Intervention (GINI) study. Journal of Allergy and Clinical Immunology2013;131(6):1565‐73. [DOI: 10.1016/j.jaci.2013.01.006; PUBMED: 23506844] vonBergA , Filipiak‐PittroffB , KramerU , LinkE , BollrathC , BrockowI , et al. GINIplus study group. Preventive effect of hydrolyzed infant formulas persists until age 6 years: long‐term results from the German Infant Nutritional Intervention Study (GINI). Journal of Allergy and Clinical Immunology2008;121(6):1442‐7. [DOI: 10.1016/j.jaci.2008.04.021; PUBMED: 18539195] vonBergA , KoletzkoS , Filipiak‐PittroffB , LaubereauB , GrublA , WichmannHE , et al. German Infant Nutritional Intervention Study Group. Certain hydrolyzed formulas reduce the incidence of atopic dermatitis but not that of asthma: three‐year results of the German Infant Nutritional Intervention Study. Journal of Allergy and Clinical Immunology2007;119(3):718‐25. [DOI: 10.1016/j.jaci.2006.11.017; PUBMED: 17240440] vonBergA , KoletzkoS , GrublA , Filipiak‐PittroffB , WichmannHE , BauerCP , et al. German Infant Nutritional Intervention Study Group. The effect of hydrolyzed cow's milk formula for allergy prevention in the first year of life: the German Infant Nutritional Intervention Study, a randomized double‐blind trial. Journal of Allergy and Clinical Immunology2003;111(3):533‐40. [PUBMED: 12642834] ">von Berg 2003</a> reported no difference in childhood eczema incidence (RR 0.92, 95% CI 0.67 to 1.26; participants = 661) and no difference in childhood eczema prevalence (RR 0.90, 95% CI 0.54 to 1.52; participants = 661). </p> <p>Meta‐analysis found no difference in infant rhinitis (typical RR 1.25, 95% CI 0.36 to 4.29; participants = 341; studies = 2; I<sup>2</sup> = 0%). </p> <p>Meta‐analysis found a reduction in infant food allergy (typical RR 0.43, 95% CI 0.19 to 0.99; participants = 341; studies = 2; I<sup>2</sup> = 0%). </p> <p><a href="./references#CD003664-bbs2-0003" title="HalkenS , HansenKS , JacobsenHP , EstmannA , FaellingAE , HansenLG , et al. Comparison of a partially hydrolyzed infant formula with two extensively hydrolyzed formulas for allergy prevention: a prospective, randomized study. Pediatric Allergy and Immunology2000;11(3):149‐61. [PUBMED: 10981524] ">Halken 2000</a> reported no difference in infant CMA (RR 0.13, 95% CI 0.01 to 1.16; participants = 246) and no difference in infant urticaria (RR 1.32, 95% CI 0.26 to 6.66; participants = 246). </p> </section> <section id="CD003664-sec-0117"> <h5 class="title">Comparison 10. Prolonged exclusive feeding: hydrolysed formula versus cow's milk formula (CMF) </h5> <p>Seven studies reported prolonged exclusive hydrolysed formula versus CMF (<a href="./references#CD003664-bbs2-0001" title="ChiricoG , GasparoniA , CiardelliL , DeAmiciM , ColomboA , RondiniG . Immunogenicity and antigenicity of a partially hydrolyzed cow's milk infant formula. Allergy1997;52(1):82‐8. [PUBMED: 9062633] ">Chirico 1997</a>; <a href="./references#CD003664-bbs2-0002" title="deSetaL , SianiP , CirilloG , DiGruttolaM , CimaduomoL , ColettaS . The prevention of allergic diseases with a hypoallergenic formula: a follow‐up at 24 months. The preliminary results. [Italian]. La Pediatria Medica e Chirurgica: Medical and Surgical Pediatrics1994;16(3):251‐4. [PUBMED: 7971447] ">de Seta 1994</a>; <a href="./references#CD003664-bbs2-0006" title="KwintaP , SawiecP , KlimekM , LisG , Cichocka‐JaroszE , PietrzykJJ . Correlation between early neonatal diet and atopic symptoms up to 5‐7 years of age in very low birth weight infants: follow‐up of randomized, double‐blind study. Pediatric Allergy and Immunology2009;20(5):458‐66. [DOI: 10.1111/j.1399‐3038.2008.00814.x; PUBMED: 19490477] ">Kwinta 2009</a>; <a href="./references#CD003664-bbs2-0007" title="LamBC , YeungCY . The effect of breast milk, infant formula and hypoallergenic formula on incidence of atopic manifestation in high risk infants. Nestle Internal Report1992. ">Lam 1992</a>; <a href="./references#CD003664-bbs2-0009" title="MariniA , AgostiM , MottaG , MoscaF . Effects of a dietary and environmental prevention programme on the incidence of allergic symptoms in high atopic risk infants: three years' follow‐up. Acta Paediatrica Supplement1996;414:1‐21. [PUBMED: 8831855] ">Marini 1996</a>; <a href="./references#CD003664-bbs2-0014" title="VandenplasY . Atopy at 3 years in high‐risk infants fed whey hydrolysate or conventional formula. Lancet1992;339(8801):1118. [PUBMED: 1349137] VandenplasY , HauserB , Van denBorreC , ClybouwC , MahlerT , Hachimi‐IdrissiS , et al. The long‐term effect of a partial whey hydrolysate formula on the prophylaxis of atopic disease. European Journal of Pediatrics1995;154(6):488‐94. [PUBMED: 7671948] VandenplasY , HauserB , Van denBorreC , SacreL , DabI . Effect of a whey hydrolysate prophylaxis of atopic disease. Annals of Allergy1992;68(5):419‐24. [PUBMED: 1586005] ">Vandenplas 1992</a>; <a href="./references#CD003664-bbs2-0016" title="WillemsR , DuchateauJ , MagrezP , DenisR , CasimirG . Influence of hypoallergenic milk formula on the incidence of early allergic manifestations in infants predisposed to atopic diseases. Annals of Allergy1993;71(2):147‐50. [PUBMED: 8346868] ">Willems 1993</a>). </p> <p>Meta‐analysis found a reduction in infant allergic disease (typical RR 0.61, 95% CI 0.46 to 0.80; participants = 425; studies = 5; I<sup>2</sup> = 0%). <a href="./references#CD003664-bbs2-0009" title="MariniA , AgostiM , MottaG , MoscaF . Effects of a dietary and environmental prevention programme on the incidence of allergic symptoms in high atopic risk infants: three years' follow‐up. Acta Paediatrica Supplement1996;414:1‐21. [PUBMED: 8831855] ">Marini 1996</a> reported a reduction in childhood allergic disease incidence (RR 0.42, 95% CI 0.19 to 0.90; participants = 78). <a href="./references#CD003664-bbs2-0006" title="KwintaP , SawiecP , KlimekM , LisG , Cichocka‐JaroszE , PietrzykJJ . Correlation between early neonatal diet and atopic symptoms up to 5‐7 years of age in very low birth weight infants: follow‐up of randomized, double‐blind study. Pediatric Allergy and Immunology2009;20(5):458‐66. [DOI: 10.1111/j.1399‐3038.2008.00814.x; PUBMED: 19490477] ">Kwinta 2009</a> reported no difference in childhood allergic disease prevalence (RR 1.76, 95% CI 0.76 to 4.09; participants = 62). </p> <p>Meta‐analysis found no difference in infant asthma (typical RR 0.57, 95% CI 0.25 to 1.31; participants = 144; studies = 2; I<sup>2</sup> = 0%). <a href="./references#CD003664-bbs2-0009" title="MariniA , AgostiM , MottaG , MoscaF . Effects of a dietary and environmental prevention programme on the incidence of allergic symptoms in high atopic risk infants: three years' follow‐up. Acta Paediatrica Supplement1996;414:1‐21. [PUBMED: 8831855] ">Marini 1996</a> reported no difference in childhood asthma incidence (RR 0.38, 95% CI 0.08 to 1.84; participants = 78). <a href="./references#CD003664-bbs2-0006" title="KwintaP , SawiecP , KlimekM , LisG , Cichocka‐JaroszE , PietrzykJJ . Correlation between early neonatal diet and atopic symptoms up to 5‐7 years of age in very low birth weight infants: follow‐up of randomized, double‐blind study. Pediatric Allergy and Immunology2009;20(5):458‐66. [DOI: 10.1111/j.1399‐3038.2008.00814.x; PUBMED: 19490477] ">Kwinta 2009</a> reported no difference in childhood asthma prevalence (RR 2.20, 95% CI 0.77 to 6.26; participants = 62). </p> <p>Meta‐analysis found no difference in infant eczema (typical RR 0.74, 95% CI 0.45 to 1.21; participants = 271; studies = 4; I<sup>2</sup> = 0%). <a href="./references#CD003664-bbs2-0009" title="MariniA , AgostiM , MottaG , MoscaF . Effects of a dietary and environmental prevention programme on the incidence of allergic symptoms in high atopic risk infants: three years' follow‐up. Acta Paediatrica Supplement1996;414:1‐21. [PUBMED: 8831855] ">Marini 1996</a> reported no difference in childhood eczema incidence (RR 0.42, 95% CI 0.14 to 1.26; participants = 78). <a href="./references#CD003664-bbs2-0006" title="KwintaP , SawiecP , KlimekM , LisG , Cichocka‐JaroszE , PietrzykJJ . Correlation between early neonatal diet and atopic symptoms up to 5‐7 years of age in very low birth weight infants: follow‐up of randomized, double‐blind study. Pediatric Allergy and Immunology2009;20(5):458‐66. [DOI: 10.1111/j.1399‐3038.2008.00814.x; PUBMED: 19490477] ">Kwinta 2009</a> reported no difference in childhood eczema prevalence (RR 0.29, 95% CI 0.03 to 2.66; participants = 62). </p> <p><a href="./references#CD003664-bbs2-0009" title="MariniA , AgostiM , MottaG , MoscaF . Effects of a dietary and environmental prevention programme on the incidence of allergic symptoms in high atopic risk infants: three years' follow‐up. Acta Paediatrica Supplement1996;414:1‐21. [PUBMED: 8831855] ">Marini 1996</a> reported that no infants had rhinitis and found no difference in childhood rhinitis incidence (RR 0.47, 95% CI 0.04 to 5.03; participants = 78). <a href="./references#CD003664-bbs2-0006" title="KwintaP , SawiecP , KlimekM , LisG , Cichocka‐JaroszE , PietrzykJJ . Correlation between early neonatal diet and atopic symptoms up to 5‐7 years of age in very low birth weight infants: follow‐up of randomized, double‐blind study. Pediatric Allergy and Immunology2009;20(5):458‐66. [DOI: 10.1111/j.1399‐3038.2008.00814.x; PUBMED: 19490477] ">Kwinta 2009</a> reported no difference in childhood rhinitis prevalence (RR 1.32, 95% CI 0.53 to 3.26; participants = 62). </p> </section> </section> <section id="CD003664-sec-0118"> <h4 class="title">Sensitivity analyses (Comparisons 11 and 12)</h4> <section id="CD003664-sec-0119"> <h5 class="title">Comparison 11. Prolonged feeding: hydrolysed formula versus cow's milk formula (CMF) ‐ studies with blinded measurement </h5> <p>Four studies reported assessment for allergic disease without knowledge of participant allocation (<a href="./references#CD003664-bbs2-0006" title="KwintaP , SawiecP , KlimekM , LisG , Cichocka‐JaroszE , PietrzykJJ . Correlation between early neonatal diet and atopic symptoms up to 5‐7 years of age in very low birth weight infants: follow‐up of randomized, double‐blind study. Pediatric Allergy and Immunology2009;20(5):458‐66. [DOI: 10.1111/j.1399‐3038.2008.00814.x; PUBMED: 19490477] ">Kwinta 2009</a>; <a href="./references#CD003664-bbs2-0011" title="OldaeusG , AnjouK , BjorkstenB , MoranJR , KjellmanNI . Extensively and partially hydrolysed infant formulas for allergy prophylaxis. Archives of Disease in Childhood1997;77(1):4‐10. [PUBMED: 9279143] OldaeusG , BjorkstenB , JenmalmMC , KjellmanNI . Cow's milk IgE and IgG antibody responses to cow's milk formulas. Allergy1999;54(4):352‐7. [PUBMED: 10371094] ">Oldaeus 1997</a>; <a href="./references#CD003664-bbs2-0014" title="VandenplasY . Atopy at 3 years in high‐risk infants fed whey hydrolysate or conventional formula. Lancet1992;339(8801):1118. [PUBMED: 1349137] VandenplasY , HauserB , Van denBorreC , ClybouwC , MahlerT , Hachimi‐IdrissiS , et al. The long‐term effect of a partial whey hydrolysate formula on the prophylaxis of atopic disease. European Journal of Pediatrics1995;154(6):488‐94. [PUBMED: 7671948] VandenplasY , HauserB , Van denBorreC , SacreL , DabI . Effect of a whey hydrolysate prophylaxis of atopic disease. Annals of Allergy1992;68(5):419‐24. [PUBMED: 1586005] ">Vandenplas 1992</a>; <a href="./references#CD003664-bbs2-0015" title="BergA , KramerU , LinkE , BollrathC , HeinrichJ , BrockowI , et al. GINIplus study group. Impact of early feeding on childhood eczema: development after nutritional intervention compared with the natural course ‐ the GINIplus study up to the age of 6 years. Clinical and Experimental Allergy2010;40(4):627‐36. [DOI: 10.1111/j.1365‐2222.2009.03444.x; PUBMED: 20082618] BrockowI , ZutavernA , HoffmannU , GrublA , vonBergA , KoletzkoS , et al. GINIplus Study Group. Early allergic sensitizations and their relevance to atopic diseases in children aged 6 years: results of the GINI study. Journal of Investigational Allergology &amp; Clinical Immunology2009;19(3):180‐7. [DOI: 19610260] LaubereauB , BrockowI , ZirngiblA , KoletzkoS , GrueblA , vonBergA , et al. GINI Study Group. Effect of breast‐feeding on the development of atopic dermatitis during the first 3 years of life ‐ results from the GINI‐birth cohort study. Journal of Pediatrics2004;144(5):602‐7. [DOI: 10.1016/j.jpeds.2003.12.029; PUBMED: 15126993] LaubereauB , Filipiak‐PittroffB , vonBergA , GrublA , ReinhardtD , WichmannHE , et al. Caesarean section and gastrointestinal symptoms, atopic dermatitis, and sensitisation during the first year of life. Archives of Disease in Childhood2004;89(11):993‐7. [DOI: 10.1136/adc.2003.043265; PUBMED: 15499049] RzehakP , SausenthalerS , KoletzkoS , BauerCP , SchaafB , vonBergA , et al. Period‐specific growth, overweight and modification by breastfeeding in the GINI and LISA birth cohorts up to age 6 years. European Journal of Epidemiology2009;24(8):449‐67. [DOI: 10.1007/s10654‐009‐9356‐5; PUBMED: 19521784] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. GINI‐plus Study Group. Long‐term effects of hydrolyzed protein infant formulas on growth ‐ extended follow‐up to 10 y of age: results from the German Infant Nutritional Intervention (GINI) study. American Journal of Clinical Nutrition2011;94(6 Suppl):1803S‐7S. [DOI: 10.3945/ajcn.110.000679; PUBMED: 21849601] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. German Infant Nutritional Intervention Study Group. Short‐ and long‐term effects of feeding hydrolyzed protein infant formulas on growth at &lt; or = 6 y of age: results from the German Infant Nutritional Intervention Study. American Journal of Clinical Nutrition2009;89(6):1846‐56. [DOI: 10.3945/ajcn.2008.27373; PUBMED: 19369380] SausenthalerS , KoletzkoS , KoletzkoB , ReinhardtD , KramerU , vonBergA , et al. GINIplus study group. Effect of hydrolysed formula feeding on taste preferences at 10 years. Data from the German Infant Nutritional Intervention Program Plus Study. Clinical Nutrition2010;29(3):304‐6. [DOI: 10.1016/j.clnu.2010.01.007; PUBMED: 20110140] SchoetzauA , Filipiak‐PittroffB , FrankeK , KoletzkoS , VonBergA , GrueblA , et al. German Infant Nutritional Intervention Study Group. Effect of exclusive breast‐feeding and early solid food avoidance on the incidence of atopic dermatitis in high‐risk infants at 1 year of age. Pediatric Allergy and Immunology2002;13(4):234‐42. [PUBMED: 12390439] SchoetzauA , GehringU , FrankeK , GrublA , KoletzkoS , vonBergA , et al. Gini Study Group. Maternal compliance with nutritional recommendations in an allergy preventive programme. Archives of Disease in Childhood2002;86(3):180‐4. [PUBMED: 11861235] VonBergA , Filipiak‐PittroffB , KrämerU , LinkE , HeinrichJ , KoletzkoS , et al. The German Infant Nutritional Intervention Study (GINI) for the preventive effect of hydrolysed infant formulas in infants at high risk for allergic diseases. Design and selected results. Allergologie2012;35(1):32‐43. VonBergA , Filipiak‐PittroffB , SchulzH , HoffmannU , LinkE , SussmannM , et al. GINIplus study group. Allergic manifestation 15 years after early intervention with hydrolyzed formulas ‐ the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2016;71(2):210‐9. [DOI: 10.1111/all.12790; PUBMED: 26465137] vonBergA , FilipiakB , KoletzkoS , KrämerU , HoffmannB , LinkE , et al. Long‐term effect of cow milk protein hydrolysates in high‐risk children. Results from the 10‐years follow‐up of the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2013;68:295‐6. vonBergA , Filipiak‐PittroffB , KramerU , HoffmannB , LinkE , BeckmannC , et al. GINIplus study group. Allergies in high‐risk schoolchildren after early intervention with cow's milk protein hydrolysates: 10‐year results from the German Infant Nutritional Intervention (GINI) study. Journal of Allergy and Clinical Immunology2013;131(6):1565‐73. [DOI: 10.1016/j.jaci.2013.01.006; PUBMED: 23506844] vonBergA , Filipiak‐PittroffB , KramerU , LinkE , BollrathC , BrockowI , et al. GINIplus study group. Preventive effect of hydrolyzed infant formulas persists until age 6 years: long‐term results from the German Infant Nutritional Intervention Study (GINI). Journal of Allergy and Clinical Immunology2008;121(6):1442‐7. [DOI: 10.1016/j.jaci.2008.04.021; PUBMED: 18539195] vonBergA , KoletzkoS , Filipiak‐PittroffB , LaubereauB , GrublA , WichmannHE , et al. German Infant Nutritional Intervention Study Group. Certain hydrolyzed formulas reduce the incidence of atopic dermatitis but not that of asthma: three‐year results of the German Infant Nutritional Intervention Study. Journal of Allergy and Clinical Immunology2007;119(3):718‐25. [DOI: 10.1016/j.jaci.2006.11.017; PUBMED: 17240440] vonBergA , KoletzkoS , GrublA , Filipiak‐PittroffB , WichmannHE , BauerCP , et al. German Infant Nutritional Intervention Study Group. The effect of hydrolyzed cow's milk formula for allergy prevention in the first year of life: the German Infant Nutritional Intervention Study, a randomized double‐blind trial. Journal of Allergy and Clinical Immunology2003;111(3):533‐40. [PUBMED: 12642834] ">von Berg 2003</a>). </p> <p>Meta‐analysis found no difference in infant allergic disease (typical RR 0.87, 95% CI 0.69 to 1.08; participants = 2156; studies = 3; I<sup>2</sup> = 52%). <a href="./references#CD003664-bbs2-0015" title="BergA , KramerU , LinkE , BollrathC , HeinrichJ , BrockowI , et al. GINIplus study group. Impact of early feeding on childhood eczema: development after nutritional intervention compared with the natural course ‐ the GINIplus study up to the age of 6 years. Clinical and Experimental Allergy2010;40(4):627‐36. [DOI: 10.1111/j.1365‐2222.2009.03444.x; PUBMED: 20082618] BrockowI , ZutavernA , HoffmannU , GrublA , vonBergA , KoletzkoS , et al. GINIplus Study Group. Early allergic sensitizations and their relevance to atopic diseases in children aged 6 years: results of the GINI study. Journal of Investigational Allergology &amp; Clinical Immunology2009;19(3):180‐7. [DOI: 19610260] LaubereauB , BrockowI , ZirngiblA , KoletzkoS , GrueblA , vonBergA , et al. GINI Study Group. Effect of breast‐feeding on the development of atopic dermatitis during the first 3 years of life ‐ results from the GINI‐birth cohort study. Journal of Pediatrics2004;144(5):602‐7. [DOI: 10.1016/j.jpeds.2003.12.029; PUBMED: 15126993] LaubereauB , Filipiak‐PittroffB , vonBergA , GrublA , ReinhardtD , WichmannHE , et al. Caesarean section and gastrointestinal symptoms, atopic dermatitis, and sensitisation during the first year of life. Archives of Disease in Childhood2004;89(11):993‐7. [DOI: 10.1136/adc.2003.043265; PUBMED: 15499049] RzehakP , SausenthalerS , KoletzkoS , BauerCP , SchaafB , vonBergA , et al. Period‐specific growth, overweight and modification by breastfeeding in the GINI and LISA birth cohorts up to age 6 years. European Journal of Epidemiology2009;24(8):449‐67. [DOI: 10.1007/s10654‐009‐9356‐5; PUBMED: 19521784] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. GINI‐plus Study Group. Long‐term effects of hydrolyzed protein infant formulas on growth ‐ extended follow‐up to 10 y of age: results from the German Infant Nutritional Intervention (GINI) study. American Journal of Clinical Nutrition2011;94(6 Suppl):1803S‐7S. [DOI: 10.3945/ajcn.110.000679; PUBMED: 21849601] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. German Infant Nutritional Intervention Study Group. Short‐ and long‐term effects of feeding hydrolyzed protein infant formulas on growth at &lt; or = 6 y of age: results from the German Infant Nutritional Intervention Study. American Journal of Clinical Nutrition2009;89(6):1846‐56. [DOI: 10.3945/ajcn.2008.27373; PUBMED: 19369380] SausenthalerS , KoletzkoS , KoletzkoB , ReinhardtD , KramerU , vonBergA , et al. GINIplus study group. Effect of hydrolysed formula feeding on taste preferences at 10 years. Data from the German Infant Nutritional Intervention Program Plus Study. Clinical Nutrition2010;29(3):304‐6. [DOI: 10.1016/j.clnu.2010.01.007; PUBMED: 20110140] SchoetzauA , Filipiak‐PittroffB , FrankeK , KoletzkoS , VonBergA , GrueblA , et al. German Infant Nutritional Intervention Study Group. Effect of exclusive breast‐feeding and early solid food avoidance on the incidence of atopic dermatitis in high‐risk infants at 1 year of age. Pediatric Allergy and Immunology2002;13(4):234‐42. [PUBMED: 12390439] SchoetzauA , GehringU , FrankeK , GrublA , KoletzkoS , vonBergA , et al. Gini Study Group. Maternal compliance with nutritional recommendations in an allergy preventive programme. Archives of Disease in Childhood2002;86(3):180‐4. [PUBMED: 11861235] VonBergA , Filipiak‐PittroffB , KrämerU , LinkE , HeinrichJ , KoletzkoS , et al. The German Infant Nutritional Intervention Study (GINI) for the preventive effect of hydrolysed infant formulas in infants at high risk for allergic diseases. Design and selected results. Allergologie2012;35(1):32‐43. VonBergA , Filipiak‐PittroffB , SchulzH , HoffmannU , LinkE , SussmannM , et al. GINIplus study group. Allergic manifestation 15 years after early intervention with hydrolyzed formulas ‐ the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2016;71(2):210‐9. [DOI: 10.1111/all.12790; PUBMED: 26465137] vonBergA , FilipiakB , KoletzkoS , KrämerU , HoffmannB , LinkE , et al. Long‐term effect of cow milk protein hydrolysates in high‐risk children. Results from the 10‐years follow‐up of the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2013;68:295‐6. vonBergA , Filipiak‐PittroffB , KramerU , HoffmannB , LinkE , BeckmannC , et al. GINIplus study group. Allergies in high‐risk schoolchildren after early intervention with cow's milk protein hydrolysates: 10‐year results from the German Infant Nutritional Intervention (GINI) study. Journal of Allergy and Clinical Immunology2013;131(6):1565‐73. [DOI: 10.1016/j.jaci.2013.01.006; PUBMED: 23506844] vonBergA , Filipiak‐PittroffB , KramerU , LinkE , BollrathC , BrockowI , et al. GINIplus study group. Preventive effect of hydrolyzed infant formulas persists until age 6 years: long‐term results from the German Infant Nutritional Intervention Study (GINI). Journal of Allergy and Clinical Immunology2008;121(6):1442‐7. [DOI: 10.1016/j.jaci.2008.04.021; PUBMED: 18539195] vonBergA , KoletzkoS , Filipiak‐PittroffB , LaubereauB , GrublA , WichmannHE , et al. German Infant Nutritional Intervention Study Group. Certain hydrolyzed formulas reduce the incidence of atopic dermatitis but not that of asthma: three‐year results of the German Infant Nutritional Intervention Study. Journal of Allergy and Clinical Immunology2007;119(3):718‐25. [DOI: 10.1016/j.jaci.2006.11.017; PUBMED: 17240440] vonBergA , KoletzkoS , GrublA , Filipiak‐PittroffB , WichmannHE , BauerCP , et al. German Infant Nutritional Intervention Study Group. The effect of hydrolyzed cow's milk formula for allergy prevention in the first year of life: the German Infant Nutritional Intervention Study, a randomized double‐blind trial. Journal of Allergy and Clinical Immunology2003;111(3):533‐40. [PUBMED: 12642834] ">von Berg 2003</a> reported no difference in childhood allergic disease incidence (RR 0.91, 95% CI 0.73 to 1.14; participants = 872). <a href="./references#CD003664-bbs2-0006" title="KwintaP , SawiecP , KlimekM , LisG , Cichocka‐JaroszE , PietrzykJJ . Correlation between early neonatal diet and atopic symptoms up to 5‐7 years of age in very low birth weight infants: follow‐up of randomized, double‐blind study. Pediatric Allergy and Immunology2009;20(5):458‐66. [DOI: 10.1111/j.1399‐3038.2008.00814.x; PUBMED: 19490477] ">Kwinta 2009</a> reported no difference in childhood allergic disease prevalence (RR 1.76, 95% CI 0.76 to 4.09; participants = 62). </p> <p><a href="./references#CD003664-bbs2-0011" title="OldaeusG , AnjouK , BjorkstenB , MoranJR , KjellmanNI . Extensively and partially hydrolysed infant formulas for allergy prophylaxis. Archives of Disease in Childhood1997;77(1):4‐10. [PUBMED: 9279143] OldaeusG , BjorkstenB , JenmalmMC , KjellmanNI . Cow's milk IgE and IgG antibody responses to cow's milk formulas. Allergy1999;54(4):352‐7. [PUBMED: 10371094] ">Oldaeus 1997</a> reported no difference in infant asthma (RR 0.48, 95% CI 0.17 to 1.42; participants = 141). Meta‐analysis found no difference in childhood asthma prevalence (typical RR 1.17, 95% CI 0.80 to 1.73; participants = 934; studies = 2; I<sup>2</sup> = 38% [heterogeneity low]). </p> <p>Meta‐analysis found no difference in infant eczema (typical RR 0.90, 95% CI 0.70 to 1.16; participants = 2089; studies = 2; I<sup>2</sup> = 0%). <a href="./references#CD003664-bbs2-0015" title="BergA , KramerU , LinkE , BollrathC , HeinrichJ , BrockowI , et al. GINIplus study group. Impact of early feeding on childhood eczema: development after nutritional intervention compared with the natural course ‐ the GINIplus study up to the age of 6 years. Clinical and Experimental Allergy2010;40(4):627‐36. [DOI: 10.1111/j.1365‐2222.2009.03444.x; PUBMED: 20082618] BrockowI , ZutavernA , HoffmannU , GrublA , vonBergA , KoletzkoS , et al. GINIplus Study Group. Early allergic sensitizations and their relevance to atopic diseases in children aged 6 years: results of the GINI study. Journal of Investigational Allergology &amp; Clinical Immunology2009;19(3):180‐7. [DOI: 19610260] LaubereauB , BrockowI , ZirngiblA , KoletzkoS , GrueblA , vonBergA , et al. GINI Study Group. Effect of breast‐feeding on the development of atopic dermatitis during the first 3 years of life ‐ results from the GINI‐birth cohort study. Journal of Pediatrics2004;144(5):602‐7. [DOI: 10.1016/j.jpeds.2003.12.029; PUBMED: 15126993] LaubereauB , Filipiak‐PittroffB , vonBergA , GrublA , ReinhardtD , WichmannHE , et al. Caesarean section and gastrointestinal symptoms, atopic dermatitis, and sensitisation during the first year of life. Archives of Disease in Childhood2004;89(11):993‐7. [DOI: 10.1136/adc.2003.043265; PUBMED: 15499049] RzehakP , SausenthalerS , KoletzkoS , BauerCP , SchaafB , vonBergA , et al. Period‐specific growth, overweight and modification by breastfeeding in the GINI and LISA birth cohorts up to age 6 years. European Journal of Epidemiology2009;24(8):449‐67. [DOI: 10.1007/s10654‐009‐9356‐5; PUBMED: 19521784] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. GINI‐plus Study Group. Long‐term effects of hydrolyzed protein infant formulas on growth ‐ extended follow‐up to 10 y of age: results from the German Infant Nutritional Intervention (GINI) study. American Journal of Clinical Nutrition2011;94(6 Suppl):1803S‐7S. [DOI: 10.3945/ajcn.110.000679; PUBMED: 21849601] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. German Infant Nutritional Intervention Study Group. Short‐ and long‐term effects of feeding hydrolyzed protein infant formulas on growth at &lt; or = 6 y of age: results from the German Infant Nutritional Intervention Study. American Journal of Clinical Nutrition2009;89(6):1846‐56. [DOI: 10.3945/ajcn.2008.27373; PUBMED: 19369380] SausenthalerS , KoletzkoS , KoletzkoB , ReinhardtD , KramerU , vonBergA , et al. GINIplus study group. Effect of hydrolysed formula feeding on taste preferences at 10 years. Data from the German Infant Nutritional Intervention Program Plus Study. Clinical Nutrition2010;29(3):304‐6. [DOI: 10.1016/j.clnu.2010.01.007; PUBMED: 20110140] SchoetzauA , Filipiak‐PittroffB , FrankeK , KoletzkoS , VonBergA , GrueblA , et al. German Infant Nutritional Intervention Study Group. Effect of exclusive breast‐feeding and early solid food avoidance on the incidence of atopic dermatitis in high‐risk infants at 1 year of age. Pediatric Allergy and Immunology2002;13(4):234‐42. [PUBMED: 12390439] SchoetzauA , GehringU , FrankeK , GrublA , KoletzkoS , vonBergA , et al. Gini Study Group. Maternal compliance with nutritional recommendations in an allergy preventive programme. Archives of Disease in Childhood2002;86(3):180‐4. [PUBMED: 11861235] VonBergA , Filipiak‐PittroffB , KrämerU , LinkE , HeinrichJ , KoletzkoS , et al. The German Infant Nutritional Intervention Study (GINI) for the preventive effect of hydrolysed infant formulas in infants at high risk for allergic diseases. Design and selected results. Allergologie2012;35(1):32‐43. VonBergA , Filipiak‐PittroffB , SchulzH , HoffmannU , LinkE , SussmannM , et al. GINIplus study group. Allergic manifestation 15 years after early intervention with hydrolyzed formulas ‐ the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2016;71(2):210‐9. [DOI: 10.1111/all.12790; PUBMED: 26465137] vonBergA , FilipiakB , KoletzkoS , KrämerU , HoffmannB , LinkE , et al. Long‐term effect of cow milk protein hydrolysates in high‐risk children. Results from the 10‐years follow‐up of the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2013;68:295‐6. vonBergA , Filipiak‐PittroffB , KramerU , HoffmannB , LinkE , BeckmannC , et al. GINIplus study group. Allergies in high‐risk schoolchildren after early intervention with cow's milk protein hydrolysates: 10‐year results from the German Infant Nutritional Intervention (GINI) study. Journal of Allergy and Clinical Immunology2013;131(6):1565‐73. [DOI: 10.1016/j.jaci.2013.01.006; PUBMED: 23506844] vonBergA , Filipiak‐PittroffB , KramerU , LinkE , BollrathC , BrockowI , et al. GINIplus study group. Preventive effect of hydrolyzed infant formulas persists until age 6 years: long‐term results from the German Infant Nutritional Intervention Study (GINI). Journal of Allergy and Clinical Immunology2008;121(6):1442‐7. [DOI: 10.1016/j.jaci.2008.04.021; PUBMED: 18539195] vonBergA , KoletzkoS , Filipiak‐PittroffB , LaubereauB , GrublA , WichmannHE , et al. German Infant Nutritional Intervention Study Group. Certain hydrolyzed formulas reduce the incidence of atopic dermatitis but not that of asthma: three‐year results of the German Infant Nutritional Intervention Study. Journal of Allergy and Clinical Immunology2007;119(3):718‐25. [DOI: 10.1016/j.jaci.2006.11.017; PUBMED: 17240440] vonBergA , KoletzkoS , GrublA , Filipiak‐PittroffB , WichmannHE , BauerCP , et al. German Infant Nutritional Intervention Study Group. The effect of hydrolyzed cow's milk formula for allergy prevention in the first year of life: the German Infant Nutritional Intervention Study, a randomized double‐blind trial. Journal of Allergy and Clinical Immunology2003;111(3):533‐40. [PUBMED: 12642834] ">von Berg 2003</a> reported no difference in childhood eczema incidence (RR 0.88, 95% CI 0.66 to 1.18; participants = 872). Meta‐analysis found a reduction in childhood eczema prevalence (typical RR 0.64, 95% CI 0.42 to 0.97; participants = 934; studies = 2; I<sup>2</sup> = 0%). </p> <p><a href="./references#CD003664-bbs2-0011" title="OldaeusG , AnjouK , BjorkstenB , MoranJR , KjellmanNI . Extensively and partially hydrolysed infant formulas for allergy prophylaxis. Archives of Disease in Childhood1997;77(1):4‐10. [PUBMED: 9279143] OldaeusG , BjorkstenB , JenmalmMC , KjellmanNI . Cow's milk IgE and IgG antibody responses to cow's milk formulas. Allergy1999;54(4):352‐7. [PUBMED: 10371094] ">Oldaeus 1997</a> reported no difference in infant rhinitis (RR 1.47, 95% CI 0.06 to 35.37; participants = 141). <a href="./references#CD003664-bbs2-0006" title="KwintaP , SawiecP , KlimekM , LisG , Cichocka‐JaroszE , PietrzykJJ . Correlation between early neonatal diet and atopic symptoms up to 5‐7 years of age in very low birth weight infants: follow‐up of randomized, double‐blind study. Pediatric Allergy and Immunology2009;20(5):458‐66. [DOI: 10.1111/j.1399‐3038.2008.00814.x; PUBMED: 19490477] ">Kwinta 2009</a> (62 infants) reported no difference in childhood rhinitis prevalence (RR 1.32, 95% CI 0.53 to 3.26; participants = 62) </p> <p><a href="./references#CD003664-bbs2-0011" title="OldaeusG , AnjouK , BjorkstenB , MoranJR , KjellmanNI . Extensively and partially hydrolysed infant formulas for allergy prophylaxis. Archives of Disease in Childhood1997;77(1):4‐10. [PUBMED: 9279143] OldaeusG , BjorkstenB , JenmalmMC , KjellmanNI . Cow's milk IgE and IgG antibody responses to cow's milk formulas. Allergy1999;54(4):352‐7. [PUBMED: 10371094] ">Oldaeus 1997</a> reported no difference in infant food allergy (RR 1.82, 95% CI 0.64 to 5.16; participants = 141). </p> </section> <section id="CD003664-sec-0120"> <h5 class="title">Comparison 12. Prolonged feeding: hydrolysed formula versus cow's milk formula (CMF) ‐ studies at low risk of bias </h5> <p>We assessed no studies as eligible for inclusion in the sensitivity analysis of studies at low risk of bias (adequate randomisation, allocation concealment and &lt; 10% loss to follow‐up). </p> </section> </section> <section id="CD003664-sec-0121"> <h4 class="title">Additional analyses (Comparisons 13 to 17)</h4> <section id="CD003664-sec-0122"> <h5 class="title">Comparison 13. Prolonged feeding: partially hydrolysed whey formula versus cow's milk formula (CMF) </h5> <p>Nine studies compared a partially hydrolysed whey formula versus CMF (<a href="./references#CD003664-bbs2-0001" title="ChiricoG , GasparoniA , CiardelliL , DeAmiciM , ColomboA , RondiniG . Immunogenicity and antigenicity of a partially hydrolyzed cow's milk infant formula. Allergy1997;52(1):82‐8. [PUBMED: 9062633] ">Chirico 1997</a>; <a href="./references#CD003664-bbs2-0002" title="deSetaL , SianiP , CirilloG , DiGruttolaM , CimaduomoL , ColettaS . The prevention of allergic diseases with a hypoallergenic formula: a follow‐up at 24 months. The preliminary results. [Italian]. La Pediatria Medica e Chirurgica: Medical and Surgical Pediatrics1994;16(3):251‐4. [PUBMED: 7971447] ">de Seta 1994</a>; <a href="./references#CD003664-bbs2-0004" title="HillD . A report on the analysis of the Melbourne Atopy Cohort Study. A study designed to test the effectiveness of different formula types on the development of atopic symptoms and signs on a cohort of atopy‐at‐risk infants. Report at year 2. Nestec Internal Report. HillDJ , SporikR , ThorburnJ , HoskingCS . The association of atopic dermatitis in infancy with immunoglobulin E food sensitization. Journal of Pediatrics2000;137(4):475‐9. [DOI: 10.1067/mpd.2000.108207; PUBMED: 11035824] KoplinJ , DharmageSC , GurrinL , OsborneN , TangML , LoweAJ , et al. Soy consumption is not a risk factor for peanut sensitization. Journal of Allergy and Clinical Immunology2008;121(6):1455‐9. [DOI: 10.1016/j.jaci.2008.03.017; PUBMED: 18436294] LoweA , HoskingC , BennettC , AllenK , CarlinJ , DharmageS , et al. The Melbourne Atopy Cohort Study: a RCT of a partially hydrolysed whey formula for the prevention of allergic disease. Internal Medicine Journal2008;38:A158. LoweAJ , AbramsonMJ , HoskingCS , CarlinJB , BennettCM , DharmageSC , et al. The temporal sequence of allergic sensitization and onset of infantile eczema. Clinical &amp; Experimental Allergy2007;37(4):536‐42; Erratum in: Clinical &amp; Experimental Allergy 2007; 37(12);1895. [DOI: 10.1111/j.1365‐2222.2007.02691.x; PUBMED: 17430350] LoweAJ , CarlinJB , BennettCM , HoskingCS , AllenKJ , RobertsonCF , et al. Paracetamol use in early life and asthma: prospective birth cohort study. BMJ2010;341:c4616. [PUBMED: 20843914] LoweAJ , HoskingCS , BennettCM , AllenKJ , AxelradC , CarlinJB , et al. Effect of a partially hydrolyzed whey infant formula at weaning on risk of allergic disease in high‐risk children: a randomized controlled trial. Journal of Allergy and Clinical Immunology2011;128(2):360‐5.e4. [DOI: 10.1016/j.jaci.2010.05.006; PUBMED: 21696814] StoneyRM , WoodsRK , HoskingCS , HillDJ , AbramsonMJ , ThienFC . Maternal breast milk long‐chain n‐3 fatty acids are associated with increased risk of atopy in breastfed infants. Clinical and Experimental Allergy2004;34(2):194‐200; Erratum in: Clinical &amp; Experimental Allergy 2007; 37(12);1895. [PUBMED: 14987297] ThomsonJA , WidjajaC , DarmaputraAA , LoweA , MathesonMC , BennettCM , et al. Early childhood infections and immunisation and the development of allergic disease in particular asthma in a high‐risk cohort: a prospective study of allergy‐prone children from birth to six years. Pediatric Allergy and Immunology2010;21(7):1076‐85. [DOI: 10.1111/j.1399‐3038.2010.01018.x; PUBMED: 20337970] ">Hill 2000</a>; <a href="./references#CD003664-bbs2-0007" title="LamBC , YeungCY . The effect of breast milk, infant formula and hypoallergenic formula on incidence of atopic manifestation in high risk infants. Nestle Internal Report1992. ">Lam 1992</a>; <a href="./references#CD003664-bbs2-0009" title="MariniA , AgostiM , MottaG , MoscaF . Effects of a dietary and environmental prevention programme on the incidence of allergic symptoms in high atopic risk infants: three years' follow‐up. Acta Paediatrica Supplement1996;414:1‐21. [PUBMED: 8831855] ">Marini 1996</a>; <a href="./references#CD003664-bbs2-0013" title="TsaiYT , ChouCC , HsiehKH . The effect of hypoallergenic formula on the occurrence of allergic diseases in high risk infants. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi1991;32(3):137‐44. [PUBMED: 1776437] ">Tsai 1991</a>; <a href="./references#CD003664-bbs2-0014" title="VandenplasY . Atopy at 3 years in high‐risk infants fed whey hydrolysate or conventional formula. Lancet1992;339(8801):1118. [PUBMED: 1349137] VandenplasY , HauserB , Van denBorreC , ClybouwC , MahlerT , Hachimi‐IdrissiS , et al. The long‐term effect of a partial whey hydrolysate formula on the prophylaxis of atopic disease. European Journal of Pediatrics1995;154(6):488‐94. [PUBMED: 7671948] VandenplasY , HauserB , Van denBorreC , SacreL , DabI . Effect of a whey hydrolysate prophylaxis of atopic disease. Annals of Allergy1992;68(5):419‐24. [PUBMED: 1586005] ">Vandenplas 1992</a>; <a href="./references#CD003664-bbs2-0015" title="BergA , KramerU , LinkE , BollrathC , HeinrichJ , BrockowI , et al. GINIplus study group. Impact of early feeding on childhood eczema: development after nutritional intervention compared with the natural course ‐ the GINIplus study up to the age of 6 years. Clinical and Experimental Allergy2010;40(4):627‐36. [DOI: 10.1111/j.1365‐2222.2009.03444.x; PUBMED: 20082618] BrockowI , ZutavernA , HoffmannU , GrublA , vonBergA , KoletzkoS , et al. GINIplus Study Group. Early allergic sensitizations and their relevance to atopic diseases in children aged 6 years: results of the GINI study. Journal of Investigational Allergology &amp; Clinical Immunology2009;19(3):180‐7. [DOI: 19610260] LaubereauB , BrockowI , ZirngiblA , KoletzkoS , GrueblA , vonBergA , et al. GINI Study Group. Effect of breast‐feeding on the development of atopic dermatitis during the first 3 years of life ‐ results from the GINI‐birth cohort study. Journal of Pediatrics2004;144(5):602‐7. [DOI: 10.1016/j.jpeds.2003.12.029; PUBMED: 15126993] LaubereauB , Filipiak‐PittroffB , vonBergA , GrublA , ReinhardtD , WichmannHE , et al. Caesarean section and gastrointestinal symptoms, atopic dermatitis, and sensitisation during the first year of life. Archives of Disease in Childhood2004;89(11):993‐7. [DOI: 10.1136/adc.2003.043265; PUBMED: 15499049] RzehakP , SausenthalerS , KoletzkoS , BauerCP , SchaafB , vonBergA , et al. Period‐specific growth, overweight and modification by breastfeeding in the GINI and LISA birth cohorts up to age 6 years. European Journal of Epidemiology2009;24(8):449‐67. [DOI: 10.1007/s10654‐009‐9356‐5; PUBMED: 19521784] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. GINI‐plus Study Group. Long‐term effects of hydrolyzed protein infant formulas on growth ‐ extended follow‐up to 10 y of age: results from the German Infant Nutritional Intervention (GINI) study. American Journal of Clinical Nutrition2011;94(6 Suppl):1803S‐7S. [DOI: 10.3945/ajcn.110.000679; PUBMED: 21849601] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. German Infant Nutritional Intervention Study Group. Short‐ and long‐term effects of feeding hydrolyzed protein infant formulas on growth at &lt; or = 6 y of age: results from the German Infant Nutritional Intervention Study. American Journal of Clinical Nutrition2009;89(6):1846‐56. [DOI: 10.3945/ajcn.2008.27373; PUBMED: 19369380] SausenthalerS , KoletzkoS , KoletzkoB , ReinhardtD , KramerU , vonBergA , et al. GINIplus study group. Effect of hydrolysed formula feeding on taste preferences at 10 years. Data from the German Infant Nutritional Intervention Program Plus Study. Clinical Nutrition2010;29(3):304‐6. [DOI: 10.1016/j.clnu.2010.01.007; PUBMED: 20110140] SchoetzauA , Filipiak‐PittroffB , FrankeK , KoletzkoS , VonBergA , GrueblA , et al. German Infant Nutritional Intervention Study Group. Effect of exclusive breast‐feeding and early solid food avoidance on the incidence of atopic dermatitis in high‐risk infants at 1 year of age. Pediatric Allergy and Immunology2002;13(4):234‐42. [PUBMED: 12390439] SchoetzauA , GehringU , FrankeK , GrublA , KoletzkoS , vonBergA , et al. Gini Study Group. Maternal compliance with nutritional recommendations in an allergy preventive programme. Archives of Disease in Childhood2002;86(3):180‐4. [PUBMED: 11861235] VonBergA , Filipiak‐PittroffB , KrämerU , LinkE , HeinrichJ , KoletzkoS , et al. The German Infant Nutritional Intervention Study (GINI) for the preventive effect of hydrolysed infant formulas in infants at high risk for allergic diseases. Design and selected results. Allergologie2012;35(1):32‐43. VonBergA , Filipiak‐PittroffB , SchulzH , HoffmannU , LinkE , SussmannM , et al. GINIplus study group. Allergic manifestation 15 years after early intervention with hydrolyzed formulas ‐ the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2016;71(2):210‐9. [DOI: 10.1111/all.12790; PUBMED: 26465137] vonBergA , FilipiakB , KoletzkoS , KrämerU , HoffmannB , LinkE , et al. Long‐term effect of cow milk protein hydrolysates in high‐risk children. Results from the 10‐years follow‐up of the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2013;68:295‐6. vonBergA , Filipiak‐PittroffB , KramerU , HoffmannB , LinkE , BeckmannC , et al. GINIplus study group. Allergies in high‐risk schoolchildren after early intervention with cow's milk protein hydrolysates: 10‐year results from the German Infant Nutritional Intervention (GINI) study. Journal of Allergy and Clinical Immunology2013;131(6):1565‐73. [DOI: 10.1016/j.jaci.2013.01.006; PUBMED: 23506844] vonBergA , Filipiak‐PittroffB , KramerU , LinkE , BollrathC , BrockowI , et al. GINIplus study group. Preventive effect of hydrolyzed infant formulas persists until age 6 years: long‐term results from the German Infant Nutritional Intervention Study (GINI). Journal of Allergy and Clinical Immunology2008;121(6):1442‐7. [DOI: 10.1016/j.jaci.2008.04.021; PUBMED: 18539195] vonBergA , KoletzkoS , Filipiak‐PittroffB , LaubereauB , GrublA , WichmannHE , et al. German Infant Nutritional Intervention Study Group. Certain hydrolyzed formulas reduce the incidence of atopic dermatitis but not that of asthma: three‐year results of the German Infant Nutritional Intervention Study. Journal of Allergy and Clinical Immunology2007;119(3):718‐25. [DOI: 10.1016/j.jaci.2006.11.017; PUBMED: 17240440] vonBergA , KoletzkoS , GrublA , Filipiak‐PittroffB , WichmannHE , BauerCP , et al. German Infant Nutritional Intervention Study Group. The effect of hydrolyzed cow's milk formula for allergy prevention in the first year of life: the German Infant Nutritional Intervention Study, a randomized double‐blind trial. Journal of Allergy and Clinical Immunology2003;111(3):533‐40. [PUBMED: 12642834] ">von Berg 2003</a>; <a href="./references#CD003664-bbs2-0016" title="WillemsR , DuchateauJ , MagrezP , DenisR , CasimirG . Influence of hypoallergenic milk formula on the incidence of early allergic manifestations in infants predisposed to atopic diseases. Annals of Allergy1993;71(2):147‐50. [PUBMED: 8346868] ">Willems 1993</a>). </p> <p>Meta‐analysis found a reduction in infant allergic disease (typical RR 0.77, 95% CI 0.59 to 1.00; participants = 1729; studies = 7; I<sup>2</sup> = 53% [heterogeneity moderate]) and no difference in childhood allergic disease incidence (typical RR 0.68, 95% CI 0.31 to 1.52; participants = 510; studies = 2; I<sup>2</sup> = 75% [heterogeneity high). </p> <p>Meta‐analysis found no difference in infant asthma (typical RR 0.61, 95% CI 0.29 to 1.28; participants = 177; studies = 3; I<sup>2</sup> = 0%). <a href="./references#CD003664-bbs2-0009" title="MariniA , AgostiM , MottaG , MoscaF . Effects of a dietary and environmental prevention programme on the incidence of allergic symptoms in high atopic risk infants: three years' follow‐up. Acta Paediatrica Supplement1996;414:1‐21. [PUBMED: 8831855] ">Marini 1996</a> reported no difference in childhood asthma incidence (RR 0.38, 95% CI 0.08 to 1.84; participants = 78). Meta‐analysis found no difference in childhood asthma prevalence (typical RR 0.98, 95% CI 0.73 to 1.31; participants = 727; studies = 2; I<sup>2</sup> = 0%). </p> <p>Meta‐analysis found no difference in infant eczema (typical RR 0.96, 95% CI 0.80 to 1.14; participants = 1608; studies = 7; I<sup>2</sup> = 0%), no difference in childhood eczema incidence (typical RR 0.85, 95% CI 0.61 to 1.19; participants = 510; studies = 2; I<sup>2</sup> = 46% [heterogeneity low]) and no difference in childhood eczema prevalence (typical RR 0.94, 95% CI 0.71 to 1.26; participants = 726; studies = 2; I<sup>2</sup> = 44% [heterogeneity low]). </p> <p>Meta‐analysis found no difference in infant rhinitis (typical RR 0.40, 95% CI 0.09 to 1.70; participants = 115; studies = 2; I<sup>2</sup> = 0%). <a href="./references#CD003664-bbs2-0009" title="MariniA , AgostiM , MottaG , MoscaF . Effects of a dietary and environmental prevention programme on the incidence of allergic symptoms in high atopic risk infants: three years' follow‐up. Acta Paediatrica Supplement1996;414:1‐21. [PUBMED: 8831855] ">Marini 1996</a> reported no difference in childhood rhinitis incidence (RR 0.47, 95% CI 0.04 to 5.03; participants = 78). <a href="./references#CD003664-bbs2-0004" title="HillD . A report on the analysis of the Melbourne Atopy Cohort Study. A study designed to test the effectiveness of different formula types on the development of atopic symptoms and signs on a cohort of atopy‐at‐risk infants. Report at year 2. Nestec Internal Report. HillDJ , SporikR , ThorburnJ , HoskingCS . The association of atopic dermatitis in infancy with immunoglobulin E food sensitization. Journal of Pediatrics2000;137(4):475‐9. [DOI: 10.1067/mpd.2000.108207; PUBMED: 11035824] KoplinJ , DharmageSC , GurrinL , OsborneN , TangML , LoweAJ , et al. Soy consumption is not a risk factor for peanut sensitization. Journal of Allergy and Clinical Immunology2008;121(6):1455‐9. [DOI: 10.1016/j.jaci.2008.03.017; PUBMED: 18436294] LoweA , HoskingC , BennettC , AllenK , CarlinJ , DharmageS , et al. The Melbourne Atopy Cohort Study: a RCT of a partially hydrolysed whey formula for the prevention of allergic disease. Internal Medicine Journal2008;38:A158. LoweAJ , AbramsonMJ , HoskingCS , CarlinJB , BennettCM , DharmageSC , et al. The temporal sequence of allergic sensitization and onset of infantile eczema. Clinical &amp; Experimental Allergy2007;37(4):536‐42; Erratum in: Clinical &amp; Experimental Allergy 2007; 37(12);1895. [DOI: 10.1111/j.1365‐2222.2007.02691.x; PUBMED: 17430350] LoweAJ , CarlinJB , BennettCM , HoskingCS , AllenKJ , RobertsonCF , et al. Paracetamol use in early life and asthma: prospective birth cohort study. BMJ2010;341:c4616. [PUBMED: 20843914] LoweAJ , HoskingCS , BennettCM , AllenKJ , AxelradC , CarlinJB , et al. Effect of a partially hydrolyzed whey infant formula at weaning on risk of allergic disease in high‐risk children: a randomized controlled trial. Journal of Allergy and Clinical Immunology2011;128(2):360‐5.e4. [DOI: 10.1016/j.jaci.2010.05.006; PUBMED: 21696814] StoneyRM , WoodsRK , HoskingCS , HillDJ , AbramsonMJ , ThienFC . Maternal breast milk long‐chain n‐3 fatty acids are associated with increased risk of atopy in breastfed infants. Clinical and Experimental Allergy2004;34(2):194‐200; Erratum in: Clinical &amp; Experimental Allergy 2007; 37(12);1895. [PUBMED: 14987297] ThomsonJA , WidjajaC , DarmaputraAA , LoweA , MathesonMC , BennettCM , et al. Early childhood infections and immunisation and the development of allergic disease in particular asthma in a high‐risk cohort: a prospective study of allergy‐prone children from birth to six years. Pediatric Allergy and Immunology2010;21(7):1076‐85. [DOI: 10.1111/j.1399‐3038.2010.01018.x; PUBMED: 20337970] ">Hill 2000</a> reported no difference in childhood rhinitis prevalence (RR 0.90, 95% CI 0.59 to 1.37; participants = 295). </p> <p><a href="./references#CD003664-bbs2-0004" title="HillD . A report on the analysis of the Melbourne Atopy Cohort Study. A study designed to test the effectiveness of different formula types on the development of atopic symptoms and signs on a cohort of atopy‐at‐risk infants. Report at year 2. Nestec Internal Report. HillDJ , SporikR , ThorburnJ , HoskingCS . The association of atopic dermatitis in infancy with immunoglobulin E food sensitization. Journal of Pediatrics2000;137(4):475‐9. [DOI: 10.1067/mpd.2000.108207; PUBMED: 11035824] KoplinJ , DharmageSC , GurrinL , OsborneN , TangML , LoweAJ , et al. Soy consumption is not a risk factor for peanut sensitization. Journal of Allergy and Clinical Immunology2008;121(6):1455‐9. [DOI: 10.1016/j.jaci.2008.03.017; PUBMED: 18436294] LoweA , HoskingC , BennettC , AllenK , CarlinJ , DharmageS , et al. The Melbourne Atopy Cohort Study: a RCT of a partially hydrolysed whey formula for the prevention of allergic disease. Internal Medicine Journal2008;38:A158. LoweAJ , AbramsonMJ , HoskingCS , CarlinJB , BennettCM , DharmageSC , et al. The temporal sequence of allergic sensitization and onset of infantile eczema. Clinical &amp; Experimental Allergy2007;37(4):536‐42; Erratum in: Clinical &amp; Experimental Allergy 2007; 37(12);1895. [DOI: 10.1111/j.1365‐2222.2007.02691.x; PUBMED: 17430350] LoweAJ , CarlinJB , BennettCM , HoskingCS , AllenKJ , RobertsonCF , et al. Paracetamol use in early life and asthma: prospective birth cohort study. BMJ2010;341:c4616. [PUBMED: 20843914] LoweAJ , HoskingCS , BennettCM , AllenKJ , AxelradC , CarlinJB , et al. Effect of a partially hydrolyzed whey infant formula at weaning on risk of allergic disease in high‐risk children: a randomized controlled trial. Journal of Allergy and Clinical Immunology2011;128(2):360‐5.e4. [DOI: 10.1016/j.jaci.2010.05.006; PUBMED: 21696814] StoneyRM , WoodsRK , HoskingCS , HillDJ , AbramsonMJ , ThienFC . Maternal breast milk long‐chain n‐3 fatty acids are associated with increased risk of atopy in breastfed infants. Clinical and Experimental Allergy2004;34(2):194‐200; Erratum in: Clinical &amp; Experimental Allergy 2007; 37(12);1895. [PUBMED: 14987297] ThomsonJA , WidjajaC , DarmaputraAA , LoweA , MathesonMC , BennettCM , et al. Early childhood infections and immunisation and the development of allergic disease in particular asthma in a high‐risk cohort: a prospective study of allergy‐prone children from birth to six years. Pediatric Allergy and Immunology2010;21(7):1076‐85. [DOI: 10.1111/j.1399‐3038.2010.01018.x; PUBMED: 20337970] ">Hill 2000</a> reported no difference in infant food allergy (RR 1.31, 95% CI 0.75 to 2.30; participants = 338). </p> <p><a href="./references#CD003664-bbs2-0004" title="HillD . A report on the analysis of the Melbourne Atopy Cohort Study. A study designed to test the effectiveness of different formula types on the development of atopic symptoms and signs on a cohort of atopy‐at‐risk infants. Report at year 2. Nestec Internal Report. HillDJ , SporikR , ThorburnJ , HoskingCS . The association of atopic dermatitis in infancy with immunoglobulin E food sensitization. Journal of Pediatrics2000;137(4):475‐9. [DOI: 10.1067/mpd.2000.108207; PUBMED: 11035824] KoplinJ , DharmageSC , GurrinL , OsborneN , TangML , LoweAJ , et al. Soy consumption is not a risk factor for peanut sensitization. Journal of Allergy and Clinical Immunology2008;121(6):1455‐9. [DOI: 10.1016/j.jaci.2008.03.017; PUBMED: 18436294] LoweA , HoskingC , BennettC , AllenK , CarlinJ , DharmageS , et al. The Melbourne Atopy Cohort Study: a RCT of a partially hydrolysed whey formula for the prevention of allergic disease. Internal Medicine Journal2008;38:A158. LoweAJ , AbramsonMJ , HoskingCS , CarlinJB , BennettCM , DharmageSC , et al. The temporal sequence of allergic sensitization and onset of infantile eczema. Clinical &amp; Experimental Allergy2007;37(4):536‐42; Erratum in: Clinical &amp; Experimental Allergy 2007; 37(12);1895. [DOI: 10.1111/j.1365‐2222.2007.02691.x; PUBMED: 17430350] LoweAJ , CarlinJB , BennettCM , HoskingCS , AllenKJ , RobertsonCF , et al. Paracetamol use in early life and asthma: prospective birth cohort study. BMJ2010;341:c4616. [PUBMED: 20843914] LoweAJ , HoskingCS , BennettCM , AllenKJ , AxelradC , CarlinJB , et al. Effect of a partially hydrolyzed whey infant formula at weaning on risk of allergic disease in high‐risk children: a randomized controlled trial. Journal of Allergy and Clinical Immunology2011;128(2):360‐5.e4. [DOI: 10.1016/j.jaci.2010.05.006; PUBMED: 21696814] StoneyRM , WoodsRK , HoskingCS , HillDJ , AbramsonMJ , ThienFC . Maternal breast milk long‐chain n‐3 fatty acids are associated with increased risk of atopy in breastfed infants. Clinical and Experimental Allergy2004;34(2):194‐200; Erratum in: Clinical &amp; Experimental Allergy 2007; 37(12);1895. [PUBMED: 14987297] ThomsonJA , WidjajaC , DarmaputraAA , LoweA , MathesonMC , BennettCM , et al. Early childhood infections and immunisation and the development of allergic disease in particular asthma in a high‐risk cohort: a prospective study of allergy‐prone children from birth to six years. Pediatric Allergy and Immunology2010;21(7):1076‐85. [DOI: 10.1111/j.1399‐3038.2010.01018.x; PUBMED: 20337970] ">Hill 2000</a> reported no difference in infant CMA (RR 2.31, 95% CI 0.24 to 21.97; participants = 338). </p> </section> <section id="CD003664-sec-0123"> <h5 class="title">Comparison 14. Prolonged feeding: partially hydrolysed casein‐containing formula versus cow's milk formula (CMF) </h5> <p>Two studies compared a PHF containing casein versus CMF (<a href="./references#CD003664-bbs2-0006" title="KwintaP , SawiecP , KlimekM , LisG , Cichocka‐JaroszE , PietrzykJJ . Correlation between early neonatal diet and atopic symptoms up to 5‐7 years of age in very low birth weight infants: follow‐up of randomized, double‐blind study. Pediatric Allergy and Immunology2009;20(5):458‐66. [DOI: 10.1111/j.1399‐3038.2008.00814.x; PUBMED: 19490477] ">Kwinta 2009</a>; <a href="./references#CD003664-bbs2-0011" title="OldaeusG , AnjouK , BjorkstenB , MoranJR , KjellmanNI . Extensively and partially hydrolysed infant formulas for allergy prophylaxis. Archives of Disease in Childhood1997;77(1):4‐10. [PUBMED: 9279143] OldaeusG , BjorkstenB , JenmalmMC , KjellmanNI . Cow's milk IgE and IgG antibody responses to cow's milk formulas. Allergy1999;54(4):352‐7. [PUBMED: 10371094] ">Oldaeus 1997</a>). </p> <p><a href="./references#CD003664-bbs2-0011" title="OldaeusG , AnjouK , BjorkstenB , MoranJR , KjellmanNI . Extensively and partially hydrolysed infant formulas for allergy prophylaxis. Archives of Disease in Childhood1997;77(1):4‐10. [PUBMED: 9279143] OldaeusG , BjorkstenB , JenmalmMC , KjellmanNI . Cow's milk IgE and IgG antibody responses to cow's milk formulas. Allergy1999;54(4):352‐7. [PUBMED: 10371094] ">Oldaeus 1997</a> reported no difference in infant allergic disease incidence (RR 1.36, 95% CI 0.80 to 2.31; participants = 91). <a href="./references#CD003664-bbs2-0006" title="KwintaP , SawiecP , KlimekM , LisG , Cichocka‐JaroszE , PietrzykJJ . Correlation between early neonatal diet and atopic symptoms up to 5‐7 years of age in very low birth weight infants: follow‐up of randomized, double‐blind study. Pediatric Allergy and Immunology2009;20(5):458‐66. [DOI: 10.1111/j.1399‐3038.2008.00814.x; PUBMED: 19490477] ">Kwinta 2009</a> reported no difference in childhood allergic disease prevalence (RR 1.76, 95% CI 0.76 to 4.09; participants = 62). </p> <p><a href="./references#CD003664-bbs2-0011" title="OldaeusG , AnjouK , BjorkstenB , MoranJR , KjellmanNI . Extensively and partially hydrolysed infant formulas for allergy prophylaxis. Archives of Disease in Childhood1997;77(1):4‐10. [PUBMED: 9279143] OldaeusG , BjorkstenB , JenmalmMC , KjellmanNI . Cow's milk IgE and IgG antibody responses to cow's milk formulas. Allergy1999;54(4):352‐7. [PUBMED: 10371094] ">Oldaeus 1997</a> reported no difference in infant asthma (RR 0.34, 95% CI 0.07 to 1.60; participants = 91). <a href="./references#CD003664-bbs2-0006" title="KwintaP , SawiecP , KlimekM , LisG , Cichocka‐JaroszE , PietrzykJJ . Correlation between early neonatal diet and atopic symptoms up to 5‐7 years of age in very low birth weight infants: follow‐up of randomized, double‐blind study. Pediatric Allergy and Immunology2009;20(5):458‐66. [DOI: 10.1111/j.1399‐3038.2008.00814.x; PUBMED: 19490477] ">Kwinta 2009</a> reported no difference in childhood asthma prevalence (RR 2.20, 95% CI 0.77 to 6.26; participants = 62). </p> <p><a href="./references#CD003664-bbs2-0011" title="OldaeusG , AnjouK , BjorkstenB , MoranJR , KjellmanNI . Extensively and partially hydrolysed infant formulas for allergy prophylaxis. Archives of Disease in Childhood1997;77(1):4‐10. [PUBMED: 9279143] OldaeusG , BjorkstenB , JenmalmMC , KjellmanNI . Cow's milk IgE and IgG antibody responses to cow's milk formulas. Allergy1999;54(4):352‐7. [PUBMED: 10371094] ">Oldaeus 1997</a> reported no difference in infant eczema (RR 1.30, 95% CI 0.66 to 2.55; participants = 91). <a href="./references#CD003664-bbs2-0006" title="KwintaP , SawiecP , KlimekM , LisG , Cichocka‐JaroszE , PietrzykJJ . Correlation between early neonatal diet and atopic symptoms up to 5‐7 years of age in very low birth weight infants: follow‐up of randomized, double‐blind study. Pediatric Allergy and Immunology2009;20(5):458‐66. [DOI: 10.1111/j.1399‐3038.2008.00814.x; PUBMED: 19490477] ">Kwinta 2009</a> reported no difference in childhood eczema prevalence (RR 0.29, 95% CI 0.03 to 2.66; participants = 62). </p> <p><a href="./references#CD003664-bbs2-0011" title="OldaeusG , AnjouK , BjorkstenB , MoranJR , KjellmanNI . Extensively and partially hydrolysed infant formulas for allergy prophylaxis. Archives of Disease in Childhood1997;77(1):4‐10. [PUBMED: 9279143] OldaeusG , BjorkstenB , JenmalmMC , KjellmanNI . Cow's milk IgE and IgG antibody responses to cow's milk formulas. Allergy1999;54(4):352‐7. [PUBMED: 10371094] ">Oldaeus 1997</a> reported that no infant had rhinitis. <a href="./references#CD003664-bbs2-0006" title="KwintaP , SawiecP , KlimekM , LisG , Cichocka‐JaroszE , PietrzykJJ . Correlation between early neonatal diet and atopic symptoms up to 5‐7 years of age in very low birth weight infants: follow‐up of randomized, double‐blind study. Pediatric Allergy and Immunology2009;20(5):458‐66. [DOI: 10.1111/j.1399‐3038.2008.00814.x; PUBMED: 19490477] ">Kwinta 2009</a> reported no difference in childhood rhinitis prevalence (RR 1.32, 95% CI 0.53 to 3.26; participants = 62). </p> <p><a href="./references#CD003664-bbs2-0011" title="OldaeusG , AnjouK , BjorkstenB , MoranJR , KjellmanNI . Extensively and partially hydrolysed infant formulas for allergy prophylaxis. Archives of Disease in Childhood1997;77(1):4‐10. [PUBMED: 9279143] OldaeusG , BjorkstenB , JenmalmMC , KjellmanNI . Cow's milk IgE and IgG antibody responses to cow's milk formulas. Allergy1999;54(4):352‐7. [PUBMED: 10371094] ">Oldaeus 1997</a> reported no difference in infant food allergy (RR 2.56, 95% CI 0.86 to 7.56; participants = 91). </p> </section> <section id="CD003664-sec-0124"> <h5 class="title">Comparison 15. Prolonged feeding: extensively hydrolysed whey formula versus cow's milk formula (CMF) </h5> <p><a href="./references#CD003664-bbs2-0015" title="BergA , KramerU , LinkE , BollrathC , HeinrichJ , BrockowI , et al. GINIplus study group. Impact of early feeding on childhood eczema: development after nutritional intervention compared with the natural course ‐ the GINIplus study up to the age of 6 years. Clinical and Experimental Allergy2010;40(4):627‐36. [DOI: 10.1111/j.1365‐2222.2009.03444.x; PUBMED: 20082618] BrockowI , ZutavernA , HoffmannU , GrublA , vonBergA , KoletzkoS , et al. GINIplus Study Group. Early allergic sensitizations and their relevance to atopic diseases in children aged 6 years: results of the GINI study. Journal of Investigational Allergology &amp; Clinical Immunology2009;19(3):180‐7. [DOI: 19610260] LaubereauB , BrockowI , ZirngiblA , KoletzkoS , GrueblA , vonBergA , et al. GINI Study Group. Effect of breast‐feeding on the development of atopic dermatitis during the first 3 years of life ‐ results from the GINI‐birth cohort study. Journal of Pediatrics2004;144(5):602‐7. [DOI: 10.1016/j.jpeds.2003.12.029; PUBMED: 15126993] LaubereauB , Filipiak‐PittroffB , vonBergA , GrublA , ReinhardtD , WichmannHE , et al. Caesarean section and gastrointestinal symptoms, atopic dermatitis, and sensitisation during the first year of life. Archives of Disease in Childhood2004;89(11):993‐7. [DOI: 10.1136/adc.2003.043265; PUBMED: 15499049] RzehakP , SausenthalerS , KoletzkoS , BauerCP , SchaafB , vonBergA , et al. Period‐specific growth, overweight and modification by breastfeeding in the GINI and LISA birth cohorts up to age 6 years. European Journal of Epidemiology2009;24(8):449‐67. [DOI: 10.1007/s10654‐009‐9356‐5; PUBMED: 19521784] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. GINI‐plus Study Group. Long‐term effects of hydrolyzed protein infant formulas on growth ‐ extended follow‐up to 10 y of age: results from the German Infant Nutritional Intervention (GINI) study. American Journal of Clinical Nutrition2011;94(6 Suppl):1803S‐7S. [DOI: 10.3945/ajcn.110.000679; PUBMED: 21849601] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. German Infant Nutritional Intervention Study Group. Short‐ and long‐term effects of feeding hydrolyzed protein infant formulas on growth at &lt; or = 6 y of age: results from the German Infant Nutritional Intervention Study. American Journal of Clinical Nutrition2009;89(6):1846‐56. [DOI: 10.3945/ajcn.2008.27373; PUBMED: 19369380] SausenthalerS , KoletzkoS , KoletzkoB , ReinhardtD , KramerU , vonBergA , et al. GINIplus study group. Effect of hydrolysed formula feeding on taste preferences at 10 years. Data from the German Infant Nutritional Intervention Program Plus Study. Clinical Nutrition2010;29(3):304‐6. [DOI: 10.1016/j.clnu.2010.01.007; PUBMED: 20110140] SchoetzauA , Filipiak‐PittroffB , FrankeK , KoletzkoS , VonBergA , GrueblA , et al. German Infant Nutritional Intervention Study Group. Effect of exclusive breast‐feeding and early solid food avoidance on the incidence of atopic dermatitis in high‐risk infants at 1 year of age. Pediatric Allergy and Immunology2002;13(4):234‐42. [PUBMED: 12390439] SchoetzauA , GehringU , FrankeK , GrublA , KoletzkoS , vonBergA , et al. Gini Study Group. Maternal compliance with nutritional recommendations in an allergy preventive programme. Archives of Disease in Childhood2002;86(3):180‐4. [PUBMED: 11861235] VonBergA , Filipiak‐PittroffB , KrämerU , LinkE , HeinrichJ , KoletzkoS , et al. The German Infant Nutritional Intervention Study (GINI) for the preventive effect of hydrolysed infant formulas in infants at high risk for allergic diseases. Design and selected results. Allergologie2012;35(1):32‐43. VonBergA , Filipiak‐PittroffB , SchulzH , HoffmannU , LinkE , SussmannM , et al. GINIplus study group. Allergic manifestation 15 years after early intervention with hydrolyzed formulas ‐ the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2016;71(2):210‐9. [DOI: 10.1111/all.12790; PUBMED: 26465137] vonBergA , FilipiakB , KoletzkoS , KrämerU , HoffmannB , LinkE , et al. Long‐term effect of cow milk protein hydrolysates in high‐risk children. Results from the 10‐years follow‐up of the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2013;68:295‐6. vonBergA , Filipiak‐PittroffB , KramerU , HoffmannB , LinkE , BeckmannC , et al. GINIplus study group. Allergies in high‐risk schoolchildren after early intervention with cow's milk protein hydrolysates: 10‐year results from the German Infant Nutritional Intervention (GINI) study. Journal of Allergy and Clinical Immunology2013;131(6):1565‐73. [DOI: 10.1016/j.jaci.2013.01.006; PUBMED: 23506844] vonBergA , Filipiak‐PittroffB , KramerU , LinkE , BollrathC , BrockowI , et al. GINIplus study group. Preventive effect of hydrolyzed infant formulas persists until age 6 years: long‐term results from the German Infant Nutritional Intervention Study (GINI). Journal of Allergy and Clinical Immunology2008;121(6):1442‐7. [DOI: 10.1016/j.jaci.2008.04.021; PUBMED: 18539195] vonBergA , KoletzkoS , Filipiak‐PittroffB , LaubereauB , GrublA , WichmannHE , et al. German Infant Nutritional Intervention Study Group. Certain hydrolyzed formulas reduce the incidence of atopic dermatitis but not that of asthma: three‐year results of the German Infant Nutritional Intervention Study. Journal of Allergy and Clinical Immunology2007;119(3):718‐25. [DOI: 10.1016/j.jaci.2006.11.017; PUBMED: 17240440] vonBergA , KoletzkoS , GrublA , Filipiak‐PittroffB , WichmannHE , BauerCP , et al. German Infant Nutritional Intervention Study Group. The effect of hydrolyzed cow's milk formula for allergy prevention in the first year of life: the German Infant Nutritional Intervention Study, a randomized double‐blind trial. Journal of Allergy and Clinical Immunology2003;111(3):533‐40. [PUBMED: 12642834] ">von Berg 2003</a> compared an extensively hydrolysed whey formula versus CMF. </p> <p><a href="./references#CD003664-bbs2-0015" title="BergA , KramerU , LinkE , BollrathC , HeinrichJ , BrockowI , et al. GINIplus study group. Impact of early feeding on childhood eczema: development after nutritional intervention compared with the natural course ‐ the GINIplus study up to the age of 6 years. Clinical and Experimental Allergy2010;40(4):627‐36. [DOI: 10.1111/j.1365‐2222.2009.03444.x; PUBMED: 20082618] BrockowI , ZutavernA , HoffmannU , GrublA , vonBergA , KoletzkoS , et al. GINIplus Study Group. Early allergic sensitizations and their relevance to atopic diseases in children aged 6 years: results of the GINI study. Journal of Investigational Allergology &amp; Clinical Immunology2009;19(3):180‐7. [DOI: 19610260] LaubereauB , BrockowI , ZirngiblA , KoletzkoS , GrueblA , vonBergA , et al. GINI Study Group. Effect of breast‐feeding on the development of atopic dermatitis during the first 3 years of life ‐ results from the GINI‐birth cohort study. Journal of Pediatrics2004;144(5):602‐7. [DOI: 10.1016/j.jpeds.2003.12.029; PUBMED: 15126993] LaubereauB , Filipiak‐PittroffB , vonBergA , GrublA , ReinhardtD , WichmannHE , et al. Caesarean section and gastrointestinal symptoms, atopic dermatitis, and sensitisation during the first year of life. Archives of Disease in Childhood2004;89(11):993‐7. [DOI: 10.1136/adc.2003.043265; PUBMED: 15499049] RzehakP , SausenthalerS , KoletzkoS , BauerCP , SchaafB , vonBergA , et al. Period‐specific growth, overweight and modification by breastfeeding in the GINI and LISA birth cohorts up to age 6 years. European Journal of Epidemiology2009;24(8):449‐67. [DOI: 10.1007/s10654‐009‐9356‐5; PUBMED: 19521784] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. GINI‐plus Study Group. Long‐term effects of hydrolyzed protein infant formulas on growth ‐ extended follow‐up to 10 y of age: results from the German Infant Nutritional Intervention (GINI) study. American Journal of Clinical Nutrition2011;94(6 Suppl):1803S‐7S. [DOI: 10.3945/ajcn.110.000679; PUBMED: 21849601] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. German Infant Nutritional Intervention Study Group. Short‐ and long‐term effects of feeding hydrolyzed protein infant formulas on growth at &lt; or = 6 y of age: results from the German Infant Nutritional Intervention Study. American Journal of Clinical Nutrition2009;89(6):1846‐56. [DOI: 10.3945/ajcn.2008.27373; PUBMED: 19369380] SausenthalerS , KoletzkoS , KoletzkoB , ReinhardtD , KramerU , vonBergA , et al. GINIplus study group. Effect of hydrolysed formula feeding on taste preferences at 10 years. Data from the German Infant Nutritional Intervention Program Plus Study. Clinical Nutrition2010;29(3):304‐6. [DOI: 10.1016/j.clnu.2010.01.007; PUBMED: 20110140] SchoetzauA , Filipiak‐PittroffB , FrankeK , KoletzkoS , VonBergA , GrueblA , et al. German Infant Nutritional Intervention Study Group. Effect of exclusive breast‐feeding and early solid food avoidance on the incidence of atopic dermatitis in high‐risk infants at 1 year of age. Pediatric Allergy and Immunology2002;13(4):234‐42. [PUBMED: 12390439] SchoetzauA , GehringU , FrankeK , GrublA , KoletzkoS , vonBergA , et al. Gini Study Group. Maternal compliance with nutritional recommendations in an allergy preventive programme. Archives of Disease in Childhood2002;86(3):180‐4. [PUBMED: 11861235] VonBergA , Filipiak‐PittroffB , KrämerU , LinkE , HeinrichJ , KoletzkoS , et al. The German Infant Nutritional Intervention Study (GINI) for the preventive effect of hydrolysed infant formulas in infants at high risk for allergic diseases. Design and selected results. Allergologie2012;35(1):32‐43. VonBergA , Filipiak‐PittroffB , SchulzH , HoffmannU , LinkE , SussmannM , et al. GINIplus study group. Allergic manifestation 15 years after early intervention with hydrolyzed formulas ‐ the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2016;71(2):210‐9. [DOI: 10.1111/all.12790; PUBMED: 26465137] vonBergA , FilipiakB , KoletzkoS , KrämerU , HoffmannB , LinkE , et al. Long‐term effect of cow milk protein hydrolysates in high‐risk children. Results from the 10‐years follow‐up of the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2013;68:295‐6. vonBergA , Filipiak‐PittroffB , KramerU , HoffmannB , LinkE , BeckmannC , et al. GINIplus study group. Allergies in high‐risk schoolchildren after early intervention with cow's milk protein hydrolysates: 10‐year results from the German Infant Nutritional Intervention (GINI) study. Journal of Allergy and Clinical Immunology2013;131(6):1565‐73. [DOI: 10.1016/j.jaci.2013.01.006; PUBMED: 23506844] vonBergA , Filipiak‐PittroffB , KramerU , LinkE , BollrathC , BrockowI , et al. GINIplus study group. Preventive effect of hydrolyzed infant formulas persists until age 6 years: long‐term results from the German Infant Nutritional Intervention Study (GINI). Journal of Allergy and Clinical Immunology2008;121(6):1442‐7. [DOI: 10.1016/j.jaci.2008.04.021; PUBMED: 18539195] vonBergA , KoletzkoS , Filipiak‐PittroffB , LaubereauB , GrublA , WichmannHE , et al. German Infant Nutritional Intervention Study Group. Certain hydrolyzed formulas reduce the incidence of atopic dermatitis but not that of asthma: three‐year results of the German Infant Nutritional Intervention Study. Journal of Allergy and Clinical Immunology2007;119(3):718‐25. [DOI: 10.1016/j.jaci.2006.11.017; PUBMED: 17240440] vonBergA , KoletzkoS , GrublA , Filipiak‐PittroffB , WichmannHE , BauerCP , et al. German Infant Nutritional Intervention Study Group. The effect of hydrolyzed cow's milk formula for allergy prevention in the first year of life: the German Infant Nutritional Intervention Study, a randomized double‐blind trial. Journal of Allergy and Clinical Immunology2003;111(3):533‐40. [PUBMED: 12642834] ">von Berg 2003</a> reported no difference in infant allergic disease (RR 0.97, 95% CI 0.71 to 1.34; participants = 972) and no difference in childhood allergic disease incidence (RR 1.07, 95% CI 0.82 to 1.38; participants = 431). </p> <p><a href="./references#CD003664-bbs2-0015" title="BergA , KramerU , LinkE , BollrathC , HeinrichJ , BrockowI , et al. GINIplus study group. Impact of early feeding on childhood eczema: development after nutritional intervention compared with the natural course ‐ the GINIplus study up to the age of 6 years. Clinical and Experimental Allergy2010;40(4):627‐36. [DOI: 10.1111/j.1365‐2222.2009.03444.x; PUBMED: 20082618] BrockowI , ZutavernA , HoffmannU , GrublA , vonBergA , KoletzkoS , et al. GINIplus Study Group. Early allergic sensitizations and their relevance to atopic diseases in children aged 6 years: results of the GINI study. Journal of Investigational Allergology &amp; Clinical Immunology2009;19(3):180‐7. [DOI: 19610260] LaubereauB , BrockowI , ZirngiblA , KoletzkoS , GrueblA , vonBergA , et al. GINI Study Group. Effect of breast‐feeding on the development of atopic dermatitis during the first 3 years of life ‐ results from the GINI‐birth cohort study. Journal of Pediatrics2004;144(5):602‐7. [DOI: 10.1016/j.jpeds.2003.12.029; PUBMED: 15126993] LaubereauB , Filipiak‐PittroffB , vonBergA , GrublA , ReinhardtD , WichmannHE , et al. Caesarean section and gastrointestinal symptoms, atopic dermatitis, and sensitisation during the first year of life. Archives of Disease in Childhood2004;89(11):993‐7. [DOI: 10.1136/adc.2003.043265; PUBMED: 15499049] RzehakP , SausenthalerS , KoletzkoS , BauerCP , SchaafB , vonBergA , et al. Period‐specific growth, overweight and modification by breastfeeding in the GINI and LISA birth cohorts up to age 6 years. European Journal of Epidemiology2009;24(8):449‐67. [DOI: 10.1007/s10654‐009‐9356‐5; PUBMED: 19521784] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. GINI‐plus Study Group. Long‐term effects of hydrolyzed protein infant formulas on growth ‐ extended follow‐up to 10 y of age: results from the German Infant Nutritional Intervention (GINI) study. American Journal of Clinical Nutrition2011;94(6 Suppl):1803S‐7S. [DOI: 10.3945/ajcn.110.000679; PUBMED: 21849601] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. German Infant Nutritional Intervention Study Group. Short‐ and long‐term effects of feeding hydrolyzed protein infant formulas on growth at &lt; or = 6 y of age: results from the German Infant Nutritional Intervention Study. American Journal of Clinical Nutrition2009;89(6):1846‐56. [DOI: 10.3945/ajcn.2008.27373; PUBMED: 19369380] SausenthalerS , KoletzkoS , KoletzkoB , ReinhardtD , KramerU , vonBergA , et al. GINIplus study group. Effect of hydrolysed formula feeding on taste preferences at 10 years. Data from the German Infant Nutritional Intervention Program Plus Study. Clinical Nutrition2010;29(3):304‐6. [DOI: 10.1016/j.clnu.2010.01.007; PUBMED: 20110140] SchoetzauA , Filipiak‐PittroffB , FrankeK , KoletzkoS , VonBergA , GrueblA , et al. German Infant Nutritional Intervention Study Group. Effect of exclusive breast‐feeding and early solid food avoidance on the incidence of atopic dermatitis in high‐risk infants at 1 year of age. Pediatric Allergy and Immunology2002;13(4):234‐42. [PUBMED: 12390439] SchoetzauA , GehringU , FrankeK , GrublA , KoletzkoS , vonBergA , et al. Gini Study Group. Maternal compliance with nutritional recommendations in an allergy preventive programme. Archives of Disease in Childhood2002;86(3):180‐4. [PUBMED: 11861235] VonBergA , Filipiak‐PittroffB , KrämerU , LinkE , HeinrichJ , KoletzkoS , et al. The German Infant Nutritional Intervention Study (GINI) for the preventive effect of hydrolysed infant formulas in infants at high risk for allergic diseases. Design and selected results. Allergologie2012;35(1):32‐43. VonBergA , Filipiak‐PittroffB , SchulzH , HoffmannU , LinkE , SussmannM , et al. GINIplus study group. Allergic manifestation 15 years after early intervention with hydrolyzed formulas ‐ the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2016;71(2):210‐9. [DOI: 10.1111/all.12790; PUBMED: 26465137] vonBergA , FilipiakB , KoletzkoS , KrämerU , HoffmannB , LinkE , et al. Long‐term effect of cow milk protein hydrolysates in high‐risk children. Results from the 10‐years follow‐up of the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2013;68:295‐6. vonBergA , Filipiak‐PittroffB , KramerU , HoffmannB , LinkE , BeckmannC , et al. GINIplus study group. Allergies in high‐risk schoolchildren after early intervention with cow's milk protein hydrolysates: 10‐year results from the German Infant Nutritional Intervention (GINI) study. Journal of Allergy and Clinical Immunology2013;131(6):1565‐73. [DOI: 10.1016/j.jaci.2013.01.006; PUBMED: 23506844] vonBergA , Filipiak‐PittroffB , KramerU , LinkE , BollrathC , BrockowI , et al. GINIplus study group. Preventive effect of hydrolyzed infant formulas persists until age 6 years: long‐term results from the German Infant Nutritional Intervention Study (GINI). Journal of Allergy and Clinical Immunology2008;121(6):1442‐7. [DOI: 10.1016/j.jaci.2008.04.021; PUBMED: 18539195] vonBergA , KoletzkoS , Filipiak‐PittroffB , LaubereauB , GrublA , WichmannHE , et al. German Infant Nutritional Intervention Study Group. Certain hydrolyzed formulas reduce the incidence of atopic dermatitis but not that of asthma: three‐year results of the German Infant Nutritional Intervention Study. Journal of Allergy and Clinical Immunology2007;119(3):718‐25. [DOI: 10.1016/j.jaci.2006.11.017; PUBMED: 17240440] vonBergA , KoletzkoS , GrublA , Filipiak‐PittroffB , WichmannHE , BauerCP , et al. German Infant Nutritional Intervention Study Group. The effect of hydrolyzed cow's milk formula for allergy prevention in the first year of life: the German Infant Nutritional Intervention Study, a randomized double‐blind trial. Journal of Allergy and Clinical Immunology2003;111(3):533‐40. [PUBMED: 12642834] ">von Berg 2003</a> reported no difference in childhood asthma prevalence (RR 1.19, 95% CI 0.73 to 1.94; participants = 431). </p> <p><a href="./references#CD003664-bbs2-0015" title="BergA , KramerU , LinkE , BollrathC , HeinrichJ , BrockowI , et al. GINIplus study group. Impact of early feeding on childhood eczema: development after nutritional intervention compared with the natural course ‐ the GINIplus study up to the age of 6 years. Clinical and Experimental Allergy2010;40(4):627‐36. [DOI: 10.1111/j.1365‐2222.2009.03444.x; PUBMED: 20082618] BrockowI , ZutavernA , HoffmannU , GrublA , vonBergA , KoletzkoS , et al. GINIplus Study Group. Early allergic sensitizations and their relevance to atopic diseases in children aged 6 years: results of the GINI study. Journal of Investigational Allergology &amp; Clinical Immunology2009;19(3):180‐7. [DOI: 19610260] LaubereauB , BrockowI , ZirngiblA , KoletzkoS , GrueblA , vonBergA , et al. GINI Study Group. Effect of breast‐feeding on the development of atopic dermatitis during the first 3 years of life ‐ results from the GINI‐birth cohort study. Journal of Pediatrics2004;144(5):602‐7. [DOI: 10.1016/j.jpeds.2003.12.029; PUBMED: 15126993] LaubereauB , Filipiak‐PittroffB , vonBergA , GrublA , ReinhardtD , WichmannHE , et al. Caesarean section and gastrointestinal symptoms, atopic dermatitis, and sensitisation during the first year of life. Archives of Disease in Childhood2004;89(11):993‐7. [DOI: 10.1136/adc.2003.043265; PUBMED: 15499049] RzehakP , SausenthalerS , KoletzkoS , BauerCP , SchaafB , vonBergA , et al. Period‐specific growth, overweight and modification by breastfeeding in the GINI and LISA birth cohorts up to age 6 years. European Journal of Epidemiology2009;24(8):449‐67. [DOI: 10.1007/s10654‐009‐9356‐5; PUBMED: 19521784] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. GINI‐plus Study Group. Long‐term effects of hydrolyzed protein infant formulas on growth ‐ extended follow‐up to 10 y of age: results from the German Infant Nutritional Intervention (GINI) study. American Journal of Clinical Nutrition2011;94(6 Suppl):1803S‐7S. [DOI: 10.3945/ajcn.110.000679; PUBMED: 21849601] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. German Infant Nutritional Intervention Study Group. Short‐ and long‐term effects of feeding hydrolyzed protein infant formulas on growth at &lt; or = 6 y of age: results from the German Infant Nutritional Intervention Study. American Journal of Clinical Nutrition2009;89(6):1846‐56. [DOI: 10.3945/ajcn.2008.27373; PUBMED: 19369380] SausenthalerS , KoletzkoS , KoletzkoB , ReinhardtD , KramerU , vonBergA , et al. GINIplus study group. Effect of hydrolysed formula feeding on taste preferences at 10 years. Data from the German Infant Nutritional Intervention Program Plus Study. Clinical Nutrition2010;29(3):304‐6. [DOI: 10.1016/j.clnu.2010.01.007; PUBMED: 20110140] SchoetzauA , Filipiak‐PittroffB , FrankeK , KoletzkoS , VonBergA , GrueblA , et al. German Infant Nutritional Intervention Study Group. Effect of exclusive breast‐feeding and early solid food avoidance on the incidence of atopic dermatitis in high‐risk infants at 1 year of age. Pediatric Allergy and Immunology2002;13(4):234‐42. [PUBMED: 12390439] SchoetzauA , GehringU , FrankeK , GrublA , KoletzkoS , vonBergA , et al. Gini Study Group. Maternal compliance with nutritional recommendations in an allergy preventive programme. Archives of Disease in Childhood2002;86(3):180‐4. [PUBMED: 11861235] VonBergA , Filipiak‐PittroffB , KrämerU , LinkE , HeinrichJ , KoletzkoS , et al. The German Infant Nutritional Intervention Study (GINI) for the preventive effect of hydrolysed infant formulas in infants at high risk for allergic diseases. Design and selected results. Allergologie2012;35(1):32‐43. VonBergA , Filipiak‐PittroffB , SchulzH , HoffmannU , LinkE , SussmannM , et al. GINIplus study group. Allergic manifestation 15 years after early intervention with hydrolyzed formulas ‐ the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2016;71(2):210‐9. [DOI: 10.1111/all.12790; PUBMED: 26465137] vonBergA , FilipiakB , KoletzkoS , KrämerU , HoffmannB , LinkE , et al. Long‐term effect of cow milk protein hydrolysates in high‐risk children. Results from the 10‐years follow‐up of the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2013;68:295‐6. vonBergA , Filipiak‐PittroffB , KramerU , HoffmannB , LinkE , BeckmannC , et al. GINIplus study group. Allergies in high‐risk schoolchildren after early intervention with cow's milk protein hydrolysates: 10‐year results from the German Infant Nutritional Intervention (GINI) study. Journal of Allergy and Clinical Immunology2013;131(6):1565‐73. [DOI: 10.1016/j.jaci.2013.01.006; PUBMED: 23506844] vonBergA , Filipiak‐PittroffB , KramerU , LinkE , BollrathC , BrockowI , et al. GINIplus study group. Preventive effect of hydrolyzed infant formulas persists until age 6 years: long‐term results from the German Infant Nutritional Intervention Study (GINI). Journal of Allergy and Clinical Immunology2008;121(6):1442‐7. [DOI: 10.1016/j.jaci.2008.04.021; PUBMED: 18539195] vonBergA , KoletzkoS , Filipiak‐PittroffB , LaubereauB , GrublA , WichmannHE , et al. German Infant Nutritional Intervention Study Group. Certain hydrolyzed formulas reduce the incidence of atopic dermatitis but not that of asthma: three‐year results of the German Infant Nutritional Intervention Study. Journal of Allergy and Clinical Immunology2007;119(3):718‐25. [DOI: 10.1016/j.jaci.2006.11.017; PUBMED: 17240440] vonBergA , KoletzkoS , GrublA , Filipiak‐PittroffB , WichmannHE , BauerCP , et al. German Infant Nutritional Intervention Study Group. The effect of hydrolyzed cow's milk formula for allergy prevention in the first year of life: the German Infant Nutritional Intervention Study, a randomized double‐blind trial. Journal of Allergy and Clinical Immunology2003;111(3):533‐40. [PUBMED: 12642834] ">von Berg 2003</a> reported no difference in infant eczema (RR 1.00, 95% CI 0.72 to 1.40; participants = 972), no difference in childhood eczema incidence (RR 1.06, 95% CI 0.75 to 1.49; participants = 431) and no difference in childhood eczema prevalence (RR 0.78, 95% CI 0.46 to 1.33; participants = 431). </p> </section> <section id="CD003664-sec-0125"> <h5 class="title">Comparison 16. Prolonged feeding: extensively hydrolysed casein formula versus cow's milk formula (CMF) </h5> <p><a href="./references#CD003664-bbs2-0015" title="BergA , KramerU , LinkE , BollrathC , HeinrichJ , BrockowI , et al. GINIplus study group. Impact of early feeding on childhood eczema: development after nutritional intervention compared with the natural course ‐ the GINIplus study up to the age of 6 years. Clinical and Experimental Allergy2010;40(4):627‐36. [DOI: 10.1111/j.1365‐2222.2009.03444.x; PUBMED: 20082618] BrockowI , ZutavernA , HoffmannU , GrublA , vonBergA , KoletzkoS , et al. GINIplus Study Group. Early allergic sensitizations and their relevance to atopic diseases in children aged 6 years: results of the GINI study. Journal of Investigational Allergology &amp; Clinical Immunology2009;19(3):180‐7. [DOI: 19610260] LaubereauB , BrockowI , ZirngiblA , KoletzkoS , GrueblA , vonBergA , et al. GINI Study Group. Effect of breast‐feeding on the development of atopic dermatitis during the first 3 years of life ‐ results from the GINI‐birth cohort study. Journal of Pediatrics2004;144(5):602‐7. [DOI: 10.1016/j.jpeds.2003.12.029; PUBMED: 15126993] LaubereauB , Filipiak‐PittroffB , vonBergA , GrublA , ReinhardtD , WichmannHE , et al. Caesarean section and gastrointestinal symptoms, atopic dermatitis, and sensitisation during the first year of life. Archives of Disease in Childhood2004;89(11):993‐7. [DOI: 10.1136/adc.2003.043265; PUBMED: 15499049] RzehakP , SausenthalerS , KoletzkoS , BauerCP , SchaafB , vonBergA , et al. Period‐specific growth, overweight and modification by breastfeeding in the GINI and LISA birth cohorts up to age 6 years. European Journal of Epidemiology2009;24(8):449‐67. [DOI: 10.1007/s10654‐009‐9356‐5; PUBMED: 19521784] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. GINI‐plus Study Group. Long‐term effects of hydrolyzed protein infant formulas on growth ‐ extended follow‐up to 10 y of age: results from the German Infant Nutritional Intervention (GINI) study. American Journal of Clinical Nutrition2011;94(6 Suppl):1803S‐7S. [DOI: 10.3945/ajcn.110.000679; PUBMED: 21849601] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. German Infant Nutritional Intervention Study Group. Short‐ and long‐term effects of feeding hydrolyzed protein infant formulas on growth at &lt; or = 6 y of age: results from the German Infant Nutritional Intervention Study. American Journal of Clinical Nutrition2009;89(6):1846‐56. [DOI: 10.3945/ajcn.2008.27373; PUBMED: 19369380] SausenthalerS , KoletzkoS , KoletzkoB , ReinhardtD , KramerU , vonBergA , et al. GINIplus study group. Effect of hydrolysed formula feeding on taste preferences at 10 years. Data from the German Infant Nutritional Intervention Program Plus Study. Clinical Nutrition2010;29(3):304‐6. [DOI: 10.1016/j.clnu.2010.01.007; PUBMED: 20110140] SchoetzauA , Filipiak‐PittroffB , FrankeK , KoletzkoS , VonBergA , GrueblA , et al. German Infant Nutritional Intervention Study Group. Effect of exclusive breast‐feeding and early solid food avoidance on the incidence of atopic dermatitis in high‐risk infants at 1 year of age. Pediatric Allergy and Immunology2002;13(4):234‐42. [PUBMED: 12390439] SchoetzauA , GehringU , FrankeK , GrublA , KoletzkoS , vonBergA , et al. Gini Study Group. Maternal compliance with nutritional recommendations in an allergy preventive programme. Archives of Disease in Childhood2002;86(3):180‐4. [PUBMED: 11861235] VonBergA , Filipiak‐PittroffB , KrämerU , LinkE , HeinrichJ , KoletzkoS , et al. The German Infant Nutritional Intervention Study (GINI) for the preventive effect of hydrolysed infant formulas in infants at high risk for allergic diseases. Design and selected results. Allergologie2012;35(1):32‐43. VonBergA , Filipiak‐PittroffB , SchulzH , HoffmannU , LinkE , SussmannM , et al. GINIplus study group. Allergic manifestation 15 years after early intervention with hydrolyzed formulas ‐ the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2016;71(2):210‐9. [DOI: 10.1111/all.12790; PUBMED: 26465137] vonBergA , FilipiakB , KoletzkoS , KrämerU , HoffmannB , LinkE , et al. Long‐term effect of cow milk protein hydrolysates in high‐risk children. Results from the 10‐years follow‐up of the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2013;68:295‐6. vonBergA , Filipiak‐PittroffB , KramerU , HoffmannB , LinkE , BeckmannC , et al. GINIplus study group. Allergies in high‐risk schoolchildren after early intervention with cow's milk protein hydrolysates: 10‐year results from the German Infant Nutritional Intervention (GINI) study. Journal of Allergy and Clinical Immunology2013;131(6):1565‐73. [DOI: 10.1016/j.jaci.2013.01.006; PUBMED: 23506844] vonBergA , Filipiak‐PittroffB , KramerU , LinkE , BollrathC , BrockowI , et al. GINIplus study group. Preventive effect of hydrolyzed infant formulas persists until age 6 years: long‐term results from the German Infant Nutritional Intervention Study (GINI). Journal of Allergy and Clinical Immunology2008;121(6):1442‐7. [DOI: 10.1016/j.jaci.2008.04.021; PUBMED: 18539195] vonBergA , KoletzkoS , Filipiak‐PittroffB , LaubereauB , GrublA , WichmannHE , et al. German Infant Nutritional Intervention Study Group. Certain hydrolyzed formulas reduce the incidence of atopic dermatitis but not that of asthma: three‐year results of the German Infant Nutritional Intervention Study. Journal of Allergy and Clinical Immunology2007;119(3):718‐25. [DOI: 10.1016/j.jaci.2006.11.017; PUBMED: 17240440] vonBergA , KoletzkoS , GrublA , Filipiak‐PittroffB , WichmannHE , BauerCP , et al. German Infant Nutritional Intervention Study Group. The effect of hydrolyzed cow's milk formula for allergy prevention in the first year of life: the German Infant Nutritional Intervention Study, a randomized double‐blind trial. Journal of Allergy and Clinical Immunology2003;111(3):533‐40. [PUBMED: 12642834] ">von Berg 2003</a> compared an extensively hydrolysed casein formula versus CMF. </p> <p><a href="./references#CD003664-bbs2-0015" title="BergA , KramerU , LinkE , BollrathC , HeinrichJ , BrockowI , et al. GINIplus study group. Impact of early feeding on childhood eczema: development after nutritional intervention compared with the natural course ‐ the GINIplus study up to the age of 6 years. Clinical and Experimental Allergy2010;40(4):627‐36. [DOI: 10.1111/j.1365‐2222.2009.03444.x; PUBMED: 20082618] BrockowI , ZutavernA , HoffmannU , GrublA , vonBergA , KoletzkoS , et al. GINIplus Study Group. Early allergic sensitizations and their relevance to atopic diseases in children aged 6 years: results of the GINI study. Journal of Investigational Allergology &amp; Clinical Immunology2009;19(3):180‐7. [DOI: 19610260] LaubereauB , BrockowI , ZirngiblA , KoletzkoS , GrueblA , vonBergA , et al. GINI Study Group. Effect of breast‐feeding on the development of atopic dermatitis during the first 3 years of life ‐ results from the GINI‐birth cohort study. Journal of Pediatrics2004;144(5):602‐7. [DOI: 10.1016/j.jpeds.2003.12.029; PUBMED: 15126993] LaubereauB , Filipiak‐PittroffB , vonBergA , GrublA , ReinhardtD , WichmannHE , et al. Caesarean section and gastrointestinal symptoms, atopic dermatitis, and sensitisation during the first year of life. Archives of Disease in Childhood2004;89(11):993‐7. [DOI: 10.1136/adc.2003.043265; PUBMED: 15499049] RzehakP , SausenthalerS , KoletzkoS , BauerCP , SchaafB , vonBergA , et al. Period‐specific growth, overweight and modification by breastfeeding in the GINI and LISA birth cohorts up to age 6 years. European Journal of Epidemiology2009;24(8):449‐67. [DOI: 10.1007/s10654‐009‐9356‐5; PUBMED: 19521784] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. GINI‐plus Study Group. Long‐term effects of hydrolyzed protein infant formulas on growth ‐ extended follow‐up to 10 y of age: results from the German Infant Nutritional Intervention (GINI) study. American Journal of Clinical Nutrition2011;94(6 Suppl):1803S‐7S. [DOI: 10.3945/ajcn.110.000679; PUBMED: 21849601] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. German Infant Nutritional Intervention Study Group. Short‐ and long‐term effects of feeding hydrolyzed protein infant formulas on growth at &lt; or = 6 y of age: results from the German Infant Nutritional Intervention Study. American Journal of Clinical Nutrition2009;89(6):1846‐56. [DOI: 10.3945/ajcn.2008.27373; PUBMED: 19369380] SausenthalerS , KoletzkoS , KoletzkoB , ReinhardtD , KramerU , vonBergA , et al. GINIplus study group. Effect of hydrolysed formula feeding on taste preferences at 10 years. Data from the German Infant Nutritional Intervention Program Plus Study. Clinical Nutrition2010;29(3):304‐6. [DOI: 10.1016/j.clnu.2010.01.007; PUBMED: 20110140] SchoetzauA , Filipiak‐PittroffB , FrankeK , KoletzkoS , VonBergA , GrueblA , et al. German Infant Nutritional Intervention Study Group. Effect of exclusive breast‐feeding and early solid food avoidance on the incidence of atopic dermatitis in high‐risk infants at 1 year of age. Pediatric Allergy and Immunology2002;13(4):234‐42. [PUBMED: 12390439] SchoetzauA , GehringU , FrankeK , GrublA , KoletzkoS , vonBergA , et al. Gini Study Group. Maternal compliance with nutritional recommendations in an allergy preventive programme. Archives of Disease in Childhood2002;86(3):180‐4. [PUBMED: 11861235] VonBergA , Filipiak‐PittroffB , KrämerU , LinkE , HeinrichJ , KoletzkoS , et al. The German Infant Nutritional Intervention Study (GINI) for the preventive effect of hydrolysed infant formulas in infants at high risk for allergic diseases. Design and selected results. Allergologie2012;35(1):32‐43. VonBergA , Filipiak‐PittroffB , SchulzH , HoffmannU , LinkE , SussmannM , et al. GINIplus study group. Allergic manifestation 15 years after early intervention with hydrolyzed formulas ‐ the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2016;71(2):210‐9. [DOI: 10.1111/all.12790; PUBMED: 26465137] vonBergA , FilipiakB , KoletzkoS , KrämerU , HoffmannB , LinkE , et al. Long‐term effect of cow milk protein hydrolysates in high‐risk children. Results from the 10‐years follow‐up of the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2013;68:295‐6. vonBergA , Filipiak‐PittroffB , KramerU , HoffmannB , LinkE , BeckmannC , et al. GINIplus study group. Allergies in high‐risk schoolchildren after early intervention with cow's milk protein hydrolysates: 10‐year results from the German Infant Nutritional Intervention (GINI) study. Journal of Allergy and Clinical Immunology2013;131(6):1565‐73. [DOI: 10.1016/j.jaci.2013.01.006; PUBMED: 23506844] vonBergA , Filipiak‐PittroffB , KramerU , LinkE , BollrathC , BrockowI , et al. GINIplus study group. Preventive effect of hydrolyzed infant formulas persists until age 6 years: long‐term results from the German Infant Nutritional Intervention Study (GINI). Journal of Allergy and Clinical Immunology2008;121(6):1442‐7. [DOI: 10.1016/j.jaci.2008.04.021; PUBMED: 18539195] vonBergA , KoletzkoS , Filipiak‐PittroffB , LaubereauB , GrublA , WichmannHE , et al. German Infant Nutritional Intervention Study Group. Certain hydrolyzed formulas reduce the incidence of atopic dermatitis but not that of asthma: three‐year results of the German Infant Nutritional Intervention Study. Journal of Allergy and Clinical Immunology2007;119(3):718‐25. [DOI: 10.1016/j.jaci.2006.11.017; PUBMED: 17240440] vonBergA , KoletzkoS , GrublA , Filipiak‐PittroffB , WichmannHE , BauerCP , et al. German Infant Nutritional Intervention Study Group. The effect of hydrolyzed cow's milk formula for allergy prevention in the first year of life: the German Infant Nutritional Intervention Study, a randomized double‐blind trial. Journal of Allergy and Clinical Immunology2003;111(3):533‐40. [PUBMED: 12642834] ">von Berg 2003</a> reported no difference in infant allergic disease (RR 0.76, 95% CI 0.54 to 1.07; participants = 976) and a reduction in childhood allergic disease incidence (RR 0.72, 95% CI 0.53 to 0.97; participants = 431). </p> <p><a href="./references#CD003664-bbs2-0015" title="BergA , KramerU , LinkE , BollrathC , HeinrichJ , BrockowI , et al. GINIplus study group. Impact of early feeding on childhood eczema: development after nutritional intervention compared with the natural course ‐ the GINIplus study up to the age of 6 years. Clinical and Experimental Allergy2010;40(4):627‐36. [DOI: 10.1111/j.1365‐2222.2009.03444.x; PUBMED: 20082618] BrockowI , ZutavernA , HoffmannU , GrublA , vonBergA , KoletzkoS , et al. GINIplus Study Group. Early allergic sensitizations and their relevance to atopic diseases in children aged 6 years: results of the GINI study. Journal of Investigational Allergology &amp; Clinical Immunology2009;19(3):180‐7. [DOI: 19610260] LaubereauB , BrockowI , ZirngiblA , KoletzkoS , GrueblA , vonBergA , et al. GINI Study Group. Effect of breast‐feeding on the development of atopic dermatitis during the first 3 years of life ‐ results from the GINI‐birth cohort study. Journal of Pediatrics2004;144(5):602‐7. [DOI: 10.1016/j.jpeds.2003.12.029; PUBMED: 15126993] LaubereauB , Filipiak‐PittroffB , vonBergA , GrublA , ReinhardtD , WichmannHE , et al. Caesarean section and gastrointestinal symptoms, atopic dermatitis, and sensitisation during the first year of life. Archives of Disease in Childhood2004;89(11):993‐7. [DOI: 10.1136/adc.2003.043265; PUBMED: 15499049] RzehakP , SausenthalerS , KoletzkoS , BauerCP , SchaafB , vonBergA , et al. Period‐specific growth, overweight and modification by breastfeeding in the GINI and LISA birth cohorts up to age 6 years. European Journal of Epidemiology2009;24(8):449‐67. [DOI: 10.1007/s10654‐009‐9356‐5; PUBMED: 19521784] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. GINI‐plus Study Group. Long‐term effects of hydrolyzed protein infant formulas on growth ‐ extended follow‐up to 10 y of age: results from the German Infant Nutritional Intervention (GINI) study. American Journal of Clinical Nutrition2011;94(6 Suppl):1803S‐7S. [DOI: 10.3945/ajcn.110.000679; PUBMED: 21849601] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. German Infant Nutritional Intervention Study Group. Short‐ and long‐term effects of feeding hydrolyzed protein infant formulas on growth at &lt; or = 6 y of age: results from the German Infant Nutritional Intervention Study. American Journal of Clinical Nutrition2009;89(6):1846‐56. [DOI: 10.3945/ajcn.2008.27373; PUBMED: 19369380] SausenthalerS , KoletzkoS , KoletzkoB , ReinhardtD , KramerU , vonBergA , et al. GINIplus study group. Effect of hydrolysed formula feeding on taste preferences at 10 years. Data from the German Infant Nutritional Intervention Program Plus Study. Clinical Nutrition2010;29(3):304‐6. [DOI: 10.1016/j.clnu.2010.01.007; PUBMED: 20110140] SchoetzauA , Filipiak‐PittroffB , FrankeK , KoletzkoS , VonBergA , GrueblA , et al. German Infant Nutritional Intervention Study Group. Effect of exclusive breast‐feeding and early solid food avoidance on the incidence of atopic dermatitis in high‐risk infants at 1 year of age. Pediatric Allergy and Immunology2002;13(4):234‐42. [PUBMED: 12390439] SchoetzauA , GehringU , FrankeK , GrublA , KoletzkoS , vonBergA , et al. Gini Study Group. Maternal compliance with nutritional recommendations in an allergy preventive programme. Archives of Disease in Childhood2002;86(3):180‐4. [PUBMED: 11861235] VonBergA , Filipiak‐PittroffB , KrämerU , LinkE , HeinrichJ , KoletzkoS , et al. The German Infant Nutritional Intervention Study (GINI) for the preventive effect of hydrolysed infant formulas in infants at high risk for allergic diseases. Design and selected results. Allergologie2012;35(1):32‐43. VonBergA , Filipiak‐PittroffB , SchulzH , HoffmannU , LinkE , SussmannM , et al. GINIplus study group. Allergic manifestation 15 years after early intervention with hydrolyzed formulas ‐ the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2016;71(2):210‐9. [DOI: 10.1111/all.12790; PUBMED: 26465137] vonBergA , FilipiakB , KoletzkoS , KrämerU , HoffmannB , LinkE , et al. Long‐term effect of cow milk protein hydrolysates in high‐risk children. Results from the 10‐years follow‐up of the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2013;68:295‐6. vonBergA , Filipiak‐PittroffB , KramerU , HoffmannB , LinkE , BeckmannC , et al. GINIplus study group. Allergies in high‐risk schoolchildren after early intervention with cow's milk protein hydrolysates: 10‐year results from the German Infant Nutritional Intervention (GINI) study. Journal of Allergy and Clinical Immunology2013;131(6):1565‐73. [DOI: 10.1016/j.jaci.2013.01.006; PUBMED: 23506844] vonBergA , Filipiak‐PittroffB , KramerU , LinkE , BollrathC , BrockowI , et al. GINIplus study group. Preventive effect of hydrolyzed infant formulas persists until age 6 years: long‐term results from the German Infant Nutritional Intervention Study (GINI). Journal of Allergy and Clinical Immunology2008;121(6):1442‐7. [DOI: 10.1016/j.jaci.2008.04.021; PUBMED: 18539195] vonBergA , KoletzkoS , Filipiak‐PittroffB , LaubereauB , GrublA , WichmannHE , et al. German Infant Nutritional Intervention Study Group. Certain hydrolyzed formulas reduce the incidence of atopic dermatitis but not that of asthma: three‐year results of the German Infant Nutritional Intervention Study. Journal of Allergy and Clinical Immunology2007;119(3):718‐25. [DOI: 10.1016/j.jaci.2006.11.017; PUBMED: 17240440] vonBergA , KoletzkoS , GrublA , Filipiak‐PittroffB , WichmannHE , BauerCP , et al. German Infant Nutritional Intervention Study Group. The effect of hydrolyzed cow's milk formula for allergy prevention in the first year of life: the German Infant Nutritional Intervention Study, a randomized double‐blind trial. Journal of Allergy and Clinical Immunology2003;111(3):533‐40. [PUBMED: 12642834] ">von Berg 2003</a> reported no difference in childhood asthma prevalence (RR 0.84, 95% CI 0.49 to 1.45; participants = 431). </p> <p><a href="./references#CD003664-bbs2-0015" title="BergA , KramerU , LinkE , BollrathC , HeinrichJ , BrockowI , et al. GINIplus study group. Impact of early feeding on childhood eczema: development after nutritional intervention compared with the natural course ‐ the GINIplus study up to the age of 6 years. Clinical and Experimental Allergy2010;40(4):627‐36. [DOI: 10.1111/j.1365‐2222.2009.03444.x; PUBMED: 20082618] BrockowI , ZutavernA , HoffmannU , GrublA , vonBergA , KoletzkoS , et al. GINIplus Study Group. Early allergic sensitizations and their relevance to atopic diseases in children aged 6 years: results of the GINI study. Journal of Investigational Allergology &amp; Clinical Immunology2009;19(3):180‐7. [DOI: 19610260] LaubereauB , BrockowI , ZirngiblA , KoletzkoS , GrueblA , vonBergA , et al. GINI Study Group. Effect of breast‐feeding on the development of atopic dermatitis during the first 3 years of life ‐ results from the GINI‐birth cohort study. Journal of Pediatrics2004;144(5):602‐7. [DOI: 10.1016/j.jpeds.2003.12.029; PUBMED: 15126993] LaubereauB , Filipiak‐PittroffB , vonBergA , GrublA , ReinhardtD , WichmannHE , et al. Caesarean section and gastrointestinal symptoms, atopic dermatitis, and sensitisation during the first year of life. Archives of Disease in Childhood2004;89(11):993‐7. [DOI: 10.1136/adc.2003.043265; PUBMED: 15499049] RzehakP , SausenthalerS , KoletzkoS , BauerCP , SchaafB , vonBergA , et al. Period‐specific growth, overweight and modification by breastfeeding in the GINI and LISA birth cohorts up to age 6 years. European Journal of Epidemiology2009;24(8):449‐67. [DOI: 10.1007/s10654‐009‐9356‐5; PUBMED: 19521784] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. GINI‐plus Study Group. Long‐term effects of hydrolyzed protein infant formulas on growth ‐ extended follow‐up to 10 y of age: results from the German Infant Nutritional Intervention (GINI) study. American Journal of Clinical Nutrition2011;94(6 Suppl):1803S‐7S. [DOI: 10.3945/ajcn.110.000679; PUBMED: 21849601] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. German Infant Nutritional Intervention Study Group. Short‐ and long‐term effects of feeding hydrolyzed protein infant formulas on growth at &lt; or = 6 y of age: results from the German Infant Nutritional Intervention Study. American Journal of Clinical Nutrition2009;89(6):1846‐56. [DOI: 10.3945/ajcn.2008.27373; PUBMED: 19369380] SausenthalerS , KoletzkoS , KoletzkoB , ReinhardtD , KramerU , vonBergA , et al. GINIplus study group. Effect of hydrolysed formula feeding on taste preferences at 10 years. Data from the German Infant Nutritional Intervention Program Plus Study. Clinical Nutrition2010;29(3):304‐6. [DOI: 10.1016/j.clnu.2010.01.007; PUBMED: 20110140] SchoetzauA , Filipiak‐PittroffB , FrankeK , KoletzkoS , VonBergA , GrueblA , et al. German Infant Nutritional Intervention Study Group. Effect of exclusive breast‐feeding and early solid food avoidance on the incidence of atopic dermatitis in high‐risk infants at 1 year of age. Pediatric Allergy and Immunology2002;13(4):234‐42. [PUBMED: 12390439] SchoetzauA , GehringU , FrankeK , GrublA , KoletzkoS , vonBergA , et al. Gini Study Group. Maternal compliance with nutritional recommendations in an allergy preventive programme. Archives of Disease in Childhood2002;86(3):180‐4. [PUBMED: 11861235] VonBergA , Filipiak‐PittroffB , KrämerU , LinkE , HeinrichJ , KoletzkoS , et al. The German Infant Nutritional Intervention Study (GINI) for the preventive effect of hydrolysed infant formulas in infants at high risk for allergic diseases. Design and selected results. Allergologie2012;35(1):32‐43. VonBergA , Filipiak‐PittroffB , SchulzH , HoffmannU , LinkE , SussmannM , et al. GINIplus study group. Allergic manifestation 15 years after early intervention with hydrolyzed formulas ‐ the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2016;71(2):210‐9. [DOI: 10.1111/all.12790; PUBMED: 26465137] vonBergA , FilipiakB , KoletzkoS , KrämerU , HoffmannB , LinkE , et al. Long‐term effect of cow milk protein hydrolysates in high‐risk children. Results from the 10‐years follow‐up of the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2013;68:295‐6. vonBergA , Filipiak‐PittroffB , KramerU , HoffmannB , LinkE , BeckmannC , et al. GINIplus study group. Allergies in high‐risk schoolchildren after early intervention with cow's milk protein hydrolysates: 10‐year results from the German Infant Nutritional Intervention (GINI) study. Journal of Allergy and Clinical Immunology2013;131(6):1565‐73. [DOI: 10.1016/j.jaci.2013.01.006; PUBMED: 23506844] vonBergA , Filipiak‐PittroffB , KramerU , LinkE , BollrathC , BrockowI , et al. GINIplus study group. Preventive effect of hydrolyzed infant formulas persists until age 6 years: long‐term results from the German Infant Nutritional Intervention Study (GINI). Journal of Allergy and Clinical Immunology2008;121(6):1442‐7. [DOI: 10.1016/j.jaci.2008.04.021; PUBMED: 18539195] vonBergA , KoletzkoS , Filipiak‐PittroffB , LaubereauB , GrublA , WichmannHE , et al. German Infant Nutritional Intervention Study Group. Certain hydrolyzed formulas reduce the incidence of atopic dermatitis but not that of asthma: three‐year results of the German Infant Nutritional Intervention Study. Journal of Allergy and Clinical Immunology2007;119(3):718‐25. [DOI: 10.1016/j.jaci.2006.11.017; PUBMED: 17240440] vonBergA , KoletzkoS , GrublA , Filipiak‐PittroffB , WichmannHE , BauerCP , et al. German Infant Nutritional Intervention Study Group. The effect of hydrolyzed cow's milk formula for allergy prevention in the first year of life: the German Infant Nutritional Intervention Study, a randomized double‐blind trial. Journal of Allergy and Clinical Immunology2003;111(3):533‐40. [PUBMED: 12642834] ">von Berg 2003</a> reported no difference in infant eczema (RR 0.69, 95% CI 0.47 to 1.00; participants = 976), a reduction in childhood eczema incidence (RR 0.66, 95% CI 0.44 to 0.98; participants = 431) and a reduction in childhood eczema prevalence (RR 0.50, 95% CI 0.27 to 0.92; participants = 431). </p> </section> <section id="CD003664-sec-0126"> <h5 class="title">Comparison 17. Prolonged feeding: extensively hydrolysed casein formula versus extensively hydrolysed whey formula </h5> <p>Two studies compared an extensively hydrolysed casein formula versus an extensively hydrolysed whey formula (<a href="./references#CD003664-bbs2-0003" title="HalkenS , HansenKS , JacobsenHP , EstmannA , FaellingAE , HansenLG , et al. Comparison of a partially hydrolyzed infant formula with two extensively hydrolyzed formulas for allergy prevention: a prospective, randomized study. Pediatric Allergy and Immunology2000;11(3):149‐61. [PUBMED: 10981524] ">Halken 2000</a>; <a href="./references#CD003664-bbs2-0015" title="BergA , KramerU , LinkE , BollrathC , HeinrichJ , BrockowI , et al. GINIplus study group. Impact of early feeding on childhood eczema: development after nutritional intervention compared with the natural course ‐ the GINIplus study up to the age of 6 years. Clinical and Experimental Allergy2010;40(4):627‐36. [DOI: 10.1111/j.1365‐2222.2009.03444.x; PUBMED: 20082618] BrockowI , ZutavernA , HoffmannU , GrublA , vonBergA , KoletzkoS , et al. GINIplus Study Group. Early allergic sensitizations and their relevance to atopic diseases in children aged 6 years: results of the GINI study. Journal of Investigational Allergology &amp; Clinical Immunology2009;19(3):180‐7. [DOI: 19610260] LaubereauB , BrockowI , ZirngiblA , KoletzkoS , GrueblA , vonBergA , et al. GINI Study Group. Effect of breast‐feeding on the development of atopic dermatitis during the first 3 years of life ‐ results from the GINI‐birth cohort study. Journal of Pediatrics2004;144(5):602‐7. [DOI: 10.1016/j.jpeds.2003.12.029; PUBMED: 15126993] LaubereauB , Filipiak‐PittroffB , vonBergA , GrublA , ReinhardtD , WichmannHE , et al. Caesarean section and gastrointestinal symptoms, atopic dermatitis, and sensitisation during the first year of life. Archives of Disease in Childhood2004;89(11):993‐7. [DOI: 10.1136/adc.2003.043265; PUBMED: 15499049] RzehakP , SausenthalerS , KoletzkoS , BauerCP , SchaafB , vonBergA , et al. Period‐specific growth, overweight and modification by breastfeeding in the GINI and LISA birth cohorts up to age 6 years. European Journal of Epidemiology2009;24(8):449‐67. [DOI: 10.1007/s10654‐009‐9356‐5; PUBMED: 19521784] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. GINI‐plus Study Group. Long‐term effects of hydrolyzed protein infant formulas on growth ‐ extended follow‐up to 10 y of age: results from the German Infant Nutritional Intervention (GINI) study. American Journal of Clinical Nutrition2011;94(6 Suppl):1803S‐7S. [DOI: 10.3945/ajcn.110.000679; PUBMED: 21849601] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. German Infant Nutritional Intervention Study Group. Short‐ and long‐term effects of feeding hydrolyzed protein infant formulas on growth at &lt; or = 6 y of age: results from the German Infant Nutritional Intervention Study. American Journal of Clinical Nutrition2009;89(6):1846‐56. [DOI: 10.3945/ajcn.2008.27373; PUBMED: 19369380] SausenthalerS , KoletzkoS , KoletzkoB , ReinhardtD , KramerU , vonBergA , et al. GINIplus study group. Effect of hydrolysed formula feeding on taste preferences at 10 years. Data from the German Infant Nutritional Intervention Program Plus Study. Clinical Nutrition2010;29(3):304‐6. [DOI: 10.1016/j.clnu.2010.01.007; PUBMED: 20110140] SchoetzauA , Filipiak‐PittroffB , FrankeK , KoletzkoS , VonBergA , GrueblA , et al. German Infant Nutritional Intervention Study Group. Effect of exclusive breast‐feeding and early solid food avoidance on the incidence of atopic dermatitis in high‐risk infants at 1 year of age. Pediatric Allergy and Immunology2002;13(4):234‐42. [PUBMED: 12390439] SchoetzauA , GehringU , FrankeK , GrublA , KoletzkoS , vonBergA , et al. Gini Study Group. Maternal compliance with nutritional recommendations in an allergy preventive programme. Archives of Disease in Childhood2002;86(3):180‐4. [PUBMED: 11861235] VonBergA , Filipiak‐PittroffB , KrämerU , LinkE , HeinrichJ , KoletzkoS , et al. The German Infant Nutritional Intervention Study (GINI) for the preventive effect of hydrolysed infant formulas in infants at high risk for allergic diseases. Design and selected results. Allergologie2012;35(1):32‐43. VonBergA , Filipiak‐PittroffB , SchulzH , HoffmannU , LinkE , SussmannM , et al. GINIplus study group. Allergic manifestation 15 years after early intervention with hydrolyzed formulas ‐ the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2016;71(2):210‐9. [DOI: 10.1111/all.12790; PUBMED: 26465137] vonBergA , FilipiakB , KoletzkoS , KrämerU , HoffmannB , LinkE , et al. Long‐term effect of cow milk protein hydrolysates in high‐risk children. Results from the 10‐years follow‐up of the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2013;68:295‐6. vonBergA , Filipiak‐PittroffB , KramerU , HoffmannB , LinkE , BeckmannC , et al. GINIplus study group. Allergies in high‐risk schoolchildren after early intervention with cow's milk protein hydrolysates: 10‐year results from the German Infant Nutritional Intervention (GINI) study. Journal of Allergy and Clinical Immunology2013;131(6):1565‐73. [DOI: 10.1016/j.jaci.2013.01.006; PUBMED: 23506844] vonBergA , Filipiak‐PittroffB , KramerU , LinkE , BollrathC , BrockowI , et al. GINIplus study group. Preventive effect of hydrolyzed infant formulas persists until age 6 years: long‐term results from the German Infant Nutritional Intervention Study (GINI). Journal of Allergy and Clinical Immunology2008;121(6):1442‐7. [DOI: 10.1016/j.jaci.2008.04.021; PUBMED: 18539195] vonBergA , KoletzkoS , Filipiak‐PittroffB , LaubereauB , GrublA , WichmannHE , et al. German Infant Nutritional Intervention Study Group. Certain hydrolyzed formulas reduce the incidence of atopic dermatitis but not that of asthma: three‐year results of the German Infant Nutritional Intervention Study. Journal of Allergy and Clinical Immunology2007;119(3):718‐25. [DOI: 10.1016/j.jaci.2006.11.017; PUBMED: 17240440] vonBergA , KoletzkoS , GrublA , Filipiak‐PittroffB , WichmannHE , BauerCP , et al. German Infant Nutritional Intervention Study Group. The effect of hydrolyzed cow's milk formula for allergy prevention in the first year of life: the German Infant Nutritional Intervention Study, a randomized double‐blind trial. Journal of Allergy and Clinical Immunology2003;111(3):533‐40. [PUBMED: 12642834] ">von Berg 2003</a>). </p> <p>Meta‐analysis found no difference in infant allergic disease (typical RR 0.96, 95% CI 0.73 to 1.26; participants = 1143; studies = 2; I<sup>2</sup> = 82% [heterogeneity high]). Neither study reported a difference. <a href="./references#CD003664-bbs2-0015" title="BergA , KramerU , LinkE , BollrathC , HeinrichJ , BrockowI , et al. GINIplus study group. Impact of early feeding on childhood eczema: development after nutritional intervention compared with the natural course ‐ the GINIplus study up to the age of 6 years. Clinical and Experimental Allergy2010;40(4):627‐36. [DOI: 10.1111/j.1365‐2222.2009.03444.x; PUBMED: 20082618] BrockowI , ZutavernA , HoffmannU , GrublA , vonBergA , KoletzkoS , et al. GINIplus Study Group. Early allergic sensitizations and their relevance to atopic diseases in children aged 6 years: results of the GINI study. Journal of Investigational Allergology &amp; Clinical Immunology2009;19(3):180‐7. [DOI: 19610260] LaubereauB , BrockowI , ZirngiblA , KoletzkoS , GrueblA , vonBergA , et al. GINI Study Group. Effect of breast‐feeding on the development of atopic dermatitis during the first 3 years of life ‐ results from the GINI‐birth cohort study. Journal of Pediatrics2004;144(5):602‐7. [DOI: 10.1016/j.jpeds.2003.12.029; PUBMED: 15126993] LaubereauB , Filipiak‐PittroffB , vonBergA , GrublA , ReinhardtD , WichmannHE , et al. Caesarean section and gastrointestinal symptoms, atopic dermatitis, and sensitisation during the first year of life. Archives of Disease in Childhood2004;89(11):993‐7. [DOI: 10.1136/adc.2003.043265; PUBMED: 15499049] RzehakP , SausenthalerS , KoletzkoS , BauerCP , SchaafB , vonBergA , et al. Period‐specific growth, overweight and modification by breastfeeding in the GINI and LISA birth cohorts up to age 6 years. European Journal of Epidemiology2009;24(8):449‐67. [DOI: 10.1007/s10654‐009‐9356‐5; PUBMED: 19521784] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. GINI‐plus Study Group. Long‐term effects of hydrolyzed protein infant formulas on growth ‐ extended follow‐up to 10 y of age: results from the German Infant Nutritional Intervention (GINI) study. American Journal of Clinical Nutrition2011;94(6 Suppl):1803S‐7S. [DOI: 10.3945/ajcn.110.000679; PUBMED: 21849601] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. German Infant Nutritional Intervention Study Group. Short‐ and long‐term effects of feeding hydrolyzed protein infant formulas on growth at &lt; or = 6 y of age: results from the German Infant Nutritional Intervention Study. American Journal of Clinical Nutrition2009;89(6):1846‐56. [DOI: 10.3945/ajcn.2008.27373; PUBMED: 19369380] SausenthalerS , KoletzkoS , KoletzkoB , ReinhardtD , KramerU , vonBergA , et al. GINIplus study group. Effect of hydrolysed formula feeding on taste preferences at 10 years. Data from the German Infant Nutritional Intervention Program Plus Study. Clinical Nutrition2010;29(3):304‐6. [DOI: 10.1016/j.clnu.2010.01.007; PUBMED: 20110140] SchoetzauA , Filipiak‐PittroffB , FrankeK , KoletzkoS , VonBergA , GrueblA , et al. German Infant Nutritional Intervention Study Group. Effect of exclusive breast‐feeding and early solid food avoidance on the incidence of atopic dermatitis in high‐risk infants at 1 year of age. Pediatric Allergy and Immunology2002;13(4):234‐42. [PUBMED: 12390439] SchoetzauA , GehringU , FrankeK , GrublA , KoletzkoS , vonBergA , et al. Gini Study Group. Maternal compliance with nutritional recommendations in an allergy preventive programme. Archives of Disease in Childhood2002;86(3):180‐4. [PUBMED: 11861235] VonBergA , Filipiak‐PittroffB , KrämerU , LinkE , HeinrichJ , KoletzkoS , et al. The German Infant Nutritional Intervention Study (GINI) for the preventive effect of hydrolysed infant formulas in infants at high risk for allergic diseases. Design and selected results. Allergologie2012;35(1):32‐43. VonBergA , Filipiak‐PittroffB , SchulzH , HoffmannU , LinkE , SussmannM , et al. GINIplus study group. Allergic manifestation 15 years after early intervention with hydrolyzed formulas ‐ the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2016;71(2):210‐9. [DOI: 10.1111/all.12790; PUBMED: 26465137] vonBergA , FilipiakB , KoletzkoS , KrämerU , HoffmannB , LinkE , et al. Long‐term effect of cow milk protein hydrolysates in high‐risk children. Results from the 10‐years follow‐up of the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2013;68:295‐6. vonBergA , Filipiak‐PittroffB , KramerU , HoffmannB , LinkE , BeckmannC , et al. GINIplus study group. Allergies in high‐risk schoolchildren after early intervention with cow's milk protein hydrolysates: 10‐year results from the German Infant Nutritional Intervention (GINI) study. Journal of Allergy and Clinical Immunology2013;131(6):1565‐73. [DOI: 10.1016/j.jaci.2013.01.006; PUBMED: 23506844] vonBergA , Filipiak‐PittroffB , KramerU , LinkE , BollrathC , BrockowI , et al. GINIplus study group. Preventive effect of hydrolyzed infant formulas persists until age 6 years: long‐term results from the German Infant Nutritional Intervention Study (GINI). Journal of Allergy and Clinical Immunology2008;121(6):1442‐7. [DOI: 10.1016/j.jaci.2008.04.021; PUBMED: 18539195] vonBergA , KoletzkoS , Filipiak‐PittroffB , LaubereauB , GrublA , WichmannHE , et al. German Infant Nutritional Intervention Study Group. Certain hydrolyzed formulas reduce the incidence of atopic dermatitis but not that of asthma: three‐year results of the German Infant Nutritional Intervention Study. Journal of Allergy and Clinical Immunology2007;119(3):718‐25. [DOI: 10.1016/j.jaci.2006.11.017; PUBMED: 17240440] vonBergA , KoletzkoS , GrublA , Filipiak‐PittroffB , WichmannHE , BauerCP , et al. German Infant Nutritional Intervention Study Group. The effect of hydrolyzed cow's milk formula for allergy prevention in the first year of life: the German Infant Nutritional Intervention Study, a randomized double‐blind trial. Journal of Allergy and Clinical Immunology2003;111(3):533‐40. [PUBMED: 12642834] ">von Berg 2003</a> reported a reduction in childhood allergic disease incidence (RR 0.68, 95% CI 0.50 to 0.90; participants = 440). </p> <p><a href="./references#CD003664-bbs2-0003" title="HalkenS , HansenKS , JacobsenHP , EstmannA , FaellingAE , HansenLG , et al. Comparison of a partially hydrolyzed infant formula with two extensively hydrolyzed formulas for allergy prevention: a prospective, randomized study. Pediatric Allergy and Immunology2000;11(3):149‐61. [PUBMED: 10981524] ">Halken 2000</a> reported no difference in infant asthma (RR 2.28, 95% CI 0.83 to 6.28; participants = 161) <a href="./references#CD003664-bbs2-0015" title="BergA , KramerU , LinkE , BollrathC , HeinrichJ , BrockowI , et al. GINIplus study group. Impact of early feeding on childhood eczema: development after nutritional intervention compared with the natural course ‐ the GINIplus study up to the age of 6 years. Clinical and Experimental Allergy2010;40(4):627‐36. [DOI: 10.1111/j.1365‐2222.2009.03444.x; PUBMED: 20082618] BrockowI , ZutavernA , HoffmannU , GrublA , vonBergA , KoletzkoS , et al. GINIplus Study Group. Early allergic sensitizations and their relevance to atopic diseases in children aged 6 years: results of the GINI study. Journal of Investigational Allergology &amp; Clinical Immunology2009;19(3):180‐7. [DOI: 19610260] LaubereauB , BrockowI , ZirngiblA , KoletzkoS , GrueblA , vonBergA , et al. GINI Study Group. Effect of breast‐feeding on the development of atopic dermatitis during the first 3 years of life ‐ results from the GINI‐birth cohort study. Journal of Pediatrics2004;144(5):602‐7. [DOI: 10.1016/j.jpeds.2003.12.029; PUBMED: 15126993] LaubereauB , Filipiak‐PittroffB , vonBergA , GrublA , ReinhardtD , WichmannHE , et al. Caesarean section and gastrointestinal symptoms, atopic dermatitis, and sensitisation during the first year of life. Archives of Disease in Childhood2004;89(11):993‐7. [DOI: 10.1136/adc.2003.043265; PUBMED: 15499049] RzehakP , SausenthalerS , KoletzkoS , BauerCP , SchaafB , vonBergA , et al. Period‐specific growth, overweight and modification by breastfeeding in the GINI and LISA birth cohorts up to age 6 years. European Journal of Epidemiology2009;24(8):449‐67. [DOI: 10.1007/s10654‐009‐9356‐5; PUBMED: 19521784] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. GINI‐plus Study Group. Long‐term effects of hydrolyzed protein infant formulas on growth ‐ extended follow‐up to 10 y of age: results from the German Infant Nutritional Intervention (GINI) study. American Journal of Clinical Nutrition2011;94(6 Suppl):1803S‐7S. [DOI: 10.3945/ajcn.110.000679; PUBMED: 21849601] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. German Infant Nutritional Intervention Study Group. Short‐ and long‐term effects of feeding hydrolyzed protein infant formulas on growth at &lt; or = 6 y of age: results from the German Infant Nutritional Intervention Study. American Journal of Clinical Nutrition2009;89(6):1846‐56. [DOI: 10.3945/ajcn.2008.27373; PUBMED: 19369380] SausenthalerS , KoletzkoS , KoletzkoB , ReinhardtD , KramerU , vonBergA , et al. GINIplus study group. Effect of hydrolysed formula feeding on taste preferences at 10 years. Data from the German Infant Nutritional Intervention Program Plus Study. Clinical Nutrition2010;29(3):304‐6. [DOI: 10.1016/j.clnu.2010.01.007; PUBMED: 20110140] SchoetzauA , Filipiak‐PittroffB , FrankeK , KoletzkoS , VonBergA , GrueblA , et al. German Infant Nutritional Intervention Study Group. Effect of exclusive breast‐feeding and early solid food avoidance on the incidence of atopic dermatitis in high‐risk infants at 1 year of age. Pediatric Allergy and Immunology2002;13(4):234‐42. [PUBMED: 12390439] SchoetzauA , GehringU , FrankeK , GrublA , KoletzkoS , vonBergA , et al. Gini Study Group. Maternal compliance with nutritional recommendations in an allergy preventive programme. Archives of Disease in Childhood2002;86(3):180‐4. [PUBMED: 11861235] VonBergA , Filipiak‐PittroffB , KrämerU , LinkE , HeinrichJ , KoletzkoS , et al. The German Infant Nutritional Intervention Study (GINI) for the preventive effect of hydrolysed infant formulas in infants at high risk for allergic diseases. Design and selected results. Allergologie2012;35(1):32‐43. VonBergA , Filipiak‐PittroffB , SchulzH , HoffmannU , LinkE , SussmannM , et al. GINIplus study group. Allergic manifestation 15 years after early intervention with hydrolyzed formulas ‐ the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2016;71(2):210‐9. [DOI: 10.1111/all.12790; PUBMED: 26465137] vonBergA , FilipiakB , KoletzkoS , KrämerU , HoffmannB , LinkE , et al. Long‐term effect of cow milk protein hydrolysates in high‐risk children. Results from the 10‐years follow‐up of the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2013;68:295‐6. vonBergA , Filipiak‐PittroffB , KramerU , HoffmannB , LinkE , BeckmannC , et al. GINIplus study group. Allergies in high‐risk schoolchildren after early intervention with cow's milk protein hydrolysates: 10‐year results from the German Infant Nutritional Intervention (GINI) study. Journal of Allergy and Clinical Immunology2013;131(6):1565‐73. [DOI: 10.1016/j.jaci.2013.01.006; PUBMED: 23506844] vonBergA , Filipiak‐PittroffB , KramerU , LinkE , BollrathC , BrockowI , et al. GINIplus study group. Preventive effect of hydrolyzed infant formulas persists until age 6 years: long‐term results from the German Infant Nutritional Intervention Study (GINI). Journal of Allergy and Clinical Immunology2008;121(6):1442‐7. [DOI: 10.1016/j.jaci.2008.04.021; PUBMED: 18539195] vonBergA , KoletzkoS , Filipiak‐PittroffB , LaubereauB , GrublA , WichmannHE , et al. German Infant Nutritional Intervention Study Group. Certain hydrolyzed formulas reduce the incidence of atopic dermatitis but not that of asthma: three‐year results of the German Infant Nutritional Intervention Study. Journal of Allergy and Clinical Immunology2007;119(3):718‐25. [DOI: 10.1016/j.jaci.2006.11.017; PUBMED: 17240440] vonBergA , KoletzkoS , GrublA , Filipiak‐PittroffB , WichmannHE , BauerCP , et al. German Infant Nutritional Intervention Study Group. The effect of hydrolyzed cow's milk formula for allergy prevention in the first year of life: the German Infant Nutritional Intervention Study, a randomized double‐blind trial. Journal of Allergy and Clinical Immunology2003;111(3):533‐40. [PUBMED: 12642834] ">von Berg 2003</a> reported no difference in childhood asthma prevalence (RR 0.71, 95% CI 0.42 to 1.19; participants = 440). </p> <p>Meta‐analysis found no difference in infant eczema (typical RR 0.81, 95% CI 0.59 to 1.10; participants = 1143; studies = 2; I<sup>2</sup> = 70% [heterogeneity moderate]). <a href="./references#CD003664-bbs2-0015" title="BergA , KramerU , LinkE , BollrathC , HeinrichJ , BrockowI , et al. GINIplus study group. Impact of early feeding on childhood eczema: development after nutritional intervention compared with the natural course ‐ the GINIplus study up to the age of 6 years. Clinical and Experimental Allergy2010;40(4):627‐36. [DOI: 10.1111/j.1365‐2222.2009.03444.x; PUBMED: 20082618] BrockowI , ZutavernA , HoffmannU , GrublA , vonBergA , KoletzkoS , et al. GINIplus Study Group. Early allergic sensitizations and their relevance to atopic diseases in children aged 6 years: results of the GINI study. Journal of Investigational Allergology &amp; Clinical Immunology2009;19(3):180‐7. [DOI: 19610260] LaubereauB , BrockowI , ZirngiblA , KoletzkoS , GrueblA , vonBergA , et al. GINI Study Group. Effect of breast‐feeding on the development of atopic dermatitis during the first 3 years of life ‐ results from the GINI‐birth cohort study. Journal of Pediatrics2004;144(5):602‐7. [DOI: 10.1016/j.jpeds.2003.12.029; PUBMED: 15126993] LaubereauB , Filipiak‐PittroffB , vonBergA , GrublA , ReinhardtD , WichmannHE , et al. Caesarean section and gastrointestinal symptoms, atopic dermatitis, and sensitisation during the first year of life. Archives of Disease in Childhood2004;89(11):993‐7. [DOI: 10.1136/adc.2003.043265; PUBMED: 15499049] RzehakP , SausenthalerS , KoletzkoS , BauerCP , SchaafB , vonBergA , et al. Period‐specific growth, overweight and modification by breastfeeding in the GINI and LISA birth cohorts up to age 6 years. European Journal of Epidemiology2009;24(8):449‐67. [DOI: 10.1007/s10654‐009‐9356‐5; PUBMED: 19521784] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. GINI‐plus Study Group. Long‐term effects of hydrolyzed protein infant formulas on growth ‐ extended follow‐up to 10 y of age: results from the German Infant Nutritional Intervention (GINI) study. American Journal of Clinical Nutrition2011;94(6 Suppl):1803S‐7S. [DOI: 10.3945/ajcn.110.000679; PUBMED: 21849601] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. German Infant Nutritional Intervention Study Group. Short‐ and long‐term effects of feeding hydrolyzed protein infant formulas on growth at &lt; or = 6 y of age: results from the German Infant Nutritional Intervention Study. American Journal of Clinical Nutrition2009;89(6):1846‐56. [DOI: 10.3945/ajcn.2008.27373; PUBMED: 19369380] SausenthalerS , KoletzkoS , KoletzkoB , ReinhardtD , KramerU , vonBergA , et al. GINIplus study group. Effect of hydrolysed formula feeding on taste preferences at 10 years. Data from the German Infant Nutritional Intervention Program Plus Study. Clinical Nutrition2010;29(3):304‐6. [DOI: 10.1016/j.clnu.2010.01.007; PUBMED: 20110140] SchoetzauA , Filipiak‐PittroffB , FrankeK , KoletzkoS , VonBergA , GrueblA , et al. German Infant Nutritional Intervention Study Group. Effect of exclusive breast‐feeding and early solid food avoidance on the incidence of atopic dermatitis in high‐risk infants at 1 year of age. Pediatric Allergy and Immunology2002;13(4):234‐42. [PUBMED: 12390439] SchoetzauA , GehringU , FrankeK , GrublA , KoletzkoS , vonBergA , et al. Gini Study Group. Maternal compliance with nutritional recommendations in an allergy preventive programme. Archives of Disease in Childhood2002;86(3):180‐4. [PUBMED: 11861235] VonBergA , Filipiak‐PittroffB , KrämerU , LinkE , HeinrichJ , KoletzkoS , et al. The German Infant Nutritional Intervention Study (GINI) for the preventive effect of hydrolysed infant formulas in infants at high risk for allergic diseases. Design and selected results. Allergologie2012;35(1):32‐43. VonBergA , Filipiak‐PittroffB , SchulzH , HoffmannU , LinkE , SussmannM , et al. GINIplus study group. Allergic manifestation 15 years after early intervention with hydrolyzed formulas ‐ the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2016;71(2):210‐9. [DOI: 10.1111/all.12790; PUBMED: 26465137] vonBergA , FilipiakB , KoletzkoS , KrämerU , HoffmannB , LinkE , et al. Long‐term effect of cow milk protein hydrolysates in high‐risk children. Results from the 10‐years follow‐up of the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2013;68:295‐6. vonBergA , Filipiak‐PittroffB , KramerU , HoffmannB , LinkE , BeckmannC , et al. GINIplus study group. Allergies in high‐risk schoolchildren after early intervention with cow's milk protein hydrolysates: 10‐year results from the German Infant Nutritional Intervention (GINI) study. Journal of Allergy and Clinical Immunology2013;131(6):1565‐73. [DOI: 10.1016/j.jaci.2013.01.006; PUBMED: 23506844] vonBergA , Filipiak‐PittroffB , KramerU , LinkE , BollrathC , BrockowI , et al. GINIplus study group. Preventive effect of hydrolyzed infant formulas persists until age 6 years: long‐term results from the German Infant Nutritional Intervention Study (GINI). Journal of Allergy and Clinical Immunology2008;121(6):1442‐7. [DOI: 10.1016/j.jaci.2008.04.021; PUBMED: 18539195] vonBergA , KoletzkoS , Filipiak‐PittroffB , LaubereauB , GrublA , WichmannHE , et al. German Infant Nutritional Intervention Study Group. Certain hydrolyzed formulas reduce the incidence of atopic dermatitis but not that of asthma: three‐year results of the German Infant Nutritional Intervention Study. Journal of Allergy and Clinical Immunology2007;119(3):718‐25. [DOI: 10.1016/j.jaci.2006.11.017; PUBMED: 17240440] vonBergA , KoletzkoS , GrublA , Filipiak‐PittroffB , WichmannHE , BauerCP , et al. German Infant Nutritional Intervention Study Group. The effect of hydrolyzed cow's milk formula for allergy prevention in the first year of life: the German Infant Nutritional Intervention Study, a randomized double‐blind trial. Journal of Allergy and Clinical Immunology2003;111(3):533‐40. [PUBMED: 12642834] ">von Berg 2003</a> reported a reduction in childhood eczema incidence (RR 0.62, 95% CI 0.42 to 0.92; participants = 440) and no difference in childhood eczema prevalence (RR 0.64, 95% CI 0.33 to 1.21; participants = 440). </p> <p><a href="./references#CD003664-bbs2-0003" title="HalkenS , HansenKS , JacobsenHP , EstmannA , FaellingAE , HansenLG , et al. Comparison of a partially hydrolyzed infant formula with two extensively hydrolyzed formulas for allergy prevention: a prospective, randomized study. Pediatric Allergy and Immunology2000;11(3):149‐61. [PUBMED: 10981524] ">Halken 2000</a> reported no difference in infant rhinitis (RR 2.08, 95% CI 0.39 to 11.02; participants = 161), no difference in infant food allergy (RR 1.45, 95% CI 0.48 to 4.39; participants = 161), no difference in infant CMA (RR 5.19, 95% CI 0.25 to 106.38; participants = 161) and no difference in urticaria (RR 4.15, 95% CI 0.47 to 36.34; participants = 161). </p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD003664-sec-0127" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD003664-sec-0127"></div> <section id="CD003664-sec-0128"> <h3 class="title" id="CD003664-sec-0128">Summary of main results</h3> <section id="CD003664-sec-0129"> <h4 class="title">Early short‐term infant feeding</h4> <p>Two studies (<a href="./references#CD003664-bbs2-0005" title="JuvonenP , ManssonM , AnderssonC , JakobssonI . Allergy development and macromolecular absorption in infants with different feeding regimens during the first three days of life. A three‐year prospective follow‐up. Acta Paediatrica1996;85(9):1047‐52. [PUBMED: 8888916] JuvonenP , ManssonM , JakobssonI . Does early diet have an effect on subsequent macromolecular absorption and serum IgE?. Journal of Pediatric Gastroenterology and Nutrition1994;18(3):344‐9. [PUBMED: 8057219] JuvonenP , ManssonM , KjellmanNI , BjorkstenB , JakobssonI . Development of immunoglobulin G and immunoglobulin E antibodies to cow's milk proteins and ovalbumin after a temporary neonatal exposure to hydrolyzed and whole cow's milk proteins. Pediatric Allergy and Immunology1999;10(3):191‐8. [PUBMED: 10565560] ">Juvonen 1996</a>; <a href="./references#CD003664-bbs2-0012" title="SaarinenKM , Juntunen‐BackmanK , JarvenpaaAL , KlemettiP , KuitunenP , LopeL , et al. Breast‐feeding and the development of cows' milk protein allergy. Advances in Experimental Medicine and Biology2000;478:121‐30. [DOI: 10.1007/0‐306‐46830‐1_10; PUBMED: 11065065] SaarinenKM , Juntunen‐BackmanK , JarvenpaaAL , KuitunenP , LopeL , RenlundM , et al. Supplementary feeding in maternity hospitals and the risk of cow's milk allergy: a prospective study of 6209 infants. Journal of Allergy and Clinical Immunology1999;104(2 Pt 1):457‐61. [PUBMED: 10452771] SaarinenKM , SavilahtiE . Infant feeding patterns affect the subsequent immunological features in cow's milk allergy. Clinical and Experimental Allergy2000;30(3):400‐6. [DOI: 10691899] SaarinenKM , SuomalainenH , SavilahtiE . Diagnostic value of skin‐prick and patch tests and serum eosinophil cationic protein and cow's milk‐specific IgE in infants with cow's milk allergy. Clinical and Experimental Allergy2001;31(3):423‐9. [PUBMED: 11260154] SaarinenKM , VaaralaO , KlemettiP , SavilahtiE . Transforming growth factor‐beta1 in mothers' colostrum and immune responses to cows' milk proteins in infants with cows' milk allergy. Journal of Allergy and Clinical Immunology1999;104(5):1093‐8. [PUBMED: 10550758] SavilahtiE , SaarinenKM . Early infant feeding and type 1 diabetes. European Journal of Nutrition2009;48(4):243‐9. [DOI: 10.1007/s00394‐009‐0008‐z; PUBMED: 19263185] SavilahtiEM , SaarinenKM , SavilahtiE . Specific antibodies to cow's milk proteins in infants: effect of early feeding and diagnosis of cow's milk allergy. European Journal of Nutrition2010;49(8):501‐4. [DOI: 10.1007/s00394‐010‐0109‐8; PUBMED: 20405136] SiltanenM , KajosaariM , PoussaT , SaarinenKM , SavilahtiE . A dual long‐term effect of breastfeeding on atopy in relation to heredity in children at 4 years of age. Allergy2003;58(6):524‐30. [PUBMED: 12757455] ">Saarinen 1999</a>) assessed the effect of three to four days' supplementation with a hydrolysed formula versus cow's milk formula (CMF) versus pasteurised human milk feeds whilst in hospital after birth. </p> <p><b>Hydrolysed formula versus pasteurised human milk:</b><a href="./references#CD003664-bbs2-0005" title="JuvonenP , ManssonM , AnderssonC , JakobssonI . Allergy development and macromolecular absorption in infants with different feeding regimens during the first three days of life. A three‐year prospective follow‐up. Acta Paediatrica1996;85(9):1047‐52. [PUBMED: 8888916] JuvonenP , ManssonM , JakobssonI . Does early diet have an effect on subsequent macromolecular absorption and serum IgE?. Journal of Pediatric Gastroenterology and Nutrition1994;18(3):344‐9. [PUBMED: 8057219] JuvonenP , ManssonM , KjellmanNI , BjorkstenB , JakobssonI . Development of immunoglobulin G and immunoglobulin E antibodies to cow's milk proteins and ovalbumin after a temporary neonatal exposure to hydrolyzed and whole cow's milk proteins. Pediatric Allergy and Immunology1999;10(3):191‐8. [PUBMED: 10565560] ">Juvonen 1996</a> assessed outcomes in 90 infants and reported no difference in rates of allergic disease, asthma, eczema, food allergy and cow's milk allergy (CMA) up to three years of age (GRADE quality of evidence very low ‐ see <a href="./full#CD003664-tbl-0001">summary of findings Table for the main comparison</a>). Quality of evidence was downgraded due to risk of bias (quasi‐random sequence allocation, incomplete outcome data and imbalances at baseline), imprecision and potential for reporting or publication bias. <a href="./references#CD003664-bbs2-0012" title="SaarinenKM , Juntunen‐BackmanK , JarvenpaaAL , KlemettiP , KuitunenP , LopeL , et al. Breast‐feeding and the development of cows' milk protein allergy. Advances in Experimental Medicine and Biology2000;478:121‐30. [DOI: 10.1007/0‐306‐46830‐1_10; PUBMED: 11065065] SaarinenKM , Juntunen‐BackmanK , JarvenpaaAL , KuitunenP , LopeL , RenlundM , et al. Supplementary feeding in maternity hospitals and the risk of cow's milk allergy: a prospective study of 6209 infants. Journal of Allergy and Clinical Immunology1999;104(2 Pt 1):457‐61. [PUBMED: 10452771] SaarinenKM , SavilahtiE . Infant feeding patterns affect the subsequent immunological features in cow's milk allergy. Clinical and Experimental Allergy2000;30(3):400‐6. [DOI: 10691899] SaarinenKM , SuomalainenH , SavilahtiE . Diagnostic value of skin‐prick and patch tests and serum eosinophil cationic protein and cow's milk‐specific IgE in infants with cow's milk allergy. Clinical and Experimental Allergy2001;31(3):423‐9. [PUBMED: 11260154] SaarinenKM , VaaralaO , KlemettiP , SavilahtiE . Transforming growth factor‐beta1 in mothers' colostrum and immune responses to cows' milk proteins in infants with cows' milk allergy. Journal of Allergy and Clinical Immunology1999;104(5):1093‐8. [PUBMED: 10550758] SavilahtiE , SaarinenKM . Early infant feeding and type 1 diabetes. European Journal of Nutrition2009;48(4):243‐9. [DOI: 10.1007/s00394‐009‐0008‐z; PUBMED: 19263185] SavilahtiEM , SaarinenKM , SavilahtiE . Specific antibodies to cow's milk proteins in infants: effect of early feeding and diagnosis of cow's milk allergy. European Journal of Nutrition2010;49(8):501‐4. [DOI: 10.1007/s00394‐010‐0109‐8; PUBMED: 20405136] SiltanenM , KajosaariM , PoussaT , SaarinenKM , SavilahtiE . A dual long‐term effect of breastfeeding on atopy in relation to heredity in children at 4 years of age. Allergy2003;58(6):524‐30. [PUBMED: 12757455] ">Saarinen 1999</a> assessed outcomes in 3559 infants and reported no difference in the rate of CMA at a mean age of 27 months (GRADE quality of evidence very low ‐ see <a href="./full#CD003664-tbl-0001">summary of findings Table for the main comparison</a>). Quality of evidence was downgraded due to risk of bias (quasi‐random sequence allocation, incomplete outcome data), imprecision and potential for reporting or publication bias. </p> <p><b>Hydrolysed formula versus CMF:</b><a href="./references#CD003664-bbs2-0005" title="JuvonenP , ManssonM , AnderssonC , JakobssonI . Allergy development and macromolecular absorption in infants with different feeding regimens during the first three days of life. A three‐year prospective follow‐up. Acta Paediatrica1996;85(9):1047‐52. [PUBMED: 8888916] JuvonenP , ManssonM , JakobssonI . Does early diet have an effect on subsequent macromolecular absorption and serum IgE?. Journal of Pediatric Gastroenterology and Nutrition1994;18(3):344‐9. [PUBMED: 8057219] JuvonenP , ManssonM , KjellmanNI , BjorkstenB , JakobssonI . Development of immunoglobulin G and immunoglobulin E antibodies to cow's milk proteins and ovalbumin after a temporary neonatal exposure to hydrolyzed and whole cow's milk proteins. Pediatric Allergy and Immunology1999;10(3):191‐8. [PUBMED: 10565560] ">Juvonen 1996</a> reporting outcomes in 77 infants reported no difference in rates of allergic disease, asthma, eczema, food allergy and CMA up to three years of age (GRADE quality of evidence very low ‐ see <a href="./full#CD003664-tbl-0002">summary of findings Table 2</a>). Quality of evidence was downgraded due to risk of bias (quasi‐random sequence allocation, incomplete outcome data and imbalances at baseline), imprecision and potential for reporting or publication bias. <a href="./references#CD003664-bbs2-0012" title="SaarinenKM , Juntunen‐BackmanK , JarvenpaaAL , KlemettiP , KuitunenP , LopeL , et al. Breast‐feeding and the development of cows' milk protein allergy. Advances in Experimental Medicine and Biology2000;478:121‐30. [DOI: 10.1007/0‐306‐46830‐1_10; PUBMED: 11065065] SaarinenKM , Juntunen‐BackmanK , JarvenpaaAL , KuitunenP , LopeL , RenlundM , et al. Supplementary feeding in maternity hospitals and the risk of cow's milk allergy: a prospective study of 6209 infants. Journal of Allergy and Clinical Immunology1999;104(2 Pt 1):457‐61. [PUBMED: 10452771] SaarinenKM , SavilahtiE . Infant feeding patterns affect the subsequent immunological features in cow's milk allergy. Clinical and Experimental Allergy2000;30(3):400‐6. [DOI: 10691899] SaarinenKM , SuomalainenH , SavilahtiE . Diagnostic value of skin‐prick and patch tests and serum eosinophil cationic protein and cow's milk‐specific IgE in infants with cow's milk allergy. Clinical and Experimental Allergy2001;31(3):423‐9. [PUBMED: 11260154] SaarinenKM , VaaralaO , KlemettiP , SavilahtiE . Transforming growth factor‐beta1 in mothers' colostrum and immune responses to cows' milk proteins in infants with cows' milk allergy. Journal of Allergy and Clinical Immunology1999;104(5):1093‐8. [PUBMED: 10550758] SavilahtiE , SaarinenKM . Early infant feeding and type 1 diabetes. European Journal of Nutrition2009;48(4):243‐9. [DOI: 10.1007/s00394‐009‐0008‐z; PUBMED: 19263185] SavilahtiEM , SaarinenKM , SavilahtiE . Specific antibodies to cow's milk proteins in infants: effect of early feeding and diagnosis of cow's milk allergy. European Journal of Nutrition2010;49(8):501‐4. [DOI: 10.1007/s00394‐010‐0109‐8; PUBMED: 20405136] SiltanenM , KajosaariM , PoussaT , SaarinenKM , SavilahtiE . A dual long‐term effect of breastfeeding on atopy in relation to heredity in children at 4 years of age. Allergy2003;58(6):524‐30. [PUBMED: 12757455] ">Saarinen 1999</a> reporting outcomes in 3473 infants reported a reduction in CMA at a mean age of 27 months (GRADE quality of evidence very low ‐ see <a href="./full#CD003664-tbl-0002">summary of findings Table 2</a>). Quality of evidence was downgraded due to risk of bias (quasi‐random sequence allocation, incomplete outcome data), imprecision and potential for reporting or publication bias. </p> </section> <section id="CD003664-sec-0130"> <h4 class="title">Prolonged infant feeding</h4> <p>The most commonly reported outcomes were infant allergic disease incidence (8 studies, 2852 infants), childhood asthma prevalence (3 studies, 1229 infants), infant eczema incidence (9 studies, 2896 infants), childhood rhinitis prevalence (2 studies, 357 infants), food allergy (2 studies 479 infants), and CMA (1 study, 338 infants). Prolonged infant feeding with a hydrolysed formula compared with a CMF was not associated with any differences in infant or childhood allergic disease, asthma, eczema or rhinitis. The GRADE quality of evidence was very low for all outcomes with downgrading due to risk of bias, imprecision, and risk of reporting or publication bias (see <a href="./full#CD003664-tbl-0003">summary of findings Table 3</a>). Prolonged infant feeding with a hydrolysed formula compared with a CMF was also not associated with any difference in infant food allergy or CMA. The GRADE quality of evidence was downgraded due to risk of bias, imprecision, and risk of reporting or publication bias. Childhood food allergy or CMA were not reported. </p> <p><b>Subgroup analyses</b> </p> <p>Infant risk of allergic disease</p> <p> <ul id="CD003664-list-0036"> <li> <p>Infants at low risk of allergic disease: a single study (<a href="./references#CD003664-bbs2-0006" title="KwintaP , SawiecP , KlimekM , LisG , Cichocka‐JaroszE , PietrzykJJ . Correlation between early neonatal diet and atopic symptoms up to 5‐7 years of age in very low birth weight infants: follow‐up of randomized, double‐blind study. Pediatric Allergy and Immunology2009;20(5):458‐66. [DOI: 10.1111/j.1399‐3038.2008.00814.x; PUBMED: 19490477] ">Kwinta 2009</a>) assessing outcomes for 62 infants reported no difference in childhood prevalence of allergic disease, asthma or eczema. </p> </li> </ul> <ul id="CD003664-list-0037"> <li> <p>Infants at high risk of allergic disease: prolonged infant feeding with a hydrolysed formula compared with CMF was not associated with any differences in infant or childhood allergic disease, asthma, eczema or rhinitis; or infant food allergy or CMA. </p> </li> </ul> </p> <p>Type of hydrolysed formula</p> <p> <ul id="CD003664-list-0038"> <li> <p>Prolonged feeding with a partially hydrolysed formula (PHF) versus a CMF was not associated with any differences in infant or childhood allergic disease, asthma, eczema or rhinitis; or infant food allergy or CMA. </p> </li> <li> <p>Prolonged feeding with an extensively hydrolysed formula (EHF) versus a CMF was not associated with any differences in infant or childhood allergic disease, asthma, eczema or rhinitis; or infant food allergy. </p> </li> <li> <p>Prolonged feeding with an EHF versus a PHF was not associated with any differences in infant or childhood allergic disease, asthma, eczema or rhinitis; or infant CMA or infant urticaria. Prolonged feeding with an EHF versus a PHF was associated with a reduction in infant food allergy of borderline statistical significance (typical RR 0.43, 95% CI 0.19 to 0.99; participants = 341; studies = 2; I<sup>2</sup> = 0%; typical risk difference (RD) ‐0.06, 95% CI ‐0.11, ‐0.00). </p> </li> </ul> </p> <p>Prolonged exclusive formula feeding</p> <p> <ul id="CD003664-list-0039"> <li> <p>Prolonged exclusive feeding with a hydrolysed formula versus CMF was associated with a reduction in infant allergic disease (typical RR 0.61, 95% CI 0.46 to 0.80; participants = 425; studies = 5; I<sup>2</sup> = 0%; typical RD ‐0.16, 95% CI ‐0.25, ‐0.08; number needed to treat for an additional beneficial outcome (NNTB) 6, 95% CI 4, 12.5). Single small studies also reported a reduction in childhood allergic disease incidence but not childhood allergic disease prevalence. Prolonged exclusive feeding with a hydrolysed formula versus CMF was not associated with any differences in infant or childhood asthma or eczema, or childhood rhinitis. </p> </li> </ul> </p> <p>Specific type of hydrolysed formula (not prespecified analyses)</p> <p> <ul id="CD003664-list-0040"> <li> <p>Prolonged feeding with a partially hydrolysed whey formula versus CMF was not associated with any differences in infant or childhood allergic disease, asthma, eczema or rhinitis; or infant food allergy or CMA. </p> </li> <li> <p>Prolonged feeding with a partially hydrolysed casein‐containing formula versus CMF was not associated with any differences in infant or childhood allergy, asthma, eczema or rhinitis; or infant food allergy. </p> </li> <li> <p>Prolonged feeding with an extensively hydrolysed whey formula versus CMF was not associated with any differences in infant or childhood allergic disease, infant asthma, or infant or childhood eczema. </p> </li> <li> <p>Prolonged feeding with an extensively hydrolysed casein formula versus CMF was not associated with any differences in infant allergic disease, childhood asthma, or infant eczema. There was a reduction in childhood allergic disease (RR 0.72, 95% CI 0.53 to 0.97; participants = 431; studies = 1; RD ‐0.10, 95% CI ‐0.18, ‐0.01), childhood eczema incidence (RR 0.66, 95% CI 0.44 to 0.98; participants = 431; studies = 1; RD ‐0.08, 95% ‐0.15, ‐0.00) and childhood eczema prevalence (RR 0.50, 95% CI 0.27 to 0.92; participants = 431; studies = 1; RD ‐0.06, 95%CI ‐0.12, ‐0.01). </p> </li> <li> <p>Prolonged feeding with an extensively hydrolysed casein formula versus extensively hydrolysed whey formula was associated with no difference in infant allergic disease but a reduction in childhood allergic disease . </p> </li> </ul> </p> </section> </section> <section id="CD003664-sec-0131"> <h3 class="title" id="CD003664-sec-0131">Overall completeness and applicability of evidence</h3> <p>For short‐term feeding (e.g. for three to four days whilst in hospital), a single small study (<a href="./references#CD003664-bbs2-0005" title="JuvonenP , ManssonM , AnderssonC , JakobssonI . Allergy development and macromolecular absorption in infants with different feeding regimens during the first three days of life. A three‐year prospective follow‐up. Acta Paediatrica1996;85(9):1047‐52. [PUBMED: 8888916] JuvonenP , ManssonM , JakobssonI . Does early diet have an effect on subsequent macromolecular absorption and serum IgE?. Journal of Pediatric Gastroenterology and Nutrition1994;18(3):344‐9. [PUBMED: 8057219] JuvonenP , ManssonM , KjellmanNI , BjorkstenB , JakobssonI . Development of immunoglobulin G and immunoglobulin E antibodies to cow's milk proteins and ovalbumin after a temporary neonatal exposure to hydrolyzed and whole cow's milk proteins. Pediatric Allergy and Immunology1999;10(3):191‐8. [PUBMED: 10565560] ">Juvonen 1996</a>) is underpowered to determine an effect of hydrolysed formula compared with human milk or CMF on childhood allergic disease, asthma, eczema or rhinitis. A much larger study (<a href="./references#CD003664-bbs2-0012" title="SaarinenKM , Juntunen‐BackmanK , JarvenpaaAL , KlemettiP , KuitunenP , LopeL , et al. Breast‐feeding and the development of cows' milk protein allergy. Advances in Experimental Medicine and Biology2000;478:121‐30. [DOI: 10.1007/0‐306‐46830‐1_10; PUBMED: 11065065] SaarinenKM , Juntunen‐BackmanK , JarvenpaaAL , KuitunenP , LopeL , RenlundM , et al. Supplementary feeding in maternity hospitals and the risk of cow's milk allergy: a prospective study of 6209 infants. Journal of Allergy and Clinical Immunology1999;104(2 Pt 1):457‐61. [PUBMED: 10452771] SaarinenKM , SavilahtiE . Infant feeding patterns affect the subsequent immunological features in cow's milk allergy. Clinical and Experimental Allergy2000;30(3):400‐6. [DOI: 10691899] SaarinenKM , SuomalainenH , SavilahtiE . Diagnostic value of skin‐prick and patch tests and serum eosinophil cationic protein and cow's milk‐specific IgE in infants with cow's milk allergy. Clinical and Experimental Allergy2001;31(3):423‐9. [PUBMED: 11260154] SaarinenKM , VaaralaO , KlemettiP , SavilahtiE . Transforming growth factor‐beta1 in mothers' colostrum and immune responses to cows' milk proteins in infants with cows' milk allergy. Journal of Allergy and Clinical Immunology1999;104(5):1093‐8. [PUBMED: 10550758] SavilahtiE , SaarinenKM . Early infant feeding and type 1 diabetes. European Journal of Nutrition2009;48(4):243‐9. [DOI: 10.1007/s00394‐009‐0008‐z; PUBMED: 19263185] SavilahtiEM , SaarinenKM , SavilahtiE . Specific antibodies to cow's milk proteins in infants: effect of early feeding and diagnosis of cow's milk allergy. European Journal of Nutrition2010;49(8):501‐4. [DOI: 10.1007/s00394‐010‐0109‐8; PUBMED: 20405136] SiltanenM , KajosaariM , PoussaT , SaarinenKM , SavilahtiE . A dual long‐term effect of breastfeeding on atopy in relation to heredity in children at 4 years of age. Allergy2003;58(6):524‐30. [PUBMED: 12757455] ">Saarinen 1999</a>) enrolling 5317 infants reported no difference in CMA upon comparing infants receiving short‐term feeding with an extensively hydrolysed whey formula versus human milk, and a reduction in CMA of borderline statistical significance when comparing infants fed an extensively hydrolysed whey formula versus CMF. Additional studies are needed to determine if infants benefit from short‐term feeding with a hydrolysed formula in hospital when human milk is unavailable for prevention of allergic disease and CMA. No studies have reported allergic disease outcomes resulting from short‐term use of a PHF for infants in hospital. Additional studies are needed to determine if infants derive benefit from using a PHF for short‐term feeding in hospital when human milk is unavailable for prevention of allergic disease and CMA. </p> <p>For women unable to exclusively breast feed, no studies have compared prolonged use of a hydrolysed formula versus human milk (e.g. from a donor milk bank) for prevention of allergic disease. This review has not compared the effect of human milk versus CMF feeding so cannot provide a conclusion about potential benefit derived from use of a human milk bank for prevention of allergic disease. </p> <p>The overall analyses found there was no benefit from prolonged use of a hydrolysed formula versus CMF for prevention of infant or childhood allergic disease, asthma, eczema, rhinitis, food allergy or CMA for infants not exclusively breast fed. The largest analyses were for infant allergic disease incidence (8 studies, 2852 infants) and infant eczema incidence (9 studies, 2896 infants). These analyses were considered imprecise so further studies are needed to determine of infants derive benefit from using a hydrolysed formula prolonged feeding when unable to be exclusively breast fed for prevention of allergic disease. Analyses of other allergic disease outcomes including for asthma, rhinitis, food allergy and CMA are even more underpowered. </p> <p>Subgroup analysis found some evidence of benefit from prolonged exclusive feeding (infants not breast fed) with a hydrolysed formula versus a CMF which was associated with a reduction in infant allergic disease, but not asthma, eczema or rhinitis. However, relatively few trials assessed the effect of exclusive formula feeding so analyses are largely underpowered. The largest analysis was infant allergic disease incidence which included five studies reporting outcomes of only 425 infants. No data were available to assess the effect of exclusive hydrolysed formula feeding on the incidence of food allergy or CMA. </p> <p>Subgroup analyses comparing prolonged use of a PHF versus CMF, or an EHF versus CMF, found no evidence of benefit from use of a hydrolysed formula for prevention of allergic disease or any type of allergic disease. Subgroup analyses of specific types of hydrolysed formulas are inconsistent, so findings should be treated with caution. Positive findings included: 1. Prolonged feeding with an EHF versus a PHF was associated with a reduction in infant food allergy (two studies (<a href="./references#CD003664-bbs2-0003" title="HalkenS , HansenKS , JacobsenHP , EstmannA , FaellingAE , HansenLG , et al. Comparison of a partially hydrolyzed infant formula with two extensively hydrolyzed formulas for allergy prevention: a prospective, randomized study. Pediatric Allergy and Immunology2000;11(3):149‐61. [PUBMED: 10981524] ">Halken 2000</a>; <a href="./references#CD003664-bbs2-0011" title="OldaeusG , AnjouK , BjorkstenB , MoranJR , KjellmanNI . Extensively and partially hydrolysed infant formulas for allergy prophylaxis. Archives of Disease in Childhood1997;77(1):4‐10. [PUBMED: 9279143] OldaeusG , BjorkstenB , JenmalmMC , KjellmanNI . Cow's milk IgE and IgG antibody responses to cow's milk formulas. Allergy1999;54(4):352‐7. [PUBMED: 10371094] ">Oldaeus 1997</a>) reporting outcomes for 341 infants); and 2. Prolonged feeding with an extensively hydrolysed casein formula versus CMF was associated with a reduction in childhood allergic disease, childhood eczema incidence and childhood eczema prevalence. However, these findings are limited to the single centre findings of a multicentre study (<a href="./references#CD003664-bbs2-0015" title="BergA , KramerU , LinkE , BollrathC , HeinrichJ , BrockowI , et al. GINIplus study group. Impact of early feeding on childhood eczema: development after nutritional intervention compared with the natural course ‐ the GINIplus study up to the age of 6 years. Clinical and Experimental Allergy2010;40(4):627‐36. [DOI: 10.1111/j.1365‐2222.2009.03444.x; PUBMED: 20082618] BrockowI , ZutavernA , HoffmannU , GrublA , vonBergA , KoletzkoS , et al. GINIplus Study Group. Early allergic sensitizations and their relevance to atopic diseases in children aged 6 years: results of the GINI study. Journal of Investigational Allergology &amp; Clinical Immunology2009;19(3):180‐7. [DOI: 19610260] LaubereauB , BrockowI , ZirngiblA , KoletzkoS , GrueblA , vonBergA , et al. GINI Study Group. Effect of breast‐feeding on the development of atopic dermatitis during the first 3 years of life ‐ results from the GINI‐birth cohort study. Journal of Pediatrics2004;144(5):602‐7. [DOI: 10.1016/j.jpeds.2003.12.029; PUBMED: 15126993] LaubereauB , Filipiak‐PittroffB , vonBergA , GrublA , ReinhardtD , WichmannHE , et al. Caesarean section and gastrointestinal symptoms, atopic dermatitis, and sensitisation during the first year of life. Archives of Disease in Childhood2004;89(11):993‐7. [DOI: 10.1136/adc.2003.043265; PUBMED: 15499049] RzehakP , SausenthalerS , KoletzkoS , BauerCP , SchaafB , vonBergA , et al. Period‐specific growth, overweight and modification by breastfeeding in the GINI and LISA birth cohorts up to age 6 years. European Journal of Epidemiology2009;24(8):449‐67. [DOI: 10.1007/s10654‐009‐9356‐5; PUBMED: 19521784] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. GINI‐plus Study Group. Long‐term effects of hydrolyzed protein infant formulas on growth ‐ extended follow‐up to 10 y of age: results from the German Infant Nutritional Intervention (GINI) study. American Journal of Clinical Nutrition2011;94(6 Suppl):1803S‐7S. [DOI: 10.3945/ajcn.110.000679; PUBMED: 21849601] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. German Infant Nutritional Intervention Study Group. Short‐ and long‐term effects of feeding hydrolyzed protein infant formulas on growth at &lt; or = 6 y of age: results from the German Infant Nutritional Intervention Study. American Journal of Clinical Nutrition2009;89(6):1846‐56. [DOI: 10.3945/ajcn.2008.27373; PUBMED: 19369380] SausenthalerS , KoletzkoS , KoletzkoB , ReinhardtD , KramerU , vonBergA , et al. GINIplus study group. Effect of hydrolysed formula feeding on taste preferences at 10 years. Data from the German Infant Nutritional Intervention Program Plus Study. Clinical Nutrition2010;29(3):304‐6. [DOI: 10.1016/j.clnu.2010.01.007; PUBMED: 20110140] SchoetzauA , Filipiak‐PittroffB , FrankeK , KoletzkoS , VonBergA , GrueblA , et al. German Infant Nutritional Intervention Study Group. Effect of exclusive breast‐feeding and early solid food avoidance on the incidence of atopic dermatitis in high‐risk infants at 1 year of age. Pediatric Allergy and Immunology2002;13(4):234‐42. [PUBMED: 12390439] SchoetzauA , GehringU , FrankeK , GrublA , KoletzkoS , vonBergA , et al. Gini Study Group. Maternal compliance with nutritional recommendations in an allergy preventive programme. Archives of Disease in Childhood2002;86(3):180‐4. [PUBMED: 11861235] VonBergA , Filipiak‐PittroffB , KrämerU , LinkE , HeinrichJ , KoletzkoS , et al. The German Infant Nutritional Intervention Study (GINI) for the preventive effect of hydrolysed infant formulas in infants at high risk for allergic diseases. Design and selected results. Allergologie2012;35(1):32‐43. VonBergA , Filipiak‐PittroffB , SchulzH , HoffmannU , LinkE , SussmannM , et al. GINIplus study group. Allergic manifestation 15 years after early intervention with hydrolyzed formulas ‐ the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2016;71(2):210‐9. [DOI: 10.1111/all.12790; PUBMED: 26465137] vonBergA , FilipiakB , KoletzkoS , KrämerU , HoffmannB , LinkE , et al. Long‐term effect of cow milk protein hydrolysates in high‐risk children. Results from the 10‐years follow‐up of the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2013;68:295‐6. vonBergA , Filipiak‐PittroffB , KramerU , HoffmannB , LinkE , BeckmannC , et al. GINIplus study group. Allergies in high‐risk schoolchildren after early intervention with cow's milk protein hydrolysates: 10‐year results from the German Infant Nutritional Intervention (GINI) study. Journal of Allergy and Clinical Immunology2013;131(6):1565‐73. [DOI: 10.1016/j.jaci.2013.01.006; PUBMED: 23506844] vonBergA , Filipiak‐PittroffB , KramerU , LinkE , BollrathC , BrockowI , et al. GINIplus study group. Preventive effect of hydrolyzed infant formulas persists until age 6 years: long‐term results from the German Infant Nutritional Intervention Study (GINI). Journal of Allergy and Clinical Immunology2008;121(6):1442‐7. [DOI: 10.1016/j.jaci.2008.04.021; PUBMED: 18539195] vonBergA , KoletzkoS , Filipiak‐PittroffB , LaubereauB , GrublA , WichmannHE , et al. German Infant Nutritional Intervention Study Group. Certain hydrolyzed formulas reduce the incidence of atopic dermatitis but not that of asthma: three‐year results of the German Infant Nutritional Intervention Study. Journal of Allergy and Clinical Immunology2007;119(3):718‐25. [DOI: 10.1016/j.jaci.2006.11.017; PUBMED: 17240440] vonBergA , KoletzkoS , GrublA , Filipiak‐PittroffB , WichmannHE , BauerCP , et al. German Infant Nutritional Intervention Study Group. The effect of hydrolyzed cow's milk formula for allergy prevention in the first year of life: the German Infant Nutritional Intervention Study, a randomized double‐blind trial. Journal of Allergy and Clinical Immunology2003;111(3):533‐40. [PUBMED: 12642834] ">von Berg 2003</a>). A large trial (<a href="./references#CD003664-bbs2-0055" title="KnipM , AkerblomHK , BeckerD , DoschHM , DupreJ , FraserW , et al. TRIGR Study Group. Hydrolyzed infant formula and early beta‐cell autoimmunity: a randomized clinical trial. JAMA2014;311(22):2279‐87. [DOI: 10.1001/jama.2014.5610; PUBMED: 24915259] KnipM , VirtanenSM , BeckerD , DupreJ , KrischerJP , AkerblomHK , TRIGR Study Group. Early feeding and risk of type 1 diabetes: experiences from the Trial to Reduce Insulin‐dependent diabetes mellitus in the Genetically at Risk (TRIGR). American Journal of Clinical Nutrition2011;94(6 Suppl):1814S‐20S. [DOI: 10.3945/ajcn.110.000711; PUBMED: 21653795] KrischerJP . Hydrolyzed infant formula and early beta‐cell autoimmunity. Diabetes2014;63:A7. NCT00179777 . TRIGR ‐ Primary prevention study for Type 1 Diabetes in children at risk [TRIGR ‐ Trial to Reduce IDDM in the Genetically at Risk]. clinicaltrials.gov/show/NCT00179777 (first received 16 September 2005). TRIGR Study Group, AkerblomHK , KrischerJ , VirtanenSM , BersethC , BeckerD , DupreJ , et al. The trial to reduce IDDM in the genetically at risk (TRIGR) study: recruitment, intervention and follow‐up. Diabetologia2011;54(3):627‐33; Erratum in: Diabetologia. 2011;54(8):2210. [DOI: 10.1007/s00125‐010‐1964‐9; NCT00179777; PUBMED: 21153533] Writing Group for the TRIGR Study Group, KnipM , ÅkerblomHK , Al TajiE , BeckerD , BruiningJ , CastanoL , et al. Effect of hydrolyzed infant formula vs conventional formula on risk of Type 1 diabetes: The TRIGR randomized clinical trial. JAMA2018;319(1):38‐48. [DOI: 10.1001/jama.2017.19826; NCT00179777; PUBMED: 29297078] ">Knip 2011</a>) comparing an extensively hydrolysed casein formula to an adapted CMF supplemented with 20% of the casein hydrolysate in infants at risk of type 1 diabetes mellitis was excluded from the review due to excess losses (2997 of 5156 randomised infants not included in analysis = 58%). The study reported no significant difference in adverse events including asthma and other forms of allergic disease at 10 years of age (extensively hydrolysed casein formula 339 / 1081 versus CMF 363 / 1078; RR 0.93, 95% CI 0.82, 1.05). If the <a href="./references#CD003664-bbs2-0055" title="KnipM , AkerblomHK , BeckerD , DoschHM , DupreJ , FraserW , et al. TRIGR Study Group. Hydrolyzed infant formula and early beta‐cell autoimmunity: a randomized clinical trial. JAMA2014;311(22):2279‐87. [DOI: 10.1001/jama.2014.5610; PUBMED: 24915259] KnipM , VirtanenSM , BeckerD , DupreJ , KrischerJP , AkerblomHK , TRIGR Study Group. Early feeding and risk of type 1 diabetes: experiences from the Trial to Reduce Insulin‐dependent diabetes mellitus in the Genetically at Risk (TRIGR). American Journal of Clinical Nutrition2011;94(6 Suppl):1814S‐20S. [DOI: 10.3945/ajcn.110.000711; PUBMED: 21653795] KrischerJP . Hydrolyzed infant formula and early beta‐cell autoimmunity. Diabetes2014;63:A7. NCT00179777 . TRIGR ‐ Primary prevention study for Type 1 Diabetes in children at risk [TRIGR ‐ Trial to Reduce IDDM in the Genetically at Risk]. clinicaltrials.gov/show/NCT00179777 (first received 16 September 2005). TRIGR Study Group, AkerblomHK , KrischerJ , VirtanenSM , BersethC , BeckerD , DupreJ , et al. The trial to reduce IDDM in the genetically at risk (TRIGR) study: recruitment, intervention and follow‐up. Diabetologia2011;54(3):627‐33; Erratum in: Diabetologia. 2011;54(8):2210. [DOI: 10.1007/s00125‐010‐1964‐9; NCT00179777; PUBMED: 21153533] Writing Group for the TRIGR Study Group, KnipM , ÅkerblomHK , Al TajiE , BeckerD , BruiningJ , CastanoL , et al. Effect of hydrolyzed infant formula vs conventional formula on risk of Type 1 diabetes: The TRIGR randomized clinical trial. JAMA2018;319(1):38‐48. [DOI: 10.1001/jama.2017.19826; NCT00179777; PUBMED: 29297078] ">Knip 2011</a> is included in meta‐analysis, the finding of reduced childhood allergic disease incidence is of borderline significance with moderate heterogeneity (typical RR 0.90, 95% CI 0.80 to 1.00; participants = 2590; studies = 2; I<sup>2</sup> = 60%). Additional studies are required to determine if prolonged feeding with an extensively hydrolysed casein formula versus CMF reduces allergic disease in infants at high risk of allergic disease unable to be exclusively breast fed. </p> </section> <section id="CD003664-sec-0132"> <h3 class="title" id="CD003664-sec-0132">Quality of the evidence</h3> <p> <ul id="CD003664-list-0041"> <li> <p>Early short‐term infant feeding: two studies reported the effect of short‐term infant feeding of a hydrolysed formula versus human milk and cow's milk. Both studies (<a href="./references#CD003664-bbs2-0005" title="JuvonenP , ManssonM , AnderssonC , JakobssonI . Allergy development and macromolecular absorption in infants with different feeding regimens during the first three days of life. A three‐year prospective follow‐up. Acta Paediatrica1996;85(9):1047‐52. [PUBMED: 8888916] JuvonenP , ManssonM , JakobssonI . Does early diet have an effect on subsequent macromolecular absorption and serum IgE?. Journal of Pediatric Gastroenterology and Nutrition1994;18(3):344‐9. [PUBMED: 8057219] JuvonenP , ManssonM , KjellmanNI , BjorkstenB , JakobssonI . Development of immunoglobulin G and immunoglobulin E antibodies to cow's milk proteins and ovalbumin after a temporary neonatal exposure to hydrolyzed and whole cow's milk proteins. Pediatric Allergy and Immunology1999;10(3):191‐8. [PUBMED: 10565560] ">Juvonen 1996</a>; <a href="./references#CD003664-bbs2-0012" title="SaarinenKM , Juntunen‐BackmanK , JarvenpaaAL , KlemettiP , KuitunenP , LopeL , et al. Breast‐feeding and the development of cows' milk protein allergy. Advances in Experimental Medicine and Biology2000;478:121‐30. [DOI: 10.1007/0‐306‐46830‐1_10; PUBMED: 11065065] SaarinenKM , Juntunen‐BackmanK , JarvenpaaAL , KuitunenP , LopeL , RenlundM , et al. Supplementary feeding in maternity hospitals and the risk of cow's milk allergy: a prospective study of 6209 infants. Journal of Allergy and Clinical Immunology1999;104(2 Pt 1):457‐61. [PUBMED: 10452771] SaarinenKM , SavilahtiE . Infant feeding patterns affect the subsequent immunological features in cow's milk allergy. Clinical and Experimental Allergy2000;30(3):400‐6. [DOI: 10691899] SaarinenKM , SuomalainenH , SavilahtiE . Diagnostic value of skin‐prick and patch tests and serum eosinophil cationic protein and cow's milk‐specific IgE in infants with cow's milk allergy. Clinical and Experimental Allergy2001;31(3):423‐9. [PUBMED: 11260154] SaarinenKM , VaaralaO , KlemettiP , SavilahtiE . Transforming growth factor‐beta1 in mothers' colostrum and immune responses to cows' milk proteins in infants with cows' milk allergy. Journal of Allergy and Clinical Immunology1999;104(5):1093‐8. [PUBMED: 10550758] SavilahtiE , SaarinenKM . Early infant feeding and type 1 diabetes. European Journal of Nutrition2009;48(4):243‐9. [DOI: 10.1007/s00394‐009‐0008‐z; PUBMED: 19263185] SavilahtiEM , SaarinenKM , SavilahtiE . Specific antibodies to cow's milk proteins in infants: effect of early feeding and diagnosis of cow's milk allergy. European Journal of Nutrition2010;49(8):501‐4. [DOI: 10.1007/s00394‐010‐0109‐8; PUBMED: 20405136] SiltanenM , KajosaariM , PoussaT , SaarinenKM , SavilahtiE . A dual long‐term effect of breastfeeding on atopy in relation to heredity in children at 4 years of age. Allergy2003;58(6):524‐30. [PUBMED: 12757455] ">Saarinen 1999</a>) had substantial methodological concerns (<a href="#CD003664-fig-0003">Figure 3</a>). Analyses of the larger study (<a href="./references#CD003664-bbs2-0012" title="SaarinenKM , Juntunen‐BackmanK , JarvenpaaAL , KlemettiP , KuitunenP , LopeL , et al. Breast‐feeding and the development of cows' milk protein allergy. Advances in Experimental Medicine and Biology2000;478:121‐30. [DOI: 10.1007/0‐306‐46830‐1_10; PUBMED: 11065065] SaarinenKM , Juntunen‐BackmanK , JarvenpaaAL , KuitunenP , LopeL , RenlundM , et al. Supplementary feeding in maternity hospitals and the risk of cow's milk allergy: a prospective study of 6209 infants. Journal of Allergy and Clinical Immunology1999;104(2 Pt 1):457‐61. [PUBMED: 10452771] SaarinenKM , SavilahtiE . Infant feeding patterns affect the subsequent immunological features in cow's milk allergy. Clinical and Experimental Allergy2000;30(3):400‐6. [DOI: 10691899] SaarinenKM , SuomalainenH , SavilahtiE . Diagnostic value of skin‐prick and patch tests and serum eosinophil cationic protein and cow's milk‐specific IgE in infants with cow's milk allergy. Clinical and Experimental Allergy2001;31(3):423‐9. [PUBMED: 11260154] SaarinenKM , VaaralaO , KlemettiP , SavilahtiE . Transforming growth factor‐beta1 in mothers' colostrum and immune responses to cows' milk proteins in infants with cows' milk allergy. Journal of Allergy and Clinical Immunology1999;104(5):1093‐8. [PUBMED: 10550758] SavilahtiE , SaarinenKM . Early infant feeding and type 1 diabetes. European Journal of Nutrition2009;48(4):243‐9. [DOI: 10.1007/s00394‐009‐0008‐z; PUBMED: 19263185] SavilahtiEM , SaarinenKM , SavilahtiE . Specific antibodies to cow's milk proteins in infants: effect of early feeding and diagnosis of cow's milk allergy. European Journal of Nutrition2010;49(8):501‐4. [DOI: 10.1007/s00394‐010‐0109‐8; PUBMED: 20405136] SiltanenM , KajosaariM , PoussaT , SaarinenKM , SavilahtiE . A dual long‐term effect of breastfeeding on atopy in relation to heredity in children at 4 years of age. Allergy2003;58(6):524‐30. [PUBMED: 12757455] ">Saarinen 1999</a>), which enrolled 5317 infants, were restricted to reporting of CMA. The other study of 90 infants (<a href="./references#CD003664-bbs2-0005" title="JuvonenP , ManssonM , AnderssonC , JakobssonI . Allergy development and macromolecular absorption in infants with different feeding regimens during the first three days of life. A three‐year prospective follow‐up. Acta Paediatrica1996;85(9):1047‐52. [PUBMED: 8888916] JuvonenP , ManssonM , JakobssonI . Does early diet have an effect on subsequent macromolecular absorption and serum IgE?. Journal of Pediatric Gastroenterology and Nutrition1994;18(3):344‐9. [PUBMED: 8057219] JuvonenP , ManssonM , KjellmanNI , BjorkstenB , JakobssonI . Development of immunoglobulin G and immunoglobulin E antibodies to cow's milk proteins and ovalbumin after a temporary neonatal exposure to hydrolyzed and whole cow's milk proteins. Pediatric Allergy and Immunology1999;10(3):191‐8. [PUBMED: 10565560] ">Juvonen 1996</a>) was underpowered to detect important differences in other allergic disease outcomes. We downgraded the GRADE quality of evidence for an effect on allergic disease and CMA to 'very low' due to risk of bias, imprecision and potential for reporting or publication bias (<a href="./full#CD003664-tbl-0001">summary of findings Table for the main comparison</a>; <a href="./full#CD003664-tbl-0002">summary of findings Table 2</a>). </p> </li> <li> <p>Prolonged infant feeding with a hydrolysed formula compared with CMF: we downgraded the GRADE quality of evidence for all outcomes due to risk of bias, imprecision and potential for reporting or publication bias for all outcomes (<a href="./full#CD003664-tbl-0003">summary of findings Table 3</a>). We had substantial methodological concerns regarding these studies (see <a href="#CD003664-fig-0002">Figure 2</a>; <a href="#CD003664-fig-0003">Figure 3</a>) and considered none to be at 'low risk' of bias. We had substantial concerns regarding the potential for publication bias or reporting bias in that substantial numbers of studies, including those in high‐risk infants, have not comprehensively reported allergic disease outcomes (see <a href="./references#CD003664-sec-0159" title="">Characteristics of excluded studies</a>). In addition, three studies (<a href="./references#CD003664-bbs2-0045" title="GiovanniniM , AgostoniC , FiocchiA , BelluR , TrojanS , RivaE . Antigen‐reduced infant formulas versus human milk: growth and metabolic parameters in the first 6 months of life. Journal of the American College of Nutrition1994;13(4):357‐63. [PUBMED: 7963141] ">Giovannini 1994</a>; <a href="./references#CD003664-bbs2-0089" title="SorensenRU , InostrozaJ , HebalE , VinetAM , FierroJ . Weaning to a partially hydrolyzed whey formula at three months of age protects against the later development of anti‐cow milk lgE antibodies in comparison to whole cows milk or extensively hydrolyzed whey formulas. Journal of Allergy and Clinical Immunology2007;119(1):S120. ">Sorensen 2007</a>; <a href="./references#CD003664-bbs2-0099" title="WopereisH , SimK , ShawA , MartinR , OozeerR , WarnerJO , et al. The developmental gut microbiota is modulated towards a pattern closer to breastfed infants by a partially hydrolyzed cow's milk formula supplemented with specific prebiotic oligosaccharides. Allergy: European Journal of Allergy and Clinical Immunology2014;69:315. ">Wopereis 2014</a>) enrolling infants at high risk of allergic disease have not reported outcomes to date. All analyses were considered to lack precision, so benefits from use of a hydrolysed formula are not excluded. </p> </li> </ul> </p> </section> <section id="CD003664-sec-0133"> <h3 class="title" id="CD003664-sec-0133">Potential biases in the review process</h3> <p>This review had strict prespecified inclusion criteria that included reporting data only when outcomes for ≥ 80% of allocated infants were noted. Ten studies (<a href="./references#CD003664-bbs2-0024" title="BarberiI , SalpietroDC , CataliotoG , FuliaF . Clinical trial of a new hypoallergenic formula for risk infants. 2nd World Congress of Perinatal Medicine; 1993 Sep 19‐24; Rome (Italy). 1993. ">Barberi 1993</a>; <a href="./references#CD003664-bbs2-0033" title="ChanYH , ShekLP , AwM , QuakSH , LeeBW . Use of hypoallergenic formula in the prevention of atopic disease among Asian children. Journal of Paediatrics and Child Health2002;38(1):84‐8. [PUBMED: 11869407] ">Chan 2002</a>; <a href="./references#CD003664-bbs2-0045" title="GiovanniniM , AgostoniC , FiocchiA , BelluR , TrojanS , RivaE . Antigen‐reduced infant formulas versus human milk: growth and metabolic parameters in the first 6 months of life. Journal of the American College of Nutrition1994;13(4):357‐63. [PUBMED: 7963141] ">Giovannini 1994</a>; <a href="./references#CD003664-bbs2-0046" title='HalkenS , HostA , HansenLG , OsterballeO . Effect of an allergy prevention programme on incidence of atopic symptoms in infancy. A prospective study of 159 "high‐risk" infants. Allergy1992;47(5):545‐53. [PUBMED: 1485660] HalkenS , HostA , HansenLG , OsterballeO . Prevention of allergy in infants. A prospective study of 159 high‐risk children. Ugeskrift for Laeger1994;156(3):308‐12. [PUBMED: 8296423] HalkenS , HostA , HansenLG , OsterballeO . Preventive effect of feeding high‐risk infants a casein hydrolysate formula or an ultrafiltrated whey hydrolysate formula. A prospective, randomized, comparative clinical study. Pediatric Allergy and Immunology1993;4(4):173‐81. [PUBMED: 8298708] '>Halken 1992</a>; <a href="./references#CD003664-bbs2-0066" title="MoranJR . Effects of prolonged exposure to partially hydrolyzed milk protein. Journal of Pediatrics1992;121(5 Pt 2):S90‐4. [PUBMED: 1447640] ">Moran 1992</a>; <a href="./references#CD003664-bbs2-0071" title="OdelramH , VantoT , JacobsenL , KjellmanNI . Whey hydrolysate compared with cow's milk‐based formula for weaning at about 6 months of age in high allergy‐risk infants: effects on atopic disease and sensitization. Allergy1996;51(3):192‐5. [PUBMED: 8781676] ">Odelram 1996</a>; <a href="./references#CD003664-bbs2-0075" title="PorchMC , ShahaneAD , LeivaLE , ElstonRC , SorensenRU . Influence of breast milk, soy or two hydrolyzed formulas on the development of allergic manifestations in infants at risk. Nutrition Research1998;18(8):1413‐24. ">Porch 1998</a>; <a href="./references#CD003664-bbs2-0092" title="SzajewskaH , MrukowiczJZ , StoinskaB , ProchowskaA . Extensively and partially hydrolysed preterm formulas in the prevention of allergic diseases in preterm infants: a randomized, double‐blind trial. Acta Paediatrica2004;93(9):1159‐65. [PUBMED: 15384877] ">Szajewska 2004</a>; <a href="./references#CD003664-bbs2-0097" title="VandenplasY , DeneyerM , SacreL , LoebH . Preliminary data on a field study with a new hypo‐allergenic formula. European Journal of Pediatrics1988;148(3):274‐7. [PUBMED: 3215202] VandenplasY , MalfrootA , DabI . Short‐term prevention of cow's milk protein allergy in infants. Immunology and Allergy Practice1989;11:430‐7. ">Vandenplas 1988</a>; <a href="./references#CD003664-bbs2-0102" title="ZeigerRS , HellerS . Development of nasal basophilic cells and nasal eosinophils from age 4 months through 4 years in children of atopic parents. Journal of Allergy and Clinical Immunology1993;91(3):723‐34. [PUBMED: 8454794] ZeigerRS , HellerS . The development and prediction of atopy in high‐risk children: follow‐up at age seven years in a prospective randomized study of combined maternal and infant food allergen avoidance. Journal of Allergy and Clinical Immunology1995;95(6):1179‐90. [PUBMED: 7797786] ZeigerRS , HellerS , MellonMH , ForsytheAB , O'ConnorRD , HamburgerRN , et al. Effect of combined maternal and infant food‐allergen avoidance on development of atopy in early infancy: a randomized study. Journal of Allergy and Clinical Immunology1989;84:72‐89. ZeigerRS , HellerS , MellonMH , HalseyJF , HamburgerRN , SampsonHA . Genetic and environmental factors affecting the development of atopy through age 4 in children of atopic parents: a prospective randomized study of food allergen avoidance. Pediatric Allergy and Immunology1992;3(3):110‐27. ">Zeiger 1989</a>) had excess losses to follow‐up, so a substantial quantity of data are not included in this review. Losses to follow‐up do not necessarily bias a study. However, when losses do bias a study, it is not possible to predict the direction of effect. The review authors have consistently applied this inclusion criterion through all updates of this review. Although the excess losses criteria is objective and not determined by the estimate of effect from each of the studies, the exclusion of these studies has the potential to bias the review and reduce the power of the review to find an effect. </p> <p>This review includes allergic disease outcomes measured using a variety of methods including physician assessment, interview and questionnaire, with and without additional clinical challenge or testing for sensitisation. This was done as the review's objective was to assess the effect on clinical allergic disease and not sensitisation. Different methods of ascertainment of clinical allergy are likely to have different levels of accuracy and objectivity. </p> <p>This review includes unpublished data to reduce concern regarding publication bias. Not all studies have been reported in peer‐reviewed journals. Some studies were provided as university theses or by formula companies. Only one formula company to date has provided additional studies (Nestle). We excluded two studies after allegations of fraud were made and the authors of these published articles did not respond to requests for data (<a href="./references#CD003664-bbs2-0034" title="ChandraRK , PuriS , HamedA . Influence of maternal diet during lactation and use of formula feeds on development of atopic eczema in high risk infants. BMJ1989;299(6693):228‐30; Erratum in: BMJ 1989;299(6704):896; Retraction in: BMJ 2015; 351(h5682). ">Chandra 1989a</a>; <a href="./references#CD003664-bbs2-0035" title="ChandraRK . Five‐year follow‐up of high‐risk infants with family history of allergy who were exclusively breast‐fed or fed partial whey hydrolysate, soy, and conventional cow's milk formulas. Journal of Pediatric Gastroenterology and Nutrition1997;24(4):380‐8; Expression of concern in: Journal of Pediatric Gastroenterology and Nutrition 2016; 63(2):307. [PUBMED: 9144119] ChandraRK , HamedA . Cumulative incidence of atopic disorders in high risk infants fed whey hydrolysate, soy, and conventional cow milk formulas. Annals of Allergy1991;67(2 Pt 1):129‐32. [PUBMED: 1867449] ChandraRK , SinghG , ShridharaB . Effect of feeding whey hydrolysate, soy and conventional cow milk formulas on incidence of atopic disease in high risk infants. Annals of Allergy1989;63(2):102‐6. [PUBMED: 2669565] ">Chandra 1989b</a>). In addition, a substantial number of studies have failed to report or comprehensively report outcomes. We consider the analyses reported in this review to be at risk of publication bias and/or reporting bias. </p> <p>This review includes studies that use random and quasi‐random methods of participant allocation. See <a href="#CD003664-sec-0132">Quality of the evidence</a>. </p> <p>We obtained data from study authors for several analyses to overcome reporting problems with publications and losses. One study (<a href="./references#CD003664-bbs2-0004" title="HillD . A report on the analysis of the Melbourne Atopy Cohort Study. A study designed to test the effectiveness of different formula types on the development of atopic symptoms and signs on a cohort of atopy‐at‐risk infants. Report at year 2. Nestec Internal Report. HillDJ , SporikR , ThorburnJ , HoskingCS . The association of atopic dermatitis in infancy with immunoglobulin E food sensitization. Journal of Pediatrics2000;137(4):475‐9. [DOI: 10.1067/mpd.2000.108207; PUBMED: 11035824] KoplinJ , DharmageSC , GurrinL , OsborneN , TangML , LoweAJ , et al. Soy consumption is not a risk factor for peanut sensitization. Journal of Allergy and Clinical Immunology2008;121(6):1455‐9. [DOI: 10.1016/j.jaci.2008.03.017; PUBMED: 18436294] LoweA , HoskingC , BennettC , AllenK , CarlinJ , DharmageS , et al. The Melbourne Atopy Cohort Study: a RCT of a partially hydrolysed whey formula for the prevention of allergic disease. Internal Medicine Journal2008;38:A158. LoweAJ , AbramsonMJ , HoskingCS , CarlinJB , BennettCM , DharmageSC , et al. The temporal sequence of allergic sensitization and onset of infantile eczema. Clinical &amp; Experimental Allergy2007;37(4):536‐42; Erratum in: Clinical &amp; Experimental Allergy 2007; 37(12);1895. [DOI: 10.1111/j.1365‐2222.2007.02691.x; PUBMED: 17430350] LoweAJ , CarlinJB , BennettCM , HoskingCS , AllenKJ , RobertsonCF , et al. Paracetamol use in early life and asthma: prospective birth cohort study. BMJ2010;341:c4616. [PUBMED: 20843914] LoweAJ , HoskingCS , BennettCM , AllenKJ , AxelradC , CarlinJB , et al. Effect of a partially hydrolyzed whey infant formula at weaning on risk of allergic disease in high‐risk children: a randomized controlled trial. Journal of Allergy and Clinical Immunology2011;128(2):360‐5.e4. [DOI: 10.1016/j.jaci.2010.05.006; PUBMED: 21696814] StoneyRM , WoodsRK , HoskingCS , HillDJ , AbramsonMJ , ThienFC . Maternal breast milk long‐chain n‐3 fatty acids are associated with increased risk of atopy in breastfed infants. Clinical and Experimental Allergy2004;34(2):194‐200; Erratum in: Clinical &amp; Experimental Allergy 2007; 37(12);1895. [PUBMED: 14987297] ThomsonJA , WidjajaC , DarmaputraAA , LoweA , MathesonMC , BennettCM , et al. Early childhood infections and immunisation and the development of allergic disease in particular asthma in a high‐risk cohort: a prospective study of allergy‐prone children from birth to six years. Pediatric Allergy and Immunology2010;21(7):1076‐85. [DOI: 10.1111/j.1399‐3038.2010.01018.x; PUBMED: 20337970] ">Hill 2000</a>) reported data for infants who were not contemporaneously randomised, and study authors kindly provided data for contemporaneously randomised infants, which the review authors believe overcame our concern regarding selection bias. For a second study (<a href="./references#CD003664-bbs2-0015" title="BergA , KramerU , LinkE , BollrathC , HeinrichJ , BrockowI , et al. GINIplus study group. Impact of early feeding on childhood eczema: development after nutritional intervention compared with the natural course ‐ the GINIplus study up to the age of 6 years. Clinical and Experimental Allergy2010;40(4):627‐36. [DOI: 10.1111/j.1365‐2222.2009.03444.x; PUBMED: 20082618] BrockowI , ZutavernA , HoffmannU , GrublA , vonBergA , KoletzkoS , et al. GINIplus Study Group. Early allergic sensitizations and their relevance to atopic diseases in children aged 6 years: results of the GINI study. Journal of Investigational Allergology &amp; Clinical Immunology2009;19(3):180‐7. [DOI: 19610260] LaubereauB , BrockowI , ZirngiblA , KoletzkoS , GrueblA , vonBergA , et al. GINI Study Group. Effect of breast‐feeding on the development of atopic dermatitis during the first 3 years of life ‐ results from the GINI‐birth cohort study. Journal of Pediatrics2004;144(5):602‐7. [DOI: 10.1016/j.jpeds.2003.12.029; PUBMED: 15126993] LaubereauB , Filipiak‐PittroffB , vonBergA , GrublA , ReinhardtD , WichmannHE , et al. Caesarean section and gastrointestinal symptoms, atopic dermatitis, and sensitisation during the first year of life. Archives of Disease in Childhood2004;89(11):993‐7. [DOI: 10.1136/adc.2003.043265; PUBMED: 15499049] RzehakP , SausenthalerS , KoletzkoS , BauerCP , SchaafB , vonBergA , et al. Period‐specific growth, overweight and modification by breastfeeding in the GINI and LISA birth cohorts up to age 6 years. European Journal of Epidemiology2009;24(8):449‐67. [DOI: 10.1007/s10654‐009‐9356‐5; PUBMED: 19521784] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. GINI‐plus Study Group. Long‐term effects of hydrolyzed protein infant formulas on growth ‐ extended follow‐up to 10 y of age: results from the German Infant Nutritional Intervention (GINI) study. American Journal of Clinical Nutrition2011;94(6 Suppl):1803S‐7S. [DOI: 10.3945/ajcn.110.000679; PUBMED: 21849601] RzehakP , SausenthalerS , KoletzkoS , ReinhardtD , vonBergA , KramerU , et al. German Infant Nutritional Intervention Study Group. Short‐ and long‐term effects of feeding hydrolyzed protein infant formulas on growth at &lt; or = 6 y of age: results from the German Infant Nutritional Intervention Study. American Journal of Clinical Nutrition2009;89(6):1846‐56. [DOI: 10.3945/ajcn.2008.27373; PUBMED: 19369380] SausenthalerS , KoletzkoS , KoletzkoB , ReinhardtD , KramerU , vonBergA , et al. GINIplus study group. Effect of hydrolysed formula feeding on taste preferences at 10 years. Data from the German Infant Nutritional Intervention Program Plus Study. Clinical Nutrition2010;29(3):304‐6. [DOI: 10.1016/j.clnu.2010.01.007; PUBMED: 20110140] SchoetzauA , Filipiak‐PittroffB , FrankeK , KoletzkoS , VonBergA , GrueblA , et al. German Infant Nutritional Intervention Study Group. Effect of exclusive breast‐feeding and early solid food avoidance on the incidence of atopic dermatitis in high‐risk infants at 1 year of age. Pediatric Allergy and Immunology2002;13(4):234‐42. [PUBMED: 12390439] SchoetzauA , GehringU , FrankeK , GrublA , KoletzkoS , vonBergA , et al. Gini Study Group. Maternal compliance with nutritional recommendations in an allergy preventive programme. Archives of Disease in Childhood2002;86(3):180‐4. [PUBMED: 11861235] VonBergA , Filipiak‐PittroffB , KrämerU , LinkE , HeinrichJ , KoletzkoS , et al. The German Infant Nutritional Intervention Study (GINI) for the preventive effect of hydrolysed infant formulas in infants at high risk for allergic diseases. Design and selected results. Allergologie2012;35(1):32‐43. VonBergA , Filipiak‐PittroffB , SchulzH , HoffmannU , LinkE , SussmannM , et al. GINIplus study group. Allergic manifestation 15 years after early intervention with hydrolyzed formulas ‐ the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2016;71(2):210‐9. [DOI: 10.1111/all.12790; PUBMED: 26465137] vonBergA , FilipiakB , KoletzkoS , KrämerU , HoffmannB , LinkE , et al. Long‐term effect of cow milk protein hydrolysates in high‐risk children. Results from the 10‐years follow‐up of the GINI study. Allergy: European Journal of Allergy and Clinical Immunology2013;68:295‐6. vonBergA , Filipiak‐PittroffB , KramerU , HoffmannB , LinkE , BeckmannC , et al. GINIplus study group. Allergies in high‐risk schoolchildren after early intervention with cow's milk protein hydrolysates: 10‐year results from the German Infant Nutritional Intervention (GINI) study. Journal of Allergy and Clinical Immunology2013;131(6):1565‐73. [DOI: 10.1016/j.jaci.2013.01.006; PUBMED: 23506844] vonBergA , Filipiak‐PittroffB , KramerU , LinkE , BollrathC , BrockowI , et al. GINIplus study group. Preventive effect of hydrolyzed infant formulas persists until age 6 years: long‐term results from the German Infant Nutritional Intervention Study (GINI). Journal of Allergy and Clinical Immunology2008;121(6):1442‐7. [DOI: 10.1016/j.jaci.2008.04.021; PUBMED: 18539195] vonBergA , KoletzkoS , Filipiak‐PittroffB , LaubereauB , GrublA , WichmannHE , et al. German Infant Nutritional Intervention Study Group. Certain hydrolyzed formulas reduce the incidence of atopic dermatitis but not that of asthma: three‐year results of the German Infant Nutritional Intervention Study. Journal of Allergy and Clinical Immunology2007;119(3):718‐25. [DOI: 10.1016/j.jaci.2006.11.017; PUBMED: 17240440] vonBergA , KoletzkoS , GrublA , Filipiak‐PittroffB , WichmannHE , BauerCP , et al. German Infant Nutritional Intervention Study Group. The effect of hydrolyzed cow's milk formula for allergy prevention in the first year of life: the German Infant Nutritional Intervention Study, a randomized double‐blind trial. Journal of Allergy and Clinical Immunology2003;111(3):533‐40. [PUBMED: 12642834] ">von Berg 2003</a>) that published outcomes to 15 years, to overcome problems related to excess losses, study authors kindly provided additional data from one centre (Wessel) that reported an intention‐to‐treat analysis up to three years with &lt; 20% losses; we have included these data in this review. Losses to follow‐up after three years were excessive (&gt; 20%), so we have excluded from this review follow‐up data from this study beyond three years. </p> </section> <section id="CD003664-sec-0134"> <h3 class="title" id="CD003664-sec-0134">Agreements and disagreements with other studies or reviews</h3> <p>The European Academy of Allergy and Clinical Immunology (EAACI) has published systematic reviews and guidelines for primary prevention of food allergy and anaphylaxis (<a href="./references#CD003664-bbs2-0124" title="deSilvaD , GeromiM , HalkenS , HostA , PanesarSS , MuraroA , et al. EAACI Food Allergy and Anaphylaxis Guidelines Group. Primary prevention of food allergy in children and adults: systematic review. Allergy2014;69(5):581‐9. [DOI: 10.1111/all.12334; PUBMED: 24433563] ">de Silva 2014</a>; <a href="./references#CD003664-bbs2-0144" title="MuraroA , HalkenS , ArshadSH , BeyerK , DuboisAE , Du ToitG , et al. EAACI Food Allergy and Anaphylaxis Guidelines Group. EAACI food allergy and anaphylaxis guidelines. Primary prevention of food allergy. Allergy2014;69(5):590‐601. ">Muraro 2014</a>). For prevention of food allergy, two systematic reviews and four randomised trials found benefit from extensively hydrolysed whey or casein formula, although one study found no benefit. Two systematic reviews, two randomised trials and two non‐randomised comparisons noted benefit when partially hydrolysed formula was compared with CMF. One randomised trial and one non‐randomised study found no effect (<a href="./references#CD003664-bbs2-0124" title="deSilvaD , GeromiM , HalkenS , HostA , PanesarSS , MuraroA , et al. EAACI Food Allergy and Anaphylaxis Guidelines Group. Primary prevention of food allergy in children and adults: systematic review. Allergy2014;69(5):581‐9. [DOI: 10.1111/all.12334; PUBMED: 24433563] ">de Silva 2014</a>). </p> <p>Recommendations that have been provided for primary prevention of food allergy include the following. </p> <p>"Recommendations for all infants:</p> <p> <ul id="CD003664-list-0042"> <li> <p>no special diet during pregnancy or for the lactating mother;</p> </li> <li> <p>exclusive breast feeding for four to six months.</p> </li> </ul> </p> <p>Further recommendations for high‐risk infants:</p> <p> <ul id="CD003664-list-0043"> <li> <p>if supplement is needed during the first four months, a documented hypoallergenic formula is recommended. </p> </li> </ul> </p> <p>Introduction of complementary foods after the age of four months according to normal standard weaning practices and nutrition recommendations, for all children irrespective of atopic heredity" (<a href="./references#CD003664-bbs2-0144" title="MuraroA , HalkenS , ArshadSH , BeyerK , DuboisAE , Du ToitG , et al. EAACI Food Allergy and Anaphylaxis Guidelines Group. EAACI food allergy and anaphylaxis guidelines. Primary prevention of food allergy. Allergy2014;69(5):590‐601. ">Muraro 2014</a>). </p> <p>Five published systematic reviews have examined hydrolysed formula for prevention of allergic disease (<a href="./references#CD003664-bbs2-0110" title="AlexanderDD , CabanaMD . Partially hydrolyzed 100% whey protein infant formula and reduced risk of atopic dermatitis: a meta‐analysis. Journal of Pediatric Gastroenterology and Nutrition2010;50(4):422‐30. [DOI: 10.1097/MPG.0b013e3181cea52b; PUBMED: 20216095] ">Alexander 2010</a>; <a href="./references#CD003664-bbs2-0117" title="BoyleRJ , IerodiakonouD , KhanT , ChivingeJ , RobinsonZ , GeogheganN , et al. Hydrolysed formula and risk of allergic or autoimmune disease: systematic review and meta‐analysis. BMJ2016;352:i974. [PUBMED: 26956579] ">Boyle 2016a</a>; <a href="./references#CD003664-bbs2-0124" title="deSilvaD , GeromiM , HalkenS , HostA , PanesarSS , MuraroA , et al. EAACI Food Allergy and Anaphylaxis Guidelines Group. Primary prevention of food allergy in children and adults: systematic review. Allergy2014;69(5):581‐9. [DOI: 10.1111/all.12334; PUBMED: 24433563] ">de Silva 2014</a>; <a href="./references#CD003664-bbs2-0134" title="IskedjianM , SzajewskaH , SpieldennerJ , FarahB , BerbariJ . Meta‐analysis of a partially hydrolysed 100%‐whey infant formula vs. extensively hydrolysed infant formulas in the prevention of atopic dermatitis. Current Medical Research and Opinion2010;26(11):2599‐606. [DOI: 10.1185/03007995.2010.525475; PUBMED: 20925453] ">Iskedjian 2010</a>; <a href="./references#CD003664-bbs2-0162" title="SzajewskaH , HorvathA . Meta‐analysis of the evidence for a partially hydrolyzed 100% whey formula for the prevention of allergic diseases. Current Medical Research and Opinion2010;26:423‐37. ">Szajewska 2010</a>). Only the report of <a href="./references#CD003664-bbs2-0117" title="BoyleRJ , IerodiakonouD , KhanT , ChivingeJ , RobinsonZ , GeogheganN , et al. Hydrolysed formula and risk of allergic or autoimmune disease: systematic review and meta‐analysis. BMJ2016;352:i974. [PUBMED: 26956579] ">Boyle 2016a</a> had no potential conflicts of interest. A systematic review (<a href="./references#CD003664-bbs2-0110" title="AlexanderDD , CabanaMD . Partially hydrolyzed 100% whey protein infant formula and reduced risk of atopic dermatitis: a meta‐analysis. Journal of Pediatric Gastroenterology and Nutrition2010;50(4):422‐30. [DOI: 10.1097/MPG.0b013e3181cea52b; PUBMED: 20216095] ">Alexander 2010</a>) studied 100% whey protein partially hydrolysed formula (PHF‐W) compared with intact protein CMF in healthy infants. A meta‐analysis revealed a reduction in atopic dermatitis (11 studies; typical RR 0.56, 95% CI 0.40 to 0.76). A published funnel plot appears asymmetrical, suggesting lack of small negative studies. Meta‐analysis limited to 'top‐tier studies' showed a similar reduction in atopic dermatitis (four studies; typical RR 0.45, 95% CI 0.30 to 0.70). Review authors concluded, .."exclusive breast‐feeding should be encouraged as the standard for infant nutrition in the first months of life. For infants who are not exclusively breast‐fed, feeding with PHF‐W instead of CMF reduces the risk of AD in infants, particularly in infants with a family history of allergic disease." This work was partially funded by Nestle. </p> <p>A recent systematic review (<a href="./references#CD003664-bbs2-0117" title="BoyleRJ , IerodiakonouD , KhanT , ChivingeJ , RobinsonZ , GeogheganN , et al. Hydrolysed formula and risk of allergic or autoimmune disease: systematic review and meta‐analysis. BMJ2016;352:i974. [PUBMED: 26956579] ">Boyle 2016a</a>) found 37 eligible trials of hydrolysed formula including more than 19,000 participants. Review authors found evidence of conflict of interest and high or unclear risk of bias in most studies of allergic outcomes and evidence of publication bias in studies of eczema and wheeze. Overall, no consistent evidence indicated that PHFs or EHFs reduce the risk of allergic or autoimmune outcomes among infants at high pre‐existing risk for these outcomes. Odds ratios for eczema from birth to four years of age were 0.84 (95% CI 0.67 to 1.07) for PHF; 0.55 (95% CI 0.28 to 1.09) for extensively hydrolysed casein‐based formula; and 1.12 (95% CI 0.88 to 1.42) for extensively hydrolysed whey‐based formula compared with CMF. Review authors concluded that findings do not support current guidelines recommending the use of hydrolysed formula to prevent allergic disease in high‐risk infants. Methodologically, the <a href="./references#CD003664-bbs2-0117" title="BoyleRJ , IerodiakonouD , KhanT , ChivingeJ , RobinsonZ , GeogheganN , et al. Hydrolysed formula and risk of allergic or autoimmune disease: systematic review and meta‐analysis. BMJ2016;352:i974. [PUBMED: 26956579] ">Boyle 2016a</a> review differs from this review in that it included studies with &gt; 20% loss to follow‐up and reported infant allergic disease assessed up to four years of age. </p> <p>Another systematic review (<a href="./references#CD003664-bbs2-0124" title="deSilvaD , GeromiM , HalkenS , HostA , PanesarSS , MuraroA , et al. EAACI Food Allergy and Anaphylaxis Guidelines Group. Primary prevention of food allergy in children and adults: systematic review. Allergy2014;69(5):581‐9. [DOI: 10.1111/all.12334; PUBMED: 24433563] ">de Silva 2014</a>) reported mixed findings regarding the preventive benefits of breast feeding for infants at high or normal risk, but evidence suggested that recommendations should include avoiding cow's milk and substituting extensively or partially hydrolysed whey or casein formulas for infants at high risk for the first four months. </p> <p>Another systematic review (<a href="./references#CD003664-bbs2-0162" title="SzajewskaH , HorvathA . Meta‐analysis of the evidence for a partially hydrolyzed 100% whey formula for the prevention of allergic diseases. Current Medical Research and Opinion2010;26:423‐37. ">Szajewska 2010</a>) assessed the effect of using a partially hydrolysed 100% whey formula (pHF) in reducing risk of allergic disease among healthy infants at high risk for allergic disease. The summary of findings reports that "meta‐analysis showed that pHF compared to SF (standard formula) reduced the risk of all allergic diseases, particularly atopic dermatitis/eczema, at some time points among children at high risk for allergic disease. Limited data suggest that the use of pHF compared with SF reduced the risk of gastrointestinal symptoms and food allergy. The pooled results did not provide evidence of a difference in the effect of pHF versus SF on the incidence of either wheezing/asthma or rhinitis. Few significant differences in outcomes were found between children who received pHF versus an extensively hydrolyzed whey formula. No significant differences in outcomes were found between children who received pHF versus an extensively hydrolyzed casein formula. These results should be interpreted with caution due to a lack of methodological rigor in many trials." A grant from Nestle Nutrition Institute supported this review. </p> <p>Another review (<a href="./references#CD003664-bbs2-0134" title="IskedjianM , SzajewskaH , SpieldennerJ , FarahB , BerbariJ . Meta‐analysis of a partially hydrolysed 100%‐whey infant formula vs. extensively hydrolysed infant formulas in the prevention of atopic dermatitis. Current Medical Research and Opinion2010;26(11):2599‐606. [DOI: 10.1185/03007995.2010.525475; PUBMED: 20925453] ">Iskedjian 2010</a>) compared a partially hydrolysed 100% whey‐based infant formula (PHF‐W) versus extensively hydrolysed whey‐ (EHF‐Whey) or casein‐based (EHF‐Casein) infant formula for prevention of atopic dermatitis (AD) among infants who cannot be breast fed exclusively. Meta‐analysis revealed no difference in AD when PHF‐W was compared with EHF‐Whey (typical RR 0.75, 95% CI 0.54 to 1.05 at 0 to 12 months; and typical RR 0.80, 95% CI 0.63 to 1.02 at 0 to 36 months); and no difference when PHF‐W was compared with EHF‐Casein (typical RR 1.06, 95% CI 0.74 to 1.53 at 0 to 12 months; and typical RR 1.13, 95% CI 0.87 to 1.47 at 0 to 36 months). Review authors concluded that the efficacy of PHF‐W falls within the range of efficacy of both EHF formulas (whey and casein). The Nestle Nutrition Institute supported this review. </p> <p>In a report (<a href="./references#CD003664-bbs2-0120" title="ChungCS , YaminiS , TrumboPR . FDA's health claim review: whey‐protein partially hydrolyzed infant formula and atopic dermatitis. Pediatrics2012;130(2):e408‐14. [DOI: 10.1542/peds.2012‐0333; PUBMED: 22778306] ">Chung 2012</a>) on the FDA Health Claim Review on whey‐protein partially hydrolysed infant formula and atopic dermatitis, "the FDA evaluated human intervention studies that evaluated the role of W‐PHF in reducing the risk of AD. The FDA concluded there is little to very little evidence, respectively, to support a qualified health claim concerning the relationship between intake of W‐PHF and a reduced risk of AD in partially breast fed and exclusively formula‐fed infants throughout the first year after birth and up to 3 years of age. In addition, the FDA required a warning statement be displayed along with the health claim to indicate to consumers that partially hydrolyzed infant formulas are not hypoallergenic and should not be fed to infants who are allergic to milk or to infants with existing milk allergy symptoms." </p> <section id="CD003664-sec-0135"> <h4 class="title">Evidence from this review for hydrolysed formula versus CMF</h4> <p>This systematic review found prolonged feeding with a hydrolysed formula compared with a CMF was not associated with any differences in infant or childhood allergic disease, asthma, eczema or rhinitis, or infant food allergy or CMA. The GRADE quality of evidence was downgraded due to risk of bias, imprecision, and risk of reporting or publication bias. However, a subgroup analysis of infants exclusively formula fed found a reduction in infant allergic disease (typical RR 0.61, 95% CI 0.46 to 0.80; participants = 425; studies = 5; I<sup>2</sup> = 0%; typical RD ‐0.16, 95% CI ‐0.25, ‐0.08; NNTB 6, 95% CI 4, 12.5), but no differences in infant or childhood asthma or eczema, or childhood rhinitis. </p> </section> <section id="CD003664-sec-0136"> <h4 class="title">Evidence from this review for PHF versus CMF</h4> <p>This systematic review found prolonged feeding with a PHF versus a CMF was not associated with any differences in infant or childhood allergic disease, asthma, eczema or rhinitis; or infant food allergy or CMA. </p> </section> <section id="CD003664-sec-0137"> <h4 class="title">Evidence from this review for EHF versus PHF</h4> <p>This systematic review found prolonged feeding with an EHF versus a CMF was not associated with any differences in infant or childhood allergic disease, asthma, eczema or rhinitis; or infant food allergy. This systematic review found prolonged feeding with an EHF versus a PHF was not associated with any differences in infant or childhood allergic disease, asthma, eczema or rhinitis; or infant CMA or infant urticaria. Prolonged feeding with an EHF versus a PHF was associated with a reduction in infant food allergy (typical RR 0.43, 95% CI 0.19 to 0.99; participants = 341; studies = 2; I<sup>2</sup> = 0%; typical RD ‐0.06, 95% CI ‐0.11, ‐0.00). </p> </section> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD003664-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/urn:x-wiley:14651858:media:CD003664:CD003664-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_t/tCD003664-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram: review update." data-id="CD003664-fig-0001" src="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram: review update.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/full#CD003664-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003664-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/urn:x-wiley:14651858:media:CD003664:CD003664-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_t/tCD003664-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD003664-fig-0002" src="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/full#CD003664-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003664-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/urn:x-wiley:14651858:media:CD003664:CD003664-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_t/tCD003664-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study." data-id="CD003664-fig-0003" src="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/full#CD003664-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003664-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/urn:x-wiley:14651858:media:CD003664:CD003664-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_t/tCD003664-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 4 Prolonged feeding: hydrolysed formula versus cow's milk formula, outcome: 4.1 All allergic disease." data-id="CD003664-fig-0004" src="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Funnel plot of comparison: 4 Prolonged feeding: hydrolysed formula versus cow's milk formula, outcome: 4.1 All allergic disease. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/full#CD003664-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003664-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/urn:x-wiley:14651858:media:CD003664:CD003664-AFig-FIG05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_t/tCD003664-AFig-FIG05.png" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 4 Prolonged feeding: hydrolysed formula versus cow's milk formula, outcome: 4.3 Eczema." data-id="CD003664-fig-0005" src="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-AFig-FIG05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Funnel plot of comparison: 4 Prolonged feeding: hydrolysed formula versus cow's milk formula, outcome: 4.3 Eczema. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/full#CD003664-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-AFig-FIG05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003664-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/urn:x-wiley:14651858:media:CD003664:CD003664-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_t/tCD003664-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Early short‐term feeding: hydrolysed formula versus human milk feeding ‐ low‐risk infants, Outcome 1 All allergic disease." data-id="CD003664-fig-0006" src="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Early short‐term feeding: hydrolysed formula versus human milk feeding ‐ low‐risk infants, Outcome 1 All allergic disease. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/references#CD003664-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003664-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/urn:x-wiley:14651858:media:CD003664:CD003664-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_t/tCD003664-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Early short‐term feeding: hydrolysed formula versus human milk feeding ‐ low‐risk infants, Outcome 2 Asthma." data-id="CD003664-fig-0007" src="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Early short‐term feeding: hydrolysed formula versus human milk feeding ‐ low‐risk infants, Outcome 2 Asthma. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/references#CD003664-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003664-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/urn:x-wiley:14651858:media:CD003664:CD003664-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_t/tCD003664-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Early short‐term feeding: hydrolysed formula versus human milk feeding ‐ low‐risk infants, Outcome 3 Eczema." data-id="CD003664-fig-0008" src="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Early short‐term feeding: hydrolysed formula versus human milk feeding ‐ low‐risk infants, Outcome 3 Eczema. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/references#CD003664-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003664-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/urn:x-wiley:14651858:media:CD003664:CD003664-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_t/tCD003664-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Early short‐term feeding: hydrolysed formula versus human milk feeding ‐ low‐risk infants, Outcome 4 Food allergy." data-id="CD003664-fig-0009" src="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Early short‐term feeding: hydrolysed formula versus human milk feeding ‐ low‐risk infants, Outcome 4 Food allergy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/references#CD003664-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003664-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/urn:x-wiley:14651858:media:CD003664:CD003664-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_t/tCD003664-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Early short‐term feeding: hydrolysed formula versus human milk feeding ‐ low‐risk infants, Outcome 5 Cow's milk allergy." data-id="CD003664-fig-0010" src="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Early short‐term feeding: hydrolysed formula versus human milk feeding ‐ low‐risk infants, Outcome 5 Cow's milk allergy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/references#CD003664-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003664-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/urn:x-wiley:14651858:media:CD003664:CD003664-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_t/tCD003664-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Early short‐term feeding: hydrolysed formula versus cow's milk formula ‐ low‐risk infants, Outcome 1 All allergic disease." data-id="CD003664-fig-0011" src="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Early short‐term feeding: hydrolysed formula versus cow's milk formula ‐ low‐risk infants, Outcome 1 All allergic disease. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/references#CD003664-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003664-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/urn:x-wiley:14651858:media:CD003664:CD003664-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_t/tCD003664-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Early short‐term feeding: hydrolysed formula versus cow's milk formula ‐ low‐risk infants, Outcome 2 Asthma." data-id="CD003664-fig-0012" src="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Early short‐term feeding: hydrolysed formula versus cow's milk formula ‐ low‐risk infants, Outcome 2 Asthma. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/references#CD003664-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003664-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/urn:x-wiley:14651858:media:CD003664:CD003664-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_t/tCD003664-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Early short‐term feeding: hydrolysed formula versus cow's milk formula ‐ low‐risk infants, Outcome 3 Eczema." data-id="CD003664-fig-0013" src="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Early short‐term feeding: hydrolysed formula versus cow's milk formula ‐ low‐risk infants, Outcome 3 Eczema. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/references#CD003664-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003664-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/urn:x-wiley:14651858:media:CD003664:CD003664-CMP-002-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_t/tCD003664-CMP-002-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Early short‐term feeding: hydrolysed formula versus cow's milk formula ‐ low‐risk infants, Outcome 4 Food allergy." data-id="CD003664-fig-0014" src="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-002-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2 Early short‐term feeding: hydrolysed formula versus cow's milk formula ‐ low‐risk infants, Outcome 4 Food allergy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/references#CD003664-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-002-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003664-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/urn:x-wiley:14651858:media:CD003664:CD003664-CMP-002-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_t/tCD003664-CMP-002-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Early short‐term feeding: hydrolysed formula versus cow's milk formula ‐ low‐risk infants, Outcome 5 Cow's milk allergy." data-id="CD003664-fig-0015" src="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-002-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2 Early short‐term feeding: hydrolysed formula versus cow's milk formula ‐ low‐risk infants, Outcome 5 Cow's milk allergy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/references#CD003664-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-002-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003664-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/urn:x-wiley:14651858:media:CD003664:CD003664-CMP-004-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_t/tCD003664-CMP-004-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Prolonged feeding: hydrolysed formula versus cow's milk formula, Outcome 1 All allergic disease." data-id="CD003664-fig-0016" src="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-004-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 Prolonged feeding: hydrolysed formula versus cow's milk formula, Outcome 1 All allergic disease. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/references#CD003664-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-004-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003664-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/urn:x-wiley:14651858:media:CD003664:CD003664-CMP-004-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_t/tCD003664-CMP-004-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Prolonged feeding: hydrolysed formula versus cow's milk formula, Outcome 2 Asthma." data-id="CD003664-fig-0017" src="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-004-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4 Prolonged feeding: hydrolysed formula versus cow's milk formula, Outcome 2 Asthma. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/references#CD003664-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-004-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003664-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/urn:x-wiley:14651858:media:CD003664:CD003664-CMP-004-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_t/tCD003664-CMP-004-03.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Prolonged feeding: hydrolysed formula versus cow's milk formula, Outcome 3 Eczema." data-id="CD003664-fig-0018" src="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-004-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.3</div> <div class="figure-caption"> <p>Comparison 4 Prolonged feeding: hydrolysed formula versus cow's milk formula, Outcome 3 Eczema. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/references#CD003664-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-004-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003664-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/urn:x-wiley:14651858:media:CD003664:CD003664-CMP-004-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_t/tCD003664-CMP-004-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Prolonged feeding: hydrolysed formula versus cow's milk formula, Outcome 4 Rhinitis." data-id="CD003664-fig-0019" src="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-004-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.4</div> <div class="figure-caption"> <p>Comparison 4 Prolonged feeding: hydrolysed formula versus cow's milk formula, Outcome 4 Rhinitis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/references#CD003664-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-004-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003664-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/urn:x-wiley:14651858:media:CD003664:CD003664-CMP-004-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_t/tCD003664-CMP-004-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Prolonged feeding: hydrolysed formula versus cow's milk formula, Outcome 5 Food allergy." data-id="CD003664-fig-0020" src="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-004-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.5</div> <div class="figure-caption"> <p>Comparison 4 Prolonged feeding: hydrolysed formula versus cow's milk formula, Outcome 5 Food allergy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/references#CD003664-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-004-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003664-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/urn:x-wiley:14651858:media:CD003664:CD003664-CMP-004-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_t/tCD003664-CMP-004-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Prolonged feeding: hydrolysed formula versus cow's milk formula, Outcome 6 Cow's milk allergy." data-id="CD003664-fig-0021" src="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-004-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.6</div> <div class="figure-caption"> <p>Comparison 4 Prolonged feeding: hydrolysed formula versus cow's milk formula, Outcome 6 Cow's milk allergy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/references#CD003664-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-004-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003664-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/urn:x-wiley:14651858:media:CD003664:CD003664-CMP-005-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_t/tCD003664-CMP-005-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Prolonged feeding: hydrolysed formula versus cow's milk formula ‐ low‐risk infants, Outcome 1 All allergic disease." data-id="CD003664-fig-0022" src="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-005-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5 Prolonged feeding: hydrolysed formula versus cow's milk formula ‐ low‐risk infants, Outcome 1 All allergic disease. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/references#CD003664-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-005-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003664-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/urn:x-wiley:14651858:media:CD003664:CD003664-CMP-005-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_t/tCD003664-CMP-005-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Prolonged feeding: hydrolysed formula versus cow's milk formula ‐ low‐risk infants, Outcome 2 Asthma." data-id="CD003664-fig-0023" src="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-005-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.2</div> <div class="figure-caption"> <p>Comparison 5 Prolonged feeding: hydrolysed formula versus cow's milk formula ‐ low‐risk infants, Outcome 2 Asthma. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/references#CD003664-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-005-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003664-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/urn:x-wiley:14651858:media:CD003664:CD003664-CMP-005-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_t/tCD003664-CMP-005-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Prolonged feeding: hydrolysed formula versus cow's milk formula ‐ low‐risk infants, Outcome 3 Eczema." data-id="CD003664-fig-0024" src="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-005-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.3</div> <div class="figure-caption"> <p>Comparison 5 Prolonged feeding: hydrolysed formula versus cow's milk formula ‐ low‐risk infants, Outcome 3 Eczema. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/references#CD003664-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-005-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003664-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/urn:x-wiley:14651858:media:CD003664:CD003664-CMP-005-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_t/tCD003664-CMP-005-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Prolonged feeding: hydrolysed formula versus cow's milk formula ‐ low‐risk infants, Outcome 4 Rhinitis." data-id="CD003664-fig-0025" src="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-005-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.4</div> <div class="figure-caption"> <p>Comparison 5 Prolonged feeding: hydrolysed formula versus cow's milk formula ‐ low‐risk infants, Outcome 4 Rhinitis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/references#CD003664-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-005-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003664-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/urn:x-wiley:14651858:media:CD003664:CD003664-CMP-006-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_t/tCD003664-CMP-006-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Prolonged feeding: hydrolysed formula versus cow's milk formula ‐ high‐risk infants, Outcome 1 All allergic disease." data-id="CD003664-fig-0026" src="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-006-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.1</div> <div class="figure-caption"> <p>Comparison 6 Prolonged feeding: hydrolysed formula versus cow's milk formula ‐ high‐risk infants, Outcome 1 All allergic disease. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/references#CD003664-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-006-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003664-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/urn:x-wiley:14651858:media:CD003664:CD003664-CMP-006-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_t/tCD003664-CMP-006-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Prolonged feeding: hydrolysed formula versus cow's milk formula ‐ high‐risk infants, Outcome 2 Asthma." data-id="CD003664-fig-0027" src="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-006-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.2</div> <div class="figure-caption"> <p>Comparison 6 Prolonged feeding: hydrolysed formula versus cow's milk formula ‐ high‐risk infants, Outcome 2 Asthma. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/references#CD003664-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-006-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003664-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/urn:x-wiley:14651858:media:CD003664:CD003664-CMP-006-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_t/tCD003664-CMP-006-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Prolonged feeding: hydrolysed formula versus cow's milk formula ‐ high‐risk infants, Outcome 3 Eczema." data-id="CD003664-fig-0028" src="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-006-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.3</div> <div class="figure-caption"> <p>Comparison 6 Prolonged feeding: hydrolysed formula versus cow's milk formula ‐ high‐risk infants, Outcome 3 Eczema. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/references#CD003664-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-006-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003664-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/urn:x-wiley:14651858:media:CD003664:CD003664-CMP-006-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_t/tCD003664-CMP-006-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Prolonged feeding: hydrolysed formula versus cow's milk formula ‐ high‐risk infants, Outcome 4 Rhinitis." data-id="CD003664-fig-0029" src="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-006-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.4</div> <div class="figure-caption"> <p>Comparison 6 Prolonged feeding: hydrolysed formula versus cow's milk formula ‐ high‐risk infants, Outcome 4 Rhinitis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/references#CD003664-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-006-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003664-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/urn:x-wiley:14651858:media:CD003664:CD003664-CMP-006-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_t/tCD003664-CMP-006-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Prolonged feeding: hydrolysed formula versus cow's milk formula ‐ high‐risk infants, Outcome 5 Food allergy." data-id="CD003664-fig-0030" src="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-006-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.5</div> <div class="figure-caption"> <p>Comparison 6 Prolonged feeding: hydrolysed formula versus cow's milk formula ‐ high‐risk infants, Outcome 5 Food allergy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/references#CD003664-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-006-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003664-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/urn:x-wiley:14651858:media:CD003664:CD003664-CMP-006-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_t/tCD003664-CMP-006-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Prolonged feeding: hydrolysed formula versus cow's milk formula ‐ high‐risk infants, Outcome 6 Cow's milk allergy." data-id="CD003664-fig-0031" src="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-006-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.6</div> <div class="figure-caption"> <p>Comparison 6 Prolonged feeding: hydrolysed formula versus cow's milk formula ‐ high‐risk infants, Outcome 6 Cow's milk allergy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/references#CD003664-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-006-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003664-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/urn:x-wiley:14651858:media:CD003664:CD003664-CMP-007-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_t/tCD003664-CMP-007-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Prolonged feeding: partially hydrolysed formula versus cow's milk formula, Outcome 1 All allergic disease." data-id="CD003664-fig-0032" src="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-007-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.1</div> <div class="figure-caption"> <p>Comparison 7 Prolonged feeding: partially hydrolysed formula versus cow's milk formula, Outcome 1 All allergic disease. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/references#CD003664-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-007-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003664-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/urn:x-wiley:14651858:media:CD003664:CD003664-CMP-007-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_t/tCD003664-CMP-007-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Prolonged feeding: partially hydrolysed formula versus cow's milk formula, Outcome 2 Asthma." data-id="CD003664-fig-0033" src="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-007-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.2</div> <div class="figure-caption"> <p>Comparison 7 Prolonged feeding: partially hydrolysed formula versus cow's milk formula, Outcome 2 Asthma. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/references#CD003664-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-007-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003664-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/urn:x-wiley:14651858:media:CD003664:CD003664-CMP-007-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_t/tCD003664-CMP-007-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Prolonged feeding: partially hydrolysed formula versus cow's milk formula, Outcome 3 Eczema." data-id="CD003664-fig-0034" src="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-007-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.3</div> <div class="figure-caption"> <p>Comparison 7 Prolonged feeding: partially hydrolysed formula versus cow's milk formula, Outcome 3 Eczema. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/references#CD003664-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-007-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003664-fig-0035"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/urn:x-wiley:14651858:media:CD003664:CD003664-CMP-007-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_t/tCD003664-CMP-007-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Prolonged feeding: partially hydrolysed formula versus cow's milk formula, Outcome 4 Rhinitis." data-id="CD003664-fig-0035" src="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-007-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.4</div> <div class="figure-caption"> <p>Comparison 7 Prolonged feeding: partially hydrolysed formula versus cow's milk formula, Outcome 4 Rhinitis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/references#CD003664-fig-0035">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-007-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003664-fig-0036"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/urn:x-wiley:14651858:media:CD003664:CD003664-CMP-007-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_t/tCD003664-CMP-007-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Prolonged feeding: partially hydrolysed formula versus cow's milk formula, Outcome 5 Food allergy." data-id="CD003664-fig-0036" src="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-007-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.5</div> <div class="figure-caption"> <p>Comparison 7 Prolonged feeding: partially hydrolysed formula versus cow's milk formula, Outcome 5 Food allergy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/references#CD003664-fig-0036">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-007-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003664-fig-0037"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/urn:x-wiley:14651858:media:CD003664:CD003664-CMP-007-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_t/tCD003664-CMP-007-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Prolonged feeding: partially hydrolysed formula versus cow's milk formula, Outcome 6 Cow's milk allergy." data-id="CD003664-fig-0037" src="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-007-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.6</div> <div class="figure-caption"> <p>Comparison 7 Prolonged feeding: partially hydrolysed formula versus cow's milk formula, Outcome 6 Cow's milk allergy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/references#CD003664-fig-0037">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-007-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003664-fig-0038"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/urn:x-wiley:14651858:media:CD003664:CD003664-CMP-008-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_t/tCD003664-CMP-008-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Prolonged feeding: extensively hydrolysed formula versus cow's milk formula, Outcome 1 All allergic disease." data-id="CD003664-fig-0038" src="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-008-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.1</div> <div class="figure-caption"> <p>Comparison 8 Prolonged feeding: extensively hydrolysed formula versus cow's milk formula, Outcome 1 All allergic disease. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/references#CD003664-fig-0038">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-008-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003664-fig-0039"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/urn:x-wiley:14651858:media:CD003664:CD003664-CMP-008-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_t/tCD003664-CMP-008-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Prolonged feeding: extensively hydrolysed formula versus cow's milk formula, Outcome 2 Asthma." data-id="CD003664-fig-0039" src="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-008-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.2</div> <div class="figure-caption"> <p>Comparison 8 Prolonged feeding: extensively hydrolysed formula versus cow's milk formula, Outcome 2 Asthma. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/references#CD003664-fig-0039">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-008-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003664-fig-0040"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/urn:x-wiley:14651858:media:CD003664:CD003664-CMP-008-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_t/tCD003664-CMP-008-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Prolonged feeding: extensively hydrolysed formula versus cow's milk formula, Outcome 3 Eczema." data-id="CD003664-fig-0040" src="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-008-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.3</div> <div class="figure-caption"> <p>Comparison 8 Prolonged feeding: extensively hydrolysed formula versus cow's milk formula, Outcome 3 Eczema. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/references#CD003664-fig-0040">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-008-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003664-fig-0041"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/urn:x-wiley:14651858:media:CD003664:CD003664-CMP-008-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_t/tCD003664-CMP-008-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Prolonged feeding: extensively hydrolysed formula versus cow's milk formula, Outcome 4 Rhinitis." data-id="CD003664-fig-0041" src="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-008-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.4</div> <div class="figure-caption"> <p>Comparison 8 Prolonged feeding: extensively hydrolysed formula versus cow's milk formula, Outcome 4 Rhinitis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/references#CD003664-fig-0041">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-008-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003664-fig-0042"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/urn:x-wiley:14651858:media:CD003664:CD003664-CMP-008-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_t/tCD003664-CMP-008-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Prolonged feeding: extensively hydrolysed formula versus cow's milk formula, Outcome 5 Food allergy." data-id="CD003664-fig-0042" src="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-008-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.5</div> <div class="figure-caption"> <p>Comparison 8 Prolonged feeding: extensively hydrolysed formula versus cow's milk formula, Outcome 5 Food allergy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/references#CD003664-fig-0042">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-008-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003664-fig-0043"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/urn:x-wiley:14651858:media:CD003664:CD003664-CMP-009-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_t/tCD003664-CMP-009-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Prolonged feeding: extensively hydrolysed formula versus partially hydrolysed formula, Outcome 1 All allergic disease." data-id="CD003664-fig-0043" src="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-009-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.1</div> <div class="figure-caption"> <p>Comparison 9 Prolonged feeding: extensively hydrolysed formula versus partially hydrolysed formula, Outcome 1 All allergic disease. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/references#CD003664-fig-0043">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-009-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003664-fig-0044"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/urn:x-wiley:14651858:media:CD003664:CD003664-CMP-009-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_t/tCD003664-CMP-009-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Prolonged feeding: extensively hydrolysed formula versus partially hydrolysed formula, Outcome 2 Asthma." data-id="CD003664-fig-0044" src="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-009-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.2</div> <div class="figure-caption"> <p>Comparison 9 Prolonged feeding: extensively hydrolysed formula versus partially hydrolysed formula, Outcome 2 Asthma. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/references#CD003664-fig-0044">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-009-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003664-fig-0045"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/urn:x-wiley:14651858:media:CD003664:CD003664-CMP-009-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_t/tCD003664-CMP-009-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Prolonged feeding: extensively hydrolysed formula versus partially hydrolysed formula, Outcome 3 Eczema." data-id="CD003664-fig-0045" src="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-009-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.3</div> <div class="figure-caption"> <p>Comparison 9 Prolonged feeding: extensively hydrolysed formula versus partially hydrolysed formula, Outcome 3 Eczema. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/references#CD003664-fig-0045">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-009-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003664-fig-0046"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/urn:x-wiley:14651858:media:CD003664:CD003664-CMP-009-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_t/tCD003664-CMP-009-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Prolonged feeding: extensively hydrolysed formula versus partially hydrolysed formula, Outcome 4 Rhinitis." data-id="CD003664-fig-0046" src="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-009-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.4</div> <div class="figure-caption"> <p>Comparison 9 Prolonged feeding: extensively hydrolysed formula versus partially hydrolysed formula, Outcome 4 Rhinitis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/references#CD003664-fig-0046">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-009-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003664-fig-0047"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/urn:x-wiley:14651858:media:CD003664:CD003664-CMP-009-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_t/tCD003664-CMP-009-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Prolonged feeding: extensively hydrolysed formula versus partially hydrolysed formula, Outcome 5 Food allergy." data-id="CD003664-fig-0047" src="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-009-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.5</div> <div class="figure-caption"> <p>Comparison 9 Prolonged feeding: extensively hydrolysed formula versus partially hydrolysed formula, Outcome 5 Food allergy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/references#CD003664-fig-0047">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-009-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003664-fig-0048"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/urn:x-wiley:14651858:media:CD003664:CD003664-CMP-009-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_t/tCD003664-CMP-009-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Prolonged feeding: extensively hydrolysed formula versus partially hydrolysed formula, Outcome 6 Cow's milk allergy." data-id="CD003664-fig-0048" src="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-009-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.6</div> <div class="figure-caption"> <p>Comparison 9 Prolonged feeding: extensively hydrolysed formula versus partially hydrolysed formula, Outcome 6 Cow's milk allergy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/references#CD003664-fig-0048">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-009-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003664-fig-0049"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/urn:x-wiley:14651858:media:CD003664:CD003664-CMP-009-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_t/tCD003664-CMP-009-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Prolonged feeding: extensively hydrolysed formula versus partially hydrolysed formula, Outcome 7 Urticaria." data-id="CD003664-fig-0049" src="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-009-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.7</div> <div class="figure-caption"> <p>Comparison 9 Prolonged feeding: extensively hydrolysed formula versus partially hydrolysed formula, Outcome 7 Urticaria. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/references#CD003664-fig-0049">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-009-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003664-fig-0050"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/urn:x-wiley:14651858:media:CD003664:CD003664-CMP-010-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_t/tCD003664-CMP-010-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 Prolonged exclusive feeding: hydrolysed formula versus cow's milk formula, Outcome 1 All allergic disease." data-id="CD003664-fig-0050" src="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-010-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.1</div> <div class="figure-caption"> <p>Comparison 10 Prolonged exclusive feeding: hydrolysed formula versus cow's milk formula, Outcome 1 All allergic disease. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/references#CD003664-fig-0050">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-010-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003664-fig-0051"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/urn:x-wiley:14651858:media:CD003664:CD003664-CMP-010-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_t/tCD003664-CMP-010-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 Prolonged exclusive feeding: hydrolysed formula versus cow's milk formula, Outcome 2 Asthma." data-id="CD003664-fig-0051" src="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-010-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.2</div> <div class="figure-caption"> <p>Comparison 10 Prolonged exclusive feeding: hydrolysed formula versus cow's milk formula, Outcome 2 Asthma. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/references#CD003664-fig-0051">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-010-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003664-fig-0052"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/urn:x-wiley:14651858:media:CD003664:CD003664-CMP-010-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_t/tCD003664-CMP-010-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 Prolonged exclusive feeding: hydrolysed formula versus cow's milk formula, Outcome 3 Eczema." data-id="CD003664-fig-0052" src="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-010-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.3</div> <div class="figure-caption"> <p>Comparison 10 Prolonged exclusive feeding: hydrolysed formula versus cow's milk formula, Outcome 3 Eczema. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/references#CD003664-fig-0052">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-010-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003664-fig-0053"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/urn:x-wiley:14651858:media:CD003664:CD003664-CMP-010-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_t/tCD003664-CMP-010-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 Prolonged exclusive feeding: hydrolysed formula versus cow's milk formula, Outcome 4 Rhinitis." data-id="CD003664-fig-0053" src="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-010-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.4</div> <div class="figure-caption"> <p>Comparison 10 Prolonged exclusive feeding: hydrolysed formula versus cow's milk formula, Outcome 4 Rhinitis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/references#CD003664-fig-0053">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-010-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003664-fig-0054"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/urn:x-wiley:14651858:media:CD003664:CD003664-CMP-011-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_t/tCD003664-CMP-011-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Prolonged feeding: hydrolysed formula versus cow's milk formula ‐ studies with blinded measurement, Outcome 1 All allergic disease." data-id="CD003664-fig-0054" src="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-011-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.1</div> <div class="figure-caption"> <p>Comparison 11 Prolonged feeding: hydrolysed formula versus cow's milk formula ‐ studies with blinded measurement, Outcome 1 All allergic disease. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/references#CD003664-fig-0054">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-011-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003664-fig-0055"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/urn:x-wiley:14651858:media:CD003664:CD003664-CMP-011-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_t/tCD003664-CMP-011-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Prolonged feeding: hydrolysed formula versus cow's milk formula ‐ studies with blinded measurement, Outcome 2 Asthma." data-id="CD003664-fig-0055" src="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-011-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.2</div> <div class="figure-caption"> <p>Comparison 11 Prolonged feeding: hydrolysed formula versus cow's milk formula ‐ studies with blinded measurement, Outcome 2 Asthma. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/references#CD003664-fig-0055">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-011-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003664-fig-0056"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/urn:x-wiley:14651858:media:CD003664:CD003664-CMP-011-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_t/tCD003664-CMP-011-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Prolonged feeding: hydrolysed formula versus cow's milk formula ‐ studies with blinded measurement, Outcome 3 Eczema." data-id="CD003664-fig-0056" src="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-011-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.3</div> <div class="figure-caption"> <p>Comparison 11 Prolonged feeding: hydrolysed formula versus cow's milk formula ‐ studies with blinded measurement, Outcome 3 Eczema. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/references#CD003664-fig-0056">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-011-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003664-fig-0057"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/urn:x-wiley:14651858:media:CD003664:CD003664-CMP-011-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_t/tCD003664-CMP-011-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Prolonged feeding: hydrolysed formula versus cow's milk formula ‐ studies with blinded measurement, Outcome 4 Rhinitis." data-id="CD003664-fig-0057" src="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-011-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.4</div> <div class="figure-caption"> <p>Comparison 11 Prolonged feeding: hydrolysed formula versus cow's milk formula ‐ studies with blinded measurement, Outcome 4 Rhinitis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/references#CD003664-fig-0057">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-011-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003664-fig-0058"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/urn:x-wiley:14651858:media:CD003664:CD003664-CMP-011-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_t/tCD003664-CMP-011-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Prolonged feeding: hydrolysed formula versus cow's milk formula ‐ studies with blinded measurement, Outcome 5 Food allergy." data-id="CD003664-fig-0058" src="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-011-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.5</div> <div class="figure-caption"> <p>Comparison 11 Prolonged feeding: hydrolysed formula versus cow's milk formula ‐ studies with blinded measurement, Outcome 5 Food allergy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/references#CD003664-fig-0058">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-011-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003664-fig-0059"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/urn:x-wiley:14651858:media:CD003664:CD003664-CMP-013-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_t/tCD003664-CMP-013-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 13 Prolonged feeding: partially hydrolysed whey formula versus cow's milk formula, Outcome 1 All allergic disease." data-id="CD003664-fig-0059" src="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-013-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 13.1</div> <div class="figure-caption"> <p>Comparison 13 Prolonged feeding: partially hydrolysed whey formula versus cow's milk formula, Outcome 1 All allergic disease. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/references#CD003664-fig-0059">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-013-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003664-fig-0060"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/urn:x-wiley:14651858:media:CD003664:CD003664-CMP-013-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_t/tCD003664-CMP-013-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 13 Prolonged feeding: partially hydrolysed whey formula versus cow's milk formula, Outcome 2 Asthma." data-id="CD003664-fig-0060" src="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-013-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 13.2</div> <div class="figure-caption"> <p>Comparison 13 Prolonged feeding: partially hydrolysed whey formula versus cow's milk formula, Outcome 2 Asthma. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/references#CD003664-fig-0060">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-013-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003664-fig-0061"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/urn:x-wiley:14651858:media:CD003664:CD003664-CMP-013-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_t/tCD003664-CMP-013-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 13 Prolonged feeding: partially hydrolysed whey formula versus cow's milk formula, Outcome 3 Eczema." data-id="CD003664-fig-0061" src="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-013-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 13.3</div> <div class="figure-caption"> <p>Comparison 13 Prolonged feeding: partially hydrolysed whey formula versus cow's milk formula, Outcome 3 Eczema. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/references#CD003664-fig-0061">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-013-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003664-fig-0062"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/urn:x-wiley:14651858:media:CD003664:CD003664-CMP-013-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_t/tCD003664-CMP-013-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 13 Prolonged feeding: partially hydrolysed whey formula versus cow's milk formula, Outcome 4 Rhinitis." data-id="CD003664-fig-0062" src="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-013-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 13.4</div> <div class="figure-caption"> <p>Comparison 13 Prolonged feeding: partially hydrolysed whey formula versus cow's milk formula, Outcome 4 Rhinitis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/references#CD003664-fig-0062">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-013-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003664-fig-0063"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/urn:x-wiley:14651858:media:CD003664:CD003664-CMP-013-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_t/tCD003664-CMP-013-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 13 Prolonged feeding: partially hydrolysed whey formula versus cow's milk formula, Outcome 5 Food allergy." data-id="CD003664-fig-0063" src="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-013-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 13.5</div> <div class="figure-caption"> <p>Comparison 13 Prolonged feeding: partially hydrolysed whey formula versus cow's milk formula, Outcome 5 Food allergy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/references#CD003664-fig-0063">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-013-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003664-fig-0064"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/urn:x-wiley:14651858:media:CD003664:CD003664-CMP-013-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_t/tCD003664-CMP-013-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 13 Prolonged feeding: partially hydrolysed whey formula versus cow's milk formula, Outcome 6 Cow's milk allergy." data-id="CD003664-fig-0064" src="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-013-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 13.6</div> <div class="figure-caption"> <p>Comparison 13 Prolonged feeding: partially hydrolysed whey formula versus cow's milk formula, Outcome 6 Cow's milk allergy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/references#CD003664-fig-0064">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-013-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003664-fig-0065"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/urn:x-wiley:14651858:media:CD003664:CD003664-CMP-014-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_t/tCD003664-CMP-014-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 14 Prolonged feeding: partially hydrolysed casein‐containing formula versus cow's milk formula, Outcome 1 All allergic disease." data-id="CD003664-fig-0065" src="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-014-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 14.1</div> <div class="figure-caption"> <p>Comparison 14 Prolonged feeding: partially hydrolysed casein‐containing formula versus cow's milk formula, Outcome 1 All allergic disease. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/references#CD003664-fig-0065">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-014-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003664-fig-0066"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/urn:x-wiley:14651858:media:CD003664:CD003664-CMP-014-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_t/tCD003664-CMP-014-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 14 Prolonged feeding: partially hydrolysed casein‐containing formula versus cow's milk formula, Outcome 2 Asthma." data-id="CD003664-fig-0066" src="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-014-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 14.2</div> <div class="figure-caption"> <p>Comparison 14 Prolonged feeding: partially hydrolysed casein‐containing formula versus cow's milk formula, Outcome 2 Asthma. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/references#CD003664-fig-0066">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-014-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003664-fig-0067"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/urn:x-wiley:14651858:media:CD003664:CD003664-CMP-014-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_t/tCD003664-CMP-014-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 14 Prolonged feeding: partially hydrolysed casein‐containing formula versus cow's milk formula, Outcome 3 Eczema." data-id="CD003664-fig-0067" src="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-014-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 14.3</div> <div class="figure-caption"> <p>Comparison 14 Prolonged feeding: partially hydrolysed casein‐containing formula versus cow's milk formula, Outcome 3 Eczema. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/references#CD003664-fig-0067">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-014-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003664-fig-0068"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/urn:x-wiley:14651858:media:CD003664:CD003664-CMP-014-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_t/tCD003664-CMP-014-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 14 Prolonged feeding: partially hydrolysed casein‐containing formula versus cow's milk formula, Outcome 4 Rhinitis." data-id="CD003664-fig-0068" src="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-014-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 14.4</div> <div class="figure-caption"> <p>Comparison 14 Prolonged feeding: partially hydrolysed casein‐containing formula versus cow's milk formula, Outcome 4 Rhinitis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/references#CD003664-fig-0068">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-014-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003664-fig-0069"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/urn:x-wiley:14651858:media:CD003664:CD003664-CMP-014-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_t/tCD003664-CMP-014-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 14 Prolonged feeding: partially hydrolysed casein‐containing formula versus cow's milk formula, Outcome 5 Food allergy." data-id="CD003664-fig-0069" src="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-014-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 14.5</div> <div class="figure-caption"> <p>Comparison 14 Prolonged feeding: partially hydrolysed casein‐containing formula versus cow's milk formula, Outcome 5 Food allergy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/references#CD003664-fig-0069">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-014-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003664-fig-0070"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/urn:x-wiley:14651858:media:CD003664:CD003664-CMP-015-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_t/tCD003664-CMP-015-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 15 Prolonged feeding: extensively hydrolysed whey formula versus cow's milk formula, Outcome 1 All allergic disease." data-id="CD003664-fig-0070" src="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-015-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 15.1</div> <div class="figure-caption"> <p>Comparison 15 Prolonged feeding: extensively hydrolysed whey formula versus cow's milk formula, Outcome 1 All allergic disease. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/references#CD003664-fig-0070">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-015-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003664-fig-0071"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/urn:x-wiley:14651858:media:CD003664:CD003664-CMP-015-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_t/tCD003664-CMP-015-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 15 Prolonged feeding: extensively hydrolysed whey formula versus cow's milk formula, Outcome 2 Asthma." data-id="CD003664-fig-0071" src="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-015-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 15.2</div> <div class="figure-caption"> <p>Comparison 15 Prolonged feeding: extensively hydrolysed whey formula versus cow's milk formula, Outcome 2 Asthma. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/references#CD003664-fig-0071">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-015-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003664-fig-0072"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/urn:x-wiley:14651858:media:CD003664:CD003664-CMP-015-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_t/tCD003664-CMP-015-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 15 Prolonged feeding: extensively hydrolysed whey formula versus cow's milk formula, Outcome 3 Eczema." data-id="CD003664-fig-0072" src="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-015-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 15.3</div> <div class="figure-caption"> <p>Comparison 15 Prolonged feeding: extensively hydrolysed whey formula versus cow's milk formula, Outcome 3 Eczema. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/references#CD003664-fig-0072">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-015-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003664-fig-0073"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/urn:x-wiley:14651858:media:CD003664:CD003664-CMP-016-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_t/tCD003664-CMP-016-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 16 Prolonged feeding: extensively hydrolysed casein formula versus cow' milk formula, Outcome 1 All allergic disease." data-id="CD003664-fig-0073" src="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-016-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.1</div> <div class="figure-caption"> <p>Comparison 16 Prolonged feeding: extensively hydrolysed casein formula versus cow' milk formula, Outcome 1 All allergic disease. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/references#CD003664-fig-0073">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-016-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003664-fig-0074"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/urn:x-wiley:14651858:media:CD003664:CD003664-CMP-016-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_t/tCD003664-CMP-016-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 16 Prolonged feeding: extensively hydrolysed casein formula versus cow' milk formula, Outcome 2 Asthma." data-id="CD003664-fig-0074" src="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-016-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.2</div> <div class="figure-caption"> <p>Comparison 16 Prolonged feeding: extensively hydrolysed casein formula versus cow' milk formula, Outcome 2 Asthma. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/references#CD003664-fig-0074">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-016-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003664-fig-0075"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/urn:x-wiley:14651858:media:CD003664:CD003664-CMP-016-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_t/tCD003664-CMP-016-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 16 Prolonged feeding: extensively hydrolysed casein formula versus cow' milk formula, Outcome 3 Eczema." data-id="CD003664-fig-0075" src="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-016-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.3</div> <div class="figure-caption"> <p>Comparison 16 Prolonged feeding: extensively hydrolysed casein formula versus cow' milk formula, Outcome 3 Eczema. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/references#CD003664-fig-0075">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-016-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003664-fig-0076"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/urn:x-wiley:14651858:media:CD003664:CD003664-CMP-017-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_t/tCD003664-CMP-017-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 17 Prolonged feeding: extensively hydrolysed casein formula versus extensively hydrolysed whey formula, Outcome 1 All allergic disease." data-id="CD003664-fig-0076" src="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-017-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 17.1</div> <div class="figure-caption"> <p>Comparison 17 Prolonged feeding: extensively hydrolysed casein formula versus extensively hydrolysed whey formula, Outcome 1 All allergic disease. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/references#CD003664-fig-0076">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-017-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003664-fig-0077"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/urn:x-wiley:14651858:media:CD003664:CD003664-CMP-017-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_t/tCD003664-CMP-017-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 17 Prolonged feeding: extensively hydrolysed casein formula versus extensively hydrolysed whey formula, Outcome 2 Asthma." data-id="CD003664-fig-0077" src="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-017-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 17.2</div> <div class="figure-caption"> <p>Comparison 17 Prolonged feeding: extensively hydrolysed casein formula versus extensively hydrolysed whey formula, Outcome 2 Asthma. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/references#CD003664-fig-0077">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-017-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003664-fig-0078"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/urn:x-wiley:14651858:media:CD003664:CD003664-CMP-017-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_t/tCD003664-CMP-017-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 17 Prolonged feeding: extensively hydrolysed casein formula versus extensively hydrolysed whey formula, Outcome 3 Eczema." data-id="CD003664-fig-0078" src="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-017-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 17.3</div> <div class="figure-caption"> <p>Comparison 17 Prolonged feeding: extensively hydrolysed casein formula versus extensively hydrolysed whey formula, Outcome 3 Eczema. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/references#CD003664-fig-0078">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-017-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003664-fig-0079"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/urn:x-wiley:14651858:media:CD003664:CD003664-CMP-017-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_t/tCD003664-CMP-017-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 17 Prolonged feeding: extensively hydrolysed casein formula versus extensively hydrolysed whey formula, Outcome 4 Rhinitis." data-id="CD003664-fig-0079" src="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-017-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 17.4</div> <div class="figure-caption"> <p>Comparison 17 Prolonged feeding: extensively hydrolysed casein formula versus extensively hydrolysed whey formula, Outcome 4 Rhinitis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/references#CD003664-fig-0079">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-017-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003664-fig-0080"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/urn:x-wiley:14651858:media:CD003664:CD003664-CMP-017-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_t/tCD003664-CMP-017-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 17 Prolonged feeding: extensively hydrolysed casein formula versus extensively hydrolysed whey formula, Outcome 5 Food allergy." data-id="CD003664-fig-0080" src="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-017-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 17.5</div> <div class="figure-caption"> <p>Comparison 17 Prolonged feeding: extensively hydrolysed casein formula versus extensively hydrolysed whey formula, Outcome 5 Food allergy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/references#CD003664-fig-0080">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-017-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003664-fig-0081"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/urn:x-wiley:14651858:media:CD003664:CD003664-CMP-017-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_t/tCD003664-CMP-017-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 17 Prolonged feeding: extensively hydrolysed casein formula versus extensively hydrolysed whey formula, Outcome 6 Cow's milk allergy." data-id="CD003664-fig-0081" src="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-017-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 17.6</div> <div class="figure-caption"> <p>Comparison 17 Prolonged feeding: extensively hydrolysed casein formula versus extensively hydrolysed whey formula, Outcome 6 Cow's milk allergy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/references#CD003664-fig-0081">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-017-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003664-fig-0082"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/urn:x-wiley:14651858:media:CD003664:CD003664-CMP-017-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_t/tCD003664-CMP-017-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 17 Prolonged feeding: extensively hydrolysed casein formula versus extensively hydrolysed whey formula, Outcome 7 Urticaria." data-id="CD003664-fig-0082" src="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-017-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 17.7</div> <div class="figure-caption"> <p>Comparison 17 Prolonged feeding: extensively hydrolysed casein formula versus extensively hydrolysed whey formula, Outcome 7 Urticaria. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/references#CD003664-fig-0082">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/media/CDSR/CD003664/image_n/nCD003664-CMP-017-07.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD003664-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Early short‐term feeding: hydrolysed formula versus human milk feeding ‐ low‐risk infants for prevention of allergic disease</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Early short‐term feeding of hydrolysed formula versus human milk for prevention of allergic disease</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> infants not selected for allergic disease risk.<br/> <b>Settings:</b> hospitals.<br/> <b>Intervention:</b> early short‐term feeding: hydrolysed formula versus human milk feeding for prevention of allergic disease </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Number of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Early short‐term feeding: hydrolysed formula vs human milk ‐ low‐risk infants</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>All allergic disease ‐ childhood (incidence)</b><br/> Follow‐up: mean 3 years </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.43</b> <br/> (0.38 to 5.37) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>90<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>a,b,c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Quality of evidence downgraded due to risk of bias, imprecision and potential for reporting or publication bias. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>75 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>108 per 1000</b><br/> (29 to 405) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Asthma ‐ childhood (incidence)</b><br/> Follow‐up: mean 3 years </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.48</b> <br/> (0.05 to 4.41) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>90<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>a,b,c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Quality of evidence downgraded due to risk of bias, imprecision and potential for reporting or publication bias. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>57 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>27 per 1000</b><br/> (3 to 250) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Eczema ‐ childhood (incidence)</b><br/> Follow‐up: mean 3 years </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.48</b> <br/> (0.05 to 4.41) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>90<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>a,b,c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Quality of evidence downgraded due to risk of bias, imprecision and potential for reporting or publication bias. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>57 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>27 per 1000</b><br/> (3 to 250) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Food allergy ‐ childhood (incidence)</b><br/> Follow‐up: mean 3 years </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.43</b> <br/> (0.38 to 5.37) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>90<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>a,b,c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Quality of evidence downgraded due to risk of bias, imprecision and potential for reporting or publication bias. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>75 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>108 per 1000</b><br/> (29 to 405) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Cow's milk allergy ‐ infancy (incidence)</b><br/> Follow‐up: mean 27 months </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.87</b> <br/> (0.52 to 1.46) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>3559<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>c,d,e</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Quality of evidence downgraded due to risk of bias, imprecision and potential for reporting or publication bias. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>17 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>15 per 1000</b><br/> (9 to 25) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Cow's milk allergy ‐ childhood (incidence)</b><br/> Follow‐up: mean 3 years </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 7.11</b> <br/> (0.35 to 143.84) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>90<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>a,b,c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Quality of evidence downgraded due to risk of bias, imprecision and potential for reporting or publication bias. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>0 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>0 per 1000</b><br/> (0 to 0) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI)<br/> <b>CI:</b> confidence interval; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate<br/> <b>Very low quality:</b> We are very uncertain about the estimate </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Methodological concerns including quasi‐random sequence allocation, incomplete outcome data and imbalances at baseline<br/> <sup>b</sup>Imprecision of estimate ‐ single small study<br/> <sup>c</sup>Reported by only a single study<br/> <sup>d</sup>Methodological concerns including quasi‐random sequence allocation and incomplete outcome data<br/> <sup>e</sup>Impression of estimate ‐ low incidence of outcome </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Early short‐term feeding: hydrolysed formula versus human milk feeding ‐ low‐risk infants for prevention of allergic disease</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/full#CD003664-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD003664-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Early short‐term feeding: hydrolysed formula versus cow's milk formula ‐ low‐risk infants for prevention of allergic disease and food allergy</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Early short‐term feeding of hydrolysed formula versus cow's milk formula for prevention of allergic disease</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> infants not selected for allergic disease risk.<br/> <b>Settings:</b> hospitals.<br/> <b>Intervention:</b> early short‐term feeding of hydrolysed formula versus cow's milk formula for prevention of allergic disease </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Number of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Early short‐term feeding: hydrolysed formula vs cow's milk formula ‐ low‐risk infants</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>All allergic disease ‐ childhood (incidence)</b><br/> Follow‐up: mean 3 years </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.37</b> <br/> (0.33 to 5.71) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>77<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>a,b,c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Quality of evidence downgraded due to risk of bias, imprecision and potential for reporting or publication bias. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>77 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>105 per 1000</b><br/> (25 to 439) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Asthma ‐ childhood (incidence)</b><br/> Follow‐up: mean 3 years </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 3.08</b> <br/> (0.13 to 73.26) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>77<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>a,b,c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Quality of evidence downgraded due to risk of bias, imprecision and potential for reporting or publication bias. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>0 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>0 per 1000</b><br/> (0 to 0) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Eczema ‐ childhood (incidence)</b><br/> Follow‐up: mean 3 years </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.34</b> <br/> (0.04 to 3.15) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>77<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>a,b,c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Quality of evidence downgraded due to risk of bias, imprecision and potential for reporting or publication bias. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>77 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>26 per 1000</b><br/> (3 to 242) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Food allergy ‐ childhood (incidence)</b><br/> Follow‐up: mean 3 years </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.37</b> <br/> (0.33 to 5.71) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>77<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>a,b,c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Quality of evidence downgraded due to risk of bias, imprecision and potential for reporting or publication bias. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>77 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>105 per 1000</b><br/> (25 to 439) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Cow's milk allergy ‐ infancy (incidence)</b><br/> Follow‐up: mean 3 years </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.62</b> <br/> (0.38 to 1) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>3473<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>a,c,d</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Quality of evidence downgraded due to risk of bias, imprecision and potential for reporting or publication bias. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>24 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>15 per 1000</b><br/> (9 to 24) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Cow's milk allergy ‐ childhood (incidence)</b><br/> Follow‐up: mean 3 years </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 5.13</b> <br/> (0.25 to 103.43) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>77<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>a,b,c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Quality of evidence downgraded due to risk of bias, imprecision and potential for reporting or publication bias. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>0 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>0 per 1000</b><br/> (0 to 0) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI)<br/> <b>CI:</b> confidence interval; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate<br/> <b>Very low quality:</b> We are very uncertain about the estimate </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Methodological concerns including quasi‐random sequence allocation, incomplete outcome data and imbalances at baseline<br/> <sup>b</sup>Imprecision of estimate ‐ single small study<br/> <sup>c</sup>Reported only by a single study<br/> <sup>d</sup>Imprecision of estimate ‐ low incidence of outcome </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Early short‐term feeding: hydrolysed formula versus cow's milk formula ‐ low‐risk infants for prevention of allergic disease and food allergy</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/full#CD003664-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD003664-tbl-0003"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Prolonged feeding: hydrolysed formula versus cow's milk formula for prevention of allergic disease</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Prolonged feeding: hydrolysed formula versus cow's milk formula for prevention of allergic disease</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> infants.<br/> <b>Settings:</b> home.<br/> <b>Intervention:</b> prolonged feeding of hydrolysed formula versus cow's milk formula for prevention of allergic disease </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Prolonged feeding: hydrolysed formula versus cow's milk formula</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>All allergic disease ‐ Infancy (incidence)</b><br/> Follow‐up: 2 years </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.88</b> <br/> (0.76 to 1.01) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2852<br/> (8 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,2,3,4,5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Quality of evidence downgraded due to risk of bias, imprecision and risk of reporting or publication bias. </p> <p>Subgroup analyses found no differences in: low‐risk or high‐risk infants; infants fed a partially hydrolysed formula versus cow's milk formula; infants fed extensively hydrolysed formula versus cow's milk formula; or infants fed partially versus extensively hydrolysed formula. </p> <p>A reduction in infant allergy was found in subgroup analysis of studies that enrolled infants receiving prolonged exclusive formula feeding (typical RR 0.61, 95% CI 0.46 to 0.80; participants = 425; studies = 5; I<sup>2</sup> = 0%). </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>274 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>241 per 1000</b><br/> (208 to 277) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>All allergic disease ‐ Childhood (incidence)</b><br/> Follow‐up: 3 years </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.85</b> <br/> (0.69 to 1.05) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>950<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,2,3,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Quality of evidence downgraded due to risk of bias, imprecision and risk of reporting or publication bias. </p> <p>Subgroup analyses found no differences in: high‐risk infants; infants fed a partially hydrolysed formula versus cow's milk formula; infants fed extensively hydrolysed formula versus cow's milk formula; or infants fed partially versus extensively hydrolysed formula. </p> <p>A single small study that enrolled infants receiving prolonged exclusive formula feeding reported a reduction in childhood allergy incidence (RR 0.42, 95% CI 0.19 to 0.90; participants = 78). </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>353 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>300 per 1000</b><br/> (244 to 371) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Asthma ‐ Infancy (incidence)</b><br/> Follow‐up: 2 years </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.57</b> <br/> (0.31 to 1.04) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>318<br/> (4 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,3,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Quality of evidence downgraded due to risk of bias, imprecision and risk of reporting or publication bias. </p> <p>Subgroup analyses found no differences in: high‐risk infants; infants fed a partially hydrolysed formula versus cow's milk formula; infants fed extensively hydrolysed formula versus cow's milk formula; infants fed partially versus extensively hydrolysed formula; or infants receiving prolonged exclusive formula feeding. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>175 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>100 per 1000</b><br/> (54 to 182) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Eczema ‐ Infancy (incidence)</b><br/> Follow‐up: 2 years </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.93</b> <br/> (0.79 to 1.09) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2896<br/> (9 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,3,4,5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Quality of evidence downgraded due to risk of bias, imprecision and risk of reporting or publication bias. </p> <p>Subgroup analyses found no differences in: high‐risk infants; infants fed a partially hydrolysed formula versus cow's milk formula; infants fed extensively hydrolysed formula versus cow's milk formula; infants fed partially versus extensively hydrolysed formula; or infants receiving prolonged exclusive formula feeding. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>202 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>187 per 1000</b><br/> (159 to 220) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Rhinitis ‐ Infancy (incidence)</b><br/> Follow‐up: 2 years </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.52</b> <br/> (0.14 to 1.85) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>256<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,3,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Quality of evidence downgraded due to risk of bias, imprecision and risk of reporting or publication bias. </p> <p>Subgroup analyses found no differences in: high‐risk infants; infants fed extensively hydrolysed formula versus cow's milk formula; infants fed partially versus extensively hydrolysed formula; or infants receiving prolonged exclusive formula feeding. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>58 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>30 per 1000</b><br/> (8 to 107) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Food allergy ‐ Infancy (incidence)</b><br/> Follow‐up: 2 years </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.42</b> <br/> (0.87 to 2.33) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>479<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,3,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Quality of evidence downgraded due to risk of bias, imprecision and risk of reporting or publication bias. </p> <p>Subgroup analyses found no differences in: high‐risk infants; infants fed a partially hydrolysed formula versus cow's milk formula; infants fed extensively hydrolysed formula versus cow's milk formula; or infants fed partially versus extensively hydrolysed formula. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>109 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>155 per 1000</b><br/> (95 to 254) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Cow's milk allergy ‐ Infancy (incidence)</b><br/> Follow‐up: 2 years </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 2.31</b> <br/> (0.24 to 21.97) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>338<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>3,6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Quality of evidence downgraded due to risk of bias, imprecision and risk of reporting or publication bias. </p> <p>Subgroup analyses found no differences in: high‐risk infants; or infants fed a partially hydrolysed formula versus cow's milk formula. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>7 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>16 per 1000</b><br/> (2 to 149) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Majority of studies had substantial methodological concerns.<br/> <sup>2</sup> Moderate heterogeneity between studies found.<br/> <sup>3</sup> Wide confidence intervals.<br/> <sup>4</sup> Substantial number of studies did not report outcome. <br/> <sup>5</sup> Funnel plot appears asymmetric.<br/> <sup>6</sup> Reported by a single study. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Prolonged feeding: hydrolysed formula versus cow's milk formula for prevention of allergic disease</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/full#CD003664-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD003664-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Early short‐term feeding: hydrolysed formula versus human milk feeding ‐ low‐risk infants</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 All allergic disease <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Childhood (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.43 [0.38, 5.37]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Asthma <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Childhood (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.48 [0.05, 4.41]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Eczema <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Childhood (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.48 [0.05, 4.41]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Food allergy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Childhood (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.43 [0.38, 5.37]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Cow's milk allergy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Infancy (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3559</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.87 [0.52, 1.46]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Childhood (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.11 [0.35, 143.84]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Early short‐term feeding: hydrolysed formula versus human milk feeding ‐ low‐risk infants</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/references#CD003664-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD003664-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Early short‐term feeding: hydrolysed formula versus cow's milk formula ‐ low‐risk infants</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 All allergic disease <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Childhood (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>77</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.37 [0.33, 5.71]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Asthma <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Childhood (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>77</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.08 [0.13, 73.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Eczema <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Childhood (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>77</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.34 [0.04, 3.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Food allergy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Childhood (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>77</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.37 [0.33, 5.71]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Cow's milk allergy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Infancy (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3473</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.62 [0.38, 1.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Childhood (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>77</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.13 [0.25, 103.43]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Early short‐term feeding: hydrolysed formula versus cow's milk formula ‐ low‐risk infants</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/references#CD003664-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD003664-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Prolonged feeding: hydrolysed formula versus cow's milk formula</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 All allergic disease <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Infancy (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2852</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.88 [0.76, 1.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Childhood (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>950</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.85 [0.69, 1.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Childhood (prevalence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.76 [0.76, 4.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Asthma <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Infancy (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>318</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.57 [0.31, 1.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Childhood (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.38 [0.08, 1.84]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 Childhood (prevalence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1229</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [0.79, 1.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Eczema <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Infancy (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2896</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.79, 1.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Childhood (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>950</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.83 [0.63, 1.10]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 Childhood (prevalence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1228</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.86 [0.66, 1.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Rhinitis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Infancy (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>256</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.52 [0.14, 1.85]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Childhood (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.48 [0.04, 5.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3 Childhood (prevalence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>357</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.66, 1.41]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Food allergy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Infancy (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>479</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.42 [0.87, 2.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Cow's milk allergy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Infancy (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>338</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.31 [0.24, 21.97]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Prolonged feeding: hydrolysed formula versus cow's milk formula</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/references#CD003664-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD003664-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Prolonged feeding: hydrolysed formula versus cow's milk formula ‐ low‐risk infants</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 All allergic disease <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Childhood (prevalence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.76 [0.76, 4.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Asthma <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Childhood (prevalence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.20 [0.77, 6.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Eczema <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Childhood (prevalence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.29 [0.03, 2.66]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Rhinitis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Childhood (prevalence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.32 [0.53, 3.26]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Prolonged feeding: hydrolysed formula versus cow's milk formula ‐ low‐risk infants</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/references#CD003664-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD003664-tbl-0008"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Prolonged feeding: hydrolysed formula versus cow's milk formula ‐ high‐risk infants</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 All allergic disease <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Infancy (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2852</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.88 [0.76, 1.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Childhood (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>950</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.85 [0.69, 1.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Asthma <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Infancy (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>318</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.57 [0.31, 1.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Childhood (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.38 [0.08, 1.84]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 Childhood (prevalence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1167</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.74, 1.27]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Eczema <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Infancy (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2896</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.79, 1.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Childhood (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>950</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.83 [0.63, 1.10]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 Childhood (prevalence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1166</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.68, 1.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Rhinitis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Infancy (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>256</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.52 [0.14, 1.85]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Childhood (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.48 [0.04, 5.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3 Childhood (prevalence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>295</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.59, 1.37]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Food allergy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Infancy (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>479</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.42 [0.87, 2.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Childhood (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.3 Childhood (prevalence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Cow's milk allergy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Infancy (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>338</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.31 [0.24, 21.97]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 Childhood (prevalence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Prolonged feeding: hydrolysed formula versus cow's milk formula ‐ high‐risk infants</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/references#CD003664-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD003664-tbl-0009"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Prolonged feeding: partially hydrolysed formula versus cow's milk formula</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 All allergic disease <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Infancy (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1820</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.77, 1.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Childhood (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>510</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.86 [0.67, 1.10]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Asthma <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Infancy (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>268</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.54 [0.28, 1.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Childhood (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.38 [0.08, 1.84]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 Childhood (prevalence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>789</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.80, 1.38]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Eczema <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Infancy (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1699</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.82, 1.16]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Childhood (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>510</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.85 [0.61, 1.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 Childhood (prevalence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>788</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.92 [0.69, 1.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Rhinitis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Infancy (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>206</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.4 [0.09, 1.70]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Childhood (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.48 [0.04, 5.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3 Childhood (prevalence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>357</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.66, 1.41]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Food allergy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Infancy (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>429</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.53 [0.93, 2.49]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Cow's milk allergy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Infancy (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>338</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.31 [0.24, 21.97]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Prolonged feeding: partially hydrolysed formula versus cow's milk formula</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/references#CD003664-tbl-0009">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD003664-tbl-0010"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">Prolonged feeding: extensively hydrolysed formula versus cow's milk formula</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 All allergic disease <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Infancy (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1561</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.87 [0.68, 1.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Childhood (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>651</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.71, 1.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Childhood (prevalence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.76 [0.76, 4.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Asthma <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Infancy (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>96</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.61 [0.18, 2.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Childhood (prevalence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>713</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.15 [0.76, 1.72]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Eczema <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Infancy (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1726</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.83 [0.63, 1.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Childhood (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>651</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.86 [0.63, 1.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 Childhood (prevalence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>713</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.61 [0.39, 0.97]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Rhinitis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Infancy (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>96</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.76 [0.12, 66.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Childhood (prevalence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.32 [0.53, 3.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Food allergy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Infancy (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>96</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.15 [0.33, 4.02]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">Prolonged feeding: extensively hydrolysed formula versus cow's milk formula</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/references#CD003664-tbl-0010">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD003664-tbl-0011"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">Prolonged feeding: extensively hydrolysed formula versus partially hydrolysed formula</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 All allergic disease <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Infancy (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1806</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.75, 1.16]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Childhood (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>661</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.74, 1.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Asthma <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Infancy (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>341</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.72 [0.74, 3.96]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Childhood (prevalence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>661</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.58, 1.35]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Eczema <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Infancy (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1865</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.73, 1.10]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Childhood (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>661</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.92 [0.67, 1.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 Childhood (prevalence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>661</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.54, 1.52]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Rhinitis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Infancy (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>341</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.25 [0.36, 4.29]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Food allergy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Infancy (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>341</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.43 [0.19, 0.99]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Cow's milk allergy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Infancy (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>246</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.13 [0.01, 1.16]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Urticaria <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 Infancy (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>246</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.32 [0.26, 6.66]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">Prolonged feeding: extensively hydrolysed formula versus partially hydrolysed formula</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/references#CD003664-tbl-0011">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD003664-tbl-0012"> <div class="table-heading"><span class="table-label">Comparison 10.</span> <span class="table-title">Prolonged exclusive feeding: hydrolysed formula versus cow's milk formula</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 All allergic disease <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Infancy (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>425</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.61 [0.46, 0.80]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Childhood (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.42 [0.19, 0.90]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Childhood (prevalence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.76 [0.76, 4.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Asthma <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Infancy (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>144</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.57 [0.25, 1.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Childhood (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.38 [0.08, 1.84]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 Childhood (prevalence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.20 [0.77, 6.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Eczema <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Infancy (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>271</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.74 [0.45, 1.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Childhood (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.42 [0.14, 1.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 Childhood (prevalence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.29 [0.03, 2.66]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Rhinitis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Infancy (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>82</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Childhood (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.48 [0.04, 5.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3 Childhood (prevalence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.32 [0.53, 3.26]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 10.</span> <span class="table-title">Prolonged exclusive feeding: hydrolysed formula versus cow's milk formula</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/references#CD003664-tbl-0012">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD003664-tbl-0013"> <div class="table-heading"><span class="table-label">Comparison 11.</span> <span class="table-title">Prolonged feeding: hydrolysed formula versus cow's milk formula ‐ studies with blinded measurement</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 All allergic disease <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Infancy (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2156</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.87 [0.69, 1.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Childhood (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>872</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.73, 1.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Childhood (prevalence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.76 [0.76, 4.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Asthma <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Infancy (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>141</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.48 [0.17, 1.42]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Childhood (prevalence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>934</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.17 [0.80, 1.73]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Eczema <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Infancy (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2089</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.70, 1.16]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Childhood (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>872</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.88 [0.66, 1.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 Childhood (prevalence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>934</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.64 [0.42, 0.97]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Rhinitis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Infancy (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>141</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.47 [0.06, 35.37]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Childhood (prevalence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.32 [0.53, 3.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Food allergy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Infancy (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>141</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.82 [0.64, 5.16]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 11.</span> <span class="table-title">Prolonged feeding: hydrolysed formula versus cow's milk formula ‐ studies with blinded measurement</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/references#CD003664-tbl-0013">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD003664-tbl-0014"> <div class="table-heading"><span class="table-label">Comparison 13.</span> <span class="table-title">Prolonged feeding: partially hydrolysed whey formula versus cow's milk formula</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 All allergic disease <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Infancy (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1729</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.77 [0.59, 1.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Childhood (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>510</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.68 [0.31, 1.52]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Asthma <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Infancy (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>177</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.61 [0.29, 1.28]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Childhood (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.38 [0.08, 1.84]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 Childhood (prevalence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>727</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.73, 1.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Eczema <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Infancy (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1608</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.80, 1.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Childhood (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>510</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.85 [0.61, 1.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 Childhood (prevalence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>726</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.71, 1.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Rhinitis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Infancy (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>115</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.4 [0.09, 1.70]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Childhood (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.48 [0.04, 5.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3 Childhood (prevalence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>295</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.59, 1.37]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Food allergy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Infancy (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>338</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.31 [0.75, 2.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Cow's milk allergy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Infancy (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>338</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.31 [0.24, 21.97]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 13.</span> <span class="table-title">Prolonged feeding: partially hydrolysed whey formula versus cow's milk formula</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/references#CD003664-tbl-0014">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD003664-tbl-0015"> <div class="table-heading"><span class="table-label">Comparison 14.</span> <span class="table-title">Prolonged feeding: partially hydrolysed casein‐containing formula versus cow's milk formula</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 All allergic disease <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Infancy (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>91</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.36 [0.80, 2.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Childhood (prevalence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.76 [0.76, 4.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Asthma <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Infancy (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>91</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.34 [0.07, 1.60]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Childhood (prevalence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.20 [0.77, 6.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Eczema <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Infancy (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>91</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.30 [0.66, 2.55]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Childhood (prevalence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.29 [0.03, 2.66]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Rhinitis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Infancy (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>91</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Childhood (prevalence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.32 [0.53, 3.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Food allergy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Infancy (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>91</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.56 [0.86, 7.56]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 14.</span> <span class="table-title">Prolonged feeding: partially hydrolysed casein‐containing formula versus cow's milk formula</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/references#CD003664-tbl-0015">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD003664-tbl-0016"> <div class="table-heading"><span class="table-label">Comparison 15.</span> <span class="table-title">Prolonged feeding: extensively hydrolysed whey formula versus cow's milk formula</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 All allergic disease <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Infancy (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>972</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.71, 1.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Childhood (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>431</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.07 [0.82, 1.38]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Asthma <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Childhood (prevalence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>431</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.19 [0.73, 1.94]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Eczema <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Infancy (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>972</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.72, 1.40]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Childhood (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>431</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.06 [0.75, 1.49]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 Childhood (prevalence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>431</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.78 [0.46, 1.33]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 15.</span> <span class="table-title">Prolonged feeding: extensively hydrolysed whey formula versus cow's milk formula</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/references#CD003664-tbl-0016">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD003664-tbl-0017"> <div class="table-heading"><span class="table-label">Comparison 16.</span> <span class="table-title">Prolonged feeding: extensively hydrolysed casein formula versus cow' milk formula</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 All allergic disease <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Infancy (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>976</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.76 [0.54, 1.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Childhood (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>431</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.72 [0.53, 0.97]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Asthma <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Childhood (prevalence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>431</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.84 [0.49, 1.45]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Eczema <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Infancy (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>976</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.69 [0.47, 1.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Childhood (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>431</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.66 [0.44, 0.98]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 Childhood (prevalence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>431</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.50 [0.27, 0.92]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 16.</span> <span class="table-title">Prolonged feeding: extensively hydrolysed casein formula versus cow' milk formula</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/references#CD003664-tbl-0017">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD003664-tbl-0018"> <div class="table-heading"><span class="table-label">Comparison 17.</span> <span class="table-title">Prolonged feeding: extensively hydrolysed casein formula versus extensively hydrolysed whey formula</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 All allergic disease <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Infancy (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1143</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.73, 1.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Childhood (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>440</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.68 [0.50, 0.90]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Asthma <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Infancy (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>161</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.28 [0.83, 6.28]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Childhood (prevalence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>440</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.71 [0.42, 1.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Eczema <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Infancy (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1143</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.81 [0.59, 1.10]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Childhood (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>440</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.62 [0.42, 0.92]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 Childhood (prevalence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>440</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.64 [0.33, 1.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Rhinitis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Infancy (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>161</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.08 [0.39, 11.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Food allergy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Infancy (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>161</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.45 [0.48, 4.39]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Cow's milk allergy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Infancy (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>161</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.19 [0.25, 106.38]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Urticaria <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 Infancy (incidence)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>161</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.15 [0.47, 36.34]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 17.</span> <span class="table-title">Prolonged feeding: extensively hydrolysed casein formula versus extensively hydrolysed whey formula</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003664.pub6/references#CD003664-tbl-0018">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD003664.pub6&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD003664-note-0001">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD003664-note-0008">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD003664-note-0017">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD003664-note-0007">Français</a> </li> <li class="section-language"> <a class="" href="ja#CD003664-note-0016">日本語</a> </li> <li class="section-language"> <a class="" href="ms#CD003664-note-0005">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pl#CD003664-note-0006">Polski</a> </li> <li class="section-language"> <a class="" href="ru#CD003664-note-0004">Русский</a> </li> <li class="section-language"> <a class="" href="th#CD003664-note-0015">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD003664-note-0002">简体中文</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD003664-note-0003">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738735355000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738735355000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003664\x2epub6\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD003664\x2epub6\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003664\x2epub6\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD003664\x2epub6"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003664\x2epub6\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD003664\x2epub6\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003664\x2epub6\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD003664\x2epub6\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003664\x2epub6\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD003664\x2epub6"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003664\x2epub6\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD003664\x2epub6\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003664\x2epub6\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD003664\x2epub6"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003664\x2epub6\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD003664\x2epub6\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003664\x2epub6\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD003664\x2epub6"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=PMzGcYGP&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD003664.pub6&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD003664.pub6';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD003664.pub6/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD003664.pub6/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD003664.pub6%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740719201336"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD003664.pub6/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740719201339"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD003664.pub6/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918de2f6de4c9368',t:'MTc0MDcxOTIwMS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 